Citrus Sinensis ID: 007542
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 599 | 2.2.26 [Sep-21-2011] | |||||||
| Q8W4J2 | 567 | Mitogen-activated protein | yes | no | 0.921 | 0.973 | 0.758 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | yes | no | 0.898 | 0.992 | 0.737 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | yes | no | 0.828 | 0.995 | 0.759 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | no | no | 0.833 | 0.816 | 0.682 | 0.0 | |
| Q9SJG9 | 606 | Mitogen-activated protein | no | no | 0.834 | 0.825 | 0.658 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | no | no | 0.841 | 0.885 | 0.614 | 0.0 | |
| Q9LV37 | 510 | Mitogen-activated protein | no | no | 0.749 | 0.880 | 0.717 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.811 | 0.854 | 0.635 | 0.0 | |
| Q9C9U4 | 576 | Mitogen-activated protein | no | no | 0.686 | 0.713 | 0.713 | 0.0 | |
| Q5Z9J0 | 580 | Mitogen-activated protein | no | no | 0.734 | 0.758 | 0.688 | 0.0 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 925 bits (2390), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/614 (75%), Positives = 502/614 (81%), Gaps = 62/614 (10%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPD RKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTD+LGTPS EAI R V
Sbjct: 241 DLMTDMLGTPSAEAIGR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKPIPFS KFP+ +PLALRLLE+ML+FEPKDRPTAEEALAD YFKG
Sbjct: 259 RNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFEPKDRPTAEEALADVYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTK+EFEFERRRITKEDVRELIYRE LEYHP+MLKE+L+GSEPT FMY
Sbjct: 319 LAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYHPKMLKEYLDGSEPTNFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPER-QHASLPRPCVLYSDKT----VQNSAAVTDD 475
PSAV+HFKKQFAYLEEHY GT+ PPER QHASLPR CVLYSD Q+SA VTD
Sbjct: 379 PSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLYSDNNHPVAQQSSAEVTDG 438
Query: 476 LSKCSIKEVEKPPMDRTSGIPMARLPIQVPQ-----GAARPGKVVSSVLRYNNCGAAAAA 530
LSKCSI++ DR + +PM+R+PI VPQ ARPGKVV SVLRYNNCGAA
Sbjct: 439 LSKCSIRDERPRGADRNAQMPMSRIPINVPQTIQGAAVARPGKVVGSVLRYNNCGAATGV 498
Query: 531 EALD--QRRVVRNPAVSTQYAASSYPRRSSACKNERVNDE---SVEGSNGLQPKPQYIAR 585
EAL+ QRR+VRNPA AAS YP+R+ CK+ R +++ + EG + L+P QYI +
Sbjct: 499 EALEQQQRRMVRNPA-----AASQYPKRTQPCKSNRGDEDCATAAEGPSRLKPNTQYIPQ 553
Query: 586 KVAAAQGGSGSNWY 599
KV+AAQ + S WY
Sbjct: 554 KVSAAQDTAMSRWY 567
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 883 bits (2282), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/590 (73%), Positives = 484/590 (82%), Gaps = 52/590 (8%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFFTEYGEG+RYKIEEVIGKGSYGVVCSA DT TG+KVAIKKINDIFEHVSDATRILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF+DTPTAIFWTDY+AT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI+TDLLGTPSP
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSP 240
Query: 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312
E I+R +RNEKARRYL+SM
Sbjct: 241 ETISR------------------------------------------IRNEKARRYLNSM 258
Query: 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 372
R+KKPIPF+QKFPNA+PLA+RLLERMLAF+PKDRP+AEEALADPYFK +A V+REPSAQP
Sbjct: 259 RRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALADPYFKNIANVDREPSAQP 318
Query: 373 VTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFA 432
+TK+EFEFERRRITKED+RELIYREILEYHP+ML+EFLEG+E TGFMYPSAVDHFKKQFA
Sbjct: 319 ITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTESTGFMYPSAVDHFKKQFA 378
Query: 433 YLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRT 492
YLEEHY KG+T APPERQH SLPRPCV+YSD Q++A+VT+DLS+C I++ D
Sbjct: 379 YLEEHYAKGSTAAPPERQHNSLPRPCVVYSDNRPQSTASVTEDLSRCLIRDNNLKSQDSA 438
Query: 493 SGIPMARLPIQVPQG-AARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYA-- 549
S + +R +PQG AARPGK V SVLRY NC +AA + +QRRVVRNPA++ +
Sbjct: 439 S-VGASR----IPQGAAARPGKAVGSVLRYGNCSTSAAEQQYEQRRVVRNPAIAPNSSVP 493
Query: 550 -ASSYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQGGSGSNW 598
SSYPRR+ CK+E + E ++ S PKP Y+A K+ A G +W
Sbjct: 494 LGSSYPRRNQTCKSETGDVERIDSSQTGPPKP-YVANKLPATVDGRSGHW 542
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 838 bits (2166), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/544 (75%), Positives = 449/544 (82%), Gaps = 48/544 (8%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFFTEYGEG+RYKIEEVIGKGSYGVVCSA DT TGEKVAIKKINDIFEHVSDATRILRE
Sbjct: 1 MDFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF+DTPTAIFWTDYVAT
Sbjct: 121 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI+TDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPST 240
Query: 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312
EAI+R +RNEKARRYLSSM
Sbjct: 241 EAISR------------------------------------------IRNEKARRYLSSM 258
Query: 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 372
R+KKPIPF+QKFPNA+PLALRLLERML+FEPKDRP AEEALADPYF+ +A V+REPSAQP
Sbjct: 259 RRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALADPYFRNIANVDREPSAQP 318
Query: 373 VTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFA 432
VTK+EFEFERRRITKED+RELIYR+ILEYHP ML+E+LEG+E GFMYPSAVDHFKKQFA
Sbjct: 319 VTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTESAGFMYPSAVDHFKKQFA 378
Query: 433 YLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRT 492
YLEEHY KG+T APPERQH SLPRP VLYSD QN+A + +DLSKC + + + +
Sbjct: 379 YLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDRPQNTANIAEDLSKCVLGDNTQKMHQGS 438
Query: 493 SGIPMARLPIQVPQGAARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYAA-- 550
+ + R+P GAARPGKVV S LRY NC + + AE + RR RNPA++T +
Sbjct: 439 ASVCANRVP---QGGAARPGKVVGSALRYGNC-STSTAEQYEHRRTDRNPALATNTVSPR 494
Query: 551 SSYP 554
SYP
Sbjct: 495 GSYP 498
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 723 bits (1867), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/551 (68%), Positives = 426/551 (77%), Gaps = 52/551 (9%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ DQRKKSS + DFFTEYG+ SRYKI+EVIGKGSYGVVCSA D TGEKVAIKKI+DIF
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILREIKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILAN++CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTPS + I+R V
Sbjct: 241 DLMTDLLGTPSMDTISR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RN+KARRYLSSMRKK+PI FSQKFP+A+PLAL LL+++LAF+PKDRPTAEEALA PYFKG
Sbjct: 259 RNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFDPKDRPTAEEALAHPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPS QP+TKMEFEFERRR+TKED+RELI+REILEYHPQ+LK+++ G+E T F+Y
Sbjct: 319 LAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYHPQLLKDYINGTERTTFLY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKT-VQNSAAVTDDLSKC 479
PSAVD F+KQFA+LEE+ G G V P +R+H SLPR +++S + + K
Sbjct: 379 PSAVDQFRKQFAHLEENGGNG-PVIPMDRKHTSLPRSTIVHSTPIPAKEQPRIGPSRDKP 437
Query: 480 SIKEVEKP-PMDRTSGIP--MARLPIQVPQGAARPGKVVSSVLRYNNCGAAAAAEALDQR 536
S + P DR SG ++ P +VP ARPG+VV VL Y N A ++ D R
Sbjct: 438 SDEPYSNPREFDRFSGNAPRTSQAPQRVP--TARPGRVVGPVLPYEN---GATKDSYDAR 492
Query: 537 RVVRNPAVSTQ 547
R+ N Q
Sbjct: 493 RLAMNSGYPPQ 503
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 714 bits (1842), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/556 (65%), Positives = 423/556 (76%), Gaps = 56/556 (10%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ D RKK++ +++FF++YG+ +R+K++EVIGKGSYGVVCSA DT TGEKVAIKKI+DIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILREIKLLRLLRHPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTPS + I+R V
Sbjct: 241 DLMTDLLGTPSLDTISR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYL+SMRKK PIPF+QKFPNA+PL+L+LLER+LAF+PKDRPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFDPKDRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPS QP+TKMEFEFERR++TKED+RELI REILEYHPQ+LK+ + G++ F+Y
Sbjct: 319 LAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYHPQLLKDHMNGADKASFLY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVD F++QFA+LEE+ GK VAP ER+HASLPR V++S + + +
Sbjct: 379 PSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHSTAVARGGQPKLMNNTNTL 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQ---GAARPGKVVSSVLRYNNCGAAAAAEALDQRR 537
E T IP IQ Q AA+P + V ++N + +A D R
Sbjct: 439 NPET-------TQNIPFNHATIQAQQRNLSAAKPSTFMGPVAPFDN--GRISRDAYDPRS 489
Query: 538 VVR--NPAVSTQYAAS 551
+R N S Q AA+
Sbjct: 490 FIRSTNLPFSQQSAAT 505
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 712 bits (1837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/581 (61%), Positives = 429/581 (73%), Gaps = 77/581 (13%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFF+EYG+ +RYKI+EVIGKGSYGVVCSA D TG+KVAIKKI++IFEH+SDA RILRE
Sbjct: 1 MDFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELM++DLHQVIKANDDLT EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+LR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT +FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD+MTDLLGTPS
Sbjct: 181 RWYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312
+ + R +RNEKARRYLSSM
Sbjct: 241 DTVTR------------------------------------------IRNEKARRYLSSM 258
Query: 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 372
RKK+P+PFS++FP A+P AL+LL+R+LAF+PKDRPTAEEALADPYFKGLAK EREPS QP
Sbjct: 259 RKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALADPYFKGLAKAEREPSCQP 318
Query: 373 VTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFA 432
+TKMEFEFERR++TKEDV+ELI+REILEYHPQ+LK+++ G+E T F+YPSA+D+F++QFA
Sbjct: 319 ITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTEKTNFLYPSALDNFRRQFA 378
Query: 433 YLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRT 492
LEE+ GK P +R+H SLPR T +SA + PP D
Sbjct: 379 NLEENGGKNGDAVPSDRKHVSLPR-------TTTVHSAPI--------------PPKDHQ 417
Query: 493 SGIPMARLPIQVPQGA-ARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAV---STQY 548
+ + QVPQ R G+ V+ + N A +QRRVVRNP + +T
Sbjct: 418 N------ITSQVPQRIPGRTGRGACPVIPFENLSAMG---PYNQRRVVRNPVLPPATTNL 468
Query: 549 AASSYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAA 589
+A +Y R+S + + E + E + QP ++ KV +
Sbjct: 469 SAYAYHRKSDSSERE-LQQELEKDRMRYQPSEHFMDAKVVS 508
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LV37|MPK9_ARATH Mitogen-activated protein kinase 9 OS=Arabidopsis thaliana GN=MPK9 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 704 bits (1817), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/492 (71%), Positives = 395/492 (80%), Gaps = 43/492 (8%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + + +FFTEYGE SRY+I+EVIGKGSYGVV SA DT +GEKVAIKKIND+FEHV
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDATRILREIKLLRLLRHPDIVEIKH++LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND P+A
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDIM
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNE 303
TDLLGTP PEAIAR +RNE
Sbjct: 242 TDLLGTPPPEAIAR------------------------------------------IRNE 259
Query: 304 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363
KARRYL +MR+K P+PF+ KFP+ +PLALRLL R+LAF+PKDRP+AEEALADPYF GLA
Sbjct: 260 KARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKDRPSAEEALADPYFYGLAN 319
Query: 364 VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSA 423
V+REPS QP+ K+EFEFERR+ITKEDVRELIYREILEYHPQML+E+L G E T FMYPS
Sbjct: 320 VDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQMLQEYLRGGEQTSFMYPSG 379
Query: 424 VDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS-IK 482
VD FK+QFA+LEE+YGKG +P +RQHASLPR V K + ++ S S +
Sbjct: 380 VDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERVPAPKKENGSHNHDIENRSIASLVT 439
Query: 483 EVEKPPMDRTSG 494
+E PP + G
Sbjct: 440 TLESPPTSQHEG 451
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/560 (63%), Positives = 423/560 (75%), Gaps = 74/560 (13%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
+DFF+EYG+ SRYKI+E++GKGSYGVVCSA D TG+KVAIKKI++IFEH+SDA RILRE
Sbjct: 1 MDFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILRE 60
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
IKLLRLLRHPDIVEIKHI+LPPSRR+FKDIYVVFELM++DLHQVIKANDDLT EH+QFFL
Sbjct: 61 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFL 120
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+LR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDTPT +FWTDYVAT
Sbjct: 121 YQMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVAT 180
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
RWYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGKNVVHQLD+MTDLLGTPS
Sbjct: 181 RWYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSM 240
Query: 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312
+AI+R +RN+KARRYLSSM
Sbjct: 241 DAISR------------------------------------------IRNDKARRYLSSM 258
Query: 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 372
R+K+P+PFS+KFPN +PLAL+LL+R+LAF+PKDRPTAEEALADPYFKGLAKVEREPS QP
Sbjct: 259 RRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALADPYFKGLAKVEREPSCQP 318
Query: 373 VTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFA 432
++KMEFEFERR++TK+D++ELI+REILEYHPQ+LK+++ GSE T F+YPSAVD+F++QFA
Sbjct: 319 ISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSENTSFLYPSAVDNFRRQFA 378
Query: 433 YLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRT 492
LEE+ GK + +R+H SLPR ++S N +D T
Sbjct: 379 ILEENGGKSGAL---DRKHVSLPRATTVHSTSIPPNEG------------------LDAT 417
Query: 493 SGIPMARLPIQVPQGAARPGKVVSSVLRYNNCGAAAAAEALDQRRVVRNPAVSTQYA-AS 551
S + R+P ARPG+ V VL + N GAA A RRVVRNP V A S
Sbjct: 418 SQV-TQRIP------TARPGRTVGPVLPFENPGAADPHSA---RRVVRNPMVPPAAANKS 467
Query: 552 SYPRRSSACKNERVNDESVE 571
Y + ++R + E +E
Sbjct: 468 GYSYNLKSDYSDRQHQEELE 487
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9C9U4|MPK15_ARATH Mitogen-activated protein kinase 15 OS=Arabidopsis thaliana GN=MPK15 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 689 bits (1779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/453 (71%), Positives = 371/453 (81%), Gaps = 42/453 (9%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA 66
KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA DT TGE+VAIKKIND+F+H+SDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 126
TRILREIKLLRLL HPD+VEIKHI+LPPSRREF+D+YVVFELMESDLHQVIKANDDLTPE
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
H+QFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTAIFW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLDIMTD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKAR 306
LGTP PEAI++ +RN+KAR
Sbjct: 312 LGTPPPEAISK------------------------------------------IRNDKAR 329
Query: 307 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 366
RYL +MRKK+P+PFS+KFP A+P ALRLLER++AF+PKDRP+AEEALADPYF GL+ R
Sbjct: 330 RYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPSAEEALADPYFNGLSSKVR 389
Query: 367 EPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDH 426
EPS QP++K+EFEFER+++TK+D+RELIYREILEYHPQML+E+L G FMYPS VD
Sbjct: 390 EPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEEYLRGGNQLSFMYPSGVDR 449
Query: 427 FKKQFAYLEEHYGKGTTVAPPERQHASLPRPCV 459
F++QFA+LEE+ G G +RQHASLPR V
Sbjct: 450 FRRQFAHLEENQGPGGRSNALQRQHASLPRERV 482
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5Z9J0|MPK12_ORYSJ Mitogen-activated protein kinase 12 OS=Oryza sativa subsp. japonica GN=MPK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 687 bits (1774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/491 (68%), Positives = 392/491 (79%), Gaps = 51/491 (10%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
+ KK++ +++FFTEYGE S+Y+I+EVIGKGSYGVV +A DTRTGE+VAIKKIND+FEHV
Sbjct: 66 ESHKKNTVEMEFFTEYGEASQYQIQEVIGKGSYGVVAAAVDTRTGERVAIKKINDVFEHV 125
Query: 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDATRILREIKLLRLLRHPDIVEIKHI+LPPSRREF+DIYVVFELMESDLHQVI+ANDDL
Sbjct: 126 SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFQDIYVVFELMESDLHQVIRANDDL 185
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLR LKYIH ANVFHRDLKPKNILAN+DCKLKICDFGLAR +FND P+A
Sbjct: 186 TPEHYQFFLYQLLRALKYIHAANVFHRDLKPKNILANSDCKLKICDFGLARASFNDAPSA 245
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG+PLFPGKNVVHQLDI+
Sbjct: 246 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGRPLFPGKNVVHQLDII 305
Query: 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNE 303
TDLLGTPS E ++R +RNE
Sbjct: 306 TDLLGTPSSETLSR------------------------------------------IRNE 323
Query: 304 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363
KARRYLS+MRKK +PFSQKF N +PLALRLLER+LAF+PKDR +AEEALADPYF LA
Sbjct: 324 KARRYLSTMRKKHAVPFSQKFRNTDPLALRLLERLLAFDPKDRSSAEEALADPYFASLAN 383
Query: 364 VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSA 423
VEREPS P++K+EFEFERR++TK+DVRELIYREILEYHPQML+E+++G E F+YPS
Sbjct: 384 VEREPSRHPISKLEFEFERRKLTKDDVRELIYREILEYHPQMLQEYMKGGEQISFLYPSG 443
Query: 424 VDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCV-----LYSDKTVQNSAAVTDDLSK 478
VD FK+QFA+LEE+Y KG +P +R+HASLPR V Y+ + + D +++
Sbjct: 444 VDRFKRQFAHLEENYSKGERGSPLQRKHASLPRERVGVSKDGYNQQNTNDQERSADSVAR 503
Query: 479 CSIKEVEKPPM 489
++ PPM
Sbjct: 504 TTV----SPPM 510
|
May be involved in defense signaling pathway. Phosphorylates EREBP1 transcriptional activator in vitro. Enhances DNA-binding activity of EREBP1 to the GCC box element of pathogenesis-related (PR) gene promoters. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 599 | ||||||
| 224107249 | 562 | predicted protein [Populus trichocarpa] | 0.928 | 0.989 | 0.847 | 0.0 | |
| 224102587 | 562 | predicted protein [Populus trichocarpa] | 0.928 | 0.989 | 0.844 | 0.0 | |
| 359477479 | 563 | PREDICTED: mitogen-activated protein kin | 0.929 | 0.989 | 0.839 | 0.0 | |
| 255551501 | 564 | big map kinase/bmk, putative [Ricinus co | 0.929 | 0.987 | 0.839 | 0.0 | |
| 356549019 | 563 | PREDICTED: mitogen-activated protein kin | 0.928 | 0.987 | 0.828 | 0.0 | |
| 449454432 | 565 | PREDICTED: mitogen-activated protein kin | 0.928 | 0.984 | 0.825 | 0.0 | |
| 449523117 | 565 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.928 | 0.984 | 0.824 | 0.0 | |
| 356555610 | 561 | PREDICTED: mitogen-activated protein kin | 0.924 | 0.987 | 0.823 | 0.0 | |
| 297748113 | 554 | mitogen-activated protein kinase 16 [Gos | 0.916 | 0.990 | 0.819 | 0.0 | |
| 357447643 | 564 | Mitogen activated protein kinase 16-2 [M | 0.928 | 0.985 | 0.830 | 0.0 |
| >gi|224107249|ref|XP_002314421.1| predicted protein [Populus trichocarpa] gi|222863461|gb|EEF00592.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1042 bits (2694), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/605 (84%), Positives = 534/605 (88%), Gaps = 49/605 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS D+DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDIDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTPSPEAIARV
Sbjct: 241 DLMTDLLGTPSPEAIARV------------------------------------------ 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKPIPFSQKFPNA+PLALRLLERMLAFEPKDRPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPIPFSQKFPNADPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREP+AQPVTKMEFEFERRRITKEDVRELIYREILEYHP+MLKEFL+GSEPTGFMY
Sbjct: 319 LAKVEREPTAQPVTKMEFEFERRRITKEDVRELIYREILEYHPKMLKEFLDGSEPTGFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVDHFKKQFAYLEEHYG G VAPPERQHASLPRPCVLYSD T+Q SA VT+DLSKCS
Sbjct: 379 PSAVDHFKKQFAYLEEHYGNGAPVAPPERQHASLPRPCVLYSDNTIQKSAEVTNDLSKCS 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQ----GAARPGKVVSSVLRYNNCGAAAAAEALDQR 536
IKE+EKP +DR+ G+PM RLP+QVPQ GAAR GKV SSVLRYNNCG AAAAE LDQ+
Sbjct: 439 IKEIEKPHVDRSDGMPMTRLPLQVPQSIQAGAARSGKVASSVLRYNNCG-AAAAENLDQQ 497
Query: 537 RVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQGGS 594
R+VRNPA+STQYA + SYPRR+ ACKNER DE VEG NGLQPKPQY+ARKVAAAQGG
Sbjct: 498 RMVRNPAISTQYATANCSYPRRNPACKNERGEDEGVEGPNGLQPKPQYMARKVAAAQGGP 557
Query: 595 GSNWY 599
G++WY
Sbjct: 558 GNHWY 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102587|ref|XP_002312737.1| predicted protein [Populus trichocarpa] gi|222852557|gb|EEE90104.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1040 bits (2690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/605 (84%), Positives = 534/605 (88%), Gaps = 49/605 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF+ELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFSELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTP+PEAIARV
Sbjct: 241 DLMTDLLGTPTPEAIARV------------------------------------------ 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKP+PFSQKFPNA+PLALRLLERMLAFEPKDRPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPVPFSQKFPNADPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREP+AQPVTKMEFEFERRRITKEDVRELIYREILEYHP+MLKE L+GSEPTGFMY
Sbjct: 319 LAKVEREPTAQPVTKMEFEFERRRITKEDVRELIYREILEYHPKMLKEHLDGSEPTGFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVDHFKKQFAYLEEHYG G V PPERQHASLPR CVLYSD T+QNSA VT+DLSKCS
Sbjct: 379 PSAVDHFKKQFAYLEEHYGNGAPVTPPERQHASLPRACVLYSDNTIQNSAEVTNDLSKCS 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQ----GAARPGKVVSSVLRYNNCGAAAAAEALDQR 536
IKE+EKP +DR+ GIPM RLP+QVPQ GAARPGKVVSSVLRYNNCG A +AE LDQR
Sbjct: 439 IKEIEKPHVDRSGGIPMTRLPLQVPQSIQAGAARPGKVVSSVLRYNNCG-APSAENLDQR 497
Query: 537 RVVRNPAVSTQY--AASSYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQGGS 594
R+VRNPA+STQY A SS+PRR+ ACKNER DE VEGSNGLQPKPQY+ARKVAAAQGG
Sbjct: 498 RMVRNPAISTQYTTANSSHPRRNPACKNERGEDEGVEGSNGLQPKPQYMARKVAAAQGGP 557
Query: 595 GSNWY 599
G++WY
Sbjct: 558 GNHWY 562
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477479|ref|XP_002279719.2| PREDICTED: mitogen-activated protein kinase 16-like [Vitis vinifera] gi|297736969|emb|CBI26170.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1036 bits (2679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/605 (83%), Positives = 534/605 (88%), Gaps = 48/605 (7%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+K+S +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRRKASVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHCGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSSREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTPS EAIARV
Sbjct: 241 DLMTDLLGTPSAEAIARV------------------------------------------ 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKPIP SQKFPNA+PLALRLLERMLAFEPKDRP+AEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPIPLSQKFPNADPLALRLLERMLAFEPKDRPSAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTK+EFEFERRRITKEDVR+LIYREILEYHP+MLKE+LEG+EPT FMY
Sbjct: 319 LAKVEREPSAQPVTKLEFEFERRRITKEDVRDLIYREILEYHPKMLKEYLEGTEPTSFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVD FKKQFAYLEEHYG G TVAPPERQHASLPRPCVLYSD ++ NSA V DDLSKC
Sbjct: 379 PSAVDQFKKQFAYLEEHYGNGATVAPPERQHASLPRPCVLYSDNSLHNSAEVADDLSKCC 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQ----GAARPGKVVSSVLRYNNCGAAAAAEALDQR 536
IKEVEKP MDR+ GIPMARLP+QVPQ GAARPGKVV SVLRYNNCGAAAAAE L+QR
Sbjct: 439 IKEVEKPHMDRSCGIPMARLPLQVPQSTQGGAARPGKVVGSVLRYNNCGAAAAAEVLEQR 498
Query: 537 RVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQGGS 594
R+VRNP V++QY AS SYPRR+S+CKNER ++E VEGSNGLQPKPQY+ARKVAAAQGGS
Sbjct: 499 RMVRNPPVASQYNASSCSYPRRNSSCKNERGDNEGVEGSNGLQPKPQYMARKVAAAQGGS 558
Query: 595 GSNWY 599
GS+WY
Sbjct: 559 GSHWY 563
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255551501|ref|XP_002516796.1| big map kinase/bmk, putative [Ricinus communis] gi|223543884|gb|EEF45410.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1035 bits (2677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/606 (83%), Positives = 531/606 (87%), Gaps = 49/606 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQRKKSS DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT GEKVAIKKINDIF
Sbjct: 1 MQPDQRKKSSVDVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHIGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRG+KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGMKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTPSPEAIAR V
Sbjct: 241 DLMTDLLGTPSPEAIAR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKPIPFSQKFPNA+PLAL LLERMLAFEPK+RPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPIPFSQKFPNADPLALHLLERMLAFEPKNRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP+MLKE+LEGSEPT FMY
Sbjct: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPKMLKEYLEGSEPTSFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVDHFKKQFAYLEEHYG G TVAPPERQHASLPRPCVLYSD TVQ+SA V +DLSKCS
Sbjct: 379 PSAVDHFKKQFAYLEEHYGNGATVAPPERQHASLPRPCVLYSDNTVQSSAEVANDLSKCS 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQ----GAARPGKVVSSVLRYNNCGAAAAA-EALDQ 535
IKE+EKP +DR+ GIPM RLP+QVPQ AARPGKVV SVLRYNNCGA A EAL+Q
Sbjct: 439 IKEMEKPQVDRSGGIPMTRLPLQVPQSIQASAARPGKVVGSVLRYNNCGATATTVEALEQ 498
Query: 536 RRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQGG 593
RR+VRNPA+STQY A+ SYPRR+ CKNER DE VEGS GLQPKPQY+ARKVAAAQGG
Sbjct: 499 RRMVRNPAISTQYTAANCSYPRRNPVCKNERGEDEGVEGSGGLQPKPQYMARKVAAAQGG 558
Query: 594 SGSNWY 599
G++WY
Sbjct: 559 PGNHWY 564
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549019|ref|XP_003542896.1| PREDICTED: mitogen-activated protein kinase 16-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1016 bits (2626), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/606 (82%), Positives = 526/606 (86%), Gaps = 50/606 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M PDQRKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MLPDQRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRG+KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGMKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTPS EAIAR V
Sbjct: 241 DLMTDLLGTPSLEAIAR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKP+P SQKFPNA+PLALRLLE+MLAFEPKDRPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPVPLSQKFPNADPLALRLLEKMLAFEPKDRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP+MLKEFLEGSEPTGFMY
Sbjct: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPKMLKEFLEGSEPTGFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVDHFKKQFAYLEEHYGKG TV PPERQHASLPRPCVLYSD ++QN++ V DDLSKC
Sbjct: 379 PSAVDHFKKQFAYLEEHYGKGGTVTPPERQHASLPRPCVLYSDHSMQNTSEVADDLSKCC 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQG----AARPGKVVSSVLRYNNCGAAAAAEALDQR 536
IKEVEK P+D +S IPM+RLP+Q PQ AARPGKVV SV+RYNNCG A AEA +QR
Sbjct: 439 IKEVEKQPIDSSSAIPMSRLPLQAPQNIQGVAARPGKVVGSVMRYNNCGVAGTAEA-EQR 497
Query: 537 RVVRNPAVSTQYAAS--SYPRRSSACKNERVNDE-SVEGSNGLQPKPQYIARKVAAAQGG 593
RVVRNP+VS QYAAS SYPRR+S K+ER +E +EGSNGLQPKPQY+ARKVAAAQ G
Sbjct: 498 RVVRNPSVSAQYAASSCSYPRRNSGYKSERGTEEGGIEGSNGLQPKPQYMARKVAAAQAG 557
Query: 594 SGSNWY 599
G WY
Sbjct: 558 PGGQWY 563
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449454432|ref|XP_004144959.1| PREDICTED: mitogen-activated protein kinase 16-like [Cucumis sativus] gi|449471012|ref|XP_004153181.1| PREDICTED: mitogen-activated protein kinase 16-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1006 bits (2601), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/608 (82%), Positives = 530/608 (87%), Gaps = 52/608 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TG+KVAIKKINDIF
Sbjct: 1 MQPDQRRKSSIDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGDKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTD LGTP+ EAIAR V
Sbjct: 241 DLMTDFLGTPNAEAIAR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKP+PFSQKFP+A+PLALRLLERMLAFEPKDRPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPVPFSQKFPHADPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP+MLKEFL+GSEPTGFMY
Sbjct: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPKMLKEFLDGSEPTGFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVDHFKKQFA+LEEHYG G VAPPERQHASLPRPCVLYSD VQN A V +DLSKCS
Sbjct: 379 PSAVDHFKKQFAFLEEHYGNGAPVAPPERQHASLPRPCVLYSDNMVQNPAQVANDLSKCS 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQ----GAARPGKVVSSVLRYNNCGAAAAA---EAL 533
IKEVE+PP+DRT IP+AR+PIQVPQ ARPGKVV SVLRY NCGAAAAA E L
Sbjct: 439 IKEVERPPVDRTCNIPLARVPIQVPQSIQGNGARPGKVVGSVLRY-NCGAAAAAVAPEVL 497
Query: 534 DQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQ 591
+QRR+ RNP++ QYA + SY RR+S+CKNER ++E++EG NGLQPKPQYIARKVAAAQ
Sbjct: 498 EQRRMTRNPSIPPQYAGNNCSYTRRNSSCKNERADEEAIEGPNGLQPKPQYIARKVAAAQ 557
Query: 592 GGSGSNWY 599
GG G+NWY
Sbjct: 558 GGPGNNWY 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523117|ref|XP_004168571.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase 16-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2597), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/608 (82%), Positives = 529/608 (87%), Gaps = 52/608 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KSS DVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TG+KVAIKKINDIF
Sbjct: 1 MQPDQRRKSSIDVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGDKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP NILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPXNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTD LGTP+ EAIAR V
Sbjct: 241 DLMTDFLGTPNAEAIAR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKP+PFSQKFP+A+PLALRLLERMLAFEPKDRPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPVPFSQKFPHADPLALRLLERMLAFEPKDRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP+MLKEFL+GSEPTGFMY
Sbjct: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPKMLKEFLDGSEPTGFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVDHFKKQFA+LEEHYG G VAPPERQHASLPRPCVLYSD VQN A V +DLSKCS
Sbjct: 379 PSAVDHFKKQFAFLEEHYGNGAPVAPPERQHASLPRPCVLYSDNMVQNPAQVANDLSKCS 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQ----GAARPGKVVSSVLRYNNCGAAAAA---EAL 533
IKEVE+PP+DRT IP+AR+PIQVPQ ARPGKVV SVLRY NCGAAAAA E L
Sbjct: 439 IKEVERPPVDRTCNIPLARVPIQVPQSIQGNGARPGKVVGSVLRY-NCGAAAAAVAPEVL 497
Query: 534 DQRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQ 591
+QRR+ RNP++ QYA + SY RR+S+CKNER ++E++EG NGLQPKPQYIARKVAAAQ
Sbjct: 498 EQRRMTRNPSIPPQYAGNNCSYTRRNSSCKNERADEEAIEGPNGLQPKPQYIARKVAAAQ 557
Query: 592 GGSGSNWY 599
GG G+NWY
Sbjct: 558 GGPGNNWY 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555610|ref|XP_003546123.1| PREDICTED: mitogen-activated protein kinase 16-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2590), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/606 (82%), Positives = 523/606 (86%), Gaps = 52/606 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M PDQRKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MLPDQRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTPS EAIAR V
Sbjct: 241 DLMTDLLGTPSLEAIAR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKP+PFSQKFP+A+P ALRLLERMLAFEPKDRPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPVPFSQKFPHADPRALRLLERMLAFEPKDRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE LEYHP+MLKEFLEG+EPTGFMY
Sbjct: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRETLEYHPKMLKEFLEGAEPTGFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVDHFKKQFAYLEEHYGKG TVAPPERQHASLPRPCVLYSD ++QN++ V DDLSKC
Sbjct: 379 PSAVDHFKKQFAYLEEHYGKGGTVAPPERQHASLPRPCVLYSDHSMQNTSEVADDLSKCC 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVPQG----AARPGKVVSSVLRYNNCGAAAAAEALDQR 536
IKEVEK P++R+S IPM+RLP+Q PQ AARP KVV SV+RYNNCG A AEA +QR
Sbjct: 439 IKEVEKQPIERSSAIPMSRLPLQAPQNIQGVAARPRKVVGSVMRYNNCGVAVTAEA-EQR 497
Query: 537 RVVRNPAVSTQYAAS--SYPRRSSACKNER-VNDESVEGSNGLQPKPQYIARKVAAAQGG 593
RVVRNP+VS QYAAS SYPRR+ KNER D+ +EGSNGLQPK Y+ARKVAAAQ G
Sbjct: 498 RVVRNPSVSAQYAASSCSYPRRNPGYKNERGAEDDGIEGSNGLQPK--YMARKVAAAQAG 555
Query: 594 SGSNWY 599
G WY
Sbjct: 556 PGGQWY 561
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297748113|gb|ADI52623.1| mitogen-activated protein kinase 16 [Gossypium hirsutum] gi|297748125|gb|ADI52629.1| mitogen-activated protein kinase 16 [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 997 bits (2577), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/604 (81%), Positives = 519/604 (85%), Gaps = 55/604 (9%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPDQR+KS+ADVDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDQRRKSAADVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHIL PPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILFPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
D+MTDLLGTPS EAIAR V
Sbjct: 241 DLMTDLLGTPSAEAIAR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKPIP S KFPNA+PLA+ LLERMLAFEPKDRP+AEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPIPLSHKFPNADPLAVLLLERMLAFEPKDRPSAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP+MLKE+LEGSEPTGFMY
Sbjct: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPKMLKEYLEGSEPTGFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSDKTVQNSAAVTDDLSKCS 480
PSAVDHFKKQFA+LEEHYG GTT AP ERQHASLPRPCVLYSD +VQNS VTD+LSKCS
Sbjct: 379 PSAVDHFKKQFAFLEEHYGNGTTAAPLERQHASLPRPCVLYSDNSVQNSTDVTDNLSKCS 438
Query: 481 IKEVEKPPMDRTSGIPMARLPIQVP---QGAARPGKVVSSVLRYNNCGAAAAAEALDQRR 537
IKE EKP +R+ IPM+RLP QVP QGAARPGKVV SVLRYNNCGA AA EAL+QRR
Sbjct: 439 IKETEKPQPERSFPIPMSRLPPQVPQSIQGAARPGKVVGSVLRYNNCGAVAAGEALEQRR 498
Query: 538 VVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQGGSG 595
+ RNP+V TQY A+ SYPRR+ CK++ N+ LQPKPQY+ARKVAAAQGGS
Sbjct: 499 MARNPSVPTQYTATNCSYPRRNPVCKDDEENE--------LQPKPQYMARKVAAAQGGSR 550
Query: 596 SNWY 599
S WY
Sbjct: 551 SQWY 554
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447643|ref|XP_003594097.1| Mitogen activated protein kinase 16-2 [Medicago truncatula] gi|355483145|gb|AES64348.1| Mitogen activated protein kinase 16-2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 991 bits (2561), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/607 (83%), Positives = 524/607 (86%), Gaps = 51/607 (8%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M DQRKKSS DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MSHDQRKKSSVDVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
DIMTD LGTPSP+AIAR V
Sbjct: 241 DIMTDFLGTPSPDAIAR------------------------------------------V 258
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
RNEKARRYLSSMRKKKP+PFS KFPNA+PLALRLLERMLAFE KDRPTAEEALADPYFKG
Sbjct: 259 RNEKARRYLSSMRKKKPVPFSHKFPNADPLALRLLERMLAFEAKDRPTAEEALADPYFKG 318
Query: 361 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMY 420
LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP+MLKEFLEG+EPTGFMY
Sbjct: 319 LAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPKMLKEFLEGAEPTGFMY 378
Query: 421 PSAVDHFKKQFAYLEEHYGKGTTVAPPERQHA-SLPRPCVLYSDKTVQNSAAVTDDLSKC 479
PSAVD FKKQFAYLEEHYGKG TVAPPERQHA SLPR CVLYSD T+QN+A V DDLSKC
Sbjct: 379 PSAVDLFKKQFAYLEEHYGKGGTVAPPERQHASSLPRACVLYSDNTMQNTAEVADDLSKC 438
Query: 480 SIKEVEKPPMDRTSGI-PMARLPIQVPQG----AARPGKVVSSVLRYNNCGAAAAAEALD 534
IKEVE+PP+DR+S I PM R+P+Q PQ AARPGKVV S +RYNNCG A AE +
Sbjct: 439 CIKEVERPPVDRSSDIHPMTRIPLQAPQNMQGLAARPGKVVGSAMRYNNCGVAVTAET-E 497
Query: 535 QRRVVRNPAVSTQYAAS--SYPRRSSACKNERVNDESVEGSNGLQPKPQYIARKVAAAQG 592
QRRVVRNP VS+QYAAS SYPRR+ K+ERV D+ +EGSNGLQPKPQYIARKVAAAQG
Sbjct: 498 QRRVVRNPPVSSQYAASSCSYPRRNPNYKSERVEDDVIEGSNGLQPKPQYIARKVAAAQG 557
Query: 593 GSGSNWY 599
G+G WY
Sbjct: 558 GAGGQWY 564
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 599 | ||||||
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.430 | 0.455 | 0.910 | 4.5e-233 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.430 | 0.425 | 0.813 | 7.7e-187 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.425 | 0.5 | 0.843 | 2e-184 | |
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.430 | 0.431 | 0.786 | 3.8e-181 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.430 | 0.419 | 0.775 | 9.4e-176 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.420 | 0.437 | 0.809 | 5.2e-175 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.422 | 0.429 | 0.811 | 6.6e-175 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.409 | 0.504 | 0.746 | 4.6e-161 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.387 | 0.438 | 0.540 | 3.5e-88 | |
| TAIR|locus:2043904 | 395 | MPK6 "MAP kinase 6" [Arabidops | 0.367 | 0.556 | 0.56 | 2.2e-84 |
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 4.5e-233, Sum P(2) = 4.5e-233
Identities = 235/258 (91%), Positives = 240/258 (93%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQPD RKKSS +VDFFTEYGEGSRY+IEEVIGKGSYGVVCSAYDT TGEKVAIKKINDIF
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDAT HPDIVEIKHILLPPSRREF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARV 258
D+MTD+LGTPS EAI RV
Sbjct: 241 DLMTDMLGTPSAEAIGRV 258
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1140 (406.4 bits), Expect = 7.7e-187, Sum P(3) = 7.7e-187
Identities = 210/258 (81%), Positives = 232/258 (89%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ D RKK++ +++FF++YG+ +R+K++EVIGKGSYGVVCSA DT TGEKVAIKKI+DIF
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EHYQFFLYQLLR LKYIHTANV+HRDLKPKNILANA+CKLKICDFGLARVAFNDT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT IFWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAE+L GKPLFPGKNVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARV 258
D+MTDLLGTPS + I+RV
Sbjct: 241 DLMTDLLGTPSLDTISRV 258
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1164 (414.8 bits), Expect = 2.0e-184, Sum P(2) = 2.0e-184
Identities = 215/255 (84%), Positives = 231/255 (90%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + + +FFTEYGE SRY+I+EVIGKGSYGVV SA DT +GEKVAIKKIND+FEHV
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDAT HPDIVEIKH++LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLK+IHTANVFHRDLKPKNILAN+DCKLKICDFGLARV+FND P+A
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLDIM
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPEAIARV 258
TDLLGTP PEAIAR+
Sbjct: 242 TDLLGTPPPEAIARI 256
|
|
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1101 (392.6 bits), Expect = 3.8e-181, Sum P(2) = 3.8e-181
Identities = 203/258 (78%), Positives = 227/258 (87%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ Q KK+ +++FFTEYG+ +RY+I EVIGKGSYGVVC+A DT+TGEKVAIKKIND+F
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EHVSDA HPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARV+FNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT +FWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARV 258
D++TDLLGTP E IA V
Sbjct: 241 DLITDLLGTPKSETIAGV 258
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 9.4e-176, Sum P(2) = 9.4e-176
Identities = 200/258 (77%), Positives = 228/258 (88%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
MQ +Q KK + +++FFTEYG+ +RY+I EVIGKGSYGVVC+A DT TGEKVAIKKIND+F
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHVSDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA HPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
DDLT EH+QFFLYQ+LR LK++HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFNDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
PT +FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DIMTDLLGTPSPEAIARV 258
+++TDLLGTP E I+ V
Sbjct: 241 ELITDLLGTPKSETISGV 258
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 5.2e-175, Sum P(2) = 5.2e-175
Identities = 204/252 (80%), Positives = 226/252 (89%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA 66
KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA DT TGE+VAIKKIND+F+H+SDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 TXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 126
T HPD+VEIKHI+LPPSRREF+D+YVVFELMESDLHQVIKANDDLTPE
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
H+QFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTAIFW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLDIMTD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPEAIARV 258
LGTP PEAI+++
Sbjct: 312 LGTPPPEAISKI 323
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1134 (404.2 bits), Expect = 6.6e-175, Sum P(2) = 6.6e-175
Identities = 207/255 (81%), Positives = 227/255 (89%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
D KK + +FFTEYGE +RY+I+EV+GKGSYGVV SA D+ TGE+VAIKKIND+FEHV
Sbjct: 85 DPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVFEHV 142
Query: 64 SDATXXXXXXXXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDL 123
SDAT HPD+VEIKHI+LPPSRREF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 143 SDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 202
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
TPEHYQFFLYQLLRGLKY+H ANVFHRDLKPKNILANADCKLKICDFGLARV+FND PTA
Sbjct: 203 TPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTA 262
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGKNVVHQLD+M
Sbjct: 263 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDLM 322
Query: 244 TDLLGTPSPEAIARV 258
TD LGTP PE+I+R+
Sbjct: 323 TDFLGTPPPESISRI 337
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 4.6e-161, Sum P(2) = 4.6e-161
Identities = 183/245 (74%), Positives = 215/245 (87%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXX 73
+FFTEYGE S+Y+I+EV+GKGSYGVV SA TG KVAIKK+ ++FEHVSDA
Sbjct: 5 EFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILREI 64
Query: 74 XXXXXXXHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
HPDIVEIKHI+LPP R+EFKDIYVVFELMESDLH V+K NDDLTP+H+QFFLY
Sbjct: 65 KLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFFLY 124
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
QLLRGLK++H+A+VFHRDLKPKNILANADCK+KICD GLARV+F D+P+A+FWTDYVATR
Sbjct: 125 QLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVATR 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
WYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGKNVVHQL+++TDLLGTPSP
Sbjct: 185 WYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPSPI 244
Query: 254 AIARV 258
++R+
Sbjct: 245 TLSRI 249
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 667 (239.9 bits), Expect = 3.5e-88, Sum P(2) = 3.5e-88
Identities = 127/235 (54%), Positives = 167/235 (71%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXXXXXXXXXHPD 83
RY I + IG G+YGVVCSA D TGEKVAIKKI+ F+++ D H +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
++ IK IL P S+ +F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQ+LRGLK+IH
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N DC LKICD GLARV D F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYRAPEVILS 325
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ +KYT AIDIWS+GCIFAELL KPLF GK+ +HQ+ ++ + +G+PS E I +
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNI 379
|
|
| TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 664 (238.8 bits), Expect = 2.2e-84, Sum P(2) = 2.2e-84
Identities = 126/225 (56%), Positives = 163/225 (72%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATXXXXXXXXXXXXXHPDIVEIKHI 90
IGKG+YG+VCSA ++ T E VAIKKI + F++ DA H +IV I+ I
Sbjct: 69 IGKGAYGIVCSAMNSETNESVAIKKIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDI 128
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
+ PP R F D+Y+ +ELM++DLHQ+I++N L+ EH Q+FLYQ+LRGLKYIH+ANV HR
Sbjct: 129 IPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 188
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
DLKP N+L NA+C LKICDFGLARV T + F T+YV TRWYRAPEL + S YT
Sbjct: 189 DLKPSNLLLNANCDLKICDFGLARV----TSESDFMTEYVVTRWYRAPELLLNS-SDYTA 243
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
AID+WS+GCIF EL+ KPLFPG++ VHQL ++ +L+GTPS E +
Sbjct: 244 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEEL 288
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q53N72 | MPK15_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7591 | 0.8280 | 0.9959 | yes | no |
| Q8W4J2 | MPK16_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7589 | 0.9215 | 0.9735 | yes | no |
| Q75KK8 | MPK14_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7372 | 0.8981 | 0.9926 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.979 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_X4145 | hypothetical protein (562 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 599 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-157 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-141 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-136 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-119 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-117 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-114 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-104 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-103 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-100 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-94 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-90 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-88 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-86 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-86 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-85 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-85 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-83 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-83 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-80 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-79 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-77 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-73 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-71 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-69 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-68 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-67 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-67 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-66 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-65 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-65 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-63 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-63 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-63 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-62 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-61 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-61 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-59 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-57 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-57 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-57 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-56 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-56 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-55 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-55 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-51 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-50 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-48 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-48 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-43 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-40 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-39 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-37 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-36 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-35 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-13 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-07 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-05 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 733 bits (1894), Expect = 0.0
Identities = 318/380 (83%), Positives = 334/380 (87%), Gaps = 42/380 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RYKI+EVIGKGSYGVVCSA DT TGEKVAIKKIND+FEHVSDATRILREIKLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IVEIKHI+LPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH+QFFLYQLLR LKYIH
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263
FFSKYTPAIDIWSIGCIFAE+LTGKPLFPGKNVVHQLD++TDLLGTPSPE I+R
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR------ 234
Query: 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323
VRNEKARRYLSSMRKK+P+PFSQK
Sbjct: 235 ------------------------------------VRNEKARRYLSSMRKKQPVPFSQK 258
Query: 324 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERR 383
FPNA+PLALRLLER+LAF+PKDRPTAEEALADPYFKGLAKVEREPSAQP+TK+EFEFERR
Sbjct: 259 FPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERR 318
Query: 384 RITKEDVRELIYREILEYHP 403
R+TKEDVRELIYREILEYHP
Sbjct: 319 RLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 529 bits (1365), Expect = 0.0
Identities = 193/374 (51%), Positives = 247/374 (66%), Gaps = 44/374 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY++ + IG G+YGVVCSA D RTG KVAIKKI+++F+ + DA RILREIKLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
I+ + IL PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LRGLKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N++C LKICDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263
S+YT AIDIWS+GCIFAELLT KPLFPG++ + QL+++ ++LGTPS E +
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK------- 232
Query: 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323
+ +EKAR YL S+ KK P S+
Sbjct: 233 -----------------------------------FITSEKARNYLKSLPKKPKKPLSKL 257
Query: 324 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERR 383
FP A+P A+ LLE+ML F+PK R TA+EALA PY L E EP A+P +F F+
Sbjct: 258 FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDF-FDDD 316
Query: 384 RITKEDVRELIYRE 397
+T+E+++ELIY E
Sbjct: 317 ELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 452 bits (1165), Expect = e-157
Identities = 192/381 (50%), Positives = 249/381 (65%), Gaps = 48/381 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++Y + IG+G+YG+VCSA ++ T EKVAIKKI + F++ DA R LREIKLLR L H
Sbjct: 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+++ IK I+ PP R F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQLLRGLKYI
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ANV HRDLKP N+L NA+C LKICDFGLAR + F T+YV TRWYRAPEL
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTT---SEKGDFMTEYVVTRWYRAPELLL 181
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
+ S+YT AID+WS+GCIFAELL KPLFPGK+ VHQL ++T+LLG+PS E +
Sbjct: 182 N-CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL------- 233
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
F+ RNEKARRY+ S+ F++
Sbjct: 234 -----------------GFI------------------RNEKARRYIRSLPYTPRQSFAR 258
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFER 382
FP+ANPLA+ LLE+ML F+P R T EEALA PY L EP Q T F+FE
Sbjct: 259 LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQ--TPFSFDFEE 316
Query: 383 RRITKEDVRELIYREILEYHP 403
+T+ED++ELIY E+L YHP
Sbjct: 317 DALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 413 bits (1064), Expect = e-141
Identities = 174/383 (45%), Positives = 237/383 (61%), Gaps = 56/383 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G RY+ IG+G+YG+VCSA TG KVAIKKI+ FEH + R LREIK+LR +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKH 62
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LRGLKY
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N +C LKICDFGLAR+A + F T+YVATRWYRAPE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
+ YT AIDIWS+GCI AE+L+ +PLFPGK+ +HQL+++ +LGTPS E + +
Sbjct: 182 LN-SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII-- 238
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
+ +AR Y+ S+ K +P++
Sbjct: 239 ----------------------------------------SLRARNYIKSLPFKPKVPWN 258
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER--EPSAQPVTKMEFE 379
+ FPNA+P AL LL++ML F P R T EEALA PY +E+ +PS +PV + F
Sbjct: 259 KLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY------LEQYHDPSDEPVAEEPFP 312
Query: 380 FE---RRRITKEDVRELIYREIL 399
F+ + KE ++ELI+ EI+
Sbjct: 313 FDFELFDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 400 bits (1030), Expect = e-136
Identities = 175/377 (46%), Positives = 243/377 (64%), Gaps = 47/377 (12%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
GSRYK E IG G+YGVVCSA DTR+G+KVAIKKI F+ + A R LRE+K+LR +H
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH 63
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I+ IL PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQLLRGLKY
Sbjct: 64 DNIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPEL 200
IH+ANV HRDLKP N+L N DC+L+I DFG+AR ++ + T F T+YVATRWYRAPEL
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260
S +YT AID+WS+GCIFAE+L + LFPGKN VHQL ++ +LG+PS E + R
Sbjct: 183 LLS-LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR--- 238
Query: 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320
+ +++ R+Y+ ++ +K+P+P+
Sbjct: 239 ---------------------------------------IGSDRVRKYIQNLPRKQPVPW 259
Query: 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 380
S+ FP A+P AL LL +ML F+P++R T E+AL P+ + EP+ P +F+F
Sbjct: 260 SKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPP--PFDFDF 317
Query: 381 ERRRITKEDVRELIYRE 397
E +++E ++E I +E
Sbjct: 318 EAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 356 bits (916), Expect = e-119
Identities = 155/381 (40%), Positives = 218/381 (57%), Gaps = 54/381 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VCSA+DT+TG KVAIKK++ F+ A R RE++LL+ + H +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 84 IVEIKHILLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+LRGLKYI
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQILRGLKYI 134
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI N DC+LKI DFGLAR ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
++ Y +DIWS+GCI AELLTGK LFPG + + QL + +L+GTP E + +
Sbjct: 189 NWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK----- 242
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
+ +E AR Y+ S+ + F +
Sbjct: 243 -------------------------------------ISSESARNYIQSLPQMPKKDFKE 265
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFER 382
F ANPLA+ LLE+ML +P R TA EALA PY E EP A P + FE
Sbjct: 266 VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAPP---YDQSFES 322
Query: 383 RRITKEDVRELIYREILEYHP 403
R +T ++ +EL+Y+EI+ + P
Sbjct: 323 RDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 350 bits (900), Expect = e-117
Identities = 150/381 (39%), Positives = 212/381 (55%), Gaps = 55/381 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H 81
+Y+I + +GKG+YG+V A D RT E VA+KKI D F + +DA R REI L+ L H
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 82 PDIVEIKHILLPPSRREF-KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+IV++ +++ + E KDIY+VFE ME+DLH VI+AN L H ++ +YQLL+ LK
Sbjct: 67 PNIVKLLNVI----KAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALK 121
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTPTAIFWTDYVATRWYRAP 198
YIH+ NV HRDLKP NIL N+DC++K+ DFGLAR + P TDYVATRWYRAP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E L GS ++YT +D+WS+GCI E+L GKPLFPG + ++QL+ + +++G PS E I
Sbjct: 182 EILLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE- 238
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
+++ A L S+ +
Sbjct: 239 -----------------------------------------SIKSPFAATMLDSLPSRPR 257
Query: 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME 377
P + P A+ AL LL+++L F P R TAEEAL PY EP +
Sbjct: 258 KPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIP 317
Query: 378 FEFERRRITKEDVRELIYREI 398
+ + +++ + R +Y EI
Sbjct: 318 LD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 343 bits (882), Expect = e-114
Identities = 168/382 (43%), Positives = 225/382 (58%), Gaps = 57/382 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
RY++ + +G+G+YG+VCSA + T E VAIKKI ++F A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEI--KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
H +I + I+ P + F ++Y+ ELME+DLHQ+I++ LT H+Q F+YQ+L G
Sbjct: 61 HKNITCLYDMDIVFPGN---FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--TAIFWTDYVATRWYR 196
LKYIH+ANV HRDLKP N+L NADC+LKICDFGLAR F++ P A F T+YVATRWYR
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
APE+ S F YT AID+WS+GCI AELL KP+F GK+ V QL+ + +LGTP E ++
Sbjct: 177 APEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235
Query: 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316
R + + KA+ Y+ S+
Sbjct: 236 R------------------------------------------IGSPKAQNYIRSLPNIP 253
Query: 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKM 376
PF FPNANPLAL LLE++LAF+P R + EEAL PY + EP Q
Sbjct: 254 KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDF 313
Query: 377 EFEFERRRITKEDVRELIYREI 398
FE E + E++R++I E+
Sbjct: 314 SFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 315 bits (808), Expect = e-104
Identities = 138/336 (41%), Positives = 181/336 (53%), Gaps = 55/336 (16%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y+ IG+G+YGVV A D TGE VAIKKI FE LREIKLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+++ + D+Y+VFE M++DL+++IK L + +LYQLL+GL + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N + LK+ DFGLAR +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
Y+ +DIWS+GCIFAELL+ +PLFPGK+ + QL + LGTP PE
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE--------- 221
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
+W AR Y S KK +P +
Sbjct: 222 --VW--------------------------------PKFTSLARNYKFSFPKKAGMPLPK 247
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
FPNA+P AL LL +ML ++P R TAE+ALA PYF
Sbjct: 248 LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 315 bits (808), Expect = e-103
Identities = 156/377 (41%), Positives = 220/377 (58%), Gaps = 60/377 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G++G+VCSA D TG+ VAIKKI F A R RE+KLL+ LRH
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+I+ + I + P +DIY V EL+ +DLH+++ + L + Q+FLYQ+LRGLKY+
Sbjct: 70 NIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQILRGLKYV 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A V HRDLKP NIL N +C LKICDFGLAR+ T YV+TR+YRAPE+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM------TGYVSTRYYRAPEIML 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
+ + KY +DIWS GCIFAE+L GKPLFPGK+ V+Q I+TDLLGTP + I +C
Sbjct: 179 T-WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC--- 234
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
+E R++ S+ K++P+PFS+
Sbjct: 235 ---------------------------------------SENTLRFVQSLPKREPVPFSE 255
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFE--F 380
KF NA+P A+ LLE+ML F+P+ R +A EALA PY +P+ +PV + +F+ F
Sbjct: 256 KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY----HDPTDEPVAEEKFDWSF 311
Query: 381 ERRRITKEDVRELIYRE 397
+ + + ++Y E
Sbjct: 312 NDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 305 bits (783), Expect = e-100
Identities = 128/339 (37%), Positives = 175/339 (51%), Gaps = 62/339 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI---NDIFEHVSDATRILREIKLLRLLRH 81
Y+ E +G+G+YGVV A D +TGE VA+KKI N+ E + LREI LL+ L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTA--LREISLLKELKH 57
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
P+IV++ ++ + +Y+VFE + DL + + L+P + +YQLLRGL
Sbjct: 58 PNIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H+ + HRDLKP+NIL N D LK+ DFGLAR T +T V T WYRAPE
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---YTHEVVTLWYRAPEI 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
L GS Y+ A+DIWS+GCIFAE++TGKPLFPG + + QL + +LGTP+ E
Sbjct: 170 LLGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE------ 221
Query: 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319
W G K Y + K P
Sbjct: 222 -----SWPGVT---------------------------------KLPDYKPTFPKFPPKD 243
Query: 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
+ P +P + LL +ML + P R +A+EAL PYF
Sbjct: 244 LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 294 bits (755), Expect = 1e-94
Identities = 147/396 (37%), Positives = 212/396 (53%), Gaps = 74/396 (18%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG G++GVV S D R G++VA+KK+ ++F+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LRGLKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N++C LKICDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGY 269
A+DIWS+GCIFAELL + LF ++ + QLD++TDLLGTPS EA+ C
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC---------- 233
Query: 270 DGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329
E AR ++ KP + ++
Sbjct: 234 ---------------------------------EGARAHILR-GPHKPPSLPVLYTLSSQ 259
Query: 330 L---ALRLLERMLAFEPKDRPTAEEALADPYFKG--------------------LAKVER 366
A+ LL RML F+P R +A +ALA PY + +
Sbjct: 260 ATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDF 319
Query: 367 EPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 402
EPSA P E+E+ + V+E +++ ILE
Sbjct: 320 EPSANPPFD--DEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 283 bits (724), Expect = 2e-90
Identities = 146/381 (38%), Positives = 215/381 (56%), Gaps = 54/381 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VC+A+DT+TG +VA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LRGLKYI
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N DC+LKI DFGLAR T T YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
++ Y +DIWS+GCI AELLTG+ LFPG + + QL ++ L+GTP E + +
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK----- 244
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
+ +E AR Y+ S+ + + F+
Sbjct: 245 -------------------------------------ISSESARNYIQSLTQMPKMNFAN 267
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFER 382
F ANPLA+ LLE+ML + R TA +ALA YF + EP A P + FE
Sbjct: 268 VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQ---SFES 324
Query: 383 RRITKEDVRELIYREILEYHP 403
R + ++ + L Y E++ + P
Sbjct: 325 RDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 2e-88
Identities = 149/381 (39%), Positives = 214/381 (56%), Gaps = 54/381 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ +G G+YG VCSAYDTR +KVA+KK++ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQLLRGLKYI
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N DC+L+I DFGLAR A ++ T YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM------TGYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
++ Y +DIWS+GCI AELL GK LFPG + + QL + +++GTPSPE + +
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK----- 242
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
+ +E AR+Y+ S+ +
Sbjct: 243 -------------------------------------ISSEHARKYIQSLPHMPQQDLKK 265
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFER 382
F ANPLA+ LLE+ML + R +A EALA PYF E EP A+P + E
Sbjct: 266 IFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDE---SPEN 322
Query: 383 RRITKEDVRELIYREILEYHP 403
+ T E+ +EL Y E+ + P
Sbjct: 323 KERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 269 bits (691), Expect = 2e-86
Identities = 122/340 (35%), Positives = 177/340 (52%), Gaps = 63/340 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
YK+ + +G G++G V A + TGE VAIKK+ F + LRE+K L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 141
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+GL +
Sbjct: 60 IVKLKEVF-----RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL- 200
IH FHRDLKP+N+L + +KI DFGLAR + P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
S Y+ +DIW++GCI AEL T +PLFPG + + QL + +LGTP+ +
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI 318
L + + GF + P
Sbjct: 227 YKLASKL-----GFR--------------------------------------FPQFAPT 243
Query: 319 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
Q PNA+P A+ L++ ML ++PK RPTA +AL PYF
Sbjct: 244 SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 271 bits (693), Expect = 5e-86
Identities = 143/382 (37%), Positives = 209/382 (54%), Gaps = 54/382 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY+ + +G G+YG VCSA D RTG KVAIKK+ F+ A R RE++LL+ ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 83 DIVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQ+L+GLKY
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKY 133
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH A + HRDLKP N+ N DC+LKI DFGLAR ++ T YV TRWYRAPE+
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM------TGYVVTRWYRAPEVI 187
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
++ YT +DIWS+GCI AE+LTGKPLF G + + QL + + GTPS E + +
Sbjct: 188 LNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK---- 242
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
+++E A+ Y+ + + + F
Sbjct: 243 --------------------------------------LQSEDAKNYVKKLPRFRKKDFR 264
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFE 381
PNANPLA+ +LE+ML + + R TA EALA PYF+ E E A P + F+
Sbjct: 265 SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YDDSFD 321
Query: 382 RRRITKEDVRELIYREILEYHP 403
+ E+ + L + EIL + P
Sbjct: 322 EVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 2e-85
Identities = 138/381 (36%), Positives = 204/381 (53%), Gaps = 55/381 (14%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY + +G G+YG VCSA D RTGEKVAIKK++ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQ+L GLKYI
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N DC+LKI DFGLAR A + T YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
++ Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P PE + +
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK----- 241
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
+ ++ A+ Y+ S+ K FS
Sbjct: 242 -------------------------------------LEDKAAKSYIKSLPKYPRKDFST 264
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFER 382
FP A+P A+ LLE+ML + R TA EAL PYF + E QP + E
Sbjct: 265 LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLEN 321
Query: 383 RRITKEDVRELIYREILEYHP 403
+++ ++ ++ IY+E+ + P
Sbjct: 322 EKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 8e-85
Identities = 127/342 (37%), Positives = 168/342 (49%), Gaps = 62/342 (18%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRI--LREIKLLRLLR 80
RY+ + +G+G+Y VV A D TG VAIKKI + D LREIKLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGL 139
HP+I+ + + S I +VFE ME+DL +VIK LTP + ++ LRGL
Sbjct: 61 HPNIIGLLDVFGHKSN-----INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+Y+H+ + HRDLKP N+L +D LK+ DFGLAR +F + T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKM--THQVVTRWYRAPE 172
Query: 200 LCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
L F Y +D+WS+GCIFAELL P PG + + QL + + LGTP+ E
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE---- 225
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
W G + + F F P
Sbjct: 226 -------NWPGV---------TSLPDYVEFKPFP-------------------------P 244
Query: 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
P Q FP A+ AL LL+R+L P R TA +AL PYF
Sbjct: 245 TPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 265 bits (678), Expect = 1e-83
Identities = 139/390 (35%), Positives = 206/390 (52%), Gaps = 66/390 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY+ + IG G+ G+VC+AYDT TG+ VAIKK++ F++V+ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ + ++ P S EF+D+Y+V ELM+++L QVI DL E + LYQ+L G+K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ +DC LKI DFGLAR A T+ T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
Y +DIWS+GCI E++ G LFPG + + Q + + + LGTPS E
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE-------- 239
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
FM + P+ VRN Y+ + K F
Sbjct: 240 ----------FMSRLQPT--------------------VRN-----YVENRPKYAGYSFE 264
Query: 322 QKFP-------NANPLALR------LLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 368
+ FP + + L+ LL +ML +P+ R + ++AL PY E
Sbjct: 265 ELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD-PSEV 323
Query: 369 SAQPVTKMEFEFERRRITKEDVRELIYREI 398
A P + + R T E+ +ELIY+E+
Sbjct: 324 EAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 4e-83
Identities = 118/338 (34%), Positives = 175/338 (51%), Gaps = 55/338 (16%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
Y+ IG+G+YG V A + +TGE VA+KKI E+ + I +REIKLL+ LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 141
+IV +K I+ + IY+VFE M+ DL ++ T + ++ QLL GL+Y
Sbjct: 59 NIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H+ + HRD+K NIL N D LK+ DFGLAR + +A + T+ V T WYR PE L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELL 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260
G+ ++Y P +D+WS+GCI AEL GKP+F G + QL+ + +L G+P+ E
Sbjct: 174 LGA--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE------- 224
Query: 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320
W G + E L + + Y +R+ F
Sbjct: 225 ----NWPGVS----------------KLPWFENL--------KPKKPYKRRLREF----F 252
Query: 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
+ AL LL+++L +PK R +A++AL YF
Sbjct: 253 KHLIDPS---ALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 2e-80
Identities = 126/337 (37%), Positives = 178/337 (52%), Gaps = 54/337 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RYKI IG+G++G+V A D TGE VA+KK+ + LREIK L+ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
+V++ + S +V E M SDL +V++ + L + ++ LL+G+ Y+
Sbjct: 61 VVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 201
H + HRDLKP N+L +AD LKI DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPELLY 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
G+ KY P +D+W++GCIFAELL G PLFPG+N + QL I+ LGTP+ E
Sbjct: 174 GA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE-------- 223
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
W G L + ++ + KPIP
Sbjct: 224 ---TWPGL----------------------TSLPDYNKIT----------FPESKPIPLE 248
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
+ FP+A+P AL LL+ +L ++P R +A EAL PYF
Sbjct: 249 EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 1e-79
Identities = 93/230 (40%), Positives = 129/230 (56%), Gaps = 16/230 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y+I E +G+GS+G V A D +TG+ VAIK I D RILREIK+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + +Y+V E E DL ++K L+ + +F+L Q+L L+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + D +K+ DFGLAR T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
Y A+DIWS+G I ELLTGKP FPG + QL + +G P P
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 2e-77
Identities = 140/377 (37%), Positives = 189/377 (50%), Gaps = 65/377 (17%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI---LREIKL 75
+ GSRY +G GS G+V SA D+ ++VA+KKI ++D + LREIK+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKHILLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPE 126
+R L H +IV++ +L P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIF 185
H + F+YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G H+L+ M
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGA---HELEQMQL 230
Query: 246 LLGT-PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEK 304
+L + P R LL +V PS
Sbjct: 231 ILESVPVVREEDRNELL-------------NVIPS------------------------F 253
Query: 305 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364
R R+ P P NP AL LE++L F P DR TAEEAL PY +
Sbjct: 254 VRNDGGEPRR----PLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309
Query: 365 EREPSAQPVTKMEFEFE 381
EP + +E E +
Sbjct: 310 FDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 7e-73
Identities = 125/340 (36%), Positives = 173/340 (50%), Gaps = 63/340 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
+IEE G+YGVV A D +TGE VA+KK+ E + I LREI +L L+HP
Sbjct: 11 NRIEE----GTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
+IV +K +++ IY+V E +E DL +++ + + QLL G+ +
Sbjct: 65 NIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LKICDFGLAR + +T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKP--YTQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260
G+ +Y+ AID+WS+GCIFAELLT KPLFPGK+ + QL+ + LLGTP+ +
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK------- 229
Query: 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320
IW G+ L A FT+ + Q+R
Sbjct: 230 ----IWPGFSE----------LPGAKKKTFTKY--PYNQLRK------------------ 255
Query: 321 SQKFPNA--NPLALRLLERMLAFEPKDRPTAEEALADPYF 358
KFP + LL R+L ++P R +AE+AL PYF
Sbjct: 256 --KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 1e-71
Identities = 120/337 (35%), Positives = 171/337 (50%), Gaps = 52/337 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y++ V+G+G+YGVV + TGE VAIKK + + LRE+K+LR LRH +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
IV +K RR+ + +Y+VFE +E L ++++A+ L P+ + +++QLL+ + Y
Sbjct: 62 IVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H+ N+ HRD+KP+NIL + LK+CDFG AR A TDYVATRWYRAPE L
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLV 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
G + Y +D+W+IGCI AELL G+PLFPG + + QL ++ LG P
Sbjct: 175 GD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL--FS 230
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
N FA F + RRY K
Sbjct: 231 SNP------------------RFAGVAFPE---PSQPESL---ERRY----PGK------ 256
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
+ AL L+ L +PK+R T +E L PYF
Sbjct: 257 -----VSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 4e-69
Identities = 83/230 (36%), Positives = 125/230 (54%), Gaps = 10/230 (4%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ +G GS+G V A TG+ VA+K + E REI++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + +Y+V E E DL + L+ + + Q+LRGL+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +KI DFGLA+ + + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
+ Y P +D+WS+G I ELLTGKP F G+N++ QL ++ +LG P
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF 221
|
Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 5e-68
Identities = 113/351 (32%), Positives = 169/351 (48%), Gaps = 62/351 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
Y+I +G+G++G V A +TG VA+KKI + + D I LREIK+L+ L+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALREIKILKKLK 65
Query: 81 HPDIVEIKHILL---PPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLL 136
HP++V + + + S+R+ +Y+V M+ DL +++ LT + ++ QLL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF--------WTD 188
G+ Y+H ++ HRD+K NIL + LKI DFGLAR P +T+
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GK+ + QL ++ L
Sbjct: 186 LVVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243
Query: 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARR 307
GTP+ E W G+ P C V +
Sbjct: 244 GTPTEET-----------WPGWR-----SLPGCEGVHS---------------------- 265
Query: 308 YLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P ++F P L LL ++L+ +P R TA +AL PYF
Sbjct: 266 -----FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 1e-67
Identities = 125/333 (37%), Positives = 171/333 (51%), Gaps = 57/333 (17%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHPDIVEIK 88
IG+G+YG+V A DT +GE VA+KK+ ++ D I LREI LL LRHP+IVE+K
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANV 147
+++ + I++V E E DL ++ + + + QLLRGL+Y+H +
Sbjct: 73 EVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFS 206
HRDLK N+L LKI DFGLAR + + T V T WYRAPE L G +
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLART-YGLPAKPM--TPKVVTLWYRAPELLLGC--T 184
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIW 266
YT AID+W++GCI AELL KPL PGK+ + QLD++ LLGTP+ IW
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES-----------IW 233
Query: 267 CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN 326
G+ S P ++ ++ K+ KFP
Sbjct: 234 PGF-----SDLPL-------------------------VGKF--TLPKQPYNNLKHKFPW 261
Query: 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ LRLL +L ++PK R TAEEAL YFK
Sbjct: 262 LSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 4e-67
Identities = 114/339 (33%), Positives = 176/339 (51%), Gaps = 62/339 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPD 83
YKI IG+G++ V A +TG+ AIK + F+ + LREI+ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKHILL-PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKY 141
I+ + +L + R + +VFELM+ +L+++IK PE + ++YQLL+ L +
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 199
+H +FHRD+KP+NIL D LK+ DFG R ++ P +T+Y++TRWYRAPE
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECL 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
L + Y P +DIW++GC+F E+L+ PLFPG N + Q+ + D+LGTP E + +
Sbjct: 171 LTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-- 225
Query: 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319
S + + F KK
Sbjct: 226 ----------------FRKS----RHMNYNFP----------------------SKKGTG 243
Query: 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
+ PNA+ L LL+++LA++P +R TA++AL PYF
Sbjct: 244 LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 1e-66
Identities = 124/339 (36%), Positives = 173/339 (51%), Gaps = 64/339 (18%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD---ATRILREIKLLRLLRHP 82
K+E+ IG+G+YGVV A D TGE VA+KKI E + +T I REI LL+ L HP
Sbjct: 3 KVEK-IGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAI-REISLLKELNHP 58
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLK 140
+IV + ++ ++ +Y+VFE ++ DL + + L P + +LYQLL+G+
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + + LK+ DFGLAR AF P + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG + + QL + LGTP
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD-------- 220
Query: 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319
+W G + P Y + K
Sbjct: 221 ---EDVWPG-----VTSLPD----------------------------YKPTFPKWARQD 244
Query: 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
S+ PN + L LL +ML ++P R +A+ AL PYF
Sbjct: 245 LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 2e-65
Identities = 114/344 (33%), Positives = 154/344 (44%), Gaps = 67/344 (19%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---H 81
Y+ IG+G+YG V A D TG VA+KK+ LREI LL+ L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 139
P+IV + + P + +VFE ++ DL + L PE + + QLLRG+
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++H+ + HRDLKP+NIL +D ++KI DFGLAR+ + T V T WYRAPE
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL----TSVVVTLWYRAPE 176
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS----PEA 254
L S Y +D+WS+GCIFAEL +PLF G + QLD + D++G PS P
Sbjct: 177 VLLQ---SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK 314
+ S+ S F
Sbjct: 234 V-------------------SLPRSSF-------------------------------PS 243
Query: 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P F P L LL++ML F P R +A EAL PYF
Sbjct: 244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 6e-65
Identities = 134/390 (34%), Positives = 201/390 (51%), Gaps = 65/390 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+A+DT G VA+KK++ F++ + A R RE+ LL+ + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P S EF+D+Y+V ELM+++L QVI +L E + LYQ+L G+K++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHL 139
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T T YV TR+YRAPE+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----CTNFMMTPYVVTRYYRAPEVIL 195
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
Y +DIWS+GCI EL+ G +F G + + Q + + + LGTPS E
Sbjct: 196 GM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE--------- 244
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
FM + P+ VRN Y+ + + I F +
Sbjct: 245 ---------FMNRLQPT--------------------VRN-----YVENRPQYPGISFEE 270
Query: 323 KFPN------------ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSA 370
FP+ A LL +ML +P R + +EAL PY + E A
Sbjct: 271 LFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT-VWYDPAEAEA 329
Query: 371 QPVTKMEFEFERRRITKEDVRELIYREILE 400
P + + E R E+ +ELIY+E+++
Sbjct: 330 PPPQIYDAQLEEREHAIEEWKELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 2e-63
Identities = 116/338 (34%), Positives = 170/338 (50%), Gaps = 59/338 (17%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+K E +G+G+Y V + TGE VA+K+I+ E + +T I REI L++ L+H +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHENI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 141
V + ++ ++ + +VFE M+ DL + + + L P + F YQLL+G+ +
Sbjct: 61 VRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
H V HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYRAP+ L
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPDVL 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260
GS Y+ +IDIWS+GCI AE++TG+PLFPG N QL + ++GTP+ +
Sbjct: 173 LGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320
L RY P
Sbjct: 231 LPEY-------------------------------------KPTFPRY-------PPQDL 246
Query: 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
Q FP+A+PL + LL R+L P+ R +A +AL P+F
Sbjct: 247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 4e-63
Identities = 135/392 (34%), Positives = 206/392 (52%), Gaps = 71/392 (18%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+AYD VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 84 IVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P S EF+D+Y+V ELM+++L QVI+ +L E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHL 135
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T+ T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMMTPYVVTRYYRAPEVIL 191
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP PE
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE--------- 240
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
FM + P+ R Y+ + K + F +
Sbjct: 241 ---------FMKKLQPT-------------------------VRNYVENRPKYAGLTFPK 266
Query: 323 KFPNA--------NPL----ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPS- 369
FP++ N L A LL +ML +P R + +EAL PY V +P+
Sbjct: 267 LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI----NVWYDPAE 322
Query: 370 --AQPVTKMEFEFERRRITKEDVRELIYREIL 399
A P + + + R T E+ +ELIY+E++
Sbjct: 323 VEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 211 bits (537), Expect = 8e-63
Identities = 138/413 (33%), Positives = 212/413 (51%), Gaps = 71/413 (17%)
Query: 8 KSSADVDFFT-EYGEGS-----RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+S D +F++ E G+ + RY+ + IG G+ G+VC+AYD VAIKK++ F+
Sbjct: 3 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKAN 120
+ + A R RE+ L++ + H +I+ + ++ P S EF+D+Y+V ELM+++L QVI+
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM- 121
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 122 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---- 176
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + + Q
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 234
Query: 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300
+ + + LGTP PE FM + P+
Sbjct: 235 NKVIEQLGTPCPE------------------FMKKLQPT--------------------- 255
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNA--------NPL----ALRLLERMLAFEPKDRPT 348
R Y+ + K F + FP+ N L A LL +ML + R +
Sbjct: 256 ----VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 349 AEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEY 401
+EAL PY + E A P + + + R T E+ +ELIY+E+++
Sbjct: 312 VDEALQHPYIN-VWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 6e-62
Identities = 125/366 (34%), Positives = 172/366 (46%), Gaps = 85/366 (23%)
Query: 23 SRYK-IEEVIGKGSYGVVCSAYDTRTGEKVAIKK--INDIFEHVSDATR----------I 69
RY +G+G+YG V AYDT TG+ VAIKK I +I V+ +
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ 129
LRE+K++ ++H +I+ + + + +F I +V ++M SDL +V+ LT +
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQVK 122
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----VAFNDTPTAI 184
L Q+L GL +H HRDL P NI N+ KI DFGLAR +
Sbjct: 123 CILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 185 F------WTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
T V T WYRAPEL G+ KY A+D+WS+GCIFAELLTGKPLFPG+N +
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240
Query: 238 HQLDIMTDLLGTPS----PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293
QL + +LLGTP+ P+A L L + FT
Sbjct: 241 DQLGRIFELLGTPNEDNWPQAK---KLPL------------------------YTEFT-- 271
Query: 294 LILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 353
+KP FPNA+ A+ LL+ +L P +R +A+EAL
Sbjct: 272 --------------------PRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 354 ADPYFK 359
YFK
Sbjct: 312 KHEYFK 317
|
Length = 335 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 5e-61
Identities = 117/368 (31%), Positives = 173/368 (47%), Gaps = 85/368 (23%)
Query: 24 RYKIEEVIGKGSYGVVCSAY--DTRTGEKVAIKKI---NDIFEHVSDATRILREIKLLRL 78
+Y+IE IG+G+YG V A + + G++ AIKK + + +S + REI LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLY 133
L+H ++V + + L + + +Y++F+ E DL Q+IK + P + L+
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVAFNDTPTAIFWTD- 188
Q+L G+ Y+H+ V HRDLKP NIL + +KI D GLAR+ FN + D
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPLKPLADLDP 174
Query: 189 YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VH 238
V T WYRAPEL G+ YT AIDIW+IGCIFAELLT +P+F G+
Sbjct: 175 VVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 239 QLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHC 298
QL+ + ++LGTP+ + W
Sbjct: 233 QLERIFEVLGTPTEK-----------DWPDI----------------------------- 252
Query: 299 QVRNEKARRYLSSMRKKKPIPFS--------QKFPNANPLALRLLERMLAFEPKDRPTAE 350
+K Y + M+ K + +K + LL ++L ++P R TAE
Sbjct: 253 ----KKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE 308
Query: 351 EALADPYF 358
EAL PYF
Sbjct: 309 EALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 5e-61
Identities = 117/344 (34%), Positives = 175/344 (50%), Gaps = 68/344 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI----LREIKLLRLL 79
+Y+ IG+GSYGVV + TG+ VAIKK F D I LREI++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
+HP++V + + RR+ K +++VFE + + ++ N PEH + ++Q L+
Sbjct: 58 KHPNLVNLIEVF----RRKRK-LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+ + H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 199 EL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
EL G ++Y P +D+W+IGC+FAELLTG+PL+PGK+ V QL ++ LG
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG--------- 218
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
+++ H Q+ ++ + +P
Sbjct: 219 ----------------------------------DLIPRHQQIF--STNQFFKGLSIPEP 242
Query: 318 ---IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P KFPN + AL L+ L +P +R + EE L PYF
Sbjct: 243 ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 5e-59
Identities = 117/337 (34%), Positives = 174/337 (51%), Gaps = 59/337 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
KIE+ IG+G+YGVV + +TG+ VA+KKI E + +REI LL+ L+HP+IV
Sbjct: 4 KIEK-IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIV 62
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDLHQ---VIKANDDLTPEHYQFFLYQLLRGLKYI 142
++ +L+ SR +Y++FE + DL + + + E + +LYQ+L+G+ +
Sbjct: 63 CLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H+ V HRDLKP+N+L + +K+ DFGLAR AF P ++ T V T WYRAPE L
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAPEVLL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
GS +Y+ +DIWSIG IFAE+ T KPLF G + + QL + +LGTP+ +
Sbjct: 175 GS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED-------- 224
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
+W G Y ++ K K
Sbjct: 225 ---VWPGV---------------------------------TSLPDYKNTFPKWKKGSLR 248
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
N + L LLE+ML ++P R +A++AL PYF
Sbjct: 249 SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-57
Identities = 117/333 (35%), Positives = 169/333 (50%), Gaps = 57/333 (17%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+IV++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTAN 146
++ +Y+VFE + DL + + A+ + + +L+QLL+GL + H+
Sbjct: 66 DVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFF 205
V HRDLKP+N+L N + +K+ DFGLAR AF P + T V T WYRAPE L G +
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILLGCKY 177
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP ++
Sbjct: 178 --YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-----------EVV 224
Query: 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP 325
W G + P Y S K FS+ P
Sbjct: 225 WPG-----VTSLPD----------------------------YKPSFPKWARQDFSKVVP 251
Query: 326 NANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
+ LL +ML ++P R +A+ ALA P+F
Sbjct: 252 PLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 3e-57
Identities = 113/345 (32%), Positives = 166/345 (48%), Gaps = 59/345 (17%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ YK + +G+GSY V TG+ VA+K+I E + T I RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKD 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ K + +VFE +++DL Q + L+ + + FL+QLLR
Sbjct: 60 LKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L + +LK+ DFGLAR + T +++ V T WYR
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT---YSNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPEAI 255
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG +V QL + +LGTP+ E
Sbjct: 172 PDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET- 228
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
W G + Y
Sbjct: 229 ----------WPGVSSNPE-------------------------FKPYSFPFY------- 246
Query: 316 KPIPFSQKFP--NANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P P P + P L + L +EPK R +A EA+ PYF
Sbjct: 247 PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 7e-57
Identities = 121/345 (35%), Positives = 171/345 (49%), Gaps = 58/345 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ E IG+G+YGVV A D T E +A+KKI E + +REI LL+ ++H +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY--QFFLYQLLRGLKY 141
IV ++ ++ R +Y+VFE ++ DL + + ++ D + +LYQ+LRG+ Y
Sbjct: 63 IVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117
Query: 142 IHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
H+ V HRDLKP+N+L + LK+ DFGLAR AF P F T V T WYRAPE
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPEI 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
L GS Y+ +DIWS+GCIFAE++ KPLFPG + + +L + +LGTP+ E
Sbjct: 175 LLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET----- 227
Query: 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319
W G + P Y S+ K P
Sbjct: 228 ------WPG-----VTSLPD----------------------------YKSAFPKWPPKD 248
Query: 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364
+ P P + LL +ML +P R TA AL YFK L
Sbjct: 249 LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 1e-56
Identities = 124/348 (35%), Positives = 172/348 (49%), Gaps = 77/348 (22%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHV-SDATRILREIKLLRLLR 80
+Y+ E IG+G+YG V A + T E VA+K++ +D E V S A LREI LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGL 139
H +IV + +L + + +VFE + DL + + N D+ PE + F++QLL+GL
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N + +LK+ DFGLAR AF P + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
L G+ Y+ +ID+WS GCIFAEL G+PLFPG +V QL + LLGTP+ E
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE---- 223
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
W G +S + KP
Sbjct: 224 -------SWPG----------------------------------------VSKLPDYKP 236
Query: 318 IP-------FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P P N LL+ +L P R +AEEAL PYF
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 3e-56
Identities = 114/348 (32%), Positives = 162/348 (46%), Gaps = 57/348 (16%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRL 78
E S+Y+ IG+G++G V A +T + VA+KK+ + E+ + I LREIK+L+L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQL 67
Query: 79 LRHPDIV---EIKHILLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQ 134
L+H ++V EI P R Y+VFE E DL ++ N T + +
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV---AFNDTPTAIFWTDYVA 191
LL GL YIH + HRD+K NIL D LK+ DFGLAR + N P +T+ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR--YTNRVV 185
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G HQL +++ L G+
Sbjct: 186 TLWYRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243
Query: 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS 310
+PE +W G D F ++ + Q R K R
Sbjct: 244 TPE-----------VWPGVDKLE---------------LFKKMELPQGQKRKVKER---- 273
Query: 311 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
K +P AL L++++L +P R A+ AL +F
Sbjct: 274 -----------LKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 1e-55
Identities = 116/344 (33%), Positives = 171/344 (49%), Gaps = 62/344 (18%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHP 82
+ I IG+G+YG V A D TGE VA+KK+ ++ + I +REIK+LR L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIKILRQLNHR 66
Query: 83 DIVEIKHILLPPS-----RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLL 136
+IV +K I+ +++ Y+VFE M+ DL ++++ + +H + F+ QLL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL Y H N HRD+K NIL N ++K+ DFGLAR+ ++ +T+ V T WYR
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYR 184
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
PEL G +Y PAID+WS GCI EL T KP+F + QL++++ L G+P P
Sbjct: 185 PPELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA-- 240
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
+W +V+ L Y ++M+ K
Sbjct: 241 ---------VW------------------------PDVIKL----------PYFNTMKPK 257
Query: 316 KPI--PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 357
K ++F AL LL+ ML +P R TAEEAL P+
Sbjct: 258 KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-55
Identities = 115/342 (33%), Positives = 167/342 (48%), Gaps = 58/342 (16%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PD 83
Y+ E IG+G+YG V A D TG+ VA+KK + LREI LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRG 138
IV + + + +Y+VFE ++SDL + + +N L + + F+YQLL+G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LKI D GL R AF+ P + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG + + QL + LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ--- 234
Query: 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316
+W G R + K
Sbjct: 235 --------VWPGVSKL----------------------------------RDWHEFPQWK 252
Query: 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P S+ P+ +P L LL++ML ++P R +A+ AL PYF
Sbjct: 253 PQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 4e-55
Identities = 115/346 (33%), Positives = 177/346 (51%), Gaps = 72/346 (20%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI-LREIKLLRLLRHP 82
+Y+ ++G+GSYG+V TG+ VAIKK + E +I +REI++L+ LRH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLE-SEDDKMVKKIAMREIRMLKQLRHE 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLY 133
++V L+ RR+ K +Y+VFE ++ H V+ DDL E Y + +L+
Sbjct: 61 NLVN----LIEVFRRK-KRLYLVFEFVD---HTVL---DDL--EKYPNGLDESRVRKYLF 107
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
Q+LRG+++ H+ N+ HRD+KP+NIL + +K+CDFG AR P ++ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG + + QL + LG P
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312
+ FA + +V+
Sbjct: 223 R---------------HQEIFQKNPL-----FAG--------MRLPEVKE---------- 244
Query: 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P ++FP + L L L ++ L +P DRP++ + L +F
Sbjct: 245 ----IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 8e-51
Identities = 71/197 (36%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G+G +G V A D +TG+KVAIK I S +LREI++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 LLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ +Y+V E E L ++K N+ L+ + L Q+L GL+Y+H+ +
Sbjct: 60 FEDENH-----LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + + K+K+ DFGL+++ +D V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAEL 224
Y+ DIWS+G I EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 6e-50
Identities = 117/346 (33%), Positives = 170/346 (49%), Gaps = 56/346 (16%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y E +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ K + +VFE ++ DL Q + ++ H + FLYQ+LR
Sbjct: 61 LKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---YSNEVVTLWYRP 172
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG V +L ++ LLGTP+ E
Sbjct: 173 PDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET-- 228
Query: 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316
W G N++ + Y + K K
Sbjct: 229 ---------WPGISS------------------------------NDEFKNY--NFPKYK 247
Query: 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362
P P P + + LL + L +E K R +AEEA+ YF+ L
Sbjct: 248 PQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 115/347 (33%), Positives = 167/347 (48%), Gaps = 56/347 (16%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKD 60
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ K + +VFE ++ DL Q + + H + FL+QLLR
Sbjct: 61 LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H V HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT---YSNEVVTLWYRP 172
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ E
Sbjct: 173 PDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET-- 228
Query: 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316
W G + NE+ + Y + K +
Sbjct: 229 ---------WPGI------------------------------LSNEEFKSY--NYPKYR 247
Query: 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363
P + LL ++L FE + R +AEEA+ PYF L +
Sbjct: 248 ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 5e-48
Identities = 68/233 (29%), Positives = 108/233 (46%), Gaps = 9/233 (3%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ E++G+GS+G V A D TGE +A+K + + + + REI++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV E + + E + L ++K L + + Q+L GL Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++D +K+ DFG A+ D T T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--DIMTDLLGTPSPE 253
+Y A DIWS+GC E+ TGKP + I + PE
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 7e-48
Identities = 89/234 (38%), Positives = 144/234 (61%), Gaps = 10/234 (4%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++++ V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
+IVE+K RR K +Y+VFE +E ++ ++++ + + PE + ++YQL++ + +
Sbjct: 61 NIVELKEAF----RRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + + LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
+ Y A+D+WS+GCI EL G+PLFPG++ + QL + +LG E +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 5e-47
Identities = 113/342 (33%), Positives = 168/342 (49%), Gaps = 56/342 (16%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y + +G+G+Y V T VA+K+I E + T I RE+ LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKN 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLR 137
L+H +IV + I+ + + +VFE ++SDL Q + +L H + F++QLLR
Sbjct: 60 LKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL Y H + HRDLKP+N+L N +LK+ DFGLAR T T +++ V T WYR
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT---YSNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG V +L ++ LLGTP+ E
Sbjct: 172 PDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET-- 227
Query: 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316
W G + S NE+ R YL + +
Sbjct: 228 ---------WPG----ITS--------------------------NEEFRSYL--FPQYR 246
Query: 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P P + + LL +L +E K R +AE AL YF
Sbjct: 247 AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 82/345 (23%), Positives = 129/345 (37%), Gaps = 77/345 (22%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
Y+I +G+GS+G V A D + VA+K + E S R LREI++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---LTPEHYQFFLYQLLRGL 139
IV++ V+ + L ++K L+ F L Q+L L
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT---PTAIFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + D +K+ DFGLA++ + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
APE+ G + + + DIWS+G ELLTG P F G+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT----------- 223
Query: 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK 314
+ S +
Sbjct: 224 ------------------------------------------LKIILELPTPSLASPLSP 241
Query: 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
P + A LL+++LA +PK+R ++ L+
Sbjct: 242 SNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 69/208 (33%), Positives = 108/208 (51%), Gaps = 17/208 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I E IGKG +G V A RTG++VAIK I E +I+ EI++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNI 59
Query: 85 VE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPE-HYQFFLYQLLRGLKY 141
V+ L ++++V E L ++K+ + E + +LL+GL+Y
Sbjct: 60 VKYYGSYLKK------DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K NIL +D ++K+ DFGL+ +DT V T ++ APE+
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI 169
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKP 229
Y DIWS+G EL GKP
Sbjct: 170 --NGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 3e-43
Identities = 73/222 (32%), Positives = 115/222 (51%), Gaps = 23/222 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
+Y+I + IGKGS+G V G+ +K+I+ ++S+ R L E+K+L+ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58
Query: 82 PDIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHYQ--FFLYQ 134
P+I++ + E + +V E + DL Q IK PE Q + Q
Sbjct: 59 PNIIKYYESFE------EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE-QILDWFVQ 111
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L LKY+H+ + HRD+KP+NI ++ +K+ DFG+++V + A V T +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGTPY 168
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
Y +PELC + Y DIWS+GC+ EL T K F G+N+
Sbjct: 169 YLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENL 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 115/357 (32%), Positives = 165/357 (46%), Gaps = 83/357 (23%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G + Y E +G+GSY V G+ VA+K I+ E T I RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKG 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQ-VIKANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ F VFE M +DL Q +I+ L P + + F++QLLR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL YIH ++ HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPEAI 255
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG +V QL+ + +LG P+ +
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED-- 227
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
W G +S +
Sbjct: 228 ---------TWPG----------------------------------------VSKLPNY 238
Query: 316 KPIPFSQKFPNANPLALR--------------LLERMLAFEPKDRPTAEEALADPYF 358
KP + F P LR L +ML PKDR +A++AL PYF
Sbjct: 239 KP----EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 7e-41
Identities = 78/211 (36%), Positives = 115/211 (54%), Gaps = 19/211 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDATRILREIKLLRLLRH 81
Y++ ++IG+G++GVV + TG+ VAIK+I I E I++EI LL+ L+H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE--EALKSIMQEIDLLKNLKH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGL 139
P+IV K+I S +Y++ E E+ L Q+IK PE ++YQ+L+GL
Sbjct: 59 PNIV--KYI---GSIETSDSLYIILEYAENGSLRQIIKKFGPF-PESLVAVYVYQVLQGL 112
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAP 198
Y+H V HRD+K NIL D +K+ DFG+A ++ V T ++ AP
Sbjct: 113 AYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD----ASVVGTPYWMAP 168
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
E+ S + A DIWS+GC ELLTG P
Sbjct: 169 EVIE--MSGASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 72/225 (32%), Positives = 113/225 (50%), Gaps = 26/225 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
Y++ E IGKGS+G V G+ + K+I+ + ++++ + ++ E+ +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHY--QFFLYQL 135
+IV I+ ++ +Y+V E E DL Q+I K E + + QL
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QL 114
Query: 136 LRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
L L H + V HRDLKP NI +A+ +K+ DFGLA++ +D+ A YV
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---KTYV 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T +Y +PE Y DIWS+GC+ EL P F +N
Sbjct: 172 GTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 87/238 (36%), Positives = 136/238 (57%), Gaps = 16/238 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLR-- 80
+Y+ IG+G+YG V A D + G + VA+K++ +RE+ +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKHI-LLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLL 136
HP++V + + + + RE K + +VFE ++ DL + + + E + ++QLL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWY 195
RGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ +F T++ V T WY
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-----VVTLWY 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
RAPE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E
Sbjct: 176 RAPEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 114/346 (32%), Positives = 174/346 (50%), Gaps = 55/346 (15%)
Query: 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL 78
+G+ Y+ E +G+GSY V G+ VA+K I E + T I RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKG 59
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L PE+ + FL+QLLR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL YIH + HRDLKP+N+L + +LK+ DFGLAR P+ + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPSPEAI 255
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K++ QL+ + +LGTP+ +
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT- 228
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
W G V ++ F E L+ +A LS +
Sbjct: 229 ----------WPG--------------VHSLPHFKPERFTLYSPKNLRQAWNKLSYVN-- 262
Query: 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
+A LA +LL+ PK+R +A+ AL+ YF L
Sbjct: 263 ----------HAEDLASKLLQ----CFPKNRLSAQAALSHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 88/240 (36%), Positives = 136/240 (56%), Gaps = 21/240 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
YK+ +IG GS+GVV A T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKHILLPPS-RREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLR 137
+ +K ++ K+I+ VV E + +H+ +K N L + + YQL R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 GLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L YIH+ + HRDLKP+N+L + + LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS----VSYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G++ V QL + +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
|
Length = 440 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 100/340 (29%), Positives = 145/340 (42%), Gaps = 57/340 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--- 80
+Y+ IG G+YG V A D +G VA+K + +RE+ LL+ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRG 138
HP+IV + + + +VFE ++ DL + L E + + Q LRG
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ + T V T WYRAP
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRAP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
E+ S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P +
Sbjct: 177 EVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---- 230
Query: 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI 318
W P +V + + + P
Sbjct: 231 -------W-----------P------------RDVTLPR------------GAFSPRGPR 248
Query: 319 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
P P +LL ML F P R +A AL P+F
Sbjct: 249 PVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
+ + +G+G++G V + +VA+K + E S+ LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKL 58
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
HP++V++ + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 59 DHPNVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIAR 113
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G++Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKL 165
Query: 193 --RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVH 238
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 PIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 72/244 (29%), Positives = 119/244 (48%), Gaps = 26/244 (10%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+GKGS+G V TG+ A+K + I + + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59
Query: 89 HILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
F+ +Y+V E +L + + E +F+ +++ L+Y+H+
Sbjct: 60 --------YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHS 111
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL +AD +K+ DFGLA+ ++ + T Y APE+
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG- 167
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTP---SPEAIARVC 259
Y A+D WS+G + E+LTGKP F ++ +++ I+ D L P SPEA +
Sbjct: 168 -KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK-ILKDPLRFPEFLSPEARDLIS 225
Query: 260 LLLN 263
LL
Sbjct: 226 GLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 116/354 (32%), Positives = 170/354 (48%), Gaps = 71/354 (20%)
Query: 31 IGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D + ++ A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 HILLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 139
+ L S R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIFWTD-YVATRW 194
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVH--QLDIMT 244
YRAPEL G+ YT AIDIW+IGCIFAELLT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238
Query: 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEK 304
++G P+ + + + D + A S + +
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKY-------------------- 278
Query: 305 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
M K K P S+ F LL+++L +P R T+E+AL DPYF
Sbjct: 279 -------MEKHKVKPDSKVF--------LLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 117/357 (32%), Positives = 174/357 (48%), Gaps = 77/357 (21%)
Query: 31 IGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G+G+YG V A D + A+K+I E + REI LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 HILLPPSRREFKDIYVVFELMESDL------HQVIKAND---DLTPEHYQFFLYQLLRGL 139
+ L + R+ ++++F+ E DL H+ KAN L + LYQ+L G+
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVAFNDTPTAIFWTD-YVATRW 194
Y+H V HRDLKP NIL + ++KI D G AR+ FN + D V T W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLKPLADLDPVVVTFW 180
Query: 195 YRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVH--QLDIMT 244
YRAPEL G+ YT AIDIW+IGCIFAELLT +P+F + N H QLD +
Sbjct: 181 YRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238
Query: 245 DLLGTPSP---EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVR 301
+++G P+ E I ++ ++ F + +C L+
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLM----KDFRRNTYTNCSLI------------------ 276
Query: 302 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
+Y M K K P S+ F LL+++L +P R T+E+A+ DPYF
Sbjct: 277 -----KY---MEKHKVKPDSKAF--------HLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 63/229 (27%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
+ + +G+G++G V +VA+K + + S+ LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE---DASEQQIEEFLREARIMRKL 58
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLL 136
HP+IV++ + + +V E M DL ++ N L+ F Q+
Sbjct: 59 DHPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT---- 192
RG++Y+ + N HRDL +N L + +KI DFGL+R ++D DY
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYKVKGGK 165
Query: 193 ---RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236
RW APE S K+T D+WS G + E+ T G+ +PG +
Sbjct: 166 LPIRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN 210
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 8e-35
Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 13/232 (5%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
V+G+GS GVV TG+ A+KKI+ + ++LRE+K LR P +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 90 ILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANV 147
I +V E M+ L ++K + + Q+L+GL Y+HT ++
Sbjct: 67 AFYKEGE-----ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRD+KP N+L N+ ++KI DFG+++V + T +V T Y +PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG--ES 176
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
Y+ A DIWS+G E GK F ++M + P P A
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 39/219 (17%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
YK E IG+G+ G V A D TG++VAIKK+ + + I+ EI +++ +HP
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----LRKQNKELIINEILIMKDCKHP 75
Query: 83 DIVE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGL 139
+IV+ L+ +++VV E M+ L +I N + + ++L+GL
Sbjct: 76 NIVDYYDSYLVG------DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVAFNDTPTAIFWTDYV 190
+Y+H+ NV HRD+K NIL + D +K+ DFG A R + TP +W
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTP---YWM--- 183
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ Y P +DIWS+G + E+ G+P
Sbjct: 184 ------APEVIKR--KDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 33/233 (14%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P+IV + + + + +Y+V E M DL ++ + + LT + Q+ +G+
Sbjct: 61 PNIVRLLGVCT-----QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ + N HRDL +N L + +KI DFGL+R + D Y
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-------DYYRKRGGGKLPI 168
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE K+T D+WS G + E+ T G+ +PG + V+ L+
Sbjct: 169 KWM-APESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
|
Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 71/242 (29%), Positives = 115/242 (47%), Gaps = 49/242 (20%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK---------- 74
+K ++IG+GS+ V A + T ++ AIK ++ +++E K
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ--------LIKEKKVKYVKIEKEV 54
Query: 75 LLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQF 130
L RL HP I+++ + F+D +Y V E + +L Q I+ L + +F
Sbjct: 55 LTRLNGHPGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF 106
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------AFNDTPT 182
+ ++L L+Y+H+ + HRDLKP+NIL + D +KI DFG A+V + T
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 183 AIFWTD---------YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
I +V T Y +PEL + D+W++GCI ++LTGKP F G
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRG 224
Query: 234 KN 235
N
Sbjct: 225 SN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-ATRILREIKLLRLLRH 81
+ + E IGKGS+G V A D RT + VAIK I+ E D I +EI+ L R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 137
P I + L S+ ++++ E DL + K L + F L ++L
Sbjct: 59 PYITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLL 109
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL+Y+H HRD+K NIL + + +K+ DFG V+ T T +V T ++ A
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWMA 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
PE+ S Y DIWS+G EL G+P
Sbjct: 167 PEVIKQ--SGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 10/216 (4%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG G++G V +A + TGE +A+K+I I E+K+L LL+HP++V+ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 91 LLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFH 149
+ RE +Y+ E L ++++ L + + QLL GL Y+H+ + H
Sbjct: 68 EV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 150 RDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSK 207
RD+KP NI + + +K+ DFG A ++ N T T Y APE+ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
+ A DIWS+GC+ E+ TGK + + Q IM
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 18/215 (8%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIND---IFEHVSDATRILREIKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I I ++ D ++L E +L + P +V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVKL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
+ S + K++Y+V E + DL +++ L + + ++ +++ L+Y+H+
Sbjct: 59 YY-----SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL +++ LK+ DFGL++V + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
++ +D WS+GCI E L G P F G+
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATR-ILREIKLLRLLRH 81
+++ VIGKG++G VC T + A+K +N E + R +L E ++L+ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE--KGSVRNVLNERRILQELNH 59
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
P +V + F+D +Y+V +L+ DL + + E +F++ +++
Sbjct: 60 PFLVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL 111
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L+Y+H+ + HRD+KP NIL + + I DF +A DT T T T Y A
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT----TSTSGTPGYMA 167
Query: 198 PELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGK 234
PE+ + Y+ A+D WS+G E L GK + G
Sbjct: 168 PEV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
R++ E++G GS+G V + G+ A+K+++ E V ++ +EI LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK---QLEQEIALLS 57
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLL 136
L+HP+IV+ + RE ++Y+ EL+ L +++K + + Q+L
Sbjct: 58 KLQHPNIVQYLG-----TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL 112
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWY 195
GL+Y+H N HRD+K NIL + + +K+ DFG+A+ V F + + ++
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYW 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ Y A DIWS+GC E+ TGKP
Sbjct: 168 MAPEVIAQ-QGGYGLAADIWSLGCTVLEMATGKP 200
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 74/208 (35%), Positives = 112/208 (53%), Gaps = 20/208 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
+KIE+ IGKG + VV A G VA+KK+ IFE + R L+EI LL+ L HP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK---ANDDLTPEH--YQFFLYQLL 136
++ IK++ S E ++ +V EL ++ DL ++IK L PE +++F QL
Sbjct: 63 NV--IKYL---ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L+++H+ + HRD+KP N+ A +K+ D GL R F+ TA V T +Y
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYYM 173
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEL 224
+PE + Y DIWS+GC+ E+
Sbjct: 174 SPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEK--VAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+ +G+G++G V + G+ VA+K + E S+ R L+E ++++ L HP+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEERKDFLKEARVMKKLGHPN 57
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN---------DDLTPEHYQFFLY 133
+V + + E + +Y+V E ME DL ++ + L+ + F
Sbjct: 58 VVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT- 192
Q+ +G++Y+ + HRDL +N L D +KI DFGL+R ++D Y
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD-------DYYRKKT 165
Query: 193 ------RWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLT-GKPLFPG 233
RW APE S +T D+WS G + E+ T G +PG
Sbjct: 166 GGKLPIRWM-APE---SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 71/212 (33%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ I E +G+GSYG V A TG+ VAIK + + E + + I++EI +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-------SDLHQVIKANDDLTPEHYQFFLYQLLR 137
V+ S + D+++V ME SD+ ++ N LT E LYQ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIV---MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLK 110
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL+Y+H+ HRD+K NIL N + + K+ DFG V+ T T + T ++ A
Sbjct: 111 GLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG---VSGQLTDTMAKRNTVIGTPFWMA 167
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
PE+ Y DIWS+G E+ GKP
Sbjct: 168 PEVIQE--IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 62/225 (27%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA---TRILREIKLLRLLRHPDIVEI 87
+G G +G V A+K + H+ + I E ++L HP IV++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK--RHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
R FKD ++ LME +L +++ +F++ ++ +Y+H
Sbjct: 59 --------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH 110
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ +RDLKP+N+L +++ +K+ DFG A+ + T WT + T Y APE+
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPEII-- 164
Query: 204 FFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
+K Y ++D WS+G + ELLTG+P F G++ ++I D+L
Sbjct: 165 -LNKGYDFSVDYWSLGILLYELLTGRPPF-GEDDEDPMEIYNDIL 207
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 53/228 (23%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATR-----ILREIKLLRLLR 80
E+IGKG+YG V A + TGE +A+K++ I + + EI+ L+ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLH------------QVIKANDDLTPEHY 128
H +IV+ Y+ FE E L ++ +
Sbjct: 67 HLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPT-- 182
+FF Q+L GL Y+H+ + HRDLK N+L +AD KI DFG+++ + ND
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 183 --AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
++FW APE+ S+ Y+ +DIWS+GC+ E+ G+
Sbjct: 171 QGSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 15/211 (7%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-----ILREIKLLRLL 79
++ +++G+G++G V YD TG ++A+K++ F+ S T+ + EI+LL+ L
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+H IV+ L R+ + + + E M + +KA LT + + Q+L G
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
E+ Y D+WS+GC E+LT KP
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ EVIG G+ VV +A EKVAIK+I D+ + + + +E++ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA--NDDLTPEHY-QFFLYQLLRG 138
++V+ S ++++V + L ++K+ E L ++L+G
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRA 197
L+Y+H+ HRD+K NIL D +KI DFG+ A +A T +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKP----LFPGK 234
PE+ Y DIWS G EL TG P K
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 20/229 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G+ GVV TG+ +A+K I +I E + +ILRE+ +L P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ--KQILRELDILHKCNSPYIVGFY 65
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKYIHTA- 145
DI + E M+ L +++K PE +L+GL Y+H
Sbjct: 66 GAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ N +V T Y APE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQG-- 173
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ--LDIMTDLLGTPSP 252
+ Y+ DIWS+G EL TG+ +P +N +++ ++ P P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I IGKGS+GVV A+K+I+ + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKY 141
I++ S + + +V E E+ DLH+++K L + F Q+L GL +
Sbjct: 62 --IRYY---ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +KI D G+A++ + F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y D+W++G + E TGK F N
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRH 81
Y V+GKG++G T V K++N + E L EI +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA--LNEIVILSLLQH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDD-LTPEHY-QFFLYQL 135
P+I+ + F D + ME L+ I L E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + YIH A + HRD+K NI +K+ DFG++++ ++ A V T +Y
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA---ETVVGTPYY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+PELC KY DIW++GC+ ELLT K F N
Sbjct: 168 MSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 69/220 (31%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+K+ + +GKGSYG V + A+K+++ +S R + EI++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI---KANDDLTPEH--YQFFLYQL 135
P+I+ K L ++ + +V E DL + I K L PE ++ F+ QL
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-TPTAIFWTDYVATRW 194
LRGL+ +H + HRDLK NIL A+ +KI D G+++V + T I T
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI------GTPH 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
Y APE+ Y+ DIWS+GC+ E+ T P F +
Sbjct: 167 YMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 15/221 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+I + IG+GS+G + A E IK+I+ V + +E+ LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY--QLLRGLK 140
IV S +E +++V E + DL + I + Q + Q+ GLK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YIHTANVFHRDLKPKNILANADCKL-KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+IH + HRD+K +NI + + + K+ DFG+AR ND+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSME--LAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
+C + Y DIWS+GC+ EL T K F G N +HQL
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-R 80
+++ EVIG+G+YG V A +TG+ VAIK ++ I + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSN 61
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQ 134
HP+I + + D +++V EL +DL + + K L E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----VAFNDTPTAIFWTDY 189
LRGL Y+H V HRD+K +NIL + ++K+ DFG++ + +T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--------F 173
Query: 190 VATRWYRAPE--LCG-SFFSKYTPAIDIWSIGCIFAELLTGKP 229
+ T ++ APE C + Y D+WS+G EL GKP
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 5e-23
Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
S Y+ E+IG+G+YG V TG VA+K IN + VSD I RE+ LL L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQL 56
Query: 80 RH---PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL 135
R P+I + L R ++++ E E + ++KA + ++ + ++
Sbjct: 57 RQSQPPNITKYYGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREV 110
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L LKYIH V HRD+K NIL +K+CDFG VA + + +V T ++
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYW 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ Y DIWS+G E+ TG P
Sbjct: 168 MAPEVITE-GKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-23
Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 32/221 (14%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKK--INDIFEHVSDATRIL-----REIKLLRLLRHP 82
+IG GS+G V + +GE +A+K+ + + D R + REI LL+ L+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+IV+ L + +I++ E + + N E + F+ Q+L+GL Y
Sbjct: 67 NIVQY---LGSSLDADHLNIFL--EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL 200
+H + HRD+K NIL + +KI DFG++ ++ N T T R P L
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST--------KTNGAR-PSL 172
Query: 201 CGSFF---------SKYTPAIDIWSIGCIFAELLTGKPLFP 232
GS F + YT DIWS+GC+ E+LTGK FP
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR---ILREIKLLRLLRHPDIVEI 87
IG+GS G+VC A D TG +VA+KK++ + R + E+ ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD-----LRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
L +++VV E +E I + + E +L+ L ++H V
Sbjct: 82 YSSYLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRD+K +IL +D ++K+ DFG + P V T ++ APE+
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LP 191
Query: 208 YTPAIDIWSIGCIFAELLTGKPLF 231
Y +DIWS+G + E++ G+P +
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 69/212 (32%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ + IG G+YG V A D TGE VAIK I E D I +EI +L+ RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHP 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV L RR+ +++V E D++QV L+ + + L+G
Sbjct: 61 NIVAYFGSYL---RRD--KLWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKG 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L Y+H HRD+K NIL D +K+ DFG V+ T T ++ T ++ AP
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFG---VSAQLTATIAKRKSFIGTPYWMAP 170
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
E Y DIW++G EL +P
Sbjct: 171 EVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 73/212 (34%), Positives = 108/212 (50%), Gaps = 16/212 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y + V+G+GS+G + +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEH--YQFFLYQLLRGL 139
IV K S +Y+V E + DL Q IK L PE Q+F+ Q+ G+
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QMCLGV 113
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++IH V HRD+K KNI + K+K+ DFG AR+ + P A + YV T +Y PE
Sbjct: 114 QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPE 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + Y DIWS+GCI EL T K F
Sbjct: 171 IWENM--PYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-22
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
+Y+ V+G+G++G+V + V IK+I E ++ R E ++L+LL H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP--VEQMTKDERLAAQNECQVLKLLSH 58
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEH--YQFFLYQLLR 137
P+I+E L E K + +V E L + I K + L E FF+ Q+L
Sbjct: 59 PNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-QILL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L ++HT + HRDLK +NIL + +KI DFG++++ + + V T Y
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCYI 168
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
+PELC Y DIW++GC+ EL + K F N+
Sbjct: 169 SPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 4e-22
Identities = 73/215 (33%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
V+GKG+YG+V +A D T ++AIK+I + + EI L L+H +IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQY-- 70
Query: 90 ILLPPSRREFKDIYVVFELME-------SDLHQV----IKANDDLTPEHYQFFLYQLLRG 138
L S F I+ ME S L + +K N+ F+ Q+L G
Sbjct: 71 -LGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTI----IFYTKQILEG 120
Query: 139 LKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYR 196
LKY+H + HRD+K N+L N +KI DFG + R+A + T F T Y
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF----TGTLQYM 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
APE+ Y DIWS+GC E+ TGKP F
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-22
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y + IG+GS+G G++ IK+IN + +E+ +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF--FLYQLLRGLK 140
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ LK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H + HRD+K +NI D +K+ DFG+ARV + A + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
C + Y DIW++GC+ E+ T K F N+
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 27/221 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIF-----EHVSDATRILREIKL 75
+ + +G G++G V D + A+K + ++ +HV + R+L+E+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-- 58
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
HP I+ L + + + +Y++ E + +L ++ + + F+ +
Sbjct: 59 ----SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
++ L+Y+H+ + +RDLKP+NIL + + +K+ DFG A+ + T WT T
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPE 163
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y APE+ S + A+D W++G + E+L G P F N
Sbjct: 164 YLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 35/219 (15%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIF-----EHVSDATRILREIKLLR 77
++ + +G GS+G V +G+ A+K I EHV L E ++L+
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV------LNEKRILQ 56
Query: 78 LLRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLY 133
+RHP +V + F+D +Y+V E + +L ++ + +F+
Sbjct: 57 SIRHPFLVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA 108
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
Q++ L+Y+H+ ++ +RDLKP+N+L ++D +KI DFG A+ T +T T
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTP 162
Query: 194 WYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLF 231
Y APE+ SK Y A+D W++G + E+L G P F
Sbjct: 163 EYLAPEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+ ++IE+ IG+G + V A + VA+KK+ IFE + R ++EI LL+ L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 134
HP++ IK++ S E ++ +V EL ++ DL Q+I K L PE +++F+ Q
Sbjct: 61 HPNV--IKYL---DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-Q 114
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L ++++H+ V HRD+KP N+ A +K+ D GL R + T A V T +
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
Y +PE + Y DIWS+GC+ E+
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 33/221 (14%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKL 75
+ S KIE+VIG G +G VCS G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENGSLDAFLRKHDG------QFTVIQ 107
Query: 135 L---LRG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
L LRG +KY+ HRDL +NIL N++ K+ DFGL+RV D P A + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW APE + K+T A D+WS G + E+++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 18/208 (8%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
IE+VIG G +G VC G+K VAIK + SD R+ L E ++
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFD 63
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ ++ ++ ++ + + ++ E ME+ L + ++ ND T L + G
Sbjct: 64 HPNIIRLEGVV---TKS--RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+KY+ N HRDL +NIL N++ K+ DFGL+R + T + RW AP
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW-TAP 177
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT 226
E + K+T A D+WS G + E+++
Sbjct: 178 EAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-21
Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 29/260 (11%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKIN--------DIFEHVSDATRILREIKL 75
Y + E +G G++G V G+ +A+K+IN D E I+ E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEH--Y 128
++ LRHP+IV L R +Y+V +L+E + +K E +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 129 QFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
F+ Q++ L+Y+H + HRDL P NI+ D K+ I DFGLA+ P + T
Sbjct: 117 NIFV-QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPES-KLT 171
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
V T Y PE+ + Y D+W+ GCI ++ T +P F N++ + + +
Sbjct: 172 SVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
Query: 248 GTPSPEAIARVCLLLNIIWC 267
P PE + + I C
Sbjct: 230 YEPLPEGMYSEDVTDVITSC 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + TG++VA+KK++ + E+ ++R H ++V++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L +++VV E +E I + + E +LR L Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL +D ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAELLTGKP 229
+DIWS+G + E++ G+P
Sbjct: 198 EVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 72/213 (33%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLLRHPDIVE 86
IG GS+G V A D RT E VAIKK++ E D I++E++ L+ LRHP+ +E
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---IIKEVRFLQQLRHPNTIE 79
Query: 87 IKHILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
K L RE + + +ME SD+ +V K L + L+GL
Sbjct: 80 YKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLA 129
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+H+ HRD+K NIL +K+ DFG A + +P F V T ++ APE+
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPANSF----VGTPYWMAPEV 182
Query: 201 CGSF-FSKYTPAIDIWSIGCIFAELLTGK-PLF 231
+ +Y +D+WS+G EL K PLF
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 28/241 (11%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI----NDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++ A D +TG +A+K++ N E + +EI+L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+ + + E + E M L + + + + QLLRGL
Sbjct: 66 IR-----MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGL 116
Query: 140 KYIHTANVFHRDLKPKNILANADCK-LKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRA 197
Y+H + HRD+K N+L ++ + L+I DFG A R+A T F + T + A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL---LGTPS-P 252
PE L G +Y + D+WS+GC+ E+ T KP + + + L ++ + PS P
Sbjct: 177 PEVLRG---EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233
Query: 253 E 253
E
Sbjct: 234 E 234
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 67/239 (28%), Positives = 119/239 (49%), Gaps = 18/239 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARV 258
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++ +
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 15/224 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A + +G +VA+K ++ + E+ ++R +H ++VE+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L ++++V+ E ++ I + L E +L+ L Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL D ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
+DIWS+G + E++ G+P + + V + + D +P P+
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPPKL 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 71/216 (32%), Positives = 104/216 (48%), Gaps = 40/216 (18%)
Query: 31 IGKGSYGVVCSA-YD---TRTGEKVAIKKINDIFE--HVSDATRILREIKLLRLLRHPDI 84
+G+G +G V YD TGE+VA+K +N E H SD REI++LR L H +I
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHENI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLY--QLLRG 138
V+ K + P R + ++ E + S D Q + + + L+ Q+ +G
Sbjct: 69 VKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQIN----LKRLLLFSSQICKG 121
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR----- 193
+ Y+ + HRDL +NIL ++ +KI DFGLA+V D DY +
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED-------KDYYYVKEPGES 174
Query: 194 ---WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE C SK++ A D+WS G EL T
Sbjct: 175 PIFWY-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 7/208 (3%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLLRH 81
+++ +++G+G++G V YD TG ++A+K++ D E + + EI+LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV+ L P ++ I+V + + + +KA LT + + Q+L+G+ Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKP 229
Y D+WS+ C E+LT KP
Sbjct: 182 SG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 68/219 (31%), Positives = 113/219 (51%), Gaps = 20/219 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+ ++IE+ IG+G + V A G VA+KK+ IF+ + R ++EI LL+ L
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLN 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEH--YQFFLYQ 134
HP++++ + E ++ +V EL ++ DL ++I K L PE +++F+ Q
Sbjct: 61 HPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L L+++H+ V HRD+KP N+ A +K+ D GL R + T A V T +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPY 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 172 YMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPD 83
++I +G+G YG V A TGE VA+K++ + R +L E +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+V++ + F+D ++ ME D ++ L+ +H +F++ ++ +
Sbjct: 63 LVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H HRDLKP+N L +A +K+ DFGL++ + + DY+ APE
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------APE 168
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
+ Y +D WS+GC+ E L G P F G
Sbjct: 169 VLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 69/239 (28%), Positives = 118/239 (49%), Gaps = 18/239 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK++N + I+ EI ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARV 258
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++ V
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERLSAV 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 58/211 (27%), Positives = 104/211 (49%), Gaps = 9/211 (4%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
+ +++ +++G+G++G V YD TG ++A+K++ + E + + EI+LL+ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
H IV+ L P R + E M + +K+ LT + + Q+L G
Sbjct: 62 LHERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEG 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+ Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
E+ Y DIWS+GC E+LT KP
Sbjct: 179 EVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 20/219 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHP 82
Y V+GKGSYG V G++ IKK+N + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DL-HQVIKANDDLTPEH--YQFFLYQLLRG 138
+IV + E +Y+V E DL H++ + L PE+ ++F+ Q+
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMA 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+Y+H ++ HRDLK +N+ +K+ D G+ARV N A + + T +Y +P
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYMSP 171
Query: 199 ELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
EL F +K Y D+W++GC E+ T K F K++
Sbjct: 172 EL---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 76/231 (32%), Positives = 116/231 (50%), Gaps = 20/231 (8%)
Query: 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREI 73
FF E E + E IG GS+G V A D RT E VAIKK++ + ++ + I++E+
Sbjct: 18 FFKEDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEV 76
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM---ESDLHQVIKANDDLTPEHYQF 130
K L+ ++HP+ +E K L RE ++V E SDL +V K L
Sbjct: 77 KFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAA 129
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+ L+GL Y+H+ N+ HRD+K NIL ++K+ DFG A +A +P +V
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---SPA----NSFV 182
Query: 191 ATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
T ++ APE+ + +Y +D+WS+G EL KP N + L
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 17/229 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK++N + I+ EI ++R +HP+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKHPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP 250
Y P +DIWS+G + E++ G+P + +N + L I T+ GTP
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--GTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 4e-19
Identities = 68/239 (28%), Positives = 119/239 (49%), Gaps = 18/239 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAIK+IN + I+ EI +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGL-ARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
V HRD+K N+L D +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP---SPEAIARV 258
Y P +DIWS+G + E++ G+P + +N + L ++ GTP +PE ++ +
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSPI 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 66/210 (31%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I H+ S+ T L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K P + +Y+V + +L ++ +F+ +LL L+ +H N
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RDLKP+NIL + + +CDFGL ++ D + T Y APEL
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH-- 168
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
YT A+D W++G + E+LTG P F +NV
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENV 198
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 33/217 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
KIEEVIG G +G VC G++ VAIK + + ++ R L E ++
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFD 63
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQL---L 136
HP+I+ ++ ++ + + + ++ E ME+ L ++ ND QF + QL L
Sbjct: 64 HPNIIHLEGVV-----TKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQLVGML 112
Query: 137 RG----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
RG +KY+ N HRDL +NIL N++ K+ DFGL+R +DT + +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW APE + K+T A D+WS G + E+++
Sbjct: 173 IPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
IG+GS G+VC A +G+ VA+KK++ + E+ ++R +H ++VE+ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150
L +++VV E +E I + + E +L+ L +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL D ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAELLTGKP 229
+DIWS+G + E++ G+P
Sbjct: 196 EVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 38/232 (16%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+E +G G +G V T KVA+K + L+E ++++ LRH +V
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGT-TKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYI 142
++ + S E IY+V E M L +K+ + L Q+ G+ Y+
Sbjct: 65 QLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
+ N HRDL +NIL + KI DFGLAR+ +D TA I WT
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT-------- 171
Query: 196 RAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE G F K D+WS G + E++T G+ +PG V+ Q++
Sbjct: 172 -APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 8e-19
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI----NDIFEHVSDATRILREIKLLRLLRHPDI 84
EV+GKG+YG V T G+ +A+K++ +++ + ++ E+ LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V+ L + I + E + + ++ L + + Q+L G+ Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPTAIFWTDYVATRWYRAPE 199
V HRD+K N++ + +K+ DFG AR V + T + + + + T ++ APE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPE 178
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
+ S Y DIWSIGC E+ TGKP
Sbjct: 179 VINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 25/218 (11%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A ++ T E VA+KK++ + ++ + I++E+K L+ L+HP+ +E K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 90 ILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
L K+ + + +ME SDL +V K L + L+GL Y+H
Sbjct: 89 CYL-------KE-HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH 138
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL ++K+ DFG A + +P +V T ++ APE+ +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---SPA----NSFVGTPYWMAPEVILA 191
Query: 204 F-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
+Y +D+WS+G EL KP N + L
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 89
IG GS+G V A D R E VAIKK++ + ++ + I++E++ L+ LRHP+ ++ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 90 ILLPPSRREFKDIYVVFELME------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
L RE + + +ME SDL +V K L + L+GL Y+H
Sbjct: 83 CYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ N+ HRD+K NIL + +K+ DFG A + P +V T ++ APE+ +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APA----NXFVGTPYWMAPEVILA 185
Query: 204 F-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
+Y +D+WS+G EL KP N + L
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 65/251 (25%), Positives = 114/251 (45%), Gaps = 24/251 (9%)
Query: 26 KIEEV--IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
KI E+ +G+G+ G V TG A+K I + +ILRE+++ + + P
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTIT-TDPNPDLQKQILRELEINKSCKSPY 60
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQ-LLRG 138
IV+ L S I + E E +++ +K E + + +L+G
Sbjct: 61 IVKYYGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L Y+H+ + HRD+KP NIL ++K+CDFG++ N + T +Y AP
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-----LAGTFTGTSFYMAP 172
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP--GKNVVHQLDIMTDLLGTPSPEAI 255
E + G Y+ D+WS+G E+ + FP G+ + +++++ ++ P+PE
Sbjct: 173 ERIQG---KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229
Query: 256 ARVCLLLNIIW 266
I W
Sbjct: 230 D--EPGNGIKW 238
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +GVV R VAIK I E + E K++ L HP++V++ +
Sbjct: 12 LGSGQFGVVHLGK-WRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 91 LLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFL---YQLLRGLKYIHTAN 146
+ + I++V E M + L ++ ++ L + ++Y+ +
Sbjct: 68 CT-----KQRPIFIVTEYMANGCLLNYLRERKGK--LGTEWLLDMCSDVCEAMEYLESNG 120
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
HRDL +N L D +K+ DFGLAR +D T+ T + +W PE+ +S
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF-PVKW-APPEVFD--YS 176
Query: 207 KYTPAIDIWSIGCIFAELLT-GKPLFPGK 234
+++ D+WS G + E+ + GK +
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 22/250 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLR 80
RY +++ +GKGS+G V D + + +K + +I + ++ + +E +LL L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLH---QVIKANDDLTPEHYQF-FLYQL 135
HP IV+ L E ++ E E DL + +K E+ + QL
Sbjct: 61 HPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L G+ Y+H + HRDLK KNI + LKI DFG++R+ A T + T +Y
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTGTPYY 171
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
+PE Y DIWS+GCI E+ F G+N L ++ ++ P+P
Sbjct: 172 MSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPSLP 226
Query: 256 ARVCLLLNII 265
LN I
Sbjct: 227 ETYSRQLNSI 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK---KINDIFEHVSDATRILREIKLLRLLRH 81
++I E IGKG+YG V + + G K A+K I+DI E + IL+ L H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKA-----LSDH 74
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQ-VIKANDDLTPEHYQFFLYQLL 136
P++V+ + + +++V EL +DL + +K + + + L++ L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL+++H HRD+K NIL + +K+ DFG V+ T T + V T ++
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 191
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ S Y D+WS+G EL G P
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 71/213 (33%), Positives = 110/213 (51%), Gaps = 35/213 (16%)
Query: 31 IGKGSYGVV--CSAYD---TRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDI 84
+GKG++G V C YD TGE VA+KK+ + EH+ D REI++L+ L+H +I
Sbjct: 12 LGKGNFGSVELCR-YDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQHDNI 67
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLY--QLLRGLKY 141
V+ K + RR + +V E L L ++ + + +H + LY Q+ +G++Y
Sbjct: 68 VKYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICKGMEY 123
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR-------- 193
+ + HRDL +NIL ++ ++KI DFGL +V D +Y R
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGESPIF 176
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE SK++ A D+WS G + EL T
Sbjct: 177 WY-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++VIG G +G V G K VAIK + + L E ++ H +I
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLKYI 142
+ ++ ++ +FK ++ E ME+ L + ++ +D + + L + G+KY+
Sbjct: 69 IRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYRAPEL 200
N HRDL +NIL N++ + K+ DFGL+RV D P + T + RW APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAPEA 181
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT 226
+ K+T A D+WS G + E+++
Sbjct: 182 IA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-18
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 47 TGEKVAIKKINDIFEHVSDA---TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103
TG +VAIK + + + R RE L L HP+IV LL ++
Sbjct: 2 TGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVA----LLDSGEAPPGLLF 55
Query: 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI-LANA 161
VFE + L +V+ A+ L + Q+L L H + HRDLKP+NI ++
Sbjct: 56 AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 162 DCK--LKICDFGLAR----VAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDI 214
+ K+ DFG+ V D T T+ + T Y APE L G TP D+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSDL 172
Query: 215 WSIGCIFAELLTGKPLFPGKNV 236
++ G IF E LTG+ + G +V
Sbjct: 173 YAWGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-18
Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 18/234 (7%)
Query: 29 EVIGKGSYG---VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+V+G+GS+G +V G+ A+K + V D R E +L + HP IV
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
++ + + +Y++ + + DL + T E +F+L +L L ++H+
Sbjct: 62 KLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + + +K+ DFGL++ + + A + T Y APE+
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR- 172
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEA 254
+T + D WS G + E+LTG F GK+ + I+ LG P SPEA
Sbjct: 173 -RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEA 225
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-18
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLLRHPDIV 85
+++G+G++G V YD TG ++A K++ + E + + + EI+LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ L R K + + E M + +KA LT + + Q+L G+ Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ HRD+K NIL ++ +K+ DFG ++ + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKP 229
Y D+WS+GC E+LT KP
Sbjct: 184 -EGYGRKADVWSLGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +GVV R KVAIK IN E + E K++ L HP +V++ +
Sbjct: 12 LGSGQFGVV-HLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 91 LLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ K +Y+V E ME+ L+ + + L+ + + G++Y+ +
Sbjct: 68 CT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDL +N L ++ +K+ DFG+ R +D T+ + +W PE+ FSKY
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN--FSKY 178
Query: 209 TPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ D+WS G + E+ T GK F K+
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK---KINDIFEHVSDATRILREIKLLRLLRH 81
++I E IGKG+YG V + + G A+K I+D+ E + IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHYQFFLYQLL 136
P++V+ + + +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
GL+++H + HRD+K NIL + +K+ DFG V+ T T + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ + Y D+WS+G EL G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 49/279 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++ +VIG+G++G V D TG+ A+K + + +R + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDI------ 54
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+ + + F+D +Y+V E M DL ++ D E +F++ +L+
Sbjct: 55 -LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------------RVAFNDTPT 182
L +H HRD+KP NIL +AD +K+ DFGL
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 183 AIFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ D+ V T Y APE L G + Y D WS+G I E+L G P F
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 232 PGKNVVH-QLDIMTDL--LGTP-----SPEAIARVCLLL 262
+ I+ L P SPEAI +C LL
Sbjct: 231 YSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 23/237 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRH 81
+ +E +G G +G V + +VAIK + +D D + E++ L+ LRH
Sbjct: 6 EEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 138
++ + + S E +Y++ ELME L +++ + L Q+ G
Sbjct: 62 KHLISLFAVC---SVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYR 196
+ Y+ N HRDL +NIL D K+ DFGLAR+ D ++ + + +W
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKW-T 171
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252
APE ++ D+WS G + E+ T G+ +PG N D +T P P
Sbjct: 172 APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLR 80
S +++ E +G GS+G V A TGE AIK K +I + + + +E +L L
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELS 76
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
HP IV + +R F +VV + + L + + +D+ +F+ +L+ +
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA----KFYHAELVLAFE 132
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+H+ ++ +RDLKP+N+L + +K+ DFG A+ + T T T Y APE+
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT------LCGTPEYLAPEV 186
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
S + A+D W++G + E + G P F
Sbjct: 187 IQS--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
L ++ ++++ E + + L L ++L+GL Y+H+
Sbjct: 69 GSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 123
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + ++K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAELLTGKP 229
DIWS+G EL G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 65/224 (29%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + +G G +G V Y KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL-------R 137
+ ++ + IY++ E ME+ L +K TPE + + +L+
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAE 113
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYV 190
G+ +I N HRDL+ NIL + KI DFGLAR+ ++ TA I WT
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT--- 170
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
APE + +T D+WS G + E++T G+ +PG
Sbjct: 171 ------APEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-16
Identities = 76/267 (28%), Positives = 123/267 (46%), Gaps = 39/267 (14%)
Query: 12 DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR 71
D+D T+ R+KI ++G+G++G V A+D + E A+K + ++ ++ DA +I
Sbjct: 123 DIDVSTQ-----RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI-- 174
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKD----IYVVFELMESDLHQVIKANDDLTPEH 127
EI+ + +R D + L +R F++ + +V L I + + H
Sbjct: 175 EIQFMEKVRQADPAD--RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRH 232
Query: 128 YQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD----------------CKLKICDF 170
++Q L Y HT ++ H DLKP+NIL C+++ICD
Sbjct: 233 LAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
G + TAI V+TR YR+PE+ Y+ D+WS+GCI EL TGK L
Sbjct: 293 G-GCCDERHSRTAI-----VSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLL 344
Query: 231 FPGKNVVHQLDIMTDLLGTPSPEAIAR 257
+ + + L +M LG E R
Sbjct: 345 YDTHDNLEHLHLMEKTLGRLPSEWAGR 371
|
Length = 467 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT E VAIK I D+ E + I +EI +L P I
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
L ++ ++++ E + + L + L ++L+GL Y+H+
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--SAY 178
Query: 209 TPAIDIWSIGCIFAELLTGKP 229
DIWS+G EL G+P
Sbjct: 179 DFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 24/229 (10%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IGKGS+G V D RT + VAIK I D+ E + I +EI +L P + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFF-----LYQLLRGLKYIH 143
L ++ ++++ E + A D L + F L ++L+GL Y+H
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGG-----SALDLLRAGPFDEFQIATMLKEILKGLDYLH 118
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ HRD+K N+L + +K+ DFG VA T T I +V T ++ APE+
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
S Y DIWS+G EL G+P P + +H + ++ + P
Sbjct: 176 --SAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S + + IG G +G+V Y KVAIK I + D + E +++ L HP
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEED---FIEEAQVMMKLSHP 59
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+V++ + E I +VFE ME L ++A + E + G+
Sbjct: 60 KLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA 114
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ ++NV HRDL +N L + +K+ DFG+ R +D T+ T + +W +PE+
Sbjct: 115 YLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVKW-SSPEV 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT 226
FSKY+ D+WS G + E+ +
Sbjct: 173 FS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRH-----PD 83
I KG++G V A TG+ AIK K +D+ A + +K R + P
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM-----IAKNQVTNVKAERAIMMIQGESPY 58
Query: 84 IVEIKHILLPPSRREFKD-IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ + + KD +Y+V E L D +IK L + + ++ +++ G++
Sbjct: 59 VAKLYYSF------QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+H + HRD+KP+N+L + LK+ DFGL+R + +V T Y APE +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDYLAPETI 165
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
G D WS+GC+ E L G P F
Sbjct: 166 LG---VGDDKMSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G YG V + VA+K + E + L+E +++ ++HP++V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQ---- 66
Query: 91 LLPPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANV 147
LL RE Y++ E M +L ++ + ++ + Q+ ++Y+ N
Sbjct: 67 LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPEL 200
HRDL +N L + +K+ DFGL+R+ DT TA I WT APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------APE- 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 176 -SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + D+ D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
R +F +ME DL I+ + +F+ +++ GL+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLK N+L +++ +KI DFG+ + T+ F T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----CGTPDYIAPEILS 169
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+ Y PA+D W++G + E+L G+ F G +
Sbjct: 170 --YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 25/209 (11%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEI 87
+G G+ GVV +G +A K I+ E + A R I+RE+K+L P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIVGF 64
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFL-YQLLRGLKYIHTA 145
+I + E M+ L QV+K + PE+ + +LRGL Y+
Sbjct: 65 YGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRI-PENILGKISIAVLRGLTYLREK 118
Query: 146 -NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGS 203
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQG- 172
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFP 232
+ YT DIWS+G E+ G+ +P
Sbjct: 173 --THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
IGKG +G V G+KVA+K + D + A L E ++ LRHP++V++
Sbjct: 12 ATIGKGEFGDVMLG--DYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLVQLL 66
Query: 89 HILLPPSRREFKDIYVVFELME---------SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
++L + +Y+V E M S VI L F + G+
Sbjct: 67 GVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG------FALDVCEGM 115
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTDYVATRWYR 196
+Y+ N HRDL +N+L + D K+ DFGLA+ A + WT
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GK---PLFPGKNVV 237
APE K++ D+WS G + E+ + G+ P P K+VV
Sbjct: 167 APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVE 86
+E++G G+ G V AY T +A+K I DI + +I+ E+++L P I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSPYIIG 63
Query: 87 IKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEH-YQFFLYQLLRGLKYIHTA 145
+R I + E M+ V + PEH +++GL Y+ +
Sbjct: 64 FYGAFFVENR-----ISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSL 114
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ HRD+KP N+L N ++K+CDFG++ N YV T Y APE
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNAYMAPERISG-- 167
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFP 232
+Y D+WS+G F EL G+ +P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + I + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + S + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A +DT T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++V D
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLR---LLRHPDIVE 86
IGKG++G V T A+K ++ + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+K S D+Y+V + M +L ++ + + +F++ +L+ L+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ D T + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAELLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A T E AIK + D+ D + E ++L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------- 53
Query: 88 KHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
KH L F+ +F +ME DL I+ + +F+ ++ L ++H
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLH 113
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
V +RDLK NIL +A+ K+ DFG+ + + T T + T Y APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQE 170
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+Y P++D W++G + E++ G+P F N
Sbjct: 171 L--EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEKV--AIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
VIGKG +G V G+K+ A+K +N I + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I LP E + V+ + DL I++ + T + F Q+ +G++Y+ +
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
HRDL +N + + +K+ DFGLAR I+ +Y + + +L +
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVKW 168
Query: 205 FS-------KYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247
+ K+T D+WS G + EL+T G P +P V DI LL
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYLL 216
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
K+E+ +G G +G V A Y+ T KVA+K + V L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
V++ ++ + IY++ E M D + + + P+ F Q+ G+
Sbjct: 64 VKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-QIAEGMA 116
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATR 193
+I N HRDL+ NIL +A KI DFGLARV ++ TA I WT
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT------ 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
APE F +T D+WS G + E++T G+ +PG
Sbjct: 171 ---APEAIN--FGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
E IGKG++G V + +VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 87 IKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + + + + IY+V EL+ S L + K + LT + G++Y+ +
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
N HRDL +N L + LKI DFG++R T + +W APE
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALN-- 168
Query: 205 FSKYTPAIDIWSIGCIFAELLTG 227
+ +YT D+WS G + E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 35/242 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDATRILREIKLLRLLRH-- 81
+ IG G+ G V +TG +A+K++ E RIL ++ ++ L H
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-LKSHDC 73
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL-YQLLRGLK 140
P IV+ + S D+++ ELM + L +++K PE + +++ L
Sbjct: 74 PYIVKCYGYFITDS-----DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128
Query: 141 YIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-TR----- 193
Y+ V HRD+KP NIL +A +K+CDFG++ D A TR
Sbjct: 129 YLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLVDSKAKTRSAGCA 178
Query: 194 WYRAPELCG--SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
Y APE KY D+WS+G EL TG+ FP KN + +++T +L
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEP 236
Query: 252 PE 253
P
Sbjct: 237 PS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+RDLK N++ +A+ +KI DFG+ + F T F T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF----CGTPDYIAPEIIA--YQ 176
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 65/213 (30%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLL----RHPD 83
V+G+G +G V A +TGE AIK K DI D L K + RHP
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANSERHPF 63
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V + + V E DL I + P F+ ++ GL+Y+
Sbjct: 64 LVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHTDVFSEPRA-VFYAACVVLGLQYL 117
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPEL 200
H + +RDLK N+L + + +KI DFGL + + F D T+ F T + APE+
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTF----CGTPEFLAPEV 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ YT A+D W +G + E+L G+ FPG
Sbjct: 173 LTE--TSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + D+ D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ P R ++ V E + DL I+ + +F+ ++ L ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLK N+L + + K+ DFG+ + FN T+ F T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF----CGTPDYIAPEILQEM 171
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y P++D W++G + E+L G F +N
Sbjct: 172 L--YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKH 89
+GKG +G VC+ TG+ A KK++ + L E K+L + IV + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 90 ILLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPE-HYQFFLYQLLRGLKYIHTAN 146
D+ +V LM DL + + PE F+ Q++ GL+++H
Sbjct: 61 AFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLKP+N+L + ++I D GLA T Y APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI----KGRAGTPGYMAPEVLQG--E 169
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLF 231
Y ++D +++GC E++ G+ F
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 29/225 (12%)
Query: 31 IGKGSYG-VVCSAYDTRTGE--KVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVE 86
+G G++G VV Y ++G+ +VA+K + EH + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + + +V EL L + +K ++ + +Q+ G+ Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDT----PTAIFWTDYVATRWYRAPEL 200
+ HRDL +N+L + KI DFG++R + TA W +WY APE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW----PLKWY-APE- 168
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT--GKPL--FPGKNVVHQLD 241
C ++ K++ D+WS G E + KP G V+ L+
Sbjct: 169 CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 70/233 (30%), Positives = 109/233 (46%), Gaps = 36/233 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + +G G +G V Y KVA+K + V L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDD---LTPEHYQFFLYQLLRGLKY 141
+ ++ ++ E IY++ E M + L +K+++ L P+ F Q+ G+ Y
Sbjct: 65 RLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-QIAEGMAY 118
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRW 194
I N HRDL+ N+L + KI DFGLARV ++ TA I WT
Sbjct: 119 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT------- 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246
APE F +T D+WS G + E++T GK +PG + D+M+ L
Sbjct: 172 --APEAIN--FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 69/236 (29%), Positives = 112/236 (47%), Gaps = 22/236 (9%)
Query: 30 VIGKGSYGVVCSAYDTR---TGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDI 84
V+GKG YG V TG+ A+K K I + D E +L ++HP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V++ + + +Y++ E L +L ++ + F+L ++ L+++H
Sbjct: 63 VDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLKP+NIL +A +K+ DFGL + + T T F T Y APE+
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF----CGTIEYMAPEILM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEA 254
S + A+D WS+G + ++LTG P F +N +D I+ L P +PEA
Sbjct: 174 R--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEA 227
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 31 IGKGSYGVV--CSAYDTR---TGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPD 83
+G+G +G V C YD TGE+VA+K K H++D + +EI++LR L H +
Sbjct: 12 LGEGHFGKVELCR-YDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHEN 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKY 141
IV+ K I K ++ E + S L + + N + + + + Q+ +G+ Y
Sbjct: 68 IVKYKGICTEDGGNGIK---LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + HRDL +N+L ++ ++KI DFGL + D D + ++ APE
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLT 226
SK+ A D+WS G ELLT
Sbjct: 185 --IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 56/221 (25%), Positives = 109/221 (49%), Gaps = 12/221 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
K+ R F YV + L + ++D T +F+ +++ L Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT----RFYGAEIVSALDYLHSGKI 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + D +KI DFGL + D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN--VVHQLDIMTDL 246
Y A+D W +G + E++ G+ F ++ + +L +M D+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 34/225 (15%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G +G V T VA+K + D L E ++++ LRHP ++++ +
Sbjct: 14 LGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 91 LLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANV 147
+ E IY+V ELM+ L + ++ L Q+ G+ Y+ N
Sbjct: 70 C---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWYRAPEL 200
HRDL +N+L + K+ DFGLARV D A I WT APE
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT---------APE- 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
+ +++++ D+WS G + E++T G+ +PG V+ Q+D
Sbjct: 175 -AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G+ G V TG +A KK+ I S +ILRE++++ R P IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 91 LLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VF 148
L + +I + E M+ L ++ K + E ++ GL Y++ + +
Sbjct: 72 FLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFN---DTPTAIFWTDYVATRWYRAPELCGSFF 205
HRD+KP NIL N+ ++K+CDFG++ N DT +V T Y +PE
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT--------FVGTSTYMSPERIQG-- 176
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFP 232
KYT D+WS+G EL GK FP
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK--FP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A K++ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V +M DL H N E F+ ++L GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
N +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAV----KIPEGESIRGRVGTVGYMAPEVLNN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
+YT + D W +GC+ E++ G+ F G+
Sbjct: 176 -QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 34/222 (15%)
Query: 26 KIEEVIGKGSYGVV-CSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++ + +G G +G V ++ T KVA+K + L E ++++ LRH +
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNT--KVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKL 63
Query: 85 VEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKY 141
V++ ++ S IY+V E M + L +K + + Q+ G+ Y
Sbjct: 64 VQLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRW 194
I N HRDL+ NIL KI DFGLAR+ ++ TA I WT
Sbjct: 118 IERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT------- 170
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
APE + + ++T D+WS G + EL+T G+ +PG N
Sbjct: 171 --APE--AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 69/254 (27%), Positives = 116/254 (45%), Gaps = 32/254 (12%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+GKG+YG V TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLT---PEH-YQFFLYQLLRGLKYIHTA- 145
+Y+ E M++ + A T PE + Y +++GLK++
Sbjct: 68 FFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE----LC 201
N+ HRD+KP N+L N + ++K+CDFG++ + ++ T+ + + Y APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN-IGCQSYMAPERIKSGG 177
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK---NVVHQLDIMTDLLGTP-------S 251
+ YT D+WS+G E+ G+ +P + N+ QL + D G P S
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPTLPSGYS 235
Query: 252 PEAIARVCLLLNII 265
+A V LN I
Sbjct: 236 DDAQDFVAKCLNKI 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL-LRLLRHPDI 84
IEE +G+G+YGVV TG +A+K+I R+L ++ + +R + P
Sbjct: 5 VIEE-LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYT 62
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIK---ANDDLTPEHYQFFL----YQLLR 137
V L RE D+++ E+M++ L + K PE L +++
Sbjct: 63 VTFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPED---ILGKIAVSIVK 114
Query: 138 GLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L+Y+H+ +V HRD+KP N+L N + ++K+CDFG++ + + T + Y
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS----VAKTIDAGCKPYM 170
Query: 197 APELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFP 232
APE ++ Y D+WS+G EL TG+ FP
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGR--FP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
E+IG+G +G V TG+KVA+K I D+ A L E ++ L H ++V +
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRL 64
Query: 88 KHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDL---TPEHYQFFLYQLLRGLKYIH 143
++L +Y+V ELM + +L ++ + QF L + G++Y+
Sbjct: 65 LGVIL------HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAEGMEYLE 117
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARV---AFNDTPTAIFWTDYVATRWYRAPEL 200
+ + HRDL +NIL + D K+ DFGLARV +++ + WT APE
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT---------APEA 168
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232
K++ D+WS G + E+ + G+ +P
Sbjct: 169 LKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + D+ D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
H+ +E ++ V E + DL I+++ +F+ +++ GL+++H
Sbjct: 60 -HLFCTFQTKEH--LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L + D +KI DFG+ + N A + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 17/238 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRL 78
+ + +V+G G++G V GEK VAIK + + ++ IL E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN-KEILDEAYVMAS 65
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 136
+ HP +V + I L + ++ +LM L V D++ ++ + Q+
Sbjct: 66 VDHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM- 178
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253
A E YT D+WS G EL+T G + G V D++ P P
Sbjct: 179 ALESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ H F+ ++ GL ++H+ +
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ +++ +KI DFG+ + D T + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+ F G++
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 56/247 (22%), Positives = 105/247 (42%), Gaps = 45/247 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
+K +++GKG G V TG+ A+K ++ + R+L E ++L L H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
P + + S + + +V + +L ++++ L+ E +F+ ++L
Sbjct: 61 PFLPTLYA-----SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT----------- 187
L+Y+H + +RDLKP+NIL + + + DF L++ + + P +
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS-DVEPPPVSKALRKGSRRSSVN 174
Query: 188 ----------------DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGK 228
+V T Y APE+ G + A+D W++G + E+L G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGT 229
Query: 229 PLFPGKN 235
F G N
Sbjct: 230 TPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIND--IFEHVSDATRILREIKLLRLLRHPDIVEI 87
V+GKG +G VC+ TG+ A KK+ I + +A L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSL 65
Query: 88 KHILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ E KD + +V LM DL H N E F+ ++ GL+ +H
Sbjct: 66 AYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ +RDLKP+NIL + ++I D GLA + +T V T Y APE+
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG-----RVGTVGYMAPEVVK 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
+ +YT + D W +GC+ E++ GK F +
Sbjct: 175 N--ERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 64/250 (25%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFE-----HVSDATRILREIKLLRLLRH 81
+VIG+G++G V TG A+KK+ +++ E HV IL E +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------N 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLR 137
P +V++ + F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 61 PWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGL------------ARVAFNDTPTAIF 185
+ IH HRD+KP N+L +A +K+ DFGL R+ + P+
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 186 WTDY-----------------------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIF 221
V T Y APE+ F Y D WS+G I
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV---FLQTGYNKECDWWSLGVIM 229
Query: 222 AELLTGKPLF 231
E+L G P F
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 31 IGKGSYGVVCSA-YDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G++G V Y + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
I E + +V EL E L++ ++ N +T ++ ++Q+ G+KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFND-----TPTAIFWTDYVATRWYRAPELCG 202
HRDL +N+L KI DFGL++ D T W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAE 223
+++ K++ D+WS G + E
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 48/230 (20%)
Query: 29 EVIGKGSYGVV-----CSAYDTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHP 82
+G+G++G V E VA+K + + +DA + RE +LL +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHE 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--------------DLTPEH 127
+IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 69 NIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ G+ Y+ + + HRDL +N L D +KI DFG++R ++ T
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVYTT 175
Query: 188 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
DY + RW PE + K+T D+WS G + E+ T GK
Sbjct: 176 DYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A TG A K I E + + EI +L +HP+IV +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII--QIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 91 LLPPSRR----EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
++ EF D + +M + LT ++ Q+L L ++H+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIML-------ELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL--CGSF 204
V HRDLK NIL D +K+ DFG V+ + T ++ T ++ APE+ C +F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFG---VSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 205 FSK-YTPAIDIWSIGCIFAELLTGKP 229
Y DIWS+G EL +P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + D+ D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT- 59
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
H+ +E +++ V E + DL I++ F+ +++ GL+++H+
Sbjct: 60 --HLYCTFQTKE--NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLK NIL + D +KI DFG+ + D T F T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF----CGTPDYIAPEIL--L 169
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KY ++D WS G + E+L G+ F G +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEIK 88
IG G+ G V TG A+K I + + D R I REI++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
+ +I V+ E M+ + D+ Q+L G+ Y+H ++
Sbjct: 139 DMF-----DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR---QILSGIAYLHRRHIV 190
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDT--PTAIFWTDYVATRWYRAPE-----LC 201
HRD+KP N+L N+ +KI DFG++R+ T P V T Y +PE L
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRI-LAQTMDPC----NSSVGTIAYMSPERINTDLN 245
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232
+ Y A DIWS+G E G+ FP
Sbjct: 246 HGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 59/231 (25%), Positives = 112/231 (48%), Gaps = 14/231 (6%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
K+ R F Y +L + + + +F+ +++ L Y+H+ +V
Sbjct: 61 KYSFQTHDRLCFVMEYA----NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + D +KI DFGL + +D T + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLL--GTPSPEA 254
Y A+D W +G + E++ G+ F + + +L +M ++ T SPEA
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA 222
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+++ + IG G+YG V A + TGE AIK I E D + +EI +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V L RR+ +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL---RRD--KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL + +K+ DFG V+ T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKP 229
Y DIW++G EL +P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K+ R F V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RD+K +N++ + D +KI DFGL + +D T + T Y APE+ +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLF 231
Y A+D W +G + E++ G+ F
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 18/234 (7%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRH---PDIV 85
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + P + F + +LM DLH + + + + +F+ +++ GL+++H
Sbjct: 61 CMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQK- 169
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIA 256
+ Y + D +S+GC+ +LL G F H++D MT + P++ +
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 36/223 (16%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGEK--VAIK--KINDIFEHVSDATRILREIKLLRLLRHPD 83
IG+G +G V Y + EK VA+K K S + L+E ++R HP
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPH 68
Query: 84 IVE-IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLK 140
IV+ I I P +++V EL +L ++ N L + YQL L
Sbjct: 69 IVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR------W 194
Y+ + HRD+ +N+L ++ +K+ DFGL+R +++ Y A++ W
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-------YKASKGKLPIKW 174
Query: 195 YRAPELCGSFFSKYTPAIDIWSIG-CIFAELLTG-KPLFPGKN 235
APE F ++T A D+W G C++ L+ G KP KN
Sbjct: 175 M-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 15/238 (6%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIND--IFEHVSDATRILREIKLLRLLRHPDIVE 86
+VIGKGS+G V A G A+K + I + + LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + + +Y V + + +L ++ +F+ ++ + Y+H+
Sbjct: 61 LHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK-- 170
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSPEAIARVCLLL 262
Y +D W +G + E+L G P F ++V D I+ L P + +A C LL
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA-ACDLL 227
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ + +G G+YG V A + TGE A+K I E D + I +EI +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V L SR + +++ E L + L+ + + L+GL Y+H
Sbjct: 69 VAYFGSYL--SREK---LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL + +K+ DFG VA T T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKP 229
Y DIW++G EL +P
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+++ +G+G +G V T KVAIK + L+E ++++ LRH +V
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 142
+ ++ + IY+V E M + L +K D + Q Q+ G+ YI
Sbjct: 65 PLYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
N HRDL+ NIL + KI DFGLAR+ ++ TA + +W APE
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
+ + ++T D+WS G + EL+T G+ +PG + V+ Q++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 20/233 (8%)
Query: 8 KSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT 67
+S D+D +++ EV+G G+YG V +TG+ AIK + D+ E +
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTE--DEEE 57
Query: 68 RILREIKLLRLLRHPDIVEIKHILL----PPSRREFKDIYVVFELME----SDLHQVIKA 119
I EI +L+ H + + PP + +++V E +DL + K
Sbjct: 58 EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD--QLWLVMEFCGAGSVTDLVKNTKG 115
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
N L + + ++LRGL ++H V HRD+K +N+L + ++K+ DFG V+
Sbjct: 116 NA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQL 171
Query: 180 TPTAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
T ++ T ++ APE+ + + Y DIWS+G E+ G P
Sbjct: 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKGS+G V A T E AIK + D+ D + E ++L L P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
H R +Y V E + DL I+ F+ ++ GL ++H +
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N++ +++ +KI DFG+ + D T + T Y APE+ +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA--YQP 177
Query: 208 YTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y ++D W+ G + E+L G+P F G++
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 30 VIGKGSYGVV--CSAY---DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPD 83
+G G++G V +AY + KVA+K + H S+ ++ E+K++ L H +
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMSHLGNHEN 100
Query: 84 IVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDD--LTPEHYQFFLYQLLRGLK 140
IV LL I V+ E DL ++ + LT E F YQ+ +G+
Sbjct: 101 IVN----LLGACTIG-GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++ + N HRDL +N+L +KICDFGLAR ND+ + + +W APE
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM-APE- 213
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
F YT D+WS G + E+ + G +PG
Sbjct: 214 -SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 57/222 (25%), Positives = 85/222 (38%), Gaps = 44/222 (19%)
Query: 30 VIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+IGK +V A T VA+KKIN D + +EI R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY---------QFFLYQLLRG 138
+ S ++YVV LM + +DL H+ F L +L
Sbjct: 65 VTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDF---------GLARVAFNDTPTAI----F 185
L YIH+ HR +K +IL + D K+ + G + +D P +
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 227
W +PE+ Y DI+S+G EL G
Sbjct: 174 WL---------SPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 45/142 (31%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 93 PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152
P S + D V L+ D + + D L+ F YQ+ RG++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +KICDFGLAR +D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAELLT-GKPLFPG 233
D+WS G + E+ + G +PG
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 18/240 (7%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRH---PDIV 85
+IG+G +G V TG+ A+K ++ + T L E +L L+ P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + P + F + +LM DLH + + + +F+ +++ GL+++H
Sbjct: 61 CMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQKG 170
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV--HQLDIMTDLLGTPSPEAIARVCLLL 262
+ Y + D +S+GC+ +LL G F H++D MT + P++ + L
Sbjct: 171 VA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIK-LLRLLRHPDIV 85
VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ + + +Y V + + +L ++ +F+ ++ L Y+H+
Sbjct: 60 GLHYSFQTADK-----LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCG 202
N+ +RDLKP+NIL ++ + + DFGL + + + T + + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FCGTPEYLAPEVLR 169
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
Y +D W +G + E+L G P F ++ D
Sbjct: 170 K--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 25/222 (11%)
Query: 29 EVIGKGSYGVVCSA--------YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+VIGKGS+G V A Y + +K AI K + +S+ +L+ +K
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK------ 54
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP +V + + +Y V + + +L ++ +F+ ++ L
Sbjct: 55 HPFLVGLHFSFQTADK-----LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 109
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE
Sbjct: 110 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYLAPE 166
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
+ Y +D W +G + E+L G P F +N D
Sbjct: 167 VLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 47/223 (21%)
Query: 31 IGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+G+GS+G+V A GE +VAIK +N+ + + L E +++ +V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 86 EIKHILL---PPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEHYQFFLY- 133
+ ++ P VV ELM + DL +++ N L P Q F+
Sbjct: 73 RLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 134 --QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
++ G+ Y+ HRDL +N + D +KI DFG+ R I+ TDY
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DIYETDYYR 176
Query: 190 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW APE +T D+WS G + E+ T
Sbjct: 177 KGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 9e-13
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++E +G+G +G V T +VAIK + L+E ++++ LRH +V
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQF--FLYQLLRGLKYI 142
++ ++ + IY+V E M + L +K Q Q+ G+ Y+
Sbjct: 65 QLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT-------- 170
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
APE + + ++T D+WS G + EL T G+ +PG
Sbjct: 171 -APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL 70
+ V F E GEG+ GK G + + + VAIK + + E
Sbjct: 5 SAVRFLEELGEGA-------FGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFR 56
Query: 71 REIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQ----------VIKA 119
+E +L+ L+HP+IV + + + + ++FE + DLH+ V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAE 111
Query: 120 NDDLTPEH---YQFFL---YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ D T + FL Q+ G++Y+ + + HRDL +N L +KI DFGL+
Sbjct: 112 SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 174 RVAFNDTPTAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
R I+ DY + RW PE + K+T DIWS G + E+
Sbjct: 172 R--------DIYSADYYRVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 47/226 (20%)
Query: 24 RY-KIEEVIGKGSYG-VVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILR-----EI 73
RY K V+G+G +G V YD TGE VA+K + + + EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK------RECGQQNTSGWKKEI 57
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFF 131
+L+ L H +IV+ K S + K + ++ E + S + K +L F
Sbjct: 58 NILKTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLF 112
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA----------RVAFN-DT 180
Q+ G+ Y+H+ + HRDL +N+L + D +KI DFGLA RV + D+
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
P +FW A E K++ A D+WS G ELLT
Sbjct: 173 P--VFWY---------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ ++ ++G+G +G V + TG+ A+K + + E + +L + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
I ++++ ++ ++Y+V E DL ++ +D E QF+L +L+ +
Sbjct: 63 IPQLQYAF-----QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFG-LARVAFNDTPTAIFWTDYVATRWYRAPEL 200
+H HRD+KP+N+L + +K+ DFG AR+ N + V T Y APE+
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM---VNSKLPVGTPDYIAPEV 174
Query: 201 C----GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
G Y D WS+G I E++ G+ F
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 63/235 (26%), Positives = 111/235 (47%), Gaps = 21/235 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + ++ + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA- 145
K+ R F V E +L + + + +F+ +++ L Y+H+
Sbjct: 61 KYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
NV +RDLK +N++ + D +KI DFGL + D T + T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED-- 170
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH----QLDIMTDLL--GTPSPEA 254
+ Y A+D W +G + E++ G+ P N H +L +M ++ T SPEA
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLFELILMEEIRFPRTLSPEA 223
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+++ E++G G+YG V +TG+ AIK ++ + + I +EI +L+ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRN 64
Query: 85 VEIKHILL----PPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLL 136
+ + PP + +++V E +DL + K N L E + ++L
Sbjct: 65 IATYYGAFIKKNPPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREIL 121
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
RGL ++H V HRD+K +N+L + ++K+ DFG V+ T ++ T ++
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQLDRTVGRRNTFIGTPYWM 178
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAELLTGKP 229
APE+ + + Y D+WS+G E+ G P
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 86/349 (24%), Positives = 129/349 (36%), Gaps = 71/349 (20%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y + + + GS G V A + V +K + L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY-QLLRGLKYIH 143
+ +K L+ + V SDL+ + P + Q+L GL+Y+H
Sbjct: 120 IRMKDTLV---SGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ HRD+K +NI N ++ I D G A+ P + V T APE+
Sbjct: 175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLAR 230
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263
KY DIWS G + E+L +P I D TP + LL
Sbjct: 231 --DKYNSKADIWSAGIVLFEMLA----YPST-------IFEDPPSTPEEYVKSCHSHLLK 277
Query: 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKAR------RYLSSMRKKKP 317
II V P F R+ +R Y S R+
Sbjct: 278 II------STLKVHPEEF------------------PRDPGSRLVRGFIEYASLERQ--- 310
Query: 318 IPFSQKFPNANPLALR-----LLERMLAFEPKDRPTAEEALADPYFKGL 361
P+++ +P + L L+ +ML F+ RP+AEE L P F L
Sbjct: 311 -PYTR-YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 69/232 (29%), Positives = 99/232 (42%), Gaps = 37/232 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVSDATRILREIKLLRLLRHP 82
RY I +IGKG G V AYD +VA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR----- 137
IV + I + Y+ ++S L V + + + L
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 138 --GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-----------VAFNDT---- 180
++Y+H+ V HRDLKP NIL ++ I D+G A + ++
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 181 -----PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLT 226
P I V T Y APE L G S+ T DI+++G I ++LT
Sbjct: 183 SSMTIPGKI-----VGTPDYMAPERLLGVPASEST---DIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
+V+GKGS+G V A GE A+K + D+ D + E ++L L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF--L 58
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
H+ +E ++ V E + DL I+ F+ +++ GL+++H+
Sbjct: 59 THLYCTFQTKE--HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N++ + D +KI DFG+ + F D + F T Y APE+
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEILQGL- 171
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
KYT ++D WS G + E+L G+ F G +
Sbjct: 172 -KYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPDIVEIK 88
+G G+ GVV +G +A K I+ + A R I+RE+++L P IV
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPYIVGFY 69
Query: 89 HILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN- 146
+I + E M+ L QV+K + E +LRGL Y+ +
Sbjct: 70 GAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFF 205
+ HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L G+ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERLQGTHY 179
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFP 232
S + DIWS+G EL G+ P
Sbjct: 180 SVQS---DIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 31 IGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVS-----DATRILREIKLLRLLRHPDI 84
+G GS+G V+ + Y VAIK+ FE + E K+L + HP
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKR----FEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 85 VEIKHILLPPSRREFKD---IYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
V + FKD +Y+V E ++ + ++ N + F+ Q++ +
Sbjct: 94 VNL--------YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ + N+ +RDLKP+N+L + D +K+ DFG A+V T T T Y APE+
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEYIAPEI 199
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + A D W++G E+L G P F
Sbjct: 200 LLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 53/245 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCSA----YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLR 77
R + + +G+G++G V A D VA+K + D D + ++ E+++++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMK 70
Query: 78 LL-RHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKAN--------------- 120
++ +H +I+ LL +E +YVV E +L ++A
Sbjct: 71 MIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 121 -DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ LT + F YQ+ RG++++ + HRDL +N+L D +KI DFGLAR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180
Query: 180 TPTAIFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GK 228
I DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 229 PLFPG 233
P +PG
Sbjct: 234 P-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 21/222 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I E + + EI++L HP IV+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYMVEIEILATCNHPYIVK---- 73
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVF 148
LL + K ++++ E I D LT Q Q+L L+Y+H+ +
Sbjct: 74 LLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK N+L D +K+ DFG V+ + T ++ T ++ APE+ K
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 209 TP---AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
TP DIWS+G E+ +P H+L+ M LL
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPH------HELNPMRVLL 225
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 20/128 (15%)
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
+ LT E + +Q+ RG++++ + HRDL +NIL + + +KICDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 NDTPTAIFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPGKNV 236
+PG +
Sbjct: 274 SPYPGVQI 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
E++GKG++G V + VA+K D+ + + + L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ ++R+ IY+V EL+ L + K D+L + F G+ Y+ +
Sbjct: 58 IGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L + LKI DFG++R +D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+Y+ D+WS G + E + G +PG
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--SDATRILREIKLLRLLRHP 82
Y + +VIG+G++G V ++ +KV K+ FE + SD+ E ++ P
Sbjct: 45 YDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ L + ++ K +Y+V E M + +N D+ + +F+ +++ L I
Sbjct: 104 WVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDYVATRWYRAP 198
H+ + HRD+KP N+L + LK+ DFG + TA+ DY+ +P
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI------SP 212
Query: 199 ELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
E+ S Y D WS+G E+L G F ++V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 21/222 (9%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90
+G G++G V A + TG A K I+ E + + EI +L HP+IV+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVK---- 66
Query: 91 LLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKYIHTANVF 148
LL E +++++ E + + LT + Q L L Y+H +
Sbjct: 67 LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 149 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY 208
HRDLK NIL D +K+ DFG V+ +T T ++ T ++ APE+ SK
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 209 TP---AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
P D+WS+G E+ +P H+L+ M LL
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPH------HELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPDIVE 86
IG+G++G V +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 87 IKHILLPPSRREFK--DIYVVFELMESDL-------HQVIKANDDLTPEHYQFFL----Y 133
L F+ D ++ ELM+ L ++V+K+ PE L
Sbjct: 68 FYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSV---IPEE---ILGKIAV 114
Query: 134 QLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
++ L Y+ + HRD+KP NIL + + +K+CDFG++ + +I T
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAGC 170
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQL 240
R Y APE + S Y D+WS+G E+ TGK +P +V QL
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 33/225 (14%)
Query: 30 VIGKGSYGVVCSAY---DTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + DIF SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKHILLPPSRREFKDI-YVVFELME-SDLHQVIKAND------DLTPEHYQFFLYQLLR 137
++ + L + I V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-------- 189
G++Y+ + N HRDL +N + N + + + DFGL++ I+ DY
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--------KIYSGDYYRQGCASK 176
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+ +W L + YT D+W+ G E++T G+ + G
Sbjct: 177 LPVKWLALESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 44/139 (31%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156
++ F+ S + DDL T E + +Q+ RG++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + + +KICDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAELLT-GKPLFPG 233
S G + E+ + G +PG
Sbjct: 261 SFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 44/130 (33%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 110 ESDLHQVIKANDDLT--PEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
+ D+ I D+L E F YQ+ +G+ ++ + N HRDL +NIL KI
Sbjct: 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKI 255
Query: 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 226
CDFGLAR ND+ + + +W APE F YT D+WS G + E+ +
Sbjct: 256 CDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFESDVWSYGILLWEIFSL 312
Query: 227 GKPLFPGKNV 236
G +PG V
Sbjct: 313 GSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+V+G G++G V GE V AIK +N+ ++ + E ++ + HP +
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMDEALIMASMDHPHL 71
Query: 85 VEIKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
V + + L P+ I +V +LM L V + D++ + + Q+ +G+ Y+
Sbjct: 72 VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ HRDL +N+L + +KI DFGLAR+ D + +W L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---ALEC 182
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT--GKP 229
+ K+T D+WS G EL+T GKP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 33/213 (15%)
Query: 29 EVIGKGSYGVVCSA-YDTRTGE--KVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDI 84
+ +G GS+GVV + T G+ VA+K + + +SD L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 85 VEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQF-FLYQLLRGLKY 141
+ + ++L + +V EL S L ++ K + Q+ G++Y
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYR---- 196
+ + HRDL +NIL +D K+KI DFGL R + N+ D+ +
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--------DHYVMEEHLKVPF 164
Query: 197 ---APELCGSFFSKYTPAIDIWSIGCIFAELLT 226
APE ++ A D+W G E+ T
Sbjct: 165 AWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+ + IGKG +G V D R G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDVMLG-DYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 142
++ +++ E +Y+V E M + L +++ L + F + ++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA---IFWTDYVATRWYRAPE 199
N HRDL +N+L + D K+ DFGL + A + T + WT APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GK---PLFPGKNVVHQLD 241
K++ D+WS G + E+ + G+ P P K+VV +++
Sbjct: 170 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 22/266 (8%)
Query: 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILRE 72
D T + +Y I V+G G+ G V A GE A+K ++ +D R E
Sbjct: 22 KDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAE 81
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLT---P 125
+ L IV+ R +++ ++ +++ DL Q IK+
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 126 EHYQFFLY-QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184
EH L+ Q+L + ++H+ ++ HRD+K NIL ++ +K+ DFG +++ +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244
T + T +Y APE+ Y+ D++S+G + ELLT K F G+N+ ++M
Sbjct: 202 GRT-FCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMH 255
Query: 245 DLLG--------TPSPEAIARVCLLL 262
L + SPE V LL
Sbjct: 256 KTLAGRYDPLPPSISPEMQEIVTALL 281
|
Length = 496 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 34/235 (14%)
Query: 27 IEEVIGKGSYGVVCSAYDTRTGEK-----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ + +G+G +G V A R + VA+K + + S+ +L E LL+ + H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNH 62
Query: 82 PDIVEI-----------------KHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-- 122
P ++++ K+ L RE + + + + + + N D
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 123 -LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
LT F +Q+ RG++Y+ + HRDL +N+L K+KI DFGL+R + +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ +W A E S F YT D+WS G + E++T G P +PG
Sbjct: 183 YVKRSKGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 31 IGKGSYGVVCSAYDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH 89
+G G +GVV Y G+ VAIK I E + E K++ L H +V++
Sbjct: 12 LGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 90 ILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147
+ + + IY+V E M + L+ + + P + G+ Y+ +
Sbjct: 67 VC-----TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK 207
HRDL +N L + +K+ DFGL+R +D T+ + + RW PE+ +SK
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW-SPPEVL--LYSK 177
Query: 208 YTPAIDIWSIGCIFAELLT-GK 228
++ D+W+ G + E+ + GK
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 32/254 (12%)
Query: 3 PDQRKKSSADVDFFTEYGE-----------GSRYKIEEVIGKGSYGVVCSAYDTRTGEKV 51
P RK + D +F Y + Y++ +VIG+G++G V T +
Sbjct: 13 PALRKNKNID-NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY 71
Query: 52 AIKKINDIFEHV--SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109
A+K ++ FE + SD+ E ++ P +V++ + ++ + +Y+V E M
Sbjct: 72 AMKLLSK-FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDRYLYMVMEYM 125
Query: 110 ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ +N D+ + +F+ +++ L IH+ HRD+KP N+L + LK+ D
Sbjct: 126 PGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 170 FG----LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAE 223
FG + + TA+ DY+ +PE+ S Y D WS+G E
Sbjct: 186 FGTCMKMNKEGMVRCDTAVGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
Query: 224 LLTGKPLFPGKNVV 237
+L G F ++V
Sbjct: 240 MLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 6/115 (5%)
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
LT E + +Q+ +G++++ + HRDL +NIL + + +KICDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GKPLFPG 233
P + D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 21/202 (10%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
E IG+G++G V S VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRLI 59
Query: 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLR-------GLKY 141
+ + + IY+V EL++ L E + + +L++ G++Y
Sbjct: 60 GVC-----TQKQPIYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LKI DFG++R + + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAE 223
+ +Y+ D+WS G + E
Sbjct: 169 N--YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 19/209 (9%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E + + I E G+ G + D +T E V IK E +LR +
Sbjct: 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIK--------AGQRGGTATEAHILRAIN 141
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
HP I+++K ++ ++DL+ + A ++ +LR ++
Sbjct: 142 HPSIIQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPE 199
Y+H + HRD+K +NI N + + DFG A + + W +AT APE
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPE 253
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
L Y PA+DIWS G + E+ T
Sbjct: 254 LLAR--DPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V LM DL H F+ ++ GL+ +H
Sbjct: 67 YAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAV----HVPEGQTIKGRVGTVGYMAPEVVKN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLF 231
+YT + D W++GC+ E++ G+ F
Sbjct: 176 -ERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 89 HILLPPSRREFKD-IYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ E KD + +V +M DL H N + F+ +L GL+ +
Sbjct: 67 YAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ +RDLKP+NIL + ++I D GLA P V T Y APE+ +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN- 175
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLF 231
KYT + D W +GC+ E++ G+ F
Sbjct: 176 -EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 58/223 (26%), Positives = 109/223 (48%), Gaps = 21/223 (9%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
++I +VIG+G++G V + + E++ KI + +E + A T RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKHILLPPSRREFKD---IYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
I + F+D +Y+V + + DL ++ +D PE +F++ +++
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND----TPTAIFWTDYVATRW 194
+ IH + HRD+KP N+L + + +++ DFG D + A+ DY++
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
+A E KY P D WS+G E+L G+ F +++V
Sbjct: 175 LQAME---DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 15/220 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-TRILREIKLLRLLRHPD 83
++I +VIG+G++G V + + +KV KI + +E + A T RE + + +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+ H ++ ++Y+V + + DL ++ +D PE +F+L +++ +
Sbjct: 62 WITTLHYAF----QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND----TPTAIFWTDYVATRWYRA 197
+H + HRD+KP NIL + + +++ DFG D + A+ DY++ +A
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
E KY P D WS+G E+L G+ F +++V
Sbjct: 178 ME---DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
KI E +G G+ GVV +G +A K I+ + A R I+RE+++L P
Sbjct: 9 KISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIRNQIIRELQVLHECNSPY 64
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 65 IVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 143 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-L 200
+ + HRD+KP NIL N+ ++K+CDFG++ + + +V TR Y +PE L
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPERL 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFP 232
G+ +S + DIWS+G E+ G+ P+ P
Sbjct: 175 QGTHYSVQS---DIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSA---YDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
K+ +++G+G +G V D + KVA+K + DI + S+ L E ++ H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDH 60
Query: 82 PDIVEIKHILLPPSRRE-FKDIYVVFELME-SDLHQ-VIKANDDLTPEHYQF-----FLY 133
P+++++ + S + V+ M+ DLH ++ + PE F+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---- 189
+ G++Y+ N HRDL +N + D + + DFGL++ I+ DY
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQG 172
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 173 RIAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 36/247 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ Y++ + IG G +G V RT E K I+ + ++++ E+ ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDL---TPEHYQF-FLYQLLR 137
+IV L + ++ +Y++ E ++ DL + I+ + EH QLL
Sbjct: 73 NIVRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 138 GLKYIHT-------ANVFHRDLKPKNILANADCK-----------------LKICDFGLA 173
L Y H V HRDLKP+NI + + KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ + V T +Y +PEL Y D+W++GCI EL +GK F
Sbjct: 190 K----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 234 KNVVHQL 240
N QL
Sbjct: 246 ANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 40/123 (32%), Positives = 58/123 (47%), Gaps = 22/123 (17%)
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F YQ+ G++++ + N HRDL +N+L +KICDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250
+W APE F + YT D+WS G + E+ T L GTP
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFT-------------------LGGTP 341
Query: 251 SPE 253
PE
Sbjct: 342 YPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEI-- 87
+GKG +G VC+ TG+ A KK++ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 88 -----KHILLPPSRREFKDI-YVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
H+ L S D+ Y ++ + E ++ +VI + Q+ G+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI------------HYSAQITCGI 108
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
++H+ ++ +RD+KP+N+L + ++ D GLA + T T Y APE
Sbjct: 109 LHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI----TQRAGTNGYMAPE 164
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ Y+ +D +++GC E++ G+ F
Sbjct: 165 ILKE--EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F Q+ +G+ ++ + N HRD+ +N+L KICDFGLAR ND+ + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
+W APE F YT D+WS G + E+ + GK +PG
Sbjct: 277 PVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 20/169 (11%)
Query: 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTP 125
L+EIK++ L+ P+I+ + + + + ++ E ME+ DL+Q + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHYQFFLY--------QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
Y Q+ G+KY+ + N HRDL +N L + +KI DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ I + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 43/199 (21%)
Query: 51 VAIKKINDIFEHVSDATRI--LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108
VA+K + SD R L+E+K+L L P+I LL + + ++ E
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIAR----LLGVCTVD-PPLCMIMEY 100
Query: 109 ME-SDLHQVIKANDDLTPEH--------YQFFLY---QLLRGLKYIHTANVFHRDLKPKN 156
ME DL+Q ++ + T + LY Q+ G++Y+ + N HRDL +N
Sbjct: 101 MENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160
Query: 157 ILANADCKLKICDFGLARVAF-ND-------TPTAIFWTDYVATRWYRAPELCGSFF-SK 207
L + +KI DFG++R + +D P I RW A E S K
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPI--------RWM-AWE---SVLLGK 208
Query: 208 YTPAIDIWSIGCIFAELLT 226
+T D+W+ G E+LT
Sbjct: 209 FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIND---IFEHVSDATRILREIKLLRLLRHPDIVE 86
+I G+YG V T ++ A+KKIN I + + R+I L +P +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFAENPFVVS 65
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ S + + +V E +E D ++K L + + + + + L+Y+H
Sbjct: 66 -----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF-WTDYVATRWYRAPELCGS- 203
+ HRDLKP N+L + +K+ DFGL+++ T ++ TR + ++CG+
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 204 --------FFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
Y +D W++G I E L G F G
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL-RHPDIVEI 87
VIG+GSY V +T A+K I ++ D + E + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A+ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 31 IGKGSYGVV--------CSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
+G+G++G V C D VA+K + D SD R RE +LL L+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKIL---VAVKTLKD----ASDNARKDFHREAELLTNLQ 65
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN-------------DDLTPE 126
H IV+ + + E + +VFE M+ DL++ ++A+ +LT
Sbjct: 66 HEHIVKFYGVCV-----EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
Q+ G+ Y+ + + HRDL +N L + +KI DFG++R ++ +
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW PE + K+T D+WS+G + E+ T
Sbjct: 181 HTMLPIRWM-PPE--SIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 48/218 (22%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 25 YKIEEVIGKGSYGVV-----CSAYDT------RTGEKVAIKKINDIFEHVSDATRILREI 73
+++ +V+G G+YG V S +D+ + +K I + EH ++L I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
+ + P +V + + ++ Y+ + + L Q + + Q +
Sbjct: 62 R-----QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSG 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+++ L+++H + +RD+K +NIL +++ + + DFGL++ D + + T
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
Y AP++ + A+D WS+G + ELLTG F
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 63/246 (25%), Positives = 99/246 (40%), Gaps = 59/246 (23%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+VIG+G++G V TG A+K ILR+ +L + I +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK--------------ILRKADMLEKEQVAHIRAER 52
Query: 89 HILLPP----------SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
IL+ S ++ +++Y++ E + D+ ++ D L+ E QF++ + +
Sbjct: 53 DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL 112
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVAF------------- 177
+ IH HRD+KP N+L +A +K+ DFGL R F
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 178 ----NDTPTAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225
N A W V T Y APE+ + Y D WS+G I E+L
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 226 TGKPLF 231
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 89/373 (23%), Positives = 138/373 (36%), Gaps = 84/373 (22%)
Query: 23 SRYKIEEVIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL---------- 70
+ +++ + + G++G +C A T E A + +N + R++
Sbjct: 148 AHFRVIDDLPAGAFGKIFIC-ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 71 -----REIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND---D 122
EI L L H +I++I+ IL + + Y++ + + DL+ +
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWK 261
Query: 123 LTPEHYQF--FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND- 179
P Q + QLL ++YIH + HRD+K +NI N D K+ + DFG A +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP----GKN 235
W VAT +PE+ Y DIWS G I ++L+ P G
Sbjct: 322 EAFDYGWVGTVAT---NSPEILAG--DGYCEITDIWSCGLILLDMLS-HDFCPIGDGGGK 375
Query: 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNII-WCGYDGFMCSVAPSCFLVFAIFFFFTEVL 294
QL + D L E C L + I D SV P L
Sbjct: 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPP---------------L 420
Query: 295 ILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354
I + +P ++P L +ML F+ RP A E LA
Sbjct: 421 I------------------RNLGLPADFEYP---------LVKMLTFDWHLRPGAAELLA 453
Query: 355 DPYFKGLAKVERE 367
P F A+ E E
Sbjct: 454 LPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 48/236 (20%)
Query: 24 RYKIEEVIGKGSYGVV--CSA----------YDTRTGEK--VAIKKINDIFEHVSDATR- 68
+ +++E +G+G +G V C A G+ VA+K + +D T+
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR------ADVTKT 59
Query: 69 ----ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI------ 117
L+EIK++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD-----PLCMITEYMENGDLNQFLSQREIE 114
Query: 118 ----KANDDLTPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
AN+ + LY Q+ G+KY+ + N HRDL +N L +KI DF
Sbjct: 115 STFTHANN-IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF 173
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
G++R ++ I + RW + K+T A D+W+ G E+ T
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 53/243 (21%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFE-----HVSDATRILREIKLLRLLRH 81
+VIG+G++G V TG A+K + D+ E H+ IL E L +++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+ S ++ ++Y++ E + D+ ++ D LT E QF++ + + +
Sbjct: 66 ----------MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAID 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLA-------RVAF---------------- 177
IH HRD+KP N+L ++ +K+ DFGL R F
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 178 -NDTPTAIFWT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
N A W V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEK----VAIKKIND-----IFEHVSDATRILREIKLLRLL 79
+++G G +G V G+ VAIK I D F+ ++D + + L
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD------HMLAMGSL 66
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
H IV + I S + +V +L S L V + D L P+ + Q+ +
Sbjct: 67 DHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HR+L +NIL +D ++I DFG+A + + D + +W
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM-- 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT 226
L F +YT D+WS G E+++
Sbjct: 179 -ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLL-RLLRHPDIVEI 87
VIG+GSY V +T A+K + ++ D + E + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 62 HSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +++ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 51/227 (22%)
Query: 31 IGKGSYGVV----CSAYDTRTGEK-VAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+G+G++G V C + VA+K + + S++ R RE +LL +L+H
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQH 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND---------------DLTPEH 127
IV + E + + +VFE M DL++ ++++ LT
Sbjct: 69 IVRFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ G+ Y+ + + HRDL +N L +KI DFG++R I+ T
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYST 175
Query: 188 DY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
DY + RW PE + K+T DIWS G + E+ T
Sbjct: 176 DYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 49/216 (22%), Positives = 91/216 (42%), Gaps = 14/216 (6%)
Query: 29 EVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
+ +G+G +G V + KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKHILLPPSRRE-FKDIYVVFELME-SDLHQVI---KANDD---LTPEHYQFFLYQLLRG 138
+ + L E + V+ M+ DLH + + D L + F+ + G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N + + + DFGL++ +N + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 6/103 (5%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR N +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 193 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT-GKPLFPG 233
+W APE + F + YT D+WS G + E+ T G +PG
Sbjct: 201 KWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL--RLLRHPDIVEI 87
VIG+GSY V + + A+K + H + ++ K + + +P +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 88 KHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
SR +++V E + DL ++ L EH +F+ ++ L ++H
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +AD +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245
+Y ++D W++G + E++ G+ F DI+TD
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPF---------DIITD 201
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 25 YKIEEVIGKGSYGVVCSA-----------YDTRTGEKVAIKKINDIFEHVSDATRILREI 73
+++ V+G G+YG V Y + +K I + EH TR R++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH----TRTERQV 57
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
L + R P +V + + ++ YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+++ L ++H + +RD+K +NIL +++ + + DFGL++ + + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
Y APE+ + A+D WS+G + ELLTG F
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDI-------FEHVSDATRILREIKLLRLLRHPD 83
+GKG +G V + TG+ A KK+N +E RIL ++ H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTP---EHYQ-FFLYQLLRG 138
+ + L + + D+ +V +M DL I D+ P E F+ Q++ G
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + D ++I D GLA V D + Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
EL +Y ++D +++G E++ + F
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 27/224 (12%)
Query: 22 GSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--SDATRILREIK 74
R K E+ VIG+G++G V + + A+K ++ FE + SD+ E
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERD 95
Query: 75 LLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 133
++ IV++ + K +Y+V E M DL ++ +N D+ + +F+
Sbjct: 96 IMAHANSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTA 149
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDY 189
+++ L IH+ HRD+KP N+L + LK+ DFG + TA+ DY
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209
Query: 190 VATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ +PE+ S Y D WS+G E+L G F
Sbjct: 210 I------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 50/214 (23%)
Query: 50 KVAIKKI-NDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVFE 107
KVA+K + +D E D + ++ E+++++++ +H +I+ LL ++ +YV+ E
Sbjct: 52 KVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIIN----LLGACTQD-GPLYVIVE 104
Query: 108 LM-ESDLHQVIKA----------NDDLTPEHYQFF------LYQLLRGLKYIHTANVFHR 150
+ +L + ++A N PE F YQ+ RG++Y+ + HR
Sbjct: 105 YASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164
Query: 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--------VATRWYRAPELCG 202
DL +N+L D +KI DFGLAR I DY + +W APE
Sbjct: 165 DLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKKTTNGRLPVKWM-APE--- 212
Query: 203 SFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ F + YT D+WS G + E+ T G P +PG
Sbjct: 213 ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 60/224 (26%), Positives = 90/224 (40%), Gaps = 24/224 (10%)
Query: 24 RYKIEEVIGKGSYG--VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+Y I + GS G VC+ + +KV +K V+ REI +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKA-------VTGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+ + H + R + +V + DL + + L E +LL L Y
Sbjct: 146 RAIINLIH-----AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTAIFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQL 240
L Y DIWS G + E+ GK V QL
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 10/140 (7%)
Query: 112 DLHQVIKA--NDDLTPEHYQ--FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
DL++ IK + L + Y+ YQ++ L +H+ + HRDLK NI +K+
Sbjct: 151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
Query: 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 227
DFG ++ ++D+ + + + T +Y APEL +Y+ D+WS+G I ELLT
Sbjct: 211 GDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTL 267
Query: 228 KPLFPGKNVVHQLDIMTDLL 247
F G + Q +IM +L
Sbjct: 268 HRPFKGPS---QREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
YQ+ RG++Y+ + HRDL +N+L + +KI DFGLAR N +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 193 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 204 KWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 48/221 (21%), Positives = 89/221 (40%), Gaps = 43/221 (19%)
Query: 30 VIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRIL---REIKLLRLLRHP 82
+G+G +G V A + GE + + K + D RE+ + R L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKA---LQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------LTPEHYQFFL 132
++V + + RE + Y++ E + DL Q ++A L+ +
Sbjct: 69 NVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
Q+ G+ ++ A HRDL +N L ++ ++K+ L++ +N +Y
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--------EYYKL 175
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ RW APE ++ D+WS G + E+ T
Sbjct: 176 RNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 31 IGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
+G G++G V Y R + VAIK + + E S ++RE +++ L +P IV +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 89 HILLPPSRREFKDIYVVFELMESD-LHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN 146
+ E + + +V E+ L++ + D++T + ++Q+ G+KY+ N
Sbjct: 62 GVC------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW---YRAPELCGS 203
HRDL +N+L KI DFGL++ D ++ A +W + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN- 171
Query: 204 FFSKYTPAIDIWSIGCIFAELLT--GKP 229
F K++ D+WS G E + KP
Sbjct: 172 -FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 24/112 (21%)
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY--- 189
YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR + DY
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVHDIDYYKK 192
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLT--GKPLFPG 233
+ +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 193 TSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 31 IGKGSYGVVCSA--YD-TRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+G+G++G V A Y+ + T +K VA+K + D ++ RE +LL L+H IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIV 70
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA----------------NDDLTPEHY 128
+ + + + +VFE M+ DL++ ++A +L
Sbjct: 71 KFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188
Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R ++ +
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK-PLF 231
+ RW PE + K+T D+WS G I E+ T GK P F
Sbjct: 186 MLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHP 82
K ++VIG+G++G V A + G ++ AIK++ + + D E+++L +L HP
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHP 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFE---------------LMESDLHQVI--KANDDLTP 125
+I+ ++L R + +Y+ E ++E+D I L+
Sbjct: 69 NII---NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 126 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPT 182
+ F + RG+ Y+ HRDL +NIL + KI DFGL+R V T
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-- 181
Query: 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 182 ----MGRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 50/218 (22%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 25 YKIEEVIGKGSYGVV-----CSAYDT------RTGEKVAIKKINDIFEHVSDATRILREI 73
+++ +V+G G+YG V + +DT + +K A+ + EH +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
+ + P +V + + ++ YV M + L+Q D+ + + +F+
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSG 112
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+++ L+++H + +RD+K +NIL +++ + + DFGL++ ++ + + T
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
Y APE+ + A+D WS+G + ELLTG F
Sbjct: 171 EYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 43/238 (18%)
Query: 21 EGSRYKIEEV--IGKGSYGVVCSA-----YDTRTGEKVAIKKINDIFEHVSDATR--ILR 71
E R IE V IG+G++G V A VA+K + E S + R
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQR 57
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--------- 121
E L+ HP+IV++ + K + ++FE M DL++ ++
Sbjct: 58 EAALMAEFDHPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112
Query: 122 -------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
L+ Q+ G+ Y+ HRDL +N L + +KI
Sbjct: 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 172
Query: 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
DFGL+R ++ D + RW PE F+++YT D+W+ G + E+ +
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK-KINDIFEHVSDAT--RILREIKLLRLL 79
+ +K +V+G G++G V GEKV I I ++ E S IL E ++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLR 137
+P + + I L + + ++ +LM L V + D++ ++ + Q+ +
Sbjct: 67 DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HRDL +N+L +KI DFGLA++ D V +W
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ YT D+WS G EL+T
Sbjct: 181 ESI---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 56/229 (24%), Positives = 107/229 (46%), Gaps = 33/229 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++I +VIG+G++G V V +K ++ A +IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKHILLPPSRR-------EFKD---IYVVFEL-MESDLHQVI-KANDDLTPEHYQFFL 132
E + +L+ RR F+D +Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTD 188
+++ + +H HRD+KP N+L + + +++ DFG L + A+ D
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
Y++ +A E +Y P D WS+G E+L G+ F +++V
Sbjct: 169 YISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 55/244 (22%)
Query: 23 SRYKIEEVIGKGSYGVV--CSA------------YDTRTGEK--VAIKKINDIFEHVSDA 66
+E +G+G +G V C ++ R G VA+K + DA
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR------PDA 58
Query: 67 TR-----ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA- 119
+ L+E+K+L L+ P+I+ + + + + + ++ E ME+ DL+Q + +
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCV-----DEDPLCMITEYMENGDLNQFLSSH 113
Query: 120 ---------NDDLTPEH------YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANA 161
ND + P H Y L+ Q+ G+KY+ + N HRDL +N L
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173
Query: 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ +KI DFG++R + I + RW A E K+T A D+W+ G
Sbjct: 174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTL 230
Query: 222 AELL 225
E+L
Sbjct: 231 WEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 49/235 (20%)
Query: 31 IGKGSYGVVC--SAYD---TRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+G G++G V +A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL------- 136
V++ + L + Y++ ELME DL ++ L +LL
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RGLKYIHTANVFHRDLKPKNILA-----NADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
+G Y+ + HRDL +N L +AD +KI DFGLAR I+ +DY
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--------DIYKSDYYR 168
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ RW APE L G F T D+WS G + E+LT G+ +P N
Sbjct: 169 KEGEGLLPVRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 40/219 (18%)
Query: 31 IGKGSYGVVC--SAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI---- 84
IG G +G V A+ + +V +K++ + L+E++ R L HP++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 85 ---VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----DLTPEHYQFFLYQL 135
+E LL V E DL +++N + Q ++
Sbjct: 62 GQCIESIPYLL------------VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD---YVAT 192
GL ++H A+ H DL +N AD +KI D+GL A P + T V
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPL 166
Query: 193 RWYRAPELCGSFFS-----KYTPAIDIWSIGCIFAELLT 226
RW APEL T +IWS+G EL T
Sbjct: 167 RWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSA--YDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLR 77
S + E +G+ +G V + T GE+ VAIK + D E E +
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRS 63
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI----------KANDD---- 122
L+HP+IV LL +E + + ++F SDLH+ + +DD
Sbjct: 64 RLQHPNIV----CLLGVVTKE-QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 123 --LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
L P + + Q+ G++++ + +V H+DL +N+L +KI D GL R +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ + RW +PE + K++ DIWS G + E+ +
Sbjct: 179 YYKLMGNSLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 46/232 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHP 82
K E+VIG+G++G V A + G K+ AIK + + F +D E+++L +L HP
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHP 63
Query: 83 DIVEIKHILLPPSRREFKDIYVVFE----------LMESDLHQVIKANDDLTPEH---YQ 129
+I+ ++L R + +Y+ E L +S +V++ + EH
Sbjct: 64 NII---NLLGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTAST 115
Query: 130 FFLYQLLR-------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFND 179
QLL+ G++Y+ HRDL +N+L + KI DFGL+R V
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
T + RW L +S YT D+WS G + E+ L G P
Sbjct: 176 T------MGRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 58/255 (22%), Positives = 96/255 (37%), Gaps = 65/255 (25%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFE-----HVSDATRILREIKLLRLLRH 81
+ +G G++G VC A T A+K + D+ HV IL E +++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVK- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
L S ++ ++Y V + + + ++ PE +F++ +L ++
Sbjct: 66 ----------LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIE 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGL----------------ARVAFNDTPTAI 184
+H HRD+KP NIL + D +K+ DFGL + + + +
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 185 FWTD----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWS 216
W D V T Y APE+ YT D WS
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWS 233
Query: 217 IGCIFAELLTGKPLF 231
+G I E+L G+P F
Sbjct: 234 VGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRL 78
S + E +G+ ++G + + G + VAIK + DI + +E L+
Sbjct: 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAE 63
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFE-LMESDLHQVI-----------KANDDLTP- 125
L HP+IV LL +E + + ++FE L + DLH+ + +++D T
Sbjct: 64 LHHPNIV----CLLGVVTQE-QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 126 ---EHYQFF--LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+H F Q+ G++Y+ + H+DL +NIL +KI D GL+R ++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ + RW PE + K++ DIWS G + E+ +
Sbjct: 179 YYRVQPKSLLPIRWM-PPE--AIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 29/221 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSA----YDTRTGEKVAIKKINDIFEHVSDA--TRILREIKLL 76
R + +++ +G++G + E+V +K + D H S+ T +L+E LL
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLL 62
Query: 77 RLLRHPDIVEIKH----------ILLP-PSRREFKDIYVVFELMESDLHQVIKANDDLTP 125
L H +I+ I H +L P + K L E++ Q + +
Sbjct: 63 YGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH- 121
Query: 126 EHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185
Q+ G+ Y+H V H+D+ +N + + + ++KI D L+R F +
Sbjct: 122 -----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ +W L +S A D+WS G + EL+T
Sbjct: 177 DNENRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK-KINDIFEHVSDAT--RILREIKLLRLLRHPDIVE 86
V+G G++G V GE V I I + E+ S IL E ++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 87 IKHILLPPSRREFKDIYVVFELMESD--LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I L + + +V +LM L V + D + + + Q+ +G+ Y+
Sbjct: 74 LLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVATRWYRAPELCG 202
+ HRDL +N+L + +KI DFGLAR+ D + D V +W +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALESI-- 183
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT--GKPL--FPGKNV 236
++T D+WS G EL+T KP P + +
Sbjct: 184 -LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 61/230 (26%), Positives = 96/230 (41%), Gaps = 47/230 (20%)
Query: 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKL 75
E G+GS + E I KG VV +TR VAIK +N E S RI L E +
Sbjct: 13 ELGQGSFGMVYEGIAKG---VVKDEPETR----VAIKTVN---EAASMRERIEFLNEASV 62
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDLTPEH 127
++ +V + ++ + + V+ ELM DL +++ N P
Sbjct: 63 MKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117
Query: 128 YQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184
+ + ++ G+ Y++ HRDL +N + D +KI DFG+ R I
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DI 169
Query: 185 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ TDY + RW L F+ Y+ D+WS G + E+ T
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 12/119 (10%)
Query: 112 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 170
DL ++K L+ + + QL+ L +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
GL ++ TP+ Y T Y +PE + G Y + D W++G + ELLTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 61/256 (23%), Positives = 96/256 (37%), Gaps = 67/256 (26%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIF-----EHVSDATRILREIKLLRLLRH 81
+ +G G++G VC A T A+K + D+ HV IL E ++R
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR- 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
L S ++ ++Y V + + + + PE +F++ +L ++
Sbjct: 66 ----------LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVE 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF--------------- 185
+H HRD+KP NIL + D +K+ DFGL F T + +
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC-TGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 186 --WTD----------------------------YVATRWYRAPELCGSFFSKYTPAIDIW 215
W D V T Y APE+ + YT D W
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWW 232
Query: 216 SIGCIFAELLTGKPLF 231
S+G I E+L G+P F
Sbjct: 233 SVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 62/269 (23%), Positives = 103/269 (38%), Gaps = 77/269 (28%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLR 77
+ +VIGKG++G V TG+ A+K + D HV +L E
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD--- 59
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLY 133
P +V + + F+D ++ +ME DL ++ D + + +F++
Sbjct: 60 ---SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA 108
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT------ 187
+ + ++ +H HRD+KP NIL + +K+ DFGL+ F+ + ++
Sbjct: 109 ECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS-TGFHKQHDSAYYQKLLQGK 167
Query: 188 ------------------------DYVATRW----------------YRAPELCGSFFSK 207
D +AT W Y APE+ F +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI---FLQQ 223
Query: 208 -YTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y D WS+G I E L G P F +N
Sbjct: 224 GYGQECDWWSLGAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 5e-07
Identities = 17/45 (37%), Positives = 25/45 (55%)
Query: 314 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
K PF + +P A L+ ++L +P+ R TAEEAL P+F
Sbjct: 210 GKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLL-RLLRHPDIV 85
+VIG+G++G V A + G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKHILLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEH---YQFFLYQLLR 137
++L R + + + + + L +V++ + + QLL
Sbjct: 60 ---NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPTAIFWT 187
G+ Y+ HRDL +NIL + KI DFGL+R V T
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT------M 170
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 171 GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 21 EGSRYKIEEV--IGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LR 71
E SR KI + +G+GS+G+V A D GE +VA+K +N E S RI L
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLN 58
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKA-------NDDL 123
E +++ +V + ++ + + VV ELM DL +++ N
Sbjct: 59 EASVMKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 124 TPEHYQFFLY---QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
P Q + ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------ 167
Query: 181 PTAIFWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
I+ TDY + RW L F+ + D+WS G + E+ +
Sbjct: 168 --DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 3/90 (3%)
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
QLL + YIH + HRD+K +N+L N + + DFG A A T + T
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY-GIAGTV 326
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223
APE+ YTP++DIWS G + E
Sbjct: 327 DTNAPEVLAG--DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 39/156 (25%), Positives = 55/156 (35%), Gaps = 59/156 (37%)
Query: 125 PEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183
E +F++ +L ++ +H HRD+KP NIL + D +K+ DFGL T
Sbjct: 99 EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC--------TG 150
Query: 184 IFWT------------------------------------------------DYVATRWY 195
WT V T Y
Sbjct: 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNY 210
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
APE+ + YT D WS+G I E+L G+P F
Sbjct: 211 IAPEVLLR--TGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 31 IGKGSYGVVCSAYDTRTGEKVAIK------KINDIFEHVSDATRILREIKLLRLLRHPDI 84
I +G++G V + A+K IN H A R L L + P I
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-----DALALSKSPFI 66
Query: 85 VEIKHILLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
V + + S + ++Y+V E L+ D+ ++ E ++ ++ L Y+H
Sbjct: 67 VHLYY-----SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+ HRDLKP N+L + + +K+ DFGL++V N
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 32/118 (27%), Positives = 51/118 (43%), Gaps = 8/118 (6%)
Query: 115 QVIKANDDLTPE--HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
+ + + +TP+ Q ++ GL ++H N H DL +N L AD +KI D+GL
Sbjct: 87 RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-----TPAIDIWSIGCIFAELL 225
+ + + +V RW APEL T ++WS+G EL
Sbjct: 147 SHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 52/213 (24%), Positives = 81/213 (38%), Gaps = 31/213 (14%)
Query: 31 IGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI----- 84
IG G +G V+ S T TG + K + L++ R+L+HP+I
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 85 --VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLY----QLLR 137
VE LL VFE E DL + L ++
Sbjct: 63 QCVEAIPYLL------------VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ ++H N H DL +N +D +K+ D+G+ + + V RW A
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-A 169
Query: 198 PELCGSFF-----SKYTPAIDIWSIGCIFAELL 225
PEL G F ++ T ++W++G EL
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVAFNDTPTAIFWTDYVAT 192
+++ L +H + RDL P NIL + +++ F + V + A+
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-------E 145
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
Y APE+ G S+ T A D WS+G I ELLTGK L
Sbjct: 146 NMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 7e-06
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 21/214 (9%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATR--ILREIKL 75
+ KIE ++G G +G +C ++ VAI + SD R L E
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA---GCSDKQRRGFLAEALT 59
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND-DLTPEHYQFFLY 133
L H +IV ++ ++ + + +V E M + L ++ ++ L L
Sbjct: 60 LGQFDHSNIVRLEGVITRGN-----TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-DYVAT 192
L G+KY+ H+ L +L N+D KI F + D AI+ T +
Sbjct: 115 GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEAIYTTMSGKSP 171
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
+ APE + ++ A D+WS G + E+++
Sbjct: 172 VLWAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ Q+L GL+ +H + HRD+KP+N+L D ++KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 50/234 (21%)
Query: 30 VIGKGSYGVVCSA-YDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+G G++G V Y R G+ +VA+K + + D + L E ++ H +I
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNI 71
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR------ 137
V + + R +++ ELM DL ++ N + LL
Sbjct: 72 VRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 138 -GLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPTAIFWTDY-- 189
G KY+ + HRD+ +N L CK KI DFG+AR I+ Y
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLT--CKGPGRVAKIADFGMAR--------DIYRASYYR 176
Query: 190 ------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 234
+ +W PE L G F SK D+WS G + E+ + G +PG+
Sbjct: 177 KGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 13/47 (27%), Positives = 21/47 (44%), Gaps = 1/47 (2%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358
+ + + A L+++ L +P RPTAEE L P+F
Sbjct: 215 LGPPLEFDEPKWSSG-SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S K E VI +G G + G + +K+IND+ + EI + L+HP
Sbjct: 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV------NSIPSSEIADMGKLQHP 743
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV++ + R K Y++ E +E +L +V++ +L+ E + + + L++
Sbjct: 744 NIVKLIGLC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRF 795
Query: 142 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+H + V +L P+ I+ + + + L + DT I + Y AP
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-------SSAYVAP 847
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
E + T DI+ G I ELLTGK
Sbjct: 848 ETRET--KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 26/213 (12%)
Query: 30 VIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G V A TGE V +++IN T + E+ + +L HP+IV
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ---------FFLYQLLRG 138
+ + + +++VV M + DL H+ + L +L+
Sbjct: 65 RATFIADN-----ELWVVTSFM------AYGSAKDLICTHFMDGMSELAIAYILQGVLKA 113
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY----VATRW 194
L YIH HR +K +IL + D K+ + N D+ V
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP 173
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 227
+ +PE+ Y DI+S+G EL G
Sbjct: 174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 9/75 (12%)
Query: 129 QFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLA---RVAFNDTPTAI 184
Q + Q+L L +H+ + HRD+KP+NI+ + KI D G A RV N P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPE 199
+++ Y APE
Sbjct: 315 --KEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 16/48 (33%), Positives = 21/48 (43%), Gaps = 6/48 (12%)
Query: 315 KKPIPFSQKFPNAN---PLALRLLERMLAFEPKDRPTAEEALADPYFK 359
K IP N P L + L +P+ RP+AEE L P+ K
Sbjct: 230 TKGIP---PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 599 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.42 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.14 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.13 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.86 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.73 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.71 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.56 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.34 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.3 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.19 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.16 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.09 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.07 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.07 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.81 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.78 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.77 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.2 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.16 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.13 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.91 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.37 | |
| PLN02236 | 344 | choline kinase | 95.35 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.43 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.34 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.9 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.21 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.91 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 91.86 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 90.48 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 90.21 | |
| PTZ00296 | 442 | choline kinase; Provisional | 89.94 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 89.88 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-78 Score=611.29 Aligned_cols=342 Identities=60% Similarity=0.995 Sum_probs=323.5
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
+.|....+|..++.||+|+||+|++|.++.||+.||||+|.+.|.+...+++.+||+.+|++++|+||+.+++++.+++.
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 45677888888999999999999999999999999999999999999999999999999999999999999999998788
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+.++++|+|+|+|+.||+++|+++..|++++++.+++||++||+|+|+.||+||||||.|+|+|.+|.+||||||+||..
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 88999999999999999999999988999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... ....++|.|+.|+||+|||++... ..|+.++||||+||||+|||+|+++|+|++..+|+++|.+++|+|+++.+.
T Consensus 176 ~~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 176 DKF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred ccc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 655 556678999999999999999764 899999999999999999999999999999999999999999999999998
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
+ +.++.+++|+.+++...+.+|...||++++.|+|||+
T Consensus 254 ~------------------------------------------i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLle 291 (359)
T KOG0660|consen 254 K------------------------------------------IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLE 291 (359)
T ss_pred H------------------------------------------hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHH
Confidence 8 7889999999999999999999999999999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhhH
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQML 406 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~~~~ 406 (599)
+||.+||.+|+|++|||+||||..++++++||.+++.... ++.. .+.+++|+++++|+..|+|+..
T Consensus 292 kmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---~~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 292 KMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---FEHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred HHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc---cccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 9999999999999999999999999999999988776443 4555 8999999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-61 Score=470.32 Aligned_cols=288 Identities=43% Similarity=0.713 Sum_probs=251.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.+|..+++||+|.||+||+|+|..||+.||||+|+.......-....+|||++|+.++|+||+.|+++|... ..+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence 589999999999999999999999999999999986533334455678999999999999999999999544 469
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
.||+|||+.+|..+|+... .++..+++.|+.++++||+|||+++|+||||||.|+||+.+|.+||+|||+|+.......
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998764 789999999999999999999999999999999999999999999999999998765443
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
. .+..+.|+||+|||++.|. ..|+..+||||+|||++||+.|.|+|+|+++.+|+..|++.+|+|.++.|..++.+
T Consensus 157 ~---~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 I---QTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred c---cccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 3455999999999999774 78999999999999999999999999999999999999999999999987663322
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
.. |+ .+......+....|+.++.++.|||.+||.+
T Consensus 233 pd--------------------------------------------Y~-~~~~~P~~~~~~lf~aas~d~ldLl~~m~~y 267 (318)
T KOG0659|consen 233 PD--------------------------------------------YV-KIQQFPKPPLNNLFPAASSDALDLLSKMLTY 267 (318)
T ss_pred cc--------------------------------------------HH-HHhcCCCCccccccccccHHHHHHHHhhhcc
Confidence 21 11 1223344556668999999999999999999
Q ss_pred CCCCCCCHHHHhcCccccCCccC
Q 007542 342 EPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
||.+|+|+.|+|+|+||+....+
T Consensus 268 nP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 268 NPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred CchhcccHHHHhcchhhhcCCCC
Confidence 99999999999999999986543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-61 Score=476.63 Aligned_cols=289 Identities=37% Similarity=0.688 Sum_probs=247.5
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|+.+.++|+|+||+||+|+++.||+.||||++....++..-.+-.+|||++|++|+|+|+|.|+++| +....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 579999999999999999999999999999999976555555556678999999999999999999999 444679
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
+||||||+.++.+.+... .+++++.++.+++|++.|+.|||++++|||||||+||||+.+|.+||||||+||....
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--- 153 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--- 153 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC---
Confidence 999999998877777665 4799999999999999999999999999999999999999999999999999998743
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
....+|+|+.|+||+|||++.+- ..|+..+|||++||+++||++|.++|+|+++++|+..|...+|...+..+.-..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~-- 230 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS-- 230 (396)
T ss_pred CcchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc--
Confidence 23457999999999999998764 789999999999999999999999999999999999999999999887654310
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
.++.+.|.. --....+.++...+|+++..+.||+++||..
T Consensus 231 ~N~~F~Gv~----------------------------------------lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~ 270 (396)
T KOG0593|consen 231 SNPFFHGVR----------------------------------------LPEPEHPEPLERKYPKISNVLLDLLKKCLKM 270 (396)
T ss_pred cCCceeeee----------------------------------------cCCCCCccchhhhcccchHHHHHHHHHHhcC
Confidence 000000000 0011234466778899999999999999999
Q ss_pred CCCCCCCHHHHhcCccccCCc
Q 007542 342 EPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~~ 362 (599)
||.+|+|-+|+|.||||.++.
T Consensus 271 dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 271 DPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred CccccccHHHHhcChHHHHHH
Confidence 999999999999999997653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-60 Score=472.97 Aligned_cols=295 Identities=39% Similarity=0.636 Sum_probs=253.2
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
...-+.|+.+..|++|+||+||+|+|+.|++.||+|+++...+.....-.-+|||.+|.+++|||||.+.+|.....
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~--- 148 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN--- 148 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---
Confidence 34457899999999999999999999999999999999876655555566789999999999999999999996543
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
.+.+|||||||+.||..++..-+ ++...+++.++.|+++||+|||.++|+|||||++|+|++..|.+||+|||+||.+.
T Consensus 149 ~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 149 MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 35699999999999999998865 89999999999999999999999999999999999999999999999999999886
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
+.. ..+|..+.|.||+|||++.+. ..|++++||||+|||++|||+++|+|+|++..+|+++|++++|+|+..
T Consensus 229 sp~---k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~---- 300 (419)
T KOG0663|consen 229 SPL---KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA---- 300 (419)
T ss_pred CCc---ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc----
Confidence 542 346889999999999999885 789999999999999999999999999999999999999999999986
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC--CHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA--NPLALRLL 335 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--s~~a~dLL 335 (599)
+|.|+.....+. . -.+.......+...|+.. +..+.|||
T Consensus 301 -------iwpg~~~lp~~k-------------------------------~-~~f~~~pyn~lr~kF~~~~lse~g~~Ll 341 (419)
T KOG0663|consen 301 -------IWPGYSELPAVK-------------------------------K-MTFSEHPYNNLRKKFGALSLSEQGFDLL 341 (419)
T ss_pred -------cCCCccccchhh-------------------------------c-cccCCCCchhhhhhccccccchhHHHHH
Confidence 466666543210 0 011122223344445554 48999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
.+||.+||.+|+||+|+|+|.||.+...
T Consensus 342 n~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 342 NKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred HHHhccCccccccHHHhhcccccccCCC
Confidence 9999999999999999999999998544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-60 Score=493.00 Aligned_cols=288 Identities=37% Similarity=0.600 Sum_probs=250.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.+.|+.++.||+|+||.||+|++..||+.||+|++..............|||.||++|.||||++|.+++... ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 5789999999999999999999999999999999986666666677788999999999999999999999765 2357
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|||||||+.||.-++...+ .+++.+++.|+.||+.||.|||++||+|||||.+|||||.+|.+||+|||||+++....
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99999999999999998765 89999999999999999999999999999999999999999999999999999875443
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
.. .+|..+.|+||+|||+|+|. ..|+.++|+||+||||+||++|+|+|+|.++++|+.+|++++|.|+++.|....+
T Consensus 273 ~~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SA--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred Cc--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 32 37899999999999999885 7899999999999999999999999999999999999999999999987663111
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc--CCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK--KKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.... .++. ....-+.+.|..+++.+++||..|
T Consensus 350 P~~~----------------------------------------------~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~l 383 (560)
T KOG0600|consen 350 PHAT----------------------------------------------IFKPQQPYKRRLRETFKDFPASALDLLEKL 383 (560)
T ss_pred Cccc----------------------------------------------ccCCCCcccchHHHHhccCCHHHHHHHHHH
Confidence 1000 0000 011224455678899999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCC
Q 007542 339 LAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|..||.+|.||.++|.|+||+.-
T Consensus 384 L~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 384 LSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred hccCccccccHHHHhcCcccccC
Confidence 99999999999999999999543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-60 Score=490.42 Aligned_cols=291 Identities=38% Similarity=0.677 Sum_probs=255.5
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~ 98 (599)
...+||.+++.||.|+||.||+|..+.+|+.||||++++.+..-.+.-. +||+..|++|+ ||||++|++++.+..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~--- 82 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDND--- 82 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccC---
Confidence 4568999999999999999999999999999999999987766444443 59999999999 999999999995432
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+|+|||||+.+|+++++..+ .+++..++.|++||++||+|+|.+|++||||||+||||..+..+||+|||+||...
T Consensus 83 -~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 -RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred -ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 3899999999999999998764 68999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
+.. .+|.|+.|+||||||+|+.. ..|+.++|||++|||++|+.+-+|+|+|.++.||+.+|.+++|+|..+.|..
T Consensus 162 Skp----PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKP----PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred cCC----CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 443 46899999999999998763 6899999999999999999999999999999999999999999999887755
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
...+.. ..=-.++...+.++..+++++++++.+||.+
T Consensus 237 g~~La~-------------------------------------------~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ 273 (538)
T KOG0661|consen 237 GYNLAS-------------------------------------------AMNFRFPQVKPSPLKDLLPNASSEAASLIER 273 (538)
T ss_pred HHHHHH-------------------------------------------HhccCCCcCCCCChHHhCcccCHHHHHHHHH
Confidence 211111 1111245667788889999999999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCcc
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
||.|||.+||||.|+|+||||+.-..
T Consensus 274 ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 274 LLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HhcCCCccCccHHHHhcCcccccccc
Confidence 99999999999999999999986543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-57 Score=473.45 Aligned_cols=338 Identities=94% Similarity=1.478 Sum_probs=302.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.++||+|+||.||+|++..+|..||||++...........++.+|+.+|+.++||||+++++++......+...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999976555555667789999999999999999999998766555566799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
+||||++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654433333
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
..+...++|++|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|+.+.+..
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 234 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR------ 234 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH------
Confidence 34466789999999999865335789999999999999999999999999999999999999999999887765
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 343 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP 343 (599)
+.+.....++..+....+.++.+.++..++.+.+||.+||+.||
T Consensus 235 ------------------------------------i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 278 (338)
T cd07859 235 ------------------------------------VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDP 278 (338)
T ss_pred ------------------------------------hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCc
Confidence 44455667777777777888888888999999999999999999
Q ss_pred CCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 344 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 344 ~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
.+|||++|+|+||||+++......+...+....++.++.+.++.+++++.+++++++|||
T Consensus 279 ~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 279 KDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338 (338)
T ss_pred ccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhcCHHHHHHHHHHHHHhcCC
Confidence 999999999999999999888888888999999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=454.64 Aligned_cols=286 Identities=40% Similarity=0.675 Sum_probs=246.4
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.|.-.++||+|+||+||.|....+++.||||++-.... .-.+|+.+|+.++|||||+|+-.|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 57889999999999999999999999999999843211 123899999999999999999999765433345778
Q ss_pred EEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-CceeeecccccccccC
Q 007542 104 VVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFN 178 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFGla~~~~~ 178 (599)
+|||||+.+|.++++. +..++.-.++-+.+||++||+|||+.||+||||||+|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9999999999999985 5689999999999999999999999999999999999999987 9999999999998866
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
+.+. .+|..|+.|||||++.+. ..|+.++||||+|||++||+.|+++|+|++..+|+.+|++++|+|+.+++..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 5554 578999999999999874 78999999999999999999999999999999999999999999999999873
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcC-CCCCCCHHHHHHHHH
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ-KFPNANPLALRLLER 337 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~s~~a~dLL~~ 337 (599)
+.. |. -...+..++.++.+ .+...++++.||+.+
T Consensus 254 n~~-------y~--------------------------------------~~~~p~ik~~~~~~~~~~~~~~d~~dll~~ 288 (364)
T KOG0658|consen 254 NPN-------YT--------------------------------------EFKFPQIKAHPWHKVFFKRLPPDALDLLSK 288 (364)
T ss_pred Ccc-------cc--------------------------------------cccCcccccccceeecccCCCHHHHHHHHH
Confidence 311 00 01123334455555 456789999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKVE 365 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~~ 365 (599)
+|+++|.+|.|+.|+|.||||..+.++.
T Consensus 289 ~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 289 LLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred HhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 9999999999999999999999987753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-56 Score=453.89 Aligned_cols=265 Identities=35% Similarity=0.588 Sum_probs=222.7
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----hhHHHHHHHHHHHHhcCCCCccccceeecCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-----SDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~-----~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~ 94 (599)
...+.|.+.+.||+|+||.|.+|+.+.||+.||||+|++..... .....+.+|+++|++|+|||||+++++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 35788999999999999999999999999999999997543222 2334578999999999999999999999543
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC---Cceeeecc
Q 007542 95 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDF 170 (599)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~---~~lKL~DF 170 (599)
...|||||||+ |+|++.+..++.+.++..+.+++||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 249 -----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 249 -----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred -----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 46799999999 6999999999999999999999999999999999999999999999999877 88999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhcC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLG 248 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~-~l~~I~~~lg 248 (599)
|+|+..++ ..++.+.|||+.|.|||++.+.... +..++||||||||||.+|+|.+||.+....- ..++|.+-
T Consensus 324 GlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G-- 397 (475)
T KOG0615|consen 324 GLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG-- 397 (475)
T ss_pred chhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC--
Confidence 99998653 3467889999999999999653233 4458999999999999999999998765332 33333221
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
........|..+|
T Consensus 398 -------------------------------------------------------------------~y~f~p~~w~~Is 410 (475)
T KOG0615|consen 398 -------------------------------------------------------------------RYAFGPLQWDRIS 410 (475)
T ss_pred -------------------------------------------------------------------cccccChhhhhhh
Confidence 1111223455688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.++++||.+||..||++|||++|||+||||+...
T Consensus 411 eea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 411 EEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 9999999999999999999999999999999653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-55 Score=442.42 Aligned_cols=294 Identities=38% Similarity=0.661 Sum_probs=249.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC-ccccceeecCCCc-CCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD-IVEIKHILLPPSR-REF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn-Iv~l~~v~~~~s~-~~~ 99 (599)
...|+.+++||+|+||+||+|+++.+|+.||+|++..............||+.+|+.++|+| |+.|++++..... +..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45677888999999999999999999999999999866554444556789999999999999 9999999975442 334
Q ss_pred ccEEEEEecCCccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 100 KDIYVVFELMESDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..+|+||||++.+|..++.... .++...++.+++||++||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 5799999999999999998765 588889999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..-.. ..+++.++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.++.+|+..|++++|+|+++.|
T Consensus 170 ~~ip~---~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 170 FSIPM---RTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hcCCc---ccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 53222 236788999999999999875 57999999999999999999999999999999999999999999999765
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCC-CCCCcCCCCCCCHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK-PIPFSQKFPNANPLALRL 334 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~s~~a~dL 334 (599)
.. .....+. -...+... +.++....+..++.+.+|
T Consensus 246 p~-----------v~~~~~~---------------------------------k~~f~~~~~~~~l~~~~~~~~~~~~dl 281 (323)
T KOG0594|consen 246 PG-----------VSSLPDY---------------------------------KAPFPKWPGPKDLSSILPKLDPDGIEL 281 (323)
T ss_pred CC-----------ccccccc---------------------------------cccCcCCCCccchHHhccccCccHHHH
Confidence 44 2221110 00122222 556667777888899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
+.+||++||.+|+||..+|+||||..+..
T Consensus 282 l~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 282 LSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred HHHHhccCcccCcCHHHHhcChhhccccc
Confidence 99999999999999999999999998754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=430.30 Aligned_cols=342 Identities=37% Similarity=0.683 Sum_probs=293.0
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCC-C
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP-S 95 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~-s 95 (599)
+.+.+..||.-+..+|.|.- .|..|.|..+++.||+|++...+.+...+++..||+.++..++|+||++++++|.+. .
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 55788899999999999999 899999999999999999988888888899999999999999999999999999764 3
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..++.++|+|||+|..+|.+++. -.+..+.++++++|+++|++|||+.||+||||||+||+++.+|.+||+|||+|+.
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 35678899999999999999998 3588899999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.... ..+++|+.|+.|+|||++.+ ..|...+||||+|||++||++|+.+|+|++..+|..+|.+.+|+|.+..+
T Consensus 168 e~~~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 168 EDTD----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred cCcc----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 4322 45789999999999999988 56999999999999999999999999999999999999999999999988
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC---------
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN--------- 326 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--------- 326 (599)
+++. ..++.|+.++++.....+++.||+
T Consensus 242 ~qL~-------------------------------------------~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~ 278 (369)
T KOG0665|consen 242 KQLQ-------------------------------------------PTVRNYVENRPQYQAISFSELFPDSLFPVVLEG 278 (369)
T ss_pred HHhh-------------------------------------------HHHHHHhhcChHhhccchhhhCCcccccccccC
Confidence 7732 234555555555555555555544
Q ss_pred ---CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 327 ---ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 327 ---~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
-...|.||+.+||..||++|+|++++|.||||+ ++-..+++..++....+..++.+..+.++|+|+|++|+.+|.+
T Consensus 279 ~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~-vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~ 357 (369)
T KOG0665|consen 279 SKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK-VWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEE 357 (369)
T ss_pred CccchHHHHHHHHHhhccChhhcccHHHHhcCCeee-eecccccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence 235789999999999999999999999999999 4444455555544445566777888899999999999999987
Q ss_pred hhHHhhhc
Q 007542 404 QMLKEFLE 411 (599)
Q Consensus 404 ~~~~~~~~ 411 (599)
....+-++
T Consensus 358 ~~~~~I~~ 365 (369)
T KOG0665|consen 358 FNKNNIMN 365 (369)
T ss_pred cccchhhc
Confidence 54443333
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-53 Score=449.99 Aligned_cols=264 Identities=33% Similarity=0.559 Sum_probs=233.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..+|...+.||+|+|+.||.+++..+|+.||+|+|.+. .......+++.+||++.+.|+|||||+++++| ++.+
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~ 91 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSN 91 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCC
Confidence 48899999999999999999999999999999999753 34455678899999999999999999999999 5556
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
++|||+|+|. ++|..+++..+.++|.++++|++||+.||.|||+++|+|||||..|||++++.+|||+|||||......
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 8999999999 799999999999999999999999999999999999999999999999999999999999999987644
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
... ..+.|||+.|.|||++.. ..++..+||||+|||||.||.|+|||..++..+.+.+|...--.
T Consensus 172 ~Er---k~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~---------- 236 (592)
T KOG0575|consen 172 GER---KKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS---------- 236 (592)
T ss_pred ccc---cceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc----------
Confidence 332 256799999999999986 78999999999999999999999999999888888777531110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
....+|.+|.|||.+||
T Consensus 237 ---------------------------------------------------------------~P~~ls~~A~dLI~~lL 253 (592)
T KOG0575|consen 237 ---------------------------------------------------------------MPSHLSAEAKDLIRKLL 253 (592)
T ss_pred ---------------------------------------------------------------cccccCHHHHHHHHHHh
Confidence 01257889999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCccCCCCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAKVEREP 368 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~~~~e~ 368 (599)
+.||.+|||++++|.|+||+....+...|
T Consensus 254 ~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 254 RPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred cCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 99999999999999999996655444444
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=450.50 Aligned_cols=306 Identities=34% Similarity=0.615 Sum_probs=246.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-C-----CCccccceeecC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H-----PDIVEIKHILLP 93 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-H-----pnIv~l~~v~~~ 93 (599)
.++.||+|+++||+|+||.|.+|.|..|++.||||+|++ ..........|+.+|..|+ | -|+|+++++|..
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 445699999999999999999999999999999999985 3345566778999999997 4 379999999954
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC--Cceeeec
Q 007542 94 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICD 169 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~--~~lKL~D 169 (599)
. +++|||+|+++.+|+++|+.+. +++...++.|+.||+.||.+||+.||||+||||+|||+..- ..|||+|
T Consensus 260 r-----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 260 R-----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred c-----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEe
Confidence 3 5899999999999999999875 78999999999999999999999999999999999998763 5799999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
||+|...... . ..|+.++.|||||++.| ..|+.++||||||||++||++|.|+|+|++..+|+..|.+++|.
T Consensus 335 FGSSc~~~q~-----v-ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 335 FGSSCFESQR-----V-YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred cccccccCCc-----c-eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 9999764321 1 27899999999999998 79999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhc-------ccHHHHHHHHhcccCCC-----
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV-------RNEKARRYLSSMRKKKP----- 317 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~-------~~~~~~~~i~~~~~~~~----- 317 (599)
|++..++..+.. ..++++. .....+|.. .....++++........
T Consensus 407 Pp~~mL~~~~~~--------~kff~~~---------------~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~ 463 (586)
T KOG0667|consen 407 PPPKMLDTAKKA--------HKFFTSL---------------KGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGS 463 (586)
T ss_pred CCHHHHHhcccc--------ceehhcc---------------CCceeeeeeecccccccchhhhhhhhhhcccccCCCCC
Confidence 999999873322 2222221 000011111 11233444443333222
Q ss_pred CCCcCCCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 318 IPFSQKFPN-ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 318 ~~~~~~~~~-~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
..+....+. -...++|||++||.+||.+|+|+.|+|+||||++....
T Consensus 464 ~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 464 RSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSLE 511 (586)
T ss_pred cccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccccccc
Confidence 223344443 34567999999999999999999999999999976543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-52 Score=410.45 Aligned_cols=300 Identities=37% Similarity=0.598 Sum_probs=238.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
-..|++++.||+|+||.||+|..+.++. .+|||+++.......-....-||+.+++.++||||+.|..+|...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~--- 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH--- 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---
Confidence 3568899999999999999997766654 689999986544444445667999999999999999999999753
Q ss_pred CCccEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC----Cceeee
Q 007542 98 EFKDIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKIC 168 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~----~~lKL~ 168 (599)
...++|++||.+.||.++|+-+ ..++...++.++.||+.|+.|||++.|+||||||.||||..+ |.|||+
T Consensus 100 -d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred -CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 3579999999999999999743 358899999999999999999999999999999999999988 999999
Q ss_pred cccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC---------hhhH
Q 007542 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---------VVHQ 239 (599)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~---------~~~~ 239 (599)
|||++|.+.+.-..-......+.|.||+|||++.|. ..|++++|||++|||++|||+-.|+|.|.. ..+|
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999875543332234567899999999999874 789999999999999999999999999875 3689
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
++.|++++|+|+.+.|..+......... +.... .+ .+.+-...+|+.
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~----------------------ls~f~-~~-~~~n~sL~~~~~--------- 304 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTL----------------------LSDFR-RH-YYDNVSLHKYYH--------- 304 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHH----------------------HHHhH-Hh-hcCcchHHHHHH---------
Confidence 9999999999999887664322211000 00000 00 011111222222
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
....-++.+.+||.+||++||.+|+|++++|+|+||..-.
T Consensus 305 ---~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 305 ---KHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred ---HhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 2333456699999999999999999999999999998643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=415.38 Aligned_cols=260 Identities=28% Similarity=0.494 Sum_probs=221.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++.+.++.||+|..|+||+++|+.|++.+|+|+|.. .......+.+.+|+++|+.++||+||+++++|+.... .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eE
Confidence 367788999999999999999999999999999943 2344567889999999999999999999999965431 59
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+ |+|.++++..++++|..+..++.++++||.|||. ++||||||||+|||||..|.|||||||.++...+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 6999999998999999999999999999999995 99999999999999999999999999999877554
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC--ChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK--NVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~--~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
...+.+||..|||||.+.+ ..|+.++||||||+.++||.+|+.||+.. ...+.++++..++..|++
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP------ 300 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP------ 300 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC------
Confidence 2367899999999999988 78999999999999999999999999874 222333333332222222
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.+... .+|+++++||..|
T Consensus 301 ------------------------------------------------------------~lP~~--~fS~ef~~FV~~C 318 (364)
T KOG0581|consen 301 ------------------------------------------------------------RLPEG--EFSPEFRSFVSCC 318 (364)
T ss_pred ------------------------------------------------------------CCCcc--cCCHHHHHHHHHH
Confidence 11111 3789999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|+.||.+|+|+.|+|+|||++...
T Consensus 319 L~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 319 LRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred hcCCcccCCCHHHHhcCHHHhhcc
Confidence 999999999999999999998764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-50 Score=420.65 Aligned_cols=337 Identities=57% Similarity=1.000 Sum_probs=288.2
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
|..+.+|++.+.||+|+||+||+|.+..++..||||++............+.+|+.+|+.++|+||+++++++.......
T Consensus 1 ~~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred CccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 34678999999999999999999999999999999999765544455667889999999999999999999886654445
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+|+|+||+.++|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 81 FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred cCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 56799999999999999999888999999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. .....+.++.+|+|||.+... ..++.++|||||||++++|++|++||.+.+....+..+...+|.+..+.+..
T Consensus 161 ~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 235 (337)
T cd07858 161 KG---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF- 235 (337)
T ss_pred Cc---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh-
Confidence 21 123456789999999987642 3588999999999999999999999999999999999999999988876643
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
+.+....+++..+.......+...++.+++.+.+||++|
T Consensus 236 -----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 274 (337)
T cd07858 236 -----------------------------------------IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKM 274 (337)
T ss_pred -----------------------------------------cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHH
Confidence 334445566666555555555556678999999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
|++||.+|||++|+|+||||..+.....++..+ ..++++||....++++++|+++.|++.|||
T Consensus 275 l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 275 LVFDPSKRITVEEALAHPYLASLHDPSDEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hcCChhhccCHHHHHcCcchhhhcCcccCccCC--CccchhhhhhhcCHHHHHHHHHHHHhhcCC
Confidence 999999999999999999999988777666654 356788888889999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=380.06 Aligned_cols=285 Identities=40% Similarity=0.671 Sum_probs=242.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.+|.-.++||+|.||+||+|+++.+++.||+|.+.....+.......+|||-+|+.++|.|||+++++.. ..+.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkkl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCcee
Confidence 3566778999999999999999999999999999866566666778899999999999999999999983 33579
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
-+|||||..+|..++.+ ++.+..+.++.++.|+++||.+||++++.||||||+|+||+.||.+||+|||+++..+ .+
T Consensus 77 tlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg--ip 154 (292)
T KOG0662|consen 77 TLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG--IP 154 (292)
T ss_pred EEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC--Cc
Confidence 99999999999999986 5689999999999999999999999999999999999999999999999999998753 22
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ..+...+.|.||++|.++.+- .-|++.+|+||.|||++|+.. |+|+|+|.+..+|+..|+.++|+|+++.|..+..
T Consensus 155 v-rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 V-RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred e-EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 2 234556889999999998773 679999999999999999985 9999999999999999999999999986544221
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc-CCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK-KKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
+.. |+- .+. ..-..++++.|+.+...+|||+++|
T Consensus 233 lpd-----yk~----------------------------------------yp~ypattswsqivp~lns~grdllqkll 267 (292)
T KOG0662|consen 233 LPD-----YKP----------------------------------------YPIYPATTSWSQIVPKLNSTGRDLLQKLL 267 (292)
T ss_pred CCC-----Ccc----------------------------------------cCCccccchHHHHhhhhcchhHHHHHHHh
Confidence 111 000 000 0112355667888888999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.-+|..|++|+++|+||||.+.
T Consensus 268 ~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 268 KCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCcccccCHHHHhcCcccccc
Confidence 9999999999999999999865
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=414.52 Aligned_cols=332 Identities=44% Similarity=0.827 Sum_probs=269.4
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR- 96 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~- 96 (599)
.+...++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3566789999999999999999999999999999999997654444455678899999999999999999998864322
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
.....+|+++++++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 90 ENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 33456899999999999888764 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... ...+++|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.+.++.+.
T Consensus 169 ~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred CCC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 322 2456899999999998652 468899999999999999999999999999999999999999999887665
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
. +.....+.++..++......+...+...++.+.+||.
T Consensus 242 ~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 279 (343)
T cd07878 242 K------------------------------------------ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLE 279 (343)
T ss_pred h------------------------------------------cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHH
Confidence 4 3333444555555544444455556678889999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 402 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~ 402 (599)
+||.+||.+|||+.|+|+||||..+..+..++...+. ....+....+.+++++..+.+...+.
T Consensus 280 ~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (343)
T cd07878 280 KMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY---DESPENKERTIEEWKELTYEEVSSFK 342 (343)
T ss_pred HHcCCChhhCCCHHHHhcCcchhccCCCccccccCcc---ccchhhhhccHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999987765544433322 22223345556777777777665544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=405.53 Aligned_cols=261 Identities=29% Similarity=0.496 Sum_probs=228.0
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.-..++|+++++||+|+||.||.++.+.|++.||+|++++.. ........+.+|..+|..++||.||+++-.|.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt---- 96 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT---- 96 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc----
Confidence 345789999999999999999999999999999999997533 233467888999999999999999999998844
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|||+||+. |+|+..|++.+.++|..+++++..|+.||.|||+.|||||||||+|||+|.+|+++|+||||++..
T Consensus 97 -~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 97 -EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred -CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 457999999999 599999999999999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
...... ..+.|||+.|||||++.+ ..|+.++|-||||+++|+||+|.+||.+.+.....+.|...-
T Consensus 176 ~~~~~~---t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------- 241 (357)
T KOG0598|consen 176 LKDGDA---TRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------- 241 (357)
T ss_pred ccCCCc---cccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---------
Confidence 443322 245799999999999988 699999999999999999999999999998777666664311
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC-CCHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLL 335 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~s~~a~dLL 335 (599)
....+. ++.+++|||
T Consensus 242 ----------------------------------------------------------------~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 242 ----------------------------------------------------------------LPLPPGYLSEEARDLL 257 (357)
T ss_pred ----------------------------------------------------------------CCCCCccCCHHHHHHH
Confidence 011233 788999999
Q ss_pred HHhcccCCCCCC----CHHHHhcCccccCCc
Q 007542 336 ERMLAFEPKDRP----TAEEALADPYFKGLA 362 (599)
Q Consensus 336 ~~mL~~DP~~Rp----Ta~e~L~HP~f~~~~ 362 (599)
+++|..||++|. .++++-+||||.++.
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 999999999996 799999999999863
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=413.15 Aligned_cols=329 Identities=37% Similarity=0.669 Sum_probs=260.7
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s-~~~ 98 (599)
...++|++.+.||+|+||+||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... ...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3468999999999999999999999999999999999866555566778889999999999999999999986542 234
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 457899999999999988864 488999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...+|.|.++.+..+
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 179 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred CC----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 21 2245688999999999977 67899999999999999999999999999999999999999999998776552
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCC------------cCCCCC
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF------------SQKFPN 326 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~------------~~~~~~ 326 (599)
... ...++...+......+ ......
T Consensus 253 ~~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (364)
T cd07875 253 QPT-------------------------------------------VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 289 (364)
T ss_pred hHH-------------------------------------------HHHHHhhCCCcCCCChHhhCcccccccccccccc
Confidence 211 1111111111111111 111122
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHh
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE 400 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~ 400 (599)
.+..+++||.+||++||.+|||++|+|+||||..+.++...+...+. ..+...+.+..+.+++++.++.|+++
T Consensus 290 ~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd07875 290 KASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPK-IPDKQLDEREHTIEEWKELIYKEVMD 362 (364)
T ss_pred ccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCCCC-CCCccchhhhccHHHHHHHHHHHHHc
Confidence 45789999999999999999999999999999887665443322221 11223344567778888888888753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=416.20 Aligned_cols=329 Identities=43% Similarity=0.733 Sum_probs=261.4
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++|+||+++++++.......+..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999999999999999976555555667889999999999999999999999765444445799
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
+|+||+.++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888899999999999999999999999999999999999999999999999999986532221
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
...+..+++++|+|||++.+. ..++.++||||+|||+|+|++|++||.+.+..+++..|.+.+|.++.+.+...+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~--- 234 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE--- 234 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH---
Confidence 223456789999999998662 4588999999999999999999999999999999999999999999877654211
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCC--CCcCCCCCCCHHHHHHHHHhccc
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI--PFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
....++.......+. .........++.+.+||.+||++
T Consensus 235 ----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 274 (372)
T cd07853 235 ----------------------------------------GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVF 274 (372)
T ss_pred ----------------------------------------HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCC
Confidence 112222111111110 01122345688999999999999
Q ss_pred CCCCCCCHHHHhcCccccCCccC--------------------CCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHh
Q 007542 342 EPKDRPTAEEALADPYFKGLAKV--------------------EREPSAQPVTKMEFEFERRRITKEDVRELIYREILE 400 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~~~~--------------------~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~ 400 (599)
||.+|||+.|+|+||||.+.... ..+|.. ...++++++....+..++++.++.++.+
T Consensus 275 dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (372)
T cd07853 275 DPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEPSA--NPPFDDEYEKNLTSVRQVKEELHQFILE 351 (372)
T ss_pred ChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCCcccCCCC--CCCCCcccccccCCHHHHHHHHHHHHHH
Confidence 99999999999999999874210 111111 1223455555566777888888777654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=397.08 Aligned_cols=288 Identities=44% Similarity=0.773 Sum_probs=250.2
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 007542 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
--+.||-|+||+||.+.|.++|+.||+|++.+.+.+-...+++.+|+.+|-.++|.|++..+++..++.-.-+..+|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 34789999999999999999999999999998888888889999999999999999999999999887766678899999
Q ss_pred ecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 107 ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 107 E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
|+|..+|+.+|.+...++.++++-|+|||++||+|||+.||.||||||.|+|+|.||.+||||||++|....+. ...+
T Consensus 137 ELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~--~~hM 214 (449)
T KOG0664|consen 137 ELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD--RLNM 214 (449)
T ss_pred HHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh--hhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999864433 3346
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIW 266 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~ 266 (599)
+..+.|.+|+|||++.|. ..|+.++||||+||||.|||..+.+|...+.+.|+++|.+++|+|+.|.+...|.
T Consensus 215 TqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE------ 287 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE------ 287 (449)
T ss_pred HHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh------
Confidence 778999999999999774 7899999999999999999999999999999999999999999999999987652
Q ss_pred cCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC-----CCCHHHHHHHHHhccc
Q 007542 267 CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP-----NANPLALRLLERMLAF 341 (599)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----~~s~~a~dLL~~mL~~ 341 (599)
.++..+-.-.. ++..+.-++. ...-++++++.+||.+
T Consensus 288 -------------------------------------GAk~H~LR~~~-k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~ 329 (449)
T KOG0664|consen 288 -------------------------------------GAKNHVLRAGL-RAPDTQRLYKIASPDDKNHEAVDLLQKLLHF 329 (449)
T ss_pred -------------------------------------hhHHHhhccCC-CCCCccceeeecCCcccchHHHHHHHHHhCC
Confidence 12222111111 1122222222 2345789999999999
Q ss_pred CCCCCCCHHHHhcCccccCC
Q 007542 342 EPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~ 361 (599)
||.+|++.+++|.|+|....
T Consensus 330 d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 330 DPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred CCcccccHhhhccccccccc
Confidence 99999999999999999764
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=408.03 Aligned_cols=334 Identities=51% Similarity=0.893 Sum_probs=275.5
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..+++|++.+.||+|+||.||+|++..+|+.||||+++.. .......++.+|+.+|+.++|+||+++++++........
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4678999999999999999999999999999999998632 233345678899999999999999999999876555555
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
..+|+|+||+.++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 67999999999999988854 46999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
...........++..|+|||.+.+. ..++.++||||+||++++|++|++||.+.+...++..+.+.++.++.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC-- 236 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH--
Confidence 2222233456889999999987542 4688999999999999999999999999999999999999999998887765
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
+.....+.++.........++....+..++.+.+||.+||
T Consensus 237 ----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 276 (336)
T cd07849 237 ----------------------------------------IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKML 276 (336)
T ss_pred ----------------------------------------hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHc
Confidence 2233334455555555555555566778899999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHH
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREIL 399 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~ 399 (599)
+.||.+|||+.|+|+||||..+.+...++..++...++++.. +.+.++..+++|+.|+.
T Consensus 277 ~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 277 TFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF-DDLPKEKLKELIFEEIM 335 (336)
T ss_pred CCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc-cccCHHHHHHHHHHHhc
Confidence 999999999999999999999987766666544444454433 55668888999988874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=419.55 Aligned_cols=262 Identities=30% Similarity=0.525 Sum_probs=228.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~ 98 (599)
...+|.+++.||.|+|++|++|+++.+++.||||++.+... .....+.+.+|-.+|.+| .||.|++|+-.|.+.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~---- 146 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE---- 146 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc----
Confidence 35789999999999999999999999999999999975443 333456778999999999 799999999999544
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+|+|+||++ |+|.++|++-+.+++..+++|+.||+.||.|||++|||||||||+|||+|.||++||.|||.|+...
T Consensus 147 -~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 147 -ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred -cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 47999999999 7999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC----------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 178 NDTPT----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 178 ~~~~~----------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
..... .......|||-.|.+||+|.. ...++.+|||+||||+|.|+.|.|||.+.+....+++|+++.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 32111 111245899999999999987 678899999999999999999999999999998888887643
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
-.. -+++
T Consensus 304 y~f-------------------------------------------------------------------------p~~f 310 (604)
T KOG0592|consen 304 YEF-------------------------------------------------------------------------PEGF 310 (604)
T ss_pred ccC-------------------------------------------------------------------------CCCC
Confidence 211 1356
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
++.+.|||+++|..||.+|+|++|+-+||||.++.
T Consensus 311 p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 311 PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred CHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 78999999999999999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=425.81 Aligned_cols=264 Identities=30% Similarity=0.482 Sum_probs=230.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.-+-|++++.||.|+.|.|.+|.|..||+.+|||+|.+.. ........|.+||.+|+.+.||||+.++++| ++.
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~ 84 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENK 84 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccC
Confidence 3467999999999999999999999999999999997653 3344567899999999999999999999999 455
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.++|+|.||+. |.|++++...|++++.++.+|+.||+.|+.|||..+|+||||||+|+|++.++++||+|||.|....+
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 68999999999 69999999999999999999999999999999999999999999999999999999999999976433
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
...+.+.||++.|.+||++.|. ...+.++||||+|||||.||+|+.||.+++....+.++..-.
T Consensus 165 ----gklLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~----------- 228 (786)
T KOG0588|consen 165 ----GKLLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV----------- 228 (786)
T ss_pred ----CccccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-----------
Confidence 3356788999999999999883 334678999999999999999999999888766666554211
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.+...+++++|+|||.+|
T Consensus 229 --------------------------------------------------------------f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 229 --------------------------------------------------------------FEMPSNISSEAQDLLRRM 246 (786)
T ss_pred --------------------------------------------------------------ccCCCcCCHHHHHHHHHH
Confidence 112246899999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCccCCCC
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLAKVERE 367 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~~~~~e 367 (599)
|..||.+|+|.+|+++|||+.+.......
T Consensus 247 l~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 247 LDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred hccCccccccHHHHhhCchhhcCCCCChh
Confidence 99999999999999999999988665433
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=399.74 Aligned_cols=287 Identities=35% Similarity=0.643 Sum_probs=235.3
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
|+.-++|+++++||+|+||+||+|++..++..||+|+++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 74 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHT----- 74 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence 5677899999999999999999999999999999999864322 2234567799999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+.++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 34789999999999999987654 57899999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+.+..+...+|.|+.+.+..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2221 12445789999999988652 5688999999999999999999999999999999999999999999887654
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
+... +....++ ++.....+.....+..+++++|||++
T Consensus 231 ~~~~-----------------------------------------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~ 267 (288)
T cd07871 231 ITSN-----------------------------------------EEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSS 267 (288)
T ss_pred cccc-----------------------------------------hhhhccc--cCccCCCchHHhCCCCCHHHHHHHHH
Confidence 2100 0000000 11111222233345678999999999
Q ss_pred hcccCCCCCCCHHHHhcCccc
Q 007542 338 MLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f 358 (599)
||++||.+|||++|+|+||||
T Consensus 268 mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 268 LLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hcCcCcccCCCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=408.56 Aligned_cols=326 Identities=38% Similarity=0.676 Sum_probs=252.7
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~~ 98 (599)
...++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 44689999999999999999999999999999999997655555566788899999999999999999999865432 34
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 457899999999999888754 488999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.|..+.+...
T Consensus 176 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 176 NF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred Cc----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 21 2245688999999999977 67899999999999999999999999999999999999999999988766552
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC------------CCC
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK------------FPN 326 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~------------~~~ 326 (599)
... ...++...+......+.+. ...
T Consensus 250 ~~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (359)
T cd07876 250 QPT-------------------------------------------VRNYVENRPQYPGISFEELFPDWIFPSESERDKL 286 (359)
T ss_pred HHH-------------------------------------------HHHHHhhCCCCCCcchhhhccccccccccccccc
Confidence 211 1111111111111111111 123
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHH
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE 397 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e 397 (599)
.++.+.+||.+||++||++|||+.|+|+||||..+..+.......+.. ...+.+.+....+.+++.+...
T Consensus 287 ~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 356 (359)
T cd07876 287 KTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQI-YDAQLEEREHAIEEWKELIYKE 356 (359)
T ss_pred cchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcccccCCCccc-cccccccccccHHHHHHHHHHH
Confidence 467899999999999999999999999999998765543322222211 1112233444455555555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=392.56 Aligned_cols=262 Identities=31% Similarity=0.486 Sum_probs=226.9
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
-..+.|++.++||+|.|++|+++.+..||+.+|+|.|+...-...+.+.+.+|++|.+.|+||||++|.+.+ .+.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----ccc
Confidence 345789999999999999999999999999999999975444445778899999999999999999999988 444
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC---Cceeeeccccccc
Q 007542 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~---~~lKL~DFGla~~ 175 (599)
...|||||+|+| +|..-|-+..-++|..+..+++||+++|.|||.+||||||+||+|+|+-.. .-+||||||+|..
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 578999999995 888777666778999999999999999999999999999999999988543 4499999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.. ....+...+||+.|+|||++.. ..|+..+|||+.|+|||.||.|++||-|.+....++.|...--
T Consensus 163 l~----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y------- 229 (355)
T KOG0033|consen 163 VN----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY------- 229 (355)
T ss_pred eC----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc-------
Confidence 65 2334677899999999999987 7899999999999999999999999999888887777753111
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
..-...|++++++|++|+
T Consensus 230 --------------------------------------------------------------d~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 230 --------------------------------------------------------------DYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred --------------------------------------------------------------CCCCcccCcCCHHHHHHH
Confidence 111235788999999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCC
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
++||..||.+|+|+.|+|+|||+.+-
T Consensus 248 rrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHhccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=417.05 Aligned_cols=258 Identities=32% Similarity=0.561 Sum_probs=230.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|.+.+.||+|+||+||+|+.+.|.+.||||.|.+......+.+.+.+|++|++.++|||||.+++.| ++..++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 579999999999999999999999999999999998888888889999999999999999999999998 555689
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 103 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
|+|+||+.|+|+.++...+.++|+.++.|.++++.||.|||+++|+|||+||.|||+...|.+|+||||+|+.... .
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~ 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---N 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998644 3
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
....+..-||+.|||||+..+ ..|+..+|+||||||+|||..|+|||-..+.......|..-
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---------------- 215 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---------------- 215 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC----------------
Confidence 345678899999999999987 79999999999999999999999999876655544444321
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
...+ ...++..+++||+.+|..|
T Consensus 216 -----------------------------------------------------~v~~----p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 216 -----------------------------------------------------PVKP----PSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred -----------------------------------------------------CCCC----cccccHHHHHHHHHHhhcC
Confidence 1111 1257888999999999999
Q ss_pred CCCCCCHHHHhcCccccCCcc
Q 007542 343 PKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f~~~~~ 363 (599)
|.+|+|..++|.|||+++--.
T Consensus 239 P~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 239 PAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred hhhcccHHHHhcChHHhhhhh
Confidence 999999999999999987543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=412.32 Aligned_cols=258 Identities=33% Similarity=0.526 Sum_probs=221.2
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC--C-hhhHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--H-VSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~--~-~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s 95 (599)
-..++|.+.+.||+|+||.|++|.+..+|..||||++++... . ....+.+.||+.+++.++ ||||+++++++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 456799999999999999999999999999999998765311 1 234567779999999999 99999999999554
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-Cceeeeccccc
Q 007542 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFGla 173 (599)
..+|+||||+.| +|+++|...+++.|..++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 359999999995 999999999999999999999999999999999999999999999999999 99999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCC-C-CcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-Y-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~-s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
.... .....+.+.+||+.|+|||++.+ .. | +.++||||+|+|||.|++|+.||...+....+..|...-
T Consensus 169 ~~~~---~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~---- 239 (370)
T KOG0583|consen 169 AISP---GEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE---- 239 (370)
T ss_pred cccC---CCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC----
Confidence 8763 22234678899999999999987 34 6 478999999999999999999999877666555543210
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC-CHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA-NPL 330 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-s~~ 330 (599)
..+. ..+ |++
T Consensus 240 ------------------------------------------------------------------~~~p---~~~~S~~ 250 (370)
T KOG0583|consen 240 ------------------------------------------------------------------FKIP---SYLLSPE 250 (370)
T ss_pred ------------------------------------------------------------------ccCC---CCcCCHH
Confidence 0111 123 899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+++||++||..||.+|+|+.++++||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=399.62 Aligned_cols=261 Identities=31% Similarity=0.474 Sum_probs=223.2
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
....+|.+.+.||+|+||+||+|+++.++..||||.|.+........+.+..||.+|+.++|||||.+++++.. .
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-----~ 81 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-----D 81 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-----C
Confidence 34578999999999999999999999999999999998665566677788999999999999999999999944 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC------Cceeeecccc
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------CKLKICDFGL 172 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~------~~lKL~DFGl 172 (599)
+.+|||||||+ |||.++|+..+.++|..++.|+.||+.||++||+++||||||||+|||++.+ -.+||+|||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 58999999999 7999999999999999999999999999999999999999999999999875 4589999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
|+...++. ...+.||++.|||||++.. ..|+-++|+||+|+|+|+|++|++||...+..+.+..|..--.
T Consensus 162 AR~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~---- 231 (429)
T KOG0595|consen 162 ARFLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE---- 231 (429)
T ss_pred hhhCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc----
Confidence 99875432 3467899999999999976 7899999999999999999999999998877665543321100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC-CCCCHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLA 331 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~s~~a 331 (599)
.-..+ ...+...
T Consensus 232 -------------------------------------------------------------------~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 232 -------------------------------------------------------------------IVPVLPAELSNPL 244 (429)
T ss_pred -------------------------------------------------------------------ccCchhhhccCch
Confidence 00011 1234456
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+|+..+|+.||..|.+.++-+.|+++..-.
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 7999999999999999999999999987643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=402.38 Aligned_cols=327 Identities=38% Similarity=0.678 Sum_probs=252.7
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~~ 98 (599)
...++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... ..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34689999999999999999999999999999999998665555666788899999999999999999999865432 34
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred cceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 457899999999999888864 488999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+|.+.++.+..+
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 172 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cc----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 2245688999999999977 67899999999999999999999999999999999999999999988766542
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCC-----------CC-cCCCCC
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI-----------PF-SQKFPN 326 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~-----------~~-~~~~~~ 326 (599)
... ...++...+..... +. ......
T Consensus 246 ~~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (355)
T cd07874 246 QPT-------------------------------------------VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 282 (355)
T ss_pred cHH-------------------------------------------HHHHHhcCCccccccchhhccccccccccccccc
Confidence 111 11111111110000 00 111123
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHH
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREI 398 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~ 398 (599)
.+..+++||.+||+.||.+|||+.|+|+||||..+.+........+ ......-.....+.+++.+.++.++
T Consensus 283 ~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (355)
T cd07874 283 KASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEV 353 (355)
T ss_pred cchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhccCCCc-cccccchhhhhccHHHHHHHHHHHh
Confidence 4567899999999999999999999999999987654322111111 1111122233445666776666654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=393.15 Aligned_cols=291 Identities=34% Similarity=0.600 Sum_probs=229.8
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
||..++|++.+.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHT----- 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEec-----
Confidence 6888999999999999999999999999999999999874322 2233467789999999999999999999853
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+.++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 3479999999999999988764 578999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~-~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... .......+|+.|+|||++.+. ..++.++||||+||++|+|++|.+||.+.. ..+++..+...++.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 122446789999999988652 468899999999999999999999998854 457788888888888776544
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC--CCCCHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLALRL 334 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~s~~a~dL 334 (599)
....... ..+.. +....+..+...+ ...++.+.+|
T Consensus 231 ~~~~~~~------------~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~dl 267 (303)
T cd07869 231 GVHSLPH------------FKPER-------------------------------FTLYSPKNLRQAWNKLSYVNHAEDL 267 (303)
T ss_pred chhhccc------------ccccc-------------------------------ccccCCccHHHHhhccCCChHHHHH
Confidence 3111000 00000 0000011111111 1245789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|.+||++||++|||++|+|+||||+++.
T Consensus 268 i~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 268 ASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred HHHHhccCchhccCHHHHhcCcccccCC
Confidence 9999999999999999999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=398.18 Aligned_cols=330 Identities=58% Similarity=0.977 Sum_probs=280.9
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|++|.||+|.+..+++.||||++..........+.+.+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455667889999999999999999999998765444556899
Q ss_pred EEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 104 VVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
+||||+.++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998764432211
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
.......++.+|+|||++.+. ..++.++|+||+||++++|++|++||.+.+..+++..+...+|.+.++.+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~------ 233 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF------ 233 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh------
Confidence 223456789999999998772 3788999999999999999999999999999999999999999998876543
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 343 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP 343 (599)
.......+++.........++.+..+..++.+.+||.+||++||
T Consensus 234 ------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 277 (330)
T cd07834 234 ------------------------------------ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277 (330)
T ss_pred ------------------------------------ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh
Confidence 23334456666666667777777788899999999999999999
Q ss_pred CCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHH
Q 007542 344 KDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE 397 (599)
Q Consensus 344 ~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e 397 (599)
.+|||++++|.||||.++.....++.......+ ..|+...+++++.+++|+.|
T Consensus 278 ~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 330 (330)
T cd07834 278 KKRITADEALAHPYLAQLHDPEDEPVAKPPFDF-DFFDDDELTEEELKELIYEE 330 (330)
T ss_pred hhCCCHHHHHhCccHHhhcccccCCCCCCcccc-cccchhhcCHHHHhHHhhcC
Confidence 999999999999999999887766655443322 14677889999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=399.30 Aligned_cols=330 Identities=52% Similarity=0.947 Sum_probs=276.8
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..+++|++.+.||+|++|.||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 2 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 80 (334)
T cd07855 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADF 80 (334)
T ss_pred chhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCC
Confidence 3458999999999999999999999999999999999765544455677889999999999999999999886543 344
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
..+|+||||+.++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 81 KDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred ceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 67999999999999999988888999999999999999999999999999999999999999999999999999765332
Q ss_pred CCC-cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .......+++.+|+|||.+.+. ..++.++||||+||++|+|++|++||.+.+...++..+...+|.|+.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~- 238 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR- 238 (334)
T ss_pred CcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh-
Confidence 221 1122346789999999998552 4588999999999999999999999999999999999999999999887655
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
........++.........++...++..++.+.+||++|
T Consensus 239 -----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 277 (334)
T cd07855 239 -----------------------------------------IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277 (334)
T ss_pred -----------------------------------------hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHH
Confidence 233344555556666666666677788899999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHH
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIY 395 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~ 395 (599)
|+.||.+|||++++|.||||.+....+.++.+. ...+++++....+.|.+.+.|.
T Consensus 278 l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 332 (334)
T cd07855 278 LQFDPEERITVEQALQHPFLAQYHDPDDEPTCP--PPFDFDFEAIELSREQLKEAIV 332 (334)
T ss_pred ccCChhhCcCHHHHHhChhhhhccCCcccccCC--CCCCCChhhhhcChhhHHHHhh
Confidence 999999999999999999999998877766543 3456677777777777766654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=396.14 Aligned_cols=333 Identities=46% Similarity=0.853 Sum_probs=281.9
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR- 96 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~- 96 (599)
.+...++|++.+.||+|++|.||+|++..++..||||++............+.+|+.+++.++|+||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 10 VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred eecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3456889999999999999999999999999999999987544444455678899999999999999999998865432
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
.....+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 34456999999999999999876 46999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... ...+.++.+|+|||++.+. ..++.++|||||||++++|++|++||.+.+....+..+.+.++.++++.+.
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 169 DDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 322 2445788999999988542 467889999999999999999999999999999999999999988887655
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
. +.......++..+.......+...+...++.+.+||.
T Consensus 242 ~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~ 279 (343)
T cd07851 242 K------------------------------------------ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLE 279 (343)
T ss_pred h------------------------------------------ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHH
Confidence 4 3344455666666666666666666778999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
+||..||.+|||+.|+|+||||..+...+.++..+ ....+|+...+..++|+++++.|+..|.|
T Consensus 280 ~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 280 KMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP---PYDQSFESRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred HhCCCChhhCCCHHHHhcCCCccccCCCccccccc---ccCcchhhhhcCHHHHHHHhHHHHHhccC
Confidence 99999999999999999999999987776655432 23567788899999999999999988865
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=388.44 Aligned_cols=284 Identities=35% Similarity=0.611 Sum_probs=232.0
Q ss_pred CceEEEEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCCccccceeecCCCcCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~-tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~v~~~~s~~~ 98 (599)
++|++++.||+|+||+||+|.+.. ++..||||+++...........+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 489999999999999999999865 578899999875443333445566788887766 6999999999986443344
Q ss_pred CccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+++||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999999764 35899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... ......+|..|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+..|.+..+.|.++.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 1234578999999999876 578999999999999999999999999999999999999999988876554
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
....... ..+......++....+.+++.+.+||.
T Consensus 235 ~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (290)
T cd07862 235 RDVALPR----------------------------------------------QAFHSKSAQPIEKFVTDIDELGKDLLL 268 (290)
T ss_pred hhhcccc----------------------------------------------hhccCCCCCCHHHHccCCCHHHHHHHH
Confidence 3110000 001122233444455678899999999
Q ss_pred HhcccCCCCCCCHHHHhcCccc
Q 007542 337 RMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f 358 (599)
+||++||++|||+.|+|+||||
T Consensus 269 ~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 269 KCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHhccCchhcCCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=383.07 Aligned_cols=267 Identities=30% Similarity=0.464 Sum_probs=222.8
Q ss_pred cccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
.++......-..|+|+++||+|+||.||++++..+|..||+|.|+....+....+.+..|+.+|++|+|||||++++.-+
T Consensus 9 ~~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 9 MDFSPPQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred cCCCCCcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 33333444567799999999999999999999999999999999865556666778899999999999999999988433
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhh--Cc--eEeccCCCCceEecCCC
Q 007542 93 PPSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT--AN--VFHRDLKPKNILANADC 163 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs--~g--IvHrDLKP~NILv~~~~ 163 (599)
. ++..-++||||||+ |||.+.|+. ...++|..+|.++.||++||.+||+ .+ |+||||||.||+++.+|
T Consensus 89 ~---~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g 165 (375)
T KOG0591|consen 89 I---EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG 165 (375)
T ss_pred h---ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC
Confidence 2 22345899999999 799999964 3468999999999999999999999 45 99999999999999999
Q ss_pred ceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 007542 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243 (599)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I 243 (599)
.+||+||||++...+.. .+-.+++|||+||+||++.+ ..|+.++||||+||++|||+.-++||.|++..+...+|
T Consensus 166 vvKLGDfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI 240 (375)
T KOG0591|consen 166 VVKLGDFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI 240 (375)
T ss_pred ceeeccchhHhHhcchh---HHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence 99999999999875443 34578999999999999988 79999999999999999999999999999877776666
Q ss_pred HHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC
Q 007542 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323 (599)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 323 (599)
...--.|-+.
T Consensus 241 ~qgd~~~~p~---------------------------------------------------------------------- 250 (375)
T KOG0591|consen 241 EQGDYPPLPD---------------------------------------------------------------------- 250 (375)
T ss_pred HcCCCCCCcH----------------------------------------------------------------------
Confidence 5421111110
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 324 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 324 ~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
...|..+..||..|+..||..||+. +|++.++..
T Consensus 251 -~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 251 -EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred -HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 1356778899999999999999997 777766543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=400.35 Aligned_cols=265 Identities=27% Similarity=0.443 Sum_probs=224.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|+++++||+|+||.||+|+.+.||+.+|+|++++... .....+.++.|-.+|....+|+||+|+-.|.+ .
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-----~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-----K 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-----C
Confidence 56899999999999999999999999999999999986433 34456788999999999999999999999954 4
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.++||||||++ ||+..+|...+.|+++.+++++.+++.||..||+.|+|||||||+|+|||.+|++||+||||+.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 58999999999 69999999999999999999999999999999999999999999999999999999999999954311
Q ss_pred C-------------------C----C-----Cc----------------ccccccccCccccCccccccccCCCCcchhh
Q 007542 179 D-------------------T----P-----TA----------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214 (599)
Q Consensus 179 ~-------------------~----~-----~~----------------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DI 214 (599)
. . . .. ......+|||.|+|||++.+ .+|+..+|.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw 371 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW 371 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence 0 0 0 00 00124689999999999988 789999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHH
Q 007542 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVL 294 (599)
Q Consensus 215 WSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 294 (599)
||||||+||||.|.|||.+++..+...+|.+---
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------------------------------------- 405 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------------------------------------- 405 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh----------------------------------------------
Confidence 9999999999999999999999888887764110
Q ss_pred HHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCCc
Q 007542 295 ILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGLA 362 (599)
Q Consensus 295 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~Rp---Ta~e~L~HP~f~~~~ 362 (599)
.+... .-...+++|+|||.+||. ||.+|+ .++|+-+||||+++.
T Consensus 406 ----------------~l~fP-------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 406 ----------------TLKFP-------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred ----------------hccCC-------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 00000 002356899999999999 999997 499999999999874
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=385.01 Aligned_cols=286 Identities=34% Similarity=0.640 Sum_probs=227.7
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|+||.||+|+++.+++.||||++............+.+|+.+++.++||||+++++++. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence 4799999999999999999999999999999999754444445567889999999999999999999984 33579
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+||||+++++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999766665544 45799999999999999999999999999999999999999999999999999986532221
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
.......+++.|+|||++.+ ..++.++||||+||++|+|++|++||++.+..+.+..+....|..+.+.+.....
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (287)
T cd07848 156 --ANYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS- 230 (287)
T ss_pred --ccccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc-
Confidence 12234678999999999876 5789999999999999999999999999998888888888888887765543110
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
...+.... . .................++.+.+||++||++
T Consensus 231 -~~~~~~~~--~-------------------------------------~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~ 270 (287)
T cd07848 231 -NPRFHGLR--F-------------------------------------PAVNHPQSLERRYLGILSGVLLDLMKNLLKL 270 (287)
T ss_pred -cchhcccc--c-------------------------------------CcccCcccHHHhhhcccCHHHHHHHHHHccC
Confidence 00000000 0 0000000000111234678899999999999
Q ss_pred CCCCCCCHHHHhcCccc
Q 007542 342 EPKDRPTAEEALADPYF 358 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f 358 (599)
||++|||++|+|+||||
T Consensus 271 ~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 271 NPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=406.60 Aligned_cols=287 Identities=35% Similarity=0.615 Sum_probs=230.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc---C
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR---R 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~---~ 97 (599)
...+|+++++||+|+||+||+|.+..+++.||||++... .....+|+.+|+.++||||+++++++..... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 356899999999999999999999999999999988532 1234579999999999999999998754321 1
Q ss_pred CCccEEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-ceeeecccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGL 172 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-~lKL~DFGl 172 (599)
....+++||||++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 138 ~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 138 KNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred CceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 2235789999999998887753 45799999999999999999999999999999999999999765 699999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
++....... ...+++|+.|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+..+++..|...+|.|..
T Consensus 218 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred chhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 986543221 2356889999999988652 46899999999999999999999999999999999999999999998
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC-CCCHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP-NANPLA 331 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~s~~a 331 (599)
+.+..+.. .+... .++...+..+...+| ..++++
T Consensus 293 ~~~~~~~~----~~~~~-----------------------------------------~~~~~~~~~l~~~~p~~~~~~~ 327 (440)
T PTZ00036 293 DQLKEMNP----NYADI-----------------------------------------KFPDVKPKDLKKVFPKGTPDDA 327 (440)
T ss_pred HHHHHhch----hhhcc-----------------------------------------cCCccCchhHHHHhccCCCHHH
Confidence 77654110 00000 000011111222223 367899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
++||.+||++||.+|+|+.|+|+||||..+..
T Consensus 328 ~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 328 INFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 99999999999999999999999999998755
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=393.54 Aligned_cols=327 Identities=39% Similarity=0.693 Sum_probs=259.9
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-cC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RR 97 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s-~~ 97 (599)
+...++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++|+||+++++++.... ..
T Consensus 12 ~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 12 FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 34678999999999999999999999999999999999765555555677889999999999999999999986543 23
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
+...+|+||||+.++|.+.+... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 44578999999999999988754 8999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ......++..|+|||.+.+ ..++.++|||||||++++|++|+.||.+.+...++..+.+.+|.|+.+.+..
T Consensus 170 ~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 170 TSF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred CCC----CCCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 321 1234568899999999876 6789999999999999999999999999999999999999999998876654
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC-------------C
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK-------------F 324 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~-------------~ 324 (599)
+.... ..++.........++.+. .
T Consensus 244 ~~~~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (353)
T cd07850 244 LQPTV-------------------------------------------RNYVENRPKYAGYSFEELFPDVLFPPDSESHN 280 (353)
T ss_pred hhhhh-------------------------------------------hHHhhcCCCCCCcchhhhCcccccCccccccc
Confidence 22111 111111111111111111 1
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHH
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE 397 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e 397 (599)
...++.+.+||.+||++||.+|||+.|+|.||||..+....+..... ....+.+.+.+..+.++|++.++.|
T Consensus 281 ~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 281 KLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPP-PAPYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred ccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCCCCC-CCccccccccccccHHHHHHHHHhh
Confidence 23466789999999999999999999999999999877654333222 2223444566778888888888776
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=385.66 Aligned_cols=291 Identities=36% Similarity=0.651 Sum_probs=238.7
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
|+..++|++++.||+|+||.||+|+++.+++.||+|+++.... ......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHT----- 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEee-----
Confidence 5777899999999999999999999999999999999874322 2233457789999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 34789999999999999887654 58999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......++..|+|||++.+. ..++.++||||+||++++|++|++||.+.+..+.+..+.+.+|.|..+.+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2211 12345788999999988652 5688999999999999999999999999999999999999999998876654
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
+.. ...... ...+...+.++....+..++.+++||.+
T Consensus 232 ~~~------------------------------------------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ 268 (309)
T cd07872 232 ISS------------------------------------------NDEFKN-YNFPKYKPQPLINHAPRLDTEGIELLTK 268 (309)
T ss_pred hcc------------------------------------------hhhhhh-hhcCccCCCchhhhccCCCHHHHHHHHH
Confidence 110 000000 0112223333344556788999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCc
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
||.+||.+|||++|+|+||||+.+.
T Consensus 269 ~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 269 FLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=373.99 Aligned_cols=254 Identities=25% Similarity=0.459 Sum_probs=224.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-++|++++.||.|+||.|.+++++.+|..+|+|++++. .-.....+...+|..+|+.+.||.++++...+. +..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-----d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-----DNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-----cCC
Confidence 46899999999999999999999999999999999742 223345677889999999999999999999884 445
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+||||||++ |.|+.++++.+++++.++++++.||+.||+|||+++|++|||||+|||+|.+|.+||.|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 8999999999 599999999999999999999999999999999999999999999999999999999999999886443
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
+ -+.|||+.|+|||++.+ ..|+.++|-|+||+++|||+.|.+||.+.+....+++|...--
T Consensus 198 T------~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v----------- 258 (355)
T KOG0616|consen 198 T------WTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV----------- 258 (355)
T ss_pred E------EEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc-----------
Confidence 2 35799999999999988 7899999999999999999999999999998888877753110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
...+.++++++|||+++|
T Consensus 259 --------------------------------------------------------------~fP~~fs~~~kdLl~~LL 276 (355)
T KOG0616|consen 259 --------------------------------------------------------------KFPSYFSSDAKDLLKKLL 276 (355)
T ss_pred --------------------------------------------------------------cCCcccCHHHHHHHHHHH
Confidence 011247889999999999
Q ss_pred ccCCCCCC-----CHHHHhcCccccCC
Q 007542 340 AFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
+.|-.+|. ...++..||||+++
T Consensus 277 ~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 277 QVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred hhhhHhhhcCcCCCccccccCcccccc
Confidence 99999993 57899999999976
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=382.09 Aligned_cols=283 Identities=35% Similarity=0.598 Sum_probs=230.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~v~~~~s~~~~~ 100 (599)
+|++++.||+|+||+||+|.++.+|+.||+|.++...........+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875433333334556787777665 699999999998655444456
Q ss_pred cEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+++||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 79999999999999998764 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ......+|..|+|||++.+ ..++.++||||+||++|+|++|+++|.+.+..+.+..+....|.+....+...
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QM----ALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cc----cCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 21 1234578999999999876 57899999999999999999999999999988899999988888766543220
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.. .. -..+....+.++....+..+..+.+||.+|
T Consensus 235 ~~---------------------------------------~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (288)
T cd07863 235 VT---------------------------------------LP-------RGAFSPRGPRPVQSVVPEIEESGAQLLLEM 268 (288)
T ss_pred cc---------------------------------------cc-------ccccCCCCCCchHHhCcCcCHHHHHHHHHH
Confidence 00 00 000112223344455667888999999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 007542 339 LAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f 358 (599)
|++||.+|||+.|+|.||||
T Consensus 269 L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 269 LTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=386.69 Aligned_cols=333 Identities=43% Similarity=0.781 Sum_probs=274.8
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR- 96 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~- 96 (599)
.+...++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+|+.++|+||+++++++.....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3567899999999999999999999999999999999986544444445678899999999999999999999865432
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
.....+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 22346799999998899988865 46999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... .....++++|+|||.+.+. ..++.++|+||+||++++|++|++||.+.+....+..+.+..+.++.+...
T Consensus 169 ~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 169 DSE------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccC------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 321 1334678999999988652 357889999999999999999999999998888888888888777766544
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
. +.......++..++...+..+....++.++.+.+||.
T Consensus 242 ~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 279 (343)
T cd07880 242 K------------------------------------------LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE 279 (343)
T ss_pred h------------------------------------------hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHH
Confidence 3 2223344555656555555555566788999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
+||..||.+|||+.++|.||||+.....+.++...+ +..+++....+-|+++.+.+-||+.|+|
T Consensus 280 ~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 280 KMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred HHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC---ccccHHhhccchHHHHHHHHHHHHhcCC
Confidence 999999999999999999999999877665554443 4455677788899999999999998875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=385.88 Aligned_cols=332 Identities=43% Similarity=0.839 Sum_probs=274.7
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~ 97 (599)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+||+++++++..... .
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 456799999999999999999999999999999999997644444456678899999999999999999998864321 2
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
....+|+|+++++++|.+++... .+++..++.++.||++||.|||+.||+||||||+||+++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~~~~~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhcccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 34568999999989998887654 69999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. .....++.+|+|||++.+. ..++.++||||+||++++|++|++||.+.+....+..+....+.+.++.+..
T Consensus 172 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 172 DE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cc------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 21 2345789999999987552 4678899999999999999999999999988888889999888888776544
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
+.....+.++..+.......+...+...++.+.+||.+
T Consensus 245 ------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 282 (345)
T cd07877 245 ------------------------------------------ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282 (345)
T ss_pred ------------------------------------------cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHH
Confidence 22333445555555555555555555678999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
||+.||.+|+|+.++|+||||+++..++.++.... ++..+..+.+..+++....|+|+..|-|
T Consensus 283 ~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 283 MLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSFESRDLLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred HcCCChhhcCCHHHHhcChhhhhcCCCCccccCCC---ccCcchhcccCHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999887777665432 4555666777789999999999987754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=373.87 Aligned_cols=301 Identities=34% Similarity=0.553 Sum_probs=243.2
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC---
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS--- 95 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s--- 95 (599)
....+.|+-+.+||+|.||.||+|+.+.+|+.||+|++-...+........+||+.+|..|+|+|++.++++|....
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 35678899999999999999999999999999999987543344445566789999999999999999999986432
Q ss_pred cCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.++...+|+||++|+.+|..++... .+++..+++.++.+++.||.|+|++.|+|||+|+.|+||+.+|.+||+|||+++
T Consensus 93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 2344579999999999999999765 589999999999999999999999999999999999999999999999999998
Q ss_pred cccCC-CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFND-TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~-~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
..... ......++..+.|.||++||++.|. ..|++.+|||..|||++||++|.++|.|++...|+..|..++|..+++
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 65322 2223346788999999999999874 789999999999999999999999999999999999999999999998
Q ss_pred HHHHHhhhhhhhhcCCCCCc--ccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFM--CSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
.|.. .+... .++.... ......++ +.+..+ ++ .-++.|
T Consensus 252 vWP~-----------~d~lpL~~sie~eP-------------------l~~~~~rk-v~n~~k----p~-----~kd~~a 291 (376)
T KOG0669|consen 252 VWPN-----------VDNLPLYQSIELEP-------------------LPKGQKRK-VKNRLK----PY-----VKDDEA 291 (376)
T ss_pred cCCC-----------cccchHHHhccCCC-------------------CCcchhhh-hhhhcc----cc-----cCChhH
Confidence 7654 22211 0000000 00111111 111100 00 126789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
.|||.+||.+||.+|++++++|+|.||..
T Consensus 292 ~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 292 LDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred HHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 99999999999999999999999999974
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=403.18 Aligned_cols=294 Identities=25% Similarity=0.443 Sum_probs=222.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCC------CccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP------DIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hp------nIv~l~~v~~~~s 95 (599)
.++|+++++||+|+||+||+|.+..+++.||||+++... .....+.+|+.+++.++|. +++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 578999999999999999999999999999999996421 2233456688887777654 477888877432
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCC-----------
Q 007542 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADC----------- 163 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~----------- 163 (599)
..++|+|||+++++|.+++...+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 204 ---~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 ---TGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred ---CceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 3478999999999999999888889999999999999999999998 5999999999999998765
Q ss_pred -----ceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhh
Q 007542 164 -----KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH 238 (599)
Q Consensus 164 -----~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~ 238 (599)
.+||+|||++..... ..+..+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998754321 1245689999999999977 679999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCHHHHHHHhhhhh--hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCC
Q 007542 239 QLDIMTDLLGTPSPEAIARVCLLLN--IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316 (599)
Q Consensus 239 ~l~~I~~~lg~p~~e~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~ 316 (599)
++..|.+.+|.++.+.... |.... .++..... + ..| .. . ..+..+...
T Consensus 353 ~~~~i~~~~g~~p~~~~~~-~~~~~~~~~~~~~~~----~-------------------~~~-~~-~---~~~~~~~~~- 402 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGR-CGTEEARLLYNSAGQ----L-------------------RPC-TD-P---KHLARIARA- 402 (467)
T ss_pred HHHHHHHHcCCCCHHHHhh-ccchhHHHHhhhccc----c-------------------ccc-CC-H---HHHHhhhcc-
Confidence 9999999999987654322 10000 00000000 0 000 00 0 000000000
Q ss_pred CCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 317 ~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
..+... ..++.+.|||.+||++||.+|||++|+|+||||.....
T Consensus 403 -~~~~~~--~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 403 -RPVREV--IRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred -cchhhh--hchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 001010 12567899999999999999999999999999998654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=395.02 Aligned_cols=282 Identities=25% Similarity=0.358 Sum_probs=221.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.+|++++.||+|+||.||+|++..+++.||||+.. ...+.+|+.+|+.++||||+++++++.. ....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCee
Confidence 68999999999999999999999999999999753 2346799999999999999999999843 3468
Q ss_pred EEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 103 YVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
++|+|++.++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999975322111
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC-------ChhhHHHHHHHhcCCCCHHHH
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-------NVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~-------~~~~~l~~I~~~lg~p~~e~i 255 (599)
......+||+.|+|||++.+ ..++.++||||||||+|+|++|+.+|.+. +...++..|...+|.++.+..
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred -cccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 12245689999999999977 67999999999999999999999666443 235677888888887654321
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHH-HHHhcccCC----CCCCcCCCCCCCHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARR-YLSSMRKKK----PIPFSQKFPNANPL 330 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~-~i~~~~~~~----~~~~~~~~~~~s~~ 330 (599)
.. ....... +........ ..+........+..
T Consensus 315 ~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (391)
T PHA03212 315 ID-------------------------------------------AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPID 351 (391)
T ss_pred cc-------------------------------------------hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhh
Confidence 00 0000000 000000000 00111111235667
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
+.+||.+||++||.+||||+|+|+||||+.+..+
T Consensus 352 l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 352 LEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 8999999999999999999999999999987543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=388.14 Aligned_cols=267 Identities=28% Similarity=0.450 Sum_probs=219.7
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc------------CChhhHHHHHHHHHHHHhcCCCCcccc
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF------------EHVSDATRILREIKLLRLLRHPDIVEI 87 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~------------~~~~~~~~i~rEi~iL~~l~HpnIv~l 87 (599)
-.-++|++++.||+|.||.|.+|++..+++.||||++.+.. ......+++.+||.+|++|.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34588999999999999999999999999999999996421 111234689999999999999999999
Q ss_pred ceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCce
Q 007542 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (599)
Q Consensus 88 ~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~-lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~l 165 (599)
+++.-++ ....+|||+|||. |.+... -.... +++..++.|++.++.||.|||.+|||||||||+|+||+.+|++
T Consensus 174 iEvLDDP---~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDP---ESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCc---ccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 9998554 3468999999999 554433 33334 9999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCC--CCCcccccccccCccccCccccccc--cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHH
Q 007542 166 KICDFGLARVAFND--TPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241 (599)
Q Consensus 166 KL~DFGla~~~~~~--~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~ 241 (599)
||+|||.+.....+ ......+...+||+.|+|||++.+. ....+.+.||||+||+||.|+.|+.||-++...+..+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 99999999765222 1222334557999999999998652 1235678999999999999999999999998888888
Q ss_pred HHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCc
Q 007542 242 IMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321 (599)
Q Consensus 242 ~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 321 (599)
+|++.- ..|
T Consensus 330 KIvn~p----------------------------------------------------------------------L~f- 338 (576)
T KOG0585|consen 330 KIVNDP----------------------------------------------------------------------LEF- 338 (576)
T ss_pred HHhcCc----------------------------------------------------------------------ccC-
Confidence 876411 111
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 322 ~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
...+.+.++++|||.+||..||++|++..++..|||...-
T Consensus 339 P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 339 PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1234567889999999999999999999999999999865
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=379.01 Aligned_cols=275 Identities=28% Similarity=0.434 Sum_probs=225.9
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...+.|++.++||.|..++||+|+.+.+++.||||+++....+. +...+.+|+..|+.++||||++++..|...
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~----- 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVD----- 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEec-----
Confidence 45789999999999999999999999999999999998654443 378899999999999999999999999654
Q ss_pred ccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
..+|+||.||. |+++++++.. .++.|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+-..
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 36999999999 7999999874 46999999999999999999999999999999999999999999999999998776
Q ss_pred cCCCCCccc-ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIF-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
......... +.+.+||++|||||++...-.+|+.++||||||++..||.+|+.||..--.... ++.++-|.|+.-.+
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTLQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHhcCCCCCccc
Confidence 544332222 267899999999999654447899999999999999999999999976554432 23444455542111
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. ...+ .....+..++.+|
T Consensus 255 ~~------------------------------------------~~~d-------------------~~k~~~ksf~e~i 273 (516)
T KOG0582|consen 255 SG------------------------------------------LDKD-------------------EDKKFSKSFREMI 273 (516)
T ss_pred cc------------------------------------------CChH-------------------HhhhhcHHHHHHH
Confidence 00 0000 0112345789999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
..||+.||.+||||+++|+|+||+....
T Consensus 274 ~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 274 ALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred HHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 9999999999999999999999997643
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=380.70 Aligned_cols=330 Identities=41% Similarity=0.765 Sum_probs=263.2
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~ 97 (599)
+...++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++|+||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 455689999999999999999999999999999999997544333445667899999999999999999999864322 2
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
....+|+|+||+..+|.+++. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 335679999999988887653 368999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. .....++.+|+|||.+.+. ..++.++|||||||++++|++|+.||.+.+....+..+....|.+.++.+..
T Consensus 169 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07879 169 AE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241 (342)
T ss_pred CC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 21 2345788999999998652 4588899999999999999999999999998889999999999888876654
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. +.....++..++......+...++..++.+.+||.+
T Consensus 242 ~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 279 (342)
T cd07879 242 LE------------------------------------------DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK 279 (342)
T ss_pred hc------------------------------------------ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHH
Confidence 21 111223333333333444555667788999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 402 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~ 402 (599)
||+.||.+|||++|+|.||||.++...+.++...+ +...-+...+..+++..-+|.|+..+.
T Consensus 280 ~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T cd07879 280 MLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLENEKLSVDEWKKHIYKEVKSFS 341 (342)
T ss_pred HcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccchhhhhhCCHHHHHHHhhhhhhccC
Confidence 99999999999999999999999876554443322 233334446667777778888765544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=379.14 Aligned_cols=327 Identities=50% Similarity=0.843 Sum_probs=262.5
Q ss_pred ceEEEEEeeecCceEEEEEEECCC--CcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~t--g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~ 100 (599)
+|++.+.||+|+||.||++.+..+ +..||||++............+.+|+.+++.+ +||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999888 99999999976544444566788999999999 5999999998754322 2335
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 101 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
.+|++++|++++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 78999999999999999888889999999999999999999999999999999999999999999999999998653221
Q ss_pred CC-cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 181 PT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 181 ~~-~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. .......+++..|+|||++.+. ..++.++||||+||++++|++|++||.+.+..+.+..+...+|.|+.+.+..+
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI- 237 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-
Confidence 11 1112346789999999987542 46889999999999999999999999999999999999999999988766552
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.......++..+.......+....+..+..+.+||.+||
T Consensus 238 -----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 276 (332)
T cd07857 238 -----------------------------------------GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLL 276 (332)
T ss_pred -----------------------------------------hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHc
Confidence 122233334444444455566666778899999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHH
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYRE 397 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e 397 (599)
++||.+|||+.|+|.||||+.++++...+.+.......| + ..-+-+++|.+|..|
T Consensus 277 ~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~ 331 (332)
T cd07857 277 AFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSF--E-SEDSMEELRDMIIEE 331 (332)
T ss_pred cCCcccCCCHHHHhcChhhhhhcCccccccccccccCCc--c-ccccHHHHHHHHhhc
Confidence 999999999999999999999987766666543333333 2 233556677766554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=381.16 Aligned_cols=265 Identities=29% Similarity=0.455 Sum_probs=213.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
...+|...+.||+|+||.||++.+.++|+..|||.+... +....+.+.+|+.+|+.++|||||++++...... + .
T Consensus 15 ~~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~ 89 (313)
T KOG0198|consen 15 EISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-D 89 (313)
T ss_pred ccchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-e
Confidence 356789999999999999999999999999999998653 2222667889999999999999999998642221 1 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-CCceeeeccccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAF 177 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-~~~lKL~DFGla~~~~ 177 (599)
.++|.|||+. |+|.++++..+ .+++..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 6899999999 69999999887 7999999999999999999999999999999999999999 7999999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC-ChhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~-~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.............||+.|||||++... .....++|||||||++.||+||++||.+. .....+..|.
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig------------ 236 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG------------ 236 (313)
T ss_pred cccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh------------
Confidence 311111223467899999999999741 23345999999999999999999999763 2111111110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.... ...+...+++++++||.
T Consensus 237 ---------------------------------------------------------~~~~--~P~ip~~ls~~a~~Fl~ 257 (313)
T KOG0198|consen 237 ---------------------------------------------------------REDS--LPEIPDSLSDEAKDFLR 257 (313)
T ss_pred ---------------------------------------------------------ccCC--CCCCCcccCHHHHHHHH
Confidence 0000 11333458999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCc
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+||..||++||||+++|+|||.+...
T Consensus 258 ~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 258 KCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999998643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=378.54 Aligned_cols=288 Identities=34% Similarity=0.578 Sum_probs=217.1
Q ss_pred EEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 007542 28 EEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
.++||+|+||+||+|+++ .++..||+|.+... .....+.+|+.+|+.++||||+++++++.... ...+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEE
Confidence 357999999999999965 46789999998642 12345678999999999999999999985432 3468999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe----cCCCceeeecccc
Q 007542 106 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 172 (599)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv----~~~~~lKL~DFGl 172 (599)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999988632 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh---------hhHHHHH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIM 243 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~---------~~~l~~I 243 (599)
++...............++|++|+|||++.+. ..++.++||||+||++++|++|++||.+.+. ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98754332222223456889999999998652 4688999999999999999999999976543 4678899
Q ss_pred HHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC
Q 007542 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323 (599)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 323 (599)
.+.+|.|....+..+......... .+..... .........+ +...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~-~~~~~~~~~~-----------~~~~ 282 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTL-----------------------MKDFRRN-TYTNCSLIKY-----------MEKH 282 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhh-----------------------hhhhhcc-ccCcccccch-----------HHhc
Confidence 999999988877653211110000 0000000 0000000000 0111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 324 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 324 ~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
....+..+.|||++||++||.+|||++|+|+||||
T Consensus 283 ~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 283 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 12346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=376.93 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=214.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence 47999999999999999999999999999999986422 12234567889999999999999999998874 3357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999997653221
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 23478999999999877 67899999999999999999999999887655443333210
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
.. ......++.+++||++||+
T Consensus 214 --------------------------------------------------------~~---~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 214 --------------------------------------------------------KL---EFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred --------------------------------------------------------Cc---CCCccCCHHHHHHHHHHcC
Confidence 00 0112357889999999999
Q ss_pred cCCCCCCC-----HHHHhcCccccCCc
Q 007542 341 FEPKDRPT-----AEEALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~RpT-----a~e~L~HP~f~~~~ 362 (599)
.||.+|++ ++|+|+||||..+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccCCC
Confidence 99999995 99999999998653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=392.56 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=223.6
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.-..+|...+.||+|+.|.||.|+...+++.||||++... .....+-+++|+.+|+..+|+|||++++-|.-.
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~----- 342 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG----- 342 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----
Confidence 3457899999999999999999999999999999999753 334456788999999999999999999988543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+|||||+ |+|.+++... .++|.++..+++.++.||+|||.+||+|||||.+|||+..+|.+||+|||++..+..
T Consensus 343 deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 47999999999 5888887655 599999999999999999999999999999999999999999999999999988755
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .....+||++|||||++.. ..|++++||||||+++.||+-|.|||-.++....+.+|.+ -|+|..
T Consensus 422 ~~~---KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l------ 489 (550)
T KOG0578|consen 422 EQS---KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL------ 489 (550)
T ss_pred ccC---ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc------
Confidence 443 2367799999999999977 7899999999999999999999999998887777766653 233221
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
+....+|+.++|||.+|
T Consensus 490 ---------------------------------------------------------------k~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 490 ---------------------------------------------------------------KNPEKLSPELKDFLDRC 506 (550)
T ss_pred ---------------------------------------------------------------CCccccCHHHHHHHHHH
Confidence 22346899999999999
Q ss_pred cccCCCCCCCHHHHhcCcccc
Q 007542 339 LAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~ 359 (599)
|+.|+.+|+||.|+|+||||+
T Consensus 507 L~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred hhcchhcCCCHHHHhcChhhh
Confidence 999999999999999999995
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=372.07 Aligned_cols=291 Identities=35% Similarity=0.624 Sum_probs=233.8
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
++.-++|++++.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----- 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT----- 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec-----
Confidence 46678999999999999999999999999999999998643222 234467789999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 3479999999999999988764 468999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.+....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2211 12344678899999988652 4678899999999999999999999999999999999999999888765543
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
+.... .|.. ...+......+....+..++.+.+||.+
T Consensus 232 ~~~~~--~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~ 268 (301)
T cd07873 232 ILSNE--EFKS-----------------------------------------YNYPKYRADCLHNHAPRLDSDGAELLSK 268 (301)
T ss_pred hhccc--cccc-----------------------------------------cccCccccccHHhhcCCCCHHHHHHHHH
Confidence 10000 0000 0000001111112235678899999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCc
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
||++||.+|||++|+|+||||..+.
T Consensus 269 ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 269 LLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred HhcCCcccCcCHHHHhcCccccccc
Confidence 9999999999999999999998774
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.49 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=214.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-++|++.+.||+|+||.||+|+++.+++.||||++.... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-----EN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-----CC
Confidence 478999999999999999999999999999999996432 222345678899999999999999999999843 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 7999999998 599999998889999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------- 230 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------- 230 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Confidence 1 23578999999999977 57889999999999999999999999877654443333210
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
... ....+++.+.+||++||
T Consensus 231 ---------------------------------------------------------~~~---~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 231 ---------------------------------------------------------RLK---FPNWFDGRARDLVKGLL 250 (329)
T ss_pred ---------------------------------------------------------CcC---CCCCCCHHHHHHHHHHh
Confidence 000 11236778999999999
Q ss_pred ccCCCCCCC-----HHHHhcCccccCC
Q 007542 340 AFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
+.||.+|++ ++++|+||||.+.
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 999999997 7999999999863
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=382.43 Aligned_cols=263 Identities=31% Similarity=0.519 Sum_probs=226.9
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~ 96 (599)
......|++.+.||+|.||+||+|+++.||+.+|+|+|.+.... ......+.+|+.+|+++. |||||.++++|.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-- 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-- 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--
Confidence 35567899999999999999999999999999999999754432 234568889999999998 99999999999543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC----Cceeeeccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFG 171 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~----~~lKL~DFG 171 (599)
..+|+|||++. |+|++.|... .++|..+..++.||+.+++|||+.||+||||||+|+|+... +.+|++|||
T Consensus 109 ---~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 109 ---DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred ---CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 47999999999 6999999877 49999999999999999999999999999999999998653 579999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
++..... .......+||+.|+|||++.. ..|+..+||||+|||+|.||+|.+||.+.+.......|...
T Consensus 185 la~~~~~----~~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~----- 253 (382)
T KOG0032|consen 185 LAKFIKP----GERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG----- 253 (382)
T ss_pred CceEccC----CceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-----
Confidence 9988654 223567899999999999987 68999999999999999999999999998876655544321
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
....-...|+.++..|
T Consensus 254 ----------------------------------------------------------------~~~f~~~~w~~is~~a 269 (382)
T KOG0032|consen 254 ----------------------------------------------------------------DFDFTSEPWDDISESA 269 (382)
T ss_pred ----------------------------------------------------------------CCCCCCCCccccCHHH
Confidence 1122335678899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+||++||.+||.+|+||.++|+|||+++..
T Consensus 270 kd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 270 KDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 9999999999999999999999999998763
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=363.69 Aligned_cols=266 Identities=29% Similarity=0.488 Sum_probs=222.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC------hhhHHHHHHHHHHHHhcC-CCCccccceeec
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH------VSDATRILREIKLLRLLR-HPDIVEIKHILL 92 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~------~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~ 92 (599)
+.-+.|.-.++||+|..++|.++.++.||..+|+|+|...... ....+...+|+.||+++. ||+|+++.++|.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3346778889999999999999999999999999999632211 112344568999999995 999999999995
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 93 PPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
.++ .+++|||+|. |.|++++.+.-.++|...+.+++||++|+.|||.++||||||||+|||++++.++||+|||
T Consensus 94 s~s-----F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDA-----FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred Ccc-----hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 544 6899999999 8999999998899999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccc----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
+|.....+ ..++..|||+.|+|||.+... ..+|+..+|+|++|+|+|.||.|.+||-.....-.+.+|..
T Consensus 169 Fa~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime-- 242 (411)
T KOG0599|consen 169 FACQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME-- 242 (411)
T ss_pred eeeccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh--
Confidence 99876443 346789999999999987542 24689999999999999999999999965544444443332
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
.+...-+..|.++
T Consensus 243 -------------------------------------------------------------------GkyqF~speWadi 255 (411)
T KOG0599|consen 243 -------------------------------------------------------------------GKYQFRSPEWADI 255 (411)
T ss_pred -------------------------------------------------------------------cccccCCcchhhc
Confidence 1111223456678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
|..++|||.+||+.||.+|+|++|+|+||||..+..
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 889999999999999999999999999999977644
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=377.88 Aligned_cols=331 Identities=44% Similarity=0.758 Sum_probs=264.9
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~ 98 (599)
...++|++.+.||+|+||.||+|.+..+|+.||||++...+........+.+|+.+++.+ +|+||+++++++... +
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~ 80 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---N 80 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---C
Confidence 456789999999999999999999999999999999875554545566778999999999 999999999988432 2
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+|+||||+.++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred CceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 2468999999999999999876 788999999999999999999999999999999999999999999999999986543
Q ss_pred CCCC--cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 179 DTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 179 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... ......+.++.+|+|||++.+. ..++.++||||+||++++|++|++||.+.+..+.+..+....|.+..+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 2211 1123456789999999987542 467889999999999999999999999999999999999999988887765
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.+. .......+..+......++....+..+..+.+||.
T Consensus 239 ~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (337)
T cd07852 239 SIK------------------------------------------SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLK 276 (337)
T ss_pred HHH------------------------------------------hhhHHHhhhhcccccccchhhhccCCCHHHHHHHH
Confidence 521 11222333344444444555666778999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHH
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREI 398 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~ 398 (599)
+||+.||.+|||+.++|+||||.++.....++.........+. ..++++..+.|..+|+|+
T Consensus 277 ~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07852 277 KLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337 (337)
T ss_pred HhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc-ccceeeHHHHHhhhhhcC
Confidence 9999999999999999999999998776666544322222222 335566666677777653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=379.88 Aligned_cols=250 Identities=25% Similarity=0.447 Sum_probs=209.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
++||+|+||.||+|.++.+|+.||||+++.... .......+++|+.+|+.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 469999999999999999999999999975322 23345677899999999999999999998843 357999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 108 ~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
|+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---Ccc
Confidence 999 5899999888899999999999999999999999999999999999999999999999999987532211 112
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIW 266 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~ 266 (599)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------------------- 210 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------------------- 210 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--------------------
Confidence 45679999999999977 67899999999999999999999999876654433322110
Q ss_pred cCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCC
Q 007542 267 CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 346 (599)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~R 346 (599)
.. .....+++.+.+||++||..||++|
T Consensus 211 --------------------------------------------------~~---~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 211 --------------------------------------------------EI---RFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred --------------------------------------------------CC---CCCCCCCHHHHHHHHHHccCCHHHc
Confidence 00 0113468889999999999999999
Q ss_pred C-----CHHHHhcCccccCC
Q 007542 347 P-----TAEEALADPYFKGL 361 (599)
Q Consensus 347 p-----Ta~e~L~HP~f~~~ 361 (599)
| ++.++|+||||.++
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.84 Aligned_cols=323 Identities=48% Similarity=0.866 Sum_probs=267.7
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.+...++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++.+++...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 81 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP--- 81 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC---
Confidence 36788999999999999999999999999999999999865444444556788999999999999999999988532
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+|+||++++|.+++.. ..+++..+..++.||++||.|||+.||+||||+|+|||++.++.+||+|||+++...
T Consensus 82 -~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 82 -LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred -CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 236899999999999988865 468899999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. .....++..|+|||.+.+. ..++.++||||+||++++|++|+++|.+.+.......+.+.+|.++.+.+..
T Consensus 160 ~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 160 PQ------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred CC------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 21 1345678899999987542 4688999999999999999999999999998888899999999998876654
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.......+++..+....+.+....++..++.+.+||++
T Consensus 233 ------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 270 (328)
T cd07856 233 ------------------------------------------ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEK 270 (328)
T ss_pred ------------------------------------------ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHH
Confidence 22222344455555555666667777889999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHH
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYR 396 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~ 396 (599)
||+.||++|||++++|.||||..+..+..++.+. .++++.++...+..+.|+-+.|.
T Consensus 271 ~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 327 (328)
T cd07856 271 MLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAE--EKFDWSFNDADLPVDTWKVMMYS 327 (328)
T ss_pred HcCCChhhCCCHHHHhcCCccccccCCccccCch--hhcCCchhcccCCHHHHHHHhcC
Confidence 9999999999999999999999887765555433 36777778788888888766553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=374.44 Aligned_cols=261 Identities=28% Similarity=0.482 Sum_probs=228.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
-+++-|.+.+.||+|.|.+|.+|+|.-||++||||+|.+...+......+..|++.|+.++|||||+|++++ .+.
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence 457889999999999999999999999999999999988777766777899999999999999999999998 334
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceE-ecCCCceeeecccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL-ANADCKLKICDFGLARVA 176 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL-v~~~~~lKL~DFGla~~~ 176 (599)
..+|||+|+-+ |+|+++|-++ .++.|+.+++||+||+.||.|||+..+|||||||+|+. +.+-|.|||.|||++..+
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 57999999998 5999999765 58999999999999999999999999999999999975 556699999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..+ ..+++.||+..|-|||++.+ ..| -+++||||||||||-|.||++||...++.+.+.+|++.--+-
T Consensus 170 ~PG----~kL~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv----- 238 (864)
T KOG4717|consen 170 QPG----KKLTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV----- 238 (864)
T ss_pred CCc----chhhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC-----
Confidence 433 34678899999999999988 555 468999999999999999999999999998888886522111
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
...++.+++|||
T Consensus 239 --------------------------------------------------------------------PshvS~eCrdLI 250 (864)
T KOG4717|consen 239 --------------------------------------------------------------------PSHVSKECRDLI 250 (864)
T ss_pred --------------------------------------------------------------------chhhhHHHHHHH
Confidence 124678899999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
..||..||++|.|.+|+..|+|++.+...
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCCC
Confidence 99999999999999999999999987643
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=363.72 Aligned_cols=282 Identities=38% Similarity=0.638 Sum_probs=227.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++++.||+|++|.||+|.+..++..||||++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 5899999999999999999999999999999987544344445677899999999999999999999853 34789
Q ss_pred EEEecCCccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 104 VVFELMESDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999999888653 468999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
.......++..|+|||++.+. ..++.++|||||||++++|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112344678999999987652 4578899999999999999999999999988888888888888776655433110
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
..++-..........+.......++++.+||++||.
T Consensus 232 --------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 267 (285)
T cd07861 232 --------------------------------------------LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLI 267 (285)
T ss_pred --------------------------------------------hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhc
Confidence 001111111111112223345578999999999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q 007542 341 FEPKDRPTAEEALADPYF 358 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f 358 (599)
.||.+|||+.++|+||||
T Consensus 268 ~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 268 YDPAKRISAKKALNHPYF 285 (285)
T ss_pred CChhhCCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=369.57 Aligned_cols=256 Identities=29% Similarity=0.509 Sum_probs=224.8
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecC-ccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
...-||++.+.||+|.||.|.+|++...|+.||||.|++ ......+.-+|.|||+||..|+||||+.++++|. +
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----N 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----N 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----C
Confidence 345789999999999999999999999999999999964 4556778889999999999999999999999994 4
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+.|||||.. |+|+++|...+.|+|.+++.||+||+.|+.|||.++++|||||.+|||+|.||++||+||||+..+.
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 457999999999 7999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
. ..++++.||++.|.+||++.+. ..-++.+|.||||++||.|..|..||.|.+....+.+|.+-.-.
T Consensus 205 ~----~kfLqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-------- 271 (668)
T KOG0611|consen 205 D----KKFLQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-------- 271 (668)
T ss_pred c----ccHHHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--------
Confidence 3 3467889999999999999883 33478999999999999999999999999877666655421100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
-|..+..|.-||+.
T Consensus 272 ------------------------------------------------------------------EP~~PSdA~gLIRw 285 (668)
T KOG0611|consen 272 ------------------------------------------------------------------EPETPSDASGLIRW 285 (668)
T ss_pred ------------------------------------------------------------------CCCCCchHHHHHHH
Confidence 13445678999999
Q ss_pred hcccCCCCCCCHHHHhcCcccc
Q 007542 338 MLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
||..||++|.|++++-.|=|+.
T Consensus 286 mLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHhcCcccchhHHHHhhhheee
Confidence 9999999999999999996664
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=381.25 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=214.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 47999999999999999999999999999999996431 222345667899999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999987542211
Q ss_pred CCc-----------------------------------ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHH
Q 007542 181 PTA-----------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (599)
Q Consensus 181 ~~~-----------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLl 225 (599)
... ......+||+.|+|||++.. ..++.++||||||||+|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 00113479999999999876 67899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHH
Q 007542 226 TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKA 305 (599)
Q Consensus 226 tG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~ 305 (599)
+|.+||.+.+....+..+.+..
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~---------------------------------------------------------- 255 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWK---------------------------------------------------------- 255 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCC----------------------------------------------------------
Confidence 9999998877554443332100
Q ss_pred HHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCC
Q 007542 306 RRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGL 361 (599)
Q Consensus 306 ~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpT---a~e~L~HP~f~~~ 361 (599)
....+. ....+++.+.+||++||. ||.+|++ ++|+|+||||++.
T Consensus 256 ----------~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 256 ----------ETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred ----------CccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 000000 012468899999999997 9999998 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=364.97 Aligned_cols=282 Identities=38% Similarity=0.615 Sum_probs=227.0
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|+||.||+|++..+|+.||+|+++...........+.+|+.+++.++|+||+++++++.+ ...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 6999999999999999999999999999999997543333334567789999999999999999999843 34789
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
+|+||++++|.+++.. .+.+++..++.++.||++||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999998875 45799999999999999999999999999999999999999999999999999976432211
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~p-F~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++..|+|||++.+. ..++.++||||+||++++|++|..| |.+.+...++..+.+.++.+....+......
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345778999999988652 4578999999999999999997655 7788888889999998888877655442111
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
... . .. ........+.+..+..++.+.+||.+||+.
T Consensus 232 ~~~-----~-------------------------------------~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 267 (284)
T cd07839 232 PDY-----K-------------------------------------PY--PMYPATTSLVNVVPKLNSTGRDLLQNLLVC 267 (284)
T ss_pred ccc-----c-------------------------------------cc--CCCCCcchhhhhcccCCHHHHHHHHHHhcC
Confidence 000 0 00 000001112344567889999999999999
Q ss_pred CCCCCCCHHHHhcCccc
Q 007542 342 EPKDRPTAEEALADPYF 358 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f 358 (599)
||.+|||++|+|.||||
T Consensus 268 ~P~~R~t~~~il~h~~f 284 (284)
T cd07839 268 NPVQRISAEEALQHPYF 284 (284)
T ss_pred ChhhcCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=375.41 Aligned_cols=261 Identities=25% Similarity=0.468 Sum_probs=218.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence 479999999999999999999999999999999974322 22345678899999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998 59999999888899999999999999999999999999999999999999999999999999976533
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------- 216 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------- 216 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence 1245679999999999977 58899999999999999999999999987765554443221000
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
+. .+ ........+++.+.+||.+||.
T Consensus 217 ---------------------------------------------------~~--~~-~~~~~~~~~s~~~~~li~~~l~ 242 (333)
T cd05600 217 ---------------------------------------------------LQ--RP-VYDDPRFNLSDEAWDLITKLIN 242 (333)
T ss_pred ---------------------------------------------------cc--CC-CCCccccccCHHHHHHHHHHhh
Confidence 00 00 0001113568899999999999
Q ss_pred cCCCCCCCHHHHhcCccccCC
Q 007542 341 FEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+|.+|+|++++++||||.++
T Consensus 243 ~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 243 DPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=379.31 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=213.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||+||+|.++.+++.||||+++.... .......+.+|+.+++.++|+||+++++.+.+ ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 479999999999999999999999999999999964321 22334577889999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 5999999988899999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC
Q 007542 181 PT--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (599)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~ 228 (599)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001124589999999999977 67899999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHH
Q 007542 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRY 308 (599)
Q Consensus 229 ~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~ 308 (599)
+||.+.+....+..|......
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~----------------------------------------------------------- 254 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKET----------------------------------------------------------- 254 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCc-----------------------------------------------------------
Confidence 999987765555444321100
Q ss_pred HHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC---CCCHHHHhcCccccCC
Q 007542 309 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD---RPTAEEALADPYFKGL 361 (599)
Q Consensus 309 i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~---RpTa~e~L~HP~f~~~ 361 (599)
..+.. ...+++.+++||.+|+. +|.+ ||+++|+|+||||+++
T Consensus 255 ---------~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 255 ---------LIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred ---------ccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 00110 12367899999999886 5554 5899999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=381.65 Aligned_cols=263 Identities=23% Similarity=0.354 Sum_probs=211.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+.|++++.||+|+||+||+|+++.+++.||||++.... ........+.+|+.+|+.++|+||+++++++.+ ...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-----~~~ 75 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-----KDN 75 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-----CCE
Confidence 36999999999999999999999999999999996432 233445678899999999999999999999853 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 76 LYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998 5999999988889999999999999999999999999999999999999999999999999975421000
Q ss_pred C--------------------------------------------CcccccccccCccccCccccccccCCCCcchhhHh
Q 007542 181 P--------------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (599)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWS 216 (599)
. ........+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceee
Confidence 0 0001124579999999999976 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHH
Q 007542 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLIL 296 (599)
Q Consensus 217 lG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 296 (599)
||||+|||++|++||.+.+.......+....+.
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------------------------------- 266 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWENT----------------------------------------------- 266 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc-----------------------------------------------
Confidence 999999999999999887654433333210000
Q ss_pred hhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc--CCCCCCCHHHHhcCccccCC
Q 007542 297 HCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF--EPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 297 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~--DP~~RpTa~e~L~HP~f~~~ 361 (599)
.. ......+++++.+||.+||.. +|..|+|++|+|+||||+++
T Consensus 267 ---------------------~~-~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 267 ---------------------LH-IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ---------------------cC-CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 00 011124688999999997755 44459999999999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=382.61 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=212.7
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|+++++||+|+||.||+|+++.+++.||||++.... ........+.+|+.+|+.++|+||+++++.+.. ...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-----~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-----KDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-----CCE
Confidence 46999999999999999999999999999999986422 123345678899999999999999999999853 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcccccccccCccccCccccccccCCCCcchhhHh
Q 007542 181 P--------------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (599)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWS 216 (599)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999977 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHH
Q 007542 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLIL 296 (599)
Q Consensus 217 lG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 296 (599)
||||+|||++|++||.+.+.......+......
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------------------------------- 266 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTS----------------------------------------------- 266 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC-----------------------------------------------
Confidence 999999999999999887654433333210000
Q ss_pred hhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCC
Q 007542 297 HCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGL 361 (599)
Q Consensus 297 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpT---a~e~L~HP~f~~~ 361 (599)
... .....+++.+.+||.+|+. ||.+|++ ++|+++||||+++
T Consensus 267 -------------------~~~---p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 267 -------------------LHI---PPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred -------------------cCC---CCcccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCCc
Confidence 000 1123578899999999875 9999997 9999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=374.71 Aligned_cols=295 Identities=31% Similarity=0.531 Sum_probs=226.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC--CC----ccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH--PD----IVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H--pn----Iv~l~~v~~~~s 95 (599)
..||+++..+|+|+||.|..+.|..++..||||+|+... ...+..+-|+++|+++.+ |+ +|.+.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF---- 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF---- 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence 789999999999999999999999999999999997431 223445569999999953 22 55565555
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC------------
Q 007542 96 RREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA------------ 161 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~------------ 161 (599)
+-.++++||||.++-++++++..++ .++..+++.+.+||++++++||+.+++|.||||+|||+..
T Consensus 161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 4456899999999999999999876 6889999999999999999999999999999999999642
Q ss_pred --------CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 007542 162 --------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (599)
Q Consensus 162 --------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g 233 (599)
+..++|+|||.|+...... +..+.|+.|+|||++.+ -+|+..+||||+||||+||.+|..+|++
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceeccc
Confidence 2448999999998754322 45689999999999998 6899999999999999999999999999
Q ss_pred CChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcc
Q 007542 234 KNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMR 313 (599)
Q Consensus 234 ~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~ 313 (599)
.++.+++.+|..++|..+...+.+........--.++ |.+.....-.+++...
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rld--------------------------w~e~~~~~~~k~v~~~- 364 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLD--------------------------WPEVSSKGKSKYVFEP- 364 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhccccc--------------------------CccccccccchhhhcC-
Confidence 9999999999999997777666653211111100111 1111111101111111
Q ss_pred cCCCCCCcCCCCCCC---HHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 314 KKKPIPFSQKFPNAN---PLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 314 ~~~~~~~~~~~~~~s---~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+.++.......+ ..+.|||++||.+||.+|+|+.|||.||||+.+.
T Consensus 365 ---ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 365 ---CKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred ---CccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 112222222222 3478999999999999999999999999999764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=364.96 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=210.7
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++|+||+++.+++.. ...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-----CCeE
Confidence 3889999999999999999999999999999986432 222234467899999999999999999998843 3479
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 5898877543 36899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. .....+||..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...+.
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----------- 218 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----------- 218 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-----------
Confidence 1 1234578999999999977 6799999999999999999999999987654322221111000
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
. ........+++.+.+||++||
T Consensus 219 ------------------------------------------------------~----~~~~~~~~~s~~~~~li~~~l 240 (285)
T cd05631 219 ------------------------------------------------------E----DQEEYSEKFSEDAKSICRMLL 240 (285)
T ss_pred ------------------------------------------------------c----ccccCCccCCHHHHHHHHHHh
Confidence 0 001122357889999999999
Q ss_pred ccCCCCCCC-----HHHHhcCccccCCc
Q 007542 340 AFEPKDRPT-----AEEALADPYFKGLA 362 (599)
Q Consensus 340 ~~DP~~RpT-----a~e~L~HP~f~~~~ 362 (599)
+.||.+|+| ++++|+||||.++.
T Consensus 241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 241 TKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred hcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 999999997 99999999998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=381.15 Aligned_cols=262 Identities=24% Similarity=0.393 Sum_probs=212.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 47999999999999999999999999999999986421 122345678899999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999986321100
Q ss_pred CC------------c--------------------------------ccccccccCccccCccccccccCCCCcchhhHh
Q 007542 181 PT------------A--------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (599)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWS 216 (599)
.. . ......+||+.|+|||++.+ ..++.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00013579999999999976 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHH
Q 007542 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLIL 296 (599)
Q Consensus 217 lG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 296 (599)
||||+|||++|.+||.+.+..+.+..|.....
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------------------------------------ 265 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWRE------------------------------------------------ 265 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccCC------------------------------------------------
Confidence 99999999999999988776555444332100
Q ss_pred hhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccCC
Q 007542 297 HCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR---PTAEEALADPYFKGL 361 (599)
Q Consensus 297 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~R---pTa~e~L~HP~f~~~ 361 (599)
...+ ......++.+.+||.+||. +|.+| +|+.|+|.||||++.
T Consensus 266 --------------------~~~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 266 --------------------TLYF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred --------------------ccCC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 0000 0112467889999999998 77776 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=376.27 Aligned_cols=262 Identities=29% Similarity=0.474 Sum_probs=216.7
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+|+.++|+||+++++++. +...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence 479999999999999999999999999999999974322 2234567889999999999999999999884 3357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999998 5999999888889999999999999999999999999999999999999999999999999997654322
Q ss_pred C--------------------------CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 007542 181 P--------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (599)
Q Consensus 181 ~--------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~ 234 (599)
. .........||+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234679999999999987 58899999999999999999999999887
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc
Q 007542 235 NVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK 314 (599)
Q Consensus 235 ~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~ 314 (599)
+.......|......
T Consensus 234 ~~~~~~~~i~~~~~~----------------------------------------------------------------- 248 (350)
T cd05573 234 TLQETYNKIINWKES----------------------------------------------------------------- 248 (350)
T ss_pred CHHHHHHHHhccCCc-----------------------------------------------------------------
Confidence 755444333221000
Q ss_pred CCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCccccCC
Q 007542 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-AEEALADPYFKGL 361 (599)
Q Consensus 315 ~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpT-a~e~L~HP~f~~~ 361 (599)
... .....+++.+.+||.+||. ||.+|++ ++|+|+||||+++
T Consensus 249 -~~~---p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 249 -LRF---PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred -ccC---CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 000 0112368899999999998 9999999 9999999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=376.32 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=214.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCC-cEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg-~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.-++|++.+.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----- 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----- 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-----
Confidence 4578999999999999999999876665 689999986422 223345678899999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 347999999998 6999999988899999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ....+||+.|+|||++.+ ..++.++||||+|||+|+|++|++||.+.+.......|....
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------- 244 (340)
T PTZ00426 183 TR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------- 244 (340)
T ss_pred CC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------
Confidence 21 134579999999999976 678899999999999999999999998876554433332100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. ...+.+++.+.+||++
T Consensus 245 ------------------------------------------------------------~---~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 245 ------------------------------------------------------------I---YFPKFLDNNCKHLMKK 261 (340)
T ss_pred ------------------------------------------------------------C---CCCCCCCHHHHHHHHH
Confidence 0 0113467889999999
Q ss_pred hcccCCCCCC-----CHHHHhcCccccCC
Q 007542 338 MLAFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
||+.||.+|+ |++++++||||.++
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999996 89999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=364.99 Aligned_cols=294 Identities=41% Similarity=0.640 Sum_probs=234.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++...........+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCC
Confidence 46789999999999999999999999999999999874433333334567899999999999999999998543 224
Q ss_pred cEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 68999999999999988764 57899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ..+...++..|+|||++.+. ..++.++||||+||++|+|++|+++|.+.+..+++..+.+.+|.+....+....
T Consensus 162 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 21 12344568899999998652 467899999999999999999999999999999999999999988776543311
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
..... .. + .+.......+...++..++.+.+||.+||
T Consensus 238 ~~~~~------~~-----------------------------------~--~~~~~~~~~~~~~~~~~~~~~~~li~~ml 274 (309)
T cd07845 238 DLPLV------GK-----------------------------------F--TLPKQPYNNLKHKFPWLSEAGLRLLNFLL 274 (309)
T ss_pred ccccc------cc-----------------------------------c--cccCCCCCchHHhccccCHHHHHHHHHHh
Confidence 10000 00 0 00000011122233456889999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCccC
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
++||++|||++|+|.||||.+...+
T Consensus 275 ~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 275 MYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cCChhhCcCHHHHhcChhhccCCCC
Confidence 9999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=380.18 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=212.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++|+||+++++.+.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCE
Confidence 47999999999999999999999999999999986421 122335667899999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CcccccccccCccccCccccccccCCCCcchhhHhHHHH
Q 007542 181 P----------------------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (599)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~I 220 (599)
. ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999977 678999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhc
Q 007542 221 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300 (599)
Q Consensus 221 l~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 300 (599)
+|+|++|+.||.+.+..+....+.....
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~---------------------------------------------------- 261 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWET---------------------------------------------------- 261 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCc----------------------------------------------------
Confidence 9999999999988765544333221000
Q ss_pred ccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCC
Q 007542 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGL 361 (599)
Q Consensus 301 ~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~Rp---Ta~e~L~HP~f~~~ 361 (599)
... ......+++.+.+||.+|+. ||.+|+ |+.|+|+||||+++
T Consensus 262 --------------~~~---~~~~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 262 --------------TLH---IPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred --------------ccc---CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCCCCcCCC
Confidence 000 01123578899999999874 999999 99999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.55 Aligned_cols=248 Identities=31% Similarity=0.487 Sum_probs=207.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (599)
||+|+||.||+|.+..+++.||+|+++... ........+.+|+.+|+.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 799999999999999999999999986432 223445678899999999999999999998843 35799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccc
Q 007542 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (599)
Q Consensus 110 ~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (599)
. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 9 59999998888899999999999999999999999999999999999999999999999999975422221 1245
Q ss_pred cccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcC
Q 007542 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCG 268 (599)
Q Consensus 189 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~ 268 (599)
.+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+....+..+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 679999999999977 6789999999999999999999999987665443322211
Q ss_pred CCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCC-
Q 007542 269 YDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP- 347 (599)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~Rp- 347 (599)
.+. ......++.+.+||.+||..||.+||
T Consensus 208 -----------------------------------------------~~~---~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 208 -----------------------------------------------EPL---RFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred -----------------------------------------------CCC---CCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 000 11134678899999999999999997
Q ss_pred --CHHHHhcCccccCC
Q 007542 348 --TAEEALADPYFKGL 361 (599)
Q Consensus 348 --Ta~e~L~HP~f~~~ 361 (599)
++.|+|.||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.43 Aligned_cols=250 Identities=24% Similarity=0.447 Sum_probs=208.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
++||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence 469999999999999999999999999975322 23345678899999999999999999998843 357999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 108 ~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
|+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---ATM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc---ccc
Confidence 998 5899999888889999999999999999999999999999999999999999999999999987532211 112
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIW 266 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~ 266 (599)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 44679999999999976 6789999999999999999999999987665443322210
Q ss_pred cCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCC
Q 007542 267 CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 346 (599)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~R 346 (599)
... .....+++.+.+||++||..||.+|
T Consensus 210 -------------------------------------------------~~~---~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 210 -------------------------------------------------EDI---KFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred -------------------------------------------------CCc---cCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 000 0113467889999999999999999
Q ss_pred C-----CHHHHhcCccccCC
Q 007542 347 P-----TAEEALADPYFKGL 361 (599)
Q Consensus 347 p-----Ta~e~L~HP~f~~~ 361 (599)
+ ++.|+|+||||.+.
T Consensus 238 ~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CCCCCCCHHHHhcCCCcCCC
Confidence 7 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.88 Aligned_cols=282 Identities=39% Similarity=0.647 Sum_probs=228.2
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.|++++.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++. +...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 489999999999999999999999999999998754333334467889999999999999999999984 334789
Q ss_pred EEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 104 VVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
+||||+.++|..++... ..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 99999998999988653 4689999999999999999999999999999999999999999999999999876532211
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.+....+.....
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS- 230 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH-
Confidence 12344678899999988652 3468899999999999999999999999998888889998888887654432110
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
...+...+.......+....+.+++.+++||.+||+.
T Consensus 231 -------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 267 (284)
T cd07860 231 -------------------------------------------LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHY 267 (284)
T ss_pred -------------------------------------------HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCC
Confidence 0111111222222223333456788899999999999
Q ss_pred CCCCCCCHHHHhcCccc
Q 007542 342 EPKDRPTAEEALADPYF 358 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f 358 (599)
||.+|||++++|.||||
T Consensus 268 ~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 268 DPNKRISAKAALAHPFF 284 (284)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=364.17 Aligned_cols=288 Identities=34% Similarity=0.582 Sum_probs=215.2
Q ss_pred EEEeeecCceEEEEEEECC--CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 007542 28 EEVIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
..+||+|+||.||+|.++. ++..||+|.+... .....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEE
Confidence 3689999999999999654 6689999998642 2234567899999999999999999998543 23478999
Q ss_pred EecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe----cCCCceeeecccc
Q 007542 106 FELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFGL 172 (599)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv----~~~~~lKL~DFGl 172 (599)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999999888532 247899999999999999999999999999999999999 5568899999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh---------hhHHHHH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---------VHQLDIM 243 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~---------~~~l~~I 243 (599)
++...............++|..|+|||++.+. ..++.++||||+||++|+|++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98764332222223456789999999998652 4588999999999999999999999976542 4677888
Q ss_pred HHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC
Q 007542 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323 (599)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 323 (599)
...+|.+..+.+..+...... .... .... .....+...... +...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~--~~~~---------------------~~~~-~~~~~~~~~~~~-----------~~~~ 282 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEY--PTLQ---------------------KDFR-RTTYANSSLIKY-----------MEKH 282 (317)
T ss_pred HHhcCCCChhhhhhhhhcccc--hhhh---------------------hhhc-ccccCCchhhhh-----------hhcc
Confidence 889998888776552211000 0000 0000 000000000000 0111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 324 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 324 ~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 283 ~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 283 KVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 12356779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=368.68 Aligned_cols=250 Identities=25% Similarity=0.445 Sum_probs=208.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
++||+|+||.||+|.++.+|..||+|++..... .......+.+|+.+|+.++||||+++++++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCEEEEEEe
Confidence 469999999999999999999999999975322 22345667889999999999999999998843 347999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 108 ~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
|++ ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---Ccc
Confidence 999 5899999888889999999999999999999999999999999999999999999999999987532211 112
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIW 266 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~ 266 (599)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-------------------- 210 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------------- 210 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------------
Confidence 34679999999999976 67899999999999999999999999876654433332110
Q ss_pred cCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCC
Q 007542 267 CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 346 (599)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~R 346 (599)
.. .....+++.+.+||.+||+.||.+|
T Consensus 211 --------------------------------------------------~~---~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 211 --------------------------------------------------EI---RFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred --------------------------------------------------CC---CCCCCCCHHHHHHHHHHccCCHHHh
Confidence 00 0112467889999999999999999
Q ss_pred C-----CHHHHhcCccccCC
Q 007542 347 P-----TAEEALADPYFKGL 361 (599)
Q Consensus 347 p-----Ta~e~L~HP~f~~~ 361 (599)
+ ++.++|+||||.+.
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=355.95 Aligned_cols=285 Identities=43% Similarity=0.736 Sum_probs=233.8
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|++|.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 6999999999999999999999999999999997544334445678899999999999999999999854 35789
Q ss_pred EEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 104 VVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
+|+||+.++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999997799999865 35689999999999999999999999999999999999999999999999999986543321
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
.......++.+|+|||.+.+. ..++.++||||+||++++|++|.++|.+.+....+..+...++.+....+...+...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 123445789999999988652 457899999999999999999999999999999999999999988886654421100
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
. |.. ..........+...+++.+..+.+||++||..|
T Consensus 233 ~--~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 269 (286)
T cd07832 233 D--YNK-----------------------------------------ITFPESKPIPLEEIFPDASPEALDLLKGLLVYD 269 (286)
T ss_pred h--hhc-----------------------------------------ccCCCCCcchHHHhCCCccHHHHHHHHHHhccC
Confidence 0 000 001111222334455677889999999999999
Q ss_pred CCCCCCHHHHhcCcccc
Q 007542 343 PKDRPTAEEALADPYFK 359 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f~ 359 (599)
|.+|||++++|+||||.
T Consensus 270 p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 270 PSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhCCCHHHHhhCcCcC
Confidence 99999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.19 Aligned_cols=273 Identities=30% Similarity=0.467 Sum_probs=223.7
Q ss_pred CCCcccccccCCCCceEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh-cCCCCcccc
Q 007542 10 SADVDFFTEYGEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL-LRHPDIVEI 87 (599)
Q Consensus 10 ~~~~~~~~~~~~~~rY~i~-~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~-l~HpnIv~l 87 (599)
..+++| .++.+.++|.+- ++||-|-.|.|..+.++.||+++|+|++.. ..+..||+++-.. -.|||||.+
T Consensus 49 ~~~m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~I 120 (400)
T KOG0604|consen 49 ESDMDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSI 120 (400)
T ss_pred hhhcch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEe
Confidence 456777 788999999985 689999999999999999999999998853 3455689987444 469999999
Q ss_pred ceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---
Q 007542 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--- 161 (599)
Q Consensus 88 ~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~--- 161 (599)
+++|... ......+.+|||.|+ |+|+..|+..+. ++|.++..|+.||..||.|||+.+|.||||||+|+|...
T Consensus 121 idVyeNs-~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~ 199 (400)
T KOG0604|consen 121 IDVYENS-YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSP 199 (400)
T ss_pred ehhhhhh-ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCC
Confidence 9999643 355678999999999 599999998875 999999999999999999999999999999999999875
Q ss_pred CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhh---
Q 007542 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH--- 238 (599)
Q Consensus 162 ~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~--- 238 (599)
|..+||+|||+|+.... ...+.+.+-|++|.|||+++. .+|+...|+||+|||+|.||+|.|||.......
T Consensus 200 na~lKLtDfGFAK~t~~----~~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp 273 (400)
T KOG0604|consen 200 NAPLKLTDFGFAKETQE----PGDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273 (400)
T ss_pred CcceEecccccccccCC----CccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh
Confidence 57799999999986532 223466789999999999988 689999999999999999999999997654321
Q ss_pred -HHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCC
Q 007542 239 -QLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317 (599)
Q Consensus 239 -~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~ 317 (599)
.-.+|..-- .
T Consensus 274 gMk~rI~~gq---------------------------------------------------------------------y 284 (400)
T KOG0604|consen 274 GMKRRIRTGQ---------------------------------------------------------------------Y 284 (400)
T ss_pred hHHhHhhccC---------------------------------------------------------------------c
Confidence 111111111 1
Q ss_pred CCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCC
Q 007542 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 366 (599)
Q Consensus 318 ~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~ 366 (599)
..-...|..+|..++|||+.||..+|.+|+|++|+++|||+.+...+..
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~ 333 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ 333 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence 1112334567889999999999999999999999999999998765443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=356.94 Aligned_cols=287 Identities=43% Similarity=0.679 Sum_probs=233.5
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~---~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
+|++.+.||+|++|.||+|.+..+|+.||||++...... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 589999999999999999999999999999999754322 2234567789999999999999999999854 35
Q ss_pred cEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+.++|.+++.... .+++..+..++.||++||.|||++||+|+||+|+|||++.++.++|+|||+++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 799999999889999998776 7999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ......++..|+|||.+.+. ..++.++||||+||++++|++|.++|.+.+..+.+..+...++.+....+....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR---KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc---cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 21 12334668899999988542 467899999999999999999999999999888888888888887766543311
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.... +. ......+.+....+...+..+.+||.+||
T Consensus 232 ~~~~--------------------------------------------~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l 266 (298)
T cd07841 232 SLPD--------------------------------------------YV-EFKPFPPTPLKQIFPAASDDALDLLQRLL 266 (298)
T ss_pred cccc--------------------------------------------cc-cccccCCcchhhhcccccHHHHHHHHHHh
Confidence 0000 00 01111222333445667889999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCccC
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
++||++|||+.|+|.||||++...+
T Consensus 267 ~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 267 TLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred cCCcccCcCHHHHhhCccccCCCCC
Confidence 9999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=381.74 Aligned_cols=256 Identities=25% Similarity=0.470 Sum_probs=220.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~ 99 (599)
-++|.++++||+|+||+|++|..+.+++.||||++++. .....+.+....|.+|+.... ||.++.|+..|.+ .
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-----~ 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-----K 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-----C
Confidence 46899999999999999999999999999999999753 334456778889999998886 9999999999944 4
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.++|+||||+.| ++. .+...+.+++..+++|+..|+.||.|||++|||+||||.+|||+|.+|.+||+|||+++..-.
T Consensus 442 ~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 589999999995 633 444556899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ...++.|||+.|+|||++.+ ..|+.++|-|||||+|||||.|.+||+|++..+.++.|...-
T Consensus 521 ~g---~~TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~----------- 584 (694)
T KOG0694|consen 521 QG---DRTSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE----------- 584 (694)
T ss_pred CC---CccccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 22 22367899999999999988 799999999999999999999999999999998887775311
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC-CCCHHHHHHHHH
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP-NANPLALRLLER 337 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~s~~a~dLL~~ 337 (599)
-.+| .+|.+++++|++
T Consensus 585 ---------------------------------------------------------------~~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 585 ---------------------------------------------------------------VRYPRFLSKEAIAIMRR 601 (694)
T ss_pred ---------------------------------------------------------------CCCCCcccHHHHHHHHH
Confidence 0112 368899999999
Q ss_pred hcccCCCCCCC-----HHHHhcCccccCCc
Q 007542 338 MLAFEPKDRPT-----AEEALADPYFKGLA 362 (599)
Q Consensus 338 mL~~DP~~RpT-----a~e~L~HP~f~~~~ 362 (599)
||+.||++|+. ++++..||||+.+.
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccCC
Confidence 99999999975 68999999999863
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=365.64 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=211.3
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCC-CccccceeecCCCcCCCcc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHP-DIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~Hp-nIv~l~~v~~~~s~~~~~~ 101 (599)
+|++++.||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+.|+ +|+.+++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----MDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-----CCE
Confidence 58999999999999999999999999999999975322 233456788899999999765 57788888743 347
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532211
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. .....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..|....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------- 217 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------- 217 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 1 1234579999999999977 678999999999999999999999998876555443332100
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
. ......++.+.+||.+||.
T Consensus 218 ---------------------------------------------------------~---~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 218 ---------------------------------------------------------V---SYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred ---------------------------------------------------------C---CCCCCCCHHHHHHHHHHhh
Confidence 0 0112467889999999999
Q ss_pred cCCCCCCCH-----HHHhcCccccCC
Q 007542 341 FEPKDRPTA-----EEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~RpTa-----~e~L~HP~f~~~ 361 (599)
.||.+|++. +++++||||..+
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999986 899999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=369.11 Aligned_cols=262 Identities=23% Similarity=0.391 Sum_probs=214.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++.+.||+|+||.||+|.++.+|+.||||+++.... .......+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 479999999999999999999999999999999975332 22344567889999999999999999998843 347
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999998 6999999876 68999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCccccCccccccc----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
... ......+|+.|+|||++... ...++.++||||||||+|+|++|+.||.+.+....+..|.....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~------- 226 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR------- 226 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 211 12345789999999998631 14578899999999999999999999987765544433321100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
...+ ...+.+++.+.+||
T Consensus 227 -------------------------------------------------------------~~~~-~~~~~~~~~~~~li 244 (330)
T cd05601 227 -------------------------------------------------------------FLKF-PEDPKVSSDFLDLI 244 (330)
T ss_pred -------------------------------------------------------------ccCC-CCCCCCCHHHHHHH
Confidence 0000 11235788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCC
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
++||. ||.+|||++++++||||..+
T Consensus 245 ~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 245 QSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 99998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=366.67 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=208.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||.||+|.++.+++.||||++.... ........+.+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999987432 1223456677899888876 69999999999843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------------------ 212 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE------------------ 212 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------------
Confidence 234579999999999976 678999999999999999999999999877655444332100
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
. ......++.+.+||++||+.||.+
T Consensus 213 ----------------------------------------------------~---~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 213 ----------------------------------------------------V---VYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred ----------------------------------------------------C---CCCCCCCHHHHHHHHHHcccCHHH
Confidence 0 011236788999999999999999
Q ss_pred CCCH------HHHhcCccccCC
Q 007542 346 RPTA------EEALADPYFKGL 361 (599)
Q Consensus 346 RpTa------~e~L~HP~f~~~ 361 (599)
|+++ ++++.||||.++
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCCC
Confidence 9998 999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=366.78 Aligned_cols=261 Identities=24% Similarity=0.410 Sum_probs=208.4
Q ss_pred ceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRR 97 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~--~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~ 97 (599)
+|++++.||+|+||+||+|++. .+++.||+|++.... ........+.+|+.+|+.++ |+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4899999999999999998864 578999999986422 22234566789999999995 9999999998843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 77 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 77 -EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 357899999999 599999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
...... .....+||+.|+|||++.+. ..++.++||||||||+|+|++|+.||.+.........+..
T Consensus 156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~----------- 221 (332)
T cd05614 156 LSEEKE--RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR----------- 221 (332)
T ss_pred cccCCC--ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH-----------
Confidence 332211 12346799999999998752 3578899999999999999999999975432211111100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
. +....+ ...+.+++.+.+||.
T Consensus 222 --------------------------------------------------~----~~~~~~----~~~~~~~~~~~~li~ 243 (332)
T cd05614 222 --------------------------------------------------R----ILKCDP----PFPSFIGPEAQDLLH 243 (332)
T ss_pred --------------------------------------------------H----HhcCCC----CCCCCCCHHHHHHHH
Confidence 0 000000 112347889999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
+||..||++|| +++++|+||||++.
T Consensus 244 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 244 KLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=361.69 Aligned_cols=302 Identities=24% Similarity=0.341 Sum_probs=219.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|++..+|..||+|++.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 578999999999999999999999999999999987532 22345678999999999999999999999853 347
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999 59999999888899999999999999999999986 6999999999999999999999999998765322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.. ..++.+....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~----~~~~~~~~~~----- 221 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE----AIFGRPVVDG----- 221 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHhccccccc-----
Confidence 1 234578999999999977 67899999999999999999999999876654322 2223221100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
..+......+.......... ..- ..........+.+..+.......+. ....++++.+||.+||
T Consensus 222 ---------~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L 285 (331)
T cd06649 222 ---------EEGEPHSISPRPRPPGRPVS--GHG---MDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCL 285 (331)
T ss_pred ---------ccCCccccCccccccccccc--ccc---cccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHc
Confidence 00000000000000000000 000 0000000111111111111111111 1246789999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
++||++|||++|+|+||||+..
T Consensus 286 ~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 286 IKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cCCcccCCCHHHHhcChHHhhc
Confidence 9999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=372.50 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=214.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ........+.+|+.+|+.++||||+++++++.. .
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-----~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-----D 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 3578999999999999999999999999999999996422 222334557789999999999999999998843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. |+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 57999999998 6899988654 689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCcccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|++||.+.+....+..|.+...
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------- 264 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-------- 264 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--------
Confidence 211 1123467999999999986421 2478899999999999999999999998776555444432100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
...+ ......+..+.+||+
T Consensus 265 ------------------------------------------------------------~~~~-~~~~~~s~~~~~li~ 283 (370)
T cd05596 265 ------------------------------------------------------------SLTF-PDDIEISKQAKDLIC 283 (370)
T ss_pred ------------------------------------------------------------cCCC-CCcCCCCHHHHHHHH
Confidence 0000 112346889999999
Q ss_pred HhcccCCCC--CCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKD--RPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~--RpTa~e~L~HP~f~~~ 361 (599)
+||+.+|.+ |+|++|+|+||||++.
T Consensus 284 ~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 284 AFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999998 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=368.05 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=207.7
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++.+++.. ...+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 469999999999999999999999999975322 22345667889999999999999999998843 347999999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 108 ~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
|+. ++|..++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 999 5899999888889999999999999999999997 7999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------------------- 211 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------- 211 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-------------------
Confidence 234679999999999976 67899999999999999999999999877654433322110
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
.. ......++.+.+||++||+.||++
T Consensus 212 ---------------------------------------------------~~---~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 212 ---------------------------------------------------EI---RFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred ---------------------------------------------------CC---CCCCCCCHHHHHHHHHHhhcCHHH
Confidence 00 011246788999999999999999
Q ss_pred CC-----CHHHHhcCccccCC
Q 007542 346 RP-----TAEEALADPYFKGL 361 (599)
Q Consensus 346 Rp-----Ta~e~L~HP~f~~~ 361 (599)
|+ ++.++|+||||.+.
T Consensus 238 R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCCC
Confidence 97 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=354.91 Aligned_cols=287 Identities=37% Similarity=0.646 Sum_probs=227.8
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
||.-++|++.+.||+|++|.||+|.++.+++.||||.+...... .....+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 74 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT----- 74 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec-----
Confidence 57789999999999999999999999999999999998643222 223456789999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 3579999999999999988764 468999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~-~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... ......++..|+|||++.+. ..++.++||||+||++++|++|+++|.+.. ..+++..+.+.++.+.++.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11233568889999987642 457889999999999999999999998776 677888888999998887665
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC--HHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN--PLALRL 334 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s--~~a~dL 334 (599)
.........-. ......+..+...++..+ ..+.+|
T Consensus 231 ~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (291)
T cd07844 231 GVSSNPEFKPY-------------------------------------------SFPFYPPRPLINHAPRLDRIPHGEEL 267 (291)
T ss_pred hhhhccccccc-------------------------------------------cccccCChhHHHhCcCCCCchhHHHH
Confidence 53211110000 000001111222233344 788999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
|.+||.+||.+|||+.|+|+||||
T Consensus 268 i~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 268 ALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HHHHhccCcccccCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=371.99 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=213.7
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+.|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.++..++|+||+++++.+. +...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 47999999999999999999999999999999996422 22334567888999999999999999999984 3357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 5999999988889999999999999999999999999999999999999999999999999987542211
Q ss_pred CC--------------------------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC
Q 007542 181 PT--------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (599)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~ 228 (599)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000124579999999999977 67999999999999999999999
Q ss_pred CCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHH
Q 007542 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRY 308 (599)
Q Consensus 229 ~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~ 308 (599)
+||.+.+....+..|.....
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~------------------------------------------------------------ 253 (360)
T cd05627 234 PPFCSETPQETYRKVMNWKE------------------------------------------------------------ 253 (360)
T ss_pred CCCCCCCHHHHHHHHHcCCC------------------------------------------------------------
Confidence 99988776554444321000
Q ss_pred HHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCC
Q 007542 309 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP---TAEEALADPYFKGL 361 (599)
Q Consensus 309 i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~Rp---Ta~e~L~HP~f~~~ 361 (599)
...+.. ....++.+++||.+|+. ||.+|+ +++|+++||||+++
T Consensus 254 --------~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 254 --------TLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred --------ceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 000000 12367899999999885 999998 58999999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.01 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=207.7
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHH---HhcCCCCccccceeecCCCcCCCc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLL---RLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL---~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
|++++.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.++ +.++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 789999999999999999999999999999997432 1223445677777665 45679999999999843 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 7999999999 588887754 47999999999999999999999999999999999999999999999999998753221
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~------------ 217 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE------------ 217 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 11 1245679999999999977 678999999999999999999999998877655443332100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
. .....+++.+.+||.+||
T Consensus 218 ---------------------------------------------------------~----~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 218 ---------------------------------------------------------V----RYPRFLSREAISIMRRLL 236 (324)
T ss_pred ---------------------------------------------------------C----CCCCCCCHHHHHHHHHHh
Confidence 0 011246788999999999
Q ss_pred ccCCCCCC-----CHHHHhcCccccCC
Q 007542 340 AFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
+.||.+|| ++.++++||||+++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999 79999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=354.29 Aligned_cols=288 Identities=38% Similarity=0.643 Sum_probs=228.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+. |+||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998754433334567889999999995 699999999986544333445
Q ss_pred EEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-CCceeeeccccccc
Q 007542 102 IYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARV 175 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-~~~lKL~DFGla~~ 175 (599)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||+|+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999988653 35799999999999999999999999999999999999999 89999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ..+...++++|+|||++.+. ..++.++||||+||++|+|++|.+||.+.+....+..+...++.++.+.+
T Consensus 161 ~~~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVK---SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCcc---ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 432211 12334678899999987542 45789999999999999999999999999988888888888887776543
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.... .. ..+. ..+...+..+....+..++.+.+||
T Consensus 237 ~~~~-----------~~---------------------------------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i 271 (295)
T cd07837 237 PGVS-----------KL---------------------------------RDWH-EFPQWKPQDLSRAVPDLSPEGLDLL 271 (295)
T ss_pred cchh-----------hc---------------------------------cchh-hcCcccchhHHHhccccCHHHHHHH
Confidence 2200 00 0000 0111111122233456788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCcccc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
.+||..||.+|||+.|+|.||||+
T Consensus 272 ~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 272 QKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHccCChhhcCCHHHHhcCCCcC
Confidence 999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=352.16 Aligned_cols=282 Identities=37% Similarity=0.685 Sum_probs=221.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|++|.||+|.++.+|+.||+|++..........+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 57999999999999999999999999999999986433222334567899999999999999999999843 3478
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999996 5555555666799999999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++.+|+|||.+.+. ..++.++||||+||++++|++|++||.+.+..+.+..+...++...+.....
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 227 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI---- 227 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh----
Confidence 12345678999999998652 4578899999999999999999999999888777777776665543321111
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC---CCCCCcCCCCCCCHHHHHHHHHh
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK---KPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
|. . ..+...+... ...++...++.++..+.+||.+|
T Consensus 228 ----~~-~------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 266 (286)
T cd07847 228 ----FS-T------------------------------------NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGC 266 (286)
T ss_pred ----cc-c------------------------------------ccccccccCCCcccccCHHHHhccCCHHHHHHHHHH
Confidence 00 0 0000000000 01112223456788999999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 007542 339 LAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f 358 (599)
|+.||++|||+.|+|.||||
T Consensus 267 l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 267 LQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred hcCCccccCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=371.05 Aligned_cols=264 Identities=25% Similarity=0.367 Sum_probs=213.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++.+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-----D 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence 3578999999999999999999999999999999986422 222344567899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 57999999998 6999998654 689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCcccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... ......+||+.|+|||++.+.. ..++.++||||+||++|+|++|++||.+.+....+..|.+....
T Consensus 195 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~------- 265 (370)
T cd05621 195 TGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS------- 265 (370)
T ss_pred CCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc-------
Confidence 211 1124567999999999986521 23788999999999999999999999988765555444321110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
..+. ....++..+++||.
T Consensus 266 -------------------------------------------------------------~~~p-~~~~~s~~~~~li~ 283 (370)
T cd05621 266 -------------------------------------------------------------LNFP-EDVEISKHAKNLIC 283 (370)
T ss_pred -------------------------------------------------------------cCCC-CcccCCHHHHHHHH
Confidence 0000 11246788999999
Q ss_pred HhcccCCCC--CCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKD--RPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~--RpTa~e~L~HP~f~~~ 361 (599)
+||..++.+ |+|++|+|+||||+..
T Consensus 284 ~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 284 AFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHccCchhccCCCCHHHHhcCcccCCC
Confidence 999865544 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.12 Aligned_cols=255 Identities=23% Similarity=0.401 Sum_probs=212.0
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCcc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+|.+++.||+|+||.||+|++..+++.||||++..... .......+..|..++..+ +|++|+++++++.. ...
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-----MDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-----CCE
Confidence 58999999999999999999999999999999975322 223345667888888877 48899999998843 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------- 217 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------------- 217 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 1 1235679999999999977 678999999999999999999999999877655544433210
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
. ......++.+.+||.+||+
T Consensus 218 ---------------------------------------------------------~---~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 218 ---------------------------------------------------------V---AYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ---------------------------------------------------------C---CCCCcCCHHHHHHHHHHcc
Confidence 0 0112467889999999999
Q ss_pred cCCCCCCC-----HHHHhcCccccCC
Q 007542 341 FEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
.||.+|++ ..++++||||+.+
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 99999998 5899999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.59 Aligned_cols=250 Identities=25% Similarity=0.414 Sum_probs=208.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||.||+|.++.+++.||||+++... ........+..|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeEEEEE
Confidence 46999999999999999999999999987432 1233445677899998866 79999999999843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||++ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875432221 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~------------------ 212 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD------------------ 212 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 245679999999999876 678999999999999999999999999887665554432100
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
. ......++.+.+||.+||+.||++
T Consensus 213 ----------------------------------------------------~---~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 213 ----------------------------------------------------V---LYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred ----------------------------------------------------C---CCCCCCCHHHHHHHHHHhccCHHH
Confidence 0 001235788999999999999999
Q ss_pred CC-------CHHHHhcCccccCC
Q 007542 346 RP-------TAEEALADPYFKGL 361 (599)
Q Consensus 346 Rp-------Ta~e~L~HP~f~~~ 361 (599)
|+ +++++++||||..+
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCCC
Confidence 99 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=361.60 Aligned_cols=302 Identities=42% Similarity=0.677 Sum_probs=231.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc---
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--- 96 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~--- 96 (599)
...++|++.+.||.|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.....
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 45789999999999999999999999999999999986432 2345678899999999999999999988754321
Q ss_pred ------CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-CCceeeec
Q 007542 97 ------REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICD 169 (599)
Q Consensus 97 ------~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-~~~lKL~D 169 (599)
.+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 12246899999999999988864 46899999999999999999999999999999999999974 56789999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
||+++................++..|+|||.+... ..++.++|||||||++|+|++|+.||.+.+.......+.+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997653222211122334678899999987542 46888999999999999999999999988887777776665555
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
+..+..... .+. ....+.........++....+..+.
T Consensus 238 ~~~~~~~~~------------------------------------------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (342)
T cd07854 238 VREEDRNEL------------------------------------------LNV-IPSFVRNDGGEPRRPLRDLLPGVNP 274 (342)
T ss_pred CChHHhhhh------------------------------------------hhh-hhhhhhhcccccCCCHHHHccCCCH
Confidence 444322210 000 0000010011122223334567888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCC
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 368 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~ 368 (599)
.+++||.+||+.||.+|||++|+|.||||+.+..+.+++
T Consensus 275 ~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~ 313 (342)
T cd07854 275 EALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEP 313 (342)
T ss_pred HHHHHHHHHhCCCchhccCHHHHhCCCccccccCCcccc
Confidence 999999999999999999999999999999776544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=363.07 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=207.4
Q ss_pred EEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 28 EEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~--~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++.||+|+||.||+|++. .+++.||||+++... ........+.+|+.+|+.++||||+++++++.. ...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-----GGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-----CCeE
Confidence 368999999999999864 578999999986432 122334567899999999999999999999843 3479
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999 59999999888899999999999999999999999999999999999999999999999999875422221
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 156 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--------------- 215 (323)
T cd05584 156 ---VTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--------------- 215 (323)
T ss_pred ---cccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------------
Confidence 1234579999999999876 57889999999999999999999999887654443333210
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
. ....+..++.+.+||++||+.
T Consensus 216 -------------------------------------------------------~---~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 216 -------------------------------------------------------K---LNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred -------------------------------------------------------C---CCCCCCCCHHHHHHHHHHccc
Confidence 0 011234678899999999999
Q ss_pred CCCCCC-----CHHHHhcCccccCC
Q 007542 342 EPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 342 DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
||.+|+ +++++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=355.38 Aligned_cols=295 Identities=36% Similarity=0.639 Sum_probs=232.4
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc---
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--- 96 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~--- 96 (599)
..-++|++.+.||+|+||.||+|.++.+++.||||++............+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 44689999999999999999999999999999999986433332233456789999999999999999998764332
Q ss_pred CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.....+|+|+||+.++|...+... ..+++..++.++.||++||.|||+.||+|+||||+|||++.++.+||+|||+++.
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 234578999999999998888654 4799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCC--------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 176 AFNDTPT--------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 176 ~~~~~~~--------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
....... ....+...+++.|+|||++.+. ..++.++||||+||++|+|++|+++|.+.+....+..+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 5332211 1122445778999999987552 458899999999999999999999999999999999999988
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
+.+.+..+.. |........ .......+..+...+...
T Consensus 244 ~~~~~~~~~~--------~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~~ 280 (311)
T cd07866 244 GTPTEETWPG--------WRSLPGCEG-----------------------------------VHSFTNYPRTLEERFGKL 280 (311)
T ss_pred CCCChhhchh--------hhhcccccc-----------------------------------cccCCCCCccHHHHcccC
Confidence 8887765433 110000000 000001111222234456
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
++.+.+||.+||..||.+|||+.|+|.||||
T Consensus 281 ~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 281 GPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 6889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=354.16 Aligned_cols=297 Identities=34% Similarity=0.549 Sum_probs=227.1
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc---
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--- 96 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~--- 96 (599)
..-++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 44568999999999999999999999999999999986443333334556789999999999999999999865431
Q ss_pred CCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.....+|+||||+.++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 89 RYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 2234679999999999998887653 789999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCC-cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... ........++..|+|||++.+. ..++.++||||+||++|+|++|+++|.+.+...++..+..+.|..+++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 5332211 1112345678899999987552 4578899999999999999999999999998888888888888777654
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+........ |. +.. ............+ .....++.+.+|
T Consensus 248 ~~~~~~~~~--~~------------------------~~~-----~~~~~~~~~~~~l----------~~~~~~~~~~dl 286 (310)
T cd07865 248 WPGVDKLEL--FK------------------------KME-----LPQGQKRKVKERL----------KPYVKDPHALDL 286 (310)
T ss_pred cccccchhh--hh------------------------hcc-----CCCccchhhHHhc----------ccccCCHHHHHH
Confidence 332000000 00 000 0000000000000 001246778999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
|.+||..||.+|||++|+|+||||
T Consensus 287 i~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 287 IDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHHhcCChhhccCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=349.91 Aligned_cols=281 Identities=41% Similarity=0.691 Sum_probs=229.9
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|++.+.||.|++|.||+|.++.+|..||||++............+.+|+.+++.++|+|++++++++.. ....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 678999999999999999999999999999987543333344667899999999999999999999843 357999
Q ss_pred EEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 105 VFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 105 V~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
||||++++|.+++.... .+++..+..++.||++||.|||+.+++|+||+|+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999999999998765 789999999999999999999999999999999999999999999999999975432211
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
......++..|+|||++.+. ..++.++||||+||++|+|++|++||.+.+....+..+.+.+++|..+.+.......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 12334668899999987552 357889999999999999999999999999888888888888888877654421110
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
++...+............+..+..+.+||.+||+.|
T Consensus 232 --------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 267 (283)
T cd07835 232 --------------------------------------------DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYD 267 (283)
T ss_pred --------------------------------------------hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCC
Confidence 111112222222333445678889999999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 007542 343 PKDRPTAEEALADPYF 358 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f 358 (599)
|.+|||++|+|+||||
T Consensus 268 P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 268 PAKRISAKAALQHPYF 283 (283)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=353.21 Aligned_cols=288 Identities=39% Similarity=0.668 Sum_probs=229.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|++|.||+|.++.+|+.||||++............+.+|+.+++.++|+||+++++++.. ...+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 57999999999999999999999999999999986543333344667899999999999999999999843 3579
Q ss_pred EEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-CCceeeecccccccccCC
Q 007542 103 YVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-~~~lKL~DFGla~~~~~~ 179 (599)
|+||||++++|.+.+..... +++..++.++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999998876543 578899999999999999999999999999999999985 567999999999764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ...+...++..|+|||.+.+. ..++.++||||+||++++|++|+++|.+.+..+.+..+.+.++.|....+..
T Consensus 157 ~---~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (294)
T PLN00009 157 V---RTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG-- 230 (294)
T ss_pred c---cccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc--
Confidence 1 112445778999999988552 4578899999999999999999999999888888888888888887654432
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
... ...+................+..++.+.+||.+||
T Consensus 231 ---------~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 268 (294)
T PLN00009 231 ---------VTS---------------------------------LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKML 268 (294)
T ss_pred ---------ccc---------------------------------chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHc
Confidence 000 00111111111112222334667889999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCcc
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
+.||++|||+.++|+||||.++..
T Consensus 269 ~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 269 RLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cCChhhCcCHHHHhcCchHhHHhc
Confidence 999999999999999999997653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=360.89 Aligned_cols=264 Identities=22% Similarity=0.405 Sum_probs=212.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence 4799999999999999999999999999999998642 1222344567889999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999998 699999976 457999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... .....+||+.|+|||++... ...++.++||||+||++|+|++|+.||.+.+..+.+..|....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------- 224 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 211 11234789999999998531 1357889999999999999999999998876555444332110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
....+....+.+++.+.+||+
T Consensus 225 -----------------------------------------------------------~~~~~~~~~~~~~~~~~~li~ 245 (331)
T cd05597 225 -----------------------------------------------------------EHFQFPPDVTDVSEEAKDLIR 245 (331)
T ss_pred -----------------------------------------------------------CcccCCCccCCCCHHHHHHHH
Confidence 001122223457889999999
Q ss_pred HhcccCCCC--CCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKD--RPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~--RpTa~e~L~HP~f~~~ 361 (599)
+||..++.+ |++++++|+||||.++
T Consensus 246 ~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 246 RLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999765554 7899999999999875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=361.26 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=205.3
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||.||+|.++.+|+.||+|+++.... .......+..|..++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 479999999999999999999999999975322 123345667788888754 89999999999843 35799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence 9998 5999999888889999999999999999999999999999999999999999999999999987432111 12
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....++.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------------------- 211 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------------------- 211 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 245679999999999977 67899999999999999999999999887654433322110
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
. .......+..+.+||++||..||.+
T Consensus 212 --------------------------------------------------~----~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 212 --------------------------------------------------T----PHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred --------------------------------------------------C----CCCCCCCCHHHHHHHHHHccCCHHH
Confidence 0 0011236788999999999999999
Q ss_pred CCCH-HHHhcCccccCC
Q 007542 346 RPTA-EEALADPYFKGL 361 (599)
Q Consensus 346 RpTa-~e~L~HP~f~~~ 361 (599)
|+|+ +++++||||...
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9997 589999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.15 Aligned_cols=258 Identities=35% Similarity=0.604 Sum_probs=212.8
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.+++.++|+||+++++++.. ...+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 899999999999999999999999999999997643333334445679999999999999999999954 457899
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
|||++.+ +|.+++...+.+++..+..++.||++||.+||+.||+|+||||+|||++.++.++|+|||.+..... ..
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 9999997 9999999778899999999999999999999999999999999999999999999999999975411 11
Q ss_pred ccccccccCccccCccccc-cccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 184 IFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~-~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
.......++..|+|||++. + ..++.++|||||||++++|++|..||......+....+.+.........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 222 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-------- 222 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH--------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccccc--------
Confidence 2235678899999999987 4 6789999999999999999999999988755555544443322111100
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
.. ........+.+||++||+.|
T Consensus 223 -------------------------------------------------~~---------~~~~~~~~l~~li~~~l~~~ 244 (260)
T PF00069_consen 223 -------------------------------------------------SQ---------QSREKSEELRDLIKKMLSKD 244 (260)
T ss_dssp -------------------------------------------------TT---------SHTTSHHHHHHHHHHHSSSS
T ss_pred -------------------------------------------------cc---------ccchhHHHHHHHHHHHccCC
Confidence 00 00011267899999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 007542 343 PKDRPTAEEALADPYF 358 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f 358 (599)
|++|||+.++|+||||
T Consensus 245 p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 245 PEQRPSAEELLKHPWF 260 (260)
T ss_dssp GGGSTTHHHHHTSGGG
T ss_pred hhHCcCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=362.42 Aligned_cols=250 Identities=26% Similarity=0.461 Sum_probs=205.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~-iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||+||+|+++.+|+.||||++.... ........+.+|.. +++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 46999999999999999999999999986432 12233455666665 4678999999999998843 35789999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------------- 211 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK------------------- 211 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 244579999999999876 67899999999999999999999999887654443332210
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
+ ....+..++.+.+||++||+.||.+
T Consensus 212 ---------------------------------------------------~---~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 212 ---------------------------------------------------P---LRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ---------------------------------------------------C---CCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 0 0122456888999999999999999
Q ss_pred CCCH----HHHhcCccccCC
Q 007542 346 RPTA----EEALADPYFKGL 361 (599)
Q Consensus 346 RpTa----~e~L~HP~f~~~ 361 (599)
|+++ .|+|+||||..+
T Consensus 238 R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9997 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=370.36 Aligned_cols=282 Identities=23% Similarity=0.294 Sum_probs=217.5
Q ss_pred CCceEEEEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.++||||+++++++.. .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~-----~ 158 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW-----K 158 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee-----C
Confidence 457999999999999999999754 45688999987532 234589999999999999999998843 3
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
..+|+|||++.++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 47999999999999999987788999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC---hhhHHHHHHHhcCCCCHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---VVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~---~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.. ...++..|.+.++..+.+...
T Consensus 239 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PDT-PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred ccc-ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 211 12235679999999999976 678999999999999999999999998764 345666666666654432110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcc--cCCCCCCcCCC--CCCCHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMR--KKKPIPFSQKF--PNANPLAL 332 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~--~~~s~~a~ 332 (599)
. ........+.... .+.+..+...+ ...+..+.
T Consensus 316 ~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (392)
T PHA03207 316 N-------------------------------------------GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVE 352 (392)
T ss_pred c-------------------------------------------cchhHHHHHHhhcccccCCccccchhhccCcchhHH
Confidence 0 0000000001000 01111111111 13567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||++||.+||++|||+.|+|.||||...
T Consensus 353 ~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 353 YLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred HHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 99999999999999999999999999753
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=359.71 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=204.7
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||+||+|.+..+++.||||+++.... .......+..|..++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 469999999999999999999999999975322 223345566777777654 79999999998843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence 9998 6999999888889999999999999999999999999999999999999999999999999997643222 12
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------------------ 212 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR------------------ 212 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------
Confidence 245679999999999977 578999999999999999999999999877554433332100
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
+ ......+..+.+||.+||+.||.+
T Consensus 213 ---------------------------------------------------~----~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 213 ---------------------------------------------------P----HFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred ---------------------------------------------------C----CCCCCCCHHHHHHHHHHccCCHHH
Confidence 0 011236778999999999999999
Q ss_pred CCCH-HHHhcCccccCC
Q 007542 346 RPTA-EEALADPYFKGL 361 (599)
Q Consensus 346 RpTa-~e~L~HP~f~~~ 361 (599)
|+++ .+++.||||..+
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 238 RLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 9986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=356.37 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=222.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-++|++++.||.|.-|+||+|..+.++..+|+|++.+... ......++..|-+||..++||.+..|+..| +...
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 4678899999999999999999999999999999986443 345567888999999999999999999999 4456
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
++|+|||||. |+|+.+.++. +.+++..+++|+..++.||+|||-.|||+|||||+||||.++|+|.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 8999999999 5999998765 479999999999999999999999999999999999999999999999999975421
Q ss_pred C---------------------------------C-C-------------------CCcccccccccCccccCccccccc
Q 007542 178 N---------------------------------D-T-------------------PTAIFWTDYVATRWYRAPELCGSF 204 (599)
Q Consensus 178 ~---------------------------------~-~-------------------~~~~~~~~~~gt~~Y~APE~l~~~ 204 (599)
- . . +........|||-.|+|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 0 0 00011235789999999999998
Q ss_pred cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhh
Q 007542 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVF 284 (599)
Q Consensus 205 ~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (599)
...+.++|-|.||+++||||.|..||.|.+....+..|. +.+.
T Consensus 310 -~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv---~~~l--------------------------------- 352 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV---GQPL--------------------------------- 352 (459)
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh---cCCC---------------------------------
Confidence 688999999999999999999999999998877665553 2111
Q ss_pred hhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCccccC
Q 007542 285 AIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT----AEEALADPYFKG 360 (599)
Q Consensus 285 ~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpT----a~e~L~HP~f~~ 360 (599)
.|. ..+..+..|+|||+++|..||.+|+. |.|+-+||||++
T Consensus 353 ----------------------------------~Fp-~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 353 ----------------------------------KFP-EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred ----------------------------------cCC-CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 111 11356788999999999999999998 999999999999
Q ss_pred Cc
Q 007542 361 LA 362 (599)
Q Consensus 361 ~~ 362 (599)
+.
T Consensus 398 Vn 399 (459)
T KOG0610|consen 398 VN 399 (459)
T ss_pred CC
Confidence 74
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=349.97 Aligned_cols=281 Identities=38% Similarity=0.689 Sum_probs=228.0
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||.|++|.||+|.+..+|..||||+++.... ......+.+|+.+++.++|+||+++++.+.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEE
Confidence 58999999999999999999999999999999875322 2234567789999999999999999999854 34789
Q ss_pred EEEecCCccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 104 VVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||+.++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 999999999999887643 58999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ......++..|++||.+.+. ..++.++||||+||++++|++|+++|.+.+..+++..+.+..+.|..+.+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 12345678899999987552 4578899999999999999999999999999999999999998888877655221
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
... +....+...........+..++.+.++|.+||+
T Consensus 231 ~~~--------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 266 (284)
T cd07836 231 LPE--------------------------------------------YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQ 266 (284)
T ss_pred Cch--------------------------------------------hcccccCCChHHHHHHhhhcCcHHHHHHHHHhc
Confidence 100 000011111111122334567889999999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q 007542 341 FEPKDRPTAEEALADPYF 358 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f 358 (599)
.||.+|||+.|+|+||||
T Consensus 267 ~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 267 LNPELRISAHDALQHPWF 284 (284)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=349.53 Aligned_cols=282 Identities=37% Similarity=0.690 Sum_probs=223.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||+++++++. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence 4799999999999999999999999999999998654433334566789999999999999999999984 33579
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+|+||+++ .|..++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999996 566666666679999999999999999999999999999999999999999999999999987653322
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
...+...++.+|+|||++.+. ..++.++||||+||++++|++|+++|.+.+..+.+..+....+...........
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ-- 229 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc--
Confidence 223456789999999988652 457889999999999999999999999988888777777766654432111100
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcc---cCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMR---KKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
. ...+..+. .....+....++.++..+.+||.+|
T Consensus 230 ----------------------------------------~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 266 (286)
T cd07846 230 ----------------------------------------K---NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQC 266 (286)
T ss_pred ----------------------------------------c---chHhhccccccccCcchHHHhCCCcCHHHHHHHHHH
Confidence 0 00000000 0011112233567889999999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 007542 339 LAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f 358 (599)
|..||.+|||+.++|+||||
T Consensus 267 l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 267 LRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hcCCcccchhHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=353.33 Aligned_cols=287 Identities=40% Similarity=0.654 Sum_probs=231.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.+.|++.+.||+|+||.||+|.+..+++.||+|.++...........+.+|+.+++.++||||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 35799999999999999999999999999999999754333333456778999999999999999999885432 257
Q ss_pred EEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+|+||+.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999987654 58999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ......++..|+|||.+.+. ..++.++||||+||++++|++|+++|.+.+..+.+..+...++.|..+.+.....
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12345678899999988652 3468899999999999999999999999999999999999999988877654211
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC--CCHHHHHHHHHh
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN--ANPLALRLLERM 338 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~s~~a~dLL~~m 338 (599)
+.... . ..........+.+.++. +++.+.+||++|
T Consensus 237 ~~~~~------------------------------------~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 273 (293)
T cd07843 237 LPGAK------------------------------------K-------KTFTKYPYNQLRKKFPALSLSDNGFDLLNRL 273 (293)
T ss_pred cchhc------------------------------------c-------cccccccchhhhccccccCCChHHHHHHHHH
Confidence 10000 0 00001111122333444 488899999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 007542 339 LAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f 358 (599)
|+.||++|||+.|+|+||||
T Consensus 274 l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 274 LTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hccCccccCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=361.15 Aligned_cols=259 Identities=23% Similarity=0.403 Sum_probs=204.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEEEEEE
Confidence 469999999999999999999999999975332 233456678999999888 69999999999843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999874322111 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~----------- 209 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNT----------- 209 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccc-----------
Confidence 235689999999999977 678999999999999999999999996422110 000000
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
....... +.. .... ....+++.+.+||++||+.||.+
T Consensus 210 ------------------------------------~~~~~~~---~~~-~~~~---~p~~~~~~~~~li~~~L~~dP~~ 246 (329)
T cd05588 210 ------------------------------------EDYLFQV---ILE-KQIR---IPRSLSVKASSVLKGFLNKDPKE 246 (329)
T ss_pred ------------------------------------hHHHHHH---HHc-CCCC---CCCCCCHHHHHHHHHHhccCHHH
Confidence 0000000 000 0111 11346788999999999999999
Q ss_pred CCC------HHHHhcCccccCC
Q 007542 346 RPT------AEEALADPYFKGL 361 (599)
Q Consensus 346 RpT------a~e~L~HP~f~~~ 361 (599)
|+| ++++++||||..+
T Consensus 247 R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 247 RLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred cCCCCCCCCHHHHhcCCCCCCC
Confidence 997 7999999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.15 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=208.4
Q ss_pred EEEeeecCceEEEEEEE---CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 28 EEVIGKGSYGVVCSAYD---TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~---~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
++.||+|+||.||++++ ..+|+.||+|++............+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEE
Confidence 36799999999999876 4678999999997543333345567789999999999999999999843 357999
Q ss_pred EEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 105 VFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 105 V~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 69999998888899999999999999999999999999999999999999999999999999876533211
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------- 214 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------- 214 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 1234678999999999976 578899999999999999999999998876554443332100
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 343 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP 343 (599)
. ......++.+.+||++||+.||
T Consensus 215 ------------------------------------------------------~---~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 215 ------------------------------------------------------L---GMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred ------------------------------------------------------C---CCCCCCCHHHHHHHHHHhhcCH
Confidence 0 0112467889999999999999
Q ss_pred CCCCC-----HHHHhcCccccCC
Q 007542 344 KDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 344 ~~RpT-----a~e~L~HP~f~~~ 361 (599)
.+||| +++++.||||..+
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=338.10 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=223.2
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
...-++|++.+.||+|.||.||.|+.+.++-.||+|++-+.. ........+.||++|-..|+||||++++++|.+.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--- 94 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--- 94 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc---
Confidence 455688999999999999999999999999999999986432 2333456788999999999999999999999544
Q ss_pred CCccEEEEEecCC-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~--~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+||++||.. |+|+..+. ....+++...+.+++|++.||.|||..+||||||||+|+|++.++.+||+|||.+.
T Consensus 95 --~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 95 --KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred --ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 46999999999 79999998 55689999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....+ ...+.|||..|.+||...+ ..++..+|+|++|++.||+|.|.+||...+..+.+..|.+.--..
T Consensus 173 ~~p~~-----kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~---- 241 (281)
T KOG0580|consen 173 HAPSN-----KRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF---- 241 (281)
T ss_pred ecCCC-----CceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC----
Confidence 64321 2256799999999999988 789999999999999999999999999888777766665421110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
-..++..|.||
T Consensus 242 ---------------------------------------------------------------------p~~is~~a~dl 252 (281)
T KOG0580|consen 242 ---------------------------------------------------------------------PSTISGGAADL 252 (281)
T ss_pred ---------------------------------------------------------------------CcccChhHHHH
Confidence 13578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|.+||..+|.+|.+..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999998643
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=362.77 Aligned_cols=279 Identities=25% Similarity=0.338 Sum_probs=208.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
...|++++.||+|+||.||+|.+..++..||+|+.... ....|+.+|+.++|+||+++++++... ..
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----Ce
Confidence 45799999999999999999999999999999975421 235799999999999999999998533 46
Q ss_pred EEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
.|+|||++.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 132 TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred eEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 8999999999999988754 579999999999999999999999999999999999999999999999999997532211
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCCCh---------hhHHHHHHHhcCCC
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNV---------VHQLDIMTDLLGTP 250 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG-~~pF~g~~~---------~~~l~~I~~~lg~p 250 (599)
......||..|+|||++.+ ..++.++|||||||++|||+++ .++|.+... ..++..+...+|..
T Consensus 212 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 212 ----AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ----ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1234578999999999977 6789999999999999999985 555554321 22333344444433
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc-CCCCCCc--CCCCCC
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK-KKPIPFS--QKFPNA 327 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~--~~~~~~ 327 (599)
+.+.... ........++..... +.+.... -...+.
T Consensus 286 ~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (357)
T PHA03209 286 PEEFPRD------------------------------------------PGSRLVRGFIEYASLERQPYTRYPCFQRVNL 323 (357)
T ss_pred hhhcCCC------------------------------------------CccHHHHHHHhhcccCCCcccccHHHhccCC
Confidence 2211000 000001111110000 0000000 001245
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+..+.+||.+||++||.+||||.|+|+||||+.+
T Consensus 324 ~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 324 PIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 6778999999999999999999999999999863
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=358.68 Aligned_cols=250 Identities=24% Similarity=0.441 Sum_probs=207.2
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
+.||+|+||+||+|.+..+++.||||+++... ........+.+|+.+++.+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 46999999999999999999999999997432 2223456677899999888 69999999999843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------------------- 211 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------------------- 211 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 234578999999999977 67899999999999999999999999887654433322110
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
.. ......++.+.+||++||..||.+
T Consensus 212 ---------------------------------------------------~~---~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 212 ---------------------------------------------------EV---RYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred ---------------------------------------------------CC---CCCCcCCHHHHHHHHHHccCCHHH
Confidence 00 011246788999999999999999
Q ss_pred CCCH-----HHHhcCccccCC
Q 007542 346 RPTA-----EEALADPYFKGL 361 (599)
Q Consensus 346 RpTa-----~e~L~HP~f~~~ 361 (599)
|||+ .++|+||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.48 Aligned_cols=280 Identities=39% Similarity=0.711 Sum_probs=223.1
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
|++++.||+|+||.||+|.+..++..||+|+++....... .....+|+.+++.+. |+||+++++++.+. ....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 7889999999999999999999999999999875443322 234458999998885 99999999998543 224789
Q ss_pred EEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 104 VVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
+||||++++|.+.+... ..+++..++.++.||+.||.|||+.||+||||+|+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999988764 57899999999999999999999999999999999999999 9999999999986543222
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
.....++.+|+|||.+... ..++.++||||+||++++|++|.+||++.+..+.+..+.+.+|.+..+.........
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 2345688999999976432 457889999999999999999999999999999999999999988875432200000
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
...+ ..+......+....+..+..+.+||.+||++|
T Consensus 231 ------------------------------------------~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 266 (282)
T cd07831 231 ------------------------------------------HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYD 266 (282)
T ss_pred ------------------------------------------cccc--cCcccccccHHHHcccccHHHHHHHHHHhccC
Confidence 0000 00111111122223456889999999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 007542 343 PKDRPTAEEALADPYF 358 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f 358 (599)
|.+|||++++|+||||
T Consensus 267 P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 267 PDERITAKQALRHPYF 282 (282)
T ss_pred cccccCHHHHhhCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=351.67 Aligned_cols=295 Identities=37% Similarity=0.591 Sum_probs=222.4
Q ss_pred ceEEEEEeeecCceEEEEEEECC--CCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTR--TGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~--tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
+|++.+.||+|++|.||+|.+.. ++..||||.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 68999999999999999999988 89999999997532 1223345678899999999999999999999643 225
Q ss_pred cEEEEEecCCccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC----CCceeeeccc
Q 007542 101 DIYVVFELMESDLHQVIKAN-----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----DCKLKICDFG 171 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~-----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~----~~~lKL~DFG 171 (599)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 79999999999888877532 26899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh---------hHHHH
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---------HQLDI 242 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~---------~~l~~ 242 (599)
+++................++.+|+|||++.+. ..++.++|||||||++++|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998654322211222345788999999987552 45789999999999999999999999876543 35677
Q ss_pred HHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcC
Q 007542 243 MTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322 (599)
Q Consensus 243 I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 322 (599)
+...++.+.+..+........... ...... .....+...... ..
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~----------------------~~~~~~~~~~~~------------~~ 280 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDT--LMKDFK----------------------TKTYPSNSLAKW------------ME 280 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchh--hhhhcc----------------------CCCCCCccHHHH------------HH
Confidence 777788777665543221111000 000000 000000000000 01
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 323 ~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
.+...+..+.+||.+||++||++|||+.|+++||||
T Consensus 281 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 281 KHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 112567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.76 Aligned_cols=255 Identities=23% Similarity=0.400 Sum_probs=210.3
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+|++.+.||+|+||.||+|.++.+|+.||||++..... .......+..|+.+++.+. |++|+++++++.. ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 47889999999999999999999999999999974322 2234456778999998886 5677888888743 347
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987542221
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+....+..|....
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------- 217 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------- 217 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 1 1234578999999999976 678999999999999999999999998876554443332100
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
. ......+..+.+|+.+||+
T Consensus 218 ---------------------------------------------------------~---~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 218 ---------------------------------------------------------V---SYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred ---------------------------------------------------------C---CCCccCCHHHHHHHHHHcc
Confidence 0 0112467889999999999
Q ss_pred cCCCCCCC-----HHHHhcCccccCC
Q 007542 341 FEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
.||.+|++ .+++++||||..+
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999997 5899999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.51 Aligned_cols=264 Identities=22% Similarity=0.395 Sum_probs=212.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++.++||+|+||.||++.++.+++.||+|++.... ........+.+|+.++..++|+||+++++.+.. ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 47999999999999999999999999999999986421 122234457789999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+. |+|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999998 699999977 457899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.. ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..|....
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (332)
T cd05623 156 GT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--------- 224 (332)
T ss_pred Cc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------
Confidence 21 112345799999999998531 1458899999999999999999999998877655544432110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
....+......+++.+.+||+
T Consensus 225 -----------------------------------------------------------~~~~~p~~~~~~s~~~~~li~ 245 (332)
T cd05623 225 -----------------------------------------------------------ERFQFPAQVTDVSEDAKDLIR 245 (332)
T ss_pred -----------------------------------------------------------ccccCCCccccCCHHHHHHHH
Confidence 011122223457899999999
Q ss_pred HhcccCCCC--CCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKD--RPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~--RpTa~e~L~HP~f~~~ 361 (599)
+||..++.+ |+|++|+++||||.++
T Consensus 246 ~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 246 RLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 999765554 6899999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=364.88 Aligned_cols=264 Identities=24% Similarity=0.355 Sum_probs=212.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++.+.||+|+||.||+|.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++.. .
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-----~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----D 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----C
Confidence 3589999999999999999999999999999999986422 222344567789999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||++ ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 57999999998 6899988754 589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCcccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|++||.+.+....+..|......
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------- 265 (371)
T cd05622 195 EGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS------- 265 (371)
T ss_pred CCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc-------
Confidence 211 1123567999999999986521 23789999999999999999999999987765544444321100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
..+ ...+.++..+.+||.
T Consensus 266 -------------------------------------------------------------~~~-~~~~~~s~~~~~li~ 283 (371)
T cd05622 266 -------------------------------------------------------------LTF-PDDNDISKEAKNLIC 283 (371)
T ss_pred -------------------------------------------------------------ccC-CCcCCCCHHHHHHHH
Confidence 001 112457889999999
Q ss_pred HhcccCCCC--CCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKD--RPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~--RpTa~e~L~HP~f~~~ 361 (599)
+||..++.+ |++++|+++||||++.
T Consensus 284 ~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 284 AFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999844433 7899999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=350.26 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=202.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (599)
||+|+||+||++.++.+|+.||+|++.... ........+..|+.+|+.++|+||+++.+++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 799999999999999999999999986432 222234567889999999999999999998843 34699999999
Q ss_pred C-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcc
Q 007542 110 E-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (599)
Q Consensus 110 ~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 184 (599)
+ ++|.+.+.. +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 588877743 346899999999999999999999999999999999999999999999999999765332221
Q ss_pred cccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhh
Q 007542 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNI 264 (599)
Q Consensus 185 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~ 264 (599)
.....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~------------------- 211 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ------------------- 211 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------------
Confidence 234578999999999977 6789999999999999999999999976543211111100
Q ss_pred hhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCC
Q 007542 265 IWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 344 (599)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~ 344 (599)
.... .+. ......++.+.+|+.+||+.||.
T Consensus 212 ----------------------------------------------~~~~-~~~---~~~~~~~~~~~~li~~~l~~~P~ 241 (280)
T cd05608 212 ----------------------------------------------RILN-DSV---TYPDKFSPASKSFCEALLAKDPE 241 (280)
T ss_pred ----------------------------------------------hhcc-cCC---CCcccCCHHHHHHHHHHhcCCHH
Confidence 0000 000 11235788899999999999999
Q ss_pred CCC-----CHHHHhcCccccCC
Q 007542 345 DRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 345 ~Rp-----Ta~e~L~HP~f~~~ 361 (599)
+|+ |++++|+||||+++
T Consensus 242 ~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 242 KRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HhcCCCCCCHHHHhcChhhhcC
Confidence 999 89999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=359.26 Aligned_cols=258 Identities=23% Similarity=0.424 Sum_probs=203.9
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.++..+ +||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 479999999999999999999999999975432 333456678899988776 79999999999843 35799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9999 58999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------~~~~------------- 207 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQ------------- 207 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcC----------Cccc-------------
Confidence 234679999999999977 678999999999999999999999995321100 0000
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHH-HhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYL-SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 344 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~ 344 (599)
....++ ..+.. ... ......+..+.+||++||+.||.
T Consensus 208 --------------------------------------~~~~~~~~~i~~-~~~---~~p~~~~~~~~~ll~~~L~~dP~ 245 (329)
T cd05618 208 --------------------------------------NTEDYLFQVILE-KQI---RIPRSLSVKAASVLKSFLNKDPK 245 (329)
T ss_pred --------------------------------------ccHHHHHHHHhc-CCC---CCCCCCCHHHHHHHHHHhcCCHH
Confidence 000000 00000 001 11235678899999999999999
Q ss_pred CCCC------HHHHhcCccccCC
Q 007542 345 DRPT------AEEALADPYFKGL 361 (599)
Q Consensus 345 ~RpT------a~e~L~HP~f~~~ 361 (599)
+|+| ++++++||||+++
T Consensus 246 ~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 246 ERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HcCCCCCCCCHHHHhcCCCCCCC
Confidence 9998 5899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=344.64 Aligned_cols=287 Identities=37% Similarity=0.628 Sum_probs=221.7
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
+|..++|++++.||+|+||.||+|.+..+|..||||.+..... ......+.+|+.+|+.++|+||+++++++..
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----- 74 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHT----- 74 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----
Confidence 4667899999999999999999999999999999999864322 2223456789999999999999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
....|+|+||+.++|.+.+... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 3478999999999888877653 568889999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~-~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... ......++..|+|||.+.+. ..++.++|||||||++++|++|.+||.+.+ ..+++..+...+|.|..+...
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 155 IPSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CCCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 2211 12334678899999998642 457889999999999999999999998765 456777777788877776543
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC--CCCHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP--NANPLALRL 334 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~s~~a~dL 334 (599)
........ .. .+ .....+..+...+. ..++.+.+|
T Consensus 231 ~~~~~~~~-----~~-----------------------------------~~---~~~~~~~~~~~~~~~~~~~~~~~~l 267 (291)
T cd07870 231 GVSKLPNY-----KP-----------------------------------EW---FLPCKPQQLRVVWKRLSRPPKAEDL 267 (291)
T ss_pred hhhhcccc-----cc-----------------------------------hh---ccccCCcchhhhccccCCChHHHHH
Confidence 31110000 00 00 00000111111111 125778999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
|.+||..||.+|||+.|+|.||||
T Consensus 268 l~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 268 ASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HHHHhCcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.87 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=209.7
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.|++.++||+|+||.||++.+..+++.||||++.... ........+.+|+.+++.++|+||+.+++.+.. ...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence 4899999999999999999999999999999986422 222234557789999999999999999998843 3479
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 5898887653 46899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...+
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~------------ 217 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV------------ 217 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh------------
Confidence 21 134478999999999976 678999999999999999999999998765433322221100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
. .. . ......+++.+.+||.+||
T Consensus 218 --------------------------------------------------~---~~-~---~~~~~~~~~~~~~li~~~l 240 (285)
T cd05605 218 --------------------------------------------------K---ED-Q---EEYSEKFSEAARSICRQLL 240 (285)
T ss_pred --------------------------------------------------h---hc-c---cccCcccCHHHHHHHHHHc
Confidence 0 00 0 0112346788999999999
Q ss_pred ccCCCCCC-----CHHHHhcCccccCC
Q 007542 340 AFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
..||.+|| +++++++||||...
T Consensus 241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 241 TKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred cCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 99999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.50 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=205.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHh-cCCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRL-LRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~-l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
+.||+|+||.||+|++..+++.||||+++.... .......+..|..++.. ++||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEEEEEE
Confidence 469999999999999999999999999975321 12334556778888876 489999999999843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
.....||..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------------- 211 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------------------- 211 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 234578999999999876 67899999999999999999999999877654433322100
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
.+ ......+..+.+||.+||+.||.+
T Consensus 212 --------------------------------------------------~~----~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 212 --------------------------------------------------NP----CYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred --------------------------------------------------CC----CCCccCCHHHHHHHHHHhccCHhh
Confidence 00 001236778999999999999999
Q ss_pred CCCHH-HHhcCccccCCc
Q 007542 346 RPTAE-EALADPYFKGLA 362 (599)
Q Consensus 346 RpTa~-e~L~HP~f~~~~ 362 (599)
|+++. ++++||||..+.
T Consensus 238 R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 238 RLGVKGDIRQHPFFREID 255 (316)
T ss_pred cCCChHHHHcCcccCCCC
Confidence 99996 999999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=334.40 Aligned_cols=291 Identities=30% Similarity=0.605 Sum_probs=235.1
Q ss_pred ccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCC
Q 007542 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPP 94 (599)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~ 94 (599)
...||..++|++++.+|+|.|+.||.|++..+.++++||+++. ...++|.||+.+|+.|. ||||++|+++..++
T Consensus 31 ~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 31 VIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 3568999999999999999999999999999999999999974 45678999999999998 99999999999775
Q ss_pred CcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-Cceeeecccc
Q 007542 95 SRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGL 172 (599)
Q Consensus 95 s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFGl 172 (599)
.. ....|||||++. +..++.. .|+.-.++.++++|+.||.|||++||.|||+||.|++||.. ..++|+|||+
T Consensus 106 ~S---ktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGL 179 (338)
T KOG0668|consen 106 ES---KTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGL 179 (338)
T ss_pred cc---cCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecch
Confidence 43 456899999995 6666653 58889999999999999999999999999999999999975 6699999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhcCCCC
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~-~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
|.+...+.. +.-.+.+++|--||++... ..|+..-|+|||||+|+.|+..+ |+|.|.++.+|+-+|.+++|+..
T Consensus 180 AEFYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 180 AEFYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred HhhcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 988754432 3456899999999999764 78999999999999999999865 77899999999999999999753
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC-----C
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP-----N 326 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-----~ 326 (599)
....-. .|.- .-+ .+|-..+......++....+ -
T Consensus 255 l~~Yl~----------KY~i----------------------------~Ld---p~~~~i~~~~~rk~w~~Fi~~~n~hl 293 (338)
T KOG0668|consen 255 LYAYLN----------KYQI----------------------------DLD---PQFEDILGRHSRKPWSRFINSENQHL 293 (338)
T ss_pred HHHHHH----------HHcc----------------------------CCC---hhHhhHhhccccccHHHhCCcccccc
Confidence 321110 0000 001 11112222223333333222 2
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
.+++|+|||.++|.+|-.+|+||.|++.||||..+.+
T Consensus 294 ~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 294 VSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred CChHHHHHHHHHHhhccccccchHHHhcCchHHHHHH
Confidence 5799999999999999999999999999999987654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=375.26 Aligned_cols=267 Identities=25% Similarity=0.373 Sum_probs=219.5
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc---
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--- 96 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~--- 96 (599)
...++|++.++||+|+||+||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 44689999999999999999999999999999999997654455566778899999999999999999887753321
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
.....+++||||+. |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 12235789999999 6999988653 468999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 189 ls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~----- 260 (496)
T PTZ00283 189 FSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG----- 260 (496)
T ss_pred cCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-----
Confidence 99865332111 11235679999999999977 67999999999999999999999999887654433332110
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
. .....+..++.+
T Consensus 261 ----------------------------------------------------------------~---~~~~~~~~~~~l 273 (496)
T PTZ00283 261 ----------------------------------------------------------------R---YDPLPPSISPEM 273 (496)
T ss_pred ----------------------------------------------------------------C---CCCCCCCCCHHH
Confidence 0 011224578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+||.+||..||.+|||+.++|+|||++.+
T Consensus 274 ~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 274 QEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 999999999999999999999999999864
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.20 Aligned_cols=286 Identities=38% Similarity=0.695 Sum_probs=226.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|++|.||+|.+..+++.||||+++...........+.+|+.+|+.++|+||+++++++.. ...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 47999999999999999999999999999999987544444455778899999999999999999999854 3479
Q ss_pred EEEEecCCccHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~-i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+|+||+++++.+. +.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99999999765544 44556799999999999999999999999999999999999999999999999999987644322
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
.....+.++.+|+|||++.+. ..++.++||||+||++++|++|+++|.+.+..+.+..+...+|...+.......
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 230 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS-- 230 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc--
Confidence 123456789999999998762 378899999999999999999999999998888888888888877665432200
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC-CCHHHHHHHHHhcc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLA 340 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~s~~a~dLL~~mL~ 340 (599)
. +.... . ........+..+...++. .++.+.+||++||.
T Consensus 231 -~------~~~~~---~------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 270 (288)
T cd07833 231 -S------NPRFA---G------------------------------VAFPEPSQPESLERRYPGKVSSPALDFLKACLR 270 (288)
T ss_pred -c------Ccccc---c------------------------------cccCCCCCcHHHHHhcCCccchHHHHHHHHHhc
Confidence 0 00000 0 000000000111112233 47889999999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q 007542 341 FEPKDRPTAEEALADPYF 358 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f 358 (599)
.||++|||++++++||||
T Consensus 271 ~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 271 MDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCchhcccHHHHhcCCCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.01 Aligned_cols=294 Identities=39% Similarity=0.599 Sum_probs=233.7
Q ss_pred cCCCCceEE-EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChh------------hHHHHHHHHHHHHhcCCCCcc
Q 007542 19 YGEGSRYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS------------DATRILREIKLLRLLRHPDIV 85 (599)
Q Consensus 19 ~~~~~rY~i-~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~------------~~~~i~rEi~iL~~l~HpnIv 85 (599)
+...+||.. .+.||+|+||+||+|.+..+++.||||++........ ....+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 467889975 5779999999999999999999999999864322110 012467999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCce
Q 007542 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (599)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~l 165 (599)
++++++.. ...+|+||||+.++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+
T Consensus 84 ~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEec-----CCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 99999843 3478999999999999999888889999999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCC-----------CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 007542 166 KICDFGLARVAFNDT-----------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (599)
Q Consensus 166 KL~DFGla~~~~~~~-----------~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~ 234 (599)
||+|||+++...... ..........++..|+|||.+.+. ..++.++|+|||||++++|++|++||.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999997654111 011112334578899999998652 45789999999999999999999999999
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc
Q 007542 235 NVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK 314 (599)
Q Consensus 235 ~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~ 314 (599)
+..+++..+...++.|....+....... . ......
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--------------------------------------------~-~~~~~~ 272 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLP--------------------------------------------L-YTEFTP 272 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcc--------------------------------------------c-ccccCc
Confidence 9999999999999888765433200000 0 000011
Q ss_pred CCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 315 ~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
..+..+...++..+..+.+||.+||+.||.+|||++|+|.||||++...
T Consensus 273 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 273 RKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred CCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 1122233344567888999999999999999999999999999997644
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=365.81 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=221.6
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.....|..++.||+|+||.||+|++..+++.||||++... ......+.+..|+.+|..++++||.++++.|....
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~---- 84 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT---- 84 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc----
Confidence 3456788889999999999999999999999999999743 23345678899999999999999999999997554
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.++++||||. |++.++++..+.+.|..+..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||.+.....
T Consensus 85 -~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 85 -KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred -cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec
Confidence 5899999999 69999999888889999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... ...+.+||+.|||||++.+ ..|+.++||||||++.+||++|.|||........+..
T Consensus 164 ~~~---rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl---------------- 222 (467)
T KOG0201|consen 164 TVK---RRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL---------------- 222 (467)
T ss_pred hhh---ccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe----------------
Confidence 332 2267899999999999986 7899999999999999999999999987654322211
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
+++..|..+. ..+++.+++|+..|
T Consensus 223 -----------------------------------------------------Ipk~~PP~L~---~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 223 -----------------------------------------------------IPKSAPPRLD---GDFSPPFKEFVEAC 246 (467)
T ss_pred -----------------------------------------------------ccCCCCCccc---cccCHHHHHHHHHH
Confidence 2222332222 26789999999999
Q ss_pred cccCCCCCCCHHHHhcCccccC
Q 007542 339 LAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~ 360 (599)
|+.||+.||||.++|+|+|++.
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHh
Confidence 9999999999999999999986
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=362.01 Aligned_cols=258 Identities=26% Similarity=0.333 Sum_probs=203.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|+||+++++++. ....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCe
Confidence 467889999999999999999999999999999986432 2234567889999999999999999999984 3457
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+.+ +|.+. ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999995 66542 346788889999999999999999999999999999999999999999999998653221
Q ss_pred CCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
. .....+||..|+|||++... ...++.++||||||||+|+|++|+.||......+....+..
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------------ 287 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------------ 287 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------------
Confidence 1 12346899999999987431 12345689999999999999999999974332111111100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
..... ........++.+.+||.+
T Consensus 288 ------------------------------------------------------~~~~~---~~~~~~~~~~~l~~li~~ 310 (353)
T PLN00034 288 ------------------------------------------------------ICMSQ---PPEAPATASREFRHFISC 310 (353)
T ss_pred ------------------------------------------------------HhccC---CCCCCCccCHHHHHHHHH
Confidence 00000 011223567889999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||..||++|||+.|+|+||||.+-
T Consensus 311 ~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 311 CLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HccCChhhCcCHHHHhcCcccccC
Confidence 999999999999999999999875
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.25 Aligned_cols=282 Identities=26% Similarity=0.321 Sum_probs=210.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.+..|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|+.++|+||+++++++.. ..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~ 233 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVV-----GG 233 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CC
Confidence 3568999999999999999999999999999999642 1235689999999999999999998743 34
Q ss_pred cEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
..|+|||++.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 234 ~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 234 LTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 68999999999999998764 46999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCC-CCCCCCh------hhHHHHHHHhcCCCCH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP-LFPGKNV------VHQLDIMTDLLGTPSP 252 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~-pF~g~~~------~~~l~~I~~~lg~p~~ 252 (599)
... ......+||..|+|||++.+ ..++.++||||||||||||++|.. +|.+... ..++..|+...+....
T Consensus 314 ~~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 314 WST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 211 11234579999999999977 678999999999999999999764 5544321 2334444333222111
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHh----cccCCCCCCcCCCCCCC
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS----MRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~s 328 (599)
+.- .. ........+... .......+....+..++
T Consensus 391 ~~~------------------~~------------------------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (461)
T PHA03211 391 EFP------------------QH------------------------AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLD 428 (461)
T ss_pred cCC------------------CC------------------------cchHHHHHHHhhhhcccCCccCCcchhhhcccc
Confidence 000 00 000000011000 00111111112233567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+.+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 429 ~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 429 LDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 78999999999999999999999999999974
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=358.36 Aligned_cols=250 Identities=28% Similarity=0.483 Sum_probs=205.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~-iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||+||+|.++.+|+.||||++..... .......+.+|.. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 469999999999999999999999999864321 2233455666665 4678999999999998843 35799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9999 58999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~------------------- 211 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK------------------- 211 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 245679999999999977 67899999999999999999999999877654433322210
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
. ....+..+..+.+||++||..||.+
T Consensus 212 ---------------------------------------------------~---~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 212 ---------------------------------------------------P---LVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ---------------------------------------------------C---ccCCCCCCHHHHHHHHHHhccCHHh
Confidence 0 0112457788999999999999999
Q ss_pred CCCH----HHHhcCccccCC
Q 007542 346 RPTA----EEALADPYFKGL 361 (599)
Q Consensus 346 RpTa----~e~L~HP~f~~~ 361 (599)
||++ .++++||||.+.
T Consensus 238 R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCCCCCCHHHHhcCCCcCCC
Confidence 9976 699999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=344.32 Aligned_cols=282 Identities=48% Similarity=0.794 Sum_probs=233.9
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|++.+.||+|++|.||+|.+..+++.+++|.++...........+.+|+.+|+.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6788999999999999999999999999999976544444567788999999999999999999998543 57999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
|+||+.++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 9999999999988764 579999999999999999999999999999999999999999999999999997764332
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
.......++.+|+|||.+.+. ..++.++|+||+||++|+|++|+++|++.+..+++..+...++.+.++.+.......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA- 230 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh-
Confidence 122445788899999998762 378899999999999999999999999999999999999999988876654411100
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 343 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP 343 (599)
.+....+............+..+..+.+||.+||..||
T Consensus 231 ------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 268 (283)
T cd05118 231 ------------------------------------------RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDP 268 (283)
T ss_pred ------------------------------------------hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCc
Confidence 11111122222333344456778999999999999999
Q ss_pred CCCCCHHHHhcCccc
Q 007542 344 KDRPTAEEALADPYF 358 (599)
Q Consensus 344 ~~RpTa~e~L~HP~f 358 (599)
.+||+++++|.||||
T Consensus 269 ~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 269 HKRITAEQALAHPYF 283 (283)
T ss_pred ccCcCHHHHhhCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=339.68 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=210.5
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC---hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH---VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~---~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
+.|++.+.||+|++|.||.|.+..++..||+|.+...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-----D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-----C
Confidence 5699999999999999999999999999999998643222 1234568899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+|+||+. ++|.+++...+.+++..++.+++||+.||.|||+.||+|+||+|+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 47999999998 58999998888899999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
............++..|+|||++.+ ..++.++||||+||++|+|++|+.||...+.......+...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------ 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ------------ 222 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc------------
Confidence 2211111134568889999999987 56889999999999999999999999765433222111100
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
. .........+..+.+||.+|
T Consensus 223 --------------------------------------------------------~---~~~~~~~~~~~~~~~li~~~ 243 (263)
T cd06625 223 --------------------------------------------------------P---TNPQLPSHVSPDARNFLRRT 243 (263)
T ss_pred --------------------------------------------------------C---CCCCCCccCCHHHHHHHHHH
Confidence 0 00111234678899999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 007542 339 LAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f 358 (599)
|..||.+|||+.|+|+||||
T Consensus 244 l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 244 FVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred hhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=354.68 Aligned_cols=299 Identities=22% Similarity=0.335 Sum_probs=217.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+|+.++|+||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 77 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGE 77 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCE
Confidence 478999999999999999999999999999999887532 22345678899999999999999999999854 347
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999998 59999999888899999999999999999999975 7999999999999999999999999998765322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH-hcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD-LLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~-~lg~p~~e~i~~~ 258 (599)
. .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.. ..|.+.......
T Consensus 158 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 229 (333)
T cd06650 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP- 229 (333)
T ss_pred c-----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc-
Confidence 1 134578999999999977 6789999999999999999999999987654332211110 111111100000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.+...........+.. .......+....+....+..+. ....++++.+||.+|
T Consensus 230 ------~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~ 282 (333)
T cd06650 230 ------RPRPPGRPLSSYGPDS-------------------RPPMAIFELLDYIVNEPPPKLP--SGVFGAEFQDFVNKC 282 (333)
T ss_pred ------ccCCccchhhhhcccc-------------------cccccHHHHHHHHhcCCCccCC--CCCcCHHHHHHHHHh
Confidence 0000000000000000 0000001111111111111111 123678899999999
Q ss_pred cccCCCCCCCHHHHhcCccccCC
Q 007542 339 LAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|++||.+|||++|+|.||||+..
T Consensus 283 L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 283 LIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccCCcccCcCHHHHhhCHHHhcC
Confidence 99999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=359.63 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=201.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCccEEEEE
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
||+|+||+||+|+++.+|+.||||++.... ..........+|..++..+ .||||+++++++.. ...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeEEEEE
Confidence 799999999999999999999999986421 1222344556677777665 69999999999843 35799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 59999998888999999999999999999999999999999999999999999999999999875432221 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------- 212 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG------------------- 212 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 2456799999999998652 45889999999999999999999999886654433322110
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
...+. ...+++.+.+||++||..||.+
T Consensus 213 ---------------------------------------------------~~~~~--~~~~~~~~~~li~~~L~~~P~~ 239 (330)
T cd05586 213 ---------------------------------------------------KVRFP--KNVLSDEGRQFVKGLLNRNPQH 239 (330)
T ss_pred ---------------------------------------------------CCCCC--CccCCHHHHHHHHHHcCCCHHH
Confidence 00000 0136788999999999999999
Q ss_pred CC----CHHHHhcCccccCC
Q 007542 346 RP----TAEEALADPYFKGL 361 (599)
Q Consensus 346 Rp----Ta~e~L~HP~f~~~ 361 (599)
|| +++++|+||||...
T Consensus 240 R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 240 RLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCCHHHHhcCccccCC
Confidence 98 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=354.73 Aligned_cols=264 Identities=22% Similarity=0.376 Sum_probs=212.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||.||++.++.+++.||+|++.... ........+.+|+.+++.++|+||+.+++++. +.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence 57999999999999999999999999999999986421 22233455778999999999999999999984 3357
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999998 699999987 467999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCcccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... .....+||+.|+|||++.+.. ..++.++||||+||++|+|++|+.||.+.+..+.+..|....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 224 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE--------- 224 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC---------
Confidence 211 112357999999999886421 357889999999999999999999998876554443332110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
...++...+..+++.+.+||.
T Consensus 225 -----------------------------------------------------------~~~~~p~~~~~~~~~~~~li~ 245 (331)
T cd05624 225 -----------------------------------------------------------ERFQFPSHITDVSEEAKDLIQ 245 (331)
T ss_pred -----------------------------------------------------------CcccCCCccccCCHHHHHHHH
Confidence 011122333457889999999
Q ss_pred HhcccCCCC--CCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKD--RPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~--RpTa~e~L~HP~f~~~ 361 (599)
+||..++.+ |++++++++||||+++
T Consensus 246 ~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 246 RLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred HHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 999976655 5799999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=355.03 Aligned_cols=250 Identities=27% Similarity=0.453 Sum_probs=204.5
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~-iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
+.||+|+||+||+|++..+++.||+|++..... .......+.+|.. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-----ADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-----CCeEEEEE
Confidence 469999999999999999999999999864221 1223344555554 4688899999999998843 35799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9999 59999998888899999999999999999999999999999999999999999999999999975422211 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------------------- 211 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------------------- 211 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC-------------------
Confidence 245679999999999977 67899999999999999999999999887655443333210
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
+ ....+..++.+.+||++||+.||.+
T Consensus 212 ---------------------------------------------------~---~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 212 ---------------------------------------------------P---LQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred ---------------------------------------------------C---cCCCCCCCHHHHHHHHHHcccCHHH
Confidence 0 0122467888999999999999999
Q ss_pred CCCHH----HHhcCccccCC
Q 007542 346 RPTAE----EALADPYFKGL 361 (599)
Q Consensus 346 RpTa~----e~L~HP~f~~~ 361 (599)
|+++. ++++|+||..+
T Consensus 238 R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCCCCHHHHhcCcccCCC
Confidence 99876 89999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.97 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=203.4
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~-iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||.||+|++..+|+.||+|++..... .......+.+|+. +++.++||||+++++++.. ...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-----~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-----AEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCEEEEEE
Confidence 479999999999999999999999999864321 2223445666665 5788999999999998843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||++ ++|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9999 58999888888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245679999999999876 6789999999999999999999999988765443332211
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
.+. ...+..+..+.+||.+||+.||.+
T Consensus 211 --------------------------------------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 211 --------------------------------------------------KPL---QLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred --------------------------------------------------CCC---CCCCCCCHHHHHHHHHHccCCHhh
Confidence 000 112356778999999999999999
Q ss_pred CCCH----HHHhcCccccCC
Q 007542 346 RPTA----EEALADPYFKGL 361 (599)
Q Consensus 346 RpTa----~e~L~HP~f~~~ 361 (599)
|+++ .|+++|+||..+
T Consensus 238 R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred cCCCCCCHHHHhCCCCcCCC
Confidence 9875 599999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=342.10 Aligned_cols=281 Identities=43% Similarity=0.739 Sum_probs=232.4
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++... ..+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 6788999999999999999999999999999976543344456778999999999999999999998543 57999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
|+||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999976533221
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
......++.+|+|||.+.+. ..++.++|||||||++++|++|+++|.+.+....+..+...++.+....+..+....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12344567889999998652 478899999999999999999999999999999999999999998887665421100
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 343 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP 343 (599)
.+-..++..........++..+..+.+||++||..||
T Consensus 231 -------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 267 (282)
T cd07829 231 -------------------------------------------DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNP 267 (282)
T ss_pred -------------------------------------------cccccccccCccchHHhcccccHHHHHHHHHhhccCc
Confidence 0000111122223334456678899999999999999
Q ss_pred CCCCCHHHHhcCccc
Q 007542 344 KDRPTAEEALADPYF 358 (599)
Q Consensus 344 ~~RpTa~e~L~HP~f 358 (599)
.+|||+++++.||||
T Consensus 268 ~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 268 AKRISAKEALKHPYF 282 (282)
T ss_pred ccCCCHHHHhhCcCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=362.72 Aligned_cols=260 Identities=30% Similarity=0.461 Sum_probs=227.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|.++++||+|+||.+++++++..+..|++|+|...-...........|+.++++++|||||.+++.|.... .
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~ 77 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----Q 77 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----c
Confidence 357899999999999999999999999999999999765545455557789999999999999999999995432 3
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
.++|||+|++ |+|.+.|+... .++|+.+..++.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+...
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 5999999999 59999997643 68999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ....+++||+.|+.||++.+ ..|+.++|||||||++|||++-++.|.+.+....+.+|......|-+
T Consensus 158 ~~~---~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp----- 227 (426)
T KOG0589|consen 158 PED---SLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP----- 227 (426)
T ss_pred Cch---hhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-----
Confidence 543 23467899999999999988 79999999999999999999999999999988887777655443322
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
...+.++..||+.
T Consensus 228 -------------------------------------------------------------------~~ys~el~~lv~~ 240 (426)
T KOG0589|consen 228 -------------------------------------------------------------------SMYSSELRSLVKS 240 (426)
T ss_pred -------------------------------------------------------------------ccccHHHHHHHHH
Confidence 2456788999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||..+|..||+|.++|.+|.+...
T Consensus 241 ~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 241 MLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HhhcCCccCCCHHHHhhChhhhhH
Confidence 999999999999999999887643
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=352.25 Aligned_cols=258 Identities=22% Similarity=0.390 Sum_probs=204.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
++||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.++..+ +||||+.+++++.. ...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 479999999999999999999999999975322 223456678999999888 59999999999843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875322111 1
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~---------~~~~~~---------- 211 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM---------NTEDYL---------- 211 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCccc---------ccHHHH----------
Confidence 235679999999999976 67899999999999999999999999643211000 000000
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
... +. ..+.. .....+..+.+||.+||..||.+
T Consensus 212 ----------------------------------------~~~---~~-~~~~~---~p~~~~~~~~~li~~~L~~dP~~ 244 (327)
T cd05617 212 ----------------------------------------FQV---IL-EKPIR---IPRFLSVKASHVLKGFLNKDPKE 244 (327)
T ss_pred ----------------------------------------HHH---HH-hCCCC---CCCCCCHHHHHHHHHHhccCHHH
Confidence 000 00 01111 12346788999999999999999
Q ss_pred CCC------HHHHhcCccccCCc
Q 007542 346 RPT------AEEALADPYFKGLA 362 (599)
Q Consensus 346 RpT------a~e~L~HP~f~~~~ 362 (599)
|++ .+++++||||.++.
T Consensus 245 R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 245 RLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred cCCCCCCCCHHHHHcCCCCCCCC
Confidence 998 57999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=332.21 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=209.9
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.|++++.||+|++|.||++.++.+++.||+|++............+.+|+.+++.++|+|++++.+.+.. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 5999999999999999999999999999999997544444455678899999999999999999887632 224689
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||+. ++|.+++... ..+++..++.++.||+.||.+||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 5899998763 458999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ......++..|+|||++.+ ..++.++|+||+||++++|++|+.||.+.+.......+....
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK------------- 218 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence 1 2234568899999999877 678899999999999999999999998765433322221100
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
+.......++.+.+||.+||+
T Consensus 219 -----------------------------------------------------------~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 219 -----------------------------------------------------------LPPMPKDYSPELGELIATMLS 239 (257)
T ss_pred -----------------------------------------------------------CCCCccccCHHHHHHHHHHhc
Confidence 001113467889999999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q 007542 341 FEPKDRPTAEEALADPYF 358 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f 358 (599)
.||.+|||+.++|+||||
T Consensus 240 ~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 240 KRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCcccCCCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.64 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=207.2
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.|++.++||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++|+||+.+++.+.. ...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-----CCEE
Confidence 47889999999999999999999999999999864322 22234567789999999999999999998843 3479
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
|+||||+. ++|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 58998886543 5899999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. .....|+..|+|||++.+ ..++.++||||+||++|+|++|++||.+.........+.
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~--------------- 214 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------------- 214 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---------------
Confidence 11 133578999999999976 578999999999999999999999997643211110000
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
..+..... ......++.+.+||.+||
T Consensus 215 -----------------------------------------------~~~~~~~~-------~~~~~~~~~~~~li~~~l 240 (285)
T cd05630 215 -----------------------------------------------RLVKEVQE-------EYSEKFSPDARSLCKMLL 240 (285)
T ss_pred -----------------------------------------------hhhhhhhh-------hcCccCCHHHHHHHHHHh
Confidence 00000000 112346788999999999
Q ss_pred ccCCCCCCC-----HHHHhcCccccCC
Q 007542 340 AFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
+.||.+||| ++|+++||||+++
T Consensus 241 ~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 241 CKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hcCHHHccCCCCCchHHHHcChhhhcc
Confidence 999999999 9999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.81 Aligned_cols=285 Identities=39% Similarity=0.666 Sum_probs=227.6
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++|+|++++++++.... ...+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78999999999999999999999999999999765433444567889999999999999999999985431 257999
Q ss_pred EEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 105 VFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
|+||++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999998765 5799999999999999999999999999999999999999999999999999987643321
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
...+...++..|+|||.+.+. ..++.++|||||||++++|++|++||.+.+....+..+.+..+.+....+........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 112344678899999987542 4678999999999999999999999999998888999998888887765433110000
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC-CCHHHHHHHHHhcccC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERMLAFE 342 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~s~~a~dLL~~mL~~D 342 (599)
+... .... ..+..+...+.. .++.+.++|++||.+|
T Consensus 235 --~~~~------------------------------~~~~-----------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 271 (287)
T cd07840 235 --FENL------------------------------KPKK-----------PYKRRLREFFKHLIDPSALDLLDKLLTLD 271 (287)
T ss_pred --hhhc------------------------------cccc-----------cchhHHHHHhcccCCHHHHHHHHHHcCCC
Confidence 0000 0000 000001112223 3788999999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 007542 343 PKDRPTAEEALADPYF 358 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f 358 (599)
|.+|||++++|+||||
T Consensus 272 P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 272 PKKRISADQALQHEYF 287 (287)
T ss_pred hhhCcCHHHHhhCcCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.81 Aligned_cols=292 Identities=38% Similarity=0.634 Sum_probs=228.9
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-----
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS----- 95 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s----- 95 (599)
..++|++.+.||+|+||.||+|.++.+|+.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 357899999999999999999999999999999999754333334456778999999999999999999886532
Q ss_pred cCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+...+|+|+||++++|...+... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 1123479999999999998888764 468999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
........ ......++..|+|||.+.+. ..++.++||||+||++++|++|+++|...+....+..+....+.+.+..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 165 LYNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred cccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 65433221 12233567889999987542 4578899999999999999999999999999999999998888877654
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+..+..... |...+ . ...........+..+++.+.+|
T Consensus 242 ~~~~~~~~~--~~~~~----------------------------------------~-~~~~~~~~~~~~~~~~~~~~~l 278 (302)
T cd07864 242 WPDVIKLPY--FNTMK----------------------------------------P-KKQYRRRLREEFSFIPTPALDL 278 (302)
T ss_pred ccccccccc--ccccc----------------------------------------c-ccccccchhhhcCCCCHHHHHH
Confidence 332100000 00000 0 0000011222334567889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
|.+||..||.+|||++++|.||||
T Consensus 279 i~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 279 LDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHccCChhhCCCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.21 Aligned_cols=282 Identities=40% Similarity=0.649 Sum_probs=224.5
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCCccccceeecCCCcCCCcc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
|++.+.||+|+||.||+|.++.++..||||+++...........+.+|+.+++.+ +|+||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999975444333345666888887766 5999999999986554333345
Q ss_pred EEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+.++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999999887643 5899999999999999999999999999999999999999999999999999775432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. .....++..|+|||++.+ ..++.++|+||+||++++|++|+++|.+.+..+.+..+.+..+.+....+...
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN- 233 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC-
Confidence 21 233467889999999876 57889999999999999999999999999988888888877766544322110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.. .............+....+..++.+.+||.+||
T Consensus 234 ----------~~-----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 268 (287)
T cd07838 234 ----------VS-----------------------------------LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKML 268 (287)
T ss_pred ----------cc-----------------------------------cchhhcccccccchhhhhhhhhHHHHHHHHHHh
Confidence 00 000001111222233444566788999999999
Q ss_pred ccCCCCCCCHHHHhcCccc
Q 007542 340 AFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f 358 (599)
+.||.+|||++|+|.||||
T Consensus 269 ~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 269 TFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccCCccCCCHHHHhcCcCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.29 Aligned_cols=279 Identities=26% Similarity=0.454 Sum_probs=221.7
Q ss_pred eEE-EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 007542 25 YKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 25 Y~i-~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~l 102 (599)
|++ .+.||+|+|+.|--+....||..||||+|.+. ......+++||++++.+++ |+||+.|+++|. +...+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE-----dd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFE-----DDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc-----ccceE
Confidence 444 36899999999999999999999999999764 3345678999999999997 999999999994 44579
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC---ceeeecccccccccC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAFN 178 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~---~lKL~DFGla~~~~~ 178 (599)
|||||-|. |.|.+.|.+...++|.++..+...|+.||.|||.+||.||||||+|||..... -+|||||.|......
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999 59999999999999999999999999999999999999999999999987654 489999998865432
Q ss_pred CCC----CcccccccccCccccCccccc---cccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 179 DTP----TAIFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 179 ~~~----~~~~~~~~~gt~~Y~APE~l~---~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
... ....+.+.+|+-.|||||+.. +....|+...|.||||+|+|.||+|.+||.|....+
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d------------- 298 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD------------- 298 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc-------------
Confidence 221 112345678999999999753 333569999999999999999999999998864321
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
||++. ..++ .-| ....+.++.......-..-|..+|.++
T Consensus 299 ---------------CGWdr--Ge~C------------------r~C------Q~~LFesIQEGkYeFPdkdWahIS~ea 337 (463)
T KOG0607|consen 299 ---------------CGWDR--GEVC------------------RVC------QNKLFESIQEGKYEFPDKDWAHISSEA 337 (463)
T ss_pred ---------------CCccC--CCcc------------------HHH------HHHHHHHHhccCCcCChhhhHHhhHHH
Confidence 11110 0000 001 123344444444444445577789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
+|||..+|..|+..|.+|.++|+|||+......
T Consensus 338 kdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 338 KDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 999999999999999999999999999987654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=366.12 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=211.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC-CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t-g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
...|.+.+.||+|++|.||+|.+..+ +..||+|++.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~ 138 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DD 138 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CC
Confidence 34599999999999999999998888 78899997743 233445667889999999999999999999843 35
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.+||||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 7999999998 699887753 34689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+... .
T Consensus 219 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~--~------ 287 (478)
T PTZ00267 219 YSDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG--K------ 287 (478)
T ss_pred cCCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C------
Confidence 543221 112345679999999999977 67899999999999999999999999876654443333210 0
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. .....+++.+.+||
T Consensus 288 -------------------------------------------------------------~~---~~~~~~s~~~~~li 303 (478)
T PTZ00267 288 -------------------------------------------------------------YD---PFPCPVSSGMKALL 303 (478)
T ss_pred -------------------------------------------------------------CC---CCCccCCHHHHHHH
Confidence 00 01124678899999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCC
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+||..||++|||++++|.|+|++.+
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.89 Aligned_cols=253 Identities=32% Similarity=0.429 Sum_probs=206.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcE-EEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEK-VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~-VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.....+.+.||+|+||+||+|.. .|.. ||||++............+.+|+.+|..++|||||++++++..+..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---- 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---- 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----
Confidence 45556677799999999999964 4666 9999997644444447789999999999999999999999965431
Q ss_pred cEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCc-eEeccCCCCceEecCCC-ceeeeccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKPKNILANADC-KLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~g-IvHrDLKP~NILv~~~~-~lKL~DFGla~~ 175 (599)
.++||||||. |+|.+++.. ...++...+..++.||++|+.|||+++ ||||||||+|||++.++ ++||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 5899999999 799999987 578999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..... ...+...||..|||||++.+....|+.++||||+|+++|||+||+.||.+.........+....-+|
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp----- 265 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP----- 265 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-----
Confidence 64321 2234578999999999998412579999999999999999999999999877633322221111010
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.+ ....++....||
T Consensus 266 -------------------------------------------------------------~~-----p~~~~~~l~~l~ 279 (362)
T KOG0192|consen 266 -------------------------------------------------------------PI-----PKECPPHLSSLM 279 (362)
T ss_pred -------------------------------------------------------------CC-----CccCCHHHHHHH
Confidence 00 112677899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 007542 336 ERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~ 354 (599)
++|+..||.+||+..+++.
T Consensus 280 ~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 280 ERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999875
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.43 Aligned_cols=301 Identities=22% Similarity=0.283 Sum_probs=209.1
Q ss_pred EEEEeeec--CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 27 IEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 27 i~~~IG~G--~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
++++||+| +|++||++.++.+|+.||||+++...........+.+|+.+++.++||||+++++++... ..+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 57889999 778999999999999999999976544444556778899999999999999999998543 47899
Q ss_pred EEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 105 VFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 105 V~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+..........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999 6899998653 4689999999999999999999999999999999999999999999999987544321111
Q ss_pred C----cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 182 T----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 182 ~----~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
. ........++..|+|||++.+....++.++||||+||++++|++|+.||.+........... .+..+ ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~-~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVP-CLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCcc-ccccc
Confidence 0 00112235677899999986532468999999999999999999999998755433222221 11111 00000
Q ss_pred Hhhhhhhhh--cCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhc-ccCCCCCCcCCCCCCCHHHHHH
Q 007542 258 VCLLLNIIW--CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM-RKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 258 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~s~~a~dL 334 (599)
......... ....+....+.. ....... ..............+++.+.+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGE---------------------------STTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCc---------------------------ccccCCcCccccCCcccccccccCHHHHHH
Confidence 000000000 000000000000 0000000 0000001111223467899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|++||++||++|||++|+|+||||+.+.
T Consensus 287 i~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 287 VEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred HHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 9999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=380.66 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=213.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++++.||+|+||+||+|.++.++..||+|++............+.+|+.+|+.|+|||||+++++|... ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence 345799999999999999999999999999999999975544555567889999999999999999999998543 22
Q ss_pred ccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhC-------ceEeccCCCCceEecC------
Q 007542 100 KDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-------NVFHRDLKPKNILANA------ 161 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~-------gIvHrDLKP~NILv~~------ 161 (599)
..+||||||+. ++|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 46899999999 699998865 35799999999999999999999985 4999999999999964
Q ss_pred -----------CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 007542 162 -----------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230 (599)
Q Consensus 162 -----------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~p 230 (599)
.+.+||+|||++....... .....++|+.|+|||++.+....++.++||||||||||+|++|..|
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 2448999999997653221 1234579999999999865335688999999999999999999999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHH
Q 007542 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS 310 (599)
Q Consensus 231 F~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~ 310 (599)
|...+...++..+..
T Consensus 243 F~~~~~~~qli~~lk----------------------------------------------------------------- 257 (1021)
T PTZ00266 243 FHKANNFSQLISELK----------------------------------------------------------------- 257 (1021)
T ss_pred CCcCCcHHHHHHHHh-----------------------------------------------------------------
Confidence 976554333211110
Q ss_pred hcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 311 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 311 ~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.... ...+..++.+.+||.+||.+||.+|||+.|+|.||||+.+
T Consensus 258 ---~~p~----lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 258 ---RGPD----LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred ---cCCC----CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 0000 0123457889999999999999999999999999999754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=336.36 Aligned_cols=280 Identities=42% Similarity=0.718 Sum_probs=227.3
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
|++.+.||+|++|+||+|.+..+++.|+||++...... .......+|+..++.++ |+||+++++++.. ....|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEE
Confidence 78899999999999999999999999999998754332 22334567999999999 9999999999854 35789
Q ss_pred EEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 104 VVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 104 lV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
+||||+.++|.+++.... .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 999999999999998764 78999999999999999999999999999999999999999999999999997653322
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
..+...++..|+|||++... ..++.++|+||+||++++|++|+++|++.+..+.+..+...++.+..+.+......
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 154 ---PYTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ---CcCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 12456788999999987542 46789999999999999999999999999999999999999999887655431100
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
.... -..+...........++..+..+.+||++||+.
T Consensus 230 ~~~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 266 (283)
T cd07830 230 ASKL-------------------------------------------GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRW 266 (283)
T ss_pred hccc-------------------------------------------cccccccccccHHHHcccCCHHHHHHHHHhccc
Confidence 0000 000111111222333445578899999999999
Q ss_pred CCCCCCCHHHHhcCccc
Q 007542 342 EPKDRPTAEEALADPYF 358 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f 358 (599)
||.+|||++|++.||||
T Consensus 267 ~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 267 DPKKRPTASQALQHPYF 283 (283)
T ss_pred CcccCCCHHHHhhCCCC
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=337.60 Aligned_cols=254 Identities=25% Similarity=0.461 Sum_probs=213.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 47999999999999999999999999999999986432 122345678899999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999996 799999998889999999999999999999999999999999999999999999999999999875433
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
.....++..|+|||.+.+ ..++.++|||||||++++|++|+.||.+.+.......+.. +
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~------------ 213 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--G------------ 213 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C------------
Confidence 123468899999999876 5678899999999999999999999987664333222210 0
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
... .....++.+.+||++||.
T Consensus 214 --------------------------------------------------------~~~---~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 214 --------------------------------------------------------KVR---FPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred --------------------------------------------------------Ccc---CCccCCHHHHHHHHHHcc
Confidence 000 112357889999999999
Q ss_pred cCCCCCC-----CHHHHhcCccccCCc
Q 007542 341 FEPKDRP-----TAEEALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~Rp-----Ta~e~L~HP~f~~~~ 362 (599)
.||.+|+ +++|+++||||..+.
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999 999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=328.22 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=211.0
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++.+... ..+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 48899999999999999999999999999999875444455667888999999999999999999998533 5789
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999998 5999999774 578999999999999999999999999999999999999999999999999988654322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ......++.+|+|||++.+ ..++.++|+|||||++++|++|+.||...+.......+....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 217 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV------------- 217 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 1 1234568899999999876 568899999999999999999999998766443332221100
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
+.......++.+.++|.+||+
T Consensus 218 -----------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 218 -----------------------------------------------------------FPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred -----------------------------------------------------------CCCCccccCHHHHHHHHHHcc
Confidence 001111456789999999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q 007542 341 FEPKDRPTAEEALADPYF 358 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f 358 (599)
.||++||++.++|+|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=337.13 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=209.5
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.|++.+.||+|+||+||+|.+..+++.||+|.+.... ........+.+|+.+|+.++|+||+.+.+.+.. ...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEE
Confidence 4788999999999999999999999999999986432 222234557889999999999999999988843 3479
Q ss_pred EEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 103 YVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999 5888887653 36999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ......|+..|+|||++.+ ..++.++|+||+||++++|++|..||.+.........+......
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~---------- 219 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE---------- 219 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc----------
Confidence 1 1234578999999999976 67899999999999999999999999876544333222110000
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
. . ....+..++.+.+|+.+||
T Consensus 220 -------------------------------------------------------~-~---~~~~~~~~~~~~~li~~~l 240 (285)
T cd05632 220 -------------------------------------------------------T-E---EVYSAKFSEEAKSICKMLL 240 (285)
T ss_pred -------------------------------------------------------c-c---cccCccCCHHHHHHHHHHc
Confidence 0 0 0112346778999999999
Q ss_pred ccCCCCCCC-----HHHHhcCccccCC
Q 007542 340 AFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
+.||.+||| +.+++.|+||...
T Consensus 241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 241 TKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred cCCHhHcCCCcccChHHHHcChhhhcC
Confidence 999999999 8999999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.51 Aligned_cols=292 Identities=24% Similarity=0.371 Sum_probs=214.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEE
Confidence 46999999999999999999999999999999986432 22344668899999999999999999999843 3579
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 5999999888889999999999999999999997 599999999999999999999999999987543221
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
....+++..|+|||++.+ ..++.++|+||+||++++|++|+.||.+.+.......+..........
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 220 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK------- 220 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccccc-------
Confidence 234578999999999876 568899999999999999999999998765333221111100000000
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
............. .......+....+....+..+ ....+++.+.+||.+||.
T Consensus 221 -------~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~ 272 (308)
T cd06615 221 -------ESHRPVSGHPPDS-------------------PRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVDKCLK 272 (308)
T ss_pred -------CCcccccCCCCCc-------------------cchhhHHHHHHHHhcCCCccC--cCcccCHHHHHHHHHHcc
Confidence 0000000000000 000000011111111111111 112367889999999999
Q ss_pred cCCCCCCCHHHHhcCccccCCc
Q 007542 341 FEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+||++|||+.|+|+||||....
T Consensus 273 ~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 273 KNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CChhhCcCHHHHhcChhhhhcc
Confidence 9999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=338.69 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=200.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (599)
||+|+||.||++.++.+|+.||+|++...... ......+..|+.+|+.++||||+++.+++.. ...+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence 79999999999999999999999998642221 2223445679999999999999999998843 35799999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 110 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 110 ~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
. ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----ee
Confidence 8 58988886543 58899999999999999999999999999999999999999999999999987653321 12
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIW 266 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~ 266 (599)
....++..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.........+..
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR--------------------- 208 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---------------------
Confidence 34578999999999876 5699999999999999999999999976432111000000
Q ss_pred cCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCC
Q 007542 267 CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 346 (599)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~R 346 (599)
..+ . . ........+++++.+||.+||+.||.+|
T Consensus 209 ----------------------------------------~~~----~-~--~~~~~~~~~~~~~~~li~~~L~~~P~~R 241 (277)
T cd05607 209 ----------------------------------------RTL----E-D--EVKFEHQNFTEESKDICRLFLAKKPEDR 241 (277)
T ss_pred ----------------------------------------Hhh----c-c--ccccccccCCHHHHHHHHHHhccCHhhC
Confidence 000 0 0 0001123568889999999999999999
Q ss_pred CCH----HHHhcCccccCCc
Q 007542 347 PTA----EEALADPYFKGLA 362 (599)
Q Consensus 347 pTa----~e~L~HP~f~~~~ 362 (599)
||+ ++++.||||+++.
T Consensus 242 ~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 242 LGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred CCCccchhhhhcChhhcCCC
Confidence 999 7788999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=332.32 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=206.7
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 468999999999999999999999999999999864322 223446788999999999999999999987542 22
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+|+||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 47899999998 58999998887899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
............++..|+|||.+.+ ..++.++||||+||++++|++|+.||........+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~---~~~-------- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA---TQP-------- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh---cCC--------
Confidence 2111111233467889999999876 578899999999999999999999997543222111110 000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.. .......++.+.+|| +|
T Consensus 226 ---------------------------------------------------------~~---~~~~~~~~~~~~~li-~~ 244 (266)
T cd06651 226 ---------------------------------------------------------TN---PQLPSHISEHARDFL-GC 244 (266)
T ss_pred ---------------------------------------------------------CC---CCCchhcCHHHHHHH-HH
Confidence 00 011123567788899 67
Q ss_pred cccCCCCCCCHHHHhcCcccc
Q 007542 339 LAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~ 359 (599)
|..||++|||++|+|+||||+
T Consensus 245 ~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 245 IFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hcCChhhCcCHHHHhcCcccc
Confidence 778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=353.60 Aligned_cols=262 Identities=28% Similarity=0.450 Sum_probs=208.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~ 99 (599)
.+..|++++.||+|+.+.||++.. .....||+|++.....+...+..+.+||.+|.+|+ |.+||+|+++=.. +
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d 432 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----D 432 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----C
Confidence 357899999999999999999975 34567788888766667778889999999999996 9999999998754 3
Q ss_pred ccEEEEEecCCccHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELMESDLHQVIKANDDL-TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l-se~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+++||||||-+.||..+|++.... ..-.++++.+|||.|++++|.+||||.||||.|+|+- .|.+||+|||.|..+..
T Consensus 433 ~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 433 GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 589999999999999999887543 3348899999999999999999999999999999875 68999999999998755
Q ss_pred CCCCcccccccccCccccCccccccccC---------CCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFS---------KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~---------~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
++ +.+.-...+||..||+||.+..... +.+.++||||||||||+|+.|++||.. ...++.++..+..
T Consensus 512 DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--~~n~~aKl~aI~~- 587 (677)
T KOG0596|consen 512 DT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--IINQIAKLHAITD- 587 (677)
T ss_pred cc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--HHHHHHHHHhhcC-
Confidence 43 3445567899999999998754211 256789999999999999999999953 1122222221110
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC-
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN- 328 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s- 328 (599)
....+. ||..+
T Consensus 588 ----------------------------------------------------------------P~~~Ie----fp~~~~ 599 (677)
T KOG0596|consen 588 ----------------------------------------------------------------PNHEIE----FPDIPE 599 (677)
T ss_pred ----------------------------------------------------------------CCcccc----ccCCCC
Confidence 001112 23322
Q ss_pred -HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 329 -PLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 329 -~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+++++++.||.+||++|||+.|+|+|||++..
T Consensus 600 ~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 600 NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 239999999999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.61 Aligned_cols=306 Identities=30% Similarity=0.471 Sum_probs=232.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC------CCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH------PDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H------pnIv~l~~v~~~~s 95 (599)
.++|.+....|+|-|++|..|.|..-|..||||+|.+ +....+.=++|+.||++|+. -++++|+..|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--- 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--- 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh---
Confidence 5899999999999999999999999999999999974 23333445689999999963 36888888874
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-Cceeeeccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 171 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFG 171 (599)
..+++|||||-+.-+|.++++.-| +|....++.|++||+-||+.|...||+|.||||+||||+.. ..+||||||
T Consensus 505 --hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 505 --HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred --hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 346899999999999999999765 68899999999999999999999999999999999999986 568999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
.|..+.... .+.|..++.|+|||++.| -.|+..+|+||+||+||||.||+.+|+|..+.+.+...+++-|..+
T Consensus 583 SA~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 583 SASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 998764332 478999999999999998 6899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHH-HHHHHHhcccCCCCCCcCCCCC----
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEK-ARRYLSSMRKKKPIPFSQKFPN---- 326 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~---- 326 (599)
...+.+....-.| ++..++-+.-...++.. .+-... +.+-+ .+++...+... +.++.
T Consensus 656 ~KmlRKgqF~dqH----FD~d~nf~~~e~D~vT~-----r~~~~v---m~~vkPtkdl~s~l~~~------q~~~deq~~ 717 (752)
T KOG0670|consen 656 NKMLRKGQFKDQH----FDQDLNFLYIEVDKVTE-----REKRTV---MVNVKPTKDLGSELIAV------QRLPDEQPK 717 (752)
T ss_pred HHHhhhcchhhhh----cccccceEEEecccccc-----ceeEEE---ecccCcchhHHHHHhcc------CCCCchhHH
Confidence 8888763222111 11111100000000000 000000 00000 01111111110 11122
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
.-..+.+||.+||..||++|+|..+||.||||++
T Consensus 718 ~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 718 IVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 2246789999999999999999999999999974
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.01 Aligned_cols=262 Identities=25% Similarity=0.432 Sum_probs=213.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++.+.||+|++|.||+|.+..+++.||||.+...... ......+.+|+.+|+.++|+||+++++.+. +...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence 4799999999999999999999999999999999753222 235567889999999999999999999984 3357
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999998 5999998764 4789999999999999999999999999999999999999999999999999875432
Q ss_pred CCCC--------------------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 007542 179 DTPT--------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 179 ~~~~--------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
.... .......+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 2110 001123578899999999876 568899999999999999999999998
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhc
Q 007542 233 GKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312 (599)
Q Consensus 233 g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~ 312 (599)
+.+....+..+...
T Consensus 234 ~~~~~~~~~~~~~~------------------------------------------------------------------ 247 (316)
T cd05574 234 GSNRDETFSNILKK------------------------------------------------------------------ 247 (316)
T ss_pred CCchHHHHHHHhcC------------------------------------------------------------------
Confidence 87654443322210
Q ss_pred ccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCccccCCc
Q 007542 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT----AEEALADPYFKGLA 362 (599)
Q Consensus 313 ~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpT----a~e~L~HP~f~~~~ 362 (599)
...+. .....++.+.+||++||..||++||| ++|+|.||||++..
T Consensus 248 ----~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 248 ----EVTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred ----CccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 00000 11226788999999999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=346.15 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=198.7
Q ss_pred CCceEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++.++||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 36899999999999999999975 2456789999986432 233456788999999999 899999999988532
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (599)
...+|+||||++ |+|.+++...
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 236899999999 6999998753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccC
Q 007542 121 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192 (599)
Q Consensus 121 --------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt 192 (599)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... ........++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-hhcccCCCCC
Confidence 2377888899999999999999999999999999999999999999999999976532211 1111233456
Q ss_pred ccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCC
Q 007542 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDG 271 (599)
Q Consensus 193 ~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~ 271 (599)
..|+|||++.+ ..++.++|||||||++|||++ |.+||.+......+.....
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-------------------------- 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK-------------------------- 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh--------------------------
Confidence 78999999876 578999999999999999997 9999987543222111100
Q ss_pred CcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 007542 272 FMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE 351 (599)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e 351 (599)
.... .......++.+.+||.+||+.||.+|||+.|
T Consensus 292 ------------------------------------------~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 292 ------------------------------------------DGTR---MRAPENATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred ------------------------------------------cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 0000 0011346788999999999999999999999
Q ss_pred Hhc
Q 007542 352 ALA 354 (599)
Q Consensus 352 ~L~ 354 (599)
+++
T Consensus 327 l~~ 329 (338)
T cd05102 327 LVE 329 (338)
T ss_pred HHH
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=335.46 Aligned_cols=261 Identities=24% Similarity=0.425 Sum_probs=209.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+|+.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeE
Confidence 47899999999999999999999999999999986432 23345678899999999999999999998854 3579
Q ss_pred EEEEecCCc-cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 103 YVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999995 898888763 378999999999999999999996 599999999999999999999999999987643
Q ss_pred CCCCCcccccccccCccccCcccccccc----CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
... .....++..|+|||.+.+.. ..++.++||||+||++++|++|+.||...........+.....
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 224 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD----- 224 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh-----
Confidence 221 12346788999999885421 2357899999999999999999999976543222222111110
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
. ......+.+++++.+
T Consensus 225 -------------------------------------------------------------~---~~~~~~~~~~~~~~~ 240 (286)
T cd06622 225 -------------------------------------------------------------G---DPPTLPSGYSDDAQD 240 (286)
T ss_pred -------------------------------------------------------------c---CCCCCCcccCHHHHH
Confidence 0 011223457888999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
||.+||..||.+||+++++++||||.....
T Consensus 241 li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 241 FVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred HHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.43 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=208.1
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------hhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-------SDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~-------~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
+|.+...||+|++|.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.++||||+++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 5888999999999999999999999999999886432221 123567899999999999999999998843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+.|++||||+|+|||++.++.++|+|||+++.
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 347899999998 59999998888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCc---ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 176 AFNDTPTA---IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 176 ~~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
........ .......++..|+|||.+.+ ..++.++|+||+||++++|++|+.||.+.+....+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN------ 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc------
Confidence 64221111 11123467889999999876 57889999999999999999999999875433222111100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
.........+..+.
T Consensus 228 ------------------------------------------------------------------~~~~~~~~~~~~~~ 241 (267)
T cd06628 228 ------------------------------------------------------------------ASPEIPSNISSEAI 241 (267)
T ss_pred ------------------------------------------------------------------CCCcCCcccCHHHH
Confidence 00011134677899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
+||++||+.||.+|||+.|+|+||||
T Consensus 242 ~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 242 DFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=365.88 Aligned_cols=287 Identities=24% Similarity=0.287 Sum_probs=205.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCC-cEEEEEEe--------------cC-ccCChhhHHHHHHHHHHHHhcCCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKI--------------ND-IFEHVSDATRILREIKLLRLLRHPDIV 85 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg-~~VAIK~i--------------~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (599)
.++|++++.||+|+||.||+|..+... ..+++|.+ .+ ..........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998765432 22222211 11 111222345678999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCCccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 86 EIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~-----~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
++++++.. ....|+|++++.++|..++.... ......++.++.||+.||.|||++||+||||||+|||++
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 99999843 34689999999999988875432 234667889999999999999999999999999999999
Q ss_pred CCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC---CChh
Q 007542 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG---KNVV 237 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g---~~~~ 237 (599)
.++.+||+|||+++....... ......+||..|+|||++.+ ..|+.++|||||||++|||++|..++.+ .+..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999986543221 11234689999999999977 6799999999999999999998754332 2345
Q ss_pred hHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc-CC
Q 007542 238 HQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK-KK 316 (599)
Q Consensus 238 ~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~-~~ 316 (599)
.++..+...++.+..+..... ....+++..... ..
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~--------------------------------------------~~~~~~i~~~~~~~~ 413 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPP--------------------------------------------CKLFDYIDSAEIDHA 413 (501)
T ss_pred HHHHHHHHhcccChhhcCCcH--------------------------------------------HHHHHHhhhhhcccC
Confidence 566666665554332211000 001111111100 00
Q ss_pred CCCCcCCC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 317 PIPFSQKF--PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 317 ~~~~~~~~--~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+..+...+ ...+..+.+||.+||++||.+|||+.|+|+||||...
T Consensus 414 ~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 414 GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 00111111 1256678999999999999999999999999999764
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.69 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=207.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC----ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~----~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
+|++.+.||+|+||.||+|.+ .+|+.+|||.+..... .......+.+|+.+|+.++|+||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-----D 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-----C
Confidence 588999999999999999986 5889999998864321 12234568899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+|+||+. ++|.+++.+.+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 57999999998 59999998888899999999999999999999999999999999999999999999999999876421
Q ss_pred CC---CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 179 DT---PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 179 ~~---~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.. ..........++..|+|||.+.+ ..++.++|+|||||++++|++|..||...+.......+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG------- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-------
Confidence 11 11112234578999999999876 6788999999999999999999999976543322211111000
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.........+..+.+||
T Consensus 226 ---------------------------------------------------------------~~~~~~~~~~~~~~~~i 242 (265)
T cd06631 226 ---------------------------------------------------------------LMPRLPDSFSAAAIDFV 242 (265)
T ss_pred ---------------------------------------------------------------CCCCCCCCCCHHHHHHH
Confidence 01112234678899999
Q ss_pred HHhcccCCCCCCCHHHHhcCccc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
++||..||.+|||+.|+|+||||
T Consensus 243 ~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 243 TSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.74 Aligned_cols=264 Identities=23% Similarity=0.389 Sum_probs=211.6
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
....+.|++++.||+|+||.||+|.+..++..|++|.+... .......+.+|+.+++.++|+||+++++.+...
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 81 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD---- 81 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC----
Confidence 45568899999999999999999999999999999998642 334567788999999999999999999998433
Q ss_pred CccEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
..+|+||||+.+ +|..++.+ ...+++..++.++.||+.+|.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 82 -GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred -CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 479999999995 77777754 457899999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
..... ......++..|+|||++.+. ...++.++|+|||||++|+|++|++||.+.+....+..+.. ..
T Consensus 161 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~--- 231 (292)
T cd06644 161 VKTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SE--- 231 (292)
T ss_pred ccccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CC---
Confidence 22211 12345678899999988421 13478899999999999999999999976553322221110 00
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.+........+..+.+
T Consensus 232 ----------------------------------------------------------------~~~~~~~~~~~~~~~~ 247 (292)
T cd06644 232 ----------------------------------------------------------------PPTLSQPSKWSMEFRD 247 (292)
T ss_pred ----------------------------------------------------------------CccCCCCcccCHHHHH
Confidence 0000112346678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
||.+||..||++||+++|+|+||||..+.
T Consensus 248 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 248 FLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 99999999999999999999999998764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=332.37 Aligned_cols=260 Identities=23% Similarity=0.412 Sum_probs=207.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcC-CC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR-EF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~-~~ 99 (599)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++.+...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 567999999999999999999999999999999986432 2345678999999998 699999999998654322 13
Q ss_pred ccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999 5999998864 36899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
..... ......++..|+|||++.+. ...++.++||||+||++|+|++|..||...........+..
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~-------- 230 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-------- 230 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--------
Confidence 32211 12345788999999998531 13588899999999999999999999965432221111100
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.... .......+..+.+
T Consensus 231 -------------------------------------------------------------~~~~--~~~~~~~~~~~~~ 247 (272)
T cd06637 231 -------------------------------------------------------------NPAP--RLKSKKWSKKFQS 247 (272)
T ss_pred -------------------------------------------------------------CCCC--CCCCCCcCHHHHH
Confidence 0000 0011245678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
||.+||..||.+|||+.|+|.||||
T Consensus 248 li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 248 FIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=325.32 Aligned_cols=255 Identities=32% Similarity=0.523 Sum_probs=211.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++++.||.|+||.||+|.+..++..||+|.+............+.+|+.+++.++|+||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999875544555667888999999999999999999987543 234689
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhh-----hCceEeccCCCCceEecCCCceeeeccccc
Q 007542 104 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIH-----TANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLH-----s~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
+||||+. ++|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||+|+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 589999875 357899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
........ ......++..|+|||.+.+ ..++.++|+|||||++++|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-------- 224 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc--------
Confidence 87543221 1234578999999999876 5688999999999999999999999987653332222111
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
. .+.......+..+.+
T Consensus 225 -------------------------------------------------------------~---~~~~~~~~~~~~~~~ 240 (265)
T cd08217 225 -------------------------------------------------------------G---KFRRIPYRYSSELNE 240 (265)
T ss_pred -------------------------------------------------------------C---CCCCCccccCHHHHH
Confidence 0 011112346788999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
||.+||..||.+|||+.++|+|||+
T Consensus 241 l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 241 VIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=352.97 Aligned_cols=260 Identities=28% Similarity=0.554 Sum_probs=217.5
Q ss_pred CCCCceEEE--EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 20 GEGSRYKIE--EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 20 ~~~~rY~i~--~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.+..-|+|. ++||+|-||+||-|.++++|+.||||+|++..-.......+.+|+.||+.+.||.||.+.-.|.++
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~--- 635 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP--- 635 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC---
Confidence 334556664 799999999999999999999999999986444444557788999999999999999998888544
Q ss_pred CCccEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC---Cceeeecccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGL 172 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~---~~lKL~DFGl 172 (599)
..+++|||.+.||+.+.|.+ .++|++..-++++.||+.||+|||-.||+|+||||+|||+... -.+||||||+
T Consensus 636 --ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 636 --ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred --ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccc
Confidence 46999999999999888865 4689999999999999999999999999999999999999765 4599999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
||.+.+.. +....+||+.|+|||++.. ..|+..-||||+|+|+|.-|.|.-||..+.+++ ++|.+.-..
T Consensus 714 ARiIgEks----FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFM--- 782 (888)
T KOG4236|consen 714 ARIIGEKS----FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFM--- 782 (888)
T ss_pred eeecchhh----hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccchh--HHhhccccc---
Confidence 99976543 4467899999999999987 789999999999999999999998886554332 223221100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
..+ ..|..++++|+
T Consensus 783 --------------------------------------------------------------yPp----~PW~eis~~Ai 796 (888)
T KOG4236|consen 783 --------------------------------------------------------------YPP----NPWSEISPEAI 796 (888)
T ss_pred --------------------------------------------------------------cCC----CchhhcCHHHH
Confidence 011 22456889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|||..+|+..-.+|.|++..|.|||+++.
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999975
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.65 Aligned_cols=261 Identities=27% Similarity=0.451 Sum_probs=225.9
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
...-|.+.+.||+|.|++|.+|++..|+..||||.|++...+......+.+|+++|+.|+|||||+++.++.. ..
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-----~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-----EA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-----cc
Confidence 3567999999999999999999999999999999999888888877889999999999999999999999944 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. |++++++.+++.+.+..++.++.|+++|++|||+++|||||||.+|||++.+.++||+|||++..+..+
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 7999999998 699999999999999999999999999999999999999999999999999999999999999887533
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ...+++|++.|.|||+..+. ...++.+|+||+|++||.|+.|..||.|.+....-...
T Consensus 209 ~----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------- 267 (596)
T KOG0586|consen 209 L----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------- 267 (596)
T ss_pred c----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh----------------
Confidence 2 45678999999999999884 45578999999999999999999999997643321110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
+..+..++ --++.++.+||++||
T Consensus 268 ----------------------------------------------------l~gk~rIp-----~~ms~dce~lLrk~l 290 (596)
T KOG0586|consen 268 ----------------------------------------------------LRGKYRIP-----FYMSCDCEDLLRKFL 290 (596)
T ss_pred ----------------------------------------------------eeeeeccc-----ceeechhHHHHHHhh
Confidence 01111111 125677999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCccC
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
..+|.+|++.+++..|.|.......
T Consensus 291 vl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 291 VLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999876544
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.52 Aligned_cols=261 Identities=25% Similarity=0.449 Sum_probs=208.8
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~----~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
+|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+|+.++|+||+++++++. +.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence 488889999999999999999999999999998643221 123467889999999999999999999984 33
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-ceeeeccccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-~lKL~DFGla~~~~ 177 (599)
..+++|+||+. ++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 57899999999 58999998888899999999999999999999999999999999999998776 59999999987654
Q ss_pred CCCCCc-ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
...... .......++..|+|||.+.+ ..++.++|+||+||++++|++|+.||...+.......+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 224 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA--------- 224 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh---------
Confidence 322111 11123467889999999876 578899999999999999999999997554332222221100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.. ..........++.+.+||.
T Consensus 225 ---------------------------------------------------------~~--~~~~~~~~~~~~~~~~~i~ 245 (268)
T cd06630 225 ---------------------------------------------------------SA--TTAPSIPEHLSPGLRDVTL 245 (268)
T ss_pred ---------------------------------------------------------cc--CCCCCCchhhCHHHHHHHH
Confidence 00 0001112346788999999
Q ss_pred HhcccCCCCCCCHHHHhcCcccc
Q 007542 337 RMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
+||..||.+|||+.|+|+||||+
T Consensus 246 ~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 246 RCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=324.59 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=212.8
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|+++++||.|+||.||.+.+..+++.|++|.+............+.+|+.+|+.++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 6999999999999999999999999999999987554445556778899999999999999999999954 35799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||+. ++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 5999999775 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ......++..|+|||.+.+ ..++.++|+||+||++++|++|..+|.+.+..+....+.. |.
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~----------- 217 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GN----------- 217 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CC-----------
Confidence 1 2244578999999999876 5688899999999999999999999987665443333321 10
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
+....+..+..+.+||.+||.
T Consensus 218 -----------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 218 -----------------------------------------------------------YTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred -----------------------------------------------------------CCCCccccCHHHHHHHHHHcc
Confidence 001114567889999999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q 007542 341 FEPKDRPTAEEALADPYF 358 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f 358 (599)
.||.+|||+.++|+|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=333.58 Aligned_cols=259 Identities=29% Similarity=0.510 Sum_probs=213.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
...+|++.+.||.|++|.||+|++..+++.|+||.+... .......+.+|+.+++.++|+||+++++.+.. ..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 89 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GD 89 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----Cc
Confidence 457899999999999999999999999999999998642 23345678899999999999999999999843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+|+||+. ++|.+++... .+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 7999999998 5888887654 6899999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+... +.
T Consensus 169 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~---------- 232 (296)
T cd06655 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT---------- 232 (296)
T ss_pred cc---cCCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC----------
Confidence 21 1133468889999999876 56889999999999999999999999887654433222110 00
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
+........++.+.+||++||
T Consensus 233 -----------------------------------------------------------~~~~~~~~~~~~~~~li~~~l 253 (296)
T cd06655 233 -----------------------------------------------------------PELQNPEKLSPIFRDFLNRCL 253 (296)
T ss_pred -----------------------------------------------------------cccCCcccCCHHHHHHHHHHh
Confidence 001112346788999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCc
Q 007542 340 AFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
..||.+|||+.++|.||||....
T Consensus 254 ~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 254 EMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred hcChhhCCCHHHHhhChHhhhcc
Confidence 99999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=331.02 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=208.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +|||++++++++........
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 368899999999999999999999999999999998642 12345677899999998 79999999999865433334
Q ss_pred ccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 57899999998 589888753 3578999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcccccccccCccccCcccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
........ .....++..|+|||++.... ..++.++||||+|||+++|++|++||...+....+..+.. .+
T Consensus 177 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~- 249 (291)
T cd06639 177 QLTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NP- 249 (291)
T ss_pred hccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CC-
Confidence 65322211 12346888999999875421 2368899999999999999999999976554333222211 00
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
...+ ......+..+
T Consensus 250 -----------------------------------------------------------------~~~~-~~~~~~~~~l 263 (291)
T cd06639 250 -----------------------------------------------------------------PPTL-LHPEKWCRSF 263 (291)
T ss_pred -----------------------------------------------------------------CCCC-CcccccCHHH
Confidence 0000 0012345678
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
.+||.+||+.||.+|||+.|+|+||||+
T Consensus 264 ~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 264 NHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=334.62 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=212.0
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.+...+|++++.||+|++|.||+|++..++..||+|.+.... ......+.+|+.+++.+.|+||+++++.+..
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~----- 88 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV----- 88 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----
Confidence 345689999999999999999999999999999999986432 2345678899999999999999999998853
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 347899999998 589998865 468999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......++..|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+....+..+.. .+.
T Consensus 168 ~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~-------- 233 (296)
T cd06654 168 PEQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGT-------- 233 (296)
T ss_pred cccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCC--------
Confidence 2211 1234578899999999876 5688999999999999999999999977654332211110 000
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
+.......+++.+.+||.+
T Consensus 234 -------------------------------------------------------------~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 234 -------------------------------------------------------------PELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred -------------------------------------------------------------CCCCCccccCHHHHHHHHH
Confidence 0001123466789999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||..||.+|||+.++|+||||...
T Consensus 253 ~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=332.21 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=208.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++.+.. .
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~ 78 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----R 78 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----C
Confidence 4456899999999999999999999999999999998643 22344567789999999999999999998843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 57899999999 59999998888999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ......++..|+|||++.. ....++.++|+|||||++|+|++|.+||........+..+...
T Consensus 159 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~----------- 224 (267)
T cd06645 159 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS----------- 224 (267)
T ss_pred ccc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-----------
Confidence 211 1234578999999998742 1145888999999999999999999998654422211111000
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
...+..+ .....++..+.+||.+
T Consensus 225 --------------------------------------------------------~~~~~~~-~~~~~~~~~~~~li~~ 247 (267)
T cd06645 225 --------------------------------------------------------NFQPPKL-KDKMKWSNSFHHFVKM 247 (267)
T ss_pred --------------------------------------------------------CCCCCcc-cccCCCCHHHHHHHHH
Confidence 0000000 0112356779999999
Q ss_pred hcccCCCCCCCHHHHhcCcc
Q 007542 338 MLAFEPKDRPTAEEALADPY 357 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~ 357 (599)
||..||++|||++++|+|||
T Consensus 248 ~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 248 ALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HccCCchhCcCHHHHhcCCC
Confidence 99999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=341.00 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=217.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.-|.++++||+|+||.||+|+|+.+|..||||++.- ..+.+.|..||.+|++++.|++|++++.|+-. .++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDL 103 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDL 103 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----Cce
Confidence 457889999999999999999999999999999853 46789999999999999999999999988543 479
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 103 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
|||||||+ |+..++++. +.+|+|+++..+++..+.||.|||...-||||||..|||++.+|..||+|||.|.......
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999999 899999975 4589999999999999999999999999999999999999999999999999997664322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ...+.+||+.|||||++.. -.|+..+||||||++..||.-|+|||.+-.....+.+| --
T Consensus 184 A---KRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT------------ 243 (502)
T KOG0574|consen 184 A---KRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PT------------ 243 (502)
T ss_pred H---hhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cC------------
Confidence 2 2256789999999999987 68999999999999999999999999765443322111 11
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
.|.+.......+|.++.||+++||.
T Consensus 244 -------------------------------------------------------~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 244 -------------------------------------------------------KPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred -------------------------------------------------------CCCCCCCChHhhhhHHHHHHHHHhc
Confidence 2222222223467889999999999
Q ss_pred cCCCCCCCHHHHhcCccccCC
Q 007542 341 FEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+|++|-||.++++|||+++-
T Consensus 269 K~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 269 KKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred CCHHHHHHHHHHhhhhhhcCC
Confidence 999999999999999999864
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=326.25 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=207.5
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..|++.+.||+|+||.||+|.+..+|..||||++..... .......+.+|+.+++.++||||+++++++.... .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 579999999999999999999999999999998853221 1233567889999999999999999999874321 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 46889999998 59999998877899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
............++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC--------
Confidence 1111111234568889999999876 578899999999999999999999997643332221111 000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
. .....+..+..+.++|.+|
T Consensus 226 ----------------------------------------------------------~--~~~~~~~~~~~~~~~i~~~ 245 (265)
T cd06652 226 ----------------------------------------------------------T--NPVLPPHVSDHCRDFLKRI 245 (265)
T ss_pred ----------------------------------------------------------C--CCCCchhhCHHHHHHHHHH
Confidence 0 0001124567789999999
Q ss_pred cccCCCCCCCHHHHhcCcccc
Q 007542 339 LAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~ 359 (599)
|. +|++|||++|+|+|||+.
T Consensus 246 l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 246 FV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hc-ChhhCCCHHHHhcCcccC
Confidence 95 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.23 Aligned_cols=297 Identities=29% Similarity=0.460 Sum_probs=219.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-----C---CCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----H---PDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-----H---pnIv~l~~v~~~ 93 (599)
+.||.++++||.|.|++||+|+|..+.+.||+|+++.. ....+..+.||++|+.++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 48999999999999999999999999999999998732 223455678999999984 3 359999999976
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCC--------
Q 007542 94 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD-------- 162 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~-------- 162 (599)
.. ....+++||||+++.+|..+|+.. .+++...++.|++|||.||.|||.. ||||.||||+|||+..+
T Consensus 154 sG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 54 456799999999999999999875 4799999999999999999999976 99999999999996210
Q ss_pred --------------------------------------------------------------------------------
Q 007542 163 -------------------------------------------------------------------------------- 162 (599)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (599)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 007542 163 ------------------------------------------------------------------------------CK 164 (599)
Q Consensus 163 ------------------------------------------------------------------------------~~ 164 (599)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 00
Q ss_pred eeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC------hhh
Q 007542 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN------VVH 238 (599)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~------~~~ 238 (599)
+||+|||-|.-. ...+|.-+.|+.|+|||++.+ ..|++.+||||++|+++||+||..+|...+ +.+
T Consensus 393 vKIaDlGNACW~------~khFT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 393 VKIADLGNACWV------HKHFTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred EEEeeccchhhh------hhhhchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 233333332111 112355678999999999998 799999999999999999999999997553 678
Q ss_pred HHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCC---cccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 239 QLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGF---MCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 239 ~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
++.+|++++|..+...+....-.-. ++.-.+. +.++.+|. +.+++..+-.+..
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRd--FFnr~G~LrhI~~LK~Wp---------L~~VL~eKY~~s~------------- 520 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRD--FFNRRGELRHIRRLKPWP---------LYEVLIEKYEWSE------------- 520 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHh--hhccccceecccccCCCc---------HHHHHHHHhCCCH-------------
Confidence 9999999999998876543110000 0000000 11111111 1111111100111
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
....++.|||.-||+++|++|+||.++|+|||+..+..+
T Consensus 521 ----------e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 521 ----------EDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred ----------HHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 112356789999999999999999999999999987654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=331.44 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=207.2
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
+..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~ 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----R 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----C
Confidence 4567899999999999999999999999999999998643 22344567899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 47899999999 58999998888899999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ......++..|+|||.+.. ....++.++|+||+||++++|++|++||...+.......+...
T Consensus 159 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 224 (267)
T cd06646 159 TIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS----------- 224 (267)
T ss_pred ccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-----------
Confidence 211 1134568889999998742 1145788999999999999999999998644322111100000
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
...+ +.......++..+.+||++
T Consensus 225 --------------------------------------------------------~~~~-~~~~~~~~~~~~~~~li~~ 247 (267)
T cd06646 225 --------------------------------------------------------NFQP-PKLKDKTKWSSTFHNFVKI 247 (267)
T ss_pred --------------------------------------------------------CCCC-CCCccccccCHHHHHHHHH
Confidence 0000 0001112467889999999
Q ss_pred hcccCCCCCCCHHHHhcCcc
Q 007542 338 MLAFEPKDRPTAEEALADPY 357 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~ 357 (599)
||..||++|||++++|+|+|
T Consensus 248 ~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 248 SLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.08 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=208.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|+||.||+|.+..+++.||||.+............+.+|+.+|+.++||||+++++.+.. ...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 6999999999999999999999999999999997544444556788899999999999999999998843 34789
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-CceeeecccccccccCC
Q 007542 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFND 179 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFGla~~~~~~ 179 (599)
+||||+. ++|.+++... ..+++..+..++.|++.+|.|||++||+|+||+|+||+++.+ +.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5999999764 358999999999999999999999999999999999999865 45899999999875432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. .....++..|+|||.+.+ ..++.++||||+||++++|++|+.+|.+.+.......+...
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~------------- 216 (256)
T cd08220 156 SK----AYTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG------------- 216 (256)
T ss_pred cc----ccccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-------------
Confidence 21 123568889999999876 56889999999999999999999999876544333222110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.........++.+.+||.+||
T Consensus 217 -----------------------------------------------------------~~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 217 -----------------------------------------------------------TFAPISDRYSPDLRQLILSML 237 (256)
T ss_pred -----------------------------------------------------------CCCCCCCCcCHHHHHHHHHHc
Confidence 000111246778999999999
Q ss_pred ccCCCCCCCHHHHhcCccc
Q 007542 340 AFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f 358 (599)
..||.+|||+.|+|+||||
T Consensus 238 ~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 238 NLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred cCChhhCCCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=331.81 Aligned_cols=269 Identities=23% Similarity=0.414 Sum_probs=211.6
Q ss_pred cccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceee
Q 007542 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHIL 91 (599)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~ 91 (599)
.+........+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+..|+.+++.+ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 34444455678999999999999999999999999999999988542 23345678899999888 699999999998
Q ss_pred cCCCc-CCCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceee
Q 007542 92 LPPSR-REFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 92 ~~~s~-~~~~~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL 167 (599)
..... .....+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 64321 23457899999998 5999988763 35889999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~ 244 (599)
+|||++........ ......++..|+|||.+... ...++.++|+|||||++|+|++|.+||........+..+.
T Consensus 163 ~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 163 VDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred eeCcchhhhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 99999875432111 12345788999999987521 1457889999999999999999999997644322211110
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
. .. ...-..
T Consensus 240 ~---------------------------------------------------------------------~~--~~~~~~ 248 (282)
T cd06636 240 R---------------------------------------------------------------------NP--PPKLKS 248 (282)
T ss_pred h---------------------------------------------------------------------CC--CCCCcc
Confidence 0 00 000111
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
...+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 2467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.22 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=210.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++.+.+... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeE
Confidence 47999999999999999999999999999999986432 233456688999999999999999999988533 579
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+|+||+. ++|.+++... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5899998875 799999999999999999999999999999999999999999999999999987643321
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++..|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+.......+...
T Consensus 154 ---~~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------------- 213 (274)
T cd06609 154 ---KRNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--------------- 213 (274)
T ss_pred ---ccccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc---------------
Confidence 1234578889999999977 56899999999999999999999999765533222211110
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
.+..+. ...+++.+.+||.+||..
T Consensus 214 ------------------------------------------------------~~~~~~--~~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 214 ------------------------------------------------------NPPSLE--GNKFSKPFKDFVSLCLNK 237 (274)
T ss_pred ------------------------------------------------------CCCCCc--ccccCHHHHHHHHHHhhC
Confidence 000000 012677899999999999
Q ss_pred CCCCCCCHHHHhcCccccCC
Q 007542 342 EPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~ 361 (599)
||++|||++++|+||||...
T Consensus 238 ~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 238 DPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ChhhCcCHHHHhhChhhcCC
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=333.60 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=211.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+.|++++.||+|+||.||+|.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence 469999999999999999999999999999999864322 2234567889999999999999999999884 3357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 899999998 5999999888889999999999999999999999999999999999999999999999999987421110
Q ss_pred CC------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 007542 181 PT------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (599)
Q Consensus 181 ~~------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg 248 (599)
.. ........++..|+|||.+.. ..++.++|+|||||++++|++|..||.+.+....+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~- 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD- 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Confidence 00 001123467888999999876 578999999999999999999999998765443332221100
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
.......+..+
T Consensus 233 ---------------------------------------------------------------------~~~~~~~~~~~ 243 (305)
T cd05609 233 ---------------------------------------------------------------------IEWPEGDEALP 243 (305)
T ss_pred ---------------------------------------------------------------------cCCCCccccCC
Confidence 00001112467
Q ss_pred HHHHHHHHHhcccCCCCCCC---HHHHhcCccccCC
Q 007542 329 PLALRLLERMLAFEPKDRPT---AEEALADPYFKGL 361 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpT---a~e~L~HP~f~~~ 361 (599)
+.+.+||++||+.||++||| +.++|+||||...
T Consensus 244 ~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 244 ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred HHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 88999999999999999998 8999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=325.18 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=208.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||.|+||.||+|.+..+++.+++|++... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCE
Confidence 36899999999999999999999999999999998643 22356778899999999999999999998843 347
Q ss_pred EEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 9999999994 899988776 68999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ......++..|+|||++.+. ...++.++|+||+||++++|++|++||.+.+.......+...--.
T Consensus 155 ~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~--------- 222 (262)
T cd06613 155 IA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP--------- 222 (262)
T ss_pred hh---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---------
Confidence 21 12345788899999998651 126788999999999999999999999876644433222110000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
+ .........+..+.+||++|
T Consensus 223 ----------------------------------------------------------~-~~~~~~~~~~~~~~~li~~~ 243 (262)
T cd06613 223 ----------------------------------------------------------P-PKLKDKEKWSPVFHDFIKKC 243 (262)
T ss_pred ----------------------------------------------------------C-ccccchhhhhHHHHHHHHHH
Confidence 0 00001123456789999999
Q ss_pred cccCCCCCCCHHHHhcCcc
Q 007542 339 LAFEPKDRPTAEEALADPY 357 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~ 357 (599)
|..||..|||+.++|.|+|
T Consensus 244 l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 244 LTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred cCCChhhCCCHHHHhcCCC
Confidence 9999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=325.23 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=210.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||.|+||+||+|.+..++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEE
Confidence 47999999999999999999999999999999986433322 56778999999999999999999998843 3578
Q ss_pred EEEEecCC-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 103 YVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
|+|+|++. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5899999764 4589999999999999999999999999999999999999999999999999977643
Q ss_pred CCCCc-ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
..... ......+++..|+|||.+... ..++.++|+||+||++++|++|+.||...+....+..+... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~------ 224 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP------ 224 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC------
Confidence 32221 112344688999999998652 36889999999999999999999999765443322221110 00
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
........+...++.+.+||.+
T Consensus 225 ----------------------------------------------------------~~~~~~~~~~~~~~~~~~li~~ 246 (267)
T cd06610 225 ----------------------------------------------------------PSLETGADYKKYSKSFRKMISL 246 (267)
T ss_pred ----------------------------------------------------------CCcCCccccccccHHHHHHHHH
Confidence 0000011124567889999999
Q ss_pred hcccCCCCCCCHHHHhcCccc
Q 007542 338 MLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f 358 (599)
||..||.+|||++++|+||||
T Consensus 247 ~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 247 CLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=324.90 Aligned_cols=253 Identities=26% Similarity=0.472 Sum_probs=209.0
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|+||.||++.+..+|+.||||.+............+.+|+.+++.++|+||+++++++. +....|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence 699999999999999999999999999999998753333445567889999999999999999999884 335799
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 104 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 59999987643 57899999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
.. .....++..|+|||++.+ ..++.++|+||+||++++|++|+.||...+..+....+.. |.
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~----------- 217 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GS----------- 217 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CC-----------
Confidence 11 123467888999999876 5688899999999999999999999976554443322211 00
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
........+..+.+||.+||+
T Consensus 218 -----------------------------------------------------------~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 218 -----------------------------------------------------------YPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred -----------------------------------------------------------CCCCcccCCHHHHHHHHHHhh
Confidence 001113467789999999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q 007542 341 FEPKDRPTAEEALADPYF 358 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f 358 (599)
.||.+||++.++|+||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=335.16 Aligned_cols=260 Identities=29% Similarity=0.480 Sum_probs=212.1
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
+...+|++++.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++|+||+++++.+.. .
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~ 88 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLV-----G 88 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 4568999999999999999999999999999999998642 22344668899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 47899999998 589988865 4689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+....+..+.. .+.+
T Consensus 168 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-------- 233 (297)
T cd06656 168 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-------- 233 (297)
T ss_pred Ccc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC--------
Confidence 221 1234578899999999876 6788999999999999999999999977554322111100 0000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
........++.+.+||.+|
T Consensus 234 -------------------------------------------------------------~~~~~~~~~~~~~~li~~~ 252 (297)
T cd06656 234 -------------------------------------------------------------ELQNPERLSAVFRDFLNRC 252 (297)
T ss_pred -------------------------------------------------------------CCCCccccCHHHHHHHHHH
Confidence 0011124567789999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|..||.+|||++++|+||||....
T Consensus 253 l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 253 LEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ccCChhhCcCHHHHhcCchhcccc
Confidence 999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=330.90 Aligned_cols=258 Identities=25% Similarity=0.437 Sum_probs=203.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|+++++||+|+||.||+|++..+++.||+|.+.... .......+.+|+.+|+.++||||+++++.+... ...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEE
Confidence 46889999999999999999999999999999986432 233456788999999999999999999998543 468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
++||||+++ +|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999995 55433 357899999999999999999999999999999999999999999999999997653221
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
....+++..|+|||++.+ ..++.++|+||+||++|+|++|+.||........ .+....+
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---------~~~~~~~------ 208 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG---------SLMPLQL------ 208 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhccccc---------ccchHHH------
Confidence 234578999999999976 5789999999999999999999999965321110 0000000
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
...+....+.. ......++.+.+||.+||+.
T Consensus 209 -----------------------------------------------~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~ 239 (279)
T cd06619 209 -----------------------------------------------LQCIVDEDPPV--LPVGQFSEKFVHFITQCMRK 239 (279)
T ss_pred -----------------------------------------------HHHHhccCCCC--CCCCcCCHHHHHHHHHHhhC
Confidence 00000000000 01234678899999999999
Q ss_pred CCCCCCCHHHHhcCccccCC
Q 007542 342 EPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~ 361 (599)
||.+||+++|+|.||||...
T Consensus 240 ~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 240 QPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ChhhCCCHHHHhcCcccccc
Confidence 99999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=326.69 Aligned_cols=262 Identities=28% Similarity=0.462 Sum_probs=209.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCc-CC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR-RE 98 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~-~~ 98 (599)
..++|++.+.||+|++|.||+|.++.+++.|++|++.... .....+.+|+.+++.+ .|+||+++++++..... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 3589999999999999999999999999999999986432 2346788999999999 69999999999865442 23
Q ss_pred CccEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 99 FKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...+|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 4578999999994 88888764 357899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
........ ......++..|+|||++... ...++.++||||||||+++|++|++||.+.+....+..+... +
T Consensus 161 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~ 234 (275)
T cd06608 161 AQLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---P 234 (275)
T ss_pred eecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---C
Confidence 76533221 12345788999999987431 134778999999999999999999999765433332222110 0
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
...+ ......+..
T Consensus 235 ------------------------------------------------------------------~~~~-~~~~~~~~~ 247 (275)
T cd06608 235 ------------------------------------------------------------------PPTL-KSPENWSKK 247 (275)
T ss_pred ------------------------------------------------------------------CCCC-CchhhcCHH
Confidence 0000 001125678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
+.+||.+||..||.+|||++|+|+|||+
T Consensus 248 ~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 248 FNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=333.34 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=222.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-++|..+++||+|.||.|.+++.+.+|+.||||++++... .......-+.|-++|+..+||.+..|.-.|. ...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-----t~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ-----TQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc-----cCc
Confidence 3678889999999999999999999999999999986432 3445667789999999999999999988774 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||.. |.|+-.+.....++|+..+++...|+.||.|||+++||.||||.+|+|+|.+|++||.|||+++..
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--- 318 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--- 318 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc---
Confidence 7999999999 589999988889999999999999999999999999999999999999999999999999999753
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
........+.|||+.|+|||++.. ..|+.++|-|.+||++|||+||+.||..++....+++|...-
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------------ 384 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------------ 384 (516)
T ss_pred ccccceeccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh------------
Confidence 222223467899999999999988 789999999999999999999999999998887777664210
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
+ .....++++|+.||..+|
T Consensus 385 ----------------------------------------~---------------------kFPr~ls~eAktLLsGLL 403 (516)
T KOG0690|consen 385 ----------------------------------------L---------------------KFPRTLSPEAKTLLSGLL 403 (516)
T ss_pred ----------------------------------------c---------------------cCCccCCHHHHHHHHHHh
Confidence 0 011247899999999999
Q ss_pred ccCCCCCCC-----HHHHhcCccccCC
Q 007542 340 AFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
..||.+|.. |.|+.+|+||.++
T Consensus 404 ~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 404 KKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred hcChHhhcCCCchhHHHHHhhhhhccC
Confidence 999999974 8999999999986
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.41 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=210.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||.|+||.||+|.+..++..||+|.+.. ........+.+|+.+++.++|+||+++++.+.. ...
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCe
Confidence 4679999999999999999999999999999999863 234455678899999999999999999999854 347
Q ss_pred EEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+++ +|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 8999999995 899988764 47999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... .....++..|+|||++... ...++.++|+||+||++|+|++|++||.+.+....+..+.. +
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~-------- 223 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--S-------- 223 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--C--------
Confidence 211 1335688899999987421 13477899999999999999999999987654332222211 0
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.. +.......++..+.+||.
T Consensus 224 -----------------------------------------------------------~~-~~~~~~~~~~~~~~~li~ 243 (280)
T cd06611 224 -----------------------------------------------------------EP-PTLDQPSKWSSSFNDFLK 243 (280)
T ss_pred -----------------------------------------------------------CC-CCcCCcccCCHHHHHHHH
Confidence 00 000111246778999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||..||.+|||++++|+||||...
T Consensus 244 ~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 244 SCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=326.93 Aligned_cols=254 Identities=27% Similarity=0.465 Sum_probs=209.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+. +...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence 58999999999999999999999999999999975332 2245678889999999999999999999883 34579
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+|+||+. ++|.+++.....+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998 5999999887789999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++..|+|||++.. ..++.++|+||+||++|+|++|..||...+.... ..+..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~---------------- 212 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRA---------------- 212 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHH----------------
Confidence 1234567889999999876 5689999999999999999999999987653211 00000
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
.... ......+..+..+.+||.+||..
T Consensus 213 -------------------------------------------------~~~~----~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 213 -------------------------------------------------KQET----ADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred -------------------------------------------------Hhcc----ccccCcccCcHHHHHHHHHHccC
Confidence 0000 00011134568899999999999
Q ss_pred CCCCCCCH--HHHhcCccc
Q 007542 342 EPKDRPTA--EEALADPYF 358 (599)
Q Consensus 342 DP~~RpTa--~e~L~HP~f 358 (599)
||.+|+++ .|+++||||
T Consensus 240 ~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ChhHcCCccHHHHhcCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=329.00 Aligned_cols=258 Identities=25% Similarity=0.435 Sum_probs=203.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHH-HHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL-LRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~i-L~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||.||+|.++.+|+.||||+++...... ....+..|+.+ ++.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCc
Confidence 47999999999999999999999999999999987543332 33456667765 677789999999999843 346
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccc
Q 007542 102 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999998888764 24689999999999999999999997 9999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccc--cCCCCcchhhHhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~-~~~~l~~I~~~lg~p~~e 253 (599)
.... ..+...++..|+|||.+.+. ...++.++|+||+||++++|++|+.||.... ....+..+.
T Consensus 155 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 221 (283)
T cd06617 155 VDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------- 221 (283)
T ss_pred cccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---------
Confidence 3221 11234678899999987541 1346889999999999999999999986421 111111110
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
... ...+ ....++..+.+
T Consensus 222 --------------------------------------------------------~~~----~~~~--~~~~~~~~l~~ 239 (283)
T cd06617 222 --------------------------------------------------------EEP----SPQL--PAEKFSPEFQD 239 (283)
T ss_pred --------------------------------------------------------hcC----CCCC--CccccCHHHHH
Confidence 000 0000 01235788999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||.+||..||.+|||+.++|+||||...
T Consensus 240 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 240 FVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 9999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=329.09 Aligned_cols=257 Identities=23% Similarity=0.357 Sum_probs=206.8
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|++.+.||+|+||.||+|.+..++..+++|.+... .......+.+|+.+++.++|+||+++++.+... ...|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEE
Confidence 78889999999999999999999999999998642 234556788999999999999999999998543 46899
Q ss_pred EEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 105 VFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 105 V~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999999 578777754 45799999999999999999999999999999999999999999999999999876432211
Q ss_pred cccccccccCccccCcccccc---ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 183 AIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~---~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
......++..|+|||++.. ....++.++||||+||++++|++|++||.+.+.......+....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE------------ 224 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC------------
Confidence 1234568899999998742 11457789999999999999999999998765443322221100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
+.. ......++..+.+||.+||
T Consensus 225 ---------------------------------------------------------~~~-~~~~~~~~~~~~~li~~~l 246 (282)
T cd06643 225 ---------------------------------------------------------PPT-LAQPSRWSSEFKDFLKKCL 246 (282)
T ss_pred ---------------------------------------------------------CCC-CCCccccCHHHHHHHHHHc
Confidence 000 0011235678999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
..||.+|||++++|+||||...
T Consensus 247 ~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 247 EKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred cCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=348.42 Aligned_cols=264 Identities=28% Similarity=0.418 Sum_probs=219.2
Q ss_pred ccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 14 ~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
++|..-+-...|.=++.||.|+||.||.|+|..+.+.||||+++.... .......|+.|+.+|+.++|||++.+.++|.
T Consensus 17 ~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL 96 (948)
T KOG0577|consen 17 DLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL 96 (948)
T ss_pred HHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence 344444555778888999999999999999999999999999975433 3445678999999999999999999999997
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 93 PPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
-.. ..|||||||-|+-.+++.-. .++.+..|..|..+.+.||+|||+.+.||||||..|||+.+.|.|||+|||
T Consensus 97 re~-----TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFG 171 (948)
T KOG0577|consen 97 REH-----TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFG 171 (948)
T ss_pred ccc-----hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeecccc
Confidence 543 57999999998766666533 479999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
.|..... -.+.+||++|||||+|... ...|+-++||||||++..||.-.+||+-.-+-...+.-|...
T Consensus 172 SAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN---- 240 (948)
T KOG0577|consen 172 SASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---- 240 (948)
T ss_pred chhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc----
Confidence 9976532 2467999999999998542 256999999999999999999999988776666555544321
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
.+..+. -+.+|..
T Consensus 241 -----------------------------------------------------------------esPtLq--s~eWS~~ 253 (948)
T KOG0577|consen 241 -----------------------------------------------------------------ESPTLQ--SNEWSDY 253 (948)
T ss_pred -----------------------------------------------------------------CCCCCC--CchhHHH
Confidence 011111 2457888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+++|+..||+.-|.+|||.+++|.|+|+..
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 999999999999999999999999999864
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=321.87 Aligned_cols=261 Identities=31% Similarity=0.473 Sum_probs=210.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
||++.+.||+|+||.||+|.+..++..|++|.++...........+.+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence 6999999999999999999999999999999997544444467789999999999999999999998743 34789
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 104 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
+|+||+. ++|.+++.....+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 699999988778999999999999999999999999999999999999999999999999999876433222
Q ss_pred ccc-ccccccCccccCcccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 183 AIF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 183 ~~~-~~~~~gt~~Y~APE~l~~~~-~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
... .....++..|+|||++.+.. ..++.++||||+||++++|++|+.||.+.+........... +
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~------------ 222 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-G------------ 222 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-C------------
Confidence 111 22356788999999987621 23788999999999999999999999764321111100000 0
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
..+........++.+.+||.+||+
T Consensus 223 --------------------------------------------------------~~~~~~~~~~~~~~~~~li~~~l~ 246 (264)
T cd06626 223 --------------------------------------------------------HKPPIPDSLQLSPEGKDFLDRCLE 246 (264)
T ss_pred --------------------------------------------------------CCCCCCcccccCHHHHHHHHHHcc
Confidence 000011123457889999999999
Q ss_pred cCCCCCCCHHHHhcCccc
Q 007542 341 FEPKDRPTAEEALADPYF 358 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f 358 (599)
.||.+|||+.|++.|||+
T Consensus 247 ~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 247 SDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCcccCCCHHHHhcCCCC
Confidence 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=327.38 Aligned_cols=267 Identities=24% Similarity=0.414 Sum_probs=209.3
Q ss_pred ccccC-CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecC
Q 007542 16 FTEYG-EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (599)
Q Consensus 16 ~~~~~-~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~ 93 (599)
++.++ ..++|++++.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++.+ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34444 578999999999999999999999999999999988642 12235677899999999 69999999998865
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeee
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
........+|+||||++ ++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 43344567999999998 589888753 3468899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 007542 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245 (599)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~ 245 (599)
|||+++....... ......++..|+|||++... ...++.++||||+||++++|++|+.||.+.+....+..+..
T Consensus 167 dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 167 DFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred cCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 9999876532211 12344689999999987531 14578899999999999999999999976543322111100
Q ss_pred hcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC
Q 007542 246 LLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP 325 (599)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 325 (599)
...... ....
T Consensus 244 ---------------------------------------------------------------------~~~~~~-~~~~ 253 (286)
T cd06638 244 ---------------------------------------------------------------------NPPPTL-HQPE 253 (286)
T ss_pred ---------------------------------------------------------------------cCCCcc-cCCC
Confidence 000000 0011
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 326 NANPLALRLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 326 ~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
..+..+.+||.+||+.||.+|||+.|+|+|+||
T Consensus 254 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 246679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=321.43 Aligned_cols=254 Identities=28% Similarity=0.485 Sum_probs=208.1
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
+|+..+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++|+||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence 58888999999999999999998999999999864321 12345678899999999999999999998743 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+|+||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 7899999998 599999988878999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ......++..|++||.+... ..++.++|+||+||++++|++|++||...........+...
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------------- 217 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------------- 217 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-------------
Confidence 2 12345688999999998652 23889999999999999999999999765432221111100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.......+..++.+.+||.+||
T Consensus 218 ----------------------------------------------------------~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 218 ----------------------------------------------------------KELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ----------------------------------------------------------ccCCCcCCCcCHHHHHHHHHHh
Confidence 0011122356788999999999
Q ss_pred ccCCCCCCCHHHHhcCccc
Q 007542 340 AFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f 358 (599)
+.||.+|||+.++|.||||
T Consensus 240 ~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 240 QRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred hcCcccCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=323.04 Aligned_cols=253 Identities=30% Similarity=0.518 Sum_probs=208.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.+..++..|++|.+... .....+.+|+.+++.++|+||+++++.+... ..
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~ 72 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TD 72 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----Cc
Confidence 46899999999999999999999999999999998642 2267788999999999999999999998543 57
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 73 ~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 73 LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999 599999875 457899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ......++..|+|||++.+ ..++.++||||+|||+++|++|++||...+.......+..
T Consensus 153 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 213 (256)
T cd06612 153 MA---KRNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------- 213 (256)
T ss_pred cc---ccccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--------------
Confidence 21 1133457889999999877 5788999999999999999999999976543322111100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
............+..+.+||.+||
T Consensus 214 --------------------------------------------------------~~~~~~~~~~~~~~~~~~~i~~~l 237 (256)
T cd06612 214 --------------------------------------------------------KPPPTLSDPEKWSPEFNDFVKKCL 237 (256)
T ss_pred --------------------------------------------------------CCCCCCCchhhcCHHHHHHHHHHH
Confidence 000000111245678999999999
Q ss_pred ccCCCCCCCHHHHhcCccc
Q 007542 340 AFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f 358 (599)
+.||.+|||+.|+|+||||
T Consensus 238 ~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 238 VKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hcChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=326.70 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=209.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|++|.||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++.+... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEE
Confidence 468889999999999999999999999999999875432 24456788999999999999999999998543 579
Q ss_pred EEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 103 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999876 789999999999999999999999 99999999999999999999999999998765322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHhcCCCCHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~--~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ....++..|+|||.+.+ ..++.++||||+||++++|++|+.||...+. ....+.+....
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 217 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV---------- 217 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh----------
Confidence 11 12567888999999877 5789999999999999999999999975431 00011111000
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC-CCCHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP-NANPLALRLLE 336 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~s~~a~dLL~ 336 (599)
...... ... ..++.+.+||.
T Consensus 218 --------------------------------------------------------~~~~~~---~~~~~~~~~~~~li~ 238 (265)
T cd06605 218 --------------------------------------------------------NEPPPR---LPSGKFSPDFQDFVN 238 (265)
T ss_pred --------------------------------------------------------cCCCCC---CChhhcCHHHHHHHH
Confidence 000000 011 16788999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||..||++|||+.++|.||||+.+
T Consensus 239 ~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 239 LCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.23 Aligned_cols=262 Identities=27% Similarity=0.478 Sum_probs=207.5
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC--------hhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH--------VSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~--------~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
+|.+.+.||+|++|.||+|.+..+|+.||||.+...... ....+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 689999999999999999999999999999988532111 1123467789999999999999999998843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...+++||||+. ++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||+++
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 80 ---EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ---CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 357899999998 5999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...... .........++..|+|||.+......++.++|+|||||++++|++|..||...+....+..+.. .
T Consensus 157 ~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~----- 227 (272)
T cd06629 157 KSDDIY-DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---K----- 227 (272)
T ss_pred cccccc-cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---c-----
Confidence 643211 1111234568889999999865323478999999999999999999999965433221111100 0
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
...........+.++..+.+|
T Consensus 228 -----------------------------------------------------------~~~~~~~~~~~~~~~~~~~~l 248 (272)
T cd06629 228 -----------------------------------------------------------RSAPPIPPDVSMNLSPVALDF 248 (272)
T ss_pred -----------------------------------------------------------ccCCcCCccccccCCHHHHHH
Confidence 000001112234568899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
|.+||..||.+|||++++|+||||
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 249 LNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.77 Aligned_cols=259 Identities=31% Similarity=0.476 Sum_probs=213.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
+.|++.+.||+|++|.||+|.+..+++.|+||++...... .....+.+|+..++.++|+||+++++++... ..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeE
Confidence 4689999999999999999999999999999998753322 4567788999999999999999999998543 579
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
|+||||+. ++|.+++.....+++..+..++.||++||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 6999999888889999999999999999999999 999999999999999999999999999998664332
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
.. .....++..|+|||.+.. ..++.++|+|||||++|+|++|+.||...+.....+.+....
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------- 216 (264)
T cd06623 155 DQ---CNTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------- 216 (264)
T ss_pred Cc---ccceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-------------
Confidence 21 134567889999999876 578899999999999999999999997654211111111000
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC-CCHHHHHHHHHhc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN-ANPLALRLLERML 339 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~s~~a~dLL~~mL 339 (599)
.... ...... .+..+.+||.+||
T Consensus 217 -----------------------------------------------------~~~~---~~~~~~~~~~~l~~li~~~l 240 (264)
T cd06623 217 -----------------------------------------------------DGPP---PSLPAEEFSPEFRDFISACL 240 (264)
T ss_pred -----------------------------------------------------cCCC---CCCCcccCCHHHHHHHHHHc
Confidence 0000 011123 6788999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
..+|++|||+.|+|+||||+..
T Consensus 241 ~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 241 QKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred cCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=332.67 Aligned_cols=269 Identities=26% Similarity=0.475 Sum_probs=214.5
Q ss_pred ccccccc-CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceee
Q 007542 13 VDFFTEY-GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (599)
Q Consensus 13 ~~~~~~~-~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~ 91 (599)
++..... +..+.|.....||+|+||.||++.+..++..||||++... .......+.+|+.+++.++|+||+++++.+
T Consensus 11 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~ 88 (292)
T cd06658 11 LQLVVSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSY 88 (292)
T ss_pred eeEEeccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHhe
Confidence 3444333 3346677788899999999999999999999999998642 233456788999999999999999999988
Q ss_pred cCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 92 LPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
.. ....|+||||+++ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 89 ~~-----~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~df 162 (292)
T cd06658 89 LV-----GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDF 162 (292)
T ss_pred ec-----CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccC
Confidence 43 3478999999985 78887754 56899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
|++........ ......++..|+|||.+.+ ..++.++|+||+||++++|++|+.||.+.+....+..+...+..
T Consensus 163 g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~- 236 (292)
T cd06658 163 GFCAQVSKEVP---KRKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP- 236 (292)
T ss_pred cchhhcccccc---cCceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-
Confidence 99875432221 1234578999999999876 57889999999999999999999999876554433222211100
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
........+..
T Consensus 237 ---------------------------------------------------------------------~~~~~~~~~~~ 247 (292)
T cd06658 237 ---------------------------------------------------------------------RVKDSHKVSSV 247 (292)
T ss_pred ---------------------------------------------------------------------ccccccccCHH
Confidence 00011235778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
+.+||.+||..||.+|||++|+|+||||.....+
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 8999999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.38 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=204.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (599)
||.|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.. ...+|+|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-----KKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-----CCccEEEEecC
Confidence 6899999999999999999999999965332 22345678899999999999999999998843 34789999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccc
Q 007542 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (599)
Q Consensus 110 ~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (599)
. ++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence 8 6999999888789999999999999999999999999999999999999999999999999998764332 1133
Q ss_pred cccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC--hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhh
Q 007542 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN--VVHQLDIMTDLLGTPSPEAIARVCLLLNIIW 266 (599)
Q Consensus 189 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~--~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~ 266 (599)
..++..|++||.+.+ ..++.++|+||+||++|+|++|..||.+.. ....+..+...
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 209 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-------------------- 209 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc--------------------
Confidence 568889999999876 578899999999999999999999997765 22221111100
Q ss_pred cCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCC
Q 007542 267 CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 346 (599)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~R 346 (599)
..... .....++.+.+||.+||..||.+|
T Consensus 210 ------------------------------------------------~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 210 ------------------------------------------------NGKLE---FPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred ------------------------------------------------CCCCC---CCcccCHHHHHHHHHHccCChhhC
Confidence 00000 112246789999999999999999
Q ss_pred CC-----HHHHhcCccccCC
Q 007542 347 PT-----AEEALADPYFKGL 361 (599)
Q Consensus 347 pT-----a~e~L~HP~f~~~ 361 (599)
+| ++|+|+||||+++
T Consensus 239 ~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 239 LGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCcccCHHHHhcChhhhCC
Confidence 99 9999999999976
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=328.07 Aligned_cols=262 Identities=26% Similarity=0.435 Sum_probs=204.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|+..+.||+|+||.||++.+..+++.||||++...... .....+.+|+.++.++. |+||+++++++... ..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----Cc
Confidence 4567788999999999999999999999999998743322 44567889999999996 99999999988543 46
Q ss_pred EEEEEecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeeccccccc
Q 007542 102 IYVVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~-----~~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.++||||+..+|.++.. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 89999999976655432 235799999999999999999999975 999999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCcccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...... .....++..|+|||++.+.. ..++.++||||+||++++|++|++||...+ .....+.......
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~---- 227 (288)
T cd06616 158 LVDSIA----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGD---- 227 (288)
T ss_pred hccCCc----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCC----
Confidence 533221 12346788999999986521 268899999999999999999999997643 1111111111000
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
.+.........++..+.+|
T Consensus 228 -------------------------------------------------------------~~~~~~~~~~~~~~~l~~l 246 (288)
T cd06616 228 -------------------------------------------------------------PPILSNSEEREFSPSFVNF 246 (288)
T ss_pred -------------------------------------------------------------CCcCCCcCCCccCHHHHHH
Confidence 0000011113477889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|.+||+.||.+|||++++++||||...
T Consensus 247 i~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 247 INLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHHccCChhhCcCHHHHhcChhhhch
Confidence 999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=317.93 Aligned_cols=253 Identities=29% Similarity=0.491 Sum_probs=207.1
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|+||.||++.++.+|..||+|.+............+.+|+.+++.++|+||+++++.+.. ...+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 6899999999999999999999999999999986533333445677899999999999999999998843 34799
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc-eeeecccccccccCC
Q 007542 104 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFND 179 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~-lKL~DFGla~~~~~~ 179 (599)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||+++.++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999998 59999987643 5799999999999999999999999999999999999998864 699999999765432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
... .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+.......+..
T Consensus 156 ~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 216 (257)
T cd08225 156 MEL---AYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-------------- 216 (257)
T ss_pred ccc---ccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--------------
Confidence 211 123468889999999876 5688999999999999999999999976554332221110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
..+....+..+..+.++|.+||
T Consensus 217 ----------------------------------------------------------~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 217 ----------------------------------------------------------GYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred ----------------------------------------------------------ccCCCCCCCCCHHHHHHHHHHh
Confidence 0011223456778999999999
Q ss_pred ccCCCCCCCHHHHhcCccc
Q 007542 340 AFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f 358 (599)
..||++|||+.|+|.||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.00 Aligned_cols=246 Identities=19% Similarity=0.240 Sum_probs=200.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhh-HHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-ATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~-~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
..||+|++|.||+|.. +|+.||||+++........ .+.+.+|+.+|+.++||||+++++++.+.. .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5699999999999976 7899999999754332222 467789999999999999999999985411 22357899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 108 ~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
|+. |+|.+++...+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 58999999888899999999999999999999984 99999999999999999999999999997653221
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
...+++..|+|||++.+....++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~---------------- 240 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS---------------- 240 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC----------------
Confidence 234688899999998654357899999999999999999999999877654443333211000
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
.. .....++.+.+||.+||+.||.+
T Consensus 241 ----------------------------------------------------~~---~~~~~~~~l~~li~~cl~~dp~~ 265 (283)
T PHA02988 241 ----------------------------------------------------LK---LPLDCPLEIKCIVEACTSHDSIK 265 (283)
T ss_pred ----------------------------------------------------CC---CCCcCcHHHHHHHHHHhcCCccc
Confidence 00 11246788999999999999999
Q ss_pred CCCHHHHhc
Q 007542 346 RPTAEEALA 354 (599)
Q Consensus 346 RpTa~e~L~ 354 (599)
|||+.|+|+
T Consensus 266 Rps~~ell~ 274 (283)
T PHA02988 266 RPNIKEILY 274 (283)
T ss_pred CcCHHHHHH
Confidence 999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=318.42 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=208.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~---~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..|.+.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++.+.+.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 57999999999999999999999999999999875321 12234567889999999999999999999885432 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 46899999998 58999998877899999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
........+...++..|+|||++.+ ..++.++|+|||||++++|++|++||.+......+..+ ...+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~------- 226 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPT------- 226 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCC-------
Confidence 2111111234568899999999876 56889999999999999999999999765433222111 11000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.......+++.+.+||++|
T Consensus 227 -------------------------------------------------------------~~~~p~~~~~~~~~~i~~~ 245 (264)
T cd06653 227 -------------------------------------------------------------KPMLPDGVSDACRDFLKQI 245 (264)
T ss_pred -------------------------------------------------------------CCCCCcccCHHHHHHHHHH
Confidence 0112235778899999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 007542 339 LAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f 358 (599)
|+ +|..|||+.++|.|||.
T Consensus 246 l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 246 FV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred hc-CcccCccHHHHhcCCCC
Confidence 99 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=324.24 Aligned_cols=258 Identities=29% Similarity=0.544 Sum_probs=210.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
..|...+.||+|++|.||+|.+..+++.|++|++... .......+.+|+.+++.++|+||+++++.+.. ....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeE
Confidence 4566678999999999999999999999999998532 22345568899999999999999999998853 3468
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+|+||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998 599998877 6799999999999999999999999999999999999999999999999998875533222
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
. .....++..|+|||.+.+ ..++.++||||+||++++|++|+.||.+.+....+..+....
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-------------- 231 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-------------- 231 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--------------
Confidence 1 133568899999999876 568899999999999999999999998765544333222110
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
+ +........+..+.+||.+||+.
T Consensus 232 -------------------------------------------------------~-~~~~~~~~~~~~l~~li~~~l~~ 255 (285)
T cd06648 232 -------------------------------------------------------P-PKLKNLHKVSPRLRSFLDRMLVR 255 (285)
T ss_pred -------------------------------------------------------C-CCCcccccCCHHHHHHHHHHccc
Confidence 0 00011123677899999999999
Q ss_pred CCCCCCCHHHHhcCccccCCcc
Q 007542 342 EPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
||++|||+.++|+||||+....
T Consensus 256 ~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 256 DPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.40 Aligned_cols=256 Identities=31% Similarity=0.543 Sum_probs=211.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~ 100 (599)
++|++.+.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.++ |+||+++++++.. ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 47999999999999999999999999999999987532 23334567889999999998 9999999998843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+|||++. ++|.+++...+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 7899999996 799999998888999999999999999999999999999999999999999999999999999765432
Q ss_pred CCC-----------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 007542 180 TPT-----------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (599)
Q Consensus 180 ~~~-----------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~ 242 (599)
... ........++..|+|||.+.. ..++.++|||||||++++|++|+.||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011233467889999999876 5688899999999999999999999987653332222
Q ss_pred HHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcC
Q 007542 243 MTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322 (599)
Q Consensus 243 I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 322 (599)
+... . ..
T Consensus 234 ~~~~----------------------------------------------------------------------~---~~ 240 (280)
T cd05581 234 ILKL----------------------------------------------------------------------E---YS 240 (280)
T ss_pred HHhc----------------------------------------------------------------------C---CC
Confidence 2100 0 01
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 007542 323 KFPNANPLALRLLERMLAFEPKDRPTA----EEALADPYF 358 (599)
Q Consensus 323 ~~~~~s~~a~dLL~~mL~~DP~~RpTa----~e~L~HP~f 358 (599)
....+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 112457889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=369.68 Aligned_cols=266 Identities=23% Similarity=0.385 Sum_probs=225.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|.|+++||+|+||.|..++++.|++.||+|++++.. ....+...|..|-.+|-.-+.+-|+.|+-.| .+.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 4688999999999999999999999999999999997521 2234556788899999988999999999888 445
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.++|+|||||. |||..++...+.++++.+++|+..|+-||.-||+.|+|||||||+|||+|..|++||+|||.+-....
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 68999999999 69999999888999999999999999999999999999999999999999999999999999876643
Q ss_pred CCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
+. .......||||.|.+||++... ...|+..+|-||+||++||||.|..||..++.++.+-+|++.-.
T Consensus 228 dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~------- 298 (1317)
T KOG0612|consen 228 DG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE------- 298 (1317)
T ss_pred CC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh-------
Confidence 32 2234667999999999998431 25699999999999999999999999999998888888764210
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
...|. .-..+|+.|+|||
T Consensus 299 -------------------------------------------------------------~l~FP-~~~~VSeeakdLI 316 (1317)
T KOG0612|consen 299 -------------------------------------------------------------SLSFP-DETDVSEEAKDLI 316 (1317)
T ss_pred -------------------------------------------------------------hcCCC-cccccCHHHHHHH
Confidence 01111 1124899999999
Q ss_pred HHhcccCCCCCCC---HHHHhcCccccCCcc
Q 007542 336 ERMLAFEPKDRPT---AEEALADPYFKGLAK 363 (599)
Q Consensus 336 ~~mL~~DP~~RpT---a~e~L~HP~f~~~~~ 363 (599)
+++|. +|..|.. ++++-.||||.++..
T Consensus 317 ~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 317 EALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 99997 7899998 999999999998743
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.00 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=200.1
Q ss_pred CCceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
..+|++.+.||+|+||.||+|.++ ..+..||+|.++... .......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR----- 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----
Confidence 467999999999999999999765 456789999987532 22334578899999999999999999999853
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||+.|++||||||+|||++.++.+|++|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 346899999999 5899888764 57899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ......++..|+|||++.+ ..++.++||||+||++++|++ |..||.+.+..+.+..+.+...
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~------- 226 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR------- 226 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------
Confidence 211110 0112234578999999876 678999999999999999775 9999987665544333321100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.+ ..+..+..+.+|+
T Consensus 227 --------------------------------------------------------------~~---~~~~~~~~~~~li 241 (266)
T cd05064 227 --------------------------------------------------------------LP---APRNCPNLLHQLM 241 (266)
T ss_pred --------------------------------------------------------------CC---CCCCCCHHHHHHH
Confidence 00 1234677899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 007542 336 ERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~ 354 (599)
.+||+.||.+|||++++++
T Consensus 242 ~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 242 LDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHcCCCchhCCCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=350.30 Aligned_cols=268 Identities=24% Similarity=0.407 Sum_probs=218.6
Q ss_pred cccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCC
Q 007542 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~ 94 (599)
+.....-.+.|.|+..||.|+||.||+|.++.++-..|.|+|.. ......+.++-||.||..+.||+||+|++.|+..
T Consensus 24 v~rdlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e 101 (1187)
T KOG0579|consen 24 VYRDLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE 101 (1187)
T ss_pred HhccCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence 33444556788999999999999999999999999999999853 3456678899999999999999999999998543
Q ss_pred CcCCCccEEEEEecCCc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccc
Q 007542 95 SRREFKDIYVVFELMES-DLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 95 s~~~~~~lylV~E~~~g-~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
+.+||+.|+|+| -...++.. ...|++.+++.+++|++.||.|||+++|||||||..|||++-+|.++|+|||.
T Consensus 102 -----nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 102 -----NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred -----CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccc
Confidence 479999999996 45555544 34799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCcccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
+....... -...+.+||++|||||+..... ..|+.++||||||++|.||..+.||-..-+....+-+|.+.
T Consensus 177 SAKn~~t~---qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--- 250 (1187)
T KOG0579|consen 177 SAKNKSTR---QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--- 250 (1187)
T ss_pred cccchhHH---hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---
Confidence 86532211 1224679999999999865421 46999999999999999999999998777766655544321
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
.+| .+.+ ...++.
T Consensus 251 ePP------------------------------------------------------------------TLlq-PS~Ws~ 263 (1187)
T KOG0579|consen 251 EPP------------------------------------------------------------------TLLQ-PSHWSR 263 (1187)
T ss_pred CCC------------------------------------------------------------------cccC-cchhhh
Confidence 111 1111 124677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+.|||++||..||..||++.++|+||||++..
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 789999999999999999999999999999753
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=314.45 Aligned_cols=253 Identities=29% Similarity=0.516 Sum_probs=211.5
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|.+.+.||+|+||.||++.+..++..|++|++............+.+|+++++.++|+|++++.+.+... ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 68999999999999999999999999999999976544445667788999999999999999999998543 5789
Q ss_pred EEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 104 VVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 104 lV~E~~~g-~L~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+|++++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999984 899998763 6799999999999999999999999999999999999999999999999999977543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. .......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+.......+..
T Consensus 156 ~~---~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 217 (258)
T cd08215 156 TV---DLAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK------------- 217 (258)
T ss_pred Cc---ceecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-------------
Confidence 32 11234578889999999876 5688999999999999999999999976653322222110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.. +.......+..+.++|.+|
T Consensus 218 --------------------------------------------------------~~---~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 218 --------------------------------------------------------GQ---YPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred --------------------------------------------------------CC---CCCCCCCCCHHHHHHHHHH
Confidence 00 0111124677899999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 007542 339 LAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f 358 (599)
|..||.+|||+.|+|+||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=322.22 Aligned_cols=263 Identities=24% Similarity=0.412 Sum_probs=207.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 47999999999999999999999999999999987432 224456788999999999999999999988543 22468
Q ss_pred EEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 103 YVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 588887653 3468999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh--hhHHHHHHHhcCCCCHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV--VHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~--~~~l~~I~~~lg~p~~e~i 255 (599)
.... ....++..|+|||.+.+ ..++.++||||||||+|+|++|..||..... ....+...
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 2221 23457889999999876 6789999999999999999999999976532 00011000
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC---CCCCCHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK---FPNANPLAL 332 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~s~~a~ 332 (599)
++... ....+... -...++.+.
T Consensus 219 ----------------------------------------------------~~~~~---~~~~~~~~~~~~~~~~~~~~ 243 (287)
T cd06621 219 ----------------------------------------------------YIVNM---PNPELKDEPGNGIKWSEEFK 243 (287)
T ss_pred ----------------------------------------------------HHhcC---CchhhccCCCCCCchHHHHH
Confidence 00000 00000000 012457789
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+||.+||..||.+|||+.|+|.||||+...
T Consensus 244 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 244 DFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred HHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.13 Aligned_cols=261 Identities=28% Similarity=0.518 Sum_probs=211.2
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
+...-|.....||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++.+.. .
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~ 90 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----G 90 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheee-----C
Confidence 4445556667899999999999999999999999998642 22335668899999999999999999998843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+|+||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 91 ~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 91 EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 47899999999 588887654 5689999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... ......++..|+|||++.+ ..++.++||||+||++++|++|+.||...+....+..+.. .
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~--------- 232 (297)
T cd06659 170 DVP---KRKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---S--------- 232 (297)
T ss_pred ccc---cccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---c---------
Confidence 221 1234678999999999876 5788999999999999999999999987665444332211 0
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
..........+++.+.+||.+|
T Consensus 233 ----------------------------------------------------------~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 233 ----------------------------------------------------------PPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ----------------------------------------------------------CCCCccccCCCCHHHHHHHHHH
Confidence 0011112235677899999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCcc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
|+.||.+|||++++++||||.....
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=324.45 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=196.8
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHh---cCCCCccccceeecCCCcCCCccEEEE
Q 007542 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRL---LRHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~---l~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
+||+|+||.||+|.+..+++.||+|.+...... ........+|..+++. ..|+||+.+++.+.. .+.+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 489999999999999999999999998653322 1222334455544444 469999999998843 3468999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcc
Q 007542 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (599)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 184 (599)
|||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 99999 5999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhh
Q 007542 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNI 264 (599)
Q Consensus 185 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~ 264 (599)
.....++..|+|||.+... ..++.++||||+||++++|++|+.||.+....... .+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------------~~~~------- 209 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-------------EIDR------- 209 (279)
T ss_pred -ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-------------HHHH-------
Confidence 1234789999999988531 46889999999999999999999999764321110 0000
Q ss_pred hhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCC
Q 007542 265 IWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 344 (599)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~ 344 (599)
...... ....+..++.+.+||++||..||.
T Consensus 210 -----------------------------------------------~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~ 239 (279)
T cd05633 210 -----------------------------------------------MTLTVN---VELPDSFSPELKSLLEGLLQRDVS 239 (279)
T ss_pred -----------------------------------------------HhhcCC---cCCccccCHHHHHHHHHHhcCCHH
Confidence 000000 012235678899999999999999
Q ss_pred CCC-----CHHHHhcCccccCCc
Q 007542 345 DRP-----TAEEALADPYFKGLA 362 (599)
Q Consensus 345 ~Rp-----Ta~e~L~HP~f~~~~ 362 (599)
+|+ |+.|+++||||+++.
T Consensus 240 ~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 240 KRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HhcCCCCCCHHHHHhCccccCCC
Confidence 999 699999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=317.09 Aligned_cols=249 Identities=29% Similarity=0.464 Sum_probs=204.5
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|+||.||++.+..++..||+|.++... .....+.+.+|+.+++.++|+||+++++.+. +...+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEE
Confidence 5899999999999999999999999999999986432 2344567889999999999999999999984 335799
Q ss_pred EEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 104 VVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 5899988653 358999999999999999999999999999999999999999999999999987653221
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ......++..|+|||++.+ ..++.++|+||+||++++|++|+.||...+.......+.. +
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~------------ 215 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ--G------------ 215 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc--C------------
Confidence 1 1234678899999999876 5789999999999999999999999987654433222211 0
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
. ........+..+.+||.+||+
T Consensus 216 -------------------------------------------------------~---~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 216 -------------------------------------------------------S---YKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred -------------------------------------------------------C---CCCCCcccCHHHHHHHHHHHh
Confidence 0 001112356789999999999
Q ss_pred cCCCCCCCHHHHhcC
Q 007542 341 FEPKDRPTAEEALAD 355 (599)
Q Consensus 341 ~DP~~RpTa~e~L~H 355 (599)
.||.+|||+.++|.-
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.68 Aligned_cols=267 Identities=27% Similarity=0.401 Sum_probs=210.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|.+..+|..||+|++.... .......+.+|+.+++.++||||+++++.+... ..
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 77 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NN 77 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CE
Confidence 367899999999999999999999999999999886432 233456788999999999999999999998543 57
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+. ++|.+++...+.+++..++.++.|++.+|.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 899999999 5899999887889999999999999999999997 58999999999999999999999999998654222
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ....+++..|+|||++.+ ..++.++||||+||++++|++|+.||.......... ...
T Consensus 158 ~-----~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~--------~~~------- 215 (284)
T cd06620 158 I-----ADTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ--------DDP------- 215 (284)
T ss_pred c-----cCccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh--------hhh-------
Confidence 1 123578999999999876 578899999999999999999999998654321100 000
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
......+..+....+..+. ....+..+.+||.+||
T Consensus 216 -------------------------------------------~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l 250 (284)
T cd06620 216 -------------------------------------------MGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACL 250 (284)
T ss_pred -------------------------------------------hHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHh
Confidence 0000111111111111110 0125678999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+.||.+|||++|+++|+||...
T Consensus 251 ~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 251 LKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred cCCcccCcCHHHHhcCcccccc
Confidence 9999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=325.42 Aligned_cols=259 Identities=21% Similarity=0.325 Sum_probs=198.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR----------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~----------------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (599)
.++|++.++||+|+||.||+|.+.. ++..||||.+.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34579999987432 233456788999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHhhhC
Q 007542 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-------------------DLTPEHYQFFLYQLLRGLKYIHTA 145 (599)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~-------------------~lse~~i~~i~~QIl~aL~yLHs~ 145 (599)
++++++... ..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999998543 46899999998 69999886532 357788899999999999999999
Q ss_pred ceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHH
Q 007542 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (599)
Q Consensus 146 gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLl 225 (599)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999765332211 11223456788999999876 57899999999999999998
Q ss_pred h--CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccH
Q 007542 226 T--GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNE 303 (599)
Q Consensus 226 t--G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~ 303 (599)
+ |..||.+.+....+..+...+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~-------------------------------------------------------- 258 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFF-------------------------------------------------------- 258 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHh--------------------------------------------------------
Confidence 7 557777655443332221110
Q ss_pred HHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 304 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 304 ~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
... .........+..+..+.+||.+||+.||.+|||++|+.+
T Consensus 259 ------~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 259 ------RDQ---GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ------hhc---cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 000 000001112346778999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=346.92 Aligned_cols=268 Identities=28% Similarity=0.492 Sum_probs=223.3
Q ss_pred CcccccccCCCCce-EEEEEeeecCceEEEEEEECCCCcEEEEEEec--CccCChhhHHHHHHHHHHHHhcCCCCccccc
Q 007542 12 DVDFFTEYGEGSRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88 (599)
Q Consensus 12 ~~~~~~~~~~~~rY-~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~--~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~ 88 (599)
+-..+.+-...+|| +...+||+|+|-+||+|.|..+|..||+-.++ .........+++..|+.+|+.|+||||++++
T Consensus 28 ~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy 107 (632)
T KOG0584|consen 28 DESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFY 107 (632)
T ss_pred ccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeee
Confidence 33445555667888 45679999999999999999999999987654 3445556678999999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCC-Cc
Q 007542 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANAD-CK 164 (599)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~-~~ 164 (599)
+.|.+... ..+.+|+|+|. |+|+.++++.+.++...++.|++|||+||.|||++. |||||||-+||+|+.+ |.
T Consensus 108 ~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~ 184 (632)
T KOG0584|consen 108 DSWVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGE 184 (632)
T ss_pred eheecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCc
Confidence 99976543 57899999999 899999999999999999999999999999999996 9999999999999986 99
Q ss_pred eeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 007542 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~ 244 (599)
|||+|+|||....... ....+|||.|||||+... .|+..+||||||++++||.|+..||.......|+.+-+
T Consensus 185 VKIGDLGLAtl~r~s~-----aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV 256 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSH-----AKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV 256 (632)
T ss_pred eeecchhHHHHhhccc-----cceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence 9999999998864333 245799999999999874 79999999999999999999999998766555443322
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
. -|. +|..|+.
T Consensus 257 ~-SGi------------------------------------------------------------------KP~sl~k-- 267 (632)
T KOG0584|consen 257 T-SGI------------------------------------------------------------------KPAALSK-- 267 (632)
T ss_pred H-cCC------------------------------------------------------------------CHHHhhc--
Confidence 1 111 1111111
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
--+|++++||.+||.. ..+|+|+.|+|.||||..-
T Consensus 268 -V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 -VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 2368899999999999 9999999999999999863
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.91 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=203.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence 47899999999999999999876655 789999986432 233456788999999999999999999998432
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
...|++|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 46899999998 6999999764 4578899999999999999999999999999999999999
Q ss_pred CCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhH
Q 007542 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~ 239 (599)
.++.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999976432221 111234467888999999876 578999999999999999998 9999987665443
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
...|... ...
T Consensus 236 ~~~i~~~---------------------------------------------------------------------~~~- 245 (283)
T cd05048 236 IEMIRSR---------------------------------------------------------------------QLL- 245 (283)
T ss_pred HHHHHcC---------------------------------------------------------------------CcC-
Confidence 3322210 000
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
......++.+.+|+.+||+.||.+|||+.|++++
T Consensus 246 --~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 246 --PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1113567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=326.69 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=211.8
Q ss_pred ccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCC
Q 007542 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPP 94 (599)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~ 94 (599)
+.......+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++.+++...
T Consensus 8 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~ 87 (307)
T cd06607 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE 87 (307)
T ss_pred hcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence 3344556789999999999999999999999999999999864322 233446788999999999999999999998543
Q ss_pred CcCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 95 SRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 95 s~~~~~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...|+|+||+.++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++
T Consensus 88 -----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 88 -----HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred -----CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcc
Confidence 46899999999999888764 457999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
...... ....++..|+|||++.+. ...++.++||||+||++|+|++|++||.+.+....+..+... .
T Consensus 163 ~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~--- 230 (307)
T cd06607 163 SLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--D--- 230 (307)
T ss_pred eecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--C---
Confidence 754221 234678889999987421 145888999999999999999999999776544332222100 0
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
+..+ ....++..+.
T Consensus 231 ----------------------------------------------------------------~~~~--~~~~~~~~~~ 244 (307)
T cd06607 231 ----------------------------------------------------------------SPTL--SSNDWSDYFR 244 (307)
T ss_pred ----------------------------------------------------------------CCCC--CchhhCHHHH
Confidence 0000 0112466789
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+||.+||..||.+|||+.+++.||||..
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 9999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.23 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=202.6
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (599)
||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+|+.++||||+++++++.. ...+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 6899999999999999999999999864322 22234566789999999999999999998843 35789999999
Q ss_pred C-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 110 E-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 110 ~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
+ ++|.+++.... .+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++....... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cc
Confidence 9 59999997765 79999999999999999999999999999999999999999999999999987653211 12
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIW 266 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~ 266 (599)
....++..|+|||.+.+ ..++.++||||+||++++|++|+.||.+.........+...
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 209 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-------------------- 209 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--------------------
Confidence 34467889999999876 45889999999999999999999999765432111111100
Q ss_pred cCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCC
Q 007542 267 CGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR 346 (599)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~R 346 (599)
....+. ...+..++.+.+||++||+.||.+|
T Consensus 210 ----------------------------------------------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R 240 (277)
T cd05577 210 ----------------------------------------------TLEMAV---EYPDKFSPEAKDLCEALLQKDPEKR 240 (277)
T ss_pred ----------------------------------------------cccccc---cCCccCCHHHHHHHHHHccCChhHc
Confidence 000000 1123468889999999999999999
Q ss_pred C-----CHHHHhcCccccCCc
Q 007542 347 P-----TAEEALADPYFKGLA 362 (599)
Q Consensus 347 p-----Ta~e~L~HP~f~~~~ 362 (599)
| ++.++|+||||..+.
T Consensus 241 ~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 241 LGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred cCCCcccHHHHHhChhhhcCC
Confidence 9 999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=325.14 Aligned_cols=260 Identities=29% Similarity=0.487 Sum_probs=211.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.+.||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+.. ..
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~ 89 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GD 89 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CC
Confidence 357999999999999999999999999999999998632 23345678899999999999999999998843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+|+||+. ++|.+++... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 6899999998 5999988754 5889999999999999999999999999999999999999999999999988654322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ......+++.|++||.+.. ..++.++|+||+||++++|++|+.||.+.+...++..+.. .+
T Consensus 169 ~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~----------- 231 (293)
T cd06647 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG----------- 231 (293)
T ss_pred cc---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CC-----------
Confidence 21 1234568889999999876 5788999999999999999999999987654332211110 00
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.+.......++..+.+||++||
T Consensus 232 ----------------------------------------------------------~~~~~~~~~~~~~l~~li~~~l 253 (293)
T cd06647 232 ----------------------------------------------------------TPELQNPEKLSAIFRDFLNRCL 253 (293)
T ss_pred ----------------------------------------------------------CCCCCCccccCHHHHHHHHHHc
Confidence 0000111235677899999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCcc
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
..||.+|||+.++|.||||+....
T Consensus 254 ~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 254 EMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred cCChhhCcCHHHHhcCHHHhcCcc
Confidence 999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=316.98 Aligned_cols=249 Identities=22% Similarity=0.437 Sum_probs=202.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
...|++.+.||+|+||.||+|.++.+++.||+|++... ......+.+|+.+|+.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPP 76 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcC-----CCC
Confidence 35699999999999999999999999999999998642 2345678899999999999999999999843 346
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+++||||+. ++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 899999998 6999998764 3589999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.+..+....+....
T Consensus 157 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 222 (263)
T cd05052 157 DTYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---------- 222 (263)
T ss_pred ceeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----------
Confidence 22111 112234567999999876 678899999999999999998 999998876544333221100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. ......++.+.+||.+
T Consensus 223 -----------------------------------------------------------~~---~~~~~~~~~~~~li~~ 240 (263)
T cd05052 223 -----------------------------------------------------------RM---ERPEGCPPKVYELMRA 240 (263)
T ss_pred -----------------------------------------------------------CC---CCCCCCCHHHHHHHHH
Confidence 00 1113467889999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||++|||+.++++
T Consensus 241 cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=312.35 Aligned_cols=253 Identities=32% Similarity=0.538 Sum_probs=211.7
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|+|++++++++.. ...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 6899999999999999999999999999999997654444566788999999999999999999998843 35789
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
+||||+++ +|.+++...+.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999984 99999988888999999999999999999999999999999999999999999999999999876443321
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
.....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+.
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 212 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------------ 212 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------------
Confidence 234467889999999876 458899999999999999999999997654322211110
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
.. ......+..++.+.+||.+||..|
T Consensus 213 ---------------------------------------------------~~---~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 213 ---------------------------------------------------QD---DHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ---------------------------------------------------cc---CCCCCCCCCCHHHHHHHHHHHhCC
Confidence 00 001122356788999999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 007542 343 PKDRPTAEEALADPYF 358 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f 358 (599)
|++|||+.++|.||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.68 Aligned_cols=251 Identities=29% Similarity=0.449 Sum_probs=198.7
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
...||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++++.. ...+|+|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-----NGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-----CCEEEEEEe
Confidence 45799999999999999999999999988642 23455678899999999999999999998843 347899999
Q ss_pred cCC-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-CCceeeecccccccccCCCCC
Q 007542 108 LME-SDLHQVIKAN-DDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 108 ~~~-g~L~~~i~~~-~~l--se~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-~~~lKL~DFGla~~~~~~~~~ 182 (599)
|+. ++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~- 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP- 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-
Confidence 998 5999998764 445 88899999999999999999999999999999999986 67899999999876533221
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
......++..|+|||++......++.++|+||+||++++|++|++||.............
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~------------------ 224 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV------------------ 224 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh------------------
Confidence 123346788999999986532458899999999999999999999996532111000000
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
.+.. .........++.+.+||++||+.|
T Consensus 225 ------------------------------------------------~~~~----~~~~~~~~~~~~~~~li~~~l~~~ 252 (268)
T cd06624 225 ------------------------------------------------GMFK----IHPEIPESLSAEAKNFILRCFEPD 252 (268)
T ss_pred ------------------------------------------------hhhc----cCCCCCcccCHHHHHHHHHHcCCC
Confidence 0000 000112346788999999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 007542 343 PKDRPTAEEALADPYF 358 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f 358 (599)
|.+|||+.|++.||||
T Consensus 253 p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 253 PDKRASAHDLLQDPFL 268 (268)
T ss_pred chhCCCHHHHHhCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.14 Aligned_cols=301 Identities=20% Similarity=0.250 Sum_probs=205.8
Q ss_pred EEeeec--CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G--~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
..||+| +||+||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-----CCceEEEE
Confidence 457776 99999999999999999999987544444456788899999999999999999999954 34689999
Q ss_pred ecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 107 ELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 107 E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999 5999988764 358999999999999999999999999999999999999999999999998654332111100
Q ss_pred -cc---ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 184 -IF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 184 -~~---~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. .....++..|+|||++.+....++.++||||+||++++|++|++||.+......+..+.......+...- .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 235 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT-T-- 235 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc-c--
Confidence 00 0112345679999998653345789999999999999999999999887654443333221111110000 0
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHh-cc-cCCCCCC-cCCCCCCCHHHHHHHH
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS-MR-KKKPIPF-SQKFPNANPLALRLLE 336 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~-~~-~~~~~~~-~~~~~~~s~~a~dLL~ 336 (599)
. +...... ...............+.. .. ......+ .......++.+.+||+
T Consensus 236 -------~----------~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 289 (328)
T cd08226 236 -------F----------PCEESRM---------KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE 289 (328)
T ss_pred -------c----------chhhhhh---------ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHH
Confidence 0 0000000 000000000000000000 00 0000000 0011235678999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
+||++||++|||++|+|+||||..+.+
T Consensus 290 ~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 290 LCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred HHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 999999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=317.78 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=199.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHH-HhcCCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL-~~l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
+.||+|+||.||+|.+..+|+.||||.+..... .......+..|..++ ...+|+|++++++++.. ...+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 579999999999999999999999999864321 122233445565544 45589999999999843 34799999
Q ss_pred ecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 107 ELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||+++....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 59999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
.....++..|+|||.+.+ ..++.++||||+|||+|+|++|.+||.+.+.......+...
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 208 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR------------------- 208 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 123467889999999876 45889999999999999999999999876544332222110
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
...........+++.+.+||.+||+.||.+
T Consensus 209 --------------------------------------------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 238 (260)
T cd05611 209 --------------------------------------------------RINWPEEVKEFCSPEAVDLINRLLCMDPAK 238 (260)
T ss_pred --------------------------------------------------ccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence 000001112356788999999999999999
Q ss_pred CCC---HHHHhcCccccCC
Q 007542 346 RPT---AEEALADPYFKGL 361 (599)
Q Consensus 346 RpT---a~e~L~HP~f~~~ 361 (599)
||| ++|+|.||||+.+
T Consensus 239 R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 239 RLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCCcHHHHHcChHhhcC
Confidence 995 5899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.78 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=209.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
...|+.++.||.|+||.||+|.+..++..||||.+... ........+.+|+.+++.+.|+||+++++++.. ...
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTK 76 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCE
Confidence 35688899999999999999999999999999998643 223446778899999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998 589998865 468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+..
T Consensus 156 ~---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--------------- 215 (277)
T cd06640 156 I---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--------------- 215 (277)
T ss_pred c---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc---------------
Confidence 1 1233467889999999876 5688999999999999999999999976553322211100
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
..+ .......+..+.+||.+||.
T Consensus 216 ------------------------------------------------------~~~---~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 216 ------------------------------------------------------NNP---PTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred ------------------------------------------------------CCC---CCCchhhhHHHHHHHHHHcc
Confidence 000 11122356678999999999
Q ss_pred cCCCCCCCHHHHhcCccccCC
Q 007542 341 FEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.||.+|||++++|+||||...
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred cCcccCcCHHHHHhChHhhhc
Confidence 999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=312.59 Aligned_cols=259 Identities=29% Similarity=0.448 Sum_probs=212.5
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|.+.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++|+||+++++.+.... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999998754443455678899999999999999999999985432 25789
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 104 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
+|+||+. ++|.+++.....+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988878999999999999999999999999999999999999999999999999999876543321
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
.......++..|+|||.+.+ ..++.++|||||||++++|++|..||...+. ....+.....
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~-------------- 218 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS-------------- 218 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc--------------
Confidence 01234568889999999876 4588999999999999999999999987651 1111111000
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
...........+..+.+||.+||..|
T Consensus 219 ------------------------------------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~ 244 (260)
T cd06606 219 ------------------------------------------------------SGEPPEIPEHLSEEAKDFLRKCLRRD 244 (260)
T ss_pred ------------------------------------------------------cCCCcCCCcccCHHHHHHHHHhCcCC
Confidence 00111122345788999999999999
Q ss_pred CCCCCCHHHHhcCccc
Q 007542 343 PKDRPTAEEALADPYF 358 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f 358 (599)
|.+|||+.|+|.||||
T Consensus 245 p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 245 PKKRPTADELLQHPFL 260 (260)
T ss_pred hhhCCCHHHHhhCCCC
Confidence 9999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=317.44 Aligned_cols=256 Identities=21% Similarity=0.359 Sum_probs=202.2
Q ss_pred eEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFK 100 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~~~~ 100 (599)
|++++.||+|+||.||+|.+..+ +..||||+++...........+.+|+.+|+.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987653 4789999997544444556788999999999999999999998865432 3345
Q ss_pred cEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
..++|+||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 6899999999 6998888542 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+......... ......++..|+|||.+.+ ..++.++||||+||++|||++ |.+||.+.+....++.+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH------- 230 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8654322110 1112234567999999866 678999999999999999999 8999987654433222211
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
... .......++.+.
T Consensus 231 --------------------------------------------------------------~~~---~~~~~~~~~~~~ 245 (273)
T cd05035 231 --------------------------------------------------------------GNR---LKQPEDCLDELY 245 (273)
T ss_pred --------------------------------------------------------------CCC---CCCCcCCCHHHH
Confidence 000 011234677899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 007542 333 RLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+||.+||+.||.+|||+.|++.+
T Consensus 246 ~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 246 DLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=327.26 Aligned_cols=284 Identities=23% Similarity=0.283 Sum_probs=201.4
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC-ccH
Q 007542 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDL 113 (599)
Q Consensus 35 ~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L 113 (599)
++|.||.+++..+++.||||+++...........+.+|+.+|+.++|+||+++++++... ..+|++|||+. ++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCH
Confidence 456677777788999999999976434455677899999999999999999999998543 46899999999 689
Q ss_pred HHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC----ccccc
Q 007542 114 HQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT----AIFWT 187 (599)
Q Consensus 114 ~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~----~~~~~ 187 (599)
.+++... ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||.+......... .....
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 9998753 46899999999999999999999999999999999999999999999999988754322111 11123
Q ss_pred ccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhc
Q 007542 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWC 267 (599)
Q Consensus 188 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~ 267 (599)
...++..|+|||++......++.++||||+||++++|++|+.||.+......+. ....|..... +.. ..+.
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~-~~~------~~~~ 237 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCL-LDK------STYP 237 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccc-ccc------Cchh
Confidence 346778899999986533468899999999999999999999998765433221 1122211110 000 0000
Q ss_pred CCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCC
Q 007542 268 GYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 347 (599)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~Rp 347 (599)
........ .. .. ..... . ....-......+++.+.+||.+||.+||.+||
T Consensus 238 ~~~~~~~~---~~-------~~----------~~~~~-------~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 287 (314)
T cd08216 238 LYEDSMSQ---SR-------SS----------NEHPN-------N---RDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287 (314)
T ss_pred hhcCCcCc---cc-------cc----------ccccc-------h---hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc
Confidence 00000000 00 00 00000 0 00000001123457789999999999999999
Q ss_pred CHHHHhcCccccCCc
Q 007542 348 TAEEALADPYFKGLA 362 (599)
Q Consensus 348 Ta~e~L~HP~f~~~~ 362 (599)
|++|+|+||||+.+.
T Consensus 288 t~~~ll~~p~~~~~~ 302 (314)
T cd08216 288 SASQLLNHSFFKQCK 302 (314)
T ss_pred CHHHHhcCchHhhhc
Confidence 999999999999775
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=315.87 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=205.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (599)
||.|+||.||+|.+..+|+.|++|++..... .......+.+|+.+++.++|+||+++++.+. ....+|+|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence 6899999999999999999999999864322 2244567889999999999999999998874 345799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC-----c
Q 007542 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-----A 183 (599)
Q Consensus 110 ~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~-----~ 183 (599)
. ++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 599999988778999999999999999999999999999999999999999999999999998765332110 1
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
.......++..|++||.+.. ..++.++|+|||||++++|++|..||...........+.. +.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~-------------- 217 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GK-------------- 217 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC--------------
Confidence 11234567889999999876 5588899999999999999999999987664443322221 00
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 343 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP 343 (599)
..+.. ....++.+.+||++||+.||
T Consensus 218 ------------------------------------------------------~~~~~-~~~~~~~~~~~i~~~l~~~p 242 (265)
T cd05579 218 ------------------------------------------------------IEWPE-DVEVSDEAIDLISKLLVPDP 242 (265)
T ss_pred ------------------------------------------------------cCCCc-cccCCHHHHHHHHHHhcCCH
Confidence 00000 01247889999999999999
Q ss_pred CCCCCH---HHHhcCccccCC
Q 007542 344 KDRPTA---EEALADPYFKGL 361 (599)
Q Consensus 344 ~~RpTa---~e~L~HP~f~~~ 361 (599)
.+|||+ .++|+||||+++
T Consensus 243 ~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 243 EKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred hhcCCCccHHHHhcCccccCC
Confidence 999999 999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.63 Aligned_cols=251 Identities=28% Similarity=0.455 Sum_probs=209.3
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
+|++.+.||+|+||.||++.+..+++.||+|++............+.+|+.+++.++|+||+++++++... ...|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 58999999999999999999999999999999976544445566788999999999999999999988543 5799
Q ss_pred EEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 104 VVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||++ ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999998 589998866 35689999999999999999999999999999999999999999999999999987644
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. .....++..|++||.+.+ ..++.++|+||+|+++++|++|+.||.+.+.......+..
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR------------- 215 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 31 123467889999999876 6788899999999999999999999987654332221110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.. +.......+.++.++|.+|
T Consensus 216 --------------------------------------------------------~~---~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 216 --------------------------------------------------------GK---YPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred --------------------------------------------------------CC---CCCCchhhCHHHHHHHHHH
Confidence 00 0011124567899999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 007542 339 LAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f 358 (599)
|..||.+|||+.|+|+||++
T Consensus 237 l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 237 LQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred cCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=320.41 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=196.0
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHH---HHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 007542 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREI---KLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi---~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
+||+|+||.||+|.+..+++.||+|.+...... .........|. .+++...||||+.+++.+.. ...+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCEEEEE
Confidence 489999999999999999999999998643222 12222233443 34455679999999998843 3478999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcc
Q 007542 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (599)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 184 (599)
|||+. ++|.+++...+.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99998 5899999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhh
Q 007542 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNI 264 (599)
Q Consensus 185 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~ 264 (599)
.....|+..|+|||++.+. ..++.++||||+||++++|++|+.||.+...........
T Consensus 152 -~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-------------------- 209 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------------- 209 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH--------------------
Confidence 1234789999999998642 468899999999999999999999997653221100000
Q ss_pred hhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCC
Q 007542 265 IWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 344 (599)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~ 344 (599)
... .... ......++.+.+||.+||..||.
T Consensus 210 -------------------------------------------~~~----~~~~---~~~~~~s~~~~~li~~~l~~~p~ 239 (278)
T cd05606 210 -------------------------------------------MTL----TMAV---ELPDSFSPELRSLLEGLLQRDVN 239 (278)
T ss_pred -------------------------------------------Hhh----ccCC---CCCCcCCHHHHHHHHHHhhcCHH
Confidence 000 0000 11123578899999999999999
Q ss_pred CCC-----CHHHHhcCccccCC
Q 007542 345 DRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 345 ~Rp-----Ta~e~L~HP~f~~~ 361 (599)
+|+ ++.++|+||||++.
T Consensus 240 ~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 240 RRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred hccCCCCCCHHHHHhCccccCC
Confidence 999 99999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=344.07 Aligned_cols=267 Identities=32% Similarity=0.519 Sum_probs=212.4
Q ss_pred cccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
++|--+|.+.++= -+||+|.||+||.|+|+.|...+|||.|.. ......+.+..||.+-++|+|.|||++++.+
T Consensus 568 iefeYeyde~~er---vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~- 641 (1226)
T KOG4279|consen 568 IEFEYEYDESNER---VVLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV- 641 (1226)
T ss_pred eEEEeeecCCCce---EEeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-
Confidence 3343444444332 369999999999999999999999999853 3344567788999999999999999999987
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-CCceee
Q 007542 93 PPSRREFKDIYVVFELME-SDLHQVIKA-NDDL--TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKI 167 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~-~~~l--se~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-~~~lKL 167 (599)
.+.+++-|.||-++ |+|.+++++ .|++ .|..+.++..||++||+|||.+.|||||||-+|+|||. .|.+||
T Consensus 642 ----senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKI 717 (1226)
T KOG4279|consen 642 ----SENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKI 717 (1226)
T ss_pred ----CCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEe
Confidence 33457888999998 699999986 4777 89999999999999999999999999999999999986 699999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
+|||-++....-++.. .+..||..|||||++.....+|+.++|||||||++.||.||+|||-. +
T Consensus 718 SDFGTsKRLAginP~T---ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E-------------l 781 (1226)
T KOG4279|consen 718 SDFGTSKRLAGINPCT---ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE-------------L 781 (1226)
T ss_pred cccccchhhccCCccc---cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee-------------c
Confidence 9999998764433332 45679999999999966558899999999999999999999999964 2
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
|.|...... ++ |-+.- ..+...+
T Consensus 782 gspqAAMFk--------------------------VG---------------------------myKvH----P~iPeel 804 (1226)
T KOG4279|consen 782 GSPQAAMFK--------------------------VG---------------------------MYKVH----PPIPEEL 804 (1226)
T ss_pred CChhHhhhh--------------------------hc---------------------------ceecC----CCCcHHH
Confidence 333221110 00 00000 0111236
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+.+|+.||.+|+.+||.+||+|.++|++||++.-.
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 77899999999999999999999999999998763
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.99 Aligned_cols=256 Identities=22% Similarity=0.374 Sum_probs=201.8
Q ss_pred eEEEEEeeecCceEEEEEEECCCCc--EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCcc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFKD 101 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~--~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~~~~~ 101 (599)
|.+.++||+|+||.||+|.+..++. .||+|.++...........+.+|+.+|+.++|+||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999887775 69999987655555667788899999999999999999998754322 22346
Q ss_pred EEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 102 IYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~------~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 899999999 699988742 2347899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
........ .......++..|++||.+.+ ..++.++|||||||++|+|++ |++||.+.+.......+.+
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------- 229 (272)
T cd05075 161 KIYNGDYY-RQGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-------- 229 (272)
T ss_pred ccCcccce-ecCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Confidence 65432211 01122345678999999877 678999999999999999999 8999987654332222211
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
... ....+..+..+.+
T Consensus 230 -------------------------------------------------------------~~~---~~~~~~~~~~~~~ 245 (272)
T cd05075 230 -------------------------------------------------------------GNR---LKQPPDCLDGLYS 245 (272)
T ss_pred -------------------------------------------------------------CCC---CCCCCCCCHHHHH
Confidence 000 0112346677999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 007542 334 LLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~H 355 (599)
||.+||+.||.+|||+.+++++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 246 LMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=318.56 Aligned_cols=257 Identities=31% Similarity=0.499 Sum_probs=207.7
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~---HpnIv~l~~v~~~~s~~~~~ 100 (599)
.|++++.||+|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.++ |||++++++++.. ..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CC
Confidence 5888999999999999999999999999999986432 2234567889999999997 9999999998843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 7899999998 5899888664 7999999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ......++..|+|||.+.+. ..++.++|+||+||++|+|++|.+||.+.+.......+.
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--------------- 215 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--------------- 215 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---------------
Confidence 21 12345788999999987542 457889999999999999999999997654332211110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
...+..+. ....+..+.+||.+||
T Consensus 216 ------------------------------------------------------~~~~~~~~--~~~~~~~~~~~i~~~l 239 (277)
T cd06917 216 ------------------------------------------------------KSKPPRLE--DNGYSKLLREFVAACL 239 (277)
T ss_pred ------------------------------------------------------cCCCCCCC--cccCCHHHHHHHHHHc
Confidence 00000000 0125678999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCc
Q 007542 340 AFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+.||.+|||+.|++.||||+...
T Consensus 240 ~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 240 DEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999998654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=319.21 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=202.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|.+.+.||+|+||.||+|.+.. ++..||||+++.... ......+.+|+.+|+.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence 4578999999999999999998753 468899999875322 22456788999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND--------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~--------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~ 161 (599)
..+|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus 81 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 81 ---DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ---CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 47899999998 69999997643 4788999999999999999999999999999999999999
Q ss_pred CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 007542 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 240 (599)
Q Consensus 162 ~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l 240 (599)
++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++++|++ |..||.+.+.....
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999754322111 11233456788999999876 678999999999999999998 99999776654433
Q ss_pred HHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCC
Q 007542 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320 (599)
Q Consensus 241 ~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 320 (599)
..+.... .
T Consensus 235 ~~~~~~~------------------------------------------------------------------------~ 242 (280)
T cd05049 235 ECITQGR------------------------------------------------------------------------L 242 (280)
T ss_pred HHHHcCC------------------------------------------------------------------------c
Confidence 3222100 0
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 321 ~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.......+..+.+||.+||+.||.+|||+.|+|+
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0111246778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.64 Aligned_cols=259 Identities=22% Similarity=0.369 Sum_probs=202.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|++.++||+|+||.||+|.++. .+..||+|.++... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 5789999999999999999997652 35589999886432 223345678999999999999999999998433
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCce
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~l 165 (599)
...|+||||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 ---QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred ---CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 46899999998 69999997532 34567888999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 007542 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~ 244 (599)
||+|||+++......... ......++..|+|||.+.+ ..++.++||||+||++++|++ |.+||.+.+..+.+..+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999997643222111 1122345677999999876 578999999999999999998 788997765443332221
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
+. . .....
T Consensus 236 ~~---------------------------------------------------------------------~---~~~~~ 243 (288)
T cd05061 236 DG---------------------------------------------------------------------G---YLDQP 243 (288)
T ss_pred cC---------------------------------------------------------------------C---CCCCC
Confidence 10 0 00011
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc------CccccCC
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALA------DPYFKGL 361 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~------HP~f~~~ 361 (599)
...++.+.+||.+||+.||++|||+.++++ ||||.++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 234678999999999999999999999987 9999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.92 Aligned_cols=255 Identities=28% Similarity=0.412 Sum_probs=206.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
..|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCce
Confidence 45777889999999999999999999999999986432 22345678899999999999999999998843 3468
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+|+||++ ++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999 589888764 5689999999999999999999999999999999999999999999999999876532211
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++..|+|||.+.+ ..++.++|+||+||++++|++|+.||...........+.
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP----------------- 214 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-----------------
Confidence 1123467889999999877 578899999999999999999999986543222111100
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
...+ .......+..+.+||.+||+.
T Consensus 215 ----------------------------------------------------~~~~---~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06642 215 ----------------------------------------------------KNSP---PTLEGQYSKPFKEFVEACLNK 239 (277)
T ss_pred ----------------------------------------------------cCCC---CCCCcccCHHHHHHHHHHccC
Confidence 0000 011123567799999999999
Q ss_pred CCCCCCCHHHHhcCccccCC
Q 007542 342 EPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~ 361 (599)
||.+|||+.++|+||||..+
T Consensus 240 ~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 240 DPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CcccCcCHHHHHHhHHHHHH
Confidence 99999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.80 Aligned_cols=263 Identities=21% Similarity=0.379 Sum_probs=207.8
Q ss_pred ceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~--~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~ 97 (599)
.|++.+.||.|+||.||+|.+. .+|..||+|++.... ......+.+.+|+.+|+.+ +|+||+.+++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 4899999999999999999875 478999999986422 1223456778999999999 59999999988843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|+|+||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||+++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 347899999999 599999988888999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
..... .......++..|+|||.+.+....++.++||||+||++++|++|..||...........+..
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----------- 222 (290)
T cd05613 156 HEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR----------- 222 (290)
T ss_pred ccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----------
Confidence 32211 11234568899999999865324577899999999999999999999965432211111110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.+.... .+ ....+++.+.+||+
T Consensus 223 ------------------------------------------------------~~~~~~-~~---~~~~~~~~~~~ll~ 244 (290)
T cd05613 223 ------------------------------------------------------RILKSE-PP---YPQEMSALAKDIIQ 244 (290)
T ss_pred ------------------------------------------------------HhhccC-CC---CCccCCHHHHHHHH
Confidence 000000 00 11246788999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCccccCCc
Q 007542 337 RMLAFEPKDRP-----TAEEALADPYFKGLA 362 (599)
Q Consensus 337 ~mL~~DP~~Rp-----Ta~e~L~HP~f~~~~ 362 (599)
+||+.||.+|+ +++++++||||..+.
T Consensus 245 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 245 RLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 99999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=314.03 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=197.0
Q ss_pred EeeecCceEEEEEEE--CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 30 VIGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~--~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
.||+|+||.||+|.+ ..++..||+|+++...........+.+|+.+++.++|+||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999964 5678999999987554444556778899999999999999999998732 25689999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 108 ~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
|+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999 6899999887889999999999999999999999999999999999999999999999999998654332211111
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+.......+...
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~------------------- 214 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG------------------- 214 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-------------------
Confidence 22334578999999865 578899999999999999998 99999876554433332210
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
... ...+..++.+.+||.+||+.||.+
T Consensus 215 --------------------------------------------------~~~---~~~~~~~~~l~~li~~~~~~~p~~ 241 (257)
T cd05116 215 --------------------------------------------------ERM---ECPQRCPPEMYDLMKLCWTYGVDE 241 (257)
T ss_pred --------------------------------------------------CCC---CCCCCCCHHHHHHHHHHhccCchh
Confidence 000 111346788999999999999999
Q ss_pred CCCHHHHhc
Q 007542 346 RPTAEEALA 354 (599)
Q Consensus 346 RpTa~e~L~ 354 (599)
|||++++..
T Consensus 242 Rp~~~~i~~ 250 (257)
T cd05116 242 RPGFAVVEL 250 (257)
T ss_pred CcCHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.45 Aligned_cols=254 Identities=20% Similarity=0.367 Sum_probs=199.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
..++|++.+.||+|+||.||+|.+.. ++..||||++... ........+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--- 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--- 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence 35789999999999999999998652 4578999998642 22334566889999999999999999999983
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~ 164 (599)
+...+++||||+. ++|.+++.... .++...+..++.|++.||.|||+.|++|+||||+|||++.++.
T Consensus 80 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 --QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred --CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 3347899999999 69999987532 3567888999999999999999999999999999999999999
Q ss_pred eeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 007542 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIM 243 (599)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I 243 (599)
++|+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+....+..+
T Consensus 158 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred EEECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999987643222111 1122345778999999876 578999999999999999998 78899876554433322
Q ss_pred HHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC
Q 007542 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323 (599)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 323 (599)
... . +...
T Consensus 235 ~~~---------------------------------------------------------------------~---~~~~ 242 (277)
T cd05062 235 MEG---------------------------------------------------------------------G---LLDK 242 (277)
T ss_pred HcC---------------------------------------------------------------------C---cCCC
Confidence 110 0 0001
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 324 FPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 324 ~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
....++.+.+||.+||+.||.+|||+.|+|++
T Consensus 243 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 243 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12356779999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=336.09 Aligned_cols=205 Identities=27% Similarity=0.441 Sum_probs=168.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++.+.||+|+||+||+|++..+| ..||||+++... .......+.+|+.+|+.+ +|+||+++++.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 468999999999999999999865444 579999997432 223456788999999999 89999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (599)
...+|+||||+. |+|.+++...
T Consensus 114 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 114 ---GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ---CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 347899999999 6999988542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcc
Q 007542 121 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (599)
Q Consensus 121 ----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 184 (599)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 13678889999999999999999999999999999999999999999999999765332211 1
Q ss_pred cccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 185 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
......++..|+|||++.+ ..++.++||||+||++|+|++ |+.||.+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 1122345667999999876 679999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=355.33 Aligned_cols=148 Identities=24% Similarity=0.409 Sum_probs=133.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-++|.+++.||+|+||.||+|++..+++.||||+++... ........+.+|+.+++.++|+||++++.++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 468999999999999999999999999999999996432 23334567889999999999999999998883 335
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.+||||||+. ++|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 7999999997 6999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.70 Aligned_cols=264 Identities=26% Similarity=0.389 Sum_probs=212.5
Q ss_pred cccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecC
Q 007542 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~ 93 (599)
++......+.|...+.||+|+||.||+|.+..+|+.|++|++..... .......+.+|+.+++.++|||++++++++..
T Consensus 13 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 13 LFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhccCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 33444555668889999999999999999999999999999864322 22344678899999999999999999999854
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccc
Q 007542 94 PSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
....|+||||+.++|.+++.. ...+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.+||+|||+
T Consensus 93 -----~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 93 -----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred -----CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCC
Confidence 346899999999999888865 34789999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
+..... .....++..|+|||++... ...++.++||||+||++++|++|.+||.+.+....+..+....
T Consensus 168 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---- 236 (313)
T cd06633 168 ASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---- 236 (313)
T ss_pred CcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----
Confidence 854311 1345788899999997421 1457889999999999999999999998766544333221100
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
.+ ....+..+..+
T Consensus 237 ----------------------------------------------------------------~~---~~~~~~~~~~l 249 (313)
T cd06633 237 ----------------------------------------------------------------SP---TLQSNEWTDSF 249 (313)
T ss_pred ----------------------------------------------------------------CC---CCCccccCHHH
Confidence 00 00113456778
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+||.+||+.||.+|||+.++|.||||...
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=330.70 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=199.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++.++||+|+||.||+|++.. +++.||+|+++... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 4689999999999999999997543 45789999987432 233456778999999999 799999999988533
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (599)
...+|+||||+. ++|.+++...
T Consensus 84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 247899999999 5899888642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCc
Q 007542 121 -------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193 (599)
Q Consensus 121 -------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~ 193 (599)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ........++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~-~~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-hhhccCCCCCc
Confidence 2578899999999999999999999999999999999999999999999999986532221 11123345677
Q ss_pred cccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCC
Q 007542 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGF 272 (599)
Q Consensus 194 ~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~ 272 (599)
.|+|||++.+ ..++.++|||||||++++|++ |..||.+....+.+.....
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~--------------------------- 290 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK--------------------------- 290 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh---------------------------
Confidence 8999999877 679999999999999999997 9999976433221111100
Q ss_pred cccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 007542 273 MCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 352 (599)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~ 352 (599)
..... ......++.+.+++.+||+.+|++|||++|+
T Consensus 291 -----------------------------------------~~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 291 -----------------------------------------EGTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred -----------------------------------------ccCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00000 0012456789999999999999999999999
Q ss_pred hcC
Q 007542 353 LAD 355 (599)
Q Consensus 353 L~H 355 (599)
++|
T Consensus 327 l~~ 329 (337)
T cd05054 327 VEI 329 (337)
T ss_pred HHH
Confidence 986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=334.80 Aligned_cols=205 Identities=29% Similarity=0.467 Sum_probs=168.4
Q ss_pred CCceEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++.++||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~- 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG- 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-
Confidence 35899999999999999999964 3567789999986432 233456788999999999 899999999998443
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-----------------------------------------------------
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------------------------------------------------- 121 (599)
...|+||||+. |+|.+++....
T Consensus 112 ----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 112 ----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred ----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 46899999999 69998886431
Q ss_pred ----------------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 122 ----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 122 ----------------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 3678889999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
... .......++..|+|||++.+ ..++.++|||||||++++|++ |..||.+..
T Consensus 268 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 268 SNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred ccc-cccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 211 11122345667999999976 678999999999999999998 889997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=306.71 Aligned_cols=251 Identities=32% Similarity=0.545 Sum_probs=207.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.|++.+.||+|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 48899999999999999999999999999999975332 3567888999999999999999999998543 4689
Q ss_pred EEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 104 VVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
+|+||++ ++|.+++... ..+++..+..++.|++.||.+||.+|++|+||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999999876 5799999999999999999999999999999999999999999999999999977644321
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
.....++..|++||.+.+ ..++.++|+||+||++++|++|+.||...+....+..+.. ..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~------------- 213 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NG------------- 213 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cC-------------
Confidence 234568889999999876 4588999999999999999999999977654333222211 00
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
...+ .....++..+.+||.+||+.
T Consensus 214 -------------------------------------------------------~~~~-~~~~~~~~~~~~~i~~~l~~ 237 (253)
T cd05122 214 -------------------------------------------------------PPGL-RNPEKWSDEFKDFLKKCLQK 237 (253)
T ss_pred -------------------------------------------------------CCCc-CcccccCHHHHHHHHHHccC
Confidence 0000 00011367899999999999
Q ss_pred CCCCCCCHHHHhcCcc
Q 007542 342 EPKDRPTAEEALADPY 357 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~ 357 (599)
||++|||+.|+|+|||
T Consensus 238 ~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 238 NPEKRPTAEQLLKHPF 253 (253)
T ss_pred ChhhCCCHHHHhcCCC
Confidence 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.52 Aligned_cols=253 Identities=22% Similarity=0.370 Sum_probs=200.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.+.|++.+.||+|++|.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 3679999999999999999999987 7889999988632 2223345688999999999999999999988433
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC---ce
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 165 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~---~l 165 (599)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++++||||||+|||++.++ .+
T Consensus 82 ---~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 ---LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcce
Confidence 45799999997 69999997653 488999999999999999999999999999999999998765 59
Q ss_pred eeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 007542 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~ 244 (599)
||+|||+++........ ........+..|+|||++.+ ..++.++|||||||++++|++ |+.||.+.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 159 KIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred EeccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999865322111 00112233567999999876 579999999999999999997 999998766544332221
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
... .. ...
T Consensus 236 ~~~---------------------------------------------------------------------~~---~~~ 243 (277)
T cd05036 236 GGG---------------------------------------------------------------------RL---DPP 243 (277)
T ss_pred cCC---------------------------------------------------------------------cC---CCC
Confidence 100 00 011
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
...+..+.+||.+||+.||++|||+.++|+|
T Consensus 244 ~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 244 KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.51 Aligned_cols=247 Identities=22% Similarity=0.350 Sum_probs=195.9
Q ss_pred CceEEEEEe--eecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 23 SRYKIEEVI--GKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~I--G~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
+.|++.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.+...+ +|+||+++++.+...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~----- 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL----- 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----
Confidence 566776666 99999999999999999999999986421111 123333222 699999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-ceeeeccccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-~lKL~DFGla~~~~ 177 (599)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 47999999998 69999998888899999999999999999999999999999999999999998 99999999987653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~-l~~I~~~lg~p~~e~i~ 256 (599)
.. ....++..|+|||++.+ ..++.++|+||+||++++|++|+.||.+...... ...+.
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 220 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL------------ 220 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH------------
Confidence 21 23467889999999976 5788999999999999999999999975432210 00000
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
... . ......+..++.+.+||.
T Consensus 221 -----------------------------------------------------~~~--~---~~~~~~~~~~~~~~~li~ 242 (267)
T PHA03390 221 -----------------------------------------------------KRQ--Q---KKLPFIKNVSKNANDFVQ 242 (267)
T ss_pred -----------------------------------------------------Hhh--c---ccCCcccccCHHHHHHHH
Confidence 000 0 001122357899999999
Q ss_pred HhcccCCCCCCC-HHHHhcCccccC
Q 007542 337 RMLAFEPKDRPT-AEEALADPYFKG 360 (599)
Q Consensus 337 ~mL~~DP~~RpT-a~e~L~HP~f~~ 360 (599)
+||+.||.+|++ ++|+|+||||..
T Consensus 243 ~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 243 SMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHhccChhhCCchHHHHhcCCcccC
Confidence 999999999996 599999999963
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.88 Aligned_cols=247 Identities=29% Similarity=0.452 Sum_probs=204.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
+.+++++.||+|-||.||.|... ....||+|.++.. ....+.+++|+.+|+.|+|+|||++++++... .-+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~pi 276 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPI 276 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----Cce
Confidence 34566799999999999999753 2348999999743 34456788999999999999999999999432 269
Q ss_pred EEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 103 YVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
|||||||. |+|.++++. ...+.......|+.||++|++||+++++|||||-..||||+.++.+||+|||+|+...++
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999 899999997 357899999999999999999999999999999999999999999999999999965433
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.... ....--..-|.|||.+.. ..++.++||||+|++|+||+| |+.||++.+..+.++.+.+-.--|-|
T Consensus 357 ~Y~~--~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P------ 426 (468)
T KOG0197|consen 357 EYTA--SEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP------ 426 (468)
T ss_pred ceee--cCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC------
Confidence 3221 122333456999999976 789999999999999999998 99999999988887776542222211
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
+..++.+.+++..|
T Consensus 427 ------------------------------------------------------------------~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 427 ------------------------------------------------------------------EGCPDEVYELMKSC 440 (468)
T ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHH
Confidence 35788899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 007542 339 LAFEPKDRPTAEEALA 354 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~ 354 (599)
+..+|++|||.+.+..
T Consensus 441 W~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLRE 456 (468)
T ss_pred hhCCcccCCCHHHHHH
Confidence 9999999999997653
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.82 Aligned_cols=260 Identities=32% Similarity=0.520 Sum_probs=214.3
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
-+..+.|++.+.||+|++|.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+...
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 87 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG---- 87 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC----
Confidence 4567889999999999999999999999999999999964322 456788999999999999999999998543
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
..+|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 88 -DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred -CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 47999999999 69999998876 8999999999999999999999999999999999999999999999999998654
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
..... ......++..|++||++.+ ..++.++|+||||||+|+|++|+.||.+.+.......+...
T Consensus 167 ~~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~---------- 231 (286)
T cd06614 167 TKEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK---------- 231 (286)
T ss_pred ccchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------
Confidence 32211 1123457788999999876 56889999999999999999999999776544332222110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.. +.......++..+.+||.
T Consensus 232 -----------------------------------------------------------~~-~~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 232 -----------------------------------------------------------GI-PPLKNPEKWSPEFKDFLN 251 (286)
T ss_pred -----------------------------------------------------------CC-CCCcchhhCCHHHHHHHH
Confidence 00 000111235678999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||+.||.+|||+.++|+||||...
T Consensus 252 ~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HHhccChhhCcCHHHHhhChHhhcc
Confidence 9999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.71 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=200.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcE----EEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~----VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
...+|++.+.||+|+||.||+|.+..+++. ||||+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--
Confidence 346799999999999999999998766664 899988642 2234456788999999999999999999998542
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..++|+||+. |+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 82 ----~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ----CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 4689999998 69999998754 68899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~-------- 226 (316)
T cd05108 158 LLGADEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------- 226 (316)
T ss_pred cccCCCcc-eeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC--------
Confidence 75432211 11122334667999999876 678999999999999999997 9999977543322111100
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.... ...+..+..+.+
T Consensus 227 -------------------------------------------------------------~~~~---~~~~~~~~~~~~ 242 (316)
T cd05108 227 -------------------------------------------------------------GERL---PQPPICTIDVYM 242 (316)
T ss_pred -------------------------------------------------------------CCCC---CCCCCCCHHHHH
Confidence 0000 011335677899
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 007542 334 LLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~H 355 (599)
++.+||..||.+|||+.+++.+
T Consensus 243 li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 243 IMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=311.66 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=200.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|+++++||+|++|.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCC
Confidence 468999999999999999999864 5678999987642 2345678899999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999998 6999998753 4688999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.........+....
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---------- 221 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2211 1123345678999999876 578899999999999999998 999998765444332221100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. ......+..+.+||.+
T Consensus 222 -----------------------------------------------------------~~---~~~~~~~~~~~~li~~ 239 (261)
T cd05072 222 -----------------------------------------------------------RM---PRMENCPDELYDIMKT 239 (261)
T ss_pred -----------------------------------------------------------CC---CCCCCCCHHHHHHHHH
Confidence 00 1123467789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||++|||++++++
T Consensus 240 ~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 240 CWKEKAEERPTFDYLQS 256 (261)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.61 Aligned_cols=246 Identities=26% Similarity=0.440 Sum_probs=202.3
Q ss_pred EEeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
+.||+|+||.||+|.+... +..|++|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEE
Confidence 4699999999999999866 8999999997543332 46788899999999999999999999854 3579999
Q ss_pred EecCC-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 106 FELME-SDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 106 ~E~~~-g~L~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||.++.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 6899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...... ........++..|+|||.+.. ..++.++|||||||++++|++ |..||.+.+..+..+.+.+ +
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~------ 223 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--G------ 223 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--C------
Confidence 643321 111234567888999999876 578999999999999999999 6999987654443333221 0
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
. ........++.+.++
T Consensus 224 -------------------------------------------------------------~---~~~~~~~~~~~~~~l 239 (262)
T cd00192 224 -------------------------------------------------------------Y---RLPKPEYCPDELYEL 239 (262)
T ss_pred -------------------------------------------------------------C---CCCCCccCChHHHHH
Confidence 0 001123457889999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 007542 335 LERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~H 355 (599)
|.+||..||.+|||++|+++|
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=312.91 Aligned_cols=202 Identities=29% Similarity=0.492 Sum_probs=172.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++.+.||+|+||.||+|++..+++.||||+++.. .........+.+|+.+|+.++||||+++++.+.. ...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence 5899999999999999999999999999999988642 2233445678899999999999999999998843 347
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+|+|+||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 899999999 589888753 345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~ 234 (599)
..... ......++..|+|||.+.+ ..++.++|+||+||++++|++|+.||...
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 32221 1233468889999999876 56889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.95 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=207.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
+-|++++.||+|+||.||+|.+..+++.||||.+.... .......+.+|+.+++.++||||+++++.+.. ...+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 77 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKL 77 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-----CCeE
Confidence 34778899999999999999999999999999886432 22345678899999999999999999999843 3578
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+||||+. ++|.+++.. ..+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999 588888864 4689999999999999999999999999999999999999999999999999876532211
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++.+|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+.......+..
T Consensus 157 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------- 215 (277)
T cd06641 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---------------- 215 (277)
T ss_pred ---hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc----------------
Confidence 1234568889999999876 5678899999999999999999999976443322221100
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
.. ........+..+.++|.+||..
T Consensus 216 -----------------------------------------------------~~---~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 216 -----------------------------------------------------NN---PPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred -----------------------------------------------------CC---CCCCCcccCHHHHHHHHHHccC
Confidence 00 0011234677899999999999
Q ss_pred CCCCCCCHHHHhcCccccCC
Q 007542 342 EPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~ 361 (599)
||.+||++.++|+||||...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=310.50 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=198.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|+||.||+|..+ .+..+|+|.+... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-----QKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEcc-----CCCE
Confidence 57899999999999999999864 4568999987632 2234567889999999999999999998843 3468
Q ss_pred EEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 103 YVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
|+||||+. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999998 6999998754 468999999999999999999999999999999999999999999999999987643222
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ......++..|+|||.+.+ ..++.++||||+||++++|++ |++||.+.+..+.+..+.....
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~----------- 219 (256)
T cd05114 155 YT--SSSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR----------- 219 (256)
T ss_pred ee--ccCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-----------
Confidence 11 1122345567999999876 578899999999999999999 9999987765554444322100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
... ....+..+.+||.+||
T Consensus 220 ----------------------------------------------------------~~~---~~~~~~~~~~li~~c~ 238 (256)
T cd05114 220 ----------------------------------------------------------LYR---PKLASMTVYEVMYSCW 238 (256)
T ss_pred ----------------------------------------------------------CCC---CCCCCHHHHHHHHHHc
Confidence 000 0124567899999999
Q ss_pred ccCCCCCCCHHHHhc
Q 007542 340 AFEPKDRPTAEEALA 354 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~ 354 (599)
+.||.+|||++++++
T Consensus 239 ~~~p~~Rps~~~l~~ 253 (256)
T cd05114 239 HEKPEGRPTFAELLR 253 (256)
T ss_pred cCCcccCcCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=310.21 Aligned_cols=245 Identities=23% Similarity=0.402 Sum_probs=192.9
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~ 108 (599)
+.||+|+||.||+|+++.+++.||+|.+.... .......+.+|+.+|+.++||||+++++++.. ...+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEee
Confidence 46999999999999999999999999886432 23345678899999999999999999999843 3468999999
Q ss_pred CC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 109 ME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 109 ~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
+. ++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......... ..
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-cC
Confidence 98 59999987644 68999999999999999999999999999999999999999999999999987543221110 01
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+..
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------------------- 211 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------------------- 211 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------------
Confidence 11123456999999876 568899999999999999997 8888865443222111110
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
..+.. .....+..+.+||.+||+.||.+
T Consensus 212 -------------------------------------------------~~~~~---~~~~~~~~~~~li~~~l~~~p~~ 239 (252)
T cd05084 212 -------------------------------------------------GVRLP---CPELCPDAVYRLMERCWEYDPGQ 239 (252)
T ss_pred -------------------------------------------------CCCCC---CcccCCHHHHHHHHHHcCCChhh
Confidence 00001 11235678999999999999999
Q ss_pred CCCHHHHhc
Q 007542 346 RPTAEEALA 354 (599)
Q Consensus 346 RpTa~e~L~ 354 (599)
|||+.++++
T Consensus 240 Rps~~~~~~ 248 (252)
T cd05084 240 RPSFSTVHQ 248 (252)
T ss_pred CcCHHHHHH
Confidence 999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.46 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=208.9
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.....|...+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++|+|++++++++...
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 97 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE---- 97 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC----
Confidence 334558999999999999999999999999999999864322 223456788999999999999999999998543
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++....
T Consensus 98 -~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 98 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred -CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 46899999999999888765 4578999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCcccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.. ....++..|+|||++.. ....++.++||||+||++++|++|++||.+.+....+..+.....
T Consensus 177 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-------- 241 (317)
T cd06635 177 PA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------- 241 (317)
T ss_pred Cc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC--------
Confidence 21 23468889999998742 114578899999999999999999999876554433332221100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
+ .......++.+.+||.
T Consensus 242 ------------------------------------------------------------~---~~~~~~~~~~l~~li~ 258 (317)
T cd06635 242 ------------------------------------------------------------P---TLQSNEWSDYFRNFVD 258 (317)
T ss_pred ------------------------------------------------------------C---CCCCccccHHHHHHHH
Confidence 0 0011235677999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+||+.||.+|||+.++++|+|+..
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhc
Confidence 999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=305.37 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=179.8
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
+-.++||.+.+.||+|+|+-||++.+..+++.||+|+|.... ..+.+..++|+..-++++||||+++++.......+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 456899999999999999999999999999999999997533 567788999999999999999999999887655555
Q ss_pred CccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCCCceeeeccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
....|||++|.. |+|.+.|.. ...++|.++..|+.+|++||++||... ..||||||.|||+.+++..+|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 667999999999 789998864 237999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc------ccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 007542 172 LARVAFNDTPTA------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 172 la~~~~~~~~~~------~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
.++...-..... -.+.....|..|+|||++.- .....+.++|||||||+||.|+.|..||.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 997643211111 11334457889999999743 12457889999999999999999999995
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.74 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=197.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCc--EEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~--~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
++|++.++||+|+||.||+|++..++. .+++|.++. .........+.+|+.++.++ +||||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-----R 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----C
Confidence 579999999999999999999887765 468888763 23334456788999999999 79999999998843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC
Q 007542 100 KDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~ 162 (599)
..+|+|+||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 46899999998 69999997532 47889999999999999999999999999999999999999
Q ss_pred CceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 007542 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (599)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~ 241 (599)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864321111 111223456999999876 578999999999999999997 999998766544333
Q ss_pred HHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCc
Q 007542 242 IMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321 (599)
Q Consensus 242 ~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 321 (599)
.+.... . .
T Consensus 230 ~~~~~~---------------------------------------------------------------------~---~ 237 (297)
T cd05089 230 KLPQGY---------------------------------------------------------------------R---M 237 (297)
T ss_pred HHhcCC---------------------------------------------------------------------C---C
Confidence 221100 0 0
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 322 ~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.....+++.+.+||.+||+.||.+|||++++++.
T Consensus 238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1113467889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.28 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=200.7
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
...|.+.+.||+|+||.||++.+. .++..||+|.+... .......+.+|+.+|+.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--- 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 467999999999999999999853 35567999988642 23345678899999999999999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND-------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~ 162 (599)
...+|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 79 --GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred --CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 346899999998 69999997543 48999999999999999999999999999999999999999
Q ss_pred CceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHH
Q 007542 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241 (599)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~ 241 (599)
+.+||+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++++|++ |.+||.+.+..+.+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred CcEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999976532211 111233445778999999876 678999999999999999998 999997766444333
Q ss_pred HHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCc
Q 007542 242 IMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321 (599)
Q Consensus 242 ~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 321 (599)
.+... ...
T Consensus 234 ~i~~~---------------------------------------------------------------------~~~--- 241 (288)
T cd05093 234 CITQG---------------------------------------------------------------------RVL--- 241 (288)
T ss_pred HHHcC---------------------------------------------------------------------CcC---
Confidence 32210 000
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 322 ~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
......++.+.+||.+||+.||.+|||+.|++.
T Consensus 242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011235678999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=347.05 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=204.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccce-eecCCCcCC-
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKH-ILLPPSRRE- 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~-v~~~~s~~~- 98 (599)
.-+++|.++|.+|+|+.||+|.+...|..||+|++-. .+......+.+||.+|+.|+ |+|||.+++ .........
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~--~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV--NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec--CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4678999999999999999999999889999999853 26667788999999999998 999999999 333332222
Q ss_pred CccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCCCceeeeccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
.-.++|+||||. |.|.+++... ..|+|.++.+|++|+++||.+||... |||||||-+||||+.+|..||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 356889999999 6999999743 46999999999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCCCc---ccc---cccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 007542 174 RVAFNDTPTA---IFW---TDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (599)
Q Consensus 174 ~~~~~~~~~~---~~~---~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~ 246 (599)
.-........ ... -....|+.|||||.|.-. ....+.++|||+|||+||-||....||.+......+
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl------ 267 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL------ 267 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE------
Confidence 6533221110 000 123568999999987321 145789999999999999999999999765321100
Q ss_pred cCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC
Q 007542 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN 326 (599)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 326 (599)
+.+ --...++.
T Consensus 268 -------------------------------------------------------ng~--------------Y~~P~~p~ 278 (738)
T KOG1989|consen 268 -------------------------------------------------------NGN--------------YSFPPFPN 278 (738)
T ss_pred -------------------------------------------------------ecc--------------ccCCCCcc
Confidence 000 00112367
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.+..+.+||+.||+.||.+||++.|++.+
T Consensus 279 ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 279 YSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 88899999999999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=309.17 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=199.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|++|.||+|.+. +++.||||.++... .....+.+|+.+++.++|+||+++++++.. .+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEP 75 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCC
Confidence 467999999999999999999875 45789999986432 234568899999999999999999998743 346
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 899999996 79999997654 689999999999999999999999999999999999999999999999999987642
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
..... ......+..|+|||++.+ ..++.++|||||||++++|++ |+.||.+.+....+..+....
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05068 156 DIYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---------- 221 (261)
T ss_pred Ccccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence 21111 111223457999999876 678999999999999999999 999998766544333322110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
..+ .....+..+.+|+.+
T Consensus 222 -----------------------------------------------------------~~~---~~~~~~~~~~~li~~ 239 (261)
T cd05068 222 -----------------------------------------------------------RMP---CPPGCPKELYDIMLD 239 (261)
T ss_pred -----------------------------------------------------------CCC---CCCcCCHHHHHHHHH
Confidence 000 112456789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||.+|||+.++++
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=310.60 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=201.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.++|++.+.||+|+||+||+|.++.+ ...||||+++... .......+.+|+.+++.++|+||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----- 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----
Confidence 46799999999999999999988654 4589999886432 23345678899999999999999999998843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|+||||+. ++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 346899999998 5999998764 47899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.+..
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (266)
T cd05033 157 EDSEATY-TTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-------- 225 (266)
T ss_pred cccccce-eccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC--------
Confidence 4221111 1112334578999999876 678999999999999999998 999987655433322221100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
..+ .....++.+.+|+
T Consensus 226 -------------------------------------------------------------~~~---~~~~~~~~l~~li 241 (266)
T cd05033 226 -------------------------------------------------------------RLP---PPMDCPSALYQLM 241 (266)
T ss_pred -------------------------------------------------------------CCC---CCCCCCHHHHHHH
Confidence 000 0124577899999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 007542 336 ERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~H 355 (599)
.+||+.||++|||++|++++
T Consensus 242 ~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 242 LDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.18 Aligned_cols=257 Identities=28% Similarity=0.520 Sum_probs=208.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
..|+...+||+|+||.||++.+..+++.||||++... .......+.+|+.+++.++|+||+++++.+.. ....
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEE
Confidence 3344457899999999999999999999999998532 23345678899999999999999999999843 3578
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+||||+.+ +|.+++. .+.+++..++.++.||+.+|+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 999999985 7888765 45689999999999999999999999999999999999999999999999999875533221
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++..|+|||.+.+ ..++.++|+||+||++++|++|.+||.+.+....+..+...+
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-------------- 232 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------- 232 (292)
T ss_pred ---cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--------------
Confidence 1234568899999999876 578899999999999999999999998766544333222100
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
+..+ ......++.+.+||.+||+.
T Consensus 233 -------------------------------------------------------~~~~-~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 233 -------------------------------------------------------PPKL-KNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred -------------------------------------------------------Cccc-CCcccCCHHHHHHHHHHHhC
Confidence 0001 11234677899999999999
Q ss_pred CCCCCCCHHHHhcCccccCCc
Q 007542 342 EPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~~ 362 (599)
||.+|||+.++|+||||....
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CcccCcCHHHHhcChHHhccC
Confidence 999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=329.55 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=214.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecC-ccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.+.|..-++||+|+||.||-++.+.||+-||.|++.+ .........-.++|-.+|.+++.+.||.+--.|. +..
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe-----Tkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE-----TKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec-----CCC
Confidence 4667888999999999999999999999999999853 2222333445679999999999999999988884 445
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
.+++|+.+|+ |||+-.|...+ .+++..+.+++.+|+.||.+||+.+||.|||||+|||+|+.|+++|+|+|||.-+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 7999999999 59998887766 89999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.+.+ .+..+||..|||||++.. ..|+...|-|||||++|||+.|+.||...-...--+.+
T Consensus 339 ~g~~----~~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv-------------- 398 (591)
T KOG0986|consen 339 EGKP----IRGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV-------------- 398 (591)
T ss_pred CCCc----cccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH--------------
Confidence 4443 356699999999999987 56999999999999999999999999754322111111
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.+-+ ...+..++ ..+|+++++|.+.
T Consensus 399 ------------------------------------------------drr~----~~~~~ey~---~kFS~eakslc~~ 423 (591)
T KOG0986|consen 399 ------------------------------------------------DRRT----LEDPEEYS---DKFSEEAKSLCEG 423 (591)
T ss_pred ------------------------------------------------HHHH----hcchhhcc---cccCHHHHHHHHH
Confidence 1111 11111111 3578999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCccccCCc
Q 007542 338 MLAFEPKDRP-----TAEEALADPYFKGLA 362 (599)
Q Consensus 338 mL~~DP~~Rp-----Ta~e~L~HP~f~~~~ 362 (599)
+|+.||.+|. +++++-+||||+++.
T Consensus 424 LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 424 LLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 9999999997 588999999999863
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=356.33 Aligned_cols=264 Identities=33% Similarity=0.501 Sum_probs=200.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCC--------
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP-------- 94 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~-------- 94 (599)
.+|+.+++||+|+||.||+++++-+|..||||+|.... ......+|.||+.+|.+|+|||||+++..|...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45677899999999999999999999999999998655 556678899999999999999999986555000
Q ss_pred ----------------------------------------------C-------c-------------------------
Q 007542 95 ----------------------------------------------S-------R------------------------- 96 (599)
Q Consensus 95 ----------------------------------------------s-------~------------------------- 96 (599)
+ .
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0 0
Q ss_pred ------------------CC--C--------ccEEEEEecCCccH-HHHHHhCCCC-CHHHHHHHHHHHHHHHHHhhhCc
Q 007542 97 ------------------RE--F--------KDIYVVFELMESDL-HQVIKANDDL-TPEHYQFFLYQLLRGLKYIHTAN 146 (599)
Q Consensus 97 ------------------~~--~--------~~lylV~E~~~g~L-~~~i~~~~~l-se~~i~~i~~QIl~aL~yLHs~g 146 (599)
++ . ..+||-||||+.+| .++|..+... ....+|++++||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 00 0 24899999999654 5555554333 47889999999999999999999
Q ss_pred eEeccCCCCceEecCCCceeeeccccccccc--------------CC-CCCcccccccccCccccCcccccccc-CCCCc
Q 007542 147 VFHRDLKPKNILANADCKLKICDFGLARVAF--------------ND-TPTAIFWTDYVATRWYRAPELCGSFF-SKYTP 210 (599)
Q Consensus 147 IvHrDLKP~NILv~~~~~lKL~DFGla~~~~--------------~~-~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~s~ 210 (599)
||||||||.||+++.++.|||+|||+|.... .. .......|..+||-.|+|||++.+.. ..|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 00 11112457889999999999997742 26999
Q ss_pred chhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhh
Q 007542 211 AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFF 290 (599)
Q Consensus 211 ~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (599)
++||||||+||+||+ +| |... .+....
T Consensus 798 KiDmYSLGIVlFEM~--yP-F~Ts--MERa~i------------------------------------------------ 824 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEML--YP-FGTS--MERASI------------------------------------------------ 824 (1351)
T ss_pred hhhhHHHHHHHHHHh--cc-CCch--HHHHHH------------------------------------------------
Confidence 999999999999998 33 6432 111111
Q ss_pred HHHHHHhhhcccHHHHHHHHhcccCCCCCC-cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 007542 291 TEVLILHCQVRNEKARRYLSSMRKKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 291 ~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
+.++++ ...++ ...+-+.=+....+|+.||+.||.+||||.|+|++.||-
T Consensus 825 ------------------L~~LR~-g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 825 ------------------LTNLRK-GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ------------------HHhccc-CCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 122221 11111 112223335578899999999999999999999999986
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.63 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=200.5
Q ss_pred CceEEEEEeeecCceEEEEEEE----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYD----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
+.|++.+.||+|+||+||+|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE---- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC----
Confidence 5789999999999999999985 3456889999987432 233456788999999999999999999998433
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 80 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 -QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 46899999998 6999988532 2478889999999999999999999999999999999999
Q ss_pred CCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhH
Q 007542 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~ 239 (599)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|+|||||++++|++ |.+||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999997653322111 1233445677999999876 568999999999999999998 9999987654443
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
.+.+... ..
T Consensus 236 ~~~~~~~---------------------------------------------------------------------~~-- 244 (283)
T cd05090 236 IEMVRKR---------------------------------------------------------------------QL-- 244 (283)
T ss_pred HHHHHcC---------------------------------------------------------------------Cc--
Confidence 3322210 00
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.......++.+.+||.+||+.||.+||++.+++++
T Consensus 245 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 245 -LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 01123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.11 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=196.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcE--EEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~--VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~ 98 (599)
-++|++.+.||+|+||.||+|.++.++.. +++|.++.. ........+.+|+.++..+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----- 79 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 79 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-----
Confidence 35899999999999999999999888764 577776532 2234456788999999999 89999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~ 161 (599)
...+|+||||+. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 347899999998 69999997542 4789999999999999999999999999999999999999
Q ss_pred CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 007542 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 240 (599)
Q Consensus 162 ~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l 240 (599)
++.+||+|||+++....... ......+..|+|||.+.+ ..++.++|||||||++++|++ |.+||.+.+..+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred CCcEEeCccccCcccchhhh----cccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 99999999999864211110 011223567999999876 568899999999999999998 99999766543322
Q ss_pred HHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCC
Q 007542 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320 (599)
Q Consensus 241 ~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 320 (599)
+.+.. ....
T Consensus 234 ~~~~~---------------------------------------------------------------------~~~~-- 242 (303)
T cd05088 234 EKLPQ---------------------------------------------------------------------GYRL-- 242 (303)
T ss_pred HHHhc---------------------------------------------------------------------CCcC--
Confidence 21110 0000
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 321 ~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
......++.+.+||.+||+.||.+|||++++|++
T Consensus 243 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 243 -EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=318.98 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=207.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...+|+..+.||+|+||.||+|+++.++..||||.+.... ........+.+|+.+++.++|+|++++++++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----- 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----
Confidence 4566888999999999999999999999999999986432 2233456788999999999999999999998543
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++.....
T Consensus 88 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 46899999999999888764 44689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
. ....++..|+|||.+.+. ...++.++|||||||++++|++|..||.+.+....+..+...
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 229 (308)
T cd06634 168 A-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----------- 229 (308)
T ss_pred c-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc-----------
Confidence 1 234678899999987421 135788999999999999999999998664433222211100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
..+ .......+..+.+||++
T Consensus 230 ---------------------------------------------------------~~~---~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 230 ---------------------------------------------------------ESP---ALQSGHWSEYFRNFVDS 249 (308)
T ss_pred ---------------------------------------------------------CCC---CcCcccccHHHHHHHHH
Confidence 000 00112466778999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||..+|.+|||++++++|||+...
T Consensus 250 cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HhhCCcccCCCHHHHhhCcccccc
Confidence 999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=310.62 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=198.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.+..+ ..||+|+++... .....+.+|+.+++.++|+||+++++.+.. ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEECC------CC
Confidence 47899999999999999999988665 469999987422 234568899999999999999999887632 34
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 799999999 5999999763 3588999999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+......+..+....
T Consensus 155 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---------- 220 (262)
T cd05071 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 220 (262)
T ss_pred ccccc--ccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC----------
Confidence 22111 123346678999998866 578999999999999999999 889998765443333221100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. ......+..+.+||.+
T Consensus 221 -----------------------------------------------------------~~---~~~~~~~~~l~~li~~ 238 (262)
T cd05071 221 -----------------------------------------------------------RM---PCPPECPESLHDLMCQ 238 (262)
T ss_pred -----------------------------------------------------------CC---CCccccCHHHHHHHHH
Confidence 00 0113456788999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||.+|||+.++++
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=307.92 Aligned_cols=257 Identities=24% Similarity=0.409 Sum_probs=211.3
Q ss_pred EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEE
Q 007542 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 26 ~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
+++..||+|+.|+|++++.+.+|...|||.+.+. .+....++|+..+.++.... .|+||+.+++|.... +++|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~I 168 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVFI 168 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHHH
Confidence 4578899999999999999999999999999754 34567789999999876654 899999999997553 6899
Q ss_pred EEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 105 VFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 105 V~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
.||.|..-+..+++. .++++|..+-++...++.||.||..+ ||+|||+||+|||+|+.|++||||||.+.....+.
T Consensus 169 cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 999999766555554 35799999999999999999999865 89999999999999999999999999997654332
Q ss_pred cccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~-~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
..+...|-+.|||||.+.-. ..+|+..+||||||+.++||.||..||.|.+ +.+.+.+|.+ .
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~----------- 310 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---E----------- 310 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---c-----------
Confidence 23456788999999998542 4679999999999999999999999999865 3444444433 1
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
.| +....-..+|+.+++|+..||+
T Consensus 311 -------------------------------------------------------eP-P~L~~~~gFSp~F~~fv~~CL~ 334 (391)
T KOG0983|consen 311 -------------------------------------------------------EP-PLLPGHMGFSPDFQSFVKDCLT 334 (391)
T ss_pred -------------------------------------------------------CC-CCCCcccCcCHHHHHHHHHHhh
Confidence 11 1111123478999999999999
Q ss_pred cCCCCCCCHHHHhcCccccCCc
Q 007542 341 FEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.|+.+||.-.++|+|||+....
T Consensus 335 kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 335 KDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred cCcccCcchHHHhcCcceeecc
Confidence 9999999999999999998653
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.69 Aligned_cols=203 Identities=31% Similarity=0.529 Sum_probs=173.5
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. .........+.+|+.+++.++|+||+++++.+... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 5899999999999999999999999999999988632 22233466788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||+++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999999 599998864 235899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
...... .....++..|+|||.+.+ ..++.++|+||+||++++|++|+.||.+..
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 332211 233468889999999876 678899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=308.73 Aligned_cols=245 Identities=21% Similarity=0.322 Sum_probs=194.9
Q ss_pred EEeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
++||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+|+.+.|+||+++++++.. ..+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 46999999999999876655 78999998754332 455678899999999999999999998732 357999
Q ss_pred EecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcc
Q 007542 106 FELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (599)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 184 (599)
|||+. ++|.+++.....+++..+..++.||+.||.|||..|++|+||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 69999998888899999999999999999999999999999999999999999999999999986543322111
Q ss_pred cccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhh
Q 007542 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 185 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~ 263 (599)
......++..|+|||.+.+ ..++.++|||||||++++|++ |.+||...+..+....+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------------ 213 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------------ 213 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------------
Confidence 1111223457999999876 678999999999999999998 9999976554332222210
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 343 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP 343 (599)
. .. .......++.+.+||.+||..||
T Consensus 214 ------------------------------------------------~---~~---~~~~~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 214 ------------------------------------------------G---ER---LPRPEECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred ------------------------------------------------C---Cc---CCCCCCCCHHHHHHHHHHhcCCh
Confidence 0 00 01123467789999999999999
Q ss_pred CCCCCHHHHhc
Q 007542 344 KDRPTAEEALA 354 (599)
Q Consensus 344 ~~RpTa~e~L~ 354 (599)
.+|||+.++++
T Consensus 240 ~~Rp~~~~l~~ 250 (257)
T cd05060 240 EDRPTFSELES 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=315.98 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=200.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++.+.||+|+||.||++.+...+ ..||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 478999999999999999999876543 789999887432 233456788999999999 79999999998843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceE
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKA----------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~----------------~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (599)
...+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 88 ---~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 ---EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred ---CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 346899999998 699999864 236889999999999999999999999999999999999
Q ss_pred ecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChh
Q 007542 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVV 237 (599)
Q Consensus 159 v~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~ 237 (599)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998654322111 1122234567999999876 678999999999999999997 99999876544
Q ss_pred hHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCC
Q 007542 238 HQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317 (599)
Q Consensus 238 ~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~ 317 (599)
.....+... ..
T Consensus 242 ~~~~~~~~~---------------------------------------------------------------------~~ 252 (293)
T cd05053 242 ELFKLLKEG---------------------------------------------------------------------YR 252 (293)
T ss_pred HHHHHHHcC---------------------------------------------------------------------Cc
Confidence 433222110 00
Q ss_pred CCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 318 ~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.......+..+.+||.+||..||++|||+.|+|++
T Consensus 253 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 253 ---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 00112456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=310.18 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=201.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
..+|++.+.||+|+||.||+|.++.++. .||+|.++... .......+.+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----- 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 4689999999999999999999875554 79999886432 23345678899999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||+++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 346899999998 5899999765 46899999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..............++..|+|||.+.+ ..++.++|+||+||+++++++ |..||.+.+..+....+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~------- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR------- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-------
Confidence 432221111112233567999999876 578999999999999999886 9999977654443333221100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.+ .....++.+.+|+
T Consensus 228 --------------------------------------------------------------~~---~~~~~~~~~~~li 242 (267)
T cd05066 228 --------------------------------------------------------------LP---APMDCPAALHQLM 242 (267)
T ss_pred --------------------------------------------------------------CC---CCCCCCHHHHHHH
Confidence 00 1124567899999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 007542 336 ERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~ 354 (599)
.+||+.+|.+|||+.++++
T Consensus 243 ~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 243 LDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHcccCchhCCCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.30 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=201.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.++|+..+.||+|+||.||+|.++.++. .||+|++.... .......+..|+.+++.++|+||+++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 77 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK----- 77 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-----
Confidence 4578999999999999999999887665 79999886432 23345678899999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+|||++.++.+||+|||++...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 346899999999 5899998764 57899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...............+..|+|||++.+ ..++.++||||+||++|+|++ |+.||...+..+....|......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~------ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL------ 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC------
Confidence 432221111111223457999999876 578999999999999999997 99999776554443333211100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
+ .....+..+.+|+
T Consensus 230 ---------------------------------------------------------------~---~~~~~~~~~~~li 243 (268)
T cd05063 230 ---------------------------------------------------------------P---APMDCPSAVYQLM 243 (268)
T ss_pred ---------------------------------------------------------------C---CCCCCCHHHHHHH
Confidence 0 0113567789999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 007542 336 ERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~ 354 (599)
.+||+.||.+||++.++++
T Consensus 244 ~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 244 LQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=310.11 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=197.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
..+|++.+.||+|+||.||+|.++ ++..+|+|++.... .....+.+|+.+++.++|+||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-----QRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-----CCc
Confidence 356889999999999999999875 56789999886422 233467889999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 899999998 5899999764 46899999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.... .....++..|+|||.+.+ ..++.++||||+||++|+|++ |++||.+.+..+....+....
T Consensus 154 ~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05059 154 QYTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY----------- 218 (256)
T ss_pred cccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 1111 111223457999999876 678999999999999999998 899997765443322221100
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.. ......++.+.+|+.+|
T Consensus 219 ----------------------------------------------------------~~---~~~~~~~~~~~~li~~c 237 (256)
T cd05059 219 ----------------------------------------------------------RL---YRPKLAPTEVYTIMYSC 237 (256)
T ss_pred ----------------------------------------------------------cC---CCCCCCCHHHHHHHHHH
Confidence 00 11124678899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|..+|++|||+.|+|+.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=309.77 Aligned_cols=247 Identities=27% Similarity=0.387 Sum_probs=198.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~ 74 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EP 74 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------CC
Confidence 468999999999999999999765 567799999864322 24568899999999999999999988732 34
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 799999998 5999999764 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
..... .....++..|+|||++.+ ..++.++|||||||++++|++ |.+||.+.+..+.+..+....
T Consensus 155 ~~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05070 155 NEYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---------- 220 (260)
T ss_pred ccccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence 22111 122345668999999866 578899999999999999999 899998766554443332110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. ......+..+.+||.+
T Consensus 221 -----------------------------------------------------------~~---~~~~~~~~~~~~li~~ 238 (260)
T cd05070 221 -----------------------------------------------------------RM---PCPQDCPISLHELMLQ 238 (260)
T ss_pred -----------------------------------------------------------CC---CCCCcCCHHHHHHHHH
Confidence 00 0112456789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||.+|||+.++++
T Consensus 239 ~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 239 CWKKDPEERPTFEYLQS 255 (260)
T ss_pred HcccCcccCcCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=308.31 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=198.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|.+.. +..||||.+.... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CC
Confidence 3579999999999999999997643 4569999886422 2245688999999999999999999998432 46
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999998 5899999764 36899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.... .....++..|++||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL----------- 218 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-----------
Confidence 2111 112345678999999876 568899999999999999998 999997655443333222100
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
... .....++.+.+|+.+|
T Consensus 219 ----------------------------------------------------------~~~---~~~~~~~~~~~li~~c 237 (256)
T cd05113 219 ----------------------------------------------------------RLY---RPHLASEKVYAIMYSC 237 (256)
T ss_pred ----------------------------------------------------------CCC---CCCCCCHHHHHHHHHH
Confidence 000 0123467899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|..||.+|||+.++|.+
T Consensus 238 l~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 238 WHEKAEERPTFQQLLSS 254 (256)
T ss_pred cCCCcccCCCHHHHHHh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=314.68 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=201.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCC----------------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG----------------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg----------------~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (599)
.++|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+|+.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999876644 458999987432 224456788999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCC
Q 007542 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (599)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (599)
++++++... ..+++|||++. ++|.+++.... .+++..++.++.||+.||.|||++||+|+|||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlk 157 (296)
T cd05051 83 RLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLA 157 (296)
T ss_pred EEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence 999998433 47899999998 69999997765 68999999999999999999999999999999
Q ss_pred CCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh--CCCCC
Q 007542 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLF 231 (599)
Q Consensus 154 P~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt--G~~pF 231 (599)
|+|||++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 99999999999999999998764322211 11233456778999999876 578999999999999999998 67777
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHh
Q 007542 232 PGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS 311 (599)
Q Consensus 232 ~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~ 311 (599)
...+....+..+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~-------------------------------------------------------------- 252 (296)
T cd05051 235 EHLTDQQVIENAGHFFRD-------------------------------------------------------------- 252 (296)
T ss_pred CCcChHHHHHHHHhcccc--------------------------------------------------------------
Confidence 665543333222211000
Q ss_pred cccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 312 ~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
..........+..+.++.+||.+||+.||.+|||+.|+++
T Consensus 253 ---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 253 ---DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ---ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 0000001112346688999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.21 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=200.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.++||+|+||.||+|.+. ++..||||.+... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPG---TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCC---ccCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCc
Confidence 578999999999999999999875 5578999998742 2334678899999999999999999998743 346
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 899999998 59999997653 689999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
..... ......+..|+|||.+.+ ..++.++||||+||++++|++ |+.||.+.+....+..+......
T Consensus 156 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------- 223 (261)
T cd05034 156 DEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------- 223 (261)
T ss_pred hhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 21111 112234567999999876 578899999999999999998 99999887655544443221100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
......+..+.+++.+
T Consensus 224 ----------------------------------------------------------------~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 224 ----------------------------------------------------------------PRPPNCPEELYDLMLQ 239 (261)
T ss_pred ----------------------------------------------------------------CCCCCCCHHHHHHHHH
Confidence 0012346778999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||.+|||++++++
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=310.41 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=202.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
..+|++++.||.|+||.||+|.+.. +..+|+|++... .......+.+|+.+|+.++|+||+++++++.. ...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 76 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-----GEP 76 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEec-----CCC
Confidence 3568999999999999999999887 899999998643 22345678899999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 899999998 5999999763 4689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... .....++..|+|||.+.. ..++.++|||||||++++|++ |+.||.+.+..+.+..+.....
T Consensus 157 ~~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (261)
T cd05148 157 DVYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR--------- 222 (261)
T ss_pred cccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---------
Confidence 2111 123345678999999876 578899999999999999998 8999987765444433321100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. ......++.+.++|.+
T Consensus 223 ------------------------------------------------------------~---~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 223 ------------------------------------------------------------M---PCPAKCPQEIYKIMLE 239 (261)
T ss_pred ------------------------------------------------------------C---CCCCCCCHHHHHHHHH
Confidence 0 0113467789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||.+|||+.++++
T Consensus 240 ~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 240 CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.17 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=199.9
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..++|+++++||+|+||+||+|.+..++. .||+|+++... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-- 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--
Confidence 45789999999999999999999877776 48999886432 233456788999999999999999999988532
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..++++||+. |+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 ----~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 ----TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred ----CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 4689999998 6999999774 468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.........+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------- 226 (279)
T cd05109 158 LLDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-------- 226 (279)
T ss_pred ecccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC--------
Confidence 65322211 11122334677999999876 578999999999999999998 8999876543222111110
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.... ...+..+..+.+
T Consensus 227 -------------------------------------------------------------~~~~---~~~~~~~~~~~~ 242 (279)
T cd05109 227 -------------------------------------------------------------GERL---PQPPICTIDVYM 242 (279)
T ss_pred -------------------------------------------------------------CCcC---CCCccCCHHHHH
Confidence 0000 112346778999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 007542 334 LLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~ 354 (599)
||.+||..||++|||+.+++.
T Consensus 243 li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 243 IMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.65 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=200.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCC-----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg-----~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|++.+.||+|+||.||+|.++..+ ..||+|.+.... .......+.+|+.+|+.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 468999999999999999999887544 889999986432 223455788999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCce
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~l 165 (599)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 82 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 ---QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 46899999998 69999986532 36788899999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 007542 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~ 244 (599)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++++|++ |.+||.+.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999999765332211 11123456778999999866 568899999999999999998 999998766544332221
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
. .... ...
T Consensus 236 ~---------------------------------------------------------------------~~~~---~~~ 243 (277)
T cd05032 236 D---------------------------------------------------------------------GGHL---DLP 243 (277)
T ss_pred c---------------------------------------------------------------------CCCC---CCC
Confidence 0 0000 011
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
...+..+.+||.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 244 ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=308.33 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=201.2
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
||.+.+.||+|+||.||++.+..++..+++|.++.... .......+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 69999999999999999999998888887877654221 223345677899999999999999999988533 4
Q ss_pred cEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..++|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 6899999998 588887753 357899999999999999999999999999999999999975 5799999999876
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..+|.+.+.......+.. +
T Consensus 155 ~~~~~~---~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~------- 220 (260)
T cd08222 155 LMGSCD---LATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--G------- 220 (260)
T ss_pred cCCCcc---cccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--C-------
Confidence 533221 1234467889999998866 5688899999999999999999999976554332222110 0
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.........+..+.+||
T Consensus 221 ---------------------------------------------------------------~~~~~~~~~~~~~~~li 237 (260)
T cd08222 221 ---------------------------------------------------------------PTPSLPETYSRQLNSIM 237 (260)
T ss_pred ---------------------------------------------------------------CCCCCcchhcHHHHHHH
Confidence 00011124567899999
Q ss_pred HHhcccCCCCCCCHHHHhcCccc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
.+||..||.+||++.|+|+||||
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=310.38 Aligned_cols=203 Identities=29% Similarity=0.496 Sum_probs=173.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++.+.||+|++|.||+|++..++..||||.+.... ........+.+|+.+++.++|+||+++++.+.. ...
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 47889999999999999999999999999999886422 233345678899999999999999999998843 347
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 899999999 589988863 346899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
..... ......++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+..
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 33221 1234568899999999876 578899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.32 Aligned_cols=245 Identities=29% Similarity=0.493 Sum_probs=202.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELM 109 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~ 109 (599)
||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++.+. ....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence 6899999999999999999999999865322 2235567889999999999999999998884 345799999999
Q ss_pred C-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccc
Q 007542 110 E-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (599)
Q Consensus 110 ~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (599)
. ++|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999999888899999999999999999999999999999999999999999999999999977543321 1234
Q ss_pred cccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcC
Q 007542 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCG 268 (599)
Q Consensus 189 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~ 268 (599)
..++..|++||.+.+ ..++.++|+|||||++++|++|..||...+.......+.. +
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~-------------------- 208 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D-------------------- 208 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C--------------------
Confidence 567889999999876 5678899999999999999999999976654322222211 0
Q ss_pred CCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 007542 269 YDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 348 (599)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpT 348 (599)
.. ......+..+.+||++||..||.+|||
T Consensus 209 ------------------------------------------------~~---~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 209 ------------------------------------------------PL---RFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ------------------------------------------------CC---CCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 00 011224678899999999999999999
Q ss_pred H---HHHhcCccc
Q 007542 349 A---EEALADPYF 358 (599)
Q Consensus 349 a---~e~L~HP~f 358 (599)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=335.83 Aligned_cols=244 Identities=30% Similarity=0.472 Sum_probs=200.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
..+.|.+...||.|+|++|..+.+..+++..++|+|.+.. ....+|+.++... +||||+++.+++ .+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~ 388 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVY-----EDG 388 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeeccee-----cCC
Confidence 3578899999999999999999999999999999997541 1223677665444 799999999999 445
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe-cCCCceeeeccccccccc
Q 007542 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA-NADCKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv-~~~~~lKL~DFGla~~~~ 177 (599)
.++|+|||++.| .|.+.+....... ..+..|++||+.|+.|||++|||||||||+|||+ +..++++|+|||.++...
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 689999999995 6666666655444 7788899999999999999999999999999999 688999999999998754
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.+ +-.-+-|..|.|||++.. ..|+.++|+||||++||+||+|+.||...... ..|...++.+
T Consensus 468 ~~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~------- 529 (612)
T KOG0603|consen 468 RS------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMP------- 529 (612)
T ss_pred hh------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCC-------
Confidence 33 223467889999999986 79999999999999999999999999765433 1121111111
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.++ ..+|+.|+|||++
T Consensus 530 -------------------------------------------------------------~~s---~~vS~~AKdLl~~ 545 (612)
T KOG0603|consen 530 -------------------------------------------------------------KFS---ECVSDEAKDLLQQ 545 (612)
T ss_pred -------------------------------------------------------------ccc---cccCHHHHHHHHH
Confidence 111 3578999999999
Q ss_pred hcccCCCCCCCHHHHhcCccc
Q 007542 338 MLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f 358 (599)
||++||.+|+++.+++.||||
T Consensus 546 LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 546 LLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred hccCChhhCcChhhhccCcch
Confidence 999999999999999999999
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.33 Aligned_cols=262 Identities=24% Similarity=0.394 Sum_probs=205.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~ 99 (599)
..+.|++.+.||+|++|.||+|.+..+++.||||.++.... ......+.+|+.++..+. |+||+++++++.. .
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----D 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeec-----C
Confidence 34779999999999999999999999999999999874322 233456777887776665 9999999999843 3
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+|+||||+.++|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 47999999999888888766 4578999999999999999999997 599999999999999999999999999987653
Q ss_pred CCCCCcccccccccCccccCcccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhcCCCCHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~-~~~l~~I~~~lg~p~~e~ 254 (599)
.... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------- 233 (296)
T cd06618 167 DSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ--------- 233 (296)
T ss_pred CCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---------
Confidence 3221 12335778899999986521 3478899999999999999999999965322 111111110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
. ..+ .+ ......+..+.+|
T Consensus 234 --------------------------------------------------------~---~~~-~~-~~~~~~~~~l~~l 252 (296)
T cd06618 234 --------------------------------------------------------E---EPP-SL-PPNEGFSPDFCSF 252 (296)
T ss_pred --------------------------------------------------------C---CCC-CC-CCCCCCCHHHHHH
Confidence 0 000 00 0011356789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|.+||..||.+|||++++|.||||....
T Consensus 253 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 253 VDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHHccCChhhCCCHHHHhcChhhhccc
Confidence 9999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=314.32 Aligned_cols=252 Identities=21% Similarity=0.342 Sum_probs=200.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.+|.+.+.||+|+||.||+|.+..+ +..||||+++... .......+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---
Confidence 4688899999999999999987543 5789999987432 223346688999999999999999999998443
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
..+++++||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 81 --~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 --QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred --CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 46899999998 5899988532 2478888999999999999999999999999999999999
Q ss_pred CCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhH
Q 007542 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~ 239 (599)
.++.+||+|||+++........ .......+++.|+|||.+.+ ..++.++|||||||+++||++ |.++|.+.+..+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe-eeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998765322211 11233456778999999865 568899999999999999998 8889987665544
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
++.+.+... .
T Consensus 236 ~~~i~~~~~---------------------------------------------------------------------~- 245 (283)
T cd05091 236 IEMIRNRQV---------------------------------------------------------------------L- 245 (283)
T ss_pred HHHHHcCCc---------------------------------------------------------------------C-
Confidence 433322100 0
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 246 --~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 246 --PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred --CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 0113467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.15 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=200.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.+.|++.+.||+|+||.||+|.++.+++ .||||+++... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----- 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----- 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----
Confidence 3579999999999999999999887765 59999987532 23445678899999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+++||||+. ++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 346899999998 5899998764 56899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCccccccc--ccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 177 FNDTPTAIFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 177 ~~~~~~~~~~~~~--~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
............. ..+..|+|||.+.+ ..++.++||||+||+++||++ |..||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~------ 228 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY------ 228 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC------
Confidence 4322211111111 12457999999876 678999999999999999886 999997765544333322110
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
..+ ..+..+..+.+
T Consensus 229 ---------------------------------------------------------------~~~---~~~~~~~~~~~ 242 (269)
T cd05065 229 ---------------------------------------------------------------RLP---PPMDCPTALHQ 242 (269)
T ss_pred ---------------------------------------------------------------cCC---CcccCCHHHHH
Confidence 000 11245678899
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 007542 334 LLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~ 354 (599)
|+.+||..||.+|||+++++.
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.68 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=199.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|+++++||+|+||.||+|.+ .+++.||+|.+.... .....+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EP 74 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CC
Confidence 56899999999999999999985 457889999986422 234678899999999999999999988632 35
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 899999998 6999998754 3688999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......++..|+|||.+.+ ..++.++|||||||++++|++ |++||.+.+..+....+.....
T Consensus 155 ~~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------- 221 (260)
T cd05067 155 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR--------- 221 (260)
T ss_pred CCcc--cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---------
Confidence 2111 1123345678999999876 568899999999999999999 9999987765443333221100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. ......+..+.+||.+
T Consensus 222 ------------------------------------------------------------~---~~~~~~~~~~~~li~~ 238 (260)
T cd05067 222 ------------------------------------------------------------M---PRPDNCPEELYELMRL 238 (260)
T ss_pred ------------------------------------------------------------C---CCCCCCCHHHHHHHHH
Confidence 0 0112356789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||++|||+++++.
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 239 CWKEKPEERPTFEYLRS 255 (260)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.71 Aligned_cols=204 Identities=28% Similarity=0.463 Sum_probs=168.3
Q ss_pred CCceEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..+|++++.||+|+||.||+|. +..++..||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--
Confidence 4689999999999999999997 4567899999998642 3344567889999999999999999999875432
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 -RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred -CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 246899999998 6999999764 4689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
...............++..|+|||.+.+ ..++.++|||||||+++||++|..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 5332221111112234456999999876 578999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.62 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=199.4
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..+|.+.+.||+|+||.||+|.+. .++..|++|.+... .......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGD--- 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc---
Confidence 357999999999999999999754 34567999988632 22334568899999999999999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv 159 (599)
....++||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 79 --GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 346899999998 69999997542 37899999999999999999999999999999999999
Q ss_pred cCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhh
Q 007542 160 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVH 238 (599)
Q Consensus 160 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~ 238 (599)
+.++.++|+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |++||...+..+
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred ccCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999976533221 111234466788999999876 678899999999999999998 999987665443
Q ss_pred HHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCC
Q 007542 239 QLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI 318 (599)
Q Consensus 239 ~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~ 318 (599)
.++.+...
T Consensus 234 ~~~~~~~~------------------------------------------------------------------------ 241 (291)
T cd05094 234 VIECITQG------------------------------------------------------------------------ 241 (291)
T ss_pred HHHHHhCC------------------------------------------------------------------------
Confidence 32222100
Q ss_pred CCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 319 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 319 ~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.........+..+.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 000111235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=348.55 Aligned_cols=206 Identities=30% Similarity=0.403 Sum_probs=172.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|+++++||+|+||.||+|++..+|+.||||++...... .....++.+|+.+++.++||||+++++++.. ...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-----~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-----GDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-----CCE
Confidence 6899999999999999999999999999999999754322 2345678999999999999999999999843 357
Q ss_pred EEEEEecCC-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeec
Q 007542 102 IYVVFELME-SDLHQVIKAN-----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-----------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~D 169 (599)
+|+||||++ ++|.+++... ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 899999999 5999988641 2345667888999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCC---------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 007542 170 FGLARVAFNDTPT---------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (599)
Q Consensus 170 FGla~~~~~~~~~---------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~ 234 (599)
||+++........ .......+||+.|+|||++.+ ..++.++||||+||++++|++|+.||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999865211100 001123579999999999877 67899999999999999999999999774
Q ss_pred C
Q 007542 235 N 235 (599)
Q Consensus 235 ~ 235 (599)
+
T Consensus 235 ~ 235 (932)
T PRK13184 235 K 235 (932)
T ss_pred c
Confidence 4
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.04 Aligned_cols=243 Identities=26% Similarity=0.434 Sum_probs=198.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||.|+||.||+|.+ .|+.||||++..... ...++.+|+.+++.++|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence 56899999999999999999976 488999999975322 46778899999999999999999999854 346
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.|+||||+. ++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999999 69999998765 689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. .....+..|+|||.+.. ..++.++|||||||++++|++ |..||......+....+..
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK------------ 214 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 21 12234567999999866 578889999999999999997 9999976543332211110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
... .......++.+.+||.+
T Consensus 215 ---------------------------------------------------------~~~---~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 215 ---------------------------------------------------------GYR---MEAPEGCPPEVYKVMKD 234 (256)
T ss_pred ---------------------------------------------------------CCC---CCCccCCCHHHHHHHHH
Confidence 000 01112457889999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||.+|||+.|+++
T Consensus 235 ~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 235 CWELDPAKRPTFKQLRE 251 (256)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=311.38 Aligned_cols=263 Identities=22% Similarity=0.386 Sum_probs=204.9
Q ss_pred ceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~--~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~ 97 (599)
.|++.+.||+|++|.||+|.+. .+++.||||.++... ........+.+|+.++..+ +|+||+++.+++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 4899999999999999999864 467899999986432 1223345678999999999 59999999998843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|+||||+. ++|.+++.....+++..++.++.|++++|.|||+.|++||||+|+||+++.++.++|+|||+++..
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 346899999998 599999988778999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
...... ......++..|+|||.+.+.....+.++|+||+||++++|++|..||...........+..
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~----------- 222 (288)
T cd05583 156 LAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------- 222 (288)
T ss_pred cccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-----------
Confidence 332211 1123467889999999865323478899999999999999999999965432211111100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
..+.. . ......+++.+.+||.
T Consensus 223 --------------------------------------------------~~~~~----~----~~~~~~~~~~l~~li~ 244 (288)
T cd05583 223 --------------------------------------------------RILKS----K----PPFPKTMSAEARDFIQ 244 (288)
T ss_pred --------------------------------------------------HHHcc----C----CCCCcccCHHHHHHHH
Confidence 00000 0 0111236778999999
Q ss_pred HhcccCCCCCCC---HHHHhcCccccCCc
Q 007542 337 RMLAFEPKDRPT---AEEALADPYFKGLA 362 (599)
Q Consensus 337 ~mL~~DP~~RpT---a~e~L~HP~f~~~~ 362 (599)
+||+.||++||| +.++|+||||+.+.
T Consensus 245 ~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 245 KLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 999999999998 57789999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.25 Aligned_cols=205 Identities=28% Similarity=0.456 Sum_probs=168.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s 95 (599)
.++|+++++||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+.+. ||||+++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 57889999999999999999987433 3579999996432 2334567899999999996 9999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------------------------------------
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (599)
...+|||||||. |+|.+++..+
T Consensus 113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 113 ---SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ---CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 347999999998 6998887542
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceE
Q 007542 121 ------------------------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (599)
Q Consensus 121 ------------------------------------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (599)
..+++..+..++.||+.||.|||+.||+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 23778888999999999999999999999999999999
Q ss_pred ecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 159 v~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 999999999999999765332211 11223456778999999876 578999999999999999997 889987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.72 Aligned_cols=247 Identities=27% Similarity=0.387 Sum_probs=197.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|.+.+.||+|++|.||+|.+..+ ..||+|.+.... .....+.+|+.+++.++|+|++++++++.. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 74 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EP 74 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CC
Confidence 46899999999999999999987655 469999876321 234567899999999999999999988732 24
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||+++++.++|+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 789999998 59999997643 478999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.........+....
T Consensus 155 ~~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05069 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY---------- 220 (260)
T ss_pred Cccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 2211 1122345677999998876 578899999999999999999 999998765544333322100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. ......+..+.+|+++
T Consensus 221 -----------------------------------------------------------~~---~~~~~~~~~~~~li~~ 238 (260)
T cd05069 221 -----------------------------------------------------------RM---PCPQGCPESLHELMKL 238 (260)
T ss_pred -----------------------------------------------------------CC---CCCcccCHHHHHHHHH
Confidence 00 0112456789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||.+|||++++++
T Consensus 239 ~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 239 CWKKDPDERPTFEYIQS 255 (260)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.59 Aligned_cols=243 Identities=23% Similarity=0.395 Sum_probs=196.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
..+|++.+.||+|+||.||++.. .|..||+|.++.. .....+.+|+.+++.++|+|++++++++... ...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~ 74 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 74 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCc
Confidence 45899999999999999999965 4888999988632 2345788999999999999999999876432 246
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 899999998 59999998654 478999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. .....+..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+..
T Consensus 155 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------------ 214 (256)
T cd05082 155 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 214 (256)
T ss_pred cC------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------------
Confidence 21 22344567999999876 578899999999999999997 9999976543332222110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
... ....+..++.+.+||.+
T Consensus 215 ---------------------------------------------------------~~~---~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 215 ---------------------------------------------------------GYK---MDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred ---------------------------------------------------------CCC---CCCCCCCCHHHHHHHHH
Confidence 000 01123467889999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||++|||+.++++
T Consensus 235 ~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPSFLQLRE 251 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.38 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=198.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~ 93 (599)
.++|.+.+.||+|+||.||+|.+.. +...||+|.++.. ........+.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 4789999999999999999998643 2357999998743 2234456788999999999 79999999999843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (599)
...+|+||||+. ++|.+++.... .++...+..++.||+.||+|||++|++||||||+|
T Consensus 96 -----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 96 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 346899999998 69999997642 47888999999999999999999999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999998765321110 00112234567999999876 578999999999999999998 889997655
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 236 ~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
..+....+.. .
T Consensus 248 ~~~~~~~~~~---------------------------------------------------------------------~ 258 (307)
T cd05098 248 VEELFKLLKE---------------------------------------------------------------------G 258 (307)
T ss_pred HHHHHHHHHc---------------------------------------------------------------------C
Confidence 4332221110 0
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.. .......+..+.+||.+||..||.+|||+.+++++
T Consensus 259 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 259 HR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 00 01123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.40 Aligned_cols=204 Identities=28% Similarity=0.421 Sum_probs=167.3
Q ss_pred Cce-EEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 23 SRY-KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 23 ~rY-~i~~~IG~G~~g~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
+|| ++++.||+|+||+||++. ...++..||+|.++... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ--- 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 466 999999999999998764 34578899999986432 223456778999999999999999999987432
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
....+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 2346899999999 5899988764 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g 233 (599)
..............++..|+|||.+.+ ..++.++|||||||++++|++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 432221111122345667999999876 5788999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.16 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=197.3
Q ss_pred EEeeecCceEEEEEEECC-CCc--EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTR-TGE--KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~-tg~--~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
++||+|++|+||+|.+.. ++. .||||.+...... .....+.+|+.+++.++|+||+++++++.. ..+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999999866 333 6999999754333 556788999999999999999999999853 478999
Q ss_pred EecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 106 FELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 106 ~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
+||+. ++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99998 69999998764 6899999999999999999999999999999999999999999999999999876432221
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
........++..|+|||.+.+ ..++.++|||||||++++|++ |+.||.+.+..+.+..+....
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------- 217 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG-------------- 217 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC--------------
Confidence 111123456778999999876 578999999999999999998 999997765544333332100
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
... ......+..+.+|+.+||..
T Consensus 218 ------------------------------------------------------~~~---~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd05040 218 ------------------------------------------------------ERL---ERPEACPQDIYNVMLQCWAH 240 (257)
T ss_pred ------------------------------------------------------CcC---CCCccCCHHHHHHHHHHCCC
Confidence 000 00123567899999999999
Q ss_pred CCCCCCCHHHHhc
Q 007542 342 EPKDRPTAEEALA 354 (599)
Q Consensus 342 DP~~RpTa~e~L~ 354 (599)
+|++|||+.++++
T Consensus 241 ~p~~Rps~~~~~~ 253 (257)
T cd05040 241 NPADRPTFAALRE 253 (257)
T ss_pred CcccCCCHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=312.07 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=199.7
Q ss_pred CCceEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|.+.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+++.+ +|+||+++++.+...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 46899999999999999999975 3356689999887432 233456788999999999 799999999988433
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+
T Consensus 112 ----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 ----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 46899999998 69999997643 389999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
++........ .......++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+......+..+..
T Consensus 188 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~------ 258 (302)
T cd05055 188 ARDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK------ 258 (302)
T ss_pred cccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH------
Confidence 9765332211 11123356778999999876 578899999999999999998 9999976543322211110
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
..... ......++.+
T Consensus 259 --------------------------------------------------------------~~~~~---~~~~~~~~~~ 273 (302)
T cd05055 259 --------------------------------------------------------------EGYRM---AQPEHAPAEI 273 (302)
T ss_pred --------------------------------------------------------------cCCcC---CCCCCCCHHH
Confidence 00000 0112457889
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.+||.+||..||++|||+.|+|+
T Consensus 274 ~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 274 YDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.89 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=198.9
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..+|.++++||+|+||.||+|... .++..||+|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG-- 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC--
Confidence 467899999999999999999643 35678999988642 234456788999999999999999999988443
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND---------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~---------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
..+|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 80 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 ---RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ---CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 46899999998 69999987643 478899999999999999999999999999999999999
Q ss_pred CCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhH
Q 007542 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~ 239 (599)
.++.+||+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCce-eecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 999999999999975432211 111123345678999999876 578999999999999999998 9999976554433
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
+..+... ...
T Consensus 234 ~~~~~~~---------------------------------------------------------------------~~~- 243 (280)
T cd05092 234 IECITQG---------------------------------------------------------------------REL- 243 (280)
T ss_pred HHHHHcC---------------------------------------------------------------------ccC-
Confidence 2222110 000
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
......++.+.+||.+||+.||.+|||+.|+++
T Consensus 244 --~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 244 --ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011246778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.47 Aligned_cols=254 Identities=24% Similarity=0.408 Sum_probs=200.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeec
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILL 92 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~-------~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~ 92 (599)
...+|.+.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3678999999999999999999753 234579999886432 234456788999999999 7999999999984
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCC
Q 007542 93 PPSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPK 155 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (599)
. ...+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+
T Consensus 92 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 92 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 3 347899999998 6999999763 24677889999999999999999999999999999
Q ss_pred ceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 007542 156 NILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 234 (599)
Q Consensus 156 NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~ 234 (599)
|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..+|.+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999865332211 11122345678999999876 578999999999999999998 88899876
Q ss_pred ChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc
Q 007542 235 NVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK 314 (599)
Q Consensus 235 ~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~ 314 (599)
+..+....+...
T Consensus 244 ~~~~~~~~~~~~-------------------------------------------------------------------- 255 (304)
T cd05101 244 PVEELFKLLKEG-------------------------------------------------------------------- 255 (304)
T ss_pred CHHHHHHHHHcC--------------------------------------------------------------------
Confidence 554433322110
Q ss_pred CCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 315 ~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.. .......+..+.+||.+||..+|.+|||+.|+|+.
T Consensus 256 -~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 256 -HR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred -Cc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 00 00113467789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=310.30 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=198.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCC--------------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcccc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG--------------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg--------------~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l 87 (599)
.++|++.+.||+|+||.||+|++..++ ..||+|+++... .......+.+|+.+|+.++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 368999999999999999999875432 358999987432 23345678899999999999999999
Q ss_pred ceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCC
Q 007542 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKAND------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 154 (599)
Q Consensus 88 ~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (599)
++++.. ...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++|+||||
T Consensus 83 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 83 LGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred EEEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 999843 346899999999 59999886532 367888999999999999999999999999999
Q ss_pred CceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh--CCCCCC
Q 007542 155 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLFP 232 (599)
Q Consensus 155 ~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt--G~~pF~ 232 (599)
+|||++.++.+||+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++++|++ |..||.
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 999999999999999999976432211 111123345678999999876 578999999999999999988 667887
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhc
Q 007542 233 GKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312 (599)
Q Consensus 233 g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~ 312 (599)
..+....+..+.... ...
T Consensus 235 ~~~~~~~~~~~~~~~--------------------------------------------------------------~~~ 252 (295)
T cd05097 235 LLSDEQVIENTGEFF--------------------------------------------------------------RNQ 252 (295)
T ss_pred ccChHHHHHHHHHhh--------------------------------------------------------------hhc
Confidence 655444333221110 000
Q ss_pred ccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 313 ~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.........+..++.+.+||.+||+.||.+|||++++++
T Consensus 253 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 253 ---GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ---cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000001112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=312.67 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=198.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~ 93 (599)
.++|.+.+.||+|+||.||+|.+.. ....||+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3689999999999999999998642 34579999887432 234456788999999999 59999999999843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (599)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 90 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 90 -----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 346899999998 6999999753 247888999999999999999999999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
||++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EEEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999997653221111 0111233457999999876 678999999999999999999 899998765
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 236 ~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
..+.+..+...
T Consensus 242 ~~~~~~~~~~~--------------------------------------------------------------------- 252 (314)
T cd05099 242 VEELFKLLREG--------------------------------------------------------------------- 252 (314)
T ss_pred HHHHHHHHHcC---------------------------------------------------------------------
Confidence 54433322110
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.. .......+..+.+||.+||..||++|||+.|+++
T Consensus 253 ~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 253 HR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 0112345678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.91 Aligned_cols=206 Identities=25% Similarity=0.410 Sum_probs=169.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.++|++++.||+|+||+||+|.+..++. .|++|++... ........+..|+.+++.+.||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---- 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---- 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC----
Confidence 3688999999999999999999887776 4677776432 122334567788889999999999999998732
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...++|+||+. ++|.+++... +.+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 81 --ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred --CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 24689999998 7999999764 5789999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChh
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVV 237 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~ 237 (599)
...... ....+...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 159 ~~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 159 LYPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred ccCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 533221 112234456778999999876 578999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=300.56 Aligned_cols=248 Identities=28% Similarity=0.476 Sum_probs=200.5
Q ss_pred eEEEEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
+++.+.||.|+||.||+|.+..++ ..||+|++.... .......+..|+.+|+.++|+||+++++++... .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----E 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----C
Confidence 357889999999999999998876 899999986432 222567888999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..|+||||+. ++|.+++..... +++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||+++...
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 7999999998 599999976554 9999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
...... .....++..|+|||.+.+ ..++.++||||+||++++|++ |++||.+.+....++.+...
T Consensus 155 ~~~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---------- 220 (258)
T smart00219 155 DDDYYK--KKGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG---------- 220 (258)
T ss_pred cccccc--cccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC----------
Confidence 331111 112236788999999865 678999999999999999998 88999875544433322110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
... ......+..+.+++.
T Consensus 221 -----------------------------------------------------------~~~---~~~~~~~~~~~~~i~ 238 (258)
T smart00219 221 -----------------------------------------------------------YRL---PKPENCPPEIYKLML 238 (258)
T ss_pred -----------------------------------------------------------CCC---CCCCcCCHHHHHHHH
Confidence 000 111236788999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 007542 337 RMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~ 354 (599)
+||..||.+|||+.|+|+
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 239 QCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHCcCChhhCcCHHHHHh
Confidence 999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=303.55 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=200.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
..+|.+.+.||+|+||.||+|.+..+ ...||||.+.... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----
Confidence 35699999999999999999987654 4568999886432 23455678899999999999999999998843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++..
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 24689999998 69999998754 5899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ..+...++..|+|||.+.. ..++.++|||||||++++|++ |+.||.+.+..+.+..+...
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~--------- 224 (270)
T cd05056 158 EDESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG--------- 224 (270)
T ss_pred ccccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 332111 1122334567999999866 578899999999999999996 99999877654433322110
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
... ...+..++.+.+||
T Consensus 225 ------------------------------------------------------------~~~---~~~~~~~~~~~~li 241 (270)
T cd05056 225 ------------------------------------------------------------ERL---PMPPNCPPTLYSLM 241 (270)
T ss_pred ------------------------------------------------------------CcC---CCCCCCCHHHHHHH
Confidence 000 11245678899999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 007542 336 ERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~H 355 (599)
.+||..||.+|||+.+++..
T Consensus 242 ~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 242 TKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=339.03 Aligned_cols=278 Identities=20% Similarity=0.277 Sum_probs=187.9
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCC----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS- 95 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~t----g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s- 95 (599)
..++|++.++||+|+||.||+|++..+ +..||||++.... ..+....| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 357899999999999999999999999 9999999986321 11111111 122223344444443332221
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHhhhCceEeccCCC
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDD--------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 154 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~--------------------lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (599)
......+++|+||+. ++|.+++..... ..+..++.++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 134567999999999 589998875421 12345678999999999999999999999999
Q ss_pred CceEecC-CCceeeecccccccccCCCCCcccccccccCccccCcccccccc--------------------CCCCcchh
Q 007542 155 KNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (599)
Q Consensus 155 ~NILv~~-~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--------------------~~~s~~~D 213 (599)
+|||++. ++.+||+|||+|+....... ......++++.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 58999999999976432211 1224568899999999653211 12445679
Q ss_pred hHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHH
Q 007542 214 IWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293 (599)
Q Consensus 214 IWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 293 (599)
|||+|||||||+++. |+..+...++..+....+..... |..
T Consensus 362 VwSlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~~~~-~~~------------------------------------ 402 (566)
T PLN03225 362 IYSAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYDLVA-WRK------------------------------------ 402 (566)
T ss_pred cHHHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCcHHH-HHH------------------------------------
Confidence 999999999999865 44555555555554443332111 100
Q ss_pred HHHhhhcccHHHHHHHHhcccCCCCCC---cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 294 LILHCQVRNEKARRYLSSMRKKKPIPF---SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 294 ~~~~~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
. +.......+ .+.+...+..+.|||++||++||.+|||+.|+|+||||.+..
T Consensus 403 --------------~---~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 403 --------------L---VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred --------------h---hccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 0 000000000 111122345678999999999999999999999999998754
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.59 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=194.4
Q ss_pred EEEEEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 26 KIEEVIGKGSYGVVCSAYDT----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 26 ~i~~~IG~G~~g~Vy~a~~~----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.+.+.||.|+||.||+|... ..+..|+||.++. .........+.+|+..|+.++||||+++++++... ..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccc-----cc
Confidence 57899999999999999887 4567899999964 23344578899999999999999999999999632 34
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+++|+||+. |+|.+++... ..+++..+..++.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999998 6999999987 6899999999999999999999999999999999999999999999999999987622
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ............|+|||.+.. ..++.++||||||++++||++ |+.||.+.+..+....+.+..
T Consensus 156 ~~~-~~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~---------- 222 (259)
T PF07714_consen 156 KSK-YKNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ---------- 222 (259)
T ss_dssp SSS-EEESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE----------
T ss_pred ccc-ccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 211 112233456778999999876 568999999999999999999 788887765544433332110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. ......+..+.+||.+
T Consensus 223 -----------------------------------------------------------~~---~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 223 -----------------------------------------------------------RL---PIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp -----------------------------------------------------------ET---TSBTTSBHHHHHHHHH
T ss_pred -----------------------------------------------------------cc---eeccchhHHHHHHHHH
Confidence 00 0112467789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||.+|||+.++++
T Consensus 241 C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HT-SSGGGS--HHHHHH
T ss_pred HcCCChhhCcCHHHHHh
Confidence 99999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.05 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=195.9
Q ss_pred ceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+|+.++||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----- 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----
Confidence 58899999999999999998754 23578888886432 23345678899999999999999999998843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCC
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~------------------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (599)
....|+|+||+. ++|.+++... ..+++..+..++.|++.||.|||++||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 346899999999 6899988642 247788999999999999999999999999999
Q ss_pred CCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 007542 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232 (599)
Q Consensus 154 P~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~ 232 (599)
|+|||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++++|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999765322211 11122345678999998866 578999999999999999998 999998
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhc
Q 007542 233 GKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312 (599)
Q Consensus 233 g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~ 312 (599)
+.......+.+....
T Consensus 232 ~~~~~~~~~~~~~~~----------------------------------------------------------------- 246 (290)
T cd05045 232 GIAPERLFNLLKTGY----------------------------------------------------------------- 246 (290)
T ss_pred CCCHHHHHHHHhCCC-----------------------------------------------------------------
Confidence 765443222211100
Q ss_pred ccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 313 ~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.. ......+..+.+||.+||+.||.+|||+.|+++
T Consensus 247 ----~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 247 ----RM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred ----CC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 001245678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=359.88 Aligned_cols=266 Identities=29% Similarity=0.413 Sum_probs=217.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.-||+-...||.|.||.||.|.+..||+..|+|-|+--.........+.+|..+|..++|||+|+.++|=.+. ..
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ek 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EK 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HH
Confidence 4577888999999999999999999999999998864333344556788999999999999999999986543 35
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||.||||+ |+|.+++...+-..|...+.+..|++.||.|||+.|||||||||.|||++.+|.+|++|||.|..+.+..
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 899999999 6999999888788888999999999999999999999999999999999999999999999999876553
Q ss_pred -CCcccccccccCccccCcccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 181 -PTAIFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 181 -~~~~~~~~~~gt~~Y~APE~l~~~~-~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.-...+.+++||+-|||||++.+.. .+...+.|||||||++.||+||+-||..-+..=+ .|
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--IM--------------- 1451 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--IM--------------- 1451 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--HH---------------
Confidence 2223356789999999999996643 4567799999999999999999999865332211 11
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
|--.+..+...| ..+|+++.|||.+|
T Consensus 1452 -------------------------------------------------y~V~~gh~Pq~P-----~~ls~~g~dFle~C 1477 (1509)
T KOG4645|consen 1452 -------------------------------------------------YHVAAGHKPQIP-----ERLSSEGRDFLEHC 1477 (1509)
T ss_pred -------------------------------------------------hHHhccCCCCCc-----hhhhHhHHHHHHHH
Confidence 111111112111 23889999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCcc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
|.-||++|+++.|+|+|-|-+.-.+
T Consensus 1478 l~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1478 LEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred HhcCchhhhHHHHHHHhhccccccc
Confidence 9999999999999999988765443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.67 Aligned_cols=206 Identities=28% Similarity=0.492 Sum_probs=167.4
Q ss_pred CCceEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++.+.||+|+||+||+|++ ..+++.||||+++... .......+.+|+.+|..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 46899999999999999999984 3567899999996432 223456788999999999 689999999987432
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-----------------------------------------------------
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------------------------------------------------- 121 (599)
...+++||||++ |+|.+++....
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 246899999999 69999886531
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccccc
Q 007542 122 --------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187 (599)
Q Consensus 122 --------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~ 187 (599)
.++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-hhhcC
Confidence 357778889999999999999999999999999999999999999999999976432211 11112
Q ss_pred ccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 188 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
...++..|+|||.+.+ ..++.++|||||||++++|++ |..||.+..
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 2345677999999876 678999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=302.86 Aligned_cols=244 Identities=22% Similarity=0.339 Sum_probs=191.4
Q ss_pred EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 30 VIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+|+.++|+||+++++++.. ..+++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 3899999999999765 445679999886432 23345678899999999999999999998732 35799999
Q ss_pred cCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccc
Q 007542 108 LME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF 185 (599)
Q Consensus 108 ~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~ 185 (599)
|++ ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 699999875 457899999999999999999999999999999999999999999999999999754332221111
Q ss_pred ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhh
Q 007542 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNI 264 (599)
Q Consensus 186 ~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~ 264 (599)
.+...++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------------- 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ------------------- 213 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------------------
Confidence 122233567999999876 568899999999999999996 9999977654433222211
Q ss_pred hhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCC
Q 007542 265 IWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPK 344 (599)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~ 344 (599)
.... ...+..++.+.+||.+||..||+
T Consensus 214 --------------------------------------------------~~~~---~~~~~~~~~l~~li~~c~~~~~~ 240 (257)
T cd05115 214 --------------------------------------------------GKRL---DCPAECPPEMYALMKDCWIYKWE 240 (257)
T ss_pred --------------------------------------------------CCCC---CCCCCCCHHHHHHHHHHcCCChh
Confidence 0000 11234678899999999999999
Q ss_pred CCCCHHHHhc
Q 007542 345 DRPTAEEALA 354 (599)
Q Consensus 345 ~RpTa~e~L~ 354 (599)
+||++.++++
T Consensus 241 ~Rp~~~~i~~ 250 (257)
T cd05115 241 DRPNFAKVEE 250 (257)
T ss_pred hCcCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=304.97 Aligned_cols=254 Identities=21% Similarity=0.351 Sum_probs=201.4
Q ss_pred CCCceEEEEEeeecCceEEEEEEECC----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTR----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..++|++.++||+|+||.||+|.+.. ++..|++|++... ........+.+|+.+|+.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 35789999999999999999999876 3688999988632 2344567788999999999999999999987543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceee
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN--------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~--------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL 167 (599)
....+++++|+. ++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||
T Consensus 81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 235789999998 6999998653 35889999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~ 246 (599)
+|||+++......... ......++..|+|||.+.+ ..++.++|||||||+++++++ |++||.+.+..+....+.+.
T Consensus 159 ~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 159 TDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CCCCCcccccCCceEE-eCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 9999997653322111 1122345677999999876 578999999999999999998 99999775543322111110
Q ss_pred cCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC
Q 007542 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN 326 (599)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 326 (599)
... .....
T Consensus 236 ---------------------------------------------------------------------~~~---~~~~~ 243 (280)
T cd05043 236 ---------------------------------------------------------------------YRL---AQPIN 243 (280)
T ss_pred ---------------------------------------------------------------------CCC---CCCCc
Confidence 000 01123
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.++.+.+++.+||..||++|||+.++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 244 CPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=309.19 Aligned_cols=270 Identities=24% Similarity=0.380 Sum_probs=201.9
Q ss_pred CceEEEEEeeecCceEEEEEEE----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYD----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.-|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+|+.++||||+++.+++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 4578999999999999999973 5678999999986432 233456788999999999999999999988543 2
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 246899999998 69999987653 6899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
..............++..|+|||.+.+ ..++.++|||||||++++|+++..++.... . .+.+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~--~---~~~~~~~~~~~~~-- 230 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPM--T---LFLKMIGPTHGQM-- 230 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCcccc--c---hhhhhcccccccc--
Confidence 432221112234556778999999876 578899999999999999999876543211 1 1111111111100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.....+..+...... ......+..+.+||.
T Consensus 231 -----------------------------------------------~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~ 260 (284)
T cd05079 231 -----------------------------------------------TVTRLVRVLEEGKRL---PRPPNCPEEVYQLMR 260 (284)
T ss_pred -----------------------------------------------cHHHHHHHHHcCccC---CCCCCCCHHHHHHHH
Confidence 000111111111111 123457889999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q 007542 337 RMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~H 355 (599)
+||+.||.+|||+.++|++
T Consensus 261 ~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 261 KCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=299.82 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=198.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-----RSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-----CCc
Confidence 458999999999999999999875 46789999886432 223467899999999999999999998843 346
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+. ++|.+++... +.++++.++.++.|++.+|.|||+.|++|+||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 5899998764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.... .....++..|+|||.+.+ ..++.++||||+||++|+|++ |.+||...+....+..+.+..
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------- 218 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF----------- 218 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-----------
Confidence 1111 122334578999999876 578899999999999999998 999997765444333221100
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
... .....+..+.+|+.+|
T Consensus 219 ----------------------------------------------------------~~~---~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 219 ----------------------------------------------------------RLY---KPRLASQSVYELMQHC 237 (256)
T ss_pred ----------------------------------------------------------CCC---CCCCCCHHHHHHHHHH
Confidence 000 0012467899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|..||++|||+.|+|++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=313.91 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=198.5
Q ss_pred CceEEEEEeeecCceEEEEEEECCC-------CcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRT-------GEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~t-------g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~ 94 (599)
.+|++++.||+|+||.||+|++... +..||+|.++.. ........+.+|+.+++.+ +|+||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 5799999999999999999986432 236899988643 2233456788999999999 79999999999843
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCce
Q 007542 95 SRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (599)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (599)
...+|+|+||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 346899999998 59999997532 367788899999999999999999999999999999
Q ss_pred EecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 007542 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (599)
Q Consensus 158 Lv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~ 236 (599)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..+|.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999765332111 11122334567999999876 678899999999999999998 8899987665
Q ss_pred hhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCC
Q 007542 237 VHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316 (599)
Q Consensus 237 ~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~ 316 (599)
.+....+... .
T Consensus 243 ~~~~~~~~~~---------------------------------------------------------------------~ 253 (334)
T cd05100 243 EELFKLLKEG---------------------------------------------------------------------H 253 (334)
T ss_pred HHHHHHHHcC---------------------------------------------------------------------C
Confidence 4433322110 0
Q ss_pred CCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 317 ~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
. .......+..+.+||.+||..+|.+|||+.|+|++
T Consensus 254 ~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 254 R---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred C---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 0 01113456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.91 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=198.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.+.||+|+||.||+|.+. .+..||+|.+... ......+.+|+.+++.++|+||+++.+++.. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 73 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------E 73 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------C
Confidence 3578999999999999999999754 5567999988642 2235678899999999999999999998743 3
Q ss_pred cEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 5799999998 6999999763 357888999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
..... ......++..|+|||++.. ..++.++|+|||||++|+|++ |++||.+.+..+....+....
T Consensus 154 ~~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------- 220 (260)
T cd05073 154 DNEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------- 220 (260)
T ss_pred CCCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---------
Confidence 22211 1122345677999999876 578899999999999999998 999998766544332221100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
. .......+..+.+++.
T Consensus 221 ------------------------------------------------------------~---~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 221 ------------------------------------------------------------R---MPRPENCPEELYNIMM 237 (260)
T ss_pred ------------------------------------------------------------C---CCCcccCCHHHHHHHH
Confidence 0 0112346778999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 007542 337 RMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~ 354 (599)
+||+.||++|||+.++++
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.44 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=201.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
...+|++.+.||+|+||+||+|.++.+|. .||+|.+.... .......+.+|+.+|+.++|+||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS--- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---
Confidence 35789999999999999999999877765 58999876432 23445678899999999999999999999854
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 81 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 81 ---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 36899999998 6999999874 468999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
......... ......++..|+|||.+.. ..++.++|+||+||++++|++ |+.||.+....+....+...
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------- 227 (279)
T cd05057 158 LLDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG------- 227 (279)
T ss_pred cccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-------
Confidence 654222111 1111223567999998865 578899999999999999998 99999876544332222110
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
... ......+..+.+
T Consensus 228 --------------------------------------------------------------~~~---~~~~~~~~~~~~ 242 (279)
T cd05057 228 --------------------------------------------------------------ERL---PQPPICTIDVYM 242 (279)
T ss_pred --------------------------------------------------------------CCC---CCCCCCCHHHHH
Confidence 000 011235677899
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 007542 334 LLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~ 354 (599)
+|.+||..||.+|||+.++++
T Consensus 243 ~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 243 VLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHcCCChhhCCCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=305.93 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=197.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|++++.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC---
Confidence 4679999999999999999998753 67899999986432 22334668899999999999999999998843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCC
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~----------------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (599)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++|||||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 80 --GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred --CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 346899999999 59999997431 36788899999999999999999999999999
Q ss_pred CCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 007542 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFP 232 (599)
Q Consensus 154 P~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~ 232 (599)
|+|||++.++.++|+|||+++........ ........+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HhheEecCCCceEECccccceecccCccc-cccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999998754322111 01122344667999999876 678999999999999999997 888887
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhc
Q 007542 233 GKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312 (599)
Q Consensus 233 g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~ 312 (599)
+.+..+.+..+.+
T Consensus 235 ~~~~~~~~~~~~~------------------------------------------------------------------- 247 (288)
T cd05050 235 GMAHEEVIYYVRD------------------------------------------------------------------- 247 (288)
T ss_pred CCCHHHHHHHHhc-------------------------------------------------------------------
Confidence 6554433222211
Q ss_pred ccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 313 ~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
... .......+..+.+||.+||+.||.+|||+.|+++
T Consensus 248 --~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 248 --GNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred --CCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 000 0111245678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=303.17 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=199.7
Q ss_pred eEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC-Cc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE-FK 100 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~-~~ 100 (599)
|.+.++||+|+||.||+|.++ .++..||||++..........+.+.+|+.+|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 36789999999765555556778899999999999999999999886543222 22
Q ss_pred cEEEEEecCC-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
..++++||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 4578999998 6898877532 14788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+........ .......++..|++||.+.. ..++.++|||||||++|+|++ |+++|.+.+..+....+...
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~------ 231 (273)
T cd05074 161 KKIYSGDYY-RQGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG------ 231 (273)
T ss_pred ccccCCcce-ecCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC------
Confidence 865322211 11122345567999999876 568899999999999999999 89999776543322221100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
.. ....+..++.+.
T Consensus 232 ---------------------------------------------------------------~~---~~~~~~~~~~~~ 245 (273)
T cd05074 232 ---------------------------------------------------------------NR---LKQPPDCLEDVY 245 (273)
T ss_pred ---------------------------------------------------------------Cc---CCCCCCCCHHHH
Confidence 00 001134667899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 007542 333 RLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+|+.+||+.+|.+|||+.|++.+
T Consensus 246 ~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 246 ELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=298.90 Aligned_cols=244 Identities=26% Similarity=0.421 Sum_probs=193.5
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~ 108 (599)
++||+|+||.||+|.+.. ++.||+|++...... .....+.+|+.+++.++|+||+++++++.. ....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEc
Confidence 469999999999999877 999999998754332 345678899999999999999999998843 3468999999
Q ss_pred CC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 109 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 109 ~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
+. ++|.+++... ..+++..+..++.|++.+|.|||++|++||||||+|||++.++.+||+|||+++......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 5899998664 468999999999999999999999999999999999999999999999999997643211110 00
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
.....+..|+|||.+.+ ..++.++|+|||||++++|++ |..||.+.........+....
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~------------------ 212 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------------------ 212 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC------------------
Confidence 11233566999999876 578999999999999999998 889997765433222221100
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
... .....+..+.+||.+||..||.+
T Consensus 213 ---------------------------------------------------~~~---~~~~~~~~~~~li~~~l~~~p~~ 238 (251)
T cd05041 213 ---------------------------------------------------RMP---APQLCPEEIYRLMLQCWAYDPEN 238 (251)
T ss_pred ---------------------------------------------------CCC---CCccCCHHHHHHHHHHhccChhh
Confidence 000 11235678999999999999999
Q ss_pred CCCHHHHhc
Q 007542 346 RPTAEEALA 354 (599)
Q Consensus 346 RpTa~e~L~ 354 (599)
|||+.|+|+
T Consensus 239 Rp~~~ell~ 247 (251)
T cd05041 239 RPSFSEIYN 247 (251)
T ss_pred CcCHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=296.81 Aligned_cols=243 Identities=24% Similarity=0.412 Sum_probs=192.5
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEec
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFEL 108 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~ 108 (599)
++||+|+||.||+|.+ .++..||+|+++.... ......+.+|+.+++.++||||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEEC
Confidence 4699999999999985 4688999999875432 2334568899999999999999999999843 3468999999
Q ss_pred CC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 109 ME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 109 ~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
+. ++|.+++... ..+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||+++......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6999988754 468999999999999999999999999999999999999999999999999987543221111 1
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhh
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNII 265 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~ 265 (599)
....++..|+|||++.+ ..++.++||||+||++++|++ |..||.+.........+...
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~------------------- 210 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG------------------- 210 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------------------
Confidence 12234567999999876 578899999999999999998 99999876543322221100
Q ss_pred hcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCC
Q 007542 266 WCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345 (599)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~ 345 (599)
.. .......+..+.+|+.+||..||++
T Consensus 211 --------------------------------------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~ 237 (250)
T cd05085 211 --------------------------------------------------YR---MSCPQKCPDDVYKVMQRCWDYKPEN 237 (250)
T ss_pred --------------------------------------------------CC---CCCCCCCCHHHHHHHHHHcccCccc
Confidence 00 0112346788999999999999999
Q ss_pred CCCHHHHhc
Q 007542 346 RPTAEEALA 354 (599)
Q Consensus 346 RpTa~e~L~ 354 (599)
|||+.|+++
T Consensus 238 Rp~~~~l~~ 246 (250)
T cd05085 238 RPKFSELQK 246 (250)
T ss_pred CCCHHHHHH
Confidence 999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.91 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=189.9
Q ss_pred EEeeecCceEEEEEEECCCCc--EEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCccEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGE--KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~--~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
++||+|+||.||+|.+..++. .+++|.++.. ........+.+|+.++..+ +||||+++++++.. ...+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEE
Confidence 368999999999999988876 4688887632 2234456788999999999 79999999999843 3468999
Q ss_pred EecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeee
Q 007542 106 FELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 106 ~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
|||+. ++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 69999997542 47889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhc
Q 007542 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~l 247 (599)
|||+++...... .......+..|+|||++.. ..++.++|||||||++++|++ |..||.+.+..+....+..
T Consensus 155 dfgl~~~~~~~~----~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-- 226 (270)
T cd05047 155 DFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 226 (270)
T ss_pred CCCCccccchhh----hccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC--
Confidence 999986322111 0111233567999999876 678999999999999999997 9999977654332222210
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
.... ......
T Consensus 227 -------------------------------------------------------------------~~~~---~~~~~~ 236 (270)
T cd05047 227 -------------------------------------------------------------------GYRL---EKPLNC 236 (270)
T ss_pred -------------------------------------------------------------------CCCC---CCCCcC
Confidence 0000 111235
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
+..+.+||.+||..||.+|||+.++|+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=327.56 Aligned_cols=260 Identities=24% Similarity=0.318 Sum_probs=205.5
Q ss_pred cccCC-CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 17 TEYGE-GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 17 ~~~~~-~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
.+|.+ .+...+...||+|+||+||+|.+ -..||||+++........++.|.+|+.+|++-+|.||+-+.+++..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 44444 45678889999999999999965 346999999877777778899999999999999999999999996553
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 96 RREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
+.||+-+|+| +|+.+|+-. .++.....+.|++||++|+.|||.++|||||||..||++.++++|||+||||+
T Consensus 462 ------~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 ------LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ------eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence 4899999997 899998744 47888999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
..-.-- .....+....|...|||||++.. ....|++++||||+||++|||++|..||.+.+....+.++-+-.+.|
T Consensus 536 tvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p-- 612 (678)
T KOG0193|consen 536 TVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP-- 612 (678)
T ss_pred eeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc--
Confidence 753211 11112234467788999999842 23569999999999999999999999998443322221111111111
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
.......+...+++
T Consensus 613 ------------------------------------------------------------------d~s~~~s~~pk~mk 626 (678)
T KOG0193|consen 613 ------------------------------------------------------------------DLSKIRSNCPKAMK 626 (678)
T ss_pred ------------------------------------------------------------------cchhhhccCHHHHH
Confidence 11222334566899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 007542 333 RLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
+|+..||.+++++||+..++|.
T Consensus 627 ~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 627 RLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999987
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.97 Aligned_cols=266 Identities=18% Similarity=0.205 Sum_probs=193.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhH---------HHHHHHHHHHHhcCCCCccccc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDA---------TRILREIKLLRLLRHPDIVEIK 88 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~---------~~i~rEi~iL~~l~HpnIv~l~ 88 (599)
.+++|++.++||+|+||+||+|.+..+ +..+|+|+........... .....++..++.+.|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 347999999999999999999998877 6677777643221111000 1122334445667899999999
Q ss_pred eeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeee
Q 007542 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
++...... .....+++++++..++.+.+......++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 87643321 12245788998888888888766667889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 007542 169 DFGLARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 169 DFGla~~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~ 244 (599)
|||+|+......... .......||+.|+|||++.+ ..++.++||||+||++++|++|.+||.+.+....+....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999998653221110 11123469999999999877 679999999999999999999999998764222111110
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
. .+++..+.... ...
T Consensus 247 ~------------------------------------------------------------~~~~~~~~~~~-----~~~ 261 (294)
T PHA02882 247 K------------------------------------------------------------CDFIKRLHEGK-----IKI 261 (294)
T ss_pred H------------------------------------------------------------HHHHHHhhhhh-----hcc
Confidence 0 01111111110 012
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
+..++.+.++++.|+..||++||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 262 KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 345788999999999999999999999975
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=300.82 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=199.2
Q ss_pred CceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
++|+++..||+|+||.||+|+.+. +.+.|++|.+... ........+.+|+.+|+.++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE---- 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC----
Confidence 689999999999999999999754 3467999987542 222245678899999999999999999998843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceee
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAND---------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~---------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL 167 (599)
....|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|
T Consensus 80 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 80 -AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred -CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 346899999999 69999998765 6899999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~ 246 (599)
+|||+++....... .......++..|+|||.+.+ ..++.++|||||||++++|++ |..+|.+......+..+..
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~- 233 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA- 233 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-
Confidence 99999875432211 12234466778999998866 567889999999999999998 7888865443322221110
Q ss_pred cCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC
Q 007542 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN 326 (599)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 326 (599)
....+ .....
T Consensus 234 ---------------------------------------------------------------------~~~~~-~~~~~ 243 (275)
T cd05046 234 ---------------------------------------------------------------------GKLEL-PVPEG 243 (275)
T ss_pred ---------------------------------------------------------------------CCcCC-CCCCC
Confidence 00000 01124
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.+..+.++|.+||+.||.+|||+.|+|.+
T Consensus 244 ~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 244 CPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 66789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.10 Aligned_cols=206 Identities=25% Similarity=0.423 Sum_probs=166.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECC----------------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR----------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~----------------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (599)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3579999999999999999986432 3457999998643 2233456788999999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCC
Q 007542 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND-----------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (599)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (599)
++++++... ..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+|||
T Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 83 RLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred eEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 999998443 36899999998 69999987642 36677899999999999999999999999999
Q ss_pred CCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh--CCCCC
Q 007542 154 PKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT--GKPLF 231 (599)
Q Consensus 154 P~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt--G~~pF 231 (599)
|+|||++.++.++|+|||+++........ .......++..|++||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999765332211 11122345678999998765 578999999999999999998 67788
Q ss_pred CCCCh
Q 007542 232 PGKNV 236 (599)
Q Consensus 232 ~g~~~ 236 (599)
...+.
T Consensus 235 ~~~~~ 239 (296)
T cd05095 235 SQLSD 239 (296)
T ss_pred cccCh
Confidence 66544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=298.76 Aligned_cols=228 Identities=25% Similarity=0.350 Sum_probs=184.3
Q ss_pred cCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC-cc
Q 007542 34 GSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SD 112 (599)
Q Consensus 34 G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~ 112 (599)
|.+|.||+|+++.+++.||+|++.... ...+|...+....||||+++++.+.. ...+|+||||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCC
Confidence 889999999999999999999996431 12345555555679999999998843 357899999999 59
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccC
Q 007542 113 LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192 (599)
Q Consensus 113 L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt 192 (599)
|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....... ....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcC
Confidence 99999887789999999999999999999999999999999999999999999999999876543221 233567
Q ss_pred ccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCC
Q 007542 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGF 272 (599)
Q Consensus 193 ~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~ 272 (599)
..|+|||.+.+ ..++.++|+||+||++|+|++|+.+|....... .
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~---------------- 190 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------N---------------- 190 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------c----------------
Confidence 78999999866 568899999999999999999998774321000 0
Q ss_pred cccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCH---
Q 007542 273 MCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTA--- 349 (599)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa--- 349 (599)
..... ...+.+++.+.+||.+||+.||.+|+|+
T Consensus 191 -----------------------------------------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 191 -----------------------------------------THTTL---NIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred -----------------------------------------ccccc---CCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 00000 0112467889999999999999999996
Q ss_pred --HHHhcCccc
Q 007542 350 --EEALADPYF 358 (599)
Q Consensus 350 --~e~L~HP~f 358 (599)
+++++||||
T Consensus 227 ~~~~~~~h~~~ 237 (237)
T cd05576 227 GVEDIKSHPFF 237 (237)
T ss_pred chHHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.69 Aligned_cols=240 Identities=26% Similarity=0.459 Sum_probs=195.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++.+.||+|+||.||++. .+++.||+|.++.. .....+.+|+.+++.++||||+++++++.. ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCc
Confidence 679999999999999999984 57889999998642 234578899999999999999999998843 236
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 59999997653 5789999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
. .....+..|+|||.+.+ ..++.++|+|||||++++|++ |++||.+.+..+....+..
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 212 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK------------- 212 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------------
Confidence 1 12234567999999876 578899999999999999997 9999987654332222110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.... ......++.+.+||++|
T Consensus 213 --------------------------------------------------------~~~~---~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 213 --------------------------------------------------------GYRM---EPPEGCPADVYVLMTSC 233 (254)
T ss_pred --------------------------------------------------------CCCC---CCCCcCCHHHHHHHHHH
Confidence 0000 01134678899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 007542 339 LAFEPKDRPTAEEALA 354 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~ 354 (599)
|+.+|.+|||+.++++
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.50 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=198.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.++|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 4678999999999999999999988876 46888876432 223344678999999999999999999988532
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..++|+||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 3579999999 68999987754 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~--------- 226 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK--------- 226 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---------
Confidence 5332211 11223456778999999876 678999999999999999997 8899977543322211110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
....+ ..+..+..+.+|
T Consensus 227 ------------------------------------------------------------~~~~~---~~~~~~~~~~~l 243 (303)
T cd05110 227 ------------------------------------------------------------GERLP---QPPICTIDVYMV 243 (303)
T ss_pred ------------------------------------------------------------CCCCC---CCCCCCHHHHHH
Confidence 00000 113356778999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 007542 335 LERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~H 355 (599)
|.+||..||++|||+.++++.
T Consensus 244 i~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 244 MVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=296.92 Aligned_cols=201 Identities=28% Similarity=0.474 Sum_probs=160.3
Q ss_pred EEeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
+.||+|+||.||+|.+.. .+..||||++... ........+.+|+.+++.++||||+++++++... ....|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEE
Confidence 468999999999998654 3457999988532 2334456788999999999999999999977432 2357899
Q ss_pred EecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC-
Q 007542 106 FELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT- 182 (599)
Q Consensus 106 ~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~- 182 (599)
+||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999 6999999764 35678888899999999999999999999999999999999999999999999754321110
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~ 236 (599)
........++..|+|||.+.+ ..++.++|||||||++++|++ |.++|...+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~ 208 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 011123345678999999876 578999999999999999999 5777876543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=297.57 Aligned_cols=203 Identities=24% Similarity=0.344 Sum_probs=158.8
Q ss_pred EeeecCceEEEEEEECC--CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 30 VIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++|+||+++++.+.. ...+|+|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-----~~~~~lv~e 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-----SIPYLLVLE 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCceEEEEE
Confidence 58999999999996433 4557888877542 223334567899999999999999999998843 346899999
Q ss_pred cCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 108 LME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 108 ~~~-g~L~~~i~~~~-----~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+. ++|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 998 69999997643 246778899999999999999999999999999999999999999999999865322111
Q ss_pred CcccccccccCccccCccccccc-----cCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhH
Q 007542 182 TAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~ 239 (599)
.. ......++..|+|||++... ...++.++|||||||++|+|++ |.+||......+.
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (269)
T cd05042 156 YI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV 218 (269)
T ss_pred ee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 00 01233456779999987421 1356889999999999999999 7888877654443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.86 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=218.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~ 99 (599)
..+|..+.+||+|+||.|.+|..+.|.+.||||++++.. ....+.+--..|-++|.... -|.++.++.+|. +.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-----Tm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-----TM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----hh
Confidence 567889999999999999999999999999999997533 23334455567888887764 678899988884 44
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. |+|.-.|++-+++.|.++.+++..|+-||-+||++|||.||||.+|||++.+|++||+|||+++..-.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 57999999999 59999999999999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
+.. ...+.+||+.|+|||++.- ..|+.++|-||+||+|||||.|.+||.|++..+.++.|.+---
T Consensus 503 ~~~---TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---------- 567 (683)
T KOG0696|consen 503 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---------- 567 (683)
T ss_pred CCc---ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC----------
Confidence 222 2356899999999999976 7899999999999999999999999999999888777754110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.....+|.+|+++.+.+
T Consensus 568 ---------------------------------------------------------------syPKslSkEAv~ickg~ 584 (683)
T KOG0696|consen 568 ---------------------------------------------------------------SYPKSLSKEAVAICKGL 584 (683)
T ss_pred ---------------------------------------------------------------cCcccccHHHHHHHHHH
Confidence 01124788999999999
Q ss_pred cccCCCCCCC-----HHHHhcCccccCCc
Q 007542 339 LAFEPKDRPT-----AEEALADPYFKGLA 362 (599)
Q Consensus 339 L~~DP~~RpT-----a~e~L~HP~f~~~~ 362 (599)
|...|.+|+. -.++-+||||+.+.
T Consensus 585 ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 585 LTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred hhcCCccccCCCCccccchhhCcchhhcc
Confidence 9999999975 46789999999763
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.83 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=198.2
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s 95 (599)
.++|.+.+.||+|+||.||+|++. .++..||||+++.... ......+.+|+.+|..+. ||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 367889999999999999999853 4567899999975422 233457889999999997 99999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-----------------------------------------------------
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAND----------------------------------------------------- 121 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~----------------------------------------------------- 121 (599)
..+|+||||+. |+|.+++...+
T Consensus 114 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 114 ----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 46899999999 69999986532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCc
Q 007542 122 ---------------------------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (599)
Q Consensus 122 ---------------------------------------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (599)
.+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25667788899999999999999999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
||++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++||||+||+++||++ |..||....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999764322111 11123456788999999876 568899999999999999998 888987654
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 236 ~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
..+.+..... ...
T Consensus 347 ~~~~~~~~~~----------------------------------------------------------------~~~--- 359 (401)
T cd05107 347 MNEQFYNAIK----------------------------------------------------------------RGY--- 359 (401)
T ss_pred chHHHHHHHH----------------------------------------------------------------cCC---
Confidence 3322111100 000
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
. .......+..+.+||.+||..||.+|||+.|+|..
T Consensus 360 -~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 360 -R---MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred -C---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 01123467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.82 Aligned_cols=264 Identities=25% Similarity=0.410 Sum_probs=214.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecC-ccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-+-|..++.||-|+||.|++++...|...||+|.+.+ ..........+..|-.||..-..+-||+|+--|. +..
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ-----Dkd 702 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKD 702 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec-----cCC
Confidence 4567889999999999999999999999999998864 2334455667889999999999999999998884 445
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ||+..+|...+-+.|+.+++++..|.+||.+.|..|+|||||||+|||||.+|++||.||||+......
T Consensus 703 nLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 703 NLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 7999999999 599999999999999999999999999999999999999999999999999999999999999653211
Q ss_pred CCC---------------------------------------cccccccccCccccCccccccccCCCCcchhhHhHHHH
Q 007542 180 TPT---------------------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (599)
Q Consensus 180 ~~~---------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~I 220 (599)
... .+.-...+||+.|+|||+|.. ..|+..+|-||.|||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVI 860 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHH
Confidence 000 001124689999999999987 789999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhc
Q 007542 221 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300 (599)
Q Consensus 221 l~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 300 (599)
||||+.|++||..........+|++ |.
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~n--------------------w~--------------------------------- 887 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVIN--------------------WR--------------------------------- 887 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeee--------------------hh---------------------------------
Confidence 9999999999987664433222211 11
Q ss_pred ccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccCCc
Q 007542 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT---AEEALADPYFKGLA 362 (599)
Q Consensus 301 ~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpT---a~e~L~HP~f~~~~ 362 (599)
.++. -....++|+++.+||.+|.. +++.|+. ++|+-.||||+++.
T Consensus 888 ------~~l~----------~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 888 ------NFLH----------IPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred ------hccc----------cccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence 0100 01235689999999998654 7888874 78899999999874
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=300.44 Aligned_cols=192 Identities=18% Similarity=0.277 Sum_probs=156.9
Q ss_pred EEeeecCceEEEEEEECCCCcE-------EEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEK-------VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~-------VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+.||+|+||.||+|.+..++.. ||+|.+... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 4699999999999998665544 888887532 233456788899999999999999999998543 36
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc--------eeeeccc
Q 007542 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--------LKICDFG 171 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~--------lKL~DFG 171 (599)
.++||||+. ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 899999998 58999997654 5899999999999999999999999999999999999987765 6999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC-CCCCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKN 235 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~-~pF~g~~ 235 (599)
++...... ....++..|+|||++.+. ..++.++||||+||++|+|++|. ++|...+
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~ 210 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhcc
Confidence 88654221 234678889999998652 45788999999999999999984 6665433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.18 Aligned_cols=201 Identities=23% Similarity=0.346 Sum_probs=159.7
Q ss_pred EEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-----VTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCCcEEEE
Confidence 36899999999999754 4567899998864332 2334578899999999999999999998843 34689999
Q ss_pred ecCC-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 107 ELME-SDLHQVIKAND-----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999 69999987532 35677888999999999999999999999999999999999999999999986543221
Q ss_pred CCcccccccccCccccCcccccccc-----CCCCcchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~-----~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~ 236 (599)
. ........++..|+|||++.+.. ..++.++||||+||++++|++ |++||.....
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 1 11112345678899999985421 135789999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=298.62 Aligned_cols=206 Identities=29% Similarity=0.451 Sum_probs=170.6
Q ss_pred CCceEEEEEeeecCceEEEEEEEC----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..+|++.+.||+|+||.||+|... .++..||||++...... .....+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~-- 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG-- 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC--
Confidence 357888999999999999999854 35889999999754332 34677899999999999999999999875422
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..
T Consensus 80 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 80 -GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred -CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 346899999998 59999997654 689999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g 233 (599)
...............++..|++||.+.+ ..++.++|||||||++++|++|..+|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCccc
Confidence 6422221111122345567999999876 5788999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=297.07 Aligned_cols=192 Identities=22% Similarity=0.297 Sum_probs=155.6
Q ss_pred EEeeecCceEEEEEEECC------------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 29 EVIGKGSYGVVCSAYDTR------------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~------------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
+.||+|+||.||+|.... ....|++|++... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 368999999999997432 2346899987642 223445678899999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc-------eee
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-------LKI 167 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~-------lKL 167 (599)
...++||||++ ++|..++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++. +|+
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 35799999999 5787777653 56899999999999999999999999999999999999987664 899
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHH-hCCCCCCCCC
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKN 235 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLl-tG~~pF~g~~ 235 (599)
+|||++...... ....++..|+|||++... ..++.++|||||||++|+|+ .|..||.+..
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 999998654221 234678889999988632 56889999999999999998 5888887643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=296.62 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=191.7
Q ss_pred EEeeecCceEEEEEEECCCC------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 29 EVIGKGSYGVVCSAYDTRTG------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg------~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
+.||+|+||.||+|.+.... ..||||.+.... .......+.+|+.+|+.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence 36999999999999876544 789999886432 123456788999999999999999999998533 368
Q ss_pred EEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-----ceeeec
Q 007542 103 YVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-----KLKICD 169 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~-------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-----~lKL~D 169 (599)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++.++ .++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6999998642 3478899999999999999999999999999999999999887 899999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg 248 (599)
||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....+...
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-- 229 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-- 229 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC--
Confidence 99987653222111 1122345678999999876 578999999999999999998 99999876544332222100
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
. ........+
T Consensus 230 -------------------------------------------------------------------~---~~~~~~~~~ 239 (269)
T cd05044 230 -------------------------------------------------------------------G---RLQKPENCP 239 (269)
T ss_pred -------------------------------------------------------------------C---ccCCcccch
Confidence 0 001113456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
..+.+||.+||..+|.+|||+.++++
T Consensus 240 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 240 DKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 78899999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=318.12 Aligned_cols=259 Identities=23% Similarity=0.388 Sum_probs=224.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-+..+++..||-|+||.|=++.-......+|+|++++. .-.....+.+..|-++|..++.|.||+|+..| ++..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 36678889999999999999876666666999998753 33445667899999999999999999999988 5667
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
++||+||-|- |+|..++...+.+.+..+++++..+++|+.|||++|||.|||||+|+|++.+|-+||.|||+|+....+
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999987 699999999999999999999999999999999999999999999999999999999999999988665
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
..+ .+.|||+.|.|||++.. ...+.++|.||||+++||||+|.|||.|.+....++.|.+-+.. |
T Consensus 574 ~KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----i---- 638 (732)
T KOG0614|consen 574 RKT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----I---- 638 (732)
T ss_pred Cce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----h----
Confidence 433 46799999999999987 67899999999999999999999999999999888888653210 0
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.....++..|.+||+++.
T Consensus 639 --------------------------------------------------------------~~Pr~I~k~a~~Lik~LC 656 (732)
T KOG0614|consen 639 --------------------------------------------------------------EFPRRITKTATDLIKKLC 656 (732)
T ss_pred --------------------------------------------------------------hcccccchhHHHHHHHHH
Confidence 000235667999999999
Q ss_pred ccCCCCCCC-----HHHHhcCccccCCc
Q 007542 340 AFEPKDRPT-----AEEALADPYFKGLA 362 (599)
Q Consensus 340 ~~DP~~RpT-----a~e~L~HP~f~~~~ 362 (599)
..+|.+|.. +.++-.|-||.++.
T Consensus 657 r~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 657 RDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred hcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 999999986 89999999998863
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.40 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=198.4
Q ss_pred ceEEEEEeeecCceEEEEEEECC-CCcEEEEEEecCcc--------CChhhHHHHHHHHHHHHh-cCCCCccccceeecC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIF--------EHVSDATRILREIKLLRL-LRHPDIVEIKHILLP 93 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~-tg~~VAIK~i~~~~--------~~~~~~~~i~rEi~iL~~-l~HpnIv~l~~v~~~ 93 (599)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.+++. ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38889999999999999999988 78899999885321 122344567789988765 789999999999843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceee
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL 167 (599)
...+|+||||+. ++|.+++.. ...+++..++.++.|++.+|.|||+ .||+|+||+|+|||++.++.+||
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 -----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 357999999998 488887743 3468999999999999999999996 68999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
+|||++....... ......++..|++||.+.+ ..++.++|+|||||++|+|++|++||...+.......+.+..
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~ 229 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhcc
Confidence 9999997653322 2345678889999999876 568999999999999999999999997655433322221110
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
.. +.. ....
T Consensus 230 ~~---------------------------------------------------------------------~~~--~~~~ 238 (269)
T cd08528 230 YE---------------------------------------------------------------------PLP--EGMY 238 (269)
T ss_pred CC---------------------------------------------------------------------cCC--cccC
Confidence 00 000 1135
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
++.+.+||.+||+.||.+|||+.|+.++
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 6789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=292.62 Aligned_cols=190 Identities=19% Similarity=0.274 Sum_probs=158.7
Q ss_pred EEeeecCceEEEEEEECCCC----------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 29 EVIGKGSYGVVCSAYDTRTG----------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg----------~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998777 357888765321 125778899999999999999999998854
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-------ceeeec
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-------KLKICD 169 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-------~lKL~D 169 (599)
...++||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 24699999999 69999998765 789999999999999999999999999999999999999887 799999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 234 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~ 234 (599)
||++...... ....++..|+|||++.+....++.++||||+||++++|++ |..+|...
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9999765321 2335667899999987622368899999999999999999 56777554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=297.81 Aligned_cols=191 Identities=19% Similarity=0.259 Sum_probs=154.4
Q ss_pred EeeecCceEEEEEEECCC------------------------CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc
Q 007542 30 VIGKGSYGVVCSAYDTRT------------------------GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~~t------------------------g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv 85 (599)
.||+|+||.||+|....+ ...|++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999975322 245889888632 223345678899999999999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC
Q 007542 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163 (599)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~ 163 (599)
++++++... ...|+||||++ ++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999998543 46899999999 588888865 45789999999999999999999999999999999999997654
Q ss_pred -------ceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHH-hCCCCCCCCC
Q 007542 164 -------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL-TGKPLFPGKN 235 (599)
Q Consensus 164 -------~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLl-tG~~pF~g~~ 235 (599)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|+.||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999988643221 223567789999988652 56899999999999999985 6899987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.89 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=210.0
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHH-HHhcCCCCccccceeecCCCcCCCccEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL-LRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~i-L~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.+-+..||.|+||+|++..|+.+|+..|||+|..... ....++++.|+.. ++.-+.||||+++++.+.. ++.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcW 139 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCW 139 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----Ccee
Confidence 3446789999999999999999999999999975332 4567788999986 5666799999999998543 4789
Q ss_pred EEEecCCccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 104 VVFELMESDLHQVIK-----ANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 104 lV~E~~~g~L~~~i~-----~~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
|.||+|+-+|..+.+ ....++|..+-.|.-..+.||.||... .|||||+||+|||++..|.+||||||.+....
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 999999976654443 345799999999999999999999865 79999999999999999999999999997654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~-~~~l~~I~~~lg~p~~e~i~ 256 (599)
++. .-+.-.|-+.|||||.+......|+.++|+||||++|+|+.||+.|+.+.+. .+|+.++. .|.|+.-
T Consensus 220 ~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l--- 290 (361)
T KOG1006|consen 220 DSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPIL--- 290 (361)
T ss_pred HHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCee---
Confidence 332 2245578999999999976545699999999999999999999999988654 34433332 2333210
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.+....-+.+..++.||.
T Consensus 291 --------------------------------------------------------------~~~~~~~~~s~~~~~fin 308 (361)
T KOG1006|consen 291 --------------------------------------------------------------LFDKECVHYSFSMVRFIN 308 (361)
T ss_pred --------------------------------------------------------------cCcccccccCHHHHHHHH
Confidence 111122346788999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
-||..|-..||...+++.+||++....
T Consensus 309 tCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 309 TCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHhhcccccCcchhhhhcCchhhhhhh
Confidence 999999999999999999999987654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=314.75 Aligned_cols=186 Identities=31% Similarity=0.503 Sum_probs=163.7
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
++-||+|+.|.||+|+ -.++.||||+++.. -..+|+-|++|+||||+.+++||... ..+|||||
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeee
Confidence 5679999999999995 46889999998531 12578889999999999999999543 47899999
Q ss_pred cCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccc
Q 007542 108 LME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186 (599)
Q Consensus 108 ~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~ 186 (599)
||. |-|..+++....++......+..+|+.|+.|||.+.|||||||.-||||..+..|||+|||-++..... .+ .
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-ST---k 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-ST---K 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hh---h
Confidence 999 899999999999999999999999999999999999999999999999999999999999998765322 11 1
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
-..+||..|||||+|.. ...+.++||||+||+|||||||..||.+-+
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccc
Confidence 35789999999999987 688999999999999999999999997643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.98 Aligned_cols=265 Identities=24% Similarity=0.427 Sum_probs=218.9
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~ 98 (599)
...+.|+|.++||.|.||.||++.++++|+.+|||+..... ...+.|..|.++|+.+. |||++.++++|.-.....
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 45788999999999999999999999999999999886432 33456778999998885 999999999997554455
Q ss_pred CccEEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.+.+|||||||+ |+.-++++. ...+.|+.+.+|++.++.||.+||.+.++|||||-.|||++.++.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 678999999999 688888864 35799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
..... ....+.+||+.|||||++... ...|+..+|+||||++..||--|.||+-+-.....+.+| --.|++
T Consensus 173 ldsT~---grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPP 246 (953)
T KOG0587|consen 173 LDSTV---GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPP 246 (953)
T ss_pred eeccc---ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCc
Confidence 64322 223567999999999998642 134778999999999999999999999766554443332 122222
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
-...+..++..+.
T Consensus 247 -------------------------------------------------------------------kLkrp~kWs~~Fn 259 (953)
T KOG0587|consen 247 -------------------------------------------------------------------KLKRPKKWSKKFN 259 (953)
T ss_pred -------------------------------------------------------------------cccchhhHHHHHH
Confidence 1222345677899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
|||..||..|-.+||+..++|.|||++.
T Consensus 260 dFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 260 DFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHhhccccCcchhhhccCCcccc
Confidence 9999999999999999999999999984
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.42 Aligned_cols=201 Identities=29% Similarity=0.474 Sum_probs=168.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.+.|.-..+||+|+||.||+|.-. +|..||||+++...... ...|.+|+.+|.+++|||+|+|+++|..... .
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~ 146 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----H 146 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----e
Confidence 467777789999999999999864 44899999887533221 4459999999999999999999999954321 5
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCc---eEeccCCCCceEecCCCceeeeccccccc
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.+||+|||. |+|.+.+.... .+++.....|+..+++||.|||... |||||||++|||+|.+...||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999999 89999998654 8999999999999999999999964 99999999999999999999999999966
Q ss_pred ccCCCCCccccccc-ccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 007542 176 AFNDTPTAIFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (599)
Q Consensus 176 ~~~~~~~~~~~~~~-~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~ 234 (599)
.... .. ..... .||..|+|||++.. ...+.++||||+|++|+||++|+.+....
T Consensus 227 ~~~~-~~--~~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 227 GPEG-DT--SVSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CCcc-cc--ceeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 4321 11 11222 79999999999876 57899999999999999999999777643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.78 Aligned_cols=304 Identities=28% Similarity=0.454 Sum_probs=223.4
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s 95 (599)
...+.|.++++||.|+|++||+|.+.. ..+.||+|.|.. .+...++.+|+++|..+. +.||+++.+++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~----ts~p~ri~~El~~L~~~gG~~ni~~~~~~~---- 104 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR----TSSPSRILNELEMLYRLGGSDNIIKLNGCF---- 104 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc----ccCchHHHHHHHHHHHhccchhhhcchhhh----
Confidence 346789999999999999999999888 789999999864 355678999999999996 99999999998
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-Cceeeeccccc
Q 007542 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFGla 173 (599)
+....+.+|+||++. +..+++.. ++...++.+++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||+|
T Consensus 105 -rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 105 -RNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred -ccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 445579999999996 56666543 7789999999999999999999999999999999999864 77899999999
Q ss_pred ccccC--------------CCC-----------------C----------cccccccccCccccCccccccccCCCCcch
Q 007542 174 RVAFN--------------DTP-----------------T----------AIFWTDYVATRWYRAPELCGSFFSKYTPAI 212 (599)
Q Consensus 174 ~~~~~--------------~~~-----------------~----------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~ 212 (599)
..... ..+ . ........||+.|+|||++..+ ..-++++
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~Qttai 259 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAI 259 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCcc
Confidence 72100 000 0 0011246799999999999875 6788999
Q ss_pred hhHhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhh--hhcCCCCCcccCCCccchhhhhhhh
Q 007542 213 DIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNI--IWCGYDGFMCSVAPSCFLVFAIFFF 289 (599)
Q Consensus 213 DIWSlG~Il~eLltG~-~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (599)
||||.|+|+..+++++ |.|...++.+.+..|..++|.-. +.++..+.+. .|..-. .+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~---mrk~A~l~g~~~l~~ksn----------------~~~ 320 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAE---MRKCAALPGRILLWQKSN----------------IPT 320 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHH---HHHHhhcCCceeeecccc----------------ccc
Confidence 9999999999999987 45677788999999999998643 3333333333 333200 001
Q ss_pred hHHHHHHhhhcccHHHHHHHHhcccCCC-CCCcCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 290 FTEVLILHCQVRNEKARRYLSSMRKKKP-IPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 290 ~~e~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~-~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
..|....+ +... +..+.+... ......+ ...+..+.|||.+||..||.+|+||+++|.||||....
T Consensus 321 ~~e~~~~f-----~s~~--~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 321 IPELRVNF-----ETLH--IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cHHHHhch-----hccC--hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 11111000 0000 111111111 0111122 23456899999999999999999999999999999543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=288.80 Aligned_cols=204 Identities=22% Similarity=0.346 Sum_probs=158.0
Q ss_pred EeeecCceEEEEEEECCC--CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEe
Q 007542 30 VIGKGSYGVVCSAYDTRT--GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~~t--g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
.||+|+||.||+|....+ ...+++|.+... ........+.+|+.+++.++||||+++++.+... ..+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEe
Confidence 599999999999975433 345667766532 2223456789999999999999999999998533 46899999
Q ss_pred cCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 108 LME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 108 ~~~-g~L~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
|+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~- 154 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY- 154 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-
Confidence 999 6999999764 2456778889999999999999999999999999999999999999999999864321111
Q ss_pred cccccccccCccccCccccccc-----cCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 007542 183 AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 240 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l 240 (599)
........++..|+|||++... ...++.++||||+||++|+|++ |.+||...+..+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~ 218 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL 218 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 0111345678899999987531 1245789999999999999997 57788765554433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=322.57 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=206.3
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
...-++.+.||+|+||.||+|.-. .....||||.++.. ......+.|.||+.+|..|+|||||+|++++.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~---- 559 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCR---- 559 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc----
Confidence 345677899999999999999743 23467999999753 23335678999999999999999999999994
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND----------D----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~----lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~ 161 (599)
+.+-+|||||||. |||++++.... . |+..+...|+.||+.|+.||-++.+|||||-..|+||.+
T Consensus 560 -~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 560 -EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred -cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 4457999999999 89999997532 2 788899999999999999999999999999999999999
Q ss_pred CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 007542 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 240 (599)
Q Consensus 162 ~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l 240 (599)
+..|||+|||++|-....+.-. ......-...|||||.|.- .+|++++||||+||+|||+++ |+.||.|-++.+.+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred ceEEEecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 9999999999998754433211 1123355678999999876 799999999999999999998 99999999888887
Q ss_pred HHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCC
Q 007542 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320 (599)
Q Consensus 241 ~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 320 (599)
+.|.+-- +
T Consensus 716 e~i~~g~------------------------------------------------------------------------l 723 (774)
T KOG1026|consen 716 ECIRAGQ------------------------------------------------------------------------L 723 (774)
T ss_pred HHHHcCC------------------------------------------------------------------------c
Confidence 7775310 0
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 007542 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEA 352 (599)
Q Consensus 321 ~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~ 352 (599)
-+...+.+..+.+|+..|++.+|++|||+.||
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 01113567889999999999999999999997
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.65 Aligned_cols=275 Identities=27% Similarity=0.439 Sum_probs=214.2
Q ss_pred cccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-----hhhHHHHHHHHHHHHhcCCCCccccce
Q 007542 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-----VSDATRILREIKLLRLLRHPDIVEIKH 89 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-----~~~~~~i~rEi~iL~~l~HpnIv~l~~ 89 (599)
|.+.-...+||-++.+||+|+|+.||+|.|....+.||+|+-.....+ ....+..-||..|-+.|.||.||++++
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 445556789999999999999999999999999999999975422111 122345679999999999999999999
Q ss_pred eecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC--ceEeccCCCCceEecC---CC
Q 007542 90 ILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--NVFHRDLKPKNILANA---DC 163 (599)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~--gIvHrDLKP~NILv~~---~~ 163 (599)
+|.... ..+|-|+|||+| +|.-+++.+.-++|.+++.|+.||+.||.||... -|||-||||.|||+.. -|
T Consensus 535 yfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 535 YFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 995433 357999999997 8988999999999999999999999999999976 4999999999998754 37
Q ss_pred ceeeecccccccccCCCCCc---ccc-cccccCccccCcccc--ccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh
Q 007542 164 KLKICDFGLARVAFNDTPTA---IFW-TDYVATRWYRAPELC--GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237 (599)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~---~~~-~~~~gt~~Y~APE~l--~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~ 237 (599)
.+||.||||++....+.... ..+ ....||-||++||.+ .....+.+.++||||+|||||.+|.|+.||..+...
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 79999999999875443321 122 346799999999975 322356889999999999999999999999754321
Q ss_pred hHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCC
Q 007542 238 HQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317 (599)
Q Consensus 238 ~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~ 317 (599)
. +.+.. ...+ +...
T Consensus 691 Q--dILqe------------------------------------------------------------NTIl----kAtE 704 (775)
T KOG1151|consen 691 Q--DILQE------------------------------------------------------------NTIL----KATE 704 (775)
T ss_pred H--HHHhh------------------------------------------------------------hchh----ccee
Confidence 1 11100 0000 0000
Q ss_pred CCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 318 ~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+.| ..-|-++++|++||++||++--++|+.+.++-.||||..
T Consensus 705 VqF-P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 705 VQF-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ccC-CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 111 112568899999999999999999999999999999964
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.76 Aligned_cols=211 Identities=25% Similarity=0.411 Sum_probs=176.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCc---E-EEEEEecC-ccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---K-VAIKKIND-IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~---~-VAIK~i~~-~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
++-.+.++||+|+||.||+|..+..+. . ||||..+. ..........+.+|.++|+.++|||||+++++....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--- 233 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--- 233 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC---
Confidence 344556899999999999998766432 3 89998874 234556678899999999999999999999998554
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.-+|||||+|. |+|.++++.++ .++..+...++++.++||+|||++++|||||-..|+|+..++.+||+|||+++.
T Consensus 234 --~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 234 --EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred --CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 35899999999 59999999987 499999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIM 243 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I 243 (599)
... . .......-....|+|||.+.. ..|+.++||||+||++||+++ |..||+|....+....|
T Consensus 312 ~~~--~-~~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 312 GSQ--Y-VMKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred Ccc--e-eeccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 421 0 000112235678999999987 589999999999999999998 88899998877665555
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=273.63 Aligned_cols=242 Identities=39% Similarity=0.653 Sum_probs=196.9
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCc-cH
Q 007542 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DL 113 (599)
Q Consensus 35 ~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L 113 (599)
+||.||+|.+..+|+.||+|++........ ...+.+|+..++.++|+||+++++.+... ...++|+|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 589999999999999999999875332221 67888999999999999999999998543 478999999996 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCc
Q 007542 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193 (599)
Q Consensus 114 ~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~ 193 (599)
..++.....++...+..++.+++.+|.+||+.||+|+||+|.||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877669999999999999999999999999999999999999999999999999998764432 123456788
Q ss_pred cccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC-ChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCC
Q 007542 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGF 272 (599)
Q Consensus 194 ~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~-~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~ 272 (599)
.|++||.+.+ ..++.++||||+|+++++|++|..+|... +....++.+...
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-------------------------- 202 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP-------------------------- 202 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--------------------------
Confidence 9999999875 57888999999999999999999999763 222222111100
Q ss_pred cccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 007542 273 MCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 352 (599)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~ 352 (599)
...........+..+.+++.+||..||.+||++.++
T Consensus 203 --------------------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 203 --------------------------------------------KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred --------------------------------------------CCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence 000111111156788999999999999999999999
Q ss_pred hcCccc
Q 007542 353 LADPYF 358 (599)
Q Consensus 353 L~HP~f 358 (599)
++||||
T Consensus 239 ~~~~~~ 244 (244)
T smart00220 239 LQHPFF 244 (244)
T ss_pred hhCCCC
Confidence 999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=306.46 Aligned_cols=278 Identities=18% Similarity=0.251 Sum_probs=187.4
Q ss_pred CCCceEEEEEeeecCceEEEEEEEC----------------CCCcEEEEEEecCccCCh------------hhHHHHHHH
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDT----------------RTGEKVAIKKINDIFEHV------------SDATRILRE 72 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~----------------~tg~~VAIK~i~~~~~~~------------~~~~~i~rE 72 (599)
..++|++.++||+|+||+||+|.+. ..++.||||++....... ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3679999999999999999999752 345689999986421110 011223346
Q ss_pred HHHHHhcCCCCc-----cccceeecCCCc---CCCccEEEEEecCC-ccHHHHHHhCC----------------------
Q 007542 73 IKLLRLLRHPDI-----VEIKHILLPPSR---REFKDIYVVFELME-SDLHQVIKAND---------------------- 121 (599)
Q Consensus 73 i~iL~~l~HpnI-----v~l~~v~~~~s~---~~~~~lylV~E~~~-g~L~~~i~~~~---------------------- 121 (599)
+.++..++|.++ +++++++..... .+....||||||+. ++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 566666643211 12346899999999 58988886421
Q ss_pred --CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCcc
Q 007542 122 --DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199 (599)
Q Consensus 122 --~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE 199 (599)
.+++..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 23566788999999999999999999999999999999999999999999997543222111 11223478999999
Q ss_pred ccccccC------------------CCC--cchhhHhHHHHHHHHHhCCC-CCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 200 LCGSFFS------------------KYT--PAIDIWSIGCIFAELLTGKP-LFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 200 ~l~~~~~------------------~~s--~~~DIWSlG~Il~eLltG~~-pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.+..... .|+ ...||||+|||+++|++|.. +|.+....... .+.
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~------------ 445 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQ------------ 445 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhh------------
Confidence 8753110 012 24799999999999999874 66432211100 000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
..+ .... +... ......+. .+...++.++|||++|
T Consensus 446 -----------------------------------------~~~-~~~~-~r~~-~~~~~~~~-~~d~~s~~~~dLi~~L 480 (507)
T PLN03224 446 -----------------------------------------YDN-DLNR-WRMY-KGQKYDFS-LLDRNKEAGWDLACKL 480 (507)
T ss_pred -----------------------------------------ccc-hHHH-HHhh-cccCCCcc-cccccChHHHHHHHHH
Confidence 000 0000 0000 11111222 3566789999999999
Q ss_pred cccCC---CCCCCHHHHhcCccccC
Q 007542 339 LAFEP---KDRPTAEEALADPYFKG 360 (599)
Q Consensus 339 L~~DP---~~RpTa~e~L~HP~f~~ 360 (599)
|..+| .+|+|++|+|+||||..
T Consensus 481 L~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 481 ITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred hccCCCCcccCCCHHHHhCCCCcCC
Confidence 99876 68999999999999963
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=322.32 Aligned_cols=252 Identities=22% Similarity=0.398 Sum_probs=206.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~-----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
...-++.+.||+|.||.||.|.-..... .||||.+++ .........|++|..+|+.++|||||++++++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-- 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-- 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--
Confidence 4567889999999999999998655433 499999975 34556778899999999999999999999999763
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeee
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN-------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
...+|++|||+ |||..+|++. ..++...+..|+.+|++|++||+++++|||||-..|+|++....+||+
T Consensus 768 ---~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 ---GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred ---CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 35799999999 6999999875 268999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhc
Q 007542 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~l 247 (599)
|||+|+.......... .....-...|||||.+.. ..++.++||||+||++||+++ |..||++.++.+.+....+--
T Consensus 845 DFGlArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRK-HGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred ccchhHhhhhchheec-cCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9999994432221111 111234467999999986 689999999999999999998 899999988776654332211
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
. ....+..
T Consensus 922 -R-----------------------------------------------------------------------L~~P~~C 929 (1025)
T KOG1095|consen 922 -R-----------------------------------------------------------------------LDPPSYC 929 (1025)
T ss_pred -c-----------------------------------------------------------------------cCCCCCC
Confidence 0 0112346
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
+..+.+||..||+.||++||++..+++
T Consensus 930 P~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 930 PEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ChHHHHHHHHHccCChhhCccHHHHHh
Confidence 677889999999999999999999987
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=284.55 Aligned_cols=201 Identities=23% Similarity=0.448 Sum_probs=176.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
-++|.++++||+|+|..|..++++.|.+.||+|++++.. ....+..-+..|-.+...- +||.+|.|+.+|.+.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes---- 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES---- 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc----
Confidence 478999999999999999999999999999999998643 3334455566777777665 5999999999996554
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+++|.||++ |+|.-.++...+|+|++++++...|+-||.|||++|||.||||.+|+|++..|.+||.|+|.++....
T Consensus 325 -rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 325 -RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred -eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 6999999999 58888888888999999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
... ...+.+||+.|.|||++.+ ..|+..+|-|+||++++||+.|+.||.
T Consensus 404 ~gd---~tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 404 PGD---TTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCc---ccccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcc
Confidence 222 2357899999999999998 799999999999999999999999995
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=313.05 Aligned_cols=247 Identities=31% Similarity=0.481 Sum_probs=191.7
Q ss_pred EEEeeecCceE-EEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEE
Q 007542 28 EEVIGKGSYGV-VCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 28 ~~~IG~G~~g~-Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
.+++|.|+.|+ ||+|. -.|+.||||.+-. .....+.|||.+|+..+ |||||+.+..= .+.+.+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 36789998885 78985 5788999998853 33456779999999985 99999987654 445679999
Q ss_pred EecCCccHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---C--Cceeeecccccccc
Q 007542 106 FELMESDLHQVIKAND-D---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---D--CKLKICDFGLARVA 176 (599)
Q Consensus 106 ~E~~~g~L~~~i~~~~-~---lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~--~~lKL~DFGla~~~ 176 (599)
.|+|..+|.++++..+ . ......+.++.|++.||++||+.+||||||||+||||.. + .+++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999999999998741 1 122456788999999999999999999999999999986 3 45899999999987
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG-~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..+...-.......||-.|+|||++.. ..-+.++||+|||||+|+.++| ..||... ...+.+.+. |.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~-~~R~~NIl~---~~------ 729 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-LERQANILT---GN------ 729 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCch-HHhhhhhhc---Cc------
Confidence 665554444567789999999999977 4556799999999999999986 7888543 222211111 00
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
..+.++-+..+.+|.|||
T Consensus 730 --------------------------------------------------------------~~L~~L~~~~d~eA~dLI 747 (903)
T KOG1027|consen 730 --------------------------------------------------------------YTLVHLEPLPDCEAKDLI 747 (903)
T ss_pred --------------------------------------------------------------cceeeeccCchHHHHHHH
Confidence 011112222233899999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccC
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
.+||.+||..||||.++|.||+|=.
T Consensus 748 ~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 748 SRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred HHhcCCCcccCCCHHHHhCCCccCC
Confidence 9999999999999999999999954
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.70 Aligned_cols=208 Identities=32% Similarity=0.492 Sum_probs=176.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s-~~~ 98 (599)
|...-|..-+.||+|+||.||+++++.||+.||||.++... .....++.-+|+++|++|+|+|||++.++=.+.. .-.
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 66677888899999999999999999999999999997543 4455677889999999999999999998853321 001
Q ss_pred CccEEEEEecCC-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC--CCc--eeeecc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCK--LKICDF 170 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~---~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~--~~~--lKL~DF 170 (599)
...-.+|||||. |+|+.++.+. .+|++..+..++..+..||.|||.+||+||||||.||++-. +|+ -||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 234689999999 6999999753 47999999999999999999999999999999999998643 344 699999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g 233 (599)
|.|+....+. .+++.+||+.|++||+... ...|+..+|.||+||++|++.||..||-.
T Consensus 169 G~Arel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 169 GAARELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999765443 4678999999999999873 26789999999999999999999999854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=290.46 Aligned_cols=246 Identities=22% Similarity=0.436 Sum_probs=206.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.+.....+||-|-||.||.+++++-.-.||||.++ ++....+.|+.|..+|+.++|||+|+|+++|... .-+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPF 338 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPF 338 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCe
Confidence 34455789999999999999999999999999987 3556788999999999999999999999999644 358
Q ss_pred EEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 103 YVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
|||+|||. |+|.++++..+ .++--.+.+++.||..|+.||..+++|||||-..|+||.++..|||+||||+++...+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999999 89999998654 4677788899999999999999999999999999999999999999999999998665
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
+.+. ....--..-|.|||-|.- ..++.++|||+|||+|||+.| |-.||+|-+....+.++.+-...
T Consensus 419 TYTA--HAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM--------- 485 (1157)
T KOG4278|consen 419 TYTA--HAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM--------- 485 (1157)
T ss_pred ceec--ccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc---------
Confidence 5432 122334567999998865 789999999999999999998 89999998766555544321110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
......++.+.+|++.|
T Consensus 486 ---------------------------------------------------------------~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 486 ---------------------------------------------------------------DGPEGCPPKVYELMRAC 502 (1157)
T ss_pred ---------------------------------------------------------------cCCCCCCHHHHHHHHHH
Confidence 01124678899999999
Q ss_pred cccCCCCCCCHHHH
Q 007542 339 LAFEPKDRPTAEEA 352 (599)
Q Consensus 339 L~~DP~~RpTa~e~ 352 (599)
++|+|.+||++.|+
T Consensus 503 W~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 503 WNWSPSDRPSFAEI 516 (1157)
T ss_pred hcCCcccCccHHHH
Confidence 99999999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=295.77 Aligned_cols=246 Identities=26% Similarity=0.464 Sum_probs=198.0
Q ss_pred EEEEEeeecCceEEEEEEECCC--C--cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 26 KIEEVIGKGSYGVVCSAYDTRT--G--EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 26 ~i~~~IG~G~~g~Vy~a~~~~t--g--~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++.++||.|-||.||.|....- | -.||||..+... ...+.+.|+.|..+|+.++||||++|++++.. .-
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QP 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec------cc
Confidence 3457899999999999975432 3 358899887533 33457889999999999999999999999954 35
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|||||++. |.|..+++.+. .|+......|++||..||.|||+.++|||||-..||||...-.+||+|||++|....+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 899999999 89999998764 7899999999999999999999999999999999999999999999999999987544
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
..-. .+...-..-|||||.+.- ..++.++|||.|||++||+|. |..||.|-.+.+.+-.|.+
T Consensus 545 ~yYk--aS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn------------- 607 (974)
T KOG4257|consen 545 AYYK--ASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN------------- 607 (974)
T ss_pred chhh--ccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-------------
Confidence 3211 111223456999999875 789999999999999999885 9999988655443322211
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.... ...++.++.+..|+.+|
T Consensus 608 --------------------------------------------------------GeRl---P~P~nCPp~LYslmskc 628 (974)
T KOG4257|consen 608 --------------------------------------------------------GERL---PCPPNCPPALYSLMSKC 628 (974)
T ss_pred --------------------------------------------------------CCCC---CCCCCCChHHHHHHHHH
Confidence 1111 12357888899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 007542 339 LAFEPKDRPTAEEALA 354 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~ 354 (599)
+.+||.+||++.|+.+
T Consensus 629 WayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 629 WAYEPSKRPRFTEIKA 644 (974)
T ss_pred hccCcccCCcHHHHHH
Confidence 9999999999888754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=295.79 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=207.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC-C--cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-G--EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t-g--~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.++..+.++||+|+||+|++|.++.- | -.||||.+....... ....|++|+.+|..|+|+|+++|++++.+.
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q---- 183 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ---- 183 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc----
Confidence 35667789999999999999977653 3 358999997544443 567899999999999999999999999653
Q ss_pred CccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
-+.||||++. |+|++.+.+. ..|-...+..|+.||+.|+.||.++++|||||-..|||+-....||||||||.|.
T Consensus 184 --p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 184 --PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred --hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 4689999999 8999999872 4677888999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
.........+-...-....|+|||.|.. .+++.++|+|++||++|||++ |..||.|......+++|-+---
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er------ 333 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER------ 333 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc------
Confidence 7655443333333445567999999987 789999999999999999998 7899999988777666531100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+ ..-+..+.+..++
T Consensus 334 ---------------------------------------------------------L---------pRPk~csedIY~i 347 (1039)
T KOG0199|consen 334 ---------------------------------------------------------L---------PRPKYCSEDIYQI 347 (1039)
T ss_pred ---------------------------------------------------------C---------CCCCCChHHHHHH
Confidence 0 0113467788999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 007542 335 LERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~H 355 (599)
+.+|+..+|.+|||+..+.+.
T Consensus 348 mk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 348 MKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHhccCCccccccHHHHHHh
Confidence 999999999999999888644
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=297.10 Aligned_cols=258 Identities=27% Similarity=0.444 Sum_probs=216.2
Q ss_pred ccccCCCCceEEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
|+.--..+...|.++||.|.||.||+|+.+..| ..||||.++... .......|+.|..||-+++||||++|.++..
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 333344677789999999999999999988766 469999998533 3455678999999999999999999999984
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 93 PPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
. ..-+.||+|||+ |+|..+++.+ +.++.-++--+++-|+.|++||-..|.|||||-..|||||.+-.+||+||
T Consensus 701 k-----s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 701 K-----SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred c-----CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccc
Confidence 3 246899999999 8999999876 57888899999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCccccccc--ccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhc
Q 007542 171 GLARVAFNDTPTAIFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~--~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~l 247 (599)
||+|...++.+.. +++. --...|.|||.|.. .+++.++||||+|++|||.++ |.-||=..++.+.+..|.+-.
T Consensus 776 GLSRvledd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy 851 (996)
T KOG0196|consen 776 GLSRVLEDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY 851 (996)
T ss_pred cceeecccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc
Confidence 9999876554322 2222 22467999999976 789999999999999999876 888887788888888777666
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
.-|+| .+.
T Consensus 852 RLPpP------------------------------------------------------------------------mDC 859 (996)
T KOG0196|consen 852 RLPPP------------------------------------------------------------------------MDC 859 (996)
T ss_pred CCCCC------------------------------------------------------------------------CCC
Confidence 55554 245
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+..+..|+..|+++|-..||++.|++.+
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 6678899999999999999999999884
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=256.52 Aligned_cols=213 Identities=26% Similarity=0.462 Sum_probs=175.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHH-HhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL-~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+...-+..||+|+||+|-+.+|..+|...|+|.|..... ....++.++|+.+. +...+|.+|.+++.+. ...+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-----regd 119 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-----REGD 119 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----cccc
Confidence 334456889999999999999999999999999975544 45567888999874 5557999999999884 3458
Q ss_pred EEEEEecCCccHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccc
Q 007542 102 IYVVFELMESDLHQV----IKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 102 lylV~E~~~g~L~~~----i~~~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+||.||.|..+|..+ ++..+.++|..+-+|+..++.||.|||++ .|||||+||+|||||.+|++|+||||.+...
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999999887554 45677899999999999999999999987 8999999999999999999999999999776
Q ss_pred cCCCCCcccccccccCccccCccccccc--cCCCCcchhhHhHHHHHHHHHhCCCCCCCC-ChhhHHHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAELLTGKPLFPGK-NVVHQLDIMTD 245 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~s~~~DIWSlG~Il~eLltG~~pF~g~-~~~~~l~~I~~ 245 (599)
.++... +-..|-..|+|||.+... ...|+.++||||||+.+.||.+++.||+.. +...|+.++.+
T Consensus 200 ~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 200 VDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 544322 334577889999998542 246999999999999999999999998754 45666665543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=282.07 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=202.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++..++++||+|-||.|.+|.- ..+.+||||+++... .......|.+||++|.+|+||||+.|+++|... .-
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----eP 609 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DP 609 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cc
Confidence 36678899999999999999963 446999999997432 223347799999999999999999999999654 35
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
++||+|||+ |+|.+++.++. .+.-.....++.||+.|++||.+.++|||||.+.|+|++.++++||+|||.+|-...
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence 899999999 89999998873 334455566999999999999999999999999999999999999999999986544
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHH--hCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL--TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLl--tG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
+..- ......+-...|||+|.+.- .+++.++|+|++|+++||++ +...||..-.+....+....++......
T Consensus 690 g~yy-~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~--- 763 (807)
T KOG1094|consen 690 GDYY-RVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ--- 763 (807)
T ss_pred CCce-eeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc---
Confidence 3321 12234566789999998765 68999999999999999976 4677886655544444333333222211
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
......+-.+..+.+||.
T Consensus 764 --------------------------------------------------------------~~l~~P~~cp~~lyelml 781 (807)
T KOG1094|consen 764 --------------------------------------------------------------VVLSRPPACPQGLYELML 781 (807)
T ss_pred --------------------------------------------------------------eeccCCCcCcHHHHHHHH
Confidence 011111335667889999
Q ss_pred HhcccCCCCCCCHHHHhcCccccC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+|+..|-.+|||.+++ |-+|++
T Consensus 782 ~Cw~~es~~RPsFe~l--h~~lq~ 803 (807)
T KOG1094|consen 782 RCWRRESEQRPSFEQL--HLFLQE 803 (807)
T ss_pred HHhchhhhcCCCHHHH--HHHHHH
Confidence 9999999999999998 444543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=273.92 Aligned_cols=202 Identities=26% Similarity=0.336 Sum_probs=165.7
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc--CCCCccccceeecCCCcC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL--RHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l--~HpnIv~l~~v~~~~s~~ 97 (599)
-...-.+++++||+|.||.||+|. -+++.||||++.. .+.+.+.+|-+|.+.. +|+||++++..-......
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 335667888999999999999995 5679999999853 4556677777776654 799999998875443322
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC---------ceEeccCCCCceEecCCCceee
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILv~~~~~lKL 167 (599)
...++||++|.+ |+|.++++.+ .+++....+++..|++||+|||+- .|+|||||.+||||..|++.-|
T Consensus 280 -~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 280 -RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred -ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 457999999999 8999999887 699999999999999999999964 5999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCC-----cchhhHhHHHHHHHHHhCCCCCC
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s-----~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
+|||||.....+.+.... -..+||+.|||||+|.+- ..+. .++||||+|.+|+||++....+.
T Consensus 358 aDFGLAl~~~p~~~~~d~-~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDT-HGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred eccceeEEecCCCCCcch-hhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 999999988655444332 347999999999999763 2333 36899999999999999876554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=293.96 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=218.1
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.-.++|+++.++|+|+||.||+|+|+.+++..|+|+++. +...+..-+..||-+++.++||||+.+++-|...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr~----- 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR----- 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhhh-----
Confidence 567899999999999999999999999999999999975 3344566778999999999999999999988543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..++++||||+ |+|.++..-.+.+++.++.++.+..++||+|||+.|=+|||||-.|||+++.|.+|+.|||.+..+..
T Consensus 85 dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh
Confidence 35899999999 58998888888999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccCccccCcccc-ccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l-~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ...+..||++|||||+- .+....|...+|||++|+...|+---++|.-.......+.++.+..-.|+.
T Consensus 165 ti~---KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~----- 236 (829)
T KOG0576|consen 165 TIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT----- 236 (829)
T ss_pred hhh---hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-----
Confidence 222 23578999999999985 222357999999999999999998777766555555555555443322221
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
+ +--..+++.+.+|++.
T Consensus 237 --------------------------------------------------------------l-kDk~kws~~fh~fvK~ 253 (829)
T KOG0576|consen 237 --------------------------------------------------------------L-KDKTKWSEFFHNFVKG 253 (829)
T ss_pred --------------------------------------------------------------c-cCCccchHHHHHHHHH
Confidence 0 0112467788999999
Q ss_pred hcccCCCCCCCHHHHhcCccccC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+|..+|++|||++.+|.|||...
T Consensus 254 altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 254 ALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HhcCCCccCCChhhheeceeecc
Confidence 99999999999999999999975
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=311.19 Aligned_cols=187 Identities=27% Similarity=0.432 Sum_probs=157.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
..|...++||+|+||.||+|.++.+|..||||++..... ....|+.+|+.++|||||++++++... ...
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~ 758 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGA 758 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCC
Confidence 346667899999999999999999999999999864221 112568899999999999999999543 468
Q ss_pred EEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh---hCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 103 YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLH---s~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
|+||||++ |+|.++++ .+++..+..++.||++||.||| +.+|+||||||+|||++.++..+++ ||.......
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999998 69999996 3889999999999999999999 6699999999999999998888776 665543211
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g 233 (599)
. ....+|..|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 835 ~-------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 D-------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred C-------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1 23468899999999876 6799999999999999999999999854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=267.34 Aligned_cols=210 Identities=26% Similarity=0.393 Sum_probs=171.8
Q ss_pred cCCCCcccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHH--HhcCCCCcc
Q 007542 8 KSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL--RLLRHPDIV 85 (599)
Q Consensus 8 ~~~~~~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL--~~l~HpnIv 85 (599)
-|...+.++.+.+++.+.++++.||+|.||.||+| +..|+.||||++.. .+.....||.+|. ..|+|+||+
T Consensus 196 GSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG--~wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENIL 268 (513)
T KOG2052|consen 196 GSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRG--RWRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENIL 268 (513)
T ss_pred CCCCCchhHhHHhhhheeEEEEEecCccccceeec--cccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhh
Confidence 35567888999999999999999999999999999 46799999999863 2233445666655 456999999
Q ss_pred ccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC--------ceEeccCCCCc
Q 007542 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKN 156 (599)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~N 156 (599)
.++..-.... .....+|||++|-+ |+|++++.. ..++.+...++++.++.||+|||.. .|.|||||..|
T Consensus 269 gFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 269 GFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 9988754332 44568999999999 899999988 4799999999999999999999954 49999999999
Q ss_pred eEecCCCceeeecccccccccCCC-CCcccccccccCccccCccccccccCC--C--CcchhhHhHHHHHHHHHh
Q 007542 157 ILANADCKLKICDFGLARVAFNDT-PTAIFWTDYVATRWYRAPELCGSFFSK--Y--TPAIDIWSIGCIFAELLT 226 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~--~--s~~~DIWSlG~Il~eLlt 226 (599)
|||..++.+-|+|+|||....+.+ ...+..+..+||-.|||||+|...-.. + -..+||||+|.|+||++.
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999999999999999998765543 233456788999999999998642111 1 135899999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=277.42 Aligned_cols=201 Identities=24% Similarity=0.387 Sum_probs=173.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC----C--hhhHHHHHHHHHHHHhcC---CCCccccceee
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE----H--VSDATRILREIKLLRLLR---HPDIVEIKHIL 91 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~----~--~~~~~~i~rEi~iL~~l~---HpnIv~l~~v~ 91 (599)
.-..|..++.+|.|+||.|++|+++.+...|+||.|.+..- + ....-.+--||.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34669999999999999999999999999999999864211 1 112234567999999997 99999999999
Q ss_pred cCCCcCCCccEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeec
Q 007542 92 LPPSRREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (599)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~D 169 (599)
++..++||+||--+ | +|+++|.-...++|..++.|+.|+.-|+++||+.||||||||-+|+.++.+|-+||+|
T Consensus 639 -----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 639 -----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred -----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEee
Confidence 45568999999888 5 9999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
||.|....++. +...+||..|.|||+++|. ...+..-|||+||++||.++....||.
T Consensus 714 fgsaa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99997764433 3457999999999999984 344778899999999999998887774
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=230.95 Aligned_cols=184 Identities=38% Similarity=0.653 Sum_probs=157.1
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME 110 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~ 110 (599)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++... ...++|+|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999987432221 356788999999999999999999998543 47899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-CCceeeecccccccccCCCCCccccc
Q 007542 111 -SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWT 187 (599)
Q Consensus 111 -g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-~~~lKL~DFGla~~~~~~~~~~~~~~ 187 (599)
++|.+++... ..++...++.++.+++++|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 6999999876 47899999999999999999999999999999999999999 89999999999976543221 123
Q ss_pred ccccCccccCccccccccCCCCcchhhHhHHHHHHHH
Q 007542 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224 (599)
Q Consensus 188 ~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eL 224 (599)
...+...|++||.+... ..++.+.|+|++|+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH
Confidence 45678889999998762 3788899999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=275.61 Aligned_cols=199 Identities=29% Similarity=0.495 Sum_probs=166.5
Q ss_pred EEEEEeeecCceEEEEEEEC----C---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcC
Q 007542 26 KIEEVIGKGSYGVVCSAYDT----R---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRR 97 (599)
Q Consensus 26 ~i~~~IG~G~~g~Vy~a~~~----~---tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~ 97 (599)
++.+.||+|.||.|++|.-. . ....||||.++..... .+.+.+..|+.+|+.+. |+||+.+++++..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~---- 373 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ---- 373 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence 56779999999999999632 1 2467999999865444 66788999999999995 9999999999954
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
...+++|+||+. |+|..+++... .++...+..|.+||+.|++||++..+|||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 457999999999 89999998765 388999999999999999999999999999999999999
Q ss_pred CCCceeeecccccccccCCCCCcccccccc--cCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 007542 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYV--ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGK 234 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~--gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~ 234 (599)
.+..+||+|||+|+.......-.. .... -...|||||.+.. ..|+.++||||+|++|||+++ |..||+|-
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999986433222110 1111 2445999999987 789999999999999999997 88999873
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=235.77 Aligned_cols=211 Identities=36% Similarity=0.637 Sum_probs=177.3
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|.+.+.||+|++|.||++.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+... ...++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEE
Confidence 67889999999999999999998999999998753222 2567888999999999999999999988433 46899
Q ss_pred EEecCCc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 105 VFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~-lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
|+|++.+ +|.+++..... +++..+..++.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999988766 899999999999999999999999999999999999999999999999999876443211
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC-CC-hhhHHHHHH
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KN-VVHQLDIMT 244 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g-~~-~~~~l~~I~ 244 (599)
......++..|++||.+.. ...++.++|+|+|||++++|++|+.||.+ .+ .....+.|.
T Consensus 155 --~~~~~~~~~~~~~pe~~~~-~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLG-GKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred --cccceeccCCcCCHhHhcC-CCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 1234567888999999832 26788899999999999999999999987 33 335555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=293.35 Aligned_cols=209 Identities=16% Similarity=0.197 Sum_probs=149.6
Q ss_pred hcCC-CCccccceeecCCCc--CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCC
Q 007542 78 LLRH-PDIVEIKHILLPPSR--REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK 153 (599)
Q Consensus 78 ~l~H-pnIv~l~~v~~~~s~--~~~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLK 153 (599)
.++| .||+.+++.|..... .....++++||+++++|++++... ..+++.+++.+++||++||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 578888887632211 122467889999999999999753 469999999999999999999999999999999
Q ss_pred CCceEecC-------------------CCceeeecccccccccCCC-------------CCcccccccccCccccCcccc
Q 007542 154 PKNILANA-------------------DCKLKICDFGLARVAFNDT-------------PTAIFWTDYVATRWYRAPELC 201 (599)
Q Consensus 154 P~NILv~~-------------------~~~lKL~DFGla~~~~~~~-------------~~~~~~~~~~gt~~Y~APE~l 201 (599)
|+||||+. ++.+||+|||+++...... +........++|++|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999954 4556667777765421100 000011225789999999998
Q ss_pred ccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccc
Q 007542 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCF 281 (599)
Q Consensus 202 ~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (599)
.+ ..|+.++||||||||||||++|.++|..... .+..+...
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~----------------------------------- 228 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR----------------------------------- 228 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-----------------------------------
Confidence 77 6789999999999999999999887653211 11100000
Q ss_pred hhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 282 LVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 282 ~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
. + + .......+.+.+++.+||..||.+|||+.|+|+||||...
T Consensus 229 --------------------------~---~----~----~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 229 --------------------------V---L----P----PQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred --------------------------h---c----C----hhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0 0 0 0001123456789999999999999999999999999875
Q ss_pred c
Q 007542 362 A 362 (599)
Q Consensus 362 ~ 362 (599)
.
T Consensus 272 ~ 272 (793)
T PLN00181 272 R 272 (793)
T ss_pred h
Confidence 3
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=245.79 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=200.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~ 98 (599)
...+.|.|.+.||+|.||.+-+|.|+.++..+++|.+... ......|.||...--.|. |.||+.-+++.+...
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~--- 94 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS--- 94 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC---
Confidence 4468899999999999999999999999999999998753 345678889998765664 899999988875433
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC--CCceeeeccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARV 175 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~--~~~lKL~DFGla~~ 175 (599)
+.+++++||++ |+|..-+..+ ++-|...+.++.|++.||.|+|+.++||||||.+||||-. ..++||||||+.+.
T Consensus 95 -d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 95 -DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred -ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 47889999999 8999988775 5889999999999999999999999999999999999854 35799999999876
Q ss_pred ccCCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
.+... ...--+..|.+||++... .-...+..|||.+|+|+|.+|+|++||......+
T Consensus 173 ~g~tV------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-------------- 232 (378)
T KOG1345|consen 173 VGTTV------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-------------- 232 (378)
T ss_pred cCcee------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--------------
Confidence 43211 111234568999986431 1235678999999999999999999997433222
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
....+|+.-...+. ......|..+++.|.
T Consensus 233 --------------------------------------------------~~Y~~~~~w~~rk~-~~~P~~F~~fs~~a~ 261 (378)
T KOG1345|consen 233 --------------------------------------------------KPYWEWEQWLKRKN-PALPKKFNPFSEKAL 261 (378)
T ss_pred --------------------------------------------------chHHHHHHHhcccC-ccCchhhcccCHHHH
Confidence 11122222222222 245566778999999
Q ss_pred HHHHHhcccCCCCC---CCHHHHhcCcccc
Q 007542 333 RLLERMLAFEPKDR---PTAEEALADPYFK 359 (599)
Q Consensus 333 dLL~~mL~~DP~~R---pTa~e~L~HP~f~ 359 (599)
.+.++-|..+|++| .++..-...-|..
T Consensus 262 r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 262 RLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred HHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 99999999999999 4555444444543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=262.89 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=197.9
Q ss_pred EEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 26 KIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 26 ~i~~~IG~G~~g~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
...++||+|+||+||+|...-.|+ +||||++. .+...+....++.|..+|..++|||+++|++++....
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~-~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLI-EFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEee-ccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 345899999999999998766665 57888775 3444555678999999999999999999999997543
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+-||++||+ |.|.++++.+ +.+-......|.+||++|+.|||.++++||||-..|+||..-..+||.|||+++....+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 789999999 7999999865 47888999999999999999999999999999999999999999999999999987544
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.... ....--..+-|+|=|.+.. ..|+.++||||+||++||++| |..|+.|....+.-+.+.+ +
T Consensus 852 ~~ey-~~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----g-------- 916 (1177)
T KOG1025|consen 852 EKEY-SAPGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----G-------- 916 (1177)
T ss_pred cccc-cccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----c--------
Confidence 3221 1122233566888888866 689999999999999999998 8889888765443222211 0
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.+ + ...|..+-++.-++-+|
T Consensus 917 -------------------------------------------------------eR----L-sqPpiCtiDVy~~mvkC 936 (1177)
T KOG1025|consen 917 -------------------------------------------------------ER----L-SQPPICTIDVYMVMVKC 936 (1177)
T ss_pred -------------------------------------------------------cc----C-CCCCCccHHHHHHHHHH
Confidence 00 0 11245667788999999
Q ss_pred cccCCCCCCCHHHHhc
Q 007542 339 LAFEPKDRPTAEEALA 354 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~ 354 (599)
|..|+..||+++++-+
T Consensus 937 wmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 937 WMIDADSRPTFKELAE 952 (1177)
T ss_pred hccCcccCccHHHHHH
Confidence 9999999999999876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=267.80 Aligned_cols=269 Identities=28% Similarity=0.371 Sum_probs=202.5
Q ss_pred Cce-EEEEEeeecCceEEEEEEECCCCcEEEEEEecC---ccCCh-hhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 23 SRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND---IFEHV-SDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 23 ~rY-~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~---~~~~~-~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
+.| ....++|.|++|.|+.+......+.++.|.... ..... .....+..|+.+-..+.|+|++..+.++....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-- 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-- 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--
Confidence 445 456789999999999988888777777776541 11111 11223667888888899999988888774332
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
.++-+||||.+||+.++...+.++...+..++.||+.||+|||+.||.|||||++|+++..+|.+||+|||.+....
T Consensus 395 ---~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 395 ---GILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred ---cchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 33444999999999999998889999999999999999999999999999999999999999999999999997754
Q ss_pred CCCCC-cccccccccCccccCccccccccCCCCc-chhhHhHHHHHHHHHhCCCCCCCCChhhHHH-HHHHhcCCCCHHH
Q 007542 178 NDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSPEA 254 (599)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~s~-~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~-~I~~~lg~p~~e~ 254 (599)
..... .......+|+..|+|||++.+ ..|++ ..||||+|+|+..|.+|+.||.-....++.. .+.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---------- 539 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---------- 539 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------
Confidence 33222 234567899999999999977 56665 6799999999999999999986544332211 000
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+..+ .........++..++...+.+
T Consensus 540 --------------~~~~-----------------------------------------~~~~~~~~~~~~~lp~~~~~~ 564 (601)
T KOG0590|consen 540 --------------YSDQ-----------------------------------------RNIFEGPNRLLSLLPRETRII 564 (601)
T ss_pred --------------cccc-----------------------------------------cccccChHHHHHhchhhHHHH
Confidence 0000 000011112223345667899
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
|.+||++||.+|+|+++||+.+||+.+..
T Consensus 565 ~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 565 IYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHccCChhheecHHHHhhChHhhhcce
Confidence 99999999999999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=217.03 Aligned_cols=107 Identities=25% Similarity=0.330 Sum_probs=94.6
Q ss_pred ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCccccccc
Q 007542 111 SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189 (599)
Q Consensus 111 g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~ 189 (599)
|+|.+++... ..+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6899999874 46999999999999999999999998 999999999999999 9998765321 22
Q ss_pred ccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 190 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
.||+.|+|||++.+ ..|+.++||||+||++|||++|+.||....
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 68899999999977 678999999999999999999999997654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-24 Score=216.07 Aligned_cols=204 Identities=36% Similarity=0.595 Sum_probs=172.1
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChh-hHHHHHHHHHHHHhcCCC-CccccceeecCCCcCCCccE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS-DATRILREIKLLRLLRHP-DIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~-~~~~i~rEi~iL~~l~Hp-nIv~l~~v~~~~s~~~~~~l 102 (599)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++.+.+... ...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEE
Confidence 889999999999999999887 8899999986555543 567889999999999988 799999999332 238
Q ss_pred EEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-ceeeeccccccccc
Q 007542 103 YVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAF 177 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-~lKL~DFGla~~~~ 177 (599)
+++++++. ++|.+++.... .+++..+..++.|++.++.|+|+.+++||||||+|||++..+ .++++|||+++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999 58887777664 799999999999999999999999999999999999999998 79999999998553
Q ss_pred CCCCCc---ccccccccCccccCcccccccc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCCh
Q 007542 178 NDTPTA---IFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236 (599)
Q Consensus 178 ~~~~~~---~~~~~~~gt~~Y~APE~l~~~~-~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~ 236 (599)
...... ......++|.+|++||.+.+.. ..++...|+||+|++++++++|..||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 332221 1346779999999999987621 3678899999999999999999999877653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=227.12 Aligned_cols=169 Identities=21% Similarity=0.226 Sum_probs=130.4
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECC-CCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFE---HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~-tg~~VAIK~i~~~~~---~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
-...+|++.++||+|+||+||+|+++. +++.||||++..... .......+.+|+.+|+.++|+|++..+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346889999999999999999999886 678889998753211 223356788999999999999998533221
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccC-CCCceEecCCCceeeeccccc
Q 007542 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILv~~~~~lKL~DFGla 173 (599)
...||||||++| +|. .+... . ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~-~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLH-LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHH-HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 246999999996 675 22211 1 1467899999999999999999999 999999999999999999999
Q ss_pred ccccCCCCCcc-----cccccccCccccCcccccc
Q 007542 174 RVAFNDTPTAI-----FWTDYVATRWYRAPELCGS 203 (599)
Q Consensus 174 ~~~~~~~~~~~-----~~~~~~gt~~Y~APE~l~~ 203 (599)
+.......... ..+..+++..|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 87643321111 1245678888999999854
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=213.91 Aligned_cols=253 Identities=18% Similarity=0.323 Sum_probs=196.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..|+++..++-+|.||.||.|+.+.. .+.|-+|.++.. ...-....++.|..+|..+.|||+..+.++...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie--- 358 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE--- 358 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee---
Confidence 46788899999999999999976543 345667766531 223345678899999999999999999999853
Q ss_pred CCCccEEEEEecCC-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceee
Q 007542 97 REFKDIYVVFELME-SDLHQVIKA--------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~--------~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL 167 (599)
+...-++++.+++ |+|..++.. ...++..++-.++.||..|+.|||+.||||.||-..|.+|++.-++||
T Consensus 359 -~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 359 -DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred -ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 3345688899999 899999972 124677788889999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHh
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDL 246 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~ 246 (599)
+|=.++|-.+........- ..-....||+||.+.. ..|+.++|+||||++||||+| |+.|+-.-+..+....+.+-
T Consensus 438 tDsaLSRDLFP~DYhcLGD-nEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGD-NENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred ccchhccccCcccccccCC-CCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 9999999876654432111 1123456999999987 789999999999999999997 88898776665544333220
Q ss_pred cCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC
Q 007542 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN 326 (599)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 326 (599)
. + +.+. -+
T Consensus 515 y-------------------------------------------------------------------R----laQP-~N 522 (563)
T KOG1024|consen 515 Y-------------------------------------------------------------------R----LAQP-FN 522 (563)
T ss_pred c-------------------------------------------------------------------e----ecCC-CC
Confidence 0 0 1111 25
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.++++..++.=|+..+|++|||.+|+..
T Consensus 523 CPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 523 CPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 6788899999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=195.27 Aligned_cols=211 Identities=26% Similarity=0.355 Sum_probs=167.1
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC-CCccccceeecCCC
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPS 95 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~v~~~~s 95 (599)
.++-.+++|.+++.||+|+||.+|.|.+..+|+.||||+-+.... ...+..|..+.+.|++ ..|..+..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~---- 80 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYG---- 80 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhc----
Confidence 345678999999999999999999999999999999997653222 2356689999999985 4555555544
Q ss_pred cCCCccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC---Cceeeeccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFG 171 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~---~~lKL~DFG 171 (599)
.+..+-.+||++++.+|.+++.- ...++...+.-++-|++.-|+|+|.+++|||||||+|+|..-+ .++.|+|||
T Consensus 81 -~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 81 -TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred -cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence 23346689999999888877753 3468999999999999999999999999999999999996543 459999999
Q ss_pred ccccccCCCC-Ccc---cccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhh
Q 007542 172 LARVAFNDTP-TAI---FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH 238 (599)
Q Consensus 172 la~~~~~~~~-~~~---~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~ 238 (599)
+|+....... ..+ .-+...||..|.+-....+ ..-+...|+-|+|.+|..+..|..||.|-....
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 9987643221 111 1245789999998776655 456788999999999999999999999865433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-22 Score=208.75 Aligned_cols=206 Identities=22% Similarity=0.276 Sum_probs=164.9
Q ss_pred ceEEEEEeeecCceEEEEEEECCCC-cEEEEEEecCccCChhhHHHHHHHHHHHHhcCC----CCccccceeecCCCcCC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLRH----PDIVEIKHILLPPSRRE 98 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg-~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H----pnIv~l~~v~~~~s~~~ 98 (599)
+|.+.+.||+|+||.||.+.+..++ ..+|+|......... ...+..|+.+|..+.. .++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 9999999999999999999988875 678888775432221 1156688999888873 57777777763 23
Q ss_pred CccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-----Cceeeeccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFG 171 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-----~~lKL~DFG 171 (599)
...-||||++++.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||.|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 3467999999999999988654 479999999999999999999999999999999999999865 469999999
Q ss_pred ccc--cccCCCCC----ccc-ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh
Q 007542 172 LAR--VAFNDTPT----AIF-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237 (599)
Q Consensus 172 la~--~~~~~~~~----~~~-~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~ 237 (599)
+++ ........ ... .....||..|.++....+ ...+...|+||++.++.+|+.|..||.+....
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 998 33222111 101 123569999999999887 67889999999999999999999999776543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=234.20 Aligned_cols=201 Identities=28% Similarity=0.427 Sum_probs=154.6
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC--ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~--~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.|...+.||++.|=.|.+|.|. ...|+||++-+... .-....+-++|++ ....+|||++.+..+. .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 7889999999999999999764 33599998854221 1122333445666 6667899999987775 33356
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc--CC
Q 007542 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF--ND 179 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~--~~ 179 (599)
-|||-+|...+|++.+.....+..-+.+.|+.||+.||+-||..||+|||||.+||||+.=+-+.|.||..-+... ++
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 7999999999999999999889999999999999999999999999999999999999998899999998765432 22
Q ss_pred CCCc--ccccccccCccccCcccccccc---------CCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 007542 180 TPTA--IFWTDYVATRWYRAPELCGSFF---------SKYTPAIDIWSIGCIFAELLT-GKPLFP 232 (599)
Q Consensus 180 ~~~~--~~~~~~~gt~~Y~APE~l~~~~---------~~~s~~~DIWSlG~Il~eLlt-G~~pF~ 232 (599)
++.. .++.+...-.+|.|||.+.... ...+++.||||+||+++||++ |+|||.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 2221 1222223334699999763310 116778999999999999998 799995
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=201.59 Aligned_cols=207 Identities=21% Similarity=0.285 Sum_probs=134.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCC----------CCccccceee
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRH----------PDIVEIKHIL 91 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~H----------pnIv~l~~v~ 91 (599)
..+...+.||.|+++.||.+.|..||+.+|||++..... .....+.+.+|.-....+.+ -.++..+++.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 356678899999999999999999999999998853222 22345666666654444322 2333344443
Q ss_pred cCCCc-------CCCc-----cEEEEEecCCccHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHhhhCceEeccC
Q 007542 92 LPPSR-------REFK-----DIYVVFELMESDLHQVIKA---NDD----LTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152 (599)
Q Consensus 92 ~~~s~-------~~~~-----~lylV~E~~~g~L~~~i~~---~~~----lse~~i~~i~~QIl~aL~yLHs~gIvHrDL 152 (599)
..... .+.. ..+++|+-+.+||.+++.. ... +.......+..|+++.+++||+.||+|+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 21110 0011 3478899999998888653 221 222233445589999999999999999999
Q ss_pred CCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccc------cCCCCcchhhHhHHHHHHHHHh
Q 007542 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLT 226 (599)
Q Consensus 153 KP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~------~~~~s~~~DIWSlG~Il~eLlt 226 (599)
+|+|+|++.+|.++|+||+.....+... .....+..|.+||+.... ...++.+.|.|+||+++|.|+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999876643211 113455779999976331 1357889999999999999999
Q ss_pred CCCCCCCCC
Q 007542 227 GKPLFPGKN 235 (599)
Q Consensus 227 G~~pF~g~~ 235 (599)
|..||....
T Consensus 246 ~~lPf~~~~ 254 (288)
T PF14531_consen 246 GRLPFGLSS 254 (288)
T ss_dssp SS-STCCCG
T ss_pred ccCCCCCCC
Confidence 999997653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-23 Score=223.08 Aligned_cols=240 Identities=26% Similarity=0.419 Sum_probs=194.3
Q ss_pred EeeecCceEEEEEE---ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEE
Q 007542 30 VIGKGSYGVVCSAY---DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~---~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~lylV 105 (599)
++|.|+||.|++++ ....|..+|+|++++.-.......+...|-.++..++ ||.+|++.-.+..+ ..+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHh
Confidence 47899999998764 3345778999988754333333334456778888887 99999999988444 478999
Q ss_pred EecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcc
Q 007542 106 FELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 184 (599)
Q Consensus 106 ~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~ 184 (599)
+++..| +|...+.....+.+...+.+...++-++.++|+.+|+|||+|++||+++.+|.+++.|||+++..-...
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999995 999998888889999999999999999999999999999999999999999999999999998753322
Q ss_pred cccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH-hcCCCCHHHHHHHhhhhh
Q 007542 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD-LLGTPSPEAIARVCLLLN 263 (599)
Q Consensus 185 ~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~-~lg~p~~e~i~~~~~~~~ 263 (599)
-.|||..|||||++.+ ...+.|-||+|+++++|++|..+|.+ +....|.+ .++.|
T Consensus 152 ---~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------- 207 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------- 207 (612)
T ss_pred ---hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------
Confidence 2289999999999874 56899999999999999999999987 33333332 11111
Q ss_pred hhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCC
Q 007542 264 IIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEP 343 (599)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP 343 (599)
..++..+.+++..|+..+|
T Consensus 208 -------------------------------------------------------------~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 208 -------------------------------------------------------------RELSAEARSLFRQLFKRNP 226 (612)
T ss_pred -------------------------------------------------------------hhhhHHHHHHHHHHHhhCH
Confidence 1356679999999999999
Q ss_pred CCCCC-----HHHHhcCccccCCcc
Q 007542 344 KDRPT-----AEEALADPYFKGLAK 363 (599)
Q Consensus 344 ~~RpT-----a~e~L~HP~f~~~~~ 363 (599)
..|.- +.|+++|+||..+..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred HHHhccCcchhHHHhccchheeeeH
Confidence 99975 589999999998754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-21 Score=191.60 Aligned_cols=226 Identities=21% Similarity=0.320 Sum_probs=180.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~ 99 (599)
.+-.|.+.++||+|+||+++.|.+.-+++.||||.=.. .+.+-.+.-|.+..+.|. .++|..++-+- .+.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----kS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG 96 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEG 96 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc----cCCcchHHHHHHHHHHHcCCCCCCceeeec-----ccc
Confidence 46789999999999999999999999999999997543 244556777888888886 57776654332 233
Q ss_pred ccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-----Cceeeeccccc
Q 007542 100 KDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-----CKLKICDFGLA 173 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-----~~lKL~DFGla 173 (599)
.+-.||+|+++.+|.+++.-. .+++...+..++.||+.-+.|+|++.+|.|||||+|+||... ..+.|+|||+|
T Consensus 97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 456799999998888888654 479999999999999999999999999999999999999764 44899999999
Q ss_pred ccccCCCC-Cccc---ccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC---ChhhHHHHHHHh
Q 007542 174 RVAFNDTP-TAIF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK---NVVHQLDIMTDL 246 (599)
Q Consensus 174 ~~~~~~~~-~~~~---~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~---~~~~~l~~I~~~ 246 (599)
+.+..... ..+. .....||-.||+-....+ ..-+...|+-|||-+|.++|-|..||.|- +..+-+++|-+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 98743322 2222 345789999999888777 67888999999999999999999999885 455667777666
Q ss_pred cCCCCHHHHHH
Q 007542 247 LGTPSPEAIAR 257 (599)
Q Consensus 247 lg~p~~e~i~~ 257 (599)
-...+.++++.
T Consensus 255 Kr~T~i~~Lc~ 265 (449)
T KOG1165|consen 255 KRSTPIEVLCE 265 (449)
T ss_pred cccCCHHHHHh
Confidence 55555555543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=225.08 Aligned_cols=230 Identities=27% Similarity=0.408 Sum_probs=174.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.....|..++.|..|+||.||..+|+.+.+.+|+ +|++ ...|+|- +|.....|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNk-------q~lilRn--ilt~a~np----------------- 132 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINK-------QNLILRN--ILTFAGNP----------------- 132 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhh-cccc-------cchhhhc--cccccCCc-----------------
Confidence 4567899999999999999999999999999999 5542 1112111 12222222
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
++| ||-...++..+.++.+. +.+++|||+-||+|||+||+|+||..-|++|+.|||+++.....
T Consensus 133 ---fvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 133 ---FVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ---cee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 222 55556666666666554 77899999999999999999999999999999999999764322
Q ss_pred CCC------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 180 TPT------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 180 ~~~------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
..+ ...-...+||+.|+|||++.. ..|+..+|-|++|+|+||+|-|..||.|+...+.+..++...
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 111 011234689999999999976 689999999999999999999999999998877665554322
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
.. |.+.-...
T Consensus 275 i~----------------------------------------------------------------------wpE~dea~ 284 (1205)
T KOG0606|consen 275 IE----------------------------------------------------------------------WPEEDEAL 284 (1205)
T ss_pred cc----------------------------------------------------------------------ccccCcCC
Confidence 11 11222346
Q ss_pred CHHHHHHHHHhcccCCCCCC---CHHHHhcCccccCCccC
Q 007542 328 NPLALRLLERMLAFEPKDRP---TAEEALADPYFKGLAKV 364 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~Rp---Ta~e~L~HP~f~~~~~~ 364 (599)
.+++.++|.+||+.+|..|. .+-++.+|+||+.+...
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 78899999999999999994 57888999999987543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=190.40 Aligned_cols=140 Identities=24% Similarity=0.256 Sum_probs=109.5
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhh------------------------HHHHHHHHHHHHhcCCCC
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD------------------------ATRILREIKLLRLLRHPD 83 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~------------------------~~~i~rEi~iL~~l~Hpn 83 (599)
.+.||+|++|.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999643221111 112345999999998887
Q ss_pred ccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhCceEeccCCCCceEecC
Q 007542 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANA 161 (599)
Q Consensus 84 Iv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILv~~ 161 (599)
+.....+.. ...+|||||++| +|...+...+.+++..+..++.||+.+|.+| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 754333221 123899999996 5555544556899999999999999999999 799999999999999998
Q ss_pred CCceeeecccccccc
Q 007542 162 DCKLKICDFGLARVA 176 (599)
Q Consensus 162 ~~~lKL~DFGla~~~ 176 (599)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=191.16 Aligned_cols=176 Identities=13% Similarity=0.121 Sum_probs=133.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhh-HHH------HHHHHHHHHhcCCCCccccceeecCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-ATR------ILREIKLLRLLRHPDIVEIKHILLPP 94 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~-~~~------i~rEi~iL~~l~HpnIv~l~~v~~~~ 94 (599)
.++|.++++||.|+||.||++.+ ++..+|||.+......... ..+ +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 68999999999999999999754 5778999999754433222 223 57899999999999999998886543
Q ss_pred CcC---CCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 95 SRR---EFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 95 s~~---~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
... -....+|||||++| +|.++. .+++ ..+.+++.+|..||..|++||||+|.||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 211 12468999999997 787763 2333 2456999999999999999999999999999988 999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHH
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELL 225 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLl 225 (599)
|............ .+... ..|+.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~d---------------~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD---------------RIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH---------------HHHHH--hHhcccccccceeEeehHHH
Confidence 9886542111100 02222 45778999999999998765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=182.71 Aligned_cols=140 Identities=23% Similarity=0.202 Sum_probs=111.3
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChh------------------------hHHHHHHHHHHHHhcCCCC
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS------------------------DATRILREIKLLRLLRHPD 83 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~------------------------~~~~i~rEi~iL~~l~Hpn 83 (599)
.+.||+|++|.||+|.+. +|+.||||+++....... ......+|+..+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 899999999875321100 0123457999999999998
Q ss_pred ccccceeecCCCcCCCccEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecC
Q 007542 84 IVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANA 161 (599)
Q Consensus 84 Iv~l~~v~~~~s~~~~~~lylV~E~~~g~-L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~ 161 (599)
+.....+... ..||||||++|. +.........+++..+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 8655444321 238999999963 44333344578889999999999999999999 9999999999999999
Q ss_pred CCceeeecccccccc
Q 007542 162 DCKLKICDFGLARVA 176 (599)
Q Consensus 162 ~~~lKL~DFGla~~~ 176 (599)
++.++|+|||++...
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 899999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-20 Score=189.22 Aligned_cols=211 Identities=29% Similarity=0.397 Sum_probs=146.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCc-----------------------------------EEEEEEecCccCChhhHH
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-----------------------------------KVAIKKINDIFEHVSDAT 67 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~-----------------------------------~VAIK~i~~~~~~~~~~~ 67 (599)
++|+|.+.||+|....||.|+....|. +.|||.+-+ ++..+...
T Consensus 157 ddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN-~~~~s~~~ 235 (598)
T KOG4158|consen 157 DDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFN-FEHDSGDA 235 (598)
T ss_pred hhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcc-cccCCchH
Confidence 679999999999999999997544221 245554422 22223333
Q ss_pred HHHH----HH------HHH--------H-------h-cCCCCccccceeecCCC----------------------cCCC
Q 007542 68 RILR----EI------KLL--------R-------L-LRHPDIVEIKHILLPPS----------------------RREF 99 (599)
Q Consensus 68 ~i~r----Ei------~iL--------~-------~-l~HpnIv~l~~v~~~~s----------------------~~~~ 99 (599)
.|++ |+ ..+ + + -+|||||++...|.+.. ....
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 3332 21 011 1 1 25999999988874321 1234
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC--CC--ceeeeccccccc
Q 007542 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DC--KLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~--~~--~lKL~DFGla~~ 175 (599)
..+|+||..+..+|++++-.+ ..+....+-++.|+++|+.|||++||.|||||.+|||+.- |+ .+.|+|||.+-.
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA 394 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA 394 (598)
T ss_pred ceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee
Confidence 579999999999999999775 4777788889999999999999999999999999999753 33 389999998754
Q ss_pred ccCCCCC---cccccccccCccccCccccccccCC----CCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 176 AFNDTPT---AIFWTDYVATRWYRAPELCGSFFSK----YTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 176 ~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~----~s~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
..+..-. ....-+.-|.-..||||+....... --.++|.|++|-+.||++....||.+..
T Consensus 395 d~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 395 DDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred ccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 3221111 1111234466778999987542111 1237899999999999999999997643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.8e-19 Score=173.45 Aligned_cols=136 Identities=20% Similarity=0.244 Sum_probs=106.8
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-----CCCCccccceeecCCCcCCCccE
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-----RHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-----~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.+.||+|+||.||. +..++.. +||++... .......+.+|+.+++.+ .||||+++++++.+.. +...+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 46899999999995 7777777 69988642 223456789999999999 5799999999996542 12344
Q ss_pred E-EEEecCC---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHhhhCceEeccCCCCceEecCC----Cceeeeccccc
Q 007542 103 Y-VVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL-KYIHTANVFHRDLKPKNILANAD----CKLKICDFGLA 173 (599)
Q Consensus 103 y-lV~E~~~---g~L~~~i~~~~~lse~~i~~i~~QIl~aL-~yLHs~gIvHrDLKP~NILv~~~----~~lKL~DFGla 173 (599)
+ +|+||.+ ++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 7899955 5999999764 56666 35678888887 99999999999999999999753 47999995433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=171.70 Aligned_cols=191 Identities=16% Similarity=0.078 Sum_probs=137.1
Q ss_pred EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChh--hHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 007542 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS--DATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 26 ~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~--~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.+...|++|+||+|+.+. ..+.+++.+.+........ ....+.+|+++|++|. |+++.+++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 356789999999999874 3788888887764333211 2235789999999996 57898887752 46
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccC-CCCceEecCCCceeeecccccccccCCC
Q 007542 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDL-KPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
|+||||+.| +|.+.+.. . ...++.|++.+|.+||++||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999997 66554321 1 1357889999999999999999999 7999999999999999999998543222
Q ss_pred CCcccc--c--------ccccCccccCccccccccCCCC-cchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 181 PTAIFW--T--------DYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 181 ~~~~~~--~--------~~~gt~~Y~APE~l~~~~~~~s-~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
.....+ . -...++.|++|+.-.-. ...+ ...+-++.|+-+|.++||..++-+++
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 100000 0 01246677788753221 1223 45677889999999999998775543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=174.99 Aligned_cols=148 Identities=19% Similarity=0.147 Sum_probs=114.4
Q ss_pred CCCCceEEEEEeeecCceEEEEEE-ECCCCcEEEEEEecCccCChh----------------------hHHHHHHHHHHH
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAY-DTRTGEKVAIKKINDIFEHVS----------------------DATRILREIKLL 76 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~-~~~tg~~VAIK~i~~~~~~~~----------------------~~~~i~rEi~iL 76 (599)
-.+.-|.+.+.||+|++|.||+|. +..+|+.||||++........ ....+.+|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 345578999999999999999998 778999999999864321000 112356899999
Q ss_pred HhcCCCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCc-eEeccCCC
Q 007542 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN-VFHRDLKP 154 (599)
Q Consensus 77 ~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g-IvHrDLKP 154 (599)
+.+.+. .+.+..++.. ...|+||||++| +|.........+....+..++.||+.+|.+||+.| |+||||||
T Consensus 105 ~~L~~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp 177 (237)
T smart00090 105 QRLYEA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSE 177 (237)
T ss_pred HHHHhc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCCh
Confidence 999753 3333333321 124899999997 56555444456677778899999999999999999 99999999
Q ss_pred CceEecCCCceeeeccccccc
Q 007542 155 KNILANADCKLKICDFGLARV 175 (599)
Q Consensus 155 ~NILv~~~~~lKL~DFGla~~ 175 (599)
+|||++ ++.++|+|||.+..
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhc
Confidence 999999 88999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-19 Score=189.55 Aligned_cols=198 Identities=25% Similarity=0.350 Sum_probs=137.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccce-------ee
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKH-------IL 91 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~-------v~ 91 (599)
...+.+.+.++..+++.+....-..+ .+.+.-+..+. .+........+++..+....|-+..-+.+ .+
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~--d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV--DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhc--cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 34445555566666666554432222 23333332211 12133445567777766665544443333 11
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceee
Q 007542 92 LPPSRREFKDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL 167 (599)
.........++||.|++|. .+|.++|.... ..+...++.++.|+..++.| +|.+|+|+||.||+...++.+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 1111112346899999999 69999997543 46677889999999999999 99999999999999999999999
Q ss_pred ecccccccccCCC---CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh
Q 007542 168 CDFGLARVAFNDT---PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226 (599)
Q Consensus 168 ~DFGla~~~~~~~---~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt 226 (599)
.|||+........ +..-..+..+||.|||+||.+.+ ..|+.++||||||+||+||+.
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHH
Confidence 9999987654332 11223567899999999999988 789999999999999999986
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-18 Score=194.78 Aligned_cols=193 Identities=25% Similarity=0.330 Sum_probs=150.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC---CCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~---HpnIv~l~~v~~~~s~~~ 98 (599)
+.+|.|.+.||+|+||.||.|.+.. |+.||||+=+....+.-.. =..++.+|+ -+.|+.+...+.-.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~~---- 766 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVFQ---- 766 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHccC----
Confidence 6789999999999999999999877 9999999866433332211 122333333 23444444443221
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-------CCceeeecc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDF 170 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-------~~~lKL~DF 170 (599)
+.-+||+||.+ |+|.+++..++.+++..+.+|.+||++.|.+||..+|||+||||+|+||.. +--++|+||
T Consensus 767 -~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 767 -NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred -CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 13489999999 899999998889999999999999999999999999999999999999753 234999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~ 228 (599)
|.+.-..-- +....+...++|-.+-.+|...| ..|+..+|.|.|+-+++.||.|+
T Consensus 846 G~siDm~lf-p~~~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLF-PDGTKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEc-CCCcEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 988543211 11223466788888999999988 78999999999999999999997
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=164.55 Aligned_cols=135 Identities=22% Similarity=0.285 Sum_probs=110.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------hhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV------SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~------~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
+.||+|++|.||+|.+ .|..|+||+........ ....++.+|+.++..+.|++|.....++... ...
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCC
Confidence 5799999999999976 78889999865322111 1234677899999999999988776665332 356
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
++||||++| +|.+++..... ....++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||+++.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 899999985 89988865432 7788999999999999999999999999999999 88999999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-19 Score=202.67 Aligned_cols=265 Identities=26% Similarity=0.367 Sum_probs=207.3
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~ 99 (599)
...|.+.+.||+|+|+.|-++... .+...+|.|.+............+..|..+-+.+. |.|++.+++....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~----- 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP----- 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----
Confidence 677889999999999999988764 34556788877655444455667777888888887 99999999887443
Q ss_pred ccEEEEEecCC-ccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHhh-hCceEeccCCCCceEecCCC-ceeeecccccc
Q 007542 100 KDIYVVFELME-SDLHQVI-KAND-DLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLAR 174 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i-~~~~-~lse~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILv~~~~-~lKL~DFGla~ 174 (599)
...+++++|.. ++++..+ .... ..+...+..++.|+..+|.|+| ..++.|+||||+|.+++.++ .+++.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 46789999977 4898888 5554 6788889999999999999999 99999999999999999999 99999999998
Q ss_pred cccCCCCCccccccccc-CccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFNDTPTAIFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~g-t~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
...............+| ++.|.|||...+. ....+..|+||+|+++..+++|..++......+.
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------------- 238 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------------- 238 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence 87653333344566788 9999999998662 3457889999999999999999988864332210
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.|..-+ ......-...|...+..+.+
T Consensus 239 -----------------------------------------------------~~~~~~-~~~~~~~~~~~~~~~~~~~~ 264 (601)
T KOG0590|consen 239 -----------------------------------------------------RYSSWK-SNKGRFTQLPWNSISDQAHD 264 (601)
T ss_pred -----------------------------------------------------cceeec-ccccccccCccccCChhhhh
Confidence 000000 00011112334567888999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
++.++|..+|..|.+.+++-.+||+..
T Consensus 265 ~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 265 LLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccCCchhccccccccccccccc
Confidence 999999999999999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-17 Score=177.46 Aligned_cols=305 Identities=22% Similarity=0.266 Sum_probs=193.8
Q ss_pred HHhcCCCCccccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCce-EeccC
Q 007542 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANV-FHRDL 152 (599)
Q Consensus 76 L~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gI-vHrDL 152 (599)
|+.+.|.|+.++++++.+. ..+++|.+||. |+|.+.+... -.++.--...+++.|+.||.|||..-| +|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678899999999999765 47899999999 8999999874 467888888899999999999999876 99999
Q ss_pred CCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccc--cCC---CCcchhhHhHHHHHHHHHhC
Q 007542 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF--FSK---YTPAIDIWSIGCIFAELLTG 227 (599)
Q Consensus 153 KP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~---~s~~~DIWSlG~Il~eLltG 227 (599)
+..|.+++....+||.|||+....... ..............|.|||++... ... .+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~-~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEET-AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhccccccc-ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999998775321 111111122234569999998652 111 46679999999999999999
Q ss_pred CCCCCCCChhh----HHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccH
Q 007542 228 KPLFPGKNVVH----QLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNE 303 (599)
Q Consensus 228 ~~pF~g~~~~~----~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~ 303 (599)
..||....... .+..+.+ .|.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-~~~------------------------------------------------------ 179 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-GGS------------------------------------------------------ 179 (484)
T ss_pred cCccccccccCChHHHHHHHHh-cCC------------------------------------------------------
Confidence 99997643221 1111111 000
Q ss_pred HHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhh
Q 007542 304 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERR 383 (599)
Q Consensus 304 ~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~ 383 (599)
....|.-.......+....++.+|+.-+|.+||+++++-.. +..+..... ... .-++..+..-
T Consensus 180 -----------~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~--~~~~~~~~~--~~~--nl~D~m~~~l 242 (484)
T KOG1023|consen 180 -----------NPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK--LLTINKGGS--SKG--NLMDSLFRML 242 (484)
T ss_pred -----------CCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh--hhhhccccc--ccc--hhHHHHHHHH
Confidence 00001001011344568999999999999999999988542 111111000 000 0111111111
Q ss_pred cCCHHHHHHHHHHHHHhhChhhHHhhhcCCCCCCCCCCchhhHHHHHHHHHHhhcCCCCCCCCCCCCCCCCCCcccccCC
Q 007542 384 RITKEDVRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPERQHASLPRPCVLYSD 463 (599)
Q Consensus 384 ~~~~e~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (599)
+.....+...+.+...++..+.........-++|..|. +..+.|..+.|..-.++.+-.+.||.++
T Consensus 243 ----e~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA----------~~lk~G~~v~pe~~~~vti~fsDiv~fT 308 (484)
T KOG1023|consen 243 ----ESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVA----------ESLKLGKTVDPESFDSVTIYFSDIVGFT 308 (484)
T ss_pred ----HHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHh----------hHhhcCCcCCccccCceeeeeHHHHHHH
Confidence 11111111111111111111111111122224554444 6778899999999999999999988887
Q ss_pred CCCCCcccc
Q 007542 464 KTVQNSAAV 472 (599)
Q Consensus 464 ~~~~~~~~~ 472 (599)
+...++.|.
T Consensus 309 ~l~~~~~P~ 317 (484)
T KOG1023|consen 309 VLSSNSTPI 317 (484)
T ss_pred HHHhcCCCc
Confidence 776666554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.1e-17 Score=158.14 Aligned_cols=139 Identities=22% Similarity=0.210 Sum_probs=105.5
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChh--------------------hHHHHHHHHHHHHhcCCCC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS--------------------DATRILREIKLLRLLRHPD 83 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~--------------------~~~~i~rEi~iL~~l~Hpn 83 (599)
.|.+.+.||+|+||.||+|.+. +|+.||||++........ ......+|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888899999999999999874 899999998753211000 1123567899999988775
Q ss_pred ccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC
Q 007542 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (599)
Q Consensus 84 Iv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~ 162 (599)
+. +...+. ....++||||++| +|..+.. ......++.+|+.++.++|+.||+||||||.||+++.+
T Consensus 95 i~-v~~~~~------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FP-VPKPID------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CC-CCceee------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence 31 222221 1235899999996 6655432 13456789999999999999999999999999999999
Q ss_pred Cceeeecccccccc
Q 007542 163 CKLKICDFGLARVA 176 (599)
Q Consensus 163 ~~lKL~DFGla~~~ 176 (599)
+.++|+|||.+...
T Consensus 162 ~~~~liDfg~~~~~ 175 (198)
T cd05144 162 EKIYIIDWPQMVST 175 (198)
T ss_pred CcEEEEECCccccC
Confidence 99999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-17 Score=162.16 Aligned_cols=242 Identities=17% Similarity=0.232 Sum_probs=179.4
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
...++.+|.....|..|+++ ..|..+++|+++-..........|..|.-.|+.+.||||+.+++.+..+ .++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLV 263 (448)
T ss_pred hhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCce
Confidence 34566788899999999995 5677888898864333333345677888899999999999999999544 4689
Q ss_pred EEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCCCceeee--cccccccc
Q 007542 104 VVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKIC--DFGLARVA 176 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~~~lKL~--DFGla~~~ 176 (599)
++..||+ |+|+.++.... .+...++.+|+..|++|+.|||+.. |.---|....++||++.+.+|. |--++..
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999 89999998654 3567788899999999999999985 4444688999999998776654 3222211
Q ss_pred cCCCCCcccccccccCccccCccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.....-++.|++||.+..... ..-.++|+||++++++||-|...||...+..+.--+|.
T Consensus 343 ---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia----------- 402 (448)
T KOG0195|consen 343 ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA----------- 402 (448)
T ss_pred ---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----------
Confidence 122345788999998854211 12347899999999999999999998766544211110
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
++.++. .+.|.+++....|+
T Consensus 403 -----------------------------------------------------leglrv-------~ippgis~hm~klm 422 (448)
T KOG0195|consen 403 -----------------------------------------------------LEGLRV-------HIPPGISRHMNKLM 422 (448)
T ss_pred -----------------------------------------------------hccccc-------cCCCCccHHHHHHH
Confidence 111111 23477899999999
Q ss_pred HHhcccCCCCCCCHHHHh
Q 007542 336 ERMLAFEPKDRPTAEEAL 353 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L 353 (599)
.-|+.-||.+||..+.++
T Consensus 423 ~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 423 NICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHhcCCCCcCCCcceeh
Confidence 999999999999987653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=154.03 Aligned_cols=131 Identities=28% Similarity=0.390 Sum_probs=102.6
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCc-cCCh-----hhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHV-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~-----~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.||+|++|.||+|. .+|..|++|+.... .... ....++.+|+.+++.+.|+++....-++... ...+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 48999999999997 46789999986432 1111 1235677999999999988765444333222 2468
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
+||||++| +|.+++..... .++.|++.+|.+||+.|++|+|++|.|||++ ++.++|+|||+++.
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999985 88887754321 7899999999999999999999999999999 89999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.4e-16 Score=174.77 Aligned_cols=139 Identities=23% Similarity=0.321 Sum_probs=108.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEe-cCccCC-----hhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEH-----VSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i-~~~~~~-----~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
...|...+.||+|+||+||++... +..+++|+. ...... .....++.+|+.+|+.++|++++....+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP- 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence 345566899999999999999754 444555543 221111 12245688999999999999998776655332
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...++||||++| +|.+++. ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++
T Consensus 409 ----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 409 ----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred ----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 246899999985 8988875 346789999999999999999999999999999 67899999999997
Q ss_pred cc
Q 007542 175 VA 176 (599)
Q Consensus 175 ~~ 176 (599)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.5e-16 Score=149.90 Aligned_cols=136 Identities=25% Similarity=0.259 Sum_probs=96.0
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHH----------------------HHHHHHHHHhcCCCC--
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR----------------------ILREIKLLRLLRHPD-- 83 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~----------------------i~rEi~iL~~l~Hpn-- 83 (599)
.+.||+|+||.||+|.+. +|+.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 8999999998643221111111 134555565554433
Q ss_pred ccccceeecCCCcCCCccEEEEEecCCc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEec
Q 007542 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLH-QVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 160 (599)
Q Consensus 84 Iv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~-~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~ 160 (599)
+.+++.+ ...++||||+++ .+. ..+.... . ...++.++.+++.++.++|. .||+|+||||+||+++
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 2222221 135899999996 221 1121111 1 16778999999999999999 9999999999999999
Q ss_pred CCCceeeecccccccc
Q 007542 161 ADCKLKICDFGLARVA 176 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~ 176 (599)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=145.81 Aligned_cols=139 Identities=22% Similarity=0.284 Sum_probs=103.0
Q ss_pred EEee-ecCceEEEEEEECCCCcEEEEEEecCc------cC-----ChhhHHHHHHHHHHHHhcCCCCc--cccceeecCC
Q 007542 29 EVIG-KGSYGVVCSAYDTRTGEKVAIKKINDI------FE-----HVSDATRILREIKLLRLLRHPDI--VEIKHILLPP 94 (599)
Q Consensus 29 ~~IG-~G~~g~Vy~a~~~~tg~~VAIK~i~~~------~~-----~~~~~~~i~rEi~iL~~l~HpnI--v~l~~v~~~~ 94 (599)
.+|| .|+.|+||.+.. .+..++||.+... .. ......++.+|+.++..|.|++| ...+.+....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 777888888854 3788999977431 01 11234578899999999998875 5566554322
Q ss_pred CcCCCccEEEEEecCCc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccc
Q 007542 95 SRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 95 s~~~~~~lylV~E~~~g--~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
. ......++|||+++| +|.+++.. ..+++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111123599999995 88888765 3566543 57899999999999999999999999999999999999998
Q ss_pred ccc
Q 007542 173 ARV 175 (599)
Q Consensus 173 a~~ 175 (599)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.2e-15 Score=162.17 Aligned_cols=260 Identities=24% Similarity=0.256 Sum_probs=198.5
Q ss_pred CCceEEEEEeee--cCceEEEEEEE--CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGK--GSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~--G~~g~Vy~a~~--~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~ 96 (599)
...+.+.+.+|. |.+|.||.+.. ..++..+|+|+=+..+.......+-++|+.-.+.+. |+|.++....+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~----- 187 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW----- 187 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----
Confidence 456677889999 99999999988 889999999985544444444445567887777775 99999977666
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHhhhCceEeccCCCCceEecCC-Cceeeecc
Q 007542 97 REFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLR----GLKYIHTANVFHRDLKPKNILANAD-CKLKICDF 170 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~-lse~~i~~i~~QIl~----aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DF 170 (599)
.+.+.+|+-+|+++.+|..+...... +++..++..+.+... ||.++|+.+++|-|+||.||++..+ +..+++||
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 44567899999999999999887654 889999999999999 9999999999999999999999999 88999999
Q ss_pred cccccccCCCCCcccc--cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 007542 171 GLARVAFNDTPTAIFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg 248 (599)
|+........-...+. ....+..-|++||++.+ .++...||+++|.++.+..+|-.++...-.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------------ 332 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKN------------ 332 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCC------------
Confidence 9998775544222111 22356677999999976 588999999999999999998765543200
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
..|....... + -.+.+...+
T Consensus 333 ---------------~~W~~~r~~~--------------------------i-------------------p~e~~~~~s 352 (524)
T KOG0601|consen 333 ---------------SSWSQLRQGY--------------------------I-------------------PLEFCEGGS 352 (524)
T ss_pred ---------------CCcccccccc--------------------------C-------------------chhhhcCcc
Confidence 0111111000 0 011222344
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
......+..|++.||..|++++.+++|+++...
T Consensus 353 ~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 353 SSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 455569999999999999999999999999853
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4e-14 Score=129.28 Aligned_cols=131 Identities=23% Similarity=0.200 Sum_probs=105.9
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC--CCccccceeecCCCcCCCccEEE
Q 007542 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH--PDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H--pnIv~l~~v~~~~s~~~~~~lyl 104 (599)
+++.||+|.++.||++.+. +..++||.+..... ...+.+|+.+++.++| .++.+++..... .+..|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-----~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-----DGWSYL 70 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-----CCccEE
Confidence 4678999999999999864 37899998864322 4567899999999976 478887776632 246899
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC---ceEeccCCCCceEecCCCceeeeccccccc
Q 007542 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
++||+.+ .+..+ +......++.+++++|.+||.. +++|+||+|.|||++.++.++++|||.++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 34433 4566677899999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-14 Score=163.72 Aligned_cols=265 Identities=23% Similarity=0.272 Sum_probs=198.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..+.+.+.+-+.+|+++.++.+.-..+|...++|+...... ...+.+.+.++-.++....+|-++...--+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 34667788899999999999998888887778776643221 122344555566665555667666543332 222
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+||++|++ ++|...++..+..+.+..+.++..+..++++||+..+.|+|++|.|+|+..++..++.|||.......
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 46899999998 59999999888899999999999999999999999999999999999999999999999984432210
Q ss_pred C--------CC------------------C--cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCC
Q 007542 179 D--------TP------------------T--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230 (599)
Q Consensus 179 ~--------~~------------------~--~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~p 230 (599)
- .. . ...-...++|+.|.+||.+.+ .....++|.|++|+++++.++|.++
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCC
Confidence 0 00 0 011123578999999999988 6778899999999999999999999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHH
Q 007542 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS 310 (599)
Q Consensus 231 F~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~ 310 (599)
|........++.|.+
T Consensus 1035 ~na~tpq~~f~ni~~----------------------------------------------------------------- 1049 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILN----------------------------------------------------------------- 1049 (1205)
T ss_pred CCCcchhhhhhcccc-----------------------------------------------------------------
Confidence 987665443322211
Q ss_pred hcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCccccCCc
Q 007542 311 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE---EALADPYFKGLA 362 (599)
Q Consensus 311 ~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~---e~L~HP~f~~~~ 362 (599)
...++..-....++.+.+++.++|..+|.+|..+. +.-.|+||++..
T Consensus 1050 -----~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1050 -----RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred -----CCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence 11222222334678899999999999999999988 889999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.6e-14 Score=143.30 Aligned_cols=189 Identities=19% Similarity=0.213 Sum_probs=131.2
Q ss_pred EEEEEEECCCCcEEEEEEecCccCChh--hHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC-ccHH
Q 007542 38 VVCSAYDTRTGEKVAIKKINDIFEHVS--DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLH 114 (599)
Q Consensus 38 ~Vy~a~~~~tg~~VAIK~i~~~~~~~~--~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~ 114 (599)
.||++.++..|..|+.-.+.......- ...+...-..-|-++-|-|||+++.+|.+.-.++...+.+++|||. |+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 467777777777776665532111111 1111111223355567999999999997766567778999999999 7999
Q ss_pred HHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCCCceeeecccccccccCCCCCcccc--
Q 007542 115 QVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW-- 186 (599)
Q Consensus 115 ~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~-- 186 (599)
+++++. ..+.....++|+-||+.||.|||+.. |+|+++..+.|++..+|-+|+.--.-.... ......+..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h-~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-PSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccc-hhhhhhhHhhh
Confidence 988753 36889999999999999999999985 999999999999999999888642221110 000000000
Q ss_pred cccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCC
Q 007542 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229 (599)
Q Consensus 187 ~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~ 229 (599)
....+-+.|.+||.-.. ...+.++|||++|.+..+|..|..
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHhee
Confidence 11234567899997543 566789999999999999988763
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-12 Score=145.74 Aligned_cols=141 Identities=22% Similarity=0.329 Sum_probs=95.2
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh--------------------------------hhHHHHHH
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV--------------------------------SDATRILR 71 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~--------------------------------~~~~~i~r 71 (599)
.|+. +.||+|++|.||+|+.+.+|+.||||++....... .....+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3554 78999999999999998889999999996431100 11122334
Q ss_pred HHHHHHhc------C----CCCccccceeecCCCcCCCccEEEEEecCCc-cHHHH--HHhCC----CCCHHHHHHHHHH
Q 007542 72 EIKLLRLL------R----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV--IKAND----DLTPEHYQFFLYQ 134 (599)
Q Consensus 72 Ei~iL~~l------~----HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~--i~~~~----~lse~~i~~i~~Q 134 (599)
|+.+++.. . +.+.+.+-.++.+- ...-+|||||+.| .|.++ +...+ .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 44444333 1 22333333333211 1345799999996 77664 33333 3556666777777
Q ss_pred HHHHHHHhhhCceEeccCCCCceEecCCC----ceeeecccccccc
Q 007542 135 LLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGLARVA 176 (599)
Q Consensus 135 Il~aL~yLHs~gIvHrDLKP~NILv~~~~----~lKL~DFGla~~~ 176 (599)
++ ..|++|+|++|.||+++.+| .++++|||++...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 76 48999999999999999988 9999999998654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-11 Score=135.68 Aligned_cols=184 Identities=23% Similarity=0.342 Sum_probs=136.6
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|.| +...-++.+..-.|..+.++.+|.|.+.+.... .....+.+-+..|+.++||||+++++.+ +....+||
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~yl 86 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYL 86 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEE
Confidence 444 444445554433566678999999998875433 4456677889999999999999999988 34458999
Q ss_pred EEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh-hCceEeccCCCCceEecCCCceeeecccccccccCCCCCc
Q 007542 105 VFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 183 (599)
Q Consensus 105 V~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~ 183 (599)
|+|-+.. |..+++. ++...+..-++||+.||.||| ..+++|++|.-+-|+|+..|..||++|.++........
T Consensus 87 vTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-- 160 (690)
T KOG1243|consen 87 VTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-- 160 (690)
T ss_pred Eeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--
Confidence 9998763 4455554 337788888999999999997 66899999999999999999999999998865432221
Q ss_pred ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhC
Q 007542 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG 227 (599)
Q Consensus 184 ~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG 227 (599)
....+.---.|..|+.+.. .. -..|.|-|||++++++.|
T Consensus 161 -~~~~~~~~~s~~~P~~~~~--s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 -PAKSLYLIESFDDPEEIDP--SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -ccccchhhhcccChhhcCc--cc--cchhhhhHHHHHHHHhCc
Confidence 0111222234677776644 12 467999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.7e-12 Score=122.58 Aligned_cols=139 Identities=22% Similarity=0.265 Sum_probs=99.5
Q ss_pred EEEeeecCceEEEEEEECC------CCcEEEEEEecCc---cCC-----------------hhhHHHHH----HHHHHHH
Q 007542 28 EEVIGKGSYGVVCSAYDTR------TGEKVAIKKINDI---FEH-----------------VSDATRIL----REIKLLR 77 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~------tg~~VAIK~i~~~---~~~-----------------~~~~~~i~----rEi~iL~ 77 (599)
...||.|.-+.||.|.... .+..+|||+.+.. +.. ......+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997643 3579999977421 100 11122233 7999999
Q ss_pred hcCC--CCccccceeecCCCcCCCccEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhCceEeccCC
Q 007542 78 LLRH--PDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLK 153 (599)
Q Consensus 78 ~l~H--pnIv~l~~v~~~~s~~~~~~lylV~E~~~g~-L~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~gIvHrDLK 153 (599)
++.. -++.+++.+. .-+|||||++++ +..-......+++..+..++.|++.+|..| |..||||+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 8863 4455555442 348999999963 322112223466667788899999999998 89999999999
Q ss_pred CCceEecCCCceeeecccccccc
Q 007542 154 PKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 154 P~NILv~~~~~lKL~DFGla~~~ 176 (599)
+.|||+. ++.+.|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 578999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.8e-11 Score=133.81 Aligned_cols=140 Identities=21% Similarity=0.261 Sum_probs=92.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhh--------------------------------HH------HHH
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD--------------------------------AT------RIL 70 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~--------------------------------~~------~i~ 70 (599)
+.||+|++|.||+|+. .+|+.||||+.+......-. .. .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 57999999998542111000 00 123
Q ss_pred HHHHHHHhc----CCCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHhh
Q 007542 71 REIKLLRLL----RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLR-GLKYIH 143 (599)
Q Consensus 71 rEi~iL~~l----~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~-~~lse~~i~~i~~QIl~-aL~yLH 143 (599)
+|...+..+ +|.+-+.+-.++...+ ..-+|||||++| +|.++.... .... ...++.+++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence 344444333 2333333334442211 235899999996 777665432 1222 2345556655 478899
Q ss_pred hCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 144 TANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 144 s~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
..|++|+|++|.||+++.++.++|+|||++...
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-11 Score=116.16 Aligned_cols=126 Identities=20% Similarity=0.184 Sum_probs=92.1
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEEE
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~v~~~~s~~~~~~lylV~ 106 (599)
++.|+.|.++.||++.. .+..|++|....... ....+.+|+.+++.+.+.+++ +++... . ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~-----~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--P-----ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--C-----CCCeEEE
Confidence 46789999999999975 478999998754321 122356899999988765554 333332 1 1237999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCce-----EeccCCCCceEecCCCceeeecccccc
Q 007542 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV-----FHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 107 E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gI-----vHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
|+++| ++.+. .. ....++.+++++|..||+.++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 71 e~i~G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 44332 01 123457899999999999985 9999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.8e-11 Score=133.32 Aligned_cols=198 Identities=21% Similarity=0.203 Sum_probs=147.5
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~ 99 (599)
..+|.++..||.|.|+.|+...-. .++..|++|.+.+..........-+.|+.+...+. |.++++....|. ..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----QL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----cc
Confidence 356788999999999999987644 67889999988765554444455567887776664 888998777763 33
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-Cceeeeccccccccc
Q 007542 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFGla~~~~ 177 (599)
...|+-.||+++ ++...+.....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||......
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 467899999984 444433334458899999999999999999999999999999999999886 778999999885321
Q ss_pred CCCCCcccccccccCcccc-CccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 007542 178 NDTPTAIFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~-APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF 231 (599)
.. .......-++. ..|++... ..+..+.|++|||.-+.+.++|.++-
T Consensus 419 ~~------~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 419 FS------SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ee------cccccccccccccchhhccc-cccccccccccccccccccccCcccC
Confidence 11 11112233344 24554432 56788999999999999999998654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.5e-10 Score=118.96 Aligned_cols=169 Identities=20% Similarity=0.257 Sum_probs=130.9
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCc--c
Q 007542 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--D 112 (599)
Q Consensus 35 ~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g--~ 112 (599)
-..+.|+|....+|..|++|+++- ... ....+.-.-++.++++.|.|||++.++|.... .....+++|++|+++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg-~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHG-DRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecc-ccc-cCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence 345789999999999999999941 111 11112234578899999999999999997433 445679999999994 7
Q ss_pred HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 113 LHQVIKA---------------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 113 L~~~i~~---------------~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
|.++.-. +.+.+|+.+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|......
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 8876632 2357899999999999999999999999999999999999999899999888776654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~ 228 (599)
++.. |.+.+ -.+-|.=.||.+++.|.||.
T Consensus 445 ~d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 445 EDPT-----------------EPLES-----QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcc
Confidence 3220 11222 24679999999999999996
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=103.21 Aligned_cols=142 Identities=23% Similarity=0.302 Sum_probs=105.4
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEe-cCccCChh-----hHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-NDIFEHVS-----DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i-~~~~~~~~-----~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.+.+|-+|+-+.|+++ ...|+..+||.= .+...+.. ...+..+|+++|.++.--.|.-..=++.+..
T Consensus 11 ~l~likQGAEArv~~~--~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRG--SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeee--ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 5788999999999999 467888888843 33333322 3456788999998886544443333333221
Q ss_pred cEEEEEecCCc--cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc---eeeeccccc
Q 007542 101 DIYVVFELMES--DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLA 173 (599)
Q Consensus 101 ~lylV~E~~~g--~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~---lKL~DFGla 173 (599)
.-.|+|||++| ++.+++.... .........++.+|-+.|.-||.++|||+||..+||++..++. +.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 23689999998 8999887642 3334444789999999999999999999999999999887654 489999998
Q ss_pred cc
Q 007542 174 RV 175 (599)
Q Consensus 174 ~~ 175 (599)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 65
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-09 Score=103.32 Aligned_cols=130 Identities=22% Similarity=0.315 Sum_probs=93.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEE-ecCccCChhh-----HHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCc
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKK-INDIFEHVSD-----ATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFK 100 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~-i~~~~~~~~~-----~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~~s~~~~~ 100 (599)
..|++|+-+.++.+.. -|..+++|. +.+...+..- ..+..+|..+|..+.--. +..++++...
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~------- 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD------- 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-------
Confidence 4578999999998843 455566663 3444444332 345668999998886433 3344444321
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...|||||++| .|.+++... .-.++..+-.-+.-||.+||+|+||+++||++..++ +.++||||+..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 34799999998 567677665 145677788888899999999999999999998654 99999999965
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.1e-09 Score=104.44 Aligned_cols=142 Identities=18% Similarity=0.268 Sum_probs=98.8
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCC--CccccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP--DIVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hp--nIv~l~~v~~~~s~~~~~~lylV~ 106 (599)
+.|+.|..+.||++... +|+.+++|+....... .....+.+|+.+++.+.+. ++.+++.+.... ...+..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEE
Confidence 67899999999999764 3689999987542211 1345678999999999763 345565554221 1123568999
Q ss_pred ecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------------
Q 007542 107 ELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------------- 144 (599)
Q Consensus 107 E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs----------------------------------------- 144 (599)
||++| +|.+.+.. ..+++.....++.+++++|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99996 45443321 345666666666666666666663
Q ss_pred ---------------CceEeccCCCCceEecC--CCceeeeccccccc
Q 007542 145 ---------------ANVFHRDLKPKNILANA--DCKLKICDFGLARV 175 (599)
Q Consensus 145 ---------------~gIvHrDLKP~NILv~~--~~~lKL~DFGla~~ 175 (599)
..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34799999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.1e-10 Score=123.63 Aligned_cols=154 Identities=23% Similarity=0.326 Sum_probs=112.9
Q ss_pred HHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccccCCCCC-ccccc-----ccccCccccCccccccccCCC
Q 007542 136 LRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWT-----DYVATRWYRAPELCGSFFSKY 208 (599)
Q Consensus 136 l~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~-~~~~~-----~~~gt~~Y~APE~l~~~~~~~ 208 (599)
..|+.|+|.. ++||++|.|++|.++.++.+||+.|+++........- ...++ -..-...|.|||++.+ ...
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~~ 186 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--TTN 186 (700)
T ss_pred cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--ccc
Confidence 3899999975 8999999999999999999999999998765432210 00011 1233457999999987 678
Q ss_pred CcchhhHhHHHHHHHHH-hCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhh
Q 007542 209 TPAIDIWSIGCIFAELL-TGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIF 287 (599)
Q Consensus 209 s~~~DIWSlG~Il~eLl-tG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (599)
+.++|++|+||++|.+. .|+.+|.+.+.......-...++
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~--------------------------------------- 227 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN--------------------------------------- 227 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc---------------------------------------
Confidence 89999999999999998 67888766543221111110000
Q ss_pred hhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 288 FFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 288 ~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
......-.++++++++=|.++|..|+..||++.+++..|||.+
T Consensus 228 ------------------------------~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 228 ------------------------------AGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred ------------------------------cccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 0011111467889999999999999999999999999999985
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-08 Score=104.42 Aligned_cols=135 Identities=15% Similarity=0.117 Sum_probs=93.6
Q ss_pred EEEEEEECCCCcEEEEEEecCccCCh---------hhHHHHHHHHHHHHhcCCCCcccc--ceeecCCCcCCCccEEEEE
Q 007542 38 VVCSAYDTRTGEKVAIKKINDIFEHV---------SDATRILREIKLLRLLRHPDIVEI--KHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 38 ~Vy~a~~~~tg~~VAIK~i~~~~~~~---------~~~~~i~rEi~iL~~l~HpnIv~l--~~v~~~~s~~~~~~lylV~ 106 (599)
.|.+. ...|+.|.||......... .-...+.+|...+..|..-+|... +.+...........-+|||
T Consensus 37 rvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 35554 3467789999664211100 001146789999888854444333 3333221111123568999
Q ss_pred ecCCc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-------CCceeeecccccc
Q 007542 107 ELMES--DLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-------DCKLKICDFGLAR 174 (599)
Q Consensus 107 E~~~g--~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-------~~~lKL~DFGla~ 174 (599)
|++++ +|.+++.. ....+......++.++...+.-||.+||+|+||++.|||++. +..+.|+||+.++
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99996 79998864 234567778899999999999999999999999999999975 4679999999775
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.7e-08 Score=97.75 Aligned_cols=126 Identities=27% Similarity=0.326 Sum_probs=81.6
Q ss_pred EEEEEEECCCCcEEEEEEecCc----------------cC------Ch--hhHHHHHHHHHHHHhcCCC--Cccccceee
Q 007542 38 VVCSAYDTRTGEKVAIKKINDI----------------FE------HV--SDATRILREIKLLRLLRHP--DIVEIKHIL 91 (599)
Q Consensus 38 ~Vy~a~~~~tg~~VAIK~i~~~----------------~~------~~--~~~~~i~rEi~iL~~l~Hp--nIv~l~~v~ 91 (599)
.||.|.. ..|..+|||+.... +. .. .......+|.+.|..+..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 56789999977421 00 00 1123467899999999865 455555443
Q ss_pred cCCCcCCCccEEEEEecCC--c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-hhhCceEeccCCCCceEecCCCceee
Q 007542 92 LPPSRREFKDIYVVFELME--S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY-IHTANVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~--g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~y-LHs~gIvHrDLKP~NILv~~~~~lKL 167 (599)
.-+|||||++ | .+..+.... ++.+....++.+++..+.. +|..||+|+||++.|||++.+ .+.|
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE
T ss_pred ---------CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEE
Confidence 2279999999 6 344333221 2245667788888885555 689999999999999999977 9999
Q ss_pred ecccccccc
Q 007542 168 CDFGLARVA 176 (599)
Q Consensus 168 ~DFGla~~~ 176 (599)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-08 Score=98.73 Aligned_cols=128 Identities=24% Similarity=0.334 Sum_probs=93.2
Q ss_pred CCcEEEEEEecCc-----cCChhhHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCccEEEEEecCCc--cHHHHH
Q 007542 47 TGEKVAIKKINDI-----FEHVSDATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFKDIYVVFELMES--DLHQVI 117 (599)
Q Consensus 47 tg~~VAIK~i~~~-----~~~~~~~~~i~rEi~iL~~l~HpnI--v~l~~v~~~~s~~~~~~lylV~E~~~g--~L~~~i 117 (599)
.++.+-+|..... ....-...+..+|...+..|..-+| .+.+.+...... ....-++|+|++++ +|.+++
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHH
Confidence 4556666643221 1111334567889988888864443 344444332221 12356899999996 799999
Q ss_pred HhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC---ceeeeccccccc
Q 007542 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARV 175 (599)
Q Consensus 118 ~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~---~lKL~DFGla~~ 175 (599)
.....++......++.++...+.-||.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 110 ~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 110 QQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 8755577788899999999999999999999999999999999987 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.6e-08 Score=99.89 Aligned_cols=136 Identities=26% Similarity=0.266 Sum_probs=100.2
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecC------------cc----CCh----hhHHHHHHHHHHHHhcCCC-
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND------------IF----EHV----SDATRILREIKLLRLLRHP- 82 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~------------~~----~~~----~~~~~i~rEi~iL~~l~Hp- 82 (599)
-+.+...||-|.-+.||.|.+. .|.++|||.=+. .. .+. .......+|..+|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3456789999999999999864 789999995321 00 111 1123456899999998644
Q ss_pred -CccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 83 -DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 83 -nIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
.|.+.+++ +.-.+|||+++| .|..+ ++..+....++..|++-+..+-..||||+|+++-|||++
T Consensus 171 ~~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~ 236 (304)
T COG0478 171 VKVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence 55555443 345899999998 34332 224556667778888888887799999999999999999
Q ss_pred CCCceeeecccccc
Q 007542 161 ADCKLKICDFGLAR 174 (599)
Q Consensus 161 ~~~~lKL~DFGla~ 174 (599)
.||.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999997654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.5e-07 Score=88.29 Aligned_cols=142 Identities=17% Similarity=0.160 Sum_probs=101.0
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecC----ccCChhhHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCccEEE
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKIND----IFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~----~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~~s~~~~~~lyl 104 (599)
-|+|+-+-|+... -.|..+=+|.-.+ ..........+.+|+..|+.|..-+ +.++. ++........-.-+|
T Consensus 26 ~~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3568888888764 3344687886542 1111224456889999999986433 33333 111111112234689
Q ss_pred EEecCCc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc--eeeeccccccc
Q 007542 105 VFELMES--DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 175 (599)
Q Consensus 105 V~E~~~g--~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~--lKL~DFGla~~ 175 (599)
|+|-+++ +|.+++... ...++.....++.++..+|+-||..|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998884 899988664 35677888899999999999999999999999999999987777 99999987754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.1e-06 Score=90.42 Aligned_cols=195 Identities=15% Similarity=0.140 Sum_probs=128.9
Q ss_pred EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh-cCCCCccc----cceeecCCCcCCCc
Q 007542 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL-LRHPDIVE----IKHILLPPSRREFK 100 (599)
Q Consensus 26 ~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~-l~HpnIv~----l~~v~~~~s~~~~~ 100 (599)
...+.||+|+-+.+|-.- .-+. .+.|+....-.. .... -+..|.. -.||.+-. -..... ..+...
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d-~VAKIYh~Pppa--~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~--G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRD-QVAKIYHAPPPA--AQAQ---KVAELAATPDAPLLNYRVAWPQATLH--GGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecc--hhhc-hhheeecCCCch--HHHH---HHHHhccCCCCcchhhhhcccHHHhh--CCCccc
Confidence 345789999999999652 1222 345655432111 1111 1222222 24654432 111111 112223
Q ss_pred cEEEEEecCCc--cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccc
Q 007542 101 DIYVVFELMES--DLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 101 ~lylV~E~~~g--~L~~~i~~------~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
.+-++|+.+.| .++.++.. -....++-+.+..+.|+.+.+.||..|.+-+|+.++|+||.+++.+.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 47889998886 56665532 12456788888999999999999999999999999999999999999998655
Q ss_pred cccccCCCCCcccccccccCccccCccccc-ccc--CCCCcchhhHhHHHHHHHHHhC-CCCCCCC
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAELLTG-KPLFPGK 234 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~--~~~s~~~DIWSlG~Il~eLltG-~~pF~g~ 234 (599)
-....+ ...+..-+|...|.+||+.. +.+ ..-+...|.|.||+++++||.| +.||.|-
T Consensus 164 fqi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 164 FQINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 443322 23345668999999999854 211 2345678999999999999987 8999874
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.2e-06 Score=84.48 Aligned_cols=143 Identities=18% Similarity=0.233 Sum_probs=90.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhh-HH------HHHHHHHHHHhcCCCCccccceee---
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSD-AT------RILREIKLLRLLRHPDIVEIKHIL--- 91 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~-~~------~i~rEi~iL~~l~HpnIv~l~~v~--- 91 (599)
..+|.+.+++-......|.+. ...|+.+++|........... .. ...+++..+..+....+..+.+++
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 578899999888777777666 467899999987542211110 01 122344444444333333332222
Q ss_pred cCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 92 LPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
.-...+-....+|||||++| .|.++.. +++ .+...|..++.-||..|++|+|..|.|+++..+ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 11111122345689999998 5655432 333 244567788999999999999999999999855 5999999
Q ss_pred ccccc
Q 007542 171 GLARV 175 (599)
Q Consensus 171 Gla~~ 175 (599)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 86653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.1e-06 Score=83.54 Aligned_cols=137 Identities=20% Similarity=0.180 Sum_probs=92.7
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChh-----------------hHHH-----HHHHHHHHHhcC--CCC
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS-----------------DATR-----ILREIKLLRLLR--HPD 83 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~-----------------~~~~-----i~rEi~iL~~l~--Hpn 83 (599)
...|++|.-+.||+|.. .++..||||+.+.....-. +... ..+|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 45677888889999964 6789999998853110000 1111 235666666664 334
Q ss_pred ccccceeecCCCcCCCccEEEEEecCCccH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEec
Q 007542 84 IVEIKHILLPPSRREFKDIYVVFELMESDL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILAN 160 (599)
Q Consensus 84 Iv~l~~v~~~~s~~~~~~lylV~E~~~g~L--~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~ 160 (599)
+.+.+.+. .-.||||+++..- .-.++ .-.+..+.+..+..++++.+.-|-. .|+||+||+.=|||+.
T Consensus 132 vP~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 132 VPEPIAFR---------NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred CCCceeec---------CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 44444443 3479999999531 00111 1123444788888999999998877 8999999999999999
Q ss_pred CCCceeeecccccccc
Q 007542 161 ADCKLKICDFGLARVA 176 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~ 176 (599)
++.+.|+|||-|...
T Consensus 202 -~~~p~iID~~QaV~~ 216 (268)
T COG1718 202 -DGEPYIIDVSQAVTI 216 (268)
T ss_pred -CCeEEEEECcccccc
Confidence 889999999988654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.6e-06 Score=90.85 Aligned_cols=135 Identities=25% Similarity=0.335 Sum_probs=83.3
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChh------------------------h--------HHH------HH
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS------------------------D--------ATR------IL 70 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~------------------------~--------~~~------i~ 70 (599)
+.|+.++-|.||+|+- .+|+.||||+........- . .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 7899999999999986 4599999998753111100 0 001 12
Q ss_pred HHHHHHHhcC----CCCccccceeecCCCcCCCccEEEEEecCCc-cHHHH--HHhCCCCC-----HHHHHHHHHHHHHH
Q 007542 71 REIKLLRLLR----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV--IKANDDLT-----PEHYQFFLYQLLRG 138 (599)
Q Consensus 71 rEi~iL~~l~----HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~--i~~~~~ls-----e~~i~~i~~QIl~a 138 (599)
+|..-+.+++ ...-+.+=.+|..-+ ..-.|+|||++| .+.++ +++ .+++ +.-+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~-- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL-- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH--
Confidence 2333333331 112222333332111 234799999998 55555 444 3344 233333333333
Q ss_pred HHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 139 L~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
..|++|.|..|-||+++.+|++.+.|||.....
T Consensus 283 -----~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 -----RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred -----hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 379999999999999999999999999988654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.1e-05 Score=76.21 Aligned_cols=139 Identities=20% Similarity=0.216 Sum_probs=79.6
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCccEEEE
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~~s~~~~~~lylV 105 (599)
++.|+.|..+.||+..... ..+++|..... .....+.+|..+++.+.... +.+++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997654 58999987532 45567889999999886443 34444432111 222347999
Q ss_pred EecCCc-cHHH----------------HHH---hC--C--CCCHHH------HHHH---------------HHHHHH-HH
Q 007542 106 FELMES-DLHQ----------------VIK---AN--D--DLTPEH------YQFF---------------LYQLLR-GL 139 (599)
Q Consensus 106 ~E~~~g-~L~~----------------~i~---~~--~--~lse~~------i~~i---------------~~QIl~-aL 139 (599)
|++++| .+.. .+. .. . .+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999997 4444 111 11 0 111000 0000 011111 23
Q ss_pred HHhh-------hCceEeccCCCCceEec-CCCceeeecccccc
Q 007542 140 KYIH-------TANVFHRDLKPKNILAN-ADCKLKICDFGLAR 174 (599)
Q Consensus 140 ~yLH-------s~gIvHrDLKP~NILv~-~~~~lKL~DFGla~ 174 (599)
..++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3333 24699999999999999 66777899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.13 E-value=7.2e-06 Score=95.82 Aligned_cols=156 Identities=18% Similarity=0.231 Sum_probs=109.7
Q ss_pred HHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCce
Q 007542 69 ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANV 147 (599)
Q Consensus 69 i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gI 147 (599)
..-|+..+..+.|+|++.++.+-...-... -.+.+..+++.. ++.+.+..-+.++....+.+..++++||.|+|+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 345666788889999999988764432111 123445577774 899999988899999999999999999999999977
Q ss_pred EeccCCCC---ceEecCCCceeee--cccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHH
Q 007542 148 FHRDLKPK---NILANADCKLKIC--DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (599)
Q Consensus 148 vHrDLKP~---NILv~~~~~lKL~--DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~ 222 (599)
.|.-|.-+ +-.++..+.+.+. ||+.......... ......+.-+.++|.............|+|.+|..+.
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 77666655 4455666777777 8887765432211 1223445567788877652233344579999999999
Q ss_pred HHHhCCC
Q 007542 223 ELLTGKP 229 (599)
Q Consensus 223 eLltG~~ 229 (599)
.+..|..
T Consensus 384 ~~~~~~~ 390 (1351)
T KOG1035|consen 384 QLSQGED 390 (1351)
T ss_pred hhhhcCc
Confidence 9988764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.9e-05 Score=77.65 Aligned_cols=132 Identities=17% Similarity=0.174 Sum_probs=78.6
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCccEEEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI--v~l~~v~~~~s~~~~~~lylV~ 106 (599)
..||+|..+.||+. .|..+++|..... .....+.+|.++|+.+..-++ .+.+.+..+ .....+||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-----~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG----FDKETIKREFDASRKVFSLGIPTPHPFDLVED-----GGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEec-----CCeeeeee
Confidence 57899999999984 2557788876531 234557899999998864333 455555422 23467899
Q ss_pred ecCCcc--HH--------------HHH-------HhC--CCCCHHH-HHHHHHHH----------HHH-HHHhh----hC
Q 007542 107 ELMESD--LH--------------QVI-------KAN--DDLTPEH-YQFFLYQL----------LRG-LKYIH----TA 145 (599)
Q Consensus 107 E~~~g~--L~--------------~~i-------~~~--~~lse~~-i~~i~~QI----------l~a-L~yLH----s~ 145 (599)
|+++|. +. ..+ ++- ....... ...+..++ ... ..+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999983 11 111 110 0111100 11111111 111 11222 12
Q ss_pred ceEeccCCCCceEecCCCceeeecccccc
Q 007542 146 NVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 146 gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 479999999999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.9e-05 Score=74.87 Aligned_cols=133 Identities=26% Similarity=0.325 Sum_probs=92.6
Q ss_pred CCceEEEEEeeecCc-eEEEEEEECCCCcEEEEEEecC---c--------cCC-h-------hhHHHHHHHHHHHHhc--
Q 007542 22 GSRYKIEEVIGKGSY-GVVCSAYDTRTGEKVAIKKIND---I--------FEH-V-------SDATRILREIKLLRLL-- 79 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~-g~Vy~a~~~~tg~~VAIK~i~~---~--------~~~-~-------~~~~~i~rEi~iL~~l-- 79 (599)
+.+++.++.||.|.- |.||++. ..|+.||||++.. . +.. . .....|..|.+..-+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 389999999999999 9999995 5788999999421 0 000 0 1223566777765555
Q ss_pred -CCCCc--cccceeecCCC-------------cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh
Q 007542 80 -RHPDI--VEIKHILLPPS-------------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143 (599)
Q Consensus 80 -~HpnI--v~l~~v~~~~s-------------~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLH 143 (599)
.+.++ |++++++.-.. ........||.||+...- .++..+ +.+|++-|..+|
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHH
Confidence 46667 88888874321 011223467888777432 233333 567888889999
Q ss_pred hCceEeccCCCCceEecCCCceeeeccccc
Q 007542 144 TANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 144 s~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999976 4589999965
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.5e-06 Score=95.70 Aligned_cols=187 Identities=16% Similarity=0.122 Sum_probs=132.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC-ccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD-IVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn-Iv~l~~v~~~~s~~~~ 99 (599)
...-|...+-+++|+++.+++++...+...+ .+++... ..+.-++++|.+++||| .+..++ +.+.+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E 306 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-----DYDGE 306 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccc-----cCCcc
Confidence 3455667778899999999999887777666 7776532 33445889999999999 333322 33555
Q ss_pred ccEEEEEecCCcc--HHHHH-HhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 100 KDIYVVFELMESD--LHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 100 ~~lylV~E~~~g~--L~~~i-~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
.+.+++++++.+. -...+ .+.-.+.+-+...+.+.-+++|+++|+.-=+|+| |||... +..|..||+.....
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence 6889999999843 11111 1111233445555666777889999998778998 777654 67999999988765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF 231 (599)
.... ..+...+++.++|||+... ..+....|.|++|.--.+|--|-+|-
T Consensus 382 ~~~~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 382 TRTM----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred Cccc----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCC
Confidence 3322 2356689999999998876 67888999999998777777676554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00023 Score=71.54 Aligned_cols=133 Identities=14% Similarity=0.064 Sum_probs=75.8
Q ss_pred EeeecCc-eEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEEEe
Q 007542 30 VIGKGSY-GVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 30 ~IG~G~~-g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
.|..|.+ ..||+... .+..+.||...... ...+.+|+.+++.+. +--+.+++...... ..-++|||
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEE
Confidence 3444555 78898853 34678888765321 335668999998885 33344555554221 34689999
Q ss_pred cCCc-cHHHHH----------------H---hCC----CCCH---HHHHHH----------------------HHHHHHH
Q 007542 108 LMES-DLHQVI----------------K---AND----DLTP---EHYQFF----------------------LYQLLRG 138 (599)
Q Consensus 108 ~~~g-~L~~~i----------------~---~~~----~lse---~~i~~i----------------------~~QIl~a 138 (599)
+++| .|.... . .-. .+.. ...... ..+++..
T Consensus 73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T cd05150 73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE 152 (244)
T ss_pred eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence 9987 333221 1 000 1110 000000 1111221
Q ss_pred HHHh----hhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 139 LKYI----HTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 139 L~yL----Hs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
|... ....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1111 12358999999999999988778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00013 Score=69.41 Aligned_cols=131 Identities=20% Similarity=0.260 Sum_probs=90.7
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.-.+.+.|++|.+|+||++. ..|..+|+|+=. ..+....+..|.++|..++-.++..=+-.+ +..+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr----~ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~ 88 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGE--WRGGEVALKVRR----RDSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDF 88 (201)
T ss_pred hhhhhhhhhcccccEEEEee--ccCceEEEEEec----CCcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhh
Confidence 34557899999999999995 467799999754 234455678899999999876665432222 1235
Q ss_pred EEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCC-CCceEecCCCceeeeccccccc
Q 007542 104 VVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLK-PKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLK-P~NILv~~~~~lKL~DFGla~~ 175 (599)
+.|||+.| .|....... +. .-+..+++.---|-..||-|+.|. |..+++-.++.+.|+||..|+.
T Consensus 89 i~me~i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 66999998 776654321 22 233455666556777899999886 5555555566999999998874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0002 Score=79.57 Aligned_cols=138 Identities=25% Similarity=0.343 Sum_probs=83.1
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChh-----------------------------hHHHHHHHHHHHH--
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS-----------------------------DATRILREIKLLR-- 77 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~-----------------------------~~~~i~rEi~iL~-- 77 (599)
+.||.-+.|.|++|+.+. |+.||||+=+....... -.+.+..|+..++
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999998655 99999997643211110 0112222322222
Q ss_pred --------hcCCCC---ccccceeecCCCcCCCccEEEEEecCCc----cHHHHHHhCCCCCHHHHHHHHHHHHHHH-HH
Q 007542 78 --------LLRHPD---IVEIKHILLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHYQFFLYQLLRGL-KY 141 (599)
Q Consensus 78 --------~l~Hpn---Iv~l~~v~~~~s~~~~~~lylV~E~~~g----~L~~~i~~~~~lse~~i~~i~~QIl~aL-~y 141 (599)
.+.|-+ -|.+=.|+.+-+ ..-.|+||||+| || +.|.+.+ ++...+. ..+.++. .-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i~---~~l~~~~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDIL---NKLVEAYLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCH-HHHHHcC-CCHHHHH---HHHHHHHHHH
Confidence 222333 122333332221 245899999997 45 5555554 4444332 2333322 12
Q ss_pred hhhCceEeccCCCCceEecC----CCceeeecccccccc
Q 007542 142 IHTANVFHRDLKPKNILANA----DCKLKICDFGLARVA 176 (599)
Q Consensus 142 LHs~gIvHrDLKP~NILv~~----~~~lKL~DFGla~~~ 176 (599)
|=..|++|+|=.|-|||+.. ++.+.+-|||+....
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 23468999999999999994 678999999998764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00028 Score=76.70 Aligned_cols=177 Identities=25% Similarity=0.350 Sum_probs=118.8
Q ss_pred hhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh
Q 007542 64 SDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143 (599)
Q Consensus 64 ~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLH 143 (599)
.....++-...+++.+.|+|....+++-.... ....+|+|+++.+|.+++..+. +-.... +
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~-------~------- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESL-------L------- 84 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhh-------c-------
Confidence 34567778889999999999999888764432 2388999999999999987764 321111 1
Q ss_pred hCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHH
Q 007542 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (599)
Q Consensus 144 s~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~e 223 (599)
.+|+.|- | .++.+| -++ +. | |- ...+++||||+|.|+.+
T Consensus 85 ~~~~~~~-----~-------~~~~td-~~~-------------t~------~--~~-------~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 85 AHGVLHL-----N-------IIYITD-HFL-------------TK------Y--PS-------PIGPKSDVWSLGFIILE 123 (725)
T ss_pred cccccee-----h-------hhhccc-ccc-------------cc------C--CC-------CCCcchhhhhHHHHHHH
Confidence 2233322 2 223333 000 00 0 11 11259999999999999
Q ss_pred HHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccH
Q 007542 224 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNE 303 (599)
Q Consensus 224 LltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~ 303 (599)
+..|..++......+++..|.+..-.+-.-..-. | +
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a-~-------------------------------------------e 159 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELLSTA-M-------------------------------------------E 159 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHH-H-------------------------------------------H
Confidence 9999999998888888888876554433221111 0 0
Q ss_pred HHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 304 KARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 304 ~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
. .+. -.++...++++.+|+-..|..||...++..|+-|...
T Consensus 160 ~--~~~---------------~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 160 H--LIQ---------------LLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred H--HHH---------------HhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 0 000 1234557899999999999999999999999999865
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00054 Score=81.28 Aligned_cols=83 Identities=17% Similarity=0.217 Sum_probs=55.2
Q ss_pred EEEEeeecCceEEEEEEECCCC--cEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCc--cccceeecCCCcCCCcc
Q 007542 27 IEEVIGKGSYGVVCSAYDTRTG--EKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDI--VEIKHILLPPSRREFKD 101 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~tg--~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnI--v~l~~v~~~~s~~~~~~ 101 (599)
-++.|+.|.+..+|+......+ ..+++|+..... .......+.+|+.+|+.+. |.+| .+++.++.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3677899999999998654432 467888764321 1123456789999999996 6665 5656555432 12245
Q ss_pred EEEEEecCCcc
Q 007542 102 IYVVFELMESD 112 (599)
Q Consensus 102 lylV~E~~~g~ 112 (599)
.|+||||++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 68999999974
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00064 Score=66.58 Aligned_cols=128 Identities=20% Similarity=0.256 Sum_probs=90.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCcc--------------CChhhHHHHHHHHHHHHhcC------CCCccccc
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--------------EHVSDATRILREIKLLRLLR------HPDIVEIK 88 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~--------------~~~~~~~~i~rEi~iL~~l~------HpnIv~l~ 88 (599)
..||+|+.-.||.- .......||++.... ..........+|+.....+. +..|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999888854 345566789886533 11223456677887766666 77888999
Q ss_pred eeecCCCcCCCccEEEEEecCC---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC
Q 007542 89 HILLPPSRREFKDIYVVFELME---S----DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (599)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~---g----~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~ 161 (599)
++..+. ..+-+|+|.+. | +|.+++... .+++ . +...|-+-..||-..+|+.+||+|.||++..
T Consensus 84 G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFVETN-----LGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEEecC-----CceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 998443 45788888875 2 688888554 4666 3 3344455567888999999999999999865
Q ss_pred CC----ceeeec
Q 007542 162 DC----KLKICD 169 (599)
Q Consensus 162 ~~----~lKL~D 169 (599)
+. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 42 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00052 Score=68.75 Aligned_cols=30 Identities=33% Similarity=0.482 Sum_probs=25.4
Q ss_pred CceEeccCCCCceEecCCCceeeecccccc
Q 007542 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 145 ~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.+++|+|+.+.|||++.++..-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 359999999999999876656799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00016 Score=86.59 Aligned_cols=154 Identities=18% Similarity=0.148 Sum_probs=113.7
Q ss_pred HHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhh
Q 007542 70 LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHT 144 (599)
Q Consensus 70 ~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs 144 (599)
+.|...++...|+++.....-..+. +....|.+++|+. |+++.+|-+. ..+.+.-+.....+.+.+..-+|+
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 3455556667898887665544332 2345689999998 7999988654 234444444444554777777776
Q ss_pred Cc-----eEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHH
Q 007542 145 AN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219 (599)
Q Consensus 145 ~g-----IvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~ 219 (599)
.. .+|++||+-|.+|..+..+|++++|+.+.. .+...+....++++.|+.+++... -.++.++|+|+.||
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk---np~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK---NPVLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRSL 1428 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCccccccccccccc---CchHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHHH
Confidence 52 699999999999999999999999999832 222233455678889999998876 57888899999999
Q ss_pred HHHHHHhCCCCC
Q 007542 220 IFAELLTGKPLF 231 (599)
Q Consensus 220 Il~eLltG~~pF 231 (599)
-+|++..|.+.|
T Consensus 1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHhcccHHH
Confidence 999999888766
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00056 Score=66.47 Aligned_cols=97 Identities=23% Similarity=0.215 Sum_probs=77.5
Q ss_pred HHHHHHHhcCC-CCccccceeecCCCcCCCccEEEEEecCC-ccHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHhhh-
Q 007542 71 REIKLLRLLRH-PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQV---IKANDDLTPEHYQFFLYQLLRGLKYIHT- 144 (599)
Q Consensus 71 rEi~iL~~l~H-pnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~---i~~~~~lse~~i~~i~~QIl~aL~yLHs- 144 (599)
.|.-+|+.+.+ +++.++++.+ .-++|.||.. +++... +..--..++.....++.++++.+.+|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C---------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC---------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC---------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence 58889999976 6899999998 2367889988 445321 1111246789999999999999999998
Q ss_pred --CceEeccCCCCceEecCCCceeeecccccccc
Q 007542 145 --ANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 145 --~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
..+.-.|++++|+-++.+|++|++|.......
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 45888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0034 Score=62.51 Aligned_cols=72 Identities=11% Similarity=0.195 Sum_probs=44.6
Q ss_pred EEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEE
Q 007542 28 EEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVV 105 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~-tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~v~~~~s~~~~~~lylV 105 (599)
++.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+...+++ +++... . . .+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~---~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF--Q---N----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe--C---C----cEE
Confidence 4667888889999986433 357888997653211 112234789999988644443 333222 1 1 379
Q ss_pred EecCCc
Q 007542 106 FELMES 111 (599)
Q Consensus 106 ~E~~~g 111 (599)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00035 Score=72.22 Aligned_cols=137 Identities=20% Similarity=0.252 Sum_probs=95.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecC---ccC------------Chh-----hHHHHHHHHHHHHhcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND---IFE------------HVS-----DATRILREIKLLRLLRH 81 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~---~~~------------~~~-----~~~~i~rEi~iL~~l~H 81 (599)
+.-|.+++.||-|.-+.||.+-+ ..|...++|.-.. .|. +.. ..-...+|...|+.|..
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred chhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999975 4678888884210 010 000 11224578888888853
Q ss_pred C--CccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceE
Q 007542 82 P--DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (599)
Q Consensus 82 p--nIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (599)
. -|.+.+++ +..++|||++.| .|.++-+- ..+..+...|+.-|.-|..+|+||+|..-=||+
T Consensus 170 ~gfpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 170 RGFPVPKPIDH---------NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIM 234 (465)
T ss_pred cCCCCCCcccc---------cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeE
Confidence 2 23333333 356899999996 66654321 233456667778888899999999999999999
Q ss_pred ecCCCceeeecccccc
Q 007542 159 ANADCKLKICDFGLAR 174 (599)
Q Consensus 159 v~~~~~lKL~DFGla~ 174 (599)
|.+++.++++||--..
T Consensus 235 v~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMV 250 (465)
T ss_pred EecCCCEEEeechHhh
Confidence 9999999999997553
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0025 Score=66.50 Aligned_cols=153 Identities=16% Similarity=0.136 Sum_probs=85.5
Q ss_pred cccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC--ccccceeec
Q 007542 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILL 92 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~ 92 (599)
++..|+. +....++.|+.|....+|++.. ++..+++|+.... .....+..|+.++..|...+ +.+++....
T Consensus 15 ~l~~y~~-~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~ 87 (307)
T TIGR00938 15 FLDGYDL-GELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRD 87 (307)
T ss_pred HHHhcCC-CCceeccccCCccccceEEEEe--CCCcEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCC
Confidence 3445555 2455577788888889998753 3446788876431 12345667888888885333 333332110
Q ss_pred CC-CcCCCccEEEEEecCCcc-H-----H------HHH---Hh-CCCC--------CHHHHH---------------HHH
Q 007542 93 PP-SRREFKDIYVVFELMESD-L-----H------QVI---KA-NDDL--------TPEHYQ---------------FFL 132 (599)
Q Consensus 93 ~~-s~~~~~~lylV~E~~~g~-L-----~------~~i---~~-~~~l--------se~~i~---------------~i~ 132 (599)
.. .....+..++|++|++|. + . ..+ +. ...+ ...... ...
T Consensus 88 g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~ 167 (307)
T TIGR00938 88 GRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMG 167 (307)
T ss_pred CCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHH
Confidence 00 001124578999999861 1 0 111 10 0111 001000 001
Q ss_pred HHHHHHHHHhh-------hCceEeccCCCCceEecCCCceeeecccccc
Q 007542 133 YQLLRGLKYIH-------TANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 133 ~QIl~aL~yLH-------s~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+...+.++. ..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 168 AELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11233444443 2589999999999999998877899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0098 Score=64.43 Aligned_cols=77 Identities=21% Similarity=0.202 Sum_probs=52.0
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCcc----C-ChhhHHHHHHHHHHHHhcC---CCCccccceeecCCCcCCC
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF----E-HVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~----~-~~~~~~~i~rEi~iL~~l~---HpnIv~l~~v~~~~s~~~~ 99 (599)
.+.||.|....||++.+...++.|+||.-.... . ......+...|...|+.+. -..+.+++.+-.
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------- 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------- 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-------
Confidence 467999999999999886444689999743110 1 1234567788888888863 234555555421
Q ss_pred ccEEEEEecCCc
Q 007542 100 KDIYVVFELMES 111 (599)
Q Consensus 100 ~~lylV~E~~~g 111 (599)
..-++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 235899999984
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0021 Score=66.54 Aligned_cols=151 Identities=17% Similarity=0.090 Sum_probs=84.6
Q ss_pred ccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC--ccccceeecC
Q 007542 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLP 93 (599)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~ 93 (599)
+..|+.+ +..-++.|..|....+|+... .+..+++|+... .....+..|+.++..+.+.+ +.+++.....
T Consensus 8 l~~y~~~-~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g 79 (296)
T cd05153 8 LADYDLG-ELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDG 79 (296)
T ss_pred HHHcCCC-chhheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCC
Confidence 3345532 233366788888889998753 445788998753 23456778899888885433 3333321100
Q ss_pred C-CcCCCccEEEEEecCCc-cH--------HHH---H---Hh-CCCCC------------HHHHH--------HHHHHHH
Q 007542 94 P-SRREFKDIYVVFELMES-DL--------HQV---I---KA-NDDLT------------PEHYQ--------FFLYQLL 136 (599)
Q Consensus 94 ~-s~~~~~~lylV~E~~~g-~L--------~~~---i---~~-~~~ls------------e~~i~--------~i~~QIl 136 (599)
. .....+..++|+++++| .+ .++ + +. ...+. ..... .....+.
T Consensus 80 ~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 159 (296)
T cd05153 80 EYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLA 159 (296)
T ss_pred cEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHH
Confidence 0 00112356899999986 21 111 1 00 00000 00000 0111122
Q ss_pred HHHHHhhh-------CceEeccCCCCceEecCCCceeeecccccc
Q 007542 137 RGLKYIHT-------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 137 ~aL~yLHs-------~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.++.++.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 160 DELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 33444443 479999999999999988778999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0025 Score=67.06 Aligned_cols=142 Identities=24% Similarity=0.289 Sum_probs=95.2
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc----------------CC------hhhHHHH--HHHHHHHHhc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF----------------EH------VSDATRI--LREIKLLRLL 79 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~----------------~~------~~~~~~i--~rEi~iL~~l 79 (599)
--.|-..|..|.-+.||.|. ..+|..+|||+++.+. .+ ....-++ ..|++-|+++
T Consensus 145 i~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 145 IVEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred eeecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 33556788999999999997 4678889999875311 11 0111122 3566677777
Q ss_pred CCCCccccceeecCCCcCCCccEEEEEecCCcc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhCceEeccCCCCce
Q 007542 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNI 157 (599)
Q Consensus 80 ~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g~-L~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NI 157 (599)
+...|.-..-+.. ..-.|||++++.+ .-.=....-.++...+..+-.|++..+.-| |..++||.||+-=|+
T Consensus 224 ~~aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 224 NNAGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred HhcCCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 6655443333332 1347999999842 111111223577778888888888888877 456899999999999
Q ss_pred EecCCCceeeecccccc
Q 007542 158 LANADCKLKICDFGLAR 174 (599)
Q Consensus 158 Lv~~~~~lKL~DFGla~ 174 (599)
|+. +|.+.|+|.+-+.
T Consensus 297 Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSV 312 (520)
T ss_pred eEE-CCEEEEEEccccc
Confidence 986 6899999988664
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0058 Score=64.01 Aligned_cols=150 Identities=17% Similarity=0.134 Sum_probs=78.6
Q ss_pred ccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
+..|+.+ .-.-.+.|+.|....+|.... ++..+++|++.. .....+..|+.+++.|...++. +-.++....
T Consensus 16 l~~y~~~-~~~~~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~-----~~~~~l~~~~~~l~~L~~~glp-vP~~i~~~~ 86 (319)
T PRK05231 16 LAPYDLG-ELLSLKGIAEGIENSNFFLTT--TQGEYVLTLFER-----LTAEDLPFFLGLMQHLAARGVP-VPAPVARRD 86 (319)
T ss_pred HHhcCCc-hhhccchhccccccceEEEEe--CCCcEEEEEecc-----CChHHhHHHHHHHHHHHHCCCC-CCcceeCCC
Confidence 3445542 333346677788889998853 234788997741 1233445677777777433321 111221111
Q ss_pred c----CCCccEEEEEecCCcc---------H---HHHHH----hCCCC--------C--H--HHHH-----------HHH
Q 007542 96 R----REFKDIYVVFELMESD---------L---HQVIK----ANDDL--------T--P--EHYQ-----------FFL 132 (599)
Q Consensus 96 ~----~~~~~lylV~E~~~g~---------L---~~~i~----~~~~l--------s--e--~~i~-----------~i~ 132 (599)
. ...+..++|+++++|. . -+.+. ....+ . . .... ..+
T Consensus 87 G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 166 (319)
T PRK05231 87 GAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALL 166 (319)
T ss_pred CCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHH
Confidence 0 1123578999999863 1 11111 00001 0 0 0000 111
Q ss_pred HHHH-HHHHHhh-------hCceEeccCCCCceEecCCCceeeecccccc
Q 007542 133 YQLL-RGLKYIH-------TANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 133 ~QIl-~aL~yLH-------s~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.+.+ ..+..+. ..++||+|+.|.|||++.+...-|+||+.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 167 EAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 1122222 2389999999999999966556899999773
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.018 Score=59.95 Aligned_cols=80 Identities=13% Similarity=0.121 Sum_probs=53.1
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC---CCccccceeecCCCcCCCc
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH---PDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H---pnIv~l~~v~~~~s~~~~~ 100 (599)
+-.-.+.||.|..+.||.... ++..+.+|..+. ......+.+|...|+.|.. -.+.++++++.... ..+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g 86 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPG 86 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCC
Confidence 344567899999999999843 233567776432 1123467799999998863 34667776654321 223
Q ss_pred cEEEEEecCCc
Q 007542 101 DIYVVFELMES 111 (599)
Q Consensus 101 ~lylV~E~~~g 111 (599)
.-+||||+++|
T Consensus 87 ~~~LVmE~i~G 97 (297)
T PRK10593 87 PDVLLLERLRG 97 (297)
T ss_pred CeEEEEeccCC
Confidence 57999999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0092 Score=61.98 Aligned_cols=29 Identities=38% Similarity=0.416 Sum_probs=26.0
Q ss_pred ceEeccCCCCceEecCC----Cceeeecccccc
Q 007542 146 NVFHRDLKPKNILANAD----CKLKICDFGLAR 174 (599)
Q Consensus 146 gIvHrDLKP~NILv~~~----~~lKL~DFGla~ 174 (599)
.++|+|+.+.|||++.+ +.+.|+||+.|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 889999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0064 Score=61.66 Aligned_cols=130 Identities=15% Similarity=0.244 Sum_probs=73.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEEEecC
Q 007542 31 IGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVVFELM 109 (599)
Q Consensus 31 IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~v~~~~s~~~~~~lylV~E~~ 109 (599)
+..|-...+|+.. .++..+++|......... .....+|..+|+.+..-+++ +++... . -++|+||+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~i 70 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEWL 70 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEec
Confidence 4568888899885 557788898754321111 01235799999988654443 222222 1 26899999
Q ss_pred Cc-cHH--------------HHHH---hCC----CCC-HHHHHHHHHHH---------HHHHHHhhh--------CceEe
Q 007542 110 ES-DLH--------------QVIK---AND----DLT-PEHYQFFLYQL---------LRGLKYIHT--------ANVFH 149 (599)
Q Consensus 110 ~g-~L~--------------~~i~---~~~----~ls-e~~i~~i~~QI---------l~aL~yLHs--------~gIvH 149 (599)
+| .+. +.+. +.. .++ ...+..+..++ ...+..+-. ..++|
T Consensus 71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 150 (256)
T TIGR02721 71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH 150 (256)
T ss_pred cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence 86 221 1111 111 111 12222222222 111222211 25899
Q ss_pred ccCCCCceEecCCCceeeecccccc
Q 007542 150 RDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 150 rDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
+|+.|.||+++.++ +.|+||+.+.
T Consensus 151 ~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 151 MDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CCCCcCcEEEeCCC-CEEEeccccC
Confidence 99999999999877 7899999774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.042 Score=58.57 Aligned_cols=82 Identities=17% Similarity=0.126 Sum_probs=52.5
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEec----Cc-cCChhhHHHHHHHHHHHHhcC--CCC-ccccceeecCCCcCCCcc
Q 007542 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN----DI-FEHVSDATRILREIKLLRLLR--HPD-IVEIKHILLPPSRREFKD 101 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~~tg~~VAIK~i~----~~-~~~~~~~~~i~rEi~iL~~l~--Hpn-Iv~l~~v~~~~s~~~~~~ 101 (599)
.||.|....||++.+...++.|+||.-. .. ........+...|...|+... -|. +.+++.+- ...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D-------~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD-------TEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc-------ccc
Confidence 5799999999999975444689999642 11 123455677788999988764 343 33443322 123
Q ss_pred EEEEEecCCc--cHHHHHH
Q 007542 102 IYVVFELMES--DLHQVIK 118 (599)
Q Consensus 102 lylV~E~~~g--~L~~~i~ 118 (599)
..+|||+++. .|+..+.
T Consensus 75 ~~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGLI 93 (370)
T ss_pred ceehHhhCccchHHHHHHH
Confidence 4689999963 4555443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.058 Score=56.61 Aligned_cols=147 Identities=18% Similarity=0.200 Sum_probs=85.7
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFK 100 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~~s~~~~~ 100 (599)
....+++.+..|-.-.+|...+. ++.+++. ...............+|..+|+.+.--. +...+.++.... ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g 98 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LG 98 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CC
Confidence 44456666655655556666443 8888888 3322333445666778888888775322 223334443222 24
Q ss_pred cEEEEEecCCc-------------------cHHHHHHh---C-----------CCCCHHHHHHHHHHH------------
Q 007542 101 DIYVVFELMES-------------------DLHQVIKA---N-----------DDLTPEHYQFFLYQL------------ 135 (599)
Q Consensus 101 ~lylV~E~~~g-------------------~L~~~i~~---~-----------~~lse~~i~~i~~QI------------ 135 (599)
..|.||++++| +|-+++.. - +.....++..+..+.
T Consensus 99 ~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 99 TPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred CceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 67899999987 11122211 0 001112222222222
Q ss_pred --HHHHHHhhhC--------ceEeccCCCCceEecCCCceeeeccccccc
Q 007542 136 --LRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 136 --l~aL~yLHs~--------gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..-..+|+.+ .++|+|+.+.||+++.++.+-|.||+++..
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2234444433 589999999999999999999999999865
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.034 Score=57.77 Aligned_cols=29 Identities=24% Similarity=0.377 Sum_probs=25.3
Q ss_pred CceEeccCCCCceEecCCCceeeecccccc
Q 007542 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 145 ~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999998663
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.055 Score=56.58 Aligned_cols=30 Identities=17% Similarity=0.135 Sum_probs=27.4
Q ss_pred ceEeccCCCCceEecCCCceeeeccccccc
Q 007542 146 NVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 146 gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
++||+|+.+.|+|++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999987743
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.033 Score=57.45 Aligned_cols=30 Identities=33% Similarity=0.570 Sum_probs=25.2
Q ss_pred ceEeccCCCCceEecCCCc-eeeeccccccc
Q 007542 146 NVFHRDLKPKNILANADCK-LKICDFGLARV 175 (599)
Q Consensus 146 gIvHrDLKP~NILv~~~~~-lKL~DFGla~~ 175 (599)
.++|+|+.|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999997555 56999997743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.054 Score=58.44 Aligned_cols=91 Identities=19% Similarity=0.171 Sum_probs=58.6
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEec----CccCChhhHHHHHHHHHHHHhcC--CCCc-cccceeec
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLLR--HPDI-VEIKHILL 92 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~----~~~~~~~~~~~i~rEi~iL~~l~--HpnI-v~l~~v~~ 92 (599)
...+.++ .+.||.|.-..||++.+...++.|+||.-. ......-...|...|...|+.+. -|.. .+++.+-
T Consensus 27 ~~~~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D- 104 (409)
T PRK12396 27 EHAKGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD- 104 (409)
T ss_pred CCcccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC-
Confidence 3344455 677899999999999875446789999542 11233456788888999998774 3543 3443322
Q ss_pred CCCcCCCccEEEEEecCCc--cHHHHHH
Q 007542 93 PPSRREFKDIYVVFELMES--DLHQVIK 118 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~g--~L~~~i~ 118 (599)
.....+|||+++. .|++.+.
T Consensus 105 ------~e~~~~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 105 ------SVMNCCVMEDLSDHTILRTALI 126 (409)
T ss_pred ------cHHhhHHHHhCcccHHHHHHHH
Confidence 1245688998863 4555543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.16 Score=53.73 Aligned_cols=28 Identities=32% Similarity=0.464 Sum_probs=24.7
Q ss_pred eEeccCCCCceEecC-CCceeeecccccc
Q 007542 147 VFHRDLKPKNILANA-DCKLKICDFGLAR 174 (599)
Q Consensus 147 IvHrDLKP~NILv~~-~~~lKL~DFGla~ 174 (599)
++|.||.+.|||+++ ++.++++||+.|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999773
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.15 Score=54.37 Aligned_cols=139 Identities=15% Similarity=0.125 Sum_probs=76.8
Q ss_pred CceEEEEEeeecCceEEEEEEECC----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTR----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRR 97 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~v~~~~s~~ 97 (599)
+...+ ..|..|-.-.+|++.... +++.|++|+..... .....+ .+|+.+++.+..-++. ++++.+..
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~---- 108 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN---- 108 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeech-HHHHHHHHHHHHcCCCCceEEEECC----
Confidence 34444 455558888999986322 34789999775421 111122 5788998888654443 44444411
Q ss_pred CCccEEEEEecCCc-cHH-----------HHH------HhCC------CCCHHHHHHHHHHHH-----------------
Q 007542 98 EFKDIYVVFELMES-DLH-----------QVI------KAND------DLTPEHYQFFLYQLL----------------- 136 (599)
Q Consensus 98 ~~~~lylV~E~~~g-~L~-----------~~i------~~~~------~lse~~i~~i~~QIl----------------- 136 (599)
..|.+|+++ .|. .+. ++.. ....+.+..++.++.
T Consensus 109 -----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~ 183 (344)
T PLN02236 109 -----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLE 183 (344)
T ss_pred -----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHH
Confidence 147777774 221 111 1110 011233333332221
Q ss_pred HHHHH----h----hhCceEeccCCCCceEecC-CCceeeecccccc
Q 007542 137 RGLKY----I----HTANVFHRDLKPKNILANA-DCKLKICDFGLAR 174 (599)
Q Consensus 137 ~aL~y----L----Hs~gIvHrDLKP~NILv~~-~~~lKL~DFGla~ 174 (599)
..+.. + +...++|+|+++.|||++. ++.+.|+||..+.
T Consensus 184 ~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 184 DEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11111 1 2236899999999999986 4789999998774
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.59 Score=50.82 Aligned_cols=76 Identities=16% Similarity=0.137 Sum_probs=50.1
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-----ChhhHHHHHHHHHHHHhcC---CCCccccceeecCCCcCC
Q 007542 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-----HVSDATRILREIKLLRLLR---HPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-----~~~~~~~i~rEi~iL~~l~---HpnIv~l~~v~~~~s~~~ 98 (599)
-.+.||.|....||+..+ .+..|+||.-..... ......+...|...|+.+. ...+.+++.+..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----- 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----- 108 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-----
Confidence 367889999999999876 345688996541111 1124556667788887664 2356667666532
Q ss_pred CccEEEEEecCCc
Q 007542 99 FKDIYVVFELMES 111 (599)
Q Consensus 99 ~~~lylV~E~~~g 111 (599)
.-++|||++++
T Consensus 109 --~~vlvME~L~~ 119 (418)
T PLN02756 109 --MALIGMRYLEP 119 (418)
T ss_pred --CCEEEEeecCC
Confidence 24788999975
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.097 Score=55.44 Aligned_cols=74 Identities=22% Similarity=0.330 Sum_probs=57.6
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+..+.|++|++-++.|..+- --..+++..|+.+.+..+.-+... ..-||||.-.||||+ +|+|.|+||-++|..
T Consensus 297 e~~y~yl~~kdhgt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 297 ETLYLYLHFKDHGTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEEEecCCceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 34578999998887664321 123566777888888777777655 589999999999999 999999999999853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.21 Score=49.56 Aligned_cols=100 Identities=18% Similarity=0.214 Sum_probs=64.2
Q ss_pred cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCCc--cHHHHHHhCCCCCHH
Q 007542 49 EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPE 126 (599)
Q Consensus 49 ~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g--~L~~~i~~~~~lse~ 126 (599)
....+|++...... -....+..+.+++.++. .|++|.. .+.-.+-++.|+|-. .+.
T Consensus 86 G~L~lKKi~slp~~-~~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~------------ 143 (308)
T PF07387_consen 86 GPLFLKKIRSLPCC-INDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINF------------ 143 (308)
T ss_pred chhhhhhccCCCcc-cchhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccch------------
Confidence 34566766532211 12334567788887764 4777652 122356788998763 111
Q ss_pred HHHHHHHHHHHHHHHhhhC--ceEeccCCCCceEecCCCceeeecccc
Q 007542 127 HYQFFLYQLLRGLKYIHTA--NVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 127 ~i~~i~~QIl~aL~yLHs~--gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
..++..=+.+|.-+|+. +.+|+|-.|+||+.|..|.+||.|-+.
T Consensus 144 --~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 144 --SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred --hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11222225667788954 699999999999999999999999764
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.38 Score=52.02 Aligned_cols=28 Identities=32% Similarity=0.309 Sum_probs=23.5
Q ss_pred CceEeccCCCCceEecCCCceeeeccccc
Q 007542 145 ANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 145 ~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...+|.||-+.|||.+. ..++++||..|
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA 254 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFA 254 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccc
Confidence 45799999999998764 56999999866
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.21 E-value=1.4 Score=46.54 Aligned_cols=71 Identities=15% Similarity=0.068 Sum_probs=40.1
Q ss_pred CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC--ccccceeecCCC--cCCCccEEEEEecCC
Q 007542 35 SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPS--RREFKDIYVVFELME 110 (599)
Q Consensus 35 ~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~~s--~~~~~~lylV~E~~~ 110 (599)
.-..||.... .+|..+++|+.... ......+..|+.++..|.... ++.... .+.. ..-.+..+.|+++++
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~---~~~~~~i~~E~~~l~~L~~~gipv~~p~~--~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPE---RWSDAQILEEHAFALELAEAEIPVVAPLA--FNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcc---cCCHHHHHHHHHHHHHHHHCCCCCCCCcc--CCCCEEEEECCEEEEEEeeeC
Confidence 3456888753 45677889876421 124556778998888875322 232211 1110 011235778999988
Q ss_pred c
Q 007542 111 S 111 (599)
Q Consensus 111 g 111 (599)
|
T Consensus 111 G 111 (325)
T PRK11768 111 G 111 (325)
T ss_pred C
Confidence 6
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.91 E-value=0.32 Score=51.22 Aligned_cols=74 Identities=26% Similarity=0.323 Sum_probs=45.8
Q ss_pred EEEEecCCcc---HHHHHH-hCCCC-CHHHHHHHHHHHHHHHHHh---h-hCceEeccCCCCceEecCC-----------
Q 007542 103 YVVFELMESD---LHQVIK-ANDDL-TPEHYQFFLYQLLRGLKYI---H-TANVFHRDLKPKNILANAD----------- 162 (599)
Q Consensus 103 ylV~E~~~g~---L~~~i~-~~~~l-se~~i~~i~~QIl~aL~yL---H-s~gIvHrDLKP~NILv~~~----------- 162 (599)
.+||+++.++ +..... ..|-. -.+-++.++.||+--.--+ - -.+.+|-||||+||||-+.
T Consensus 247 IIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 326 (434)
T PF05445_consen 247 IIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNR 326 (434)
T ss_pred EEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCe
Confidence 5889887742 222221 22222 2455677788876543222 2 3469999999999998543
Q ss_pred -------Cceeeecccccccc
Q 007542 163 -------CKLKICDFGLARVA 176 (599)
Q Consensus 163 -------~~lKL~DFGla~~~ 176 (599)
-.++|.||.+++..
T Consensus 327 ~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 327 NYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred EEEecccceeeecccCHHHhc
Confidence 22677888888764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=91.86 E-value=1.5 Score=44.01 Aligned_cols=67 Identities=18% Similarity=0.283 Sum_probs=42.8
Q ss_pred eEEEEEEECCCC-cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEEEEecCC
Q 007542 37 GVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME 110 (599)
Q Consensus 37 g~Vy~a~~~~tg-~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~ 110 (599)
|.|..|....+| ..|-||+=. ......+..|+.-|+.+.-.|-+.+-.++... ....+.|+|+||++
T Consensus 27 G~inea~~v~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G--~~~~~sylVle~L~ 94 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVG--ASRDHSYLVLEYLP 94 (286)
T ss_pred ccccceeEeecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEec--CCCCeeEEEEeecc
Confidence 455555554544 567787532 23455677888888888766655555554332 33457899999998
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=90.48 E-value=0.4 Score=49.28 Aligned_cols=47 Identities=28% Similarity=0.338 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHhhhC--ceEeccCCCCceEecCCCceeeeccccccc
Q 007542 129 QFFLYQLLRGLKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 129 ~~i~~QIl~aL~yLHs~--gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
+..+..+-.++.-++.. -++|+|+.|.|+|.++.+.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33444555555555555 589999999999999999999999987743
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=90.21 E-value=0.27 Score=51.40 Aligned_cols=134 Identities=22% Similarity=0.296 Sum_probs=86.2
Q ss_pred EEEEeeecCceEEEEEEE-------CC---CCcEEEEEEecCc---c-------------C------ChhhHHHHHH--H
Q 007542 27 IEEVIGKGSYGVVCSAYD-------TR---TGEKVAIKKINDI---F-------------E------HVSDATRILR--E 72 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~-------~~---tg~~VAIK~i~~~---~-------------~------~~~~~~~i~r--E 72 (599)
|-.+|..|.-++|.-|+- .. .-..+|||+++.. | . +.....++.. |
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 446788899999988842 11 2346889876421 1 0 1111223333 3
Q ss_pred HHHHHhcC-----CCCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhC
Q 007542 73 IKLLRLLR-----HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTA 145 (599)
Q Consensus 73 i~iL~~l~-----HpnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~ 145 (599)
..-|.+++ .|.+|.+... .|||-+++. .+-.--.++-.|+.++.+..-.|++.++.-| |..
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkkh------------vLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec 403 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKKH------------VLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKEC 403 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeecc------------eEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhh
Confidence 33344442 4666666443 589999884 2211111223588889999999999988876 566
Q ss_pred ceEeccCCCCceEecCCCceeeeccccc
Q 007542 146 NVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 146 gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
-+||-||+--|||.... .+.++|..-+
T Consensus 404 ~LVHADlSEyN~Lw~~g-Kvw~IDVsQs 430 (531)
T KOG2269|consen 404 LLVHADLSEYNLLWTPG-KVWVIDVSQS 430 (531)
T ss_pred heeecchhhhhheecCC-ceEEEechhc
Confidence 79999999999999865 9999997655
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.94 E-value=4.6 Score=44.58 Aligned_cols=27 Identities=30% Similarity=0.525 Sum_probs=23.1
Q ss_pred ceEeccCCCCceEecCCCceeeeccccc
Q 007542 146 NVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 146 gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
.++|.|+-+.|||.+.+ .++|+||..|
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYA 311 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYS 311 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeeccc
Confidence 48999999999987654 4999999866
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.88 E-value=1.3 Score=47.99 Aligned_cols=61 Identities=18% Similarity=0.189 Sum_probs=42.4
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHh-hhCceEeccCCCCceEecCC
Q 007542 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI-HTANVFHRDLKPKNILANAD 162 (599)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILv~~~ 162 (599)
...||-+|+.| ++..+++.. ..+|+..+.+..-...||--+ ---+++|.|+.|.||++..+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 34566677777 777777654 355666677766666665443 34589999999999998644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 599 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-79 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-79 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-75 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-75 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-75 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-75 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-75 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-75 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-75 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-75 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-75 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-75 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-75 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-75 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-75 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-74 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-74 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-74 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-74 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-74 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-74 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-73 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-73 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-73 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-72 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-71 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-68 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-68 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-68 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-68 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-68 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-68 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-68 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-68 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-68 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-68 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-68 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-68 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-68 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-68 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-68 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-68 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-68 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-68 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-68 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-68 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-68 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-68 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-68 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-68 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-68 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-68 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-68 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-68 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-68 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-68 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-68 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-68 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-68 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-68 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-67 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-67 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-67 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-67 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-67 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-67 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-67 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-67 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-67 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-67 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-67 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-67 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-67 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-67 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-67 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-67 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-67 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-67 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-67 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-67 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-67 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-67 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-67 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-66 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-66 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-66 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-66 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-66 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-66 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-66 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-66 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-59 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-59 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-59 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-57 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-55 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-52 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-52 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-52 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-52 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-52 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-52 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-52 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-52 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-51 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-51 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-51 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-51 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-51 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-51 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-51 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-51 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-51 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-51 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-51 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-51 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-51 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-51 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-50 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-50 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-50 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-50 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-50 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-50 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-50 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-49 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-49 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-49 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-49 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-48 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-44 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-43 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-43 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-43 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-43 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-38 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-37 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-37 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-37 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-37 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-37 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-37 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-37 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-37 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-37 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-37 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-37 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-37 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-37 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-37 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-37 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-37 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-37 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-37 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-37 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-37 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-37 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-37 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-37 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-37 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-37 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-37 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-37 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-37 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-37 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-37 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-37 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-37 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-36 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-36 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-36 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-35 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-35 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-35 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-35 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-35 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-35 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-34 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-34 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-33 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-33 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-33 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-33 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-33 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-33 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-33 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-33 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-33 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-33 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-33 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-32 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-32 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-32 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-32 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-32 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-32 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-32 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-32 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-32 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-32 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-32 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-32 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-32 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-31 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-30 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-30 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-30 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-30 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-30 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-30 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-30 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-30 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-29 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-28 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-28 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-28 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-28 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-27 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-26 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-22 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-22 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-21 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-20 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-20 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-20 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-20 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-20 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-20 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-20 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-19 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-19 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-19 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-19 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-19 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-18 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-17 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-17 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-17 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-17 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-17 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-17 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-17 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-17 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-17 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-15 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-15 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-07 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 564 bits (1457), Expect = 0.0
Identities = 146/392 (37%), Positives = 217/392 (55%), Gaps = 53/392 (13%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
Y S ++++ ++G+G+YGVVCSA TGE VAIKKI F+ A R LREIK+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKIL 63
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 136
+ +H +I+ I +I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-------TPTAIFWTDY 189
R +K +H +NV HRDLKP N+L N++C LK+CDFGLAR+ T ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
VATRWYRAPE+ + +KY+ A+D+WS GCI AEL +P+FPG++ HQL ++ ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYL 309
P + R + + +AR Y+
Sbjct: 242 PHSDNDLR-----------------------------------------CIESPRAREYI 260
Query: 310 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPS 369
S+ P + FP NP + LL+RML F+P R TA+EAL PY + EP
Sbjct: 261 KSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE 320
Query: 370 AQPVTKMEFEF--ERRRITKEDVRELIYREIL 399
+P+ FEF + +T +D+++LI+ EI
Sbjct: 321 GEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 564 bits (1456), Expect = 0.0
Identities = 164/403 (40%), Positives = 229/403 (56%), Gaps = 47/403 (11%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+ ++ + G RY IG+G+YG+VCSAYD +VAIKKI+ FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FE 64
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND 121
H + R LREIK+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
L+ +H +FLYQ+LRGLKYIH+ANV HRDLKP N+L N C LKICDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 IMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVR 301
+ +LG+PS E + +
Sbjct: 243 HILGILGSPSQEDLNCII------------------------------------------ 260
Query: 302 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
N KAR YL S+ K +P+++ FPNA+ AL LL++ML F P R E+ALA PY +
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320
Query: 362 AKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 404
EP A+ +F+ E + KE ++ELI+ E + P
Sbjct: 321 YDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPG 361
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 566 bits (1461), Expect = 0.0
Identities = 142/468 (30%), Positives = 214/468 (45%), Gaps = 94/468 (20%)
Query: 1 MQPDQRKKSSADVDFFTEYGE---GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M S + +F Y I+ +IG+GSYG V AYD T + VAIKK+N
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVI 117
+FE + D RILREI +L L+ I+ + +++P +F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
K LT EH + LY LL G +IH + + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 NDTPTAI-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
++ T I T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAELLTG-----------KPLFPG-----------------KNVVHQLDIMTDLLGTP 250
CIFAELL PLFPG K+ QL+I+ +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS 310
+ + + + + +Y+
Sbjct: 300 TEDDLKNIN------------------------------------------KPEVIKYIK 317
Query: 311 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSA 370
+KPI QK+P+ + + LLE ML F P R T ++AL PY K + K + E +
Sbjct: 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFS 377
Query: 371 QPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPTGF 418
+ F+ + +++ +R + +E+ +HP+++ + F
Sbjct: 378 TKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNF 424
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 539 bits (1392), Expect = 0.0
Identities = 125/410 (30%), Positives = 185/410 (45%), Gaps = 63/410 (15%)
Query: 5 QRKKSSADVDFF-TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIND----- 58
Q K +A D + S Y ++ I GSYG VC+ D+ G VAIK++ +
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDG 61
Query: 59 ----IFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLH 114
I R+LREI+LL HP+I+ ++ I + +Y+V ELM +DL
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 115 QVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
QVI ++P+H Q+F+Y +L GL +H A V HRDL P NIL + + ICDF LA
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 182 REDTADA----NKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293
+QL+ + +++GTP E +
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVM------------------------------------ 260
Query: 294 LILHCQVRNEKARRYL-SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA 352
+ AR YL +S+ ++ P A+P+AL L+ +ML F P+ R + E+A
Sbjct: 261 ------FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 353 LADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 402
L PYF+ L F F+ D+ ++ E+ ++
Sbjct: 315 LRHPYFESLFDPLDLTEGLS---ERFHFDESVTDVYDMHKIFTAEVERFN 361
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 539 bits (1390), Expect = 0.0
Identities = 142/414 (34%), Positives = 217/414 (52%), Gaps = 55/414 (13%)
Query: 3 PDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
P + +V T + + Y+ + +G G+YG VCSA D RTG KVAIKK+ F+
Sbjct: 6 PARSGFYRQEV-TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS 64
Query: 63 VSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDLHQVIKAND 121
A R RE++LL+ +RH +++ + + P + +F D Y+V M +DL +++K
Sbjct: 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
L + QF +YQ+L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR A ++
Sbjct: 125 -LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-- 181
Query: 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
T YV TRWYRAPE+ + + +YT +DIWS+GCI AE++TGK LF G + + QL
Sbjct: 182 ----MTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 236
Query: 242 IMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVR 301
+ + GTP E + R ++
Sbjct: 237 EIMKVTGTPPAEFVQR------------------------------------------LQ 254
Query: 302 NEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
+++A+ Y+ + + + F+ NA+PLA+ LLE+ML + + R TA EALA PYF+ L
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314
Query: 362 AKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEP 415
E EP Q + F+ T ++ + + Y+E+L + P E
Sbjct: 315 HDTEDEPQVQK---YDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKET 365
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 536 bits (1384), Expect = 0.0
Identities = 139/388 (35%), Positives = 205/388 (52%), Gaps = 54/388 (13%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + Y +G G+YG VCSA D R+GEKVAIKK++ F+ A R RE+ LL
Sbjct: 18 TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77
Query: 77 RLLRHPDIVEIKHILLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ ++H +++ + + P S R F D Y+V M++DL +++ + E Q+ +YQ+
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQM 135
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+GLKYIH+A V HRDLKP N+ N DC+LKI DFGLAR A + T YV TRWY
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ S + Y +DIWS+GCI AE+LTGK LF GK+ + QL + + G P E +
Sbjct: 190 RAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
++ ++ A+ Y+ S+ +
Sbjct: 249 QKLN------------------------------------------DKAAKSYIQSLPQT 266
Query: 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 375
F+Q FP A+P A LLE+ML + R TA +AL P+F+ E E AQ
Sbjct: 267 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--P 324
Query: 376 MEFEFERRRITKEDVRELIYREILEYHP 403
+ E ++T ++ ++ IY+EI+ + P
Sbjct: 325 FDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 537 bits (1386), Expect = 0.0
Identities = 138/429 (32%), Positives = 216/429 (50%), Gaps = 85/429 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
+Y++ + +GKG+YG+V + D RTGE VA+KKI D F++ +DA R REI +L L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
H +IV + ++L + +D+Y+VF+ ME+DLH VI+AN L P H Q+ +YQL++ +K
Sbjct: 68 HENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIK 123
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARV------------------AFNDTPT 182
Y+H+ + HRD+KP NIL NA+C +K+ DFGL+R N
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 183 AIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG + ++QL+
Sbjct: 184 QPILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 242 IMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVR 301
+ ++ PS E + ++
Sbjct: 242 RIIGVIDFPSNEDVES------------------------------------------IQ 259
Query: 302 NEKARRYLSSMRKKKPIPFSQKF----------------PNANPLALRLLERMLAFEPKD 345
+ A+ + S+++K I S K + N AL LL+++L F P
Sbjct: 260 SPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319
Query: 346 RPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 405
R +A +AL P+ EP+ + + + + + +D R L+Y EI ++
Sbjct: 320 RISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKREL 378
Query: 406 LKEFLEGSE 414
+ + +
Sbjct: 379 ISNKHQNVQ 387
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 534 bits (1378), Expect = 0.0
Identities = 148/415 (35%), Positives = 221/415 (53%), Gaps = 60/415 (14%)
Query: 1 MQPDQRKKSSADVDFF------TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK 54
M S F+ T + RY+ +G G+YG VC+A+DT+TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE-FKDIYVVFELMESDL 113
K++ F+ + A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
+ ++K LT +H QF +YQ+LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R + T YVATRWYRAPE+ + + Y +DIWS+GCI AELLTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293
+ + QL ++ L+GTP E + +
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKK------------------------------------ 256
Query: 294 LILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 353
+ +E AR Y+ S+ + + F+ F ANPLA+ LLE+ML + R TA +AL
Sbjct: 257 ------ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 354 ADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKE 408
A YF + EP A P + E R + ++ + L Y E++ + P L +
Sbjct: 311 AHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTYDEVISFVPPPLDQ 362
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 537 bits (1386), Expect = 0.0
Identities = 149/459 (32%), Positives = 213/459 (46%), Gaps = 99/459 (21%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
Q K +++ +++ RY+I +IG GSYG VC AYD VAIKKI +FE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND 121
+ D RILREI +L L H +V++ I++P +F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA----- 176
LT H + LY LL G+KY+H+A + HRDLKP N L N DC +K+CDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAELLT-----------GKPLFPGKNVV--------------------HQLDIMTDL 246
GCIFAELL PLFPG + QL+++ ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKAR 306
LGTPS E I + E A+
Sbjct: 331 LGTPSEEDIEA------------------------------------------LEKEDAK 348
Query: 307 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 366
RY+ K++ +++FP ++ A+ LL+RML F P R T E LA P+FK + E
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408
Query: 367 EPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 405
E +A ++ F + + + +R +EI YHP++
Sbjct: 409 ETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 524 bits (1351), Expect = 0.0
Identities = 133/442 (30%), Positives = 214/442 (48%), Gaps = 71/442 (16%)
Query: 1 MQPDQRKKSSADVDFFT-EYGE-----GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK 54
+ KS D F++ E G+ RY+ + IG G+ G+VC+AYD VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP-PSRREFKDIYVVFELMESDL 113
K++ F++ + A R RE+ L++ + H +I+ + ++ P + EF+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
QVI+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
R A T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTA----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293
++ + Q + + + LGTP PE + ++
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL----------------------------------- 290
Query: 294 LILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA------------NPLALRLLERMLAF 341
R Y+ + K + F + FP++ A LL +ML
Sbjct: 291 --------QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 342 EPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEY 401
+P R + ++AL PY A P + + + R T E+ +ELIY+E++
Sbjct: 343 DPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDEREHTIEEWKELIYKEVMNS 401
Query: 402 HPQMLKEFLEGSEPTGFMYPSA 423
+ ++G ++
Sbjct: 402 EEKTKNGVVKGQPSPSGAAVNS 423
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 519 bits (1339), Expect = 0.0
Identities = 128/420 (30%), Positives = 204/420 (48%), Gaps = 69/420 (16%)
Query: 1 MQPDQRKKS---SADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M ++ + S ++ + + RY+ + IG G+ G+VC+AYD VAIKK++
Sbjct: 1 MGSRSKRDNNFYSVEI-GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS 59
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP-SRREFKDIYVVFELMESDLHQV 116
F++ + A R RE+ L++ + H +I+ + ++ P S EF+D+Y+V ELM+++L QV
Sbjct: 60 RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV 119
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176
I+ +L E + LYQ+L G+K++H+A + HRDLKP NI+ +DC LKI DFGLAR A
Sbjct: 120 IQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
T+ T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG +
Sbjct: 178 ----GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231
Query: 237 VHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLIL 296
+ Q + + + LGTP PE + ++
Sbjct: 232 IDQWNKVIEQLGTPCPEFMKKL-------------------------------------- 253
Query: 297 HCQVRNEKARRYLSSMRKKKPIPFSQKFPNA------------NPLALRLLERMLAFEPK 344
R Y+ + K F + FP+ A LL +ML +
Sbjct: 254 -----QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308
Query: 345 DRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 404
R + +EAL PY + P + + + R T E+ +ELIY+E+++
Sbjct: 309 KRISVDEALQHPYINVWYDPSEAEAPPP-KIPDKQLDEREHTIEEWKELIYKEVMDLEHH 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 506 bits (1304), Expect = e-178
Identities = 125/357 (35%), Positives = 174/357 (48%), Gaps = 57/357 (15%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
GSRY + +G G G+V SA D ++VAIKKI + LREIK++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKHILLPPSRR---------EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL 132
+IV++ IL P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
YQLLRGLKYIH+ANV HRDLKP N+ N D LKI DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + + Q+ ++ + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS 311
E + Y+ +
Sbjct: 246 EEDRQELL-------------------------------------------SVIPVYIRN 262
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 368
+ P +Q P + A+ LE++L F P DR TAEEAL+ PY + EP
Sbjct: 263 DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 459 bits (1182), Expect = e-159
Identities = 115/393 (29%), Positives = 176/393 (44%), Gaps = 69/393 (17%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E R+++E + G+G++G V + TG VAIKK+ + R L+ ++ L +L
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLH 77
Query: 81 HPDIVEIKHILLPPSRREFKDIY--VVFELMESDLHQVIK----ANDDLTPEHYQFFLYQ 134
HP+IV+++ R+ +DIY VV E + LH+ + P + FL+Q
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 135 LLRGLKYIH--TANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
L+R + +H + NV HRD+KP N+L N AD LK+CDFG A+ P Y+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN----VAYIC 193
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
+R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G N QL + +LG PS
Sbjct: 194 SRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS 311
E + + + L
Sbjct: 253 REVLRK------------------------------------------LNPSHTDVDL-- 268
Query: 312 MRKKKPIPFSQKF----PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 367
K IP+S F A LL +L + P++R EAL PYF L +
Sbjct: 269 -YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK 327
Query: 368 -PSAQPVTKMEFEFERR--RITKEDVRELIYRE 397
P+ + + + F F + E + + R+
Sbjct: 328 LPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 424 bits (1093), Expect = e-145
Identities = 119/441 (26%), Positives = 195/441 (44%), Gaps = 75/441 (17%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
+ + D T Y +VIG GS+GVV A + E VAIKK+
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV---- 72
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREFKDIYVVFELMESDLHQVI-- 117
+ D RE++++R+++HP++V++K +++ + +V E + +++
Sbjct: 73 --LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH 130
Query: 118 --KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLAR 174
K + + ++YQLLR L YIH+ + HRD+KP+N+L + LK+ DFG A+
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
Query: 175 VAFNDTPTAIFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ P Y+ +R+YRAPEL G+ + YT IDIWS GC+ AEL+ G+PLFPG
Sbjct: 191 ILIAGEPN----VSYICSRYYRAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293
++ + QL + +LGTPS E I +
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTM----------------------------------- 269
Query: 294 LILHCQVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEA 352
+ +P PFS+ F P P A+ L+ R+L + P R TA EA
Sbjct: 270 ----------NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319
Query: 353 LADPYFKGLAKVE-REPSAQPVTKM-EFEFERRRITKEDVRELIYREILEYHPQMLKEFL 410
L P+F L E R P+ + + + + E + + + L+ H + +
Sbjct: 320 LCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVP-----QHAEA-ELLS 373
Query: 411 EGSEPTGFMYPSAVDHFKKQF 431
G + F P ++ K
Sbjct: 374 RGIDVHNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-144
Identities = 104/424 (24%), Positives = 178/424 (41%), Gaps = 109/424 (25%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y + + +G GS+G+VC +D +G++ A+KK+ D RE+ ++++L H
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHV 60
Query: 83 DIVEIKHIL---------------------------------LPPSRREFKDIYVVFELM 109
+I+++ + + + K + V+ E +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 110 ESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCK 164
LH+V+ ++ + ++YQL R + +IH+ + HRD+KP+N+L N+ D
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFAE 223
LK+CDFG A+ P+ Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F E
Sbjct: 181 LKLCDFGSAKKLIPSEPS----VAYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFGE 234
Query: 224 LLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLV 283
L+ GKPLF G+ + QL + ++GTP+ E + R
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIR-------------------------- 268
Query: 284 FAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP-LALRLLERMLAFE 342
+ K + + P P LA+ LLE++L +E
Sbjct: 269 ----------------MNPHYTEVRFP---TLKAKDWRKILPEGTPSLAIDLLEQILRYE 309
Query: 343 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKME---------FEF---ERRRITKEDV 390
P R EA+A P+F L F F E I +
Sbjct: 310 PDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVL 369
Query: 391 RELI 394
++
Sbjct: 370 NRIL 373
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 412 bits (1062), Expect = e-140
Identities = 110/381 (28%), Positives = 170/381 (44%), Gaps = 67/381 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKHILLPPS-RREFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRG 138
IV +++ +++ + +V + + +++V + A L + + ++YQL R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + D LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN----VSYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PEL G+ + YT +ID+WS GC+ AELL G+P+FPG + V QL + +LGTP+ E I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316
+ + K
Sbjct: 283 EM---------------------------------------------NPNYTEFKFPQIK 297
Query: 317 PIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 375
P+++ F P P A+ L R+L + P R T EA A +F L + T
Sbjct: 298 AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTP 357
Query: 376 MEFEFERR--RITKEDVRELI 394
F F + LI
Sbjct: 358 ALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-130
Identities = 86/359 (23%), Positives = 151/359 (42%), Gaps = 64/359 (17%)
Query: 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK 74
E+G Y++ +G+G Y V A + EKV +K + + +I REIK
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 75 LLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 133
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
++L+ L Y H+ + HRD+KP N++ + KL++ D+GLA + VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ----EYNVRVAS 193
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPS 251
R+++ PEL + Y ++D+WS+GC+ A ++ K P F G + QL + +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS 311
E R+
Sbjct: 253 LYDYIDK-----------------------------------------YNIELDPRFNDI 271
Query: 312 MRKKKPIPFSQKFPNAN-----PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 365
+ + + + + N P AL L+++L ++ + R TA EA+ PYF + K +
Sbjct: 272 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-118
Identities = 104/351 (29%), Positives = 162/351 (46%), Gaps = 54/351 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ IG+GSYGVV + TG+ VAIKK + + LREI++L+ L+HP+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
+V + + R + +++VFE + + + + + +Q L+ + +
Sbjct: 64 LVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H N HRD+KP+NIL +K+CDFG AR P+ + D VATRWYR+PE L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELLV 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
G ++Y P +D+W+IGC+FAELL+G PL+PGK+ V QL ++ LG P
Sbjct: 176 GD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR-------- 225
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
+ + + P
Sbjct: 226 ---HQQV-------------------------------FSTNQYFSGVKIPDPEDMEPLE 251
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 372
KFPN + AL LL+ L +P +R T E+ L PYF+ + ++E
Sbjct: 252 LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHD 302
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-109
Identities = 96/338 (28%), Positives = 158/338 (46%), Gaps = 54/338 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ ++G+GSYG+V + TG VAIKK + + +REIKLL+ LRH +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
+V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ G+ +
Sbjct: 86 LVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 201
H+ N+ HRD+KP+NIL + +K+CDFG AR P ++ D VATRWYRAPEL
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELLV 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
G KY A+D+W+IGC+ E+ G+PLFPG + + QL + LG P
Sbjct: 198 GD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR-------- 247
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
+ K+ P
Sbjct: 248 ---HQEL-------------------------------FNKNPVFAGVRLPEIKEREPLE 273
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+++P + + + L ++ L +P RP E L +F+
Sbjct: 274 RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-100
Identities = 101/348 (29%), Positives = 141/348 (40%), Gaps = 66/348 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI-----LREIKLLR 77
SRY+ IG G+YG V A D +G VA+K + + +RE+ LLR
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLR 66
Query: 78 LLR---HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFL 132
L HP++V + + + +VFE ++ DL + L E + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 192
Q LRGL ++H + HRDLKP+NIL + +K+ DFGLAR ++ T V T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA---LTPVVVT 182
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
WYRAPE L S Y +D+WS+GCIFAE+ KPLF G + QL + DL+G P
Sbjct: 183 LWYRAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239
Query: 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS 311
+ W P +
Sbjct: 240 ED-----------DWPRDVSL-----PRG------------------------------A 253
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ P P P +LL ML F P R +A AL Y
Sbjct: 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 306 bits (787), Expect = e-100
Identities = 112/342 (32%), Positives = 156/342 (45%), Gaps = 60/342 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRI--LREIKLLRLL 79
RY+ + +G+G + V A D T + VAIKKI D LREIKLL+ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ + S I +VF+ ME+DL +IK N LTP H + ++ L+G
Sbjct: 70 SHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+Y+H + HRDLKP N+L + + LK+ DFGLA+ +F P + T V TRWYRAP
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRAP 181
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
E L G+ Y +D+W++GCI AELL P PG + + QL + + LGTP+ E
Sbjct: 182 ELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE---- 235
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
W P + +
Sbjct: 236 -------QWPDMCSL-----PDY-----------------------------VTFKSFPG 254
Query: 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
IP F A L L++ + F P R TA +AL YF
Sbjct: 255 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-100
Identities = 124/364 (34%), Positives = 175/364 (48%), Gaps = 60/364 (16%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
S+ + G +Y+ E +G+G+YGVV A D G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIR--LDAE 58
Query: 64 SDATRI--LREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-N 120
+ +REI LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
L + +LYQLLRG+ + H + HRDLKP+N+L N+D LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
P + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQ 299
L + +LGTP+P W +
Sbjct: 229 LPKIFSILGTPNPR-----------EWPQVQ----------------------------E 249
Query: 300 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ K R + + + P+S P + LL ML F+P R +A +A+ PYFK
Sbjct: 250 LPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
Query: 360 GLAK 363
L
Sbjct: 306 DLDP 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-100
Identities = 113/367 (30%), Positives = 169/367 (46%), Gaps = 60/367 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y + +G+G+Y V T VA+K+I E + T I RE+ LL+ L+H +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYI 142
IV + I+ + +VFE ++ DL Q + + + + + FL+QLLRGL Y
Sbjct: 62 IVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LC 201
H V HRDLKP+N+L N +LK+ DFGLAR A + PT + + V T WYR P+ L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPDILL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
GS + Y+ ID+W +GCIF E+ TG+PLFPG V QL + +LGTP+ E
Sbjct: 174 GS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE-------- 223
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
W G K Y K +
Sbjct: 224 ---TWPGIL----------------------------SNEEFKTYNY----PKYRAEALL 248
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL----AKVEREPSAQPVTKME 377
P + LL ++L FE ++R +AE+A+ P+F L K+ S + +++
Sbjct: 249 SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQ 308
Query: 378 FEFERRR 384
+ E
Sbjct: 309 LQKEASL 315
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = 1e-99
Identities = 114/340 (33%), Positives = 166/340 (48%), Gaps = 61/340 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIR--LEKEDEGIPSTTIREISILKELKH 59
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 140
+IV++ ++ R + +VFE ++ DL +++ L + FL QLL G+
Sbjct: 60 SNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y H V HRDLKP+N+L N + +LKI DFGLAR AF P + T + T WYRAP+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPDV 171
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
L GS KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ +
Sbjct: 172 LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK------ 223
Query: 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319
W + +Y + +P+P
Sbjct: 224 -----NWPNV---------------------------------TELPKYDPNFTVYEPLP 245
Query: 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ + + LL +ML +P R TA++AL YFK
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = 7e-99
Identities = 117/343 (34%), Positives = 163/343 (47%), Gaps = 61/343 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRH 81
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKH 60
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLK 140
+IV + +L + + +VFE + DL + + N DL PE + FL+QLL+GL
Sbjct: 61 KNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
+ H+ NV HRDLKP+N+L N + +LK+ +FGLAR AF P + + V T WYR P+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPDV 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
L G+ Y+ +ID+WS GCIFAEL G+PLFPG +V QL + LLGTP+ E
Sbjct: 173 LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE----- 225
Query: 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI 318
W K Y
Sbjct: 226 ------QWPSM---------------------------------TKLPDYKPYPMYPATT 246
Query: 319 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
P N LL+ +L P R +AEEAL PYF
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = 9e-99
Identities = 106/368 (28%), Positives = 162/368 (44%), Gaps = 65/368 (17%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRI--LREIKLLRLL 79
+Y+ IG+G+YG V A D + G VA+K++ + + + +RE+ +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
LLRGL ++H+ V HRDLKP+NIL + ++K+ DFGLAR ++ T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA---LTSVVVTLW 184
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
YRAPE L S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMR 313
W P +
Sbjct: 242 -----------DWPRDVAL-----P------------------------------RQAFH 255
Query: 314 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK-VEREPSAQP 372
K P + + + L LL + L F P R +A AL+ PYF+ L + E S P
Sbjct: 256 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLP 315
Query: 373 VTKMEFEF 380
++ E
Sbjct: 316 PSQNTSEL 323
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 2e-97
Identities = 112/348 (32%), Positives = 162/348 (46%), Gaps = 65/348 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
RY+ +G+G+YG V A DT T E VAIK+I EH + +RE+ LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
H +I+E+K ++ R ++++FE E+DL + + N D++ + FLYQL+ G+
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YIHTANVFHRDLKPKNILANADCK-----LKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ H+ HRDLKP+N+L + LKI DFGLAR AF P F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG + + QL + ++LG P
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT- 260
Query: 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK 314
W G + S K
Sbjct: 261 ----------TWPGV---------------------------------TALPDWKQSFPK 277
Query: 315 KKPIPFSQKFPNA-NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
+ + + L LL ML +P R +A+ AL PYF
Sbjct: 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 5e-97
Identities = 110/377 (29%), Positives = 167/377 (44%), Gaps = 64/377 (16%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
S+Y+ IG+G++G V A +TG+KVA+KK+ + E+ + I LREIK+L+LL+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV--LMENEKEGFPITALREIKILQLLK 74
Query: 81 HPDIV---EIKHILLPPSRREFKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLL 136
H ++V EI P R IY+VF+ E DL ++ T + + LL
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---VATR 193
GL YIH + HRD+K N+L D LK+ DFGLAR AF+ Y V T
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVVTL 192
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
WYR PE L G Y P ID+W GCI AE+ T P+ G HQL +++ L G+ +P
Sbjct: 193 WYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312
E +W D + + +
Sbjct: 251 E-----------VWPNVDNY-----ELYEKL---------------------------EL 267
Query: 313 RKKKPIPFSQKFPN--ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL---AKVERE 367
K + + +P AL L++++L +P R +++AL +F + ++
Sbjct: 268 VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGM 327
Query: 368 PSAQPVTKMEFEFERRR 384
S + E+ RR
Sbjct: 328 LSTHLTSMFEYLAPPRR 344
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 1e-96
Identities = 107/351 (30%), Positives = 168/351 (47%), Gaps = 67/351 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S++K E +G G+Y V + TG VA+K++ E + +T I REI L++ L+H
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKELKHE 63
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLL 136
+IV + ++ ++ + +VFE M++DL + + + L ++F +QLL
Sbjct: 64 NIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+GL + H + HRDLKP+N+L N +LK+ DFGLAR AF P F + V T WYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTLWYR 175
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
AP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG N QL ++ D++GTP+
Sbjct: 176 APDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES-- 231
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
+W +Y +++++
Sbjct: 232 ---------LWPSVTKL---------------------------------PKYNPNIQQR 249
Query: 316 KPIPFSQKFPNA-----NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
P Q + + L +L P R +A++AL P+F
Sbjct: 250 PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-84
Identities = 109/398 (27%), Positives = 175/398 (43%), Gaps = 78/398 (19%)
Query: 23 SRYKIE-EVIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL 79
++ E +G+G+YG V A D + + A+K+I +S + REI LLR L
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLREL 75
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD---------LTPEHYQF 130
+HP+++ ++ + L + + ++++F+ E DL +IK + L +
Sbjct: 76 KHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCK----LKICDFGLARVAFNDTPTAIF- 185
LYQ+L G+ Y+H V HRDLKP NIL + +KI D G AR FN P
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPLA 190
Query: 186 -WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-------- 235
V T WYRAPE L G+ YT AIDIW+IGCIFAELLT +P+F +
Sbjct: 191 DLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 236 -VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVL 294
QLD + +++G P+ + W +
Sbjct: 249 YHHDQLDRIFNVMGFPADK-----------DWEDIKK----------------------M 275
Query: 295 ILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354
H + + R ++ K + + + A LL+++L +P R T+E+A+
Sbjct: 276 PEHSTLMKDFRRNTYTNCSLIKYM--EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333
Query: 355 DPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRE 392
DPYF P++ + + +R E+ +
Sbjct: 334 DPYFLEDPL----PTSDVFAGCQIPYPKREFLTEEEPD 367
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 4e-68
Identities = 98/355 (27%), Positives = 162/355 (45%), Gaps = 52/355 (14%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
RY++ +VIGKGS+G V AYD + + VA+K + + + EI++L LR
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAE--EIRILEHLRK 152
Query: 82 PDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
D +++ F++ I + FEL+ +L+++IK N + + F + +L+
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 139 LKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
L +H + H DLKP+NIL +K+ DFG + T Y+ +R+YR
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT------YIQSRFYR 266
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE + G+ +Y ID+WS+GCI AELLTG PL PG++ QL M +LLG PS + +
Sbjct: 267 APEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
A F ++ +C V + + +
Sbjct: 324 DAS------------------------KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRS 359
Query: 316 -----KPIPFSQKFPNANPLALR-----LLERMLAFEPKDRPTAEEALADPYFKG 360
+ P S+++ NA L++ L ++P R T +AL P+ +
Sbjct: 360 RRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-63
Identities = 95/370 (25%), Positives = 161/370 (43%), Gaps = 47/370 (12%)
Query: 11 ADVDFFTEYGE--GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--NDIFEHVSDA 66
+ D+ + GE RY+I+ +IGKGS+G V AYD E VAIK I F + +
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-- 97
Query: 67 TRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--L 123
E++LL L+ D +I+ F++ + +VFE++ +L+ +++ + +
Sbjct: 98 ---QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154
Query: 124 TPEHYQFFLYQLLRGLKYIHT--ANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFND 179
+ + F Q+ L ++ T ++ H DLKP+NIL +KI DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
Query: 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
Y+ +R+YR+PE+ Y AID+WS+GCI E+ TG+PLF G N V Q
Sbjct: 215 IYQ------YIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQ 299
++ + ++LG P + + A F + + +
Sbjct: 267 MNKIVEVLGIPPAHILDQ----------------APKARKFFEKLPDGTWNLKKTKDGKR 310
Query: 300 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR-------LLERMLAFEPKDRPTAEEA 352
R L ++ + + + + L+ RML ++PK R A
Sbjct: 311 EYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYA 370
Query: 353 LADPYFKGLA 362
L +FK A
Sbjct: 371 LQHSFFKKTA 380
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 7e-62
Identities = 70/371 (18%), Positives = 139/371 (37%), Gaps = 77/371 (20%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ + + +G G++G V + A+K + +I + + + +I E +L+ +++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI--EADILKKIQN 90
Query: 82 PDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRG 138
D + +I+ + + D + ++FE + L+++I N+ E + + ++L+
Sbjct: 91 DD-INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 139 LKYIHTANVFHRDLKPKNIL-------------------------ANADCKLKICDFGLA 173
L Y+ ++ H DLKP+NIL +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-- 207
Query: 174 RVAFNDTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
A F +D + TR YRAPE + + + D+WS GC+ AEL TG
Sbjct: 208 --------CATFKSDYHGSIINTRQYRAPEVILNL---GWDVSSDMWSFGCVLAELYTGS 256
Query: 229 PLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFF 288
LF + L +M ++ +
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNG-----------------------SK 293
Query: 289 FFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT 348
+ + + N + + ++K P+ K + L L +L +P RP+
Sbjct: 294 YVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK----HELFCDFLYSILQIDPTLRPS 349
Query: 349 AEEALADPYFK 359
E L + +
Sbjct: 350 PAELLKHKFLE 360
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-60
Identities = 88/370 (23%), Positives = 145/370 (39%), Gaps = 73/370 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+RY+I + +G+G++G V D + G VA+K + ++ + +A R EI++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
D + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAFN 178
+ ++H+ + H DLKP+NIL + +K+ DFG
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG------- 182
Query: 179 DTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+A + + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 183 ---SATYDDEHHSTLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293
+ L +M +LG I + +F
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTR------------------------KRKYFHHDR- 271
Query: 294 LILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 353
L + R + + K SQ + L+++ML ++P R T EAL
Sbjct: 272 --LDWDEHSSAGRYVSRACKPLKEFMLSQDVE--HERLFDLIQKMLEYDPAKRITLREAL 327
Query: 354 ADPYFKGLAK 363
P+F L K
Sbjct: 328 KHPFFDLLKK 337
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-58
Identities = 93/381 (24%), Positives = 143/381 (37%), Gaps = 75/381 (19%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
RY+I +G+G++G V D R +VA+K I ++ +A R+ EI +L+ ++
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL--EINVLKKIK 74
Query: 81 HPDIVEIKHILLPPSRREFKD-IYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
D +L F + + FEL+ + + +K N+ H + YQL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 138 GLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAFN 178
L+++H + H DLKP+NIL + + +++ DFG
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG------- 187
Query: 179 DTPTAIFWTD----YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+A F + VATR YR PE + + D+WSIGCI E G LF
Sbjct: 188 ---SATFDHEHHTTIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 234 KNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293
L +M +LG I R +F+
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRT------------------------RKQKYFYKGG- 276
Query: 294 LILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 353
L + R + + K + L+ RML F+P R T EAL
Sbjct: 277 --LVWDENSSDGRYVKENCKPLKSYMLQDSLE--HVQLFDLMRRMLEFDPAQRITLAEAL 332
Query: 354 ADPYFKGLAKVER--EPSAQP 372
P+F GL ER S P
Sbjct: 333 LHPFFAGLTPEERSFHTSRNP 353
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 78/370 (21%), Positives = 133/370 (35%), Gaps = 69/370 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G + V A D VA+K + + ++A EIKLL+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVNDA 75
Query: 83 DIVEIKHILLPPSRR-----EFKDIYV-----VFELMESDLHQVIKANDD--LTPEHYQF 130
D + + + K VFE++ +L +IK + + + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 131 FLYQLLRGLKYIHT-ANVFHRDLKPKNILAN------ADCKLKICDFGLARVAFNDTPTA 183
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY--- 192
Query: 184 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV------ 236
T+ + TR YR+PE L G+ + DIWS C+ EL+TG LF
Sbjct: 193 ---TNSIQTREYRSPEVLLGA---PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 237 VHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLIL 296
+ + +LLG + + FF + L+
Sbjct: 247 DDHIAQIIELLGELPSYLLRNG------------------------KYTRTFFNSRGLLR 282
Query: 297 HCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADP 356
+ + + + K +++ L ML +P+ R A + P
Sbjct: 283 NISKLKFWPLEDVLTEKYKFSKDEAKEI-------SDFLSPMLQLDPRKRADAGGLVNHP 335
Query: 357 YFKGLAKVER 366
+ K +E
Sbjct: 336 WLKDTLGMEE 345
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-57
Identities = 63/245 (25%), Positives = 94/245 (38%), Gaps = 19/245 (7%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
+ ++ F + +G Y I + IG G V + + AIK +N
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA 65
Query: 62 HVSDATRILREIKLLRLLRHP--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ P + + +L + IH + H DLKP N L D LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
T T++ V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 T-TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKN 235
F
Sbjct: 239 FQQII 243
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 14/64 (21%), Positives = 22/64 (34%), Gaps = 7/64 (10%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 371
+ I F +L+ L +PK R + E LA PY +++ P Q
Sbjct: 253 IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV----QIQTHPVNQ 305
Query: 372 PVTK 375
Sbjct: 306 MAKG 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-56
Identities = 59/228 (25%), Positives = 101/228 (44%), Gaps = 19/228 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHP 82
+ ++V+G G+ G + VA+K+I +D RE++LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKY 141
+++ + ++ + Y+ EL + L + ++ D L Q GL +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 IHTANVFHRDLKPKNIL-----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K I DFGL + + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
APE L T +DI+S GC+F +++ GK++ Q +I+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 30/154 (19%), Positives = 59/154 (38%), Gaps = 19/154 (12%)
Query: 303 EKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362
+ +R + + + + + +A L+E+M+A +P+ RP+A+ L P+F L
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291
Query: 363 K-----------VEREPSAQPVTKMEFEFERRRITKEDVRELIYREILE-------YHPQ 404
K +E+E P+ K + E R + K D RE I + Y
Sbjct: 292 KQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKFRTYKGG 350
Query: 405 MLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHY 438
+++ L Y ++ L + +
Sbjct: 351 SVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDF 384
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 192 bits (488), Expect = 8e-56
Identities = 56/392 (14%), Positives = 99/392 (25%), Gaps = 103/392 (26%)
Query: 9 SSADVDFFTEYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDA 66
+A+ + +G R K+ E + G VV D E A+K S+
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106
Query: 67 TRILREIKLLRLLRHPDIVEIK---HILLPP------------------SRREFKDIYVV 105
R+ L E + +LLP + ++
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 106 FELMESDLHQVIKANDDLTPEHY-------QFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158
DL + D + QL+R + + + H P N+
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226
Query: 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
D +L + D P Y E + + +T A++ W +G
Sbjct: 227 IMPDGRLMLGDVSALWKVGTRGPA------SSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 219 CIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAP 278
+WC + P
Sbjct: 281 LSIYR-----------------------------------------VWCLF-------LP 292
Query: 279 SCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338
F T + +R + + F L+ R
Sbjct: 293 --------FGLVTPGI-------KGSWKRPSLRVPGTDSLAFGSC-TPLPDFVKTLIGRF 336
Query: 339 LAFEPKDRPTAEEALADPYFKGLAKVEREPSA 370
L F+ + R EA+ P F +++ E S+
Sbjct: 337 LNFDRRRRLLPLEAMETPEFL---QLQNEISS 365
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-54
Identities = 62/225 (27%), Positives = 87/225 (38%), Gaps = 19/225 (8%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G Y I + IG G V + + AIK +N EI L L+
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 82 P--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
I+ + + IY+V E DL+ +K + P + + +L +
Sbjct: 67 HSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
IH + H DLKP N L D LK+ DFG+A DT T++ V T Y PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT-TSVVKDSQVGTVNYMPPE 179
Query: 200 L---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
G SK +P D+WS+GCI + GK F
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 13/73 (17%), Positives = 25/73 (34%), Gaps = 3/73 (4%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 371
+ I F +L+ L +PK R + E LA PY + + +
Sbjct: 234 IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290
Query: 372 PVTKMEFEFERRR 384
+M++ +
Sbjct: 291 TTEEMKYVLGQLV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-53
Identities = 65/245 (26%), Positives = 95/245 (38%), Gaps = 21/245 (8%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
D K SS+ + + +G Y I + IG G V + + AIK +N
Sbjct: 37 TDDDDKASSSANECISV--KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA 93
Query: 62 HVSDATRILREIKLLRLLRHP--DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKA 119
EI L L+ I+ + + + IY+V E DL+ +K
Sbjct: 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKK 148
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
+ P + + +L + IH + H DLKP N L D LK+ DFG+A D
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207
Query: 180 TPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
T T++ V Y PE G SK +P D+WS+GCI + GK
Sbjct: 208 T-TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
Query: 231 FPGKN 235
F
Sbjct: 267 FQQII 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 13/73 (17%), Positives = 25/73 (34%), Gaps = 3/73 (4%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 371
+ I F +L+ L +PK R + E LA PY + + +
Sbjct: 281 IDPNHEIEFP---DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337
Query: 372 PVTKMEFEFERRR 384
+M++ +
Sbjct: 338 TTEEMKYVLGQLV 350
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-53
Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 18/241 (7%)
Query: 1 MQPDQRKKSSADVDFFTEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI 59
M S D+ Y + +Y + IG+GS+G T G + IK+IN
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-- 58
Query: 60 FEHVSDATR--ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV 116
+S R RE+ +L ++HP+IV+ + S E +Y+V + E DL +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKR 113
Query: 117 IK-ANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174
I L E + Q+ LK++H + HRD+K +NI D +++ DFG+AR
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
V + A + T +Y +PE+C + Y DIW++GC+ EL T K F
Sbjct: 174 VLNSTVELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAG 228
Query: 235 N 235
+
Sbjct: 229 S 229
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 6e-53
Identities = 62/355 (17%), Positives = 115/355 (32%), Gaps = 66/355 (18%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + +++G+G+ V +TG+ AIK N+I + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 139
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF----VSLYGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
P++ KY +D+WSIG F TG F +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE------- 234
Query: 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYL 309
++ II G I Q +
Sbjct: 235 ----------VMYKIITGKPSG----------------------AISGVQKAENGPIDWS 262
Query: 310 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364
M + L +L +L + + ++ A+
Sbjct: 263 GDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN 312
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 8e-52
Identities = 72/402 (17%), Positives = 136/402 (33%), Gaps = 69/402 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + +++G+G+ V +TG+ AIK N+I + +RE ++L+ L H +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN---DDLTPEHYQFFLYQLLRGL 139
IV++ I + R ++ E L+ V++ L + L ++ G+
Sbjct: 69 IVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 140 KYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++ + HR++KP NI+ + K+ DFG AR +D + T Y
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEY 181
Query: 196 RAPEL------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
P++ KY +D+WSIG F TG F +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE------- 234
Query: 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYL 309
++ II G I Q +
Sbjct: 235 ----------VMYKIITGKPSG----------------------AISGVQKAENGPIDWS 262
Query: 310 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPS 369
M + L +L +L + + ++ A+ V S
Sbjct: 263 GDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFS 317
Query: 370 AQPVTKMEFEFERRRITKEDVRELIYRE--ILEYHPQMLKEF 409
Q +T + T EL+Y++ I+ + +++ E
Sbjct: 318 LQQMTAHKIYIHSYN-TATIFHELVYKQTKIISSNQELIYEG 358
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-51
Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 18/240 (7%)
Query: 3 PDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
P + + + Y + ++IE+ IG+G + V A G VA+KK+ IF+
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ-IFDL 70
Query: 63 VSDATR--ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA 119
+ R ++EI LL+ L HP++++ S E ++ +V EL ++ DL ++IK
Sbjct: 71 MDAKARADCIKEIDLLKQLNHPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKH 125
Query: 120 ---NDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175
L PE + QL L+++H+ V HRD+KP N+ A +K+ D GL R
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+ T A V T +Y +PE + Y DIWS+GC+ E+ + F G
Sbjct: 186 FSSKTTAA---HSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-51
Identities = 70/228 (30%), Positives = 110/228 (48%), Gaps = 21/228 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
Y + + +G G+ G V A++ +T +KVAI+ I+ A + EI++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 136
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-51
Identities = 62/234 (26%), Positives = 94/234 (40%), Gaps = 27/234 (11%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G +K E+IG G +G V A G+ IK++ + + RE+K L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVEIKH-----------ILLPPSRREFKDIYVVFELMES-DLHQVIK-ANDDLTPEHY 128
+IV SR + K +++ E + L Q I+ + +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 129 -QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT 187
Q+ +G+ YIH+ + +RDLKP NI ++KI DFGL ND
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 240
T Y +PE S Y +D++++G I AELL F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-51
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRH 81
Y++ IG GSYG G+ + K+++ + +++A + ++ E+ LLR L+H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKH 64
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA---NDDLTPEHY-QFFLYQLL 136
P+IV ++ R +Y+V E E DL VI E + + QL
Sbjct: 65 PNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 137 RGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
LK H + V HRDLKP N+ + +K+ DFGLAR+ +DT A +V
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KTFVG 178
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T +Y +PE Y DIWS+GC+ EL P F +
Sbjct: 179 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFS 220
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-50
Identities = 59/246 (23%), Positives = 93/246 (37%), Gaps = 17/246 (6%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRH 81
++ +G GSYG V G A+K+ F D R L E+ ++ +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
P V ++ + E +Y+ EL L Q +A PE +L L L
Sbjct: 117 PCCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H+ + H D+KP NI + K+ DFGL + Y APEL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL 227
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL---DIMTDLLGTPSPEAIAR 257
Y A D++S+G E+ L G QL + + S E +
Sbjct: 228 LQ---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSV 284
Query: 258 VCLLLN 263
+ ++L
Sbjct: 285 LVMMLE 290
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 25/240 (10%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ + +G+G +GVV A + AIK+I + +++RE+K L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIVEIKH-------ILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF---F 131
IV + +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------- 183
Q+ ++++H+ + HRDLKP NI D +K+ DFGL D
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 184 -IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242
T V T+ Y +PE + Y+ +DI+S+G I ELL P V L
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 12/60 (20%), Positives = 24/60 (40%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 371
+ + + F F P +++ ML+ P +RP A + + F+ L + Q
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-50
Identities = 71/228 (31%), Positives = 110/228 (48%), Gaps = 21/228 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
Y + + +G G+ G V A++ +T +KVAIK I+ A + EI++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLL 136
L HP I++IK+ + +D Y+V ELME +L + N L + + YQ+L
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
++Y+H + HRDLKP+N+L DC +KI DFG +++ + T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Y APE L + Y A+D WS+G I L+G P F L
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-50
Identities = 62/237 (26%), Positives = 97/237 (40%), Gaps = 27/237 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S ++ V+G+G++G V A + AIKKI + IL E+ LL L H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQ 62
Query: 83 DIVEIKH--------ILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPE-HYQFFL 132
+V + + ++ +++ E E L+ +I + + Y
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW------ 186
Q+L L YIH+ + HRDLKP NI + +KI DFGLA+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 187 -----TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH 238
T + T Y A E+ Y ID++S+G IF E++ P G V+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 10/53 (18%), Positives = 20/53 (37%), Gaps = 1/53 (1%)
Query: 314 KKKPIPFSQKFP-NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 365
+ I F F N + +++ ++ +P RP A L + + E
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-48
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 15/226 (6%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
Y + +G+G + V G A+K+I D RE + RL H
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNH 85
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLL 136
P+I+ + L + + +++ + L I+ + LT + + L +
Sbjct: 86 PNILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA------IFWTDYV 190
RGL+ IH HRDLKP NIL + + + D G A + W
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 191 ATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-47
Identities = 65/226 (28%), Positives = 95/226 (42%), Gaps = 30/226 (13%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR 80
RY +GKG + D T E A K + + ++ EI + R L
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
H +V ++VV EL L ++ K LT +++L Q++ G
Sbjct: 74 HQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------TPTAIFWTDYV 190
+Y+H V HRDLK N+ N D ++KI DFGLA D TP +Y+
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI 182
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
APE+ ++ +D+WSIGCI LL GKP F +
Sbjct: 183 ------APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 66/246 (26%), Positives = 99/246 (40%), Gaps = 30/246 (12%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIF 60
P + + + RY +GKG + D T E A K + +
Sbjct: 20 APAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL 79
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKA 119
++ EI + R L H +V ++VV EL L ++ K
Sbjct: 80 LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKR 134
Query: 120 NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
LT +++L Q++ G +Y+H V HRDLK N+ N D ++KI DFGLA D
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 180 ---------TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
TP +Y+ APE+ ++ +D+WSIGCI LL GKP
Sbjct: 195 GERKKVLCGTP------NYI------APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 231 FPGKNV 236
F +
Sbjct: 241 FETSCL 246
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 17/247 (6%)
Query: 2 QPDQRKKSSADVDFFTEYGEGS---RY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
Q ++ ++ + T+ S R+ K + IG+GS+ V DT T +VA ++
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 58 DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQV 116
D S+ R E ++L+ L+HP+IV + + K I +V ELM S L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTY 119
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLA 173
+K + + + + Q+L+GL+++HT + HRDLK NI +KI D GLA
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ A+ T + APE+ KY ++D+++ G E+ T + +
Sbjct: 180 TLKRASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSE 231
Query: 234 KNVVHQL 240
Q+
Sbjct: 232 CQNAAQI 238
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-46
Identities = 65/260 (25%), Positives = 102/260 (39%), Gaps = 52/260 (20%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
+Y ++ IG+GSYGVV A + +T AIK +N + D RI E++L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQF-------- 130
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQLLRGLKYIHTANVFHRDLKPKNIL 158
+ Q+ L Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N ++K+ DFGL++ + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAELLTGKPLFPGKN 235
S G + LL G FPG N
Sbjct: 261 SAGVLLHLLLMGAVPFPGVN 280
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-46
Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y+ + +G G+YG V D T + AIK I S +++L E+ +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+++ F+D Y+V E + +L I + Q+L G
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y+H N+ HRDLKP+N+L D +KI DFGL+ V F + + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQKK---MKERLGTAYY 204
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
APE+ KY D+WSIG I LL G P F G+
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQT 241
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-45
Identities = 81/239 (33%), Positives = 114/239 (47%), Gaps = 24/239 (10%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + RY I ++GKGS+G V D T ++ A+K IN
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKAN 120
D + ILRE++LL+ L HP+I+++ I +D Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAF 177
+ + Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ F
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-F 174
Query: 178 NDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
D + T +Y APE L G Y D+WS G I LL+G P F GKN
Sbjct: 175 QQNTK---MKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN 226
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 14/61 (22%), Positives = 24/61 (39%), Gaps = 1/61 (1%)
Query: 314 KKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQP 372
+ F ++ + A L+ +ML F P R TA + L P+ + + S P
Sbjct: 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLP 294
Query: 373 V 373
Sbjct: 295 S 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 4e-45
Identities = 72/221 (32%), Positives = 112/221 (50%), Gaps = 23/221 (10%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
RYK + V+GKGS+G V D TG++ A+K I+ + +D +LRE++LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLR 137
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 138 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
G+ Y+H + HRDLKP+N+L + D ++I DFGL+ F + D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-FEASKK---MKDKIGTAY 193
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y APE+ Y D+WS G I LL+G P F G N
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGAN 231
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 12/59 (20%), Positives = 24/59 (40%), Gaps = 1/59 (1%)
Query: 314 KKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 371
+K F ++ + A L+ +ML + P R +A +AL + + K +
Sbjct: 240 EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-45
Identities = 68/218 (31%), Positives = 95/218 (43%), Gaps = 20/218 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y +E IG+GS+G V A T + A KKI V D R +EI++++ L HP
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHP 66
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ + + DIY+V EL +L + + + +L + Y
Sbjct: 67 NIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 142 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
H NV HRDLKP+N L + D LK+ DFGLA V T +Y +P
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+ L G Y P D WS G + LL G P F
Sbjct: 178 QVLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-44
Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 15/229 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++++E +G G +G V TGE+VAIK+ + R EI++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKHILLPPSRREFKD-IYVVFELMES-DLHQVIKANDD---LTPEHYQFFLYQLLRG 138
+V + + + D + E E DL + + ++ L + L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ KI D G A+ T++V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244
APEL KYT +D WS G + E +TG F Q
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 60/240 (25%), Positives = 113/240 (47%), Gaps = 33/240 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------------------------DI 59
+Y +++ IGKGSYGVV AY+ A+K ++
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 60 FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIK 118
+ ++ +EI +L+ L HP++V++ +L P+ +Y+VFEL+ + +V
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPT 130
Query: 119 ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
L+ + +F+ L++G++Y+H + HRD+KP N+L D +KI DFG++
Sbjct: 131 -LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NEF 187
Query: 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVV 237
A+ V T + APE ++ A+D+W++G + G+ F + ++
Sbjct: 188 KGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-44
Identities = 81/236 (34%), Positives = 115/236 (48%), Gaps = 18/236 (7%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + RY I ++GKGS+G V D T ++ A+K IN
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDL 123
D + ILRE++LL+ L HP+I+++ IL + Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 124 TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDT 180
+ + Q+ G+ Y+H N+ HRDLKP+NIL DC +KI DFGL+ +T
Sbjct: 119 SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 181 PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
D + T +Y APE L G Y D+WS G I LL+G P F GKN
Sbjct: 179 ----KMKDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKN 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-44
Identities = 71/232 (30%), Positives = 100/232 (43%), Gaps = 35/232 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-----------DIFEHVSDATRILR 71
Y +G G+YG V + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 72 EIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEH 127
EI LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAI 184
+ Q+L G+ Y+H N+ HRD+KP+NIL N+ +KI DFGL+ F+
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKDYK-- 204
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
D + T +Y APE L KY D+WS G I LL G P F G+N
Sbjct: 205 -LRDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQN 251
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 1/59 (1%)
Query: 314 KKKPIPF-SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 371
+K F + N + A L++ ML ++ R TAEEAL + K A + +
Sbjct: 260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 9e-44
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 17/218 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y ++E +GKG++ VV TG + A K IN D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV + + +E Y+VF+L+ +L + I A + + + Q+L + Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 142 IHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGYLSP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
E L Y+ +DIW+ G I LL G P F ++
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 45/245 (18%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLR 80
+ E+++G GS G V + G VA+K++ + L EIKLL
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML-----IDFCDIALMEIKLLTESDD 67
Query: 81 HPDIVEIKHILLPPSRREFKD---IYVVFELMESDLHQVIKANDDLTPEHYQF------- 130
HP+++ +Y+ EL +L ++++ +
Sbjct: 68 HPNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNIL-------------ANADCKLKICDFGLAR-VA 176
L Q+ G+ ++H+ + HRDLKP+NIL + ++ I DFGL + +
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 177 FNDTPTAIFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 231 FPGKN 235
F K
Sbjct: 240 FGDKY 244
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 16/69 (23%), Positives = 27/69 (39%), Gaps = 3/69 (4%)
Query: 325 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRR 384
+ A L+ +M+ +P RPTA + L P F +K + V+ E E R
Sbjct: 266 RSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRD 322
Query: 385 ITKEDVREL 393
+ +
Sbjct: 323 PPSALLMKF 331
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 23/221 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
+K+ ++GKGS+ V A TG +VAIK I+ R+ E+K+ L+HP
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
I+E+ + + +Y+V E+ + ++++ +K + + F++Q++ G+
Sbjct: 72 SILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATRWY 195
Y+H+ + HRDL N+L + +KI DFGLA P +T +Y+
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYTLCGTPNYI----- 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
+PE+ S + D+WS+GC+F LL G+P F V
Sbjct: 180 -SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 22/226 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-------DIFEHVSDATRILREIKL 75
Y+ +E++G+G VV T ++ A+K I+ E L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
Y APE + S Y +D+WS G I LL G P F +
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-43
Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRH 81
+Y + +++G+GSYG V D+ T + A+K + + + + +EI+LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHYQFFLYQLLRGL 139
+++++ +L + + +Y+V E + +++ + QL+ GL
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATRW 194
+Y+H+ + H+D+KP N+L LKI G+A T +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ---- 178
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNV 236
PE+ + ++ +DIWS G + TG F G N+
Sbjct: 179 --PPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 65/241 (26%), Positives = 107/241 (44%), Gaps = 25/241 (10%)
Query: 5 QRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS 64
SS + + + + + +G G++G V + +G + IK IN
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN-KDRSQV 62
Query: 65 DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDL 123
+I EI++L+ L HP+I++I + ++ ++Y+V E E +L + I +
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQA- 116
Query: 124 TPEHY-----QFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV 175
+ + Q++ L Y H+ +V H+DLKP+NIL + +KI DFGLA +
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 176 AFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234
+D T+ T Y APE T DIWS G + LLTG F G
Sbjct: 177 FKSDE----HSTNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 235 N 235
+
Sbjct: 229 S 229
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 51/235 (21%), Positives = 91/235 (38%), Gaps = 23/235 (9%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR- 80
R ++ V+ +G + V A D +G + A+K++ I++E+ ++ L
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSG 84
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME---SDLHQVI---KANDDLTPEHYQFFLYQ 134
HP+IV+ L E L + + ++ L+ + YQ
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 135 LLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA- 191
R ++++H + HRDLK +N+L + +K+CDFG A + +
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 192 --------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
T YR PE+ +S DIW++GCI L + F
Sbjct: 205 EEEITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 23/220 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G+GS+G V A +T +KVA+K I+ + + R+ REI L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+++ ++ P DI +V E +L I +T + + F Q++ ++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-----YRA 197
H + HRDLKP+N+L + + +KI DFGL+ I Y A
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLS---------NIMTDGNFLKTSCGSPNYAA 175
Query: 198 PELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNV 236
PE+ Y P +D+WS G + +L G+ F + +
Sbjct: 176 PEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-42
Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
++I +GKG +G V A + ++ +A+K + E ++ RE+++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND-------TPTAIFWTDYVATR 193
Y H+ V HRD+KP+N+L + +LKI DFG + A + T DY+
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL------DYL--- 174
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
PE+ + +D+WS+G + E L GKP F
Sbjct: 175 ---PPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-42
Identities = 50/243 (20%), Positives = 82/243 (33%), Gaps = 38/243 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRH 81
+ + E IG G +G V G AIK+ D LRE+ L +H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLT---PEHY-QFFLYQLL 136
+V + E + + E L I N + E + L Q+
Sbjct: 71 SHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 137 RGLKYIHTANVFHRDLKPKNIL-------------------ANADCKLKICDFGLARVAF 177
RGL+YIH+ ++ H D+KP NI A+ KI D G
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-I 184
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
+ + A E+ ++ + P DI+++ +PL +
Sbjct: 185 SSPQV------EEGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQW 237
Query: 238 HQL 240
H++
Sbjct: 238 HEI 240
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-42
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 26/225 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y++ E +G G + +V TG++ A K I I RE+ +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+RHP+I+ + I F++ + ++ EL+ +L + + LT + FL Q
Sbjct: 65 IRHPNIITLHDI--------FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ 116
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+H+ + H DLKP+NI+ + ++K+ DFG+A + +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE----FKNIF 172
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T + APE+ + D+WSIG I LL+G F G+
Sbjct: 173 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGET 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ EV+G G++ V TG+ A+K I + + EI +L+ ++H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK--SPAFRDSSLENEIAVLKKIKHE 66
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV ++ I ++ Y+V +L+ +L I T + + Q+L
Sbjct: 67 NIVTLEDI--------YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+KY+H + HRDLKP+N+L + K+ I DFGL+++ N + T Y
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGY 173
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
APE L Y+ A+D WSIG I LL G P F +
Sbjct: 174 VAPEVLAQ---KPYSKAVDCWSIGVITYILLCGYPPFYEET 211
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-42
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLL 76
+Y ++VIG+G VV TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFF 131
R + HP I+ + ++ +++VF+LM +L + L+ + +
Sbjct: 154 RQVAGHPHIITLIDS--------YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI 205
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
+ LL + ++H N+ HRDLKP+NIL + + ++++ DFG + +
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH-LEPGE---KLRELCG 261
Query: 192 TRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T Y APE L S Y +D+W+ G I LL G P F +
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y ++E +GKG++ VV TG + A K IN D ++ RE ++ R L+HP
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV + ++ Y+VF+L+ +L + I A + + + Q+L
Sbjct: 89 NIVRLHDS--------IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y H+ + HR+LKP+N+L +K+ DFGLA ND+ W + T Y
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSE---AWHGFAGTPGY 196
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+PE L Y+ +DIW+ G I LL G P F ++
Sbjct: 197 LSPEVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDED 234
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-42
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K +N + +I REI+ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+++ ++ P+ D ++V E + +L I + + + Q+L + Y
Sbjct: 72 HIIKLYQVISTPT-----DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND--------TPTAIFWTDYVATR 193
H V HRDLKP+N+L +A KI DFGL+ + + +P
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----------- 175
Query: 194 WYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNV 236
Y APE+ Y P +DIWS G I LL G F ++V
Sbjct: 176 -YAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-42
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 18 EYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
EY E + +G+GS+G V D +TG + A+KK+ E E+
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVAC 104
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 134
L P IV + + RE + + EL+E S L Q+IK L + ++L Q
Sbjct: 105 AGLSSPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQ 158
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV--AFNDTPTAIFWTDYVA 191
L GL+Y+HT + H D+K N+L ++D + +CDFG A + +
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
T + APE+ +DIWS C+ +L G
Sbjct: 219 TETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K I D+ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAELLTG 227
++ +D+WS G + +L G
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAG 204
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 62/217 (28%), Positives = 111/217 (51%), Gaps = 17/217 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y++ + IGKG++ V A TG +VAIK I+ + + ++ RE++++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ ++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +AD +KI DFG + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNV 236
F KY P +D+WS+G I L++G F G+N+
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-41
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 22/221 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y++ E +GKG++ VV G++ A IN D ++ RE ++ RLL+HP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+IV + + Y++F+L+ +L + I A + + + Q+L
Sbjct: 71 NIVRLHDS--------ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + H V HR+LKP+N+L +K+ DFGLA + W + T Y
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGY 179
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+PE L Y +D+W+ G I LL G P F ++
Sbjct: 180 LSPEVLRK---DPYGKPVDLWACGVILYILLVGYPPFWDED 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 75/355 (21%), Positives = 124/355 (34%), Gaps = 43/355 (12%)
Query: 23 SRYKIEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
Y++ VIGKG V A TGE V +++IN T + E+ + +L
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKA--NDDLTPEHYQFFLYQLL 136
HP+IV + + + +++VV M S +I D + + L +L
Sbjct: 85 HPNIVPYRATFIADN-----ELWVVTSFMAYGS-AKDLICTHFMDGMNELAIAYILQGVL 138
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDYVAT 192
+ L YIH HR +K +IL + D K+ + + F V
Sbjct: 139 KALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252
+ +PE+ Y DI+S+G EL G P K+ + ++ + L P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV--PFKD-MPATQMLLEKLNGTVP 255
Query: 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312
LL+ S P+ L + + + S
Sbjct: 256 C-------LLD----------TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298
Query: 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVERE 367
FS F + +E+ L P RP+A L +FK + + E
Sbjct: 299 SHPYHRTFSPHFHH-------FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-41
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y E +G G + VV + TG + A K I I RE+ +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+H+ + H DLKP+NI+ ++KI DFGLA + +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIF 178
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T + APE+ + D+WSIG I LL+G F G
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K I D+ V I +EI + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E +L I+ + + Q F +QL+ G+ Y+
Sbjct: 67 VVKFYGHRREGN-----IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 203 SFFS--KYT-PAIDIWSIGCIFAELLTG 227
++ +D+WS G + +L G
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
+ I +GKG +G V A + + +A+K + E ++ REI++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + + R IY++ E +L++ ++ + + F+ +L L
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATRWY 195
Y H V HRD+KP+N+L +LKI DFG + P+ T DY+
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRTMCGTLDYL----- 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
PE+ + +D+W G + E L G P F +
Sbjct: 180 -PPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+ HP+I+ + + +++ + ++ EL+ +L + + L+ E F+ Q
Sbjct: 72 VLHPNIITLHDV--------YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIF 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T + APE+ + D+WSIG I LL+G F G
Sbjct: 180 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT 222
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 26/225 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
Y I E +G G + +V + TG + A K I I RE+ +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
+ H +++ + + +++ + ++ EL+ +L + + L+ E F+ Q
Sbjct: 72 VLHHNVITLHDV--------YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 135 LLRGLKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
+L G+ Y+HT + H DLKP+NI+ +K+ DFGLA + + +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE----FKNIF 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T + APE+ + D+WSIG I LL+G F G
Sbjct: 180 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDT 222
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---DIFEHVSDATRILREIKLLRLL 79
Y++ EVIGKG + VV + TG++ A+K ++ + RE + +L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 80 RHPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVI----KANDDLTPEHYQFF 131
+HP IVE+ + +Y+VFE M+ +DL I A + +
Sbjct: 84 KHPHIVELLET--------YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 188
+ Q+L L+Y H N+ HRD+KP +L +K+ FG+A
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---AGG 192
Query: 189 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
V T + APE + Y +D+W G I LL+G F G
Sbjct: 193 RVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYGTK 237
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 26/221 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY + IG G++GV D T E VA+K I + + REI R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPN 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV K ++L P+ + ++ E +L++ I + + +FF QLL G+ Y
Sbjct: 78 IVRFKEVILTPT-----HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 143 HTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTP--TAIFWTDYVATRWYRAP 198
H+ + HRDLK +N L + +LKICDFG ++ + + + V T Y AP
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 186
Query: 199 ELCGSFFS--KYT-PAIDIWSIGCIFAELLTGKPLFPGKNV 236
E+ +Y D+WS G +L G F
Sbjct: 187 EV----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 71/229 (31%), Positives = 101/229 (44%), Gaps = 19/229 (8%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
E V+GKG+YG+V + D ++AIK+I + + EI L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLK 77
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLL 136
H +IV+ S E I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRW 194
GLKY+H + HRD+K N+L N LKI DFG + R+A + T F T
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF----TGTLQ 188
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
Y APE+ Y A DIWS+GC E+ TGKP P + M
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP--PFYELGEPQAAM 235
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 27/242 (11%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
++ + +Y ++V+G G G V + RTG+K A+K + D
Sbjct: 12 LEVLFQGPEPKKYAVTDDYQLS-----KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-- 64
Query: 61 EHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI- 117
+ + +E+ + P IV I + + + + ++ E ME +L I
Sbjct: 65 -----SPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQ 118
Query: 118 -KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLA 173
+ + T + + ++++H+ N+ HRD+KP+N+L D LK+ DFG A
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+ + T +Y APE+ G KY + D+WS+G I LL G P F
Sbjct: 179 KETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYS 231
Query: 234 KN 235
Sbjct: 232 NT 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN------DIFEHVSDATRILREIKLLR 77
+Y +G G++G V +A D ++V +K I D + ++ EI +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 135
+ H +I+++ I +V E S DL I + L + QL
Sbjct: 85 RVEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ + Y+ ++ HRD+K +NI+ D +K+ DFG A +F+T + T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYT-FCGTIEY 195
Query: 196 RAPELCGSFFS--KYT-PAIDIWSIGCIFAELLTG 227
APE+ Y P +++WS+G L+
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-39
Identities = 69/221 (31%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
Y + + +G G++G V TG KVA+K +N + +I REI+ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
I+++ ++ P DI++V E + +L I N L + + Q+L G+ Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW-----YR 196
H V HRDLKP+N+L +A KI DFGL+ + Y
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLS---------NMMSDGEFLRTSCGSPNYA 182
Query: 197 APELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNV 236
APE+ Y P +DIWS G I LL G F +V
Sbjct: 183 APEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 31/245 (12%)
Query: 12 DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILR 71
D F+ Y ++ +G+GS+ + ++ + A+K I+ +
Sbjct: 3 DSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQK 54
Query: 72 EIKLLRLLR-HPDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPE 126
EI L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 55 EITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSET 106
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTA 183
+ + +L+ + ++H V HRDLKP+N+L N + ++KI DFG AR+ D
Sbjct: 107 EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165
Query: 184 IFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242
T Y APE L + Y + D+WS+G I +L+G+ F +
Sbjct: 166 --LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 243 MTDLL 247
+++
Sbjct: 221 AVEIM 225
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 37/267 (13%), Positives = 70/267 (26%), Gaps = 36/267 (13%)
Query: 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------------------ 61
V+G+ A D TGE +
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 62 -----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQV 116
+ A LR I L++ P ++ + L + ++ M+S+L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 117 IKANDDLTPEHYQ-------FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAELLT 226
F A A + + T A D W++G +
Sbjct: 255 FEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 227 GKPLFPGKNVVHQLD-IMTDLLGTPSP 252
+ + I P P
Sbjct: 313 ADLPNTDDAALGGSEWIFRSCKNIPQP 339
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 26/251 (10%)
Query: 24 RYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-H 81
Y++ E+V+G+G++ V + + T ++ A+K I + +R+ RE+++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGH 70
Query: 82 PDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 137
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 138 GLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARV----AFNDTPTAIFWTDYV 190
L ++H + HRDLKP+NIL N +KICDF L +
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 191 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247
+ Y APE+ S Y D+WS+G I LL+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 248 GTPSPEAIARV 258
+
Sbjct: 243 PACQNMLFESI 253
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 43/247 (17%), Positives = 90/247 (36%), Gaps = 47/247 (19%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN---------------DIFEHVSDATR 68
Y+I + +G + + + + A+KK D S
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 69 ILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEH 127
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 128 YQ--------FFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+ +L YIH N+ HRD+KP NIL + + ++K+ DFG +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES----E 200
Query: 179 DTPTAIFWT-----DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
+++ PE + S +DIWS+G + F
Sbjct: 201 YMVDKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 234 KNVVHQL 240
K + +L
Sbjct: 255 KISLVEL 261
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 23/220 (10%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G G++GVV + TG K IN + D + EI ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLR 137
++ + F+D + ++ E + +L I A D E ++ Q
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
GLK++H ++ H D+KP+NI+ +KI DFGLA D AT +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI----VKVTTATAEF 216
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
APE+ D+W+IG + LL+G F G++
Sbjct: 217 AAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 13/67 (19%), Positives = 24/67 (35%)
Query: 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEF 380
F + +P A ++ +L EP+ R T +AL P+ KG +
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQK 330
Query: 381 ERRRITK 387
+ +
Sbjct: 331 IKEKYAD 337
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 27/226 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+++E +G+G+ +V T + A+K + D + EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHP 108
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+++K I F+ I +V EL+ +L I + + Q+L
Sbjct: 109 NIIKLKEI--------FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
+ Y+H + HRDLKP+N+L D LKI DFGL+++ + T Y
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGY 216
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
APE L G Y P +D+WS+G I LL G F + +
Sbjct: 217 CAPEILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 32/255 (12%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
+Y++ ++G G +G V S VAIK + + + + TR+ E+ LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFLYQL 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
L +++ H V HRD+K +NIL + + +LK+ DFG + DT +TD+ TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTV----YTDFDGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP--- 250
Y PE + +Y + +WS+G + +++ G F +I+ +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQVFFRQRV 266
Query: 251 SPEAIA--RVCLLLN 263
S E R CL L
Sbjct: 267 SSECQHLIRWCLALR 281
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 49/221 (22%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y I E +G+G +G+V +T + + K + +D + +EI +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHR 61
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLH-QVIKANDDLTPEHYQFFLYQLLR 137
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+++H+ N+ H D++P+NI+ +KI +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEY 169
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
APE + A D+WS+G + LL+G F +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAET 207
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 30/230 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHP 82
Y+++E IG GSY V T + A+K I+ EI+ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 139 LKYIHTANVFHRDLKPKNIL----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
++Y+H V HRDLKP NIL + ++ICDFG A+ + T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTAN 185
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
+ APE L Y A DIWS+G + +LTG F +I+
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-38
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDL-HQVIKANDDLTPEHYQFFLYQLLR 137
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 138 GLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
GL ++H N H DLKP+NI+ +LK+ DFGL T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEF 322
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
APE+ D+WS+G + LL+G F G+N
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN 360
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 7e-38
Identities = 42/279 (15%), Positives = 83/279 (29%), Gaps = 48/279 (17%)
Query: 15 FFTEYGEGSR-YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK------------------- 54
+E GE R V+G+ A D TGE +
Sbjct: 64 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 123
Query: 55 ----KINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME 110
++ ++ A LR I L++ P ++ + L + ++ M+
Sbjct: 124 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 183
Query: 111 SDLHQVIKANDDLTPEHYQF-------FLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163
S+L + + H Q++R L +H + H L+P +I+ +
Sbjct: 184 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243
Query: 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDI 214
+ + F + +R + PEL + T + D
Sbjct: 244 GVFLTGFEHLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 215 WSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSP 252
W++G + + + + I P P
Sbjct: 297 WALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP 335
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 9/33 (27%), Positives = 15/33 (45%)
Query: 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
LLE L + +DR +A+ P ++ L
Sbjct: 334 QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 24/217 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
+ Y++ ++GKG +G V + + +VAIK I + +SD+ E+ LL
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 79 LR----HPDIVEIKHILLPPSRREFKDIYVVFELMES--DLHQVIKANDDLTPEHYQFFL 132
+ HP ++ + + +V E DL I L + F
Sbjct: 91 VGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVA 191
Q++ +++ H+ V HRD+K +NIL + K+ DFG + +D P +TD+
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEP----YTDFDG 200
Query: 192 TRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAELLTG 227
TR Y PE +Y +WS+G + +++ G
Sbjct: 201 TRVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCG 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 31/227 (13%)
Query: 23 SRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ Y + + +G+G + VV TG++ A K + IL EI +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHY-----QFF 131
P ++ + + +++ I ++ E ++ + E
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRL 136
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTD 188
+ Q+L G+ Y+H N+ H DLKP+NIL +KI DFG++R + +
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE----LRE 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+ T Y APE+ + T A D+W+IG I LLT F G++
Sbjct: 193 IMGTPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGED 237
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 36/248 (14%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M D +S ++D +++ E++G G+YG V +TG+ AIK ++
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 61 EHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFKD-IYVVFELME----SDLH 114
+ + I +EI +L+ H +I + + D +++V E +DL
Sbjct: 62 DEEEE---IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 115 QVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA- 173
+ K N L E + ++LRGL ++H V HRD+K +N+L + ++K+ DFG++
Sbjct: 119 KNTKGNT-LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 174 --------RVAFNDTPTAIFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCIFA 222
R F TP +W APE C + Y D+WS+G I A
Sbjct: 178 QLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-ITA 224
Query: 223 -ELLTGKP 229
E+ G P
Sbjct: 225 IEMAEGAP 232
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI-----NDIFEHVSDATRILREIKLLRLLR 80
+ E+ IGKG +G+V + VAIK + E + RE+ ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVI-KANDDLTPEHYQFFLYQLLRG 138
HP+IV++ ++ P +V E + DL+ + + + + G
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYIHTAN--VFHRDLKPKNIL-----ANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
++Y+ N + HRDL+ NI NA K+ DFGL++ + + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGLLGN---- 189
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+W APE G+ YT D +S I +LTG+ F +
Sbjct: 190 FQW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 38/235 (16%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREI 73
+Y +V+G G G V ++ RT EK A+K + D + RE+
Sbjct: 58 AIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREV 105
Query: 74 KLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFF 131
+L R + P IV I + K + +V E ++ +L I+ D Q F
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGD------QAF 158
Query: 132 --------LYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDT 180
+ + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ +
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
T T +Y APE+ G KY + D+WS+G I LL G P F +
Sbjct: 219 S----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 15/74 (20%), Positives = 26/74 (35%)
Query: 334 LLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVREL 393
L+ +L EP R T E + P+ KV + P E + + +E L
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 360
Query: 394 IYREILEYHPQMLK 407
+ ++ K
Sbjct: 361 ATMRVDYEQIKIKK 374
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 66/241 (27%), Positives = 104/241 (43%), Gaps = 30/241 (12%)
Query: 1 MQPDQRKKSSADVDFFTEYGEG---SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN 57
M R S D D + + + IG GS+G V A D R E VAIKK++
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 58 -DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQV 116
+ I++E++ L+ LRHP+ ++ + L ++V E +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TAWLVMEYCLGSASDL 143
Query: 117 IKANDDLTPEHY-QFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-- 173
++ + E + L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 174 ---RVAFNDTPTAIFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-ELLTGK 228
+F TP +W APE+ +Y +D+WS+G I EL K
Sbjct: 204 MAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERK 250
Query: 229 P 229
P
Sbjct: 251 P 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 7e-37
Identities = 34/238 (14%), Positives = 73/238 (30%), Gaps = 36/238 (15%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
+ ++G+G++ V A D + +K +K + + + ++ L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMERL 121
Query: 77 RLLRHPDIVEIKHILLPPSRREFKD-IYVVFELME-SDLHQVIK-----ANDDLTPEHYQ 129
+ ++ F++ +V EL L I +
Sbjct: 122 KPSMQHMFMKFYSAH------LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNIL-----------ANADCKLKICDFGLARVAFN 178
F ++L ++ +H + H D+KP N + + L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 179 DTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
IF T ++ E L + ID + + +L G +
Sbjct: 236 FPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 22/221 (9%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
EV+GKG +G TGE + +K++ E L+E+K++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT--FLKEVKVMRCLEHPNVL 70
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+ + ++ K + + E ++ L +IK+ D F + G+ Y+H
Sbjct: 71 K----FIGVLYKD-KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT-----------PTAIFWTDYVAT 192
+ N+ HRDL N L + + + DFGLAR+ ++ P V
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
++ APE+ Y +D++S G + E++ P
Sbjct: 186 PYWMAPEMIN--GRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 59/245 (24%), Positives = 104/245 (42%), Gaps = 22/245 (8%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ + IG GS+G V + VA+K +N E+ +LR RH +I+
Sbjct: 27 TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
P + +V + E S L+ + A++ + Q RG+ Y+H
Sbjct: 84 LFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
++ HRDLK NI + D +KI DFGLA + + + + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-------VVHQLDIMTDLLGTPS--PE 253
+ Y+ D+++ G + EL+TG+ + N +V + + DL S P+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK 256
Query: 254 AIARV 258
+ R+
Sbjct: 257 RMKRL 261
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++EEV+G+G++GVVC A + VAIK+I S+ + E++ L + HP+IV
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIV 64
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVI---KANDDLTPEHYQFFLYQLLRGLKY 141
++ L P + +V E E L+ V+ + T H + Q +G+ Y
Sbjct: 65 KLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 142 IHTAN---VFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
+H+ + HRDLKP N+L A LKICDFG A T+ + + A
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TNNKGSAAWMA 171
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
PE+ S Y+ D++S G I E++T + F
Sbjct: 172 PEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIG 207
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
I+E IG GS+G V A + G VA+K + + H LRE+ +++ LRHP+I
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 85 VE-IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGL 139
V + + PP ++ +V E + L++++ + L Y + +G+
Sbjct: 97 VLFMGAVTQPP------NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 140 KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
Y+H N + HR+LK N+L + +K+CDFGL+R+ + ++ T + A
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMA 207
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
PE+ D++S G I EL T + + N
Sbjct: 208 PEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLN 243
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 23 SRYKIE--EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
S Y + E++G G +G V +T TG K+A K I + D + EI ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKHILLPPSRREF---KDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQL 135
H +++++ F DI +V E ++ +L I E F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 136 LRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
G++++H + H DLKP+NIL ++KI DFGLAR T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----LKVNFGTP 252
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
+ APE + F + D+WS+G I LL+G F G N
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGDN 292
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-36
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+IV S +++VV E + L V+ + + L+ L++
Sbjct: 78 NIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEF 131
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H+ V HRD+K NIL D +K+ DFG TP + V T ++ APE+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFG---FCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 202 GSFFSKYTPAIDIWSIGCIFA-ELLTGKP 229
Y P +DIWS+G I A E++ G+P
Sbjct: 189 TR--KAYGPKVDIWSLG-IMAIEMIEGEP 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 79/366 (21%), Positives = 137/366 (37%), Gaps = 48/366 (13%)
Query: 5 QRKKSSADVDFFTEYGEGSR--YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH 62
QRK+ A + + GE ++ +G G+ GVV +G +A K I +
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIK 71
Query: 63 VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKAND 121
+ +I+RE+++L P IV +I + E M+ L QV+K
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAG 126
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
+ + +++GL Y+ + HRD+KP NIL N+ ++K+CDFG++ D+
Sbjct: 127 RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS 185
Query: 181 PTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239
F V TR Y +PE L G + Y+ DIWS+G E+ G+ P +
Sbjct: 186 MANSF----VGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238
Query: 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQ 299
+ + + E R + +A L
Sbjct: 239 ELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI---------------FELLDY 283
Query: 300 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ NE + FS +F + + + L P +R ++ + + K
Sbjct: 284 IVNEPPPK-------LPSGVFSLEFQD-------FVNKCLIKNPAERADLKQLMVHAFIK 329
Query: 360 GLAKVE 365
E
Sbjct: 330 RSDAEE 335
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-36
Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 22/222 (9%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+I E+IGKG +G V GE VAI+ I+ ++ RE+ R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 86 E-IKHILLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYI 142
+ + PP + ++ L + L+ V+ A L + ++++G+ Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR--APEL 200
H + H+DLK KN+ + + K+ I DFGL ++ + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 201 -------CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
++ D++++G I+ EL + F +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-36
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLRHPD 83
+EE+IG G +G V A G++VA+K + T + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ ++ + L + +V E L++V+ + P+ + Q+ RG+ Y+
Sbjct: 68 IIALRGVCLKEPN-----LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYL 121
Query: 143 HTAN---VFHRDLKPKNIL--------ANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
H + HRDLK NIL ++ LKI DFGLAR T +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA---- 177
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
W APE+ + S ++ D+WS G + ELLTG+ F G +
Sbjct: 178 YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID 218
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-36
Identities = 86/402 (21%), Positives = 139/402 (34%), Gaps = 107/402 (26%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
RY + +G G + V ++D + + VA+ K+ EH ++ EI+LL+ +R+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAM-KVVKSAEHYTETAL--DEIRLLKSVRNS 93
Query: 83 DIVEIKHILLPPSRREFKD-------IYVVFELMESDLHQVIKANDD--LTPEHYQFFLY 133
D + ++ +FK I +VFE++ L + I ++ L + +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 134 QLLRGLKYIHT-ANVFHRDLKPKNILANAD------------------------------ 162
Q+L+GL Y+HT + H D+KP+NIL + +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 163 -------------------CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
K+KI D G A +T+ + TR YR+ E+
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL-- 265
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI------MTDLLGTPSPEAIAR 257
S Y DIWS C+ EL TG LF + + +LLG + I
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
G FFT+ L + K + +K
Sbjct: 326 -------------GKYSKE------------FFTKKGDL-KHITKLKPWGLFEVLVEKYE 359
Query: 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ L ML P+ R TA E L P+
Sbjct: 360 WSQEEA-----AGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 57/237 (24%), Positives = 105/237 (44%), Gaps = 20/237 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ +G+G+YGVV +G+ +A+K+I + + R+L ++ +R + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
V L D+++ ELM + QVI + + +++ L
Sbjct: 68 TVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 140 KYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+++H+ +V HRD+KP N+L NA ++K+CDFG++ + + + Y AP
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKPYMAP 178
Query: 199 E--LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
E Y+ DIWS+G EL + FP + + ++ PSP+
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQ 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 19/217 (8%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
K IG+G+YG V +G+ +A+K+I + ++L ++ ++R P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM----ESDLHQVIKANDDLTPEHY-QFFLYQLLRG 138
IV+ L D ++ ELM + V DD+ PE ++
Sbjct: 83 IVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 139 LKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L ++ + HRD+KP NIL + +K+CDFG++ + +I T R Y A
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCRPYMA 193
Query: 198 PE--LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232
PE + Y D+WS+G EL TG+ +P
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 16/215 (7%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPD 83
+ +G G+ G V +TG +A+K++ + + RIL ++ +L+ P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPY 85
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 142
IV+ + + D+++ ELM + ++ K PE +++ L Y+
Sbjct: 86 IVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 143 HTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 199
V HRD+KP NIL + ++K+CDFG++ + Y APE
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYMAPERI 196
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
Y D+WS+G EL TG+ +
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 59/242 (24%), Positives = 99/242 (40%), Gaps = 50/242 (20%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
++ + K +A +D + +V+G G G V ++ RT EK A+K + D
Sbjct: 4 VKSGLQIKKNAIIDDY--------KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC- 54
Query: 61 EHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI- 117
+ RE++L R + P IV I + K + +V E ++ +L I
Sbjct: 55 ------PKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQ 107
Query: 118 -KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLA 173
+ + T + + ++Y+H+ N+ HRD+KP+N+L + LK+ DFG
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF- 166
Query: 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233
A E G KY + D+WS+G I LL G P F
Sbjct: 167 -----------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 234 KN 235
+
Sbjct: 201 NH 202
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
IG+GS G+VC A + +G +VA+K ++ + E+ ++R +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHF 102
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
++VE+ S ++++V+ E ++ L ++ L E +L+ L Y
Sbjct: 103 NVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAY 156
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H V HRD+K +IL D ++K+ DFG + V T ++ APE+
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKSLVGTPYWMAPEVI 213
Query: 202 GSFFSKYTPAIDIWSIGCIFA-ELLTGKP 229
S Y +DIWS+G I E++ G+P
Sbjct: 214 SR--SLYATEVDIWSLG-IMVIEMVDGEP 239
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-35
Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 40/243 (16%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF 60
M + + E + E IGKGS+G V D RT + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQNLKADPE-ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLE 58
Query: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQV 116
E + I +EI +L P + + L + ++++ E + DL +
Sbjct: 59 EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWIIMEYLGGGSALDLLE- 112
Query: 117 IKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA--- 173
L L ++L+GL Y+H+ HRD+K N+L + ++K+ DFG+A
Sbjct: 113 ---PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169
Query: 174 ------RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLT 226
R F TP FW APE+ S Y DIWS+G I A EL
Sbjct: 170 TDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLG-ITAIELAR 214
Query: 227 GKP 229
G+P
Sbjct: 215 GEP 217
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++I +G G++G V A + TG A K I + + + EI++L HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPY 77
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
IV++ ++++ E + +++ + LT Q Q+L L
Sbjct: 78 IVKLLGAYYHDG-----KLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEAL 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLA---------RVAFNDTPTAIFWTDYV 190
++H+ + HRDLK N+L + +++ DFG++ R +F TP +W
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP---YWM--- 184
Query: 191 ATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-ELLTGKP 229
APE+ K Y DIWS+G I E+ +P
Sbjct: 185 ------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 71/233 (30%), Positives = 111/233 (47%), Gaps = 23/233 (9%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE 61
P +R+ D D T+ E + + E +G+GSYG V A TG+ VAIK++ +
Sbjct: 9 NPPRRQLKKLDEDSLTKQPE-EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVES 66
Query: 62 HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVI 117
+ + I++EI +++ P +V+ + D+++V E SD+ ++
Sbjct: 67 DLQE---IIKEISIMQQCDSPHVVKYYGSYFKNT-----DLWIVMEYCGAGSVSDIIRLR 118
Query: 118 KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
N LT + L L+GL+Y+H HRD+K NIL N + K+ DFG VA
Sbjct: 119 --NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG---VAG 173
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-ELLTGKP 229
T T + T ++ APE+ Y DIWS+G I A E+ GKP
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLG-ITAIEMAEGKP 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 18/218 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
Y+++EVIG G+ VV +AY EKVAIK+I ++ + + +L+EI+ + HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTP-----EHYQFFLY 133
+IV + ++++V +L+ D+ + I A + L
Sbjct: 74 NIVSYYTSFVVKD-----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVA 191
++L GL+Y+H HRD+K NIL D ++I DFG++ D +V
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
T + APE+ Y DIWS G EL TG
Sbjct: 189 TPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAA 225
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRLLR 80
Y++ ++G+G G V A DT VA+K +++ SD R+ RE + L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE--TLSSDPVFRTRMQREARTAGRLQ 92
Query: 81 HPDIVEIKHILLPPSRREFKDI-YVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
P +V I H E YV L+ DL +++ L P + Q+
Sbjct: 93 EPHVVPI-H-----DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV-ATRWYRA 197
L H A HRD+KP+NIL +AD + DFG+A ++ T T +Y A
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ---LGNTVGTLYYMA 203
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
PE S T DI+++ C+ E LTG P + G +
Sbjct: 204 PERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 34/218 (15%), Positives = 73/218 (33%), Gaps = 23/218 (10%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ + G + + G + +K + + E LR+ HP++
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 85 VEIK-HILLPPSRREFKDIYVVFELMES-DLHQVI--KANDDLTPEHYQFFLYQLLRGLK 140
+ + PP+ ++ M L+ V+ N + F + RG+
Sbjct: 70 LPVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 141 YIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
++HT + L ++++ + D +I + + + W AP
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM---YA----PAWV-AP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
E L + D+WS + EL+T + F +
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 71/228 (31%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRL 78
RYKI + +G G V A DT KVAIK I R RE+
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQ 67
Query: 79 LRHPDIVEIKHILLPPSRREFKDI-------YVVFELME-SDLHQVIKANDDLTPEHYQF 130
L H +IV + D+ Y+V E +E L + I+++ L+ +
Sbjct: 68 LSHQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN 115
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
F Q+L G+K+ H + HRD+KP+NIL +++ LKI DFG+A+ + T T++V
Sbjct: 116 FTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ---TNHV 172
Query: 191 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
T Y +PE DI+SIG + E+L G+P F G+ V
Sbjct: 173 LGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 27/229 (11%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRL 78
RY++ E++G G V A D R VA+K + + D + R RE +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAA 68
Query: 79 LRHPDIVEI--------KHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ 129
L HP IV + LP Y+V E ++ L ++ +TP+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 130 FFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
+ + L + H + HRD+KP NI+ +A +K+ DFG+AR A D+ ++ T
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAA 178
Query: 190 V-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
V T Y +PE D++S+GC+ E+LTG+P F G + V
Sbjct: 179 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 46/255 (18%), Positives = 80/255 (31%), Gaps = 27/255 (10%)
Query: 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86
I + + + + S +I+ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQ---FFLYQLLRGLKYI 142
+Y+ +L +L + L + Q+ ++++
Sbjct: 126 QLQ-----PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFND---------TPTAIFWTDYVATR 193
H+ + HRDLKP NI D +K+ DFGL D P T V T+
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI-----MTDLLG 248
Y +PE + Y+ +DI+S+G I ELL V + L
Sbjct: 241 LYMSPEQIHG--NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFT 296
Query: 249 TPSPEAIARVCLLLN 263
P+ V +L+
Sbjct: 297 QKYPQEHMMVQDMLS 311
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 19/76 (25%), Positives = 35/76 (46%), Gaps = 8/76 (10%)
Query: 286 IFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKD 345
I F L+ + E+ R K P+ F+QK+P + +++ ML+ P +
Sbjct: 265 ILFE----LLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH----MMVQDMLSPSPTE 316
Query: 346 RPTAEEALADPYFKGL 361
RP A + + + F+ L
Sbjct: 317 RPEATDIIENAIFENL 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 60/221 (27%), Positives = 88/221 (39%), Gaps = 31/221 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++E IGKG +G V GE+VA+K + R EI +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 86 -----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+ K +++V + E L + +T E GL
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 140 KYIHTANVF--------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYV 190
++H V HRDLK KNIL + I D GLA + T T I V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 191 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAELLTG 227
T+ Y APE L S K+ + DI+++G +F E+
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 29/240 (12%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDI 59
P Q +K + DF K +++G+GS+ V A + T + AIK + I
Sbjct: 20 PPPQPRKKRPE-DF----------KFGKILGEGSFSTVVLARELATSREYAIKILEKRHI 68
Query: 60 FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELMES-DLHQ 115
+ + + RE ++ L HP V++ F+D +Y ++ +L +
Sbjct: 69 IKE-NKVPYVTRERDVMSRLDHPFFVKLYF--------TFQDDEKLYFGLSYAKNGELLK 119
Query: 116 VIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175
I+ +F+ +++ L+Y+H + HRDLKP+NIL N D ++I DFG A+V
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV 179
Query: 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235
++ A + +V T Y +PEL + D+W++GCI +L+ G P F N
Sbjct: 180 LSPESKQARANS-FVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
++ + IGKG YG V + GEKVA+K E S EI L+RH +I
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT-EEASWFRE--TEIYQTVLMRHENI 93
Query: 85 VE-IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ I + +Y++ + E+ L+ +K+ L + Y + GL ++
Sbjct: 94 LGFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHL 150
Query: 143 HTANVF--------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYVATR 193
HT HRDLK KNIL + I D GLA +DT I V T+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 194 WYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAELLTG 227
Y PE L S + + D++S G I E+
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-31
Identities = 54/241 (22%), Positives = 96/241 (39%), Gaps = 19/241 (7%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+Y+++ I G G + A D G V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP IV+I + + R Y+V E + L + L +L ++L L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ + +LK+ D G N T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY------GTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
+ + T A DI+++G A L P G+ V + D + ++ R+
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---LPEDDPVLKTYDSYGRLL 301
Query: 260 L 260
Sbjct: 302 R 302
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 31/221 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ E +GKG YG V + GE VA+K + R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
++ ++++ E L+ ++ L + + GL
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYIHTA--------NVFHRDLKPKNILANADCKLKICDFGLARV-AFNDTPTAIFWTDYV 190
++H + HRDLK KNIL + + I D GLA + + + + V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAELLTG 227
T+ Y APE L + +DIW+ G + E+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K + +GKG++G V TGE VA+KK+ REI++L+ L+H
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQH 70
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+IV+ K + RR ++ ++ E + L ++ + + + + Q+ +G+
Sbjct: 71 DNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ T HRDL +NIL + ++KI DFGL +V D +
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKEPGESPI 181
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE SK++ A D+WS G + EL T
Sbjct: 182 FWY-APE--SLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K + +GKG++G V TGE VA+KK+ REI++L+ L+H
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQH 101
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+IV+ K + RR ++ ++ E + L ++ + + + + Q+ +G+
Sbjct: 102 DNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ T HRDL +NIL + ++KI DFGL +V D Y
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKEPGESPI 212
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE SK++ A D+WS G + EL T
Sbjct: 213 FWY-APE--SLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLL 79
K +G+G +G V TGE+VA+K + + +EI++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNL 80
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
H +IV+ K I + I ++ E + S L + + N + + + + Q+ +
Sbjct: 81 YHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G+ Y+ + HRDL +N+L ++ ++KI DFGL + D Y
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDS 191
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE SK+ A D+WS G ELLT
Sbjct: 192 PVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 45/239 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69
Query: 83 DIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLY 133
++V+ LL PP Y++ E M +L ++ + +++ +
Sbjct: 70 NLVQ----LLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFW 186
Q+ ++Y+ N HRDL +N L + +K+ DFGL+R+ DT TA I W
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
T APE ++K++ D+W+ G + E+ T G +PG + V L+
Sbjct: 179 T---------APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 27/214 (12%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +GKG++G V TG VA+K++ REI++L+ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHS 83
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
IV+ + + P R + + +V E + S L ++ + L + Q+ +G+
Sbjct: 84 DFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
+Y+ + HRDL +NIL ++ +KI DFGLA++ D YV
Sbjct: 141 EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY------YVVREPGQSPI 194
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE + ++ D+WS G + EL T
Sbjct: 195 FWY-APE--SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 35/231 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
K+ + IGKG +G V G KVA+K I + DAT L E ++ LR
Sbjct: 21 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 137
H ++V+ LL E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQ----LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIF---WTDYVATRW 194
++Y+ N HRDL +N+L + D K+ DFGL + A + T WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 53/233 (22%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 276
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGL 139
++V++ + Y++ E M +L ++ + +++ + Q+ +
Sbjct: 277 NLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
+Y+ N HR+L +N L + +K+ DFGL+R+ DT TA I WT
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----- 386
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 387 ----APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +V+G G++G V GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------R 193
Y+ + HRDL +N+L +KI DFGLA++ + Y A +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIK 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W A E YT D+WS G EL+T G + G + L+
Sbjct: 185 WM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 34/234 (14%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGE--KVAIKKI-NDIFEHVSDATRILREIKLLRLLRH 81
++ E +G GS+GVV +D +G+ VA+K + D+ +RE+ + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
+++ + ++L P + +V EL L ++ + + Q+ G+
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------- 192
Y+ + HRDL +N+L +KI DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 193 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G N ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 45/235 (19%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ + +G G +GVV + VA+K I E +E + + L HP +V
Sbjct: 11 TLLKELGSGQFGVVKLGK-WKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 86 EIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLR 137
+ P IY+V E + + L ++++ L P Y +
Sbjct: 67 K----FYGVCSKEYP-------IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
G+ ++ + HRDL +N L + D +K+ DFG+ R +D YV++
Sbjct: 116 GMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKF 167
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE + KY+ D+W+ G + E+ + GK + VV ++
Sbjct: 168 PVKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ IG G +G+V Y +KVAIK I E + E +++ L HP +V
Sbjct: 11 TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
+ L + I +V E ME L ++ E + G+ Y+
Sbjct: 67 Q----LYGVCLEQ-APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYR 196
A V HRDL +N L + +K+ DFG+ R +D Y ++ +W
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFPVKWA- 172
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+PE FS+Y+ D+WS G + E+ + GK + ++ VV +
Sbjct: 173 SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 33/231 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLLRHPD 83
+ E IG+G++G V S VA+K E + + L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQL 135
IV L+ P IY+V EL++ D ++ L + +
Sbjct: 174 IVR----LIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
G++Y+ + HRDL +N L LKI DFG++R + A V +W
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 196 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE + + +Y+ D+WS G + E + G +P + ++
Sbjct: 283 -APE---ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 60/252 (23%), Positives = 99/252 (39%), Gaps = 32/252 (12%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ EV +G +G V A E VA+K + + E+ L ++H +I+
Sbjct: 27 QLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 86 -----EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
E + D++++ E L +KAN ++ + RGL
Sbjct: 82 QFIGAEKR------GTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGL 134
Query: 140 KYIHTA----------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
Y+H + HRD+K KN+L + I DFGLA F +A
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQ 193
Query: 190 VATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246
V TR Y APE+ +F ID++++G + EL + G + L ++
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253
Query: 247 LGTPSPEAIARV 258
PS E + V
Sbjct: 254 GQHPSLEDMQEV 265
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 61/233 (26%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
IE++IG G G VC G+ VAIK + ++ R L E ++
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFD 108
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP+I+ ++ ++ + +V E ME+ L ++ +D T L + G
Sbjct: 109 HPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
++Y+ HRDL +N+L +++ K+ DFGL+RV +D A Y T
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPI 218
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW APE F ++ A D+WS G + E+L G+ + V+ ++
Sbjct: 219 RWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 58/215 (26%), Positives = 85/215 (39%), Gaps = 30/215 (13%)
Query: 26 KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRI--LREIKLLRLL 79
K +G+G +G V + TGE VA+K + R +EI +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK---ADAGPQHRSGWKQEIDILRTL 90
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
H I++ K + +V E + L + + + F Q+ G
Sbjct: 91 YHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
+ Y+H + HRDL +N+L + D +KI DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
WY APE K+ A D+WS G ELLT
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 29/228 (12%)
Query: 28 EEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ +G G++G V Y + VA+K + + + +L E +++ L +P IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I S +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 82 RMIGICEAES------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYRA 197
+N HRDL +N+L KI DFGL++ D Y A +WY A
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------YKAQTHGKWPVKWY-A 188
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
PE + K++ D+WS G + E + G+ + G V L+
Sbjct: 189 PE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 52/236 (22%), Positives = 92/236 (38%), Gaps = 34/236 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRL 78
+ + +V+G G +G V GE V IK I D + + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGS 71
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 136
L H IV + + S + +V + + L ++ + L P+ + Q+
Sbjct: 72 LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT---- 192
+G+ Y+ + HR+L +N+L + ++++ DFG+A + D +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSEAK 178
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E F KYT D+WS G EL+T G + G V L+
Sbjct: 179 TPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
++ IG+G +G V VAIK SD+ R L+E +R
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 74
Query: 81 HPDIVEIKHILL-PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLR 137
HP IV++ ++ P ++++ EL +L ++ L + YQL
Sbjct: 75 HPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT----- 192
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKL 179
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 180 PIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 33/236 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLR 77
+ I++V+G G +G VCS +K VAIK + ++ R L E ++
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMG 101
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQL 135
HP+I+ ++ ++ + K + +V E ME+ L ++ +D T L +
Sbjct: 102 QFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT--- 192
G+KY+ HRDL +NIL N++ K+ DFGL RV +D A Y
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA-----YTTRGGK 211
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW +PE + K+T A D+WS G + E+++ G+ + + V+ +D
Sbjct: 212 IPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 56/235 (23%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEK--VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
+ ++G+G +G V Y GEK VA+K + + + + E +++ L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLD 71
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRG 138
HP IV++ I+ +++ EL +L ++ N + L + Q+ +
Sbjct: 72 HPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------ 192
+ Y+ + N HRD+ +NIL + +K+ DFGL+R ++ DY
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKASVTRLP 177
Query: 193 -RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 178 IKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V T +VAIK + L+E ++++ LRH
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 239
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 240 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----- 348
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + EL T G+ +PG + V+ Q++
Sbjct: 349 ----APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 23/246 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
V+GKG +G VC+ TG+ A KK+ + L E ++L + +V +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 89 HILLPPSRREFKDIYVVFELMES-DL--HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ + +V LM DL H F+ ++ GL+ +H
Sbjct: 251 YAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 205
+ +RDLKP+NIL + ++I D GLA V T Y APE+ +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKN-- 359
Query: 206 SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-----IMTDLLGTP---SPEAIAR 257
+YT + D W++GC+ E++ G+ F + + + + SP+A +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSL 419
Query: 258 VCLLLN 263
LL
Sbjct: 420 CSQLLC 425
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 50/229 (21%), Positives = 91/229 (39%), Gaps = 33/229 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
+ +G G +GVV R VAIK I E + E K++ L H +V
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIH 143
++ + + + I+++ E M + L ++ + + ++Y+
Sbjct: 83 QLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWYR 196
+ HRDL +N L N +K+ DFGL+R +D +Y ++ RW
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKFPVRWS- 188
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
PE +SK++ DIW+ G + E+ + GK + +
Sbjct: 189 PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 64/248 (25%), Positives = 114/248 (45%), Gaps = 27/248 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
IGKGS+G VC T + A+K +N E ++ + +E+++++ L HP +V +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHPFLVNL 80
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ F+D +++V +L+ DL ++ N E + F+ +L+ L Y+
Sbjct: 81 WY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ HRD+KP NIL + + I DF +A + +T T+ Y APE
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEMFSS 188
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP-------SPEAI 255
+ Y+ A+D WS+G ELL G+ + ++ +I+ T S E +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248
Query: 256 ARVCLLLN 263
+ + LL
Sbjct: 249 SLLKKLLE 256
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 34/237 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRI--LREIKLL 76
S ++VIG G +G V + VAIK + ++ R+ L E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIM 100
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQ 134
H +I+ ++ ++ ++K + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-- 192
+ G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 193 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
RW APE + K+T A D+WS G + E++T G+ + + V+ ++
Sbjct: 211 KIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 32/232 (13%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRH 81
K +V+G G++G V GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ +G+
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT------R 193
Y+ + HRDL +N+L +KI DFGLA++ + Y A +
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIK 184
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W A E YT D+WS G EL+T G + G + L+
Sbjct: 185 WM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 29/228 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATR--ILREIKLLRLLR 80
K+ + IGKG +G V G KVA+K I + DAT L E ++ LR
Sbjct: 193 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQLR 244
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLR 137
H ++V+ LL E +Y+V E M L +++ L + F +
Sbjct: 245 HSNLVQ----LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
++Y+ N HRDL +N+L + D K+ DFGL + A + T +W A
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT-A 354
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
PE K++ D+WS G + E+ + G+ +P K+VV +++
Sbjct: 355 PE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 62/285 (21%), Positives = 116/285 (40%), Gaps = 35/285 (12%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEE-------VIGKGSYGVVCSAYDTRTGEKVAIK 54
P Q S F ++ + E V+G+G +G V + TG+ A K
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACK 216
Query: 55 KIN--DIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES- 111
K+N + + + E K+L + IV + + + + +V +M
Sbjct: 217 KLNKKRLKKR-KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGG 270
Query: 112 DL----HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167
D+ + V + N F+ Q++ GL+++H N+ +RDLKP+N+L + D ++I
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRI 330
Query: 168 CDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
D GLA + T T + T + APEL +Y ++D +++G E++
Sbjct: 331 SDLGLAVELKAGQTKTKGY----AGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIA 384
Query: 227 GKPLFPGKNVVHQLD-----IMTDLLGTP---SPEAIARVCLLLN 263
+ F + + ++ + P SP + LL
Sbjct: 385 ARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-26
Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V T +VAIK + L+E ++++ LRH
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 322
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M L +K L Q+ G+
Sbjct: 323 KLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVAT 192
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA I WT
Sbjct: 377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----- 431
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE + + ++T D+WS G + EL T G+ +PG + V+ Q++
Sbjct: 432 ----APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 67/238 (28%), Positives = 99/238 (41%), Gaps = 45/238 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ E +G G +G V Y KVA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 83 DIVEIKHILL-----PPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQ 134
+V L P IY++ E ME+ L +K LT Q
Sbjct: 69 RLVR----LYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWT 187
+ G+ +I N HRDL+ NIL + KI DFGLAR+ ++ TA I WT
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE + +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 178 ---------APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 55/238 (23%), Positives = 92/238 (38%), Gaps = 39/238 (16%)
Query: 26 KIEEVIGKGSYGVVCSA-YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
K+ E+IG+G YG V D VA+K + + + + I + L+ H +I
Sbjct: 16 KLLELIGRGRYGAVYKGSLD---ERPVAVKVFSF--ANRQNFIN-EKNIYRVPLMEHDNI 69
Query: 85 V-----EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRG 138
+ + + + +V E + L + + + + + RG
Sbjct: 70 ARFIVGDER-----VTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRG 123
Query: 139 LKYIHTANVF---------HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189
L Y+HT HRDL +N+L D I DFGL+ + D
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 190 -----VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNV 236
V T Y APE L G+ +D++++G I+ E+ LFPG++V
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 33/231 (14%)
Query: 27 IEEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++G V Y R + VAIK + E +D ++RE +++ L +P I
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 72
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ G+KY+
Sbjct: 73 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 126
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWY 195
N HRDL +N+L KI DFGL++ D Y A +WY
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 180
Query: 196 RAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 181 -APE---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 52/221 (23%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++ V +TG+ A+K +N D+ + + + E +L I ++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-GEVSCFREERDVLVNGDRRWITQL 126
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
F+D +Y+V E DL + K + + E +F+L +++ + +
Sbjct: 127 HF--------AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL- 200
H HRD+KP NIL + +++ DFG ++ + T + V T Y +PE+
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS--LV-AVGTPDYLSPEIL 235
Query: 201 ----CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
G Y P D W++G E+ G+ F +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-26
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
K+E+ +G G +G V A + KVA+K + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYI 142
++ ++ + IY++ E M L +K+++ F Q+ G+ +I
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-------IFWTDYVATRWY 195
N HRDL+ NIL +A KI DFGLARV ++ TA I WT
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT-------- 352
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG---KNVVHQLD 241
APE F +T D+WS G + E++T G+ +PG V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 49/241 (20%), Positives = 93/241 (38%), Gaps = 33/241 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLL 79
+ + +++G+G +G V + KVA+K + + L E ++
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFFL 132
HP+++ + + + S + V+ M+ DLH + + + + F+
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD-YVA 191
+ G++Y+ N HRDL +N + D + + DFGL++ I+ D Y
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYYRQ 205
Query: 192 T-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQL 240
+W A E YT D+W+ G E+ T G +PG + L
Sbjct: 206 GRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 241 D 241
Sbjct: 263 L 263
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
EVIG+G +G V K A+K +N I + + ++ L E +++ HP
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHP 86
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ LL R VV M+ DL I+ + T + F Q+ +G+K
Sbjct: 87 NVLS----LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
Y+ + HRDL +N + + +K+ DFGLAR ++ +Y +
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNKTGAKL 194
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + EL+T G P +P N + L
Sbjct: 195 PVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 57/230 (24%), Positives = 100/230 (43%), Gaps = 31/230 (13%)
Query: 27 IEEVIGKGSYGVVCSA-YDTRTGE-KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G++G V Y R + VAIK + E +D ++RE +++ L +P I
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYI 398
Query: 85 VEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLLRGLKYI 142
V + + + + +V E+ LH+ + + + + L+Q+ G+KY+
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------RWY 195
N HR+L +N+L KI DFGL++ D Y A +WY
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY 506
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
APE F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 507 -APE--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 63/249 (25%), Positives = 105/249 (42%), Gaps = 29/249 (11%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
+IG+G +G V TG+ A+K + + +L + P
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---CP 252
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV + + P + + + +LM DLH + + + +F+ +++ GL++
Sbjct: 253 FIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H V +RDLKP NIL + ++I D GLA P A V T Y APE+
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVL 362
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN--VVHQLD--IMTDLLGTP---SPEA 254
Y + D +S+GC+ +LL G F H++D +T + P SPE
Sbjct: 363 QK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421
Query: 255 IARVCLLLN 263
+ + LL
Sbjct: 422 RSLLEGLLQ 430
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
EVIG+G +G V K A+K +N I + + ++ L E +++ HP
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFSHP 150
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ LL R VV M+ DL I+ + T + F Q+ +G+K
Sbjct: 151 NVLS----LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 206
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
++ + HRDL +N + + +K+ DFGLAR ++ ++ +
Sbjct: 207 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNKTGAKL 258
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E K+T D+WS G + EL+T G P +P N + L
Sbjct: 259 PVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ VIGKG +GVV + + AIK ++ I E LRE L+R L HP
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-QQVEAFLREGLLMRGLNHP 82
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLK 140
+++ L+ +V+ M DL Q I++ + T + F Q+ RG++
Sbjct: 83 NVLA----LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT-------- 192
Y+ HRDL +N + + +K+ DFGLAR I +Y +
Sbjct: 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD--------ILDREYYSVQQHRHARL 190
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W A E ++T D+WS G + ELLT G P + + + H L
Sbjct: 191 PVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++G V + A+K +N ++ + ++ E +L I +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR-AETACFREERDVLVNGDSKWITTL 139
Query: 88 KHILLPPSRREFKD---IYVVFELMES-DL-HQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ F+D +Y+V + DL + K D L E +F+L +++ + +
Sbjct: 140 HY--------AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATRWYRAPEL- 200
H + HRD+KP NIL + + +++ DFG ++ + T + V T Y +PE+
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SV-AVGTPDYISPEIL 248
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
+Y P D WS+G E+L G+ F +++V
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 37/234 (15%), Positives = 59/234 (25%), Gaps = 42/234 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLR 80
RY++ G A DT +VA+ ++ L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
P + + ++ + VV E + L +V + +P + L
Sbjct: 90 KPGVARVLDVVHTRAG-----GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
H A V P + + D + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSP 252
P DI IG LL + P V L D G P
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE 224
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDIVEI 87
VIG+G++G V T + A+K ++ ++ + SD+ E ++ P +V++
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-SDSAFFWEERDIMAFANSPWVVQL 134
Query: 88 KHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
+ F+D +Y+V E M DL ++ N D+ + +F+ +++ L IH
Sbjct: 135 FY--------AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIH 185
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE--LC 201
+ HRD+KP N+L + LK+ DFG N T V T Y +PE
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDT-AVGTPDYISPEVLKS 243
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237
Y D WS+G E+L G F ++V
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 48/239 (20%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRI--LREIKLLRLLR 80
++ IG+G +G V VAIK SD+ R L+E +R
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK---NCTSDSVREKFLQEALTMRQFD 449
Query: 81 HPDIVEIKHILL-----PPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLY 133
HP IV+ L+ P ++++ EL +L ++ L + Y
Sbjct: 450 HPHIVK----LIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498
Query: 134 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT- 192
QL L Y+ + HRD+ +N+L +++ +K+ DFGL+R + Y
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKAS 550
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 551 KGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 34/242 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLL 79
++ + ++GKG +G V A + KVA+K + SD LRE ++
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 80 RHPDIVEIKHI-LLPPSRREFKDIYVVFELMES-DLHQVIKAN------DDLTPEHYQFF 131
HP + ++ + L ++ V+ M+ DLH + A+ +L + F
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-- 189
+ + G++Y+ + N HRDL +N + D + + DFGL+R I+ DY
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDYYR 194
Query: 190 ------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQ 239
+ +W A E + YT D+W+ G E++T G+ + G + +
Sbjct: 195 QGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 240 LD 241
L
Sbjct: 252 LI 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 67/250 (26%), Positives = 112/250 (44%), Gaps = 32/250 (12%)
Query: 30 VIGKGSYG---VVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLRHPDI 84
V+GKG YG V TG+ A+K + I + D E +L ++HP I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 85 VEIKHILLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
V++ + + +Y++ EL + ++ + F+L ++
Sbjct: 84 VDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAEISMA 133
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H + +RDLKP+NI+ N +K+ DFGL + + +D + T Y AP
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIEYMAP 190
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPE 253
E L S + A+D WS+G + ++LTG P F G+N +D I+ L P + E
Sbjct: 191 EILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247
Query: 254 AIARVCLLLN 263
A + LL
Sbjct: 248 ARDLLKKLLK 257
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 37/239 (15%), Positives = 76/239 (31%), Gaps = 40/239 (16%)
Query: 26 KIEEVIGKGSYGVVCSAYDTRTGE-------KVAIKKINDIFEHVSDATRILREIKLLRL 78
E +G+G++ + G+ +V +K ++ H + + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSK 68
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD-LTPEHYQFFLYQLL 136
L H +V + + + +V E ++ L +K N + + QL
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKL--------KICDFGLARVAFNDTPTAIFWTD 188
+ ++ + H ++ KNIL + K+ D G++ D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------D 175
Query: 189 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN---VVHQLD 241
W PE C A D WS G E+ + G + + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 57/245 (23%), Positives = 106/245 (43%), Gaps = 38/245 (15%)
Query: 7 KKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIK--KINDI 59
K+ D E + ++++ +G GS+G V +G A+K +
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 60 F-----EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD---IYVVFELME- 110
EH + RIL+ + P +V+++ FKD +Y+V E +
Sbjct: 80 VKLKQIEHTLNEKRILQAV------NFPFLVKLEF--------SFKDNSNLYMVMEYVAG 125
Query: 111 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
++ ++ + H +F+ Q++ +Y+H+ ++ +RDLKP+N+L + +++ DF
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL 230
G A+ T WT T APE+ S Y A+D W++G + E+ G P
Sbjct: 186 GFAKRVKGRT-----WT-LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 231 FPGKN 235
F
Sbjct: 238 FFADQ 242
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 63/245 (25%), Positives = 115/245 (46%), Gaps = 26/245 (10%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDIVEI 87
++GKG++G V + TG A+K + I + + E ++L+ RHP + +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVTESRVLQNTRHPFLTAL 70
Query: 88 KHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN 146
K+ R + V E +L + T E +F+ +++ L+Y+H+ +
Sbjct: 71 KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 147 VFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCGS 203
V +RD+K +N++ + D +KI DFGL + ++ T F T Y APE L
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTF----CGTPEYLAPEVLED- 179
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SPEAIARV 258
+ Y A+D W +G + E++ G+ F ++ +L I+ + + P SPEA + +
Sbjct: 180 --NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIRFPRTLSPEAKSLL 236
Query: 259 CLLLN 263
LL
Sbjct: 237 AGLLK 241
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 67/276 (24%), Positives = 114/276 (41%), Gaps = 42/276 (15%)
Query: 2 QPDQRKKSSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI----- 56
+P + K + DF + +++GKGS+G V A +T + AIK +
Sbjct: 7 RPSLQIKLKIE-DF----------ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 55
Query: 57 --NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DL 113
+D E T + + + L HP + + ++ V E + DL
Sbjct: 56 LMDDDVEC----TMVEKRV-LSLAWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDL 105
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
I++ F+ +++ GL+++H+ + +RDLK NIL + D +KI DFG+
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
Query: 174 R--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231
+ + + T F T Y APE+ KY ++D WS G + E+L G+ F
Sbjct: 166 KENMLGDAK-TNTF----CGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPF 218
Query: 232 PGKNVVHQLD-IMTDLLGTP---SPEAIARVCLLLN 263
G++ I D P EA + L
Sbjct: 219 HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 254
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 60/241 (24%), Positives = 112/241 (46%), Gaps = 17/241 (7%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPDIVEIK 88
++GKG++G V + TG A+K + ++ + L E ++L+ RHP + +K
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-N 146
+ R + V E +L + + + +F+ +++ L Y+H+ N
Sbjct: 215 YSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 147 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 206
V +RDLK +N++ + D +KI DFGL + D T + T Y APE+ +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED--N 324
Query: 207 KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIARVCLLL 262
Y A+D W +G + E++ G+ F ++ + I+ + + P PEA + + LL
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384
Query: 263 N 263
Sbjct: 385 K 385
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 68/280 (24%), Positives = 116/280 (41%), Gaps = 48/280 (17%)
Query: 9 SSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKKI------- 56
++ V F G R K+ + V+GKGS+G V + T E A+K +
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 57 NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFE------LME 110
+D E T + + + L + P + ++ R +Y V E LM
Sbjct: 61 DDDVEC----TMVEKRV-LALPGKPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDLM- 109
Query: 111 SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170
H I+ H F+ ++ GL ++ + + +RDLK N++ +++ +KI DF
Sbjct: 110 --YH--IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 165
Query: 171 GLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTG 227
G+ + + T T F T Y APE + Y ++D W+ G + E+L G
Sbjct: 166 GMCKENIWDGVT-TKTF----CGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAG 217
Query: 228 KPLFPGKNVVHQLD-IMTDLLGTP---SPEAIARVCLLLN 263
+ F G++ IM + P S EA+A L+
Sbjct: 218 QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 257
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 3e-22
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHP 82
++I +G GS+G V G A+K K + E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKHILLPPSRREFKD---IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
I+ + F+D I+++ + +E +L +++ + +F+ ++
Sbjct: 67 FIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVATR 193
L+Y+H+ ++ +RDLKP+NIL + + +KI DFG A+ + T +T DY+
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYI--- 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236
APE+ + Y +ID WS G + E+L G F N
Sbjct: 171 ---APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 5e-22
Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 33/249 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
V+GKGS+G V + T E A+K + +D E T + + + L + P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC----TMVEKRV-LALPGKPP 402
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ R +Y V E + DL I+ H F+ ++ GL +
Sbjct: 403 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE 199
+ + + +RDLK N++ +++ +KI DFG+ + + T T F T Y APE
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTF----CGTPDYIAPE 512
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEA 254
+ Y ++D W+ G + E+L G+ F G++ IM + P S EA
Sbjct: 513 IIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569
Query: 255 IARVCLLLN 263
+A L+
Sbjct: 570 VAICKGLMT 578
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 56/255 (21%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
++ +G+G++G V Y+ + VA+K + D + A R RE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD----PTLAARKDFQREAEL 70
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN-------------- 120
L L+H IV+ + +VFE M+ DL++ ++A+
Sbjct: 71 LTNLQHEHIVK----FYGVCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 121 --DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178
+L Q+ G+ Y+ + + HRDL +N L A+ +KI DFG++R
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--- 182
Query: 179 DTPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 229
++ TDY RW PE + K+T D+WS G I E+ T GK
Sbjct: 183 -----VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 230 LFPGKN---VVHQLD 241
+ + V+ +
Sbjct: 235 PWFQLSNTEVIECIT 249
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 66/251 (26%), Positives = 114/251 (45%), Gaps = 36/251 (14%)
Query: 30 VIGKGSYG---VVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIKLLRLLRHPDI 84
V+G+GS+G +V + + A+K K + D R E +L + HP I
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFI 88
Query: 85 VEIKHILLPPSRREFKDIYVVF------ELMESDLHQVIKANDDLTPEHYQFFLYQLLRG 138
V++ + + +Y++ +L + T E +F+L +L
Sbjct: 89 VKLHYAFQTEGK-----LYLILDFLRGGDLF---TR--LSKEVMFTEEDVKFYLAELALA 138
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L ++H+ + +RDLKP+NIL + + +K+ DFGL++ + + A + T Y AP
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVEYMAP 195
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SP 252
E + +T + D WS G + E+LTG F GK+ + I+ LG P SP
Sbjct: 196 EVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMILKAKLGMPQFLSP 251
Query: 253 EAIARVCLLLN 263
EA + + +L
Sbjct: 252 EAQSLLRMLFK 262
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 64/249 (25%), Positives = 106/249 (42%), Gaps = 33/249 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIKKI-------NDIFEHVSDATRILREIKLLRLLRHP 82
V+GKGS+G V A TG+ A+K + +D E T + I L HP
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC----TMTEKRI-LSLARNHP 84
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+ ++ P R ++ V E + DL I+ + +F+ +++ L +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLA--RVAFNDTPTAIFWTDYVATRWYRAPE 199
+H + +RDLK N+L + + K+ DFG+ + T TA F T Y APE
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATF----CGTPDYIAPE 194
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEA 254
L Y PA+D W++G + E+L G F +N + I+ D + P +A
Sbjct: 195 ILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDA 251
Query: 255 IARVCLLLN 263
+ +
Sbjct: 252 TGILKSFMT 260
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 57/254 (22%), Positives = 101/254 (39%), Gaps = 55/254 (21%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
++ +G+G++G V ++ + VA+K + + S++ R RE +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAEL 96
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD------------ 122
L +L+H IV + + +VFE M DL++ ++++
Sbjct: 97 LTMLQHQHIVR----FFGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 123 ---LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179
L Q+ G+ Y+ + HRDL +N L +KI DFG++R
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD---- 207
Query: 180 TPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230
I+ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ----IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
Query: 231 FPGKN---VVHQLD 241
+ + + +
Sbjct: 261 WYQLSNTEAIDCIT 274
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 58/247 (23%), Positives = 92/247 (37%), Gaps = 66/247 (26%)
Query: 26 KIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKLLRL 78
+ +G+GS+G+V A E +VAIK +N E S RI L E +++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKE 84
Query: 79 LRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----------D 121
+V LL P V+ ELM DL +++
Sbjct: 85 FNCHHVVR----LLGVVSQGQP-------TLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
+ ++ G+ Y++ HRDL +N + D +KI DFG+ R
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD------ 187
Query: 182 TAIFWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
I+ TDY YR +PE +T D+WS G + E+ T +
Sbjct: 188 --IYETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 229 PLFPGKN 235
+ G +
Sbjct: 239 QPYQGLS 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 56/242 (23%), Positives = 91/242 (37%), Gaps = 63/242 (26%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
S + E +G+ +G V + GE VAIK + + R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAML 65
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+HP++V LL P + ++F DLH+ +
Sbjct: 66 RARLQHPNVVC----LLGVVTKDQP-------LSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 121 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
L P + + Q+ G++Y+ + +V H+DL +N+L +KI D GL
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 173 ARVAFNDTPTAIFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224
R ++ DY RW APE + K++ DIWS G + E+
Sbjct: 175 FRE--------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEV 223
Query: 225 LT 226
+
Sbjct: 224 FS 225
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 39/269 (14%)
Query: 20 GEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILRE 72
G +++ VIG+GSY V +T A+K K + + D + E
Sbjct: 1 GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTE 59
Query: 73 IK-LLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQF 130
+ HP +V + SR ++ V E + DL ++ L EH +F
Sbjct: 60 KHVFEQASNHPFLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARF 114
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTD 188
+ ++ L Y+H + +RDLK N+L +++ +K+ D+G+ + + DT T+ F
Sbjct: 115 YSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTF--- 170
Query: 189 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD------ 241
T Y APE L G Y ++D W++G + E++ G+ F D
Sbjct: 171 -CGTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226
Query: 242 ----IMTDLLGTP---SPEAIARVCLLLN 263
I+ + P S +A + + LN
Sbjct: 227 LFQVILEKQIRIPRSLSVKAASVLKSFLN 255
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 48/288 (16%)
Query: 1 MQPDQRKKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYGVVCSAYDTRTGEKVAIKK 55
M + + K + VIGKGS+G V A A+K
Sbjct: 11 MNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV 70
Query: 56 I-------NDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVF-- 106
+ +H R + LL+ ++HP +V + + +Y V
Sbjct: 71 LQKKAILKKKEEKH----IMSERNV-LLKNVKHPFLVGLHFSFQTADK-----LYFVLDY 120
Query: 107 ----ELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162
EL H ++ +F+ ++ L Y+H+ N+ +RDLKP+NIL ++
Sbjct: 121 INGGELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 163 CKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220
+ + DFGL + + N T T+ F T Y APE+ Y +D W +G +
Sbjct: 176 GHIVLTDFGLCKENIEHNST-TSTF----CGTPEYLAPEVLHK--QPYDRTVDWWCLGAV 228
Query: 221 FAELLTGKPLFPGKNVVHQL--DIMTDLLGTP---SPEAIARVCLLLN 263
E+L G P F +N ++ +I+ L + A + LL
Sbjct: 229 LYEMLYGLPPFYSRN-TAEMYDNILNKPLQLKPNITNSARHLLEGLLQ 275
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 7e-21
Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 34/254 (13%)
Query: 30 VIGKGSYGVVCSAYDTRTGEKVAIK--KINDIFEHVSDATRILREIK-LLRLLRHPDIVE 86
VIG+GSY V +T A++ K + + D + E + HP +V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVG 117
Query: 87 IKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA 145
+ SR ++ V E + DL ++ L EH +F+ ++ L Y+H
Sbjct: 118 LHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 146 NVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPE-LCG 202
+ +RDLK N+L +++ +K+ D+G+ + + DT T+ F T Y APE L G
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTF----CGTPNYIAPEILRG 227
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD----------IMTDLLGTP-- 250
Y ++D W++G + E++ G+ F D I+ + P
Sbjct: 228 ---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
Query: 251 -SPEAIARVCLLLN 263
S +A + + LN
Sbjct: 285 LSVKAASVLKSFLN 298
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 91.5 bits (226), Expect = 3e-20
Identities = 54/384 (14%), Positives = 92/384 (23%), Gaps = 103/384 (26%)
Query: 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI------NDIFEHVSDATRI 69
F+ + + E IG+G +G V T VAIK I H I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 70 LREIKLLRLL---------RHPDIVEIKHILL-------------------------PPS 95
L EI + + L R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVF-HRDLKP 154
+ +++V E + + + L+QL L + F HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + + + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV------------------SIIDYTLSRLE 232
Query: 215 WSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMC 274
+F ++ + LF G +Q DI L+ + N++W Y
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFDI-YRLMKKENNNRWGEYHPYSNVLWLHY----- 285
Query: 275 SVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334
+ K +
Sbjct: 286 ------------------------------LTDKMLKQMTFKTKCNTPAMKQIKRKIQEF 315
Query: 335 LERMLAFEPKDRPTAEEALADPYF 358
ML F +A + L
Sbjct: 316 HRTMLNFS-----SATDLLCQHSL 334
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 49/249 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +G G++G V +VA+K + E S+ + L E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 86
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ H +IV + S + +++ ELM DL ++ + +
Sbjct: 87 ISKFNHQNIVR----CIGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 135 LL-------RGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 184
LL G +Y+ + HRD+ +N L KI DFG+AR I
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------I 193
Query: 185 FWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ Y +W PE +T D WS G + E+ + G +P K+
Sbjct: 194 YRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 236 ---VVHQLD 241
V+ +
Sbjct: 251 NQEVLEFVT 259
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 52/252 (20%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
R K+ + +G+G++G V A+ VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V LL + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD-- 197
Query: 178 NDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GK 228
I+ YV +W APE F YT D+WS G + E+ + G
Sbjct: 198 ------IYKDPDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGA 248
Query: 229 PLFPGKNVVHQL 240
+PG + +
Sbjct: 249 SPYPGVKIDEEF 260
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 60/282 (21%), Positives = 116/282 (41%), Gaps = 31/282 (10%)
Query: 4 DQRKKSSADVDFFTEYGEGSRYKIEE-----VIGKGSYG---VVCSAYDTRTGEKVAIKK 55
+Q ++ G + IE V+G G+YG +V TG+ A+K
Sbjct: 30 EQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV 89
Query: 56 IN--DIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSRREFKDIYVVFELMES- 111
+ I + E ++L +R P +V + + ++ ++++ + +
Sbjct: 90 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK-----LHLILDYINGG 144
Query: 112 DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171
+L + + T Q ++ +++ L+++H + +RD+K +NIL +++ + + DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 172 LAR--VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
L++ VA F T Y AP++ S + A+D WS+G + ELLTG
Sbjct: 205 LSKEFVADETERAYDF----CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
Query: 230 LFPGKNVVHQLD-----IMTDLLGTP---SPEAIARVCLLLN 263
F + I+ P S A + LL
Sbjct: 261 PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLM 302
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 51/249 (20%), Positives = 88/249 (35%), Gaps = 49/249 (19%)
Query: 23 SRYKIEEVIGKGSYGVVCS--AYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +G G++G V +VA+K + E S+ + L E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALI 127
Query: 76 LRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQ 134
+ H +IV + S + +++ ELM DL ++ + +
Sbjct: 128 ISKFNHQNIVR----CIGVSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 135 LL-------RGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAI 184
LL G +Y+ + HRD+ +N L KI DFG+AR I
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--------I 234
Query: 185 FWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235
+ Y +W PE +T D WS G + E+ + G +P K+
Sbjct: 235 YRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 236 ---VVHQLD 241
V+ +
Sbjct: 292 NQEVLEFVT 300
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 62/231 (26%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRI--LREIKLL-R 77
+ K ++VIG+G++G V A + G + AIK++ E+ S E+++L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCK 81
Query: 78 LLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN---------- 120
L HP+I+ LL +Y+ E +L ++ +
Sbjct: 82 LGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 121 ------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 175 VAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIG 218
+ YV RW A E +S YT D+WS G
Sbjct: 191 --GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVYTTNSDVWSYG 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 56/247 (22%), Positives = 91/247 (36%), Gaps = 81/247 (32%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + IG+G++G V A E VA+K + E S + RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKANDD------ 122
+ +P+IV+ LL P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVK----LLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 123 ------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
L+ Q+ G+ Y+ HRDL +N L +
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 212
Query: 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYR------------APELCGS-FFSKYTPA 211
+KI DFGL+R I+ DY Y+ PE S F+++YT
Sbjct: 213 VKIADFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTE 256
Query: 212 IDIWSIG 218
D+W+ G
Sbjct: 257 SDVWAYG 263
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 58/255 (22%), Positives = 98/255 (38%), Gaps = 61/255 (23%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + + +G G++G V +A+ + KVA+K + + + E+K+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKI 102
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELME---------------SDL 113
+ L +H +IV LL P + V+ E
Sbjct: 103 MSHLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 114 HQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173
AN + F Q+ +G+ ++ + N HRD+ +N+L KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 174 RVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226
R ND ++Y+ +W APE F YT D+WS G + E+ +
Sbjct: 212 RDIMND-------SNYIVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFS 261
Query: 227 -GKPLFPGKNVVHQL 240
G +PG V +
Sbjct: 262 LGLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 73/243 (30%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ + +G+G +G V +A+ + VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+ + HP +++ L P + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 121 ----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
LT F +Q+ +G++Y+ + HRDL +NIL K
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 165 LKICDFGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIW 215
+KI DFGL+R ++ D YV +W A E S F YT D+W
Sbjct: 189 MKISDFGLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVW 236
Query: 216 SIG 218
S G
Sbjct: 237 SFG 239
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 68/260 (26%), Positives = 96/260 (36%), Gaps = 67/260 (25%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+R + +G G++G V +AY + VA+K + R + E+K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN------- 120
L L H +IV LL P V+ E DL ++
Sbjct: 80 LSYLGNHMNIVN----LLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
L E F YQ+ +G+ ++ + N HRDL +NIL KICD
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
FGLAR I YV +W APE F YT D+WS G
Sbjct: 189 FGLARD--------IKNDSNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFL 237
Query: 222 AELLT-GKPLFPGKNVVHQL 240
EL + G +PG V +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL-REIKLLRLLR 80
G +++ + IG G++G + + T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 132
I ++ + K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 174
QL+ ++Y+H+ N+ +RD+KP+N L + I DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 61/263 (23%), Positives = 106/263 (40%), Gaps = 70/263 (26%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREI 73
+ + + +G+G++G V A + VA+K + + ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 91
Query: 74 KLL-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 120
+++ + +H +I+ LL P +YV+ E +L + ++A
Sbjct: 92 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 140
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ +T + YQL RG++Y+ + HRDL +N+L + +KI D
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
FGLAR I D Y T +W APE F YT D+WS G +
Sbjct: 201 FGLARD--------INNIDYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLM 249
Query: 222 AELLT-GK---PLFPGKNVVHQL 240
E+ T G P P + + L
Sbjct: 250 WEIFTLGGSPYPGIPVEELFKLL 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 61/261 (23%), Positives = 106/261 (40%), Gaps = 72/261 (27%)
Query: 26 KIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREIKLL 76
+ + +G+G +G V A + VA+K + + ++ + E++++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMM 140
Query: 77 -RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN-------- 120
+ +H +I+ LL P +YV+ E +L + ++A
Sbjct: 141 KMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEYS 189
Query: 121 --------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
+ +T + YQL RG++Y+ + HRDL +N+L + +KI DFGL
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 173 ARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAE 223
AR I D Y T +W APE + F YT D+WS G + E
Sbjct: 250 ARD--------INNIDYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWE 297
Query: 224 LLT-GKPLFPG---KNVVHQL 240
+ T G +PG + + L
Sbjct: 298 IFTLGGSPYPGIPVEELFKLL 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 63/264 (23%), Positives = 107/264 (40%), Gaps = 72/264 (27%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE-----KVAIKKINDIFEHVSDATRI--LREI 73
R + + +G+G++G V A + KVA+K + ++ + E+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEM 125
Query: 74 KLL-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELMES-DLHQVIKAN----- 120
+++ + +H +I+ LL P +YV+ E +L + ++A
Sbjct: 126 EMMKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 121 -----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 170 FGLARVAFNDTPTAIFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCI 220
FGLAR I D Y T +W APE + F YT D+WS G +
Sbjct: 235 FGLARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVL 282
Query: 221 FAELLT-GK---PLFPGKNVVHQL 240
E+ T G P P + + L
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLL 306
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATRILREIKLLRLLR 80
G+RY++ IG GS+G + D GE+VAIK E V + ++ E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 138
I I+ E +V EL+ L + + + Q++
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++YIH+ N HRD+KP N L + I DFGLA+
Sbjct: 118 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 66/266 (24%), Positives = 105/266 (39%), Gaps = 74/266 (27%)
Query: 23 SRYKIEEVIGKGSYGVV--CSAYDTRTGE---KVAIKKINDIFEHVSDATRI--LREIKL 75
+ +V+G G++G V +AY +VA+K + E + R + E+K+
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 101
Query: 76 L-RLLRHPDIVEIKHILL------PPSRREFKDIYVVFELME------------------ 110
+ +L H +IV LL P IY++FE
Sbjct: 102 MTQLGSHENIVN----LLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 111 ------SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164
+ + + LT E F YQ+ +G++++ + HRDL +N+L
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 165 LKICDFGLAR-VAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIW 215
+KICDFGLAR + + YV +W APE S F YT D+W
Sbjct: 211 VKICDFGLARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVW 258
Query: 216 SIGCIFAELLT-GKPLFPGKNVVHQL 240
S G + E+ + G +PG V
Sbjct: 259 SYGILLWEIFSLGVNPYPGIPVDANF 284
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 35/170 (20%), Positives = 73/170 (42%), Gaps = 21/170 (12%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G+++ + + IG G +G++ A+ T EK A + E+ + + E+K + +
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAK 92
Query: 82 PDIVE-------IKHILLP-------PSRREFKDIYVVFELMESDLHQVIKANDDLTPEH 127
D ++ + ++ +P + ++V E + DL ++ N
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 128 YQFFLYQLLRGLKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++L L+YIH H D+K N+L N D ++ + D+GL+
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-SDATRILREIKLLRLLR 80
G+++++ IG GS+G + + +T E+VAIK E+V + ++L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRG 138
I ++ E +V +L+ L + L+ + Q++
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLAR 174
++++H+ + HRD+KP N L ++ I DFGLA+
Sbjct: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 30/167 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL-REIKLLRLLR 80
G YK+ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFL------- 132
I + + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQLLRGLKYIHTANVFHRDLKPKNIL-----ANADCKLKICDFGLAR 174
Q+L ++ IH ++ +RD+KP N L + + + DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 65/284 (22%), Positives = 104/284 (36%), Gaps = 93/284 (32%)
Query: 30 VIGKGSYGVVCSAYD--TRTGEKVAIKKINDI-------FEHVSDATRILREIKLLRLLR 80
+IG G +G V Y R G KVA+K+ F EI+ L R
Sbjct: 46 LIGHGVFGKV---YKGVLRDGAKVALKRRTPESSQGIEEF---------ETEIETLSFCR 93
Query: 81 HPDIV-------EIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHY 128
HP +V E ++L +++ M + L+ ++ E
Sbjct: 94 HPHLVSLIGFCDERNEMIL------------IYKYMENGNLKRHLYGSDLPTMSMSWE-- 139
Query: 129 QFFLYQLL-------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
Q L RGL Y+HT + HRD+K NIL + + KI DFG+++
Sbjct: 140 -----QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194
Query: 182 TAIFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAELLTGKP----- 229
T +++T Y PE +F + T D++S G + E+L +
Sbjct: 195 T------HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244
Query: 230 LFPGK-NVVH---------QLDIMTD--LLGTPSPEAIARVCLL 261
L N+ QL+ + D L PE++ +
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDT 288
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 79.5 bits (195), Expect = 1e-15
Identities = 88/530 (16%), Positives = 155/530 (29%), Gaps = 183/530 (34%)
Query: 44 DTRTGE-KVAIKKINDIFE----------HVSDATR-ILREIKLLRLLRHPDIVEIKHIL 91
D TGE + K I +FE V D + IL + EI HI+
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK------------EEIDHII 55
Query: 92 LPPSRREFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQL--------LRGLKY 141
+ +F + S ++++ + L Y+F + + + Y
Sbjct: 56 MSKDAVS--GTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTRMY 112
Query: 142 IHTANVFHRD-----------LKPKNILANADCKLK----ICDFG--------LARVAFN 178
I + + D L+P L A +L+ + G +A
Sbjct: 113 IEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL 172
Query: 179 DT------PTAIFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAEL 224
IFW + + +PE L +T D
Sbjct: 173 SYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD----------- 218
Query: 225 LTGKPLFPGKNVVHQLDIMTD-----LLGTPSPEAIARVCLL-LNIIWCGYDGFMCSVAP 278
N+ ++ + L P CLL L + +
Sbjct: 219 -------HSSNIKLRIHSIQAELRRLLKSKPYEN-----CLLVLLNVQ---N-------A 256
Query: 279 SCFLVFAIFFFFTEVLILHCQV----RNEKARRYLSSMRKKKP--IPFSQKFPNANPLAL 332
+ F + C++ R ++ +LS+ S
Sbjct: 257 KAWNAFNL----------SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE--VK 304
Query: 333 RLLERMLAFEPKDRPTAEEALA-DPYFKGL-AKVEREPSAQPVTKMEFEFER-RRITKED 389
LL + L P+D P E L +P + A+ R+ A ++ + + +
Sbjct: 305 SLLLKYLDCRPQDLP--REVLTTNPRRLSIIAESIRDGLAT--------WDNWKHVNCDK 354
Query: 390 VRELIYREILEYHPQMLKEFLEGSEPTGFMYPSAVDHFKKQFAYLEEHYGKGTTVAPPER 449
+ +I + L EP ++K F L +V PP
Sbjct: 355 LTTII------------ESSLNVLEP---------AEYRKMFDRL--------SVFPP-- 383
Query: 450 QHASLPRP--CVLYSDKTVQNSAAVTDDLSKCSIKEVEKPPMDRTSGIPM 497
A +P +++ D + V + L K S+ VEK P + T IP
Sbjct: 384 -SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL--VEKQPKESTISIPS 430
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 65/230 (28%)
Query: 30 VIGKGSYGVVCSAYD-TRTGEKVAIKKINDIFEHVSD--ATRILREIKLLRLLRHPDIV- 85
+G+G +GVV Y VA+KK+ + + ++ + +EIK++ +H ++V
Sbjct: 38 KMGEGGFGVV---YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL--- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL-----LDRLSCLDGTP 128
Query: 137 ---------------RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181
G+ ++H + HRD+K NIL + KI DFGLAR +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 182 TAIFWTDYVA-TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229
T + T + T Y APE L G + TP DI+S G + E++TG P
Sbjct: 189 TVM--TSRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 36/176 (20%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
+ +K+ IG+G +G + A D + E V + SD + E+K +
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 82 PDIVE-------IKHILLPP-------SRREFKDIYVVFELMESDLHQVIKANDDLTPEH 127
P+ ++ +K++ +P + +++ + SDL ++ +AN
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------ 146
Query: 128 YQFFL-------YQLLRGLKYIHTANVFHRDLKPKNIL--ANADCKLKICDFGLAR 174
+F ++L L+YIH H D+K N+L ++ + D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 26/176 (14%), Positives = 63/176 (35%), Gaps = 30/176 (17%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG--------EKVAIKKINDIFEHVSDATRILREI 73
G ++K++ + + G++ A T T +K ++K + R+ E
Sbjct: 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKD--GRLFNEQ 93
Query: 74 KLL-RLLRHPDIVEIKHILLPPS----------RREFKDIYVVFELMESDLHQVIKANDD 122
R + + + K + P + K ++V + L + +
Sbjct: 94 NFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPK 153
Query: 123 LT-PEHYQFFL-YQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI--CDFGLAR 174
E + +LL L+++H H ++ +NI + + + ++ +G A
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168
+E + D LT EH + +Q+ +G++++ + HRDL +NIL + +KIC
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFNDTPTAIFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AELLT-GKPLFPGKNVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 45/220 (20%)
Query: 30 VIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATR-ILREIKLLRLLRHPDIV- 85
++G+G +G V Y G VA+K++ + E E++++ + H +++
Sbjct: 37 ILGRGGFGKV---YKGRLADGTLVAVKRLKE--ERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 86 ------EIKHILLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLT-PEHYQFFLY 133
LL V+ M S L + ++ L P+ + L
Sbjct: 92 LRGFCMTPTERLL------------VYPYMANGSVASCLRERPESQPPLDWPKRQRIAL- 138
Query: 134 QLLRGLKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 190
RGL Y+H + HRD+K NIL + + + + DFGLA++ + T + T
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDTHVT-TAVR 196
Query: 191 ATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAELLTGK 228
T + APE G K + D++ G + EL+TG+
Sbjct: 197 GTIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 599 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.66 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.0 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.8 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.3 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.27 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.69 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.38 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.06 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-67 Score=567.67 Aligned_cols=342 Identities=50% Similarity=0.889 Sum_probs=298.8
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS- 95 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s- 95 (599)
..+..+++|++++.||+|+||+||+|+++.+|+.||||+|+.........+++++|+.+|+.++|||||++++++....
T Consensus 48 ~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 48 VTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 3456778999999999999999999999999999999999877666677788999999999999999999999986542
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..+...+|||||||+|+|.+++...+.+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 128 ~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 128 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 34557899999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCC-CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDT-PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
..... ......++.+||++|+|||++.+. ..|+.++||||+|||+|||++|++||.|.+..+++..|.+..|.|+.+.
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 54322 122334678999999999998763 4679999999999999999999999999999999999999999998875
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+.. ........++..++...+.++...++.++++++||
T Consensus 287 ~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 324 (398)
T 4b99_A 287 IQA------------------------------------------VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSL 324 (398)
T ss_dssp TC-----------------------------------------------CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHH
T ss_pred hhh------------------------------------------hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHH
Confidence 433 33344567788888888889999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
|++||++||.+||||+|||+||||+.+.+++.+|.+.+ .+++.++...++.+++++++++|+.+||.
T Consensus 325 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~~~~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 325 LGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PFDFAFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp HHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CCCCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CCCCccchhhcCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999988887776654 45677888899999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-59 Score=506.20 Aligned_cols=350 Identities=39% Similarity=0.705 Sum_probs=300.1
Q ss_pred cccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
...+..+...++|+++++||+|+||+||+|+++.+|+.||||++...+.......++.+|+.+|+.++||||+++++++.
T Consensus 16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 34556788899999999999999999999999999999999999877777777889999999999999999999999997
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccc
Q 007542 93 PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
.........+|+||||++++|.+++.....+++..++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 76555567899999999999999999988899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-------------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-------
Q 007542 173 ARVAFNDTPT-------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT------- 226 (599)
Q Consensus 173 a~~~~~~~~~-------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt------- 226 (599)
++........ ....+.++||++|+|||++... ..|+.++||||||||+|||++
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccc
Confidence 9876433211 0234678999999999986442 579999999999999999997
Q ss_pred ----CCCCCCCCC-----------------hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhh
Q 007542 227 ----GKPLFPGKN-----------------VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFA 285 (599)
Q Consensus 227 ----G~~pF~g~~-----------------~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (599)
|+++|+|.+ ..+++..|.+++|.|+.+.+..
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~---------------------------- 306 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN---------------------------- 306 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHT----------------------------
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHh----------------------------
Confidence 788888876 4789999999999999998776
Q ss_pred hhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCC
Q 007542 286 IFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 365 (599)
Q Consensus 286 ~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~ 365 (599)
+....+.+++..++...+.++...++.+++.+++||++||++||.+|||++|+|+||||+++....
T Consensus 307 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 307 --------------INKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp --------------CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred --------------ccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 667778889999999889999999999999999999999999999999999999999999998877
Q ss_pred CCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhhH
Q 007542 366 REPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQML 406 (599)
Q Consensus 366 ~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~~~~ 406 (599)
.++.+.......++ +...++.+++++++++|+..|+|+..
T Consensus 373 ~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 373 LENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELV 412 (432)
T ss_dssp TC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred cCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCcccc
Confidence 77654322222222 22578999999999999999998853
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-59 Score=510.63 Aligned_cols=345 Identities=43% Similarity=0.762 Sum_probs=286.3
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..+...++|+++++||+|+||+||+|+++.+|+.||||++..........+++.+|+.+|+.++||||+++++++.....
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 47 SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp SSCCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcCccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 34677899999999999999999999999999999999998777777778899999999999999999999999977665
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
.....+|+||||++++|.+++.....+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 127 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 127 EKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp TTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred ccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 66678999999999999999999889999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCC------------------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh------
Q 007542 177 FNDTPT------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT------ 226 (599)
Q Consensus 177 ~~~~~~------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt------ 226 (599)
...... ....+.++||++|+|||++... ..|+.++||||||||||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 422111 1134667999999999986432 579999999999999999998
Q ss_pred -----CCCCCCCCC--------------------hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccc
Q 007542 227 -----GKPLFPGKN--------------------VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCF 281 (599)
Q Consensus 227 -----G~~pF~g~~--------------------~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (599)
|+++|+|.+ ..+++..|.+++|.|+.+.+..
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~------------------------ 341 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEA------------------------ 341 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHT------------------------
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhh------------------------
Confidence 889999876 3789999999999999998776
Q ss_pred hhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 282 LVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 282 ~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+.......++..++......+...++..++.+++||++||.+||.+|||++|+|+||||+++
T Consensus 342 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 342 ------------------LEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp ------------------SSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred ------------------cCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 55667788888898888899999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhh
Q 007542 362 AKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 405 (599)
Q Consensus 362 ~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~~~ 405 (599)
.....++.......+.++ +...++.+++++.+++|+..|||+.
T Consensus 404 ~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~ 446 (458)
T 3rp9_A 404 RIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446 (458)
T ss_dssp CCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCTTC
T ss_pred CCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCccc
Confidence 877666654332222322 2357889999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=493.20 Aligned_cols=269 Identities=26% Similarity=0.440 Sum_probs=221.3
Q ss_pred CCCcccccc---cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccc
Q 007542 10 SADVDFFTE---YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVE 86 (599)
Q Consensus 10 ~~~~~~~~~---~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~ 86 (599)
+..+|+.++ |..-++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.|+|||||+
T Consensus 8 ssgvd~gten~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~ 87 (350)
T 4b9d_A 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87 (350)
T ss_dssp -------CCCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCccCCCcccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 456676665 34568999999999999999999999999999999999866556666788999999999999999999
Q ss_pred cceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC
Q 007542 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163 (599)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~ 163 (599)
+++++.+ ...+|||||||+ |+|.++|...+ .+++..++.|+.||+.||.|||++|||||||||+|||++.+|
T Consensus 88 ~~~~~~~-----~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g 162 (350)
T 4b9d_A 88 YRESFEE-----NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG 162 (350)
T ss_dssp EEEEEEE-----TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC
T ss_pred EEEEEEE-----CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC
Confidence 9999953 357999999999 69999997653 579999999999999999999999999999999999999999
Q ss_pred ceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 007542 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243 (599)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I 243 (599)
.+||+|||+|+..... ....+..+||++|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|
T Consensus 163 ~vKl~DFGla~~~~~~---~~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i 237 (350)
T 4b9d_A 163 TVQLGDFGIARVLNST---VELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237 (350)
T ss_dssp CEEECSTTEESCCCHH---HHHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CEEEcccccceeecCC---cccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 9999999999865321 112345789999999999987 68999999999999999999999999998877766655
Q ss_pred HHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC
Q 007542 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323 (599)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 323 (599)
.+.- +...
T Consensus 238 ~~~~------------------------------------------------------------------------~~~~ 245 (350)
T 4b9d_A 238 ISGS------------------------------------------------------------------------FPPV 245 (350)
T ss_dssp HHTC------------------------------------------------------------------------CCCC
T ss_pred HcCC------------------------------------------------------------------------CCCC
Confidence 4311 0112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 324 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 324 ~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
...+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 2457899999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-59 Score=489.31 Aligned_cols=258 Identities=28% Similarity=0.504 Sum_probs=222.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 145 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 145 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 3679999999999999999999999999999999964322 234567899999999999999999999954 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|||||||+ |+|.+++.. +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999 599998876 469999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ..+..+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|.+...
T Consensus 225 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------ 287 (346)
T 4fih_A 225 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------ 287 (346)
T ss_dssp C---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC------------
T ss_pred C---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 2 2356799999999999987 6899999999999999999999999999887777666643210
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
+....+..+|+++++||.+||+
T Consensus 288 ----------------------------------------------------------~~~~~~~~~s~~~~dli~~~L~ 309 (346)
T 4fih_A 288 ----------------------------------------------------------PRLKNLHKVSPSLKGFLDRLLV 309 (346)
T ss_dssp ----------------------------------------------------------CCCSCGGGSCHHHHHHHHHHSC
T ss_pred ----------------------------------------------------------CCCCccccCCHHHHHHHHHHcC
Confidence 0111234578999999999999
Q ss_pred cCCCCCCCHHHHhcCccccCCc
Q 007542 341 FEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.||++|||++|+|+||||+...
T Consensus 310 ~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 310 RDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SSTTTSCCHHHHTTCGGGGGCC
T ss_pred CChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999998653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-59 Score=485.16 Aligned_cols=260 Identities=26% Similarity=0.448 Sum_probs=224.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|+++++||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+ ..
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CC
Confidence 467999999999999999999999999999999997432 223345788999999999999999999999954 45
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|||||||+ |+|.++|...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 7999999999 599999999889999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. .....+.+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+....+..|.+.-
T Consensus 186 ~~-~~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------ 250 (311)
T 4aw0_A 186 SK-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------------ 250 (311)
T ss_dssp TT-CCCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred CC-cccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------
Confidence 22 223456799999999999987 689999999999999999999999999988777666554310
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.. ....++++++|||++||
T Consensus 251 ----------------------------------------------------------~~---~p~~~s~~~~dli~~lL 269 (311)
T 4aw0_A 251 ----------------------------------------------------------YD---FPEKFFPKARDLVEKLL 269 (311)
T ss_dssp ----------------------------------------------------------CC---CCTTCCHHHHHHHHHHS
T ss_pred ----------------------------------------------------------CC---CCcccCHHHHHHHHHHc
Confidence 00 11357899999999999
Q ss_pred ccCCCCCCCHHH------HhcCccccCCc
Q 007542 340 AFEPKDRPTAEE------ALADPYFKGLA 362 (599)
Q Consensus 340 ~~DP~~RpTa~e------~L~HP~f~~~~ 362 (599)
+.||.+|||++| +++||||+++.
T Consensus 270 ~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 270 VLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred cCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 999999999987 58999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=483.53 Aligned_cols=336 Identities=41% Similarity=0.769 Sum_probs=285.2
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS- 95 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s- 95 (599)
+.+...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 4467789999999999999999999999999999999999776666667788999999999999999999999997642
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..+...+|+||||++++|.+++.. +.+++..++.+++||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 99 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 234467899999998899999987 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.... .+.+++|++|+|||++.+. ..++.++||||||||+++|++|++||.+.+..+++..|.+.+|.|+.+.+
T Consensus 178 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 5322 3567899999999998653 57899999999999999999999999999999999999999999999877
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. +.+.....++..++......+...++..++.+.+||
T Consensus 251 ~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 288 (367)
T 1cm8_A 251 QR------------------------------------------LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 288 (367)
T ss_dssp HT------------------------------------------CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHH
T ss_pred HH------------------------------------------hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 65 566777889999998888899999999999999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhh
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 405 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~~~ 405 (599)
.+||++||.+|||++|+|+||||+.+...+.++...+ +++.++....+.+++++++++|+..|+|+.
T Consensus 289 ~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (367)
T 1cm8_A 289 EKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK---YDDSFDDVDRTLDEWKRVTYKEVLSFKPPR 355 (367)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCC---CCCC-----CCHHHHHHHHHHHHHTCCC--
T ss_pred HHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCCC---CCCChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence 9999999999999999999999999988877776553 456677778899999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=473.45 Aligned_cols=254 Identities=32% Similarity=0.546 Sum_probs=206.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||+||+|+++.+|+.||||++++... ......++.+|+.+|+.++|||||++++++.+ ...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 589999999999999999999999999999999975432 23345678999999999999999999999954 357
Q ss_pred EEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 102 IYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
+||||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998653322
Q ss_pred CcccccccccCccccCccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
..++.+||+.|+|||++.+ ..| +.++|||||||++|+|++|++||.+.+....+..|.+..
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------- 228 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------- 228 (275)
T ss_dssp -----------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------------
T ss_pred ---ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 2346799999999999977 444 689999999999999999999999887655544443210
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
. .....+|+.+++||.+||+
T Consensus 229 ---------------------------------------------------------~---~~p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 229 ---------------------------------------------------------Y---TLPKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp ---------------------------------------------------------C---CCCTTSCHHHHHHHHHHSC
T ss_pred ---------------------------------------------------------C---CCCCCCCHHHHHHHHHHcc
Confidence 0 0113478999999999999
Q ss_pred cCCCCCCCHHHHhcCccccC
Q 007542 341 FEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~ 360 (599)
.||++|||++|+|+||||+.
T Consensus 249 ~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 249 VNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SSGGGSCCHHHHHHCHHHHT
T ss_pred CChhHCcCHHHHHcCccccc
Confidence 99999999999999999973
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=490.67 Aligned_cols=258 Identities=28% Similarity=0.501 Sum_probs=223.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCE
Confidence 467999999999999999999999999999999997432 2334568899999999999999999999954 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|||||||+ |+|.+++... .+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999 5999998764 69999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. ..+..+||++|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|.+...
T Consensus 302 ~---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------ 364 (423)
T 4fie_A 302 P---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------ 364 (423)
T ss_dssp C---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------------
T ss_pred c---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------------
Confidence 2 2356799999999999987 6899999999999999999999999999887777666543110
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
+....+..+|+.+++||.+||+
T Consensus 365 ----------------------------------------------------------~~~~~~~~~s~~~~dli~~~L~ 386 (423)
T 4fie_A 365 ----------------------------------------------------------PRLKNLHKVSPSLKGFLDRLLV 386 (423)
T ss_dssp ----------------------------------------------------------CCCSCTTSSCHHHHHHHHHHSC
T ss_pred ----------------------------------------------------------CCCcccccCCHHHHHHHHHHcC
Confidence 1112335689999999999999
Q ss_pred cCCCCCCCHHHHhcCccccCCc
Q 007542 341 FEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.||.+|||++|+|+||||+...
T Consensus 387 ~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 387 RDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SSTTTSCCHHHHTTCGGGGGCC
T ss_pred CChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999998643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-57 Score=482.93 Aligned_cols=339 Identities=39% Similarity=0.731 Sum_probs=265.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|++++.||+|+||+||+|.++.+|+.||||++...........++.+|+.+|+.+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 47899999999999999999999999999999999877777778889999999999997 99999999999643 235
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 101 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
.+|+|||||+++|.+++... .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp CEEEEEECCSEEHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEEecccCcCHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 79999999999999999874 79999999999999999999999999999999999999999999999999998653211
Q ss_pred ------------------CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 007542 181 ------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (599)
Q Consensus 181 ------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~ 242 (599)
......+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234567999999999998653 5789999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCC---CCC
Q 007542 243 MTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK---PIP 319 (599)
Q Consensus 243 I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~---~~~ 319 (599)
|...+|.|+.+.+..+ .......++..+.... ...
T Consensus 243 i~~~~~~p~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~ 280 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESI------------------------------------------QSPFAKTMIESLKEKVEIRQSN 280 (388)
T ss_dssp HHHHHCCCCHHHHHTS------------------------------------------CCSSHHHHHHHHHHHCC-----
T ss_pred HHHhcCCCCHHHHHhc------------------------------------------cCHHHHHHHHhCcccccccCCC
Confidence 9999999999877641 1111222222222111 112
Q ss_pred CcCCC-------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCC
Q 007542 320 FSQKF-------------PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRIT 386 (599)
Q Consensus 320 ~~~~~-------------~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~ 386 (599)
+...+ ...++.+++||.+||++||.+|||++|+|+||||+.+..+..++.+.......++ +....+
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 359 (388)
T 3oz6_A 281 KRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHS 359 (388)
T ss_dssp CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CC
T ss_pred HHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCC
Confidence 22222 2678999999999999999999999999999999999888877766544333332 235678
Q ss_pred HHHHHHHHHHHHHhhChhhHHh
Q 007542 387 KEDVRELIYREILEYHPQMLKE 408 (599)
Q Consensus 387 ~e~~~~~~~~e~~~~~~~~~~~ 408 (599)
.+++++.+++|+.++++++..+
T Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~ 381 (388)
T 3oz6_A 360 IDDYRNLVYSEISRRKRELISN 381 (388)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHHhhhhhhhh
Confidence 9999999999999999886543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=466.08 Aligned_cols=262 Identities=26% Similarity=0.387 Sum_probs=219.0
Q ss_pred CCCCce-EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 20 GEGSRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY-~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
...+|| ++.++||+|+||+||+|+++.++..||||++..........+++.+|+.+|+.++|||||++++++.... ..
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CC
Confidence 345566 7888999999999999999999999999999766556666788999999999999999999999985432 23
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecC-CCceeeecccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLAR 174 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~-~~~lKL~DFGla~ 174 (599)
...+|||||||+ |+|.+++...+.+++..++.|+.||+.||.|||++| |+||||||+|||++. +|.+||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 357999999999 699999999889999999999999999999999999 999999999999984 7999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
..... ..+..+||+.|+|||++.+ .|+.++||||||||+|||++|++||.+.+...++...... +..
T Consensus 181 ~~~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~---- 247 (290)
T 3fpq_A 181 LKRAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVK---- 247 (290)
T ss_dssp GCCTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCC----
T ss_pred eCCCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCC----
Confidence 64321 2346789999999999865 5999999999999999999999999876654443222110 000
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+ .......++++.+|
T Consensus 248 --------------------------------------------------------------~---~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 248 --------------------------------------------------------------P---ASFDKVAIPEVKEI 262 (290)
T ss_dssp --------------------------------------------------------------C---GGGGGCCCHHHHHH
T ss_pred --------------------------------------------------------------C---CCCCccCCHHHHHH
Confidence 0 01113467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
|.+||+.||.+|||++|+|+||||++
T Consensus 263 i~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 263 IEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=481.83 Aligned_cols=337 Identities=43% Similarity=0.826 Sum_probs=282.2
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCC-C
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPP-S 95 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~-s 95 (599)
+.+...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++... .
T Consensus 23 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 23 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 346678999999999999999999999999999999999987666666778899999999999999999999999654 2
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
......+|+|+|+++++|.+++.. +.+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 103 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp GGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred cccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 234567899999999999999876 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.... .+.+++|++|+|||++.+. ..++.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|+.+.+
T Consensus 182 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 182 TADE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5321 3457899999999998653 57899999999999999999999999999999999999999999999876
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. +.+...+.++..+.......+...++..++.+.+||
T Consensus 255 ~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl 292 (367)
T 2fst_X 255 KK------------------------------------------ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292 (367)
T ss_dssp TT------------------------------------------CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHH
T ss_pred HH------------------------------------------hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHH
Confidence 65 566777888888888888888888999999999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhhH
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQML 406 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~~~~ 406 (599)
++||++||.+|||++|+|+||||+.+..+..++...+ +++.++......+++++++++|+..|+|+..
T Consensus 293 ~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 360 (367)
T 2fst_X 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSLESRDLLIDEWKSLTYDEVISFVPPPL 360 (367)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCGGGSSCCCCHHHHHHHHHHHHHHCCCCC-
T ss_pred HHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCcchhhccCCHHHHHHHHHHHHHHhccCcc
Confidence 9999999999999999999999999988877776653 4566777889999999999999999998743
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=475.71 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=215.0
Q ss_pred CCceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.++|++++.||+|+||+||+|++. .+++.||||+++..........++.+|+.+|+.++|||||++++++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----- 97 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----- 97 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----
Confidence 478999999999999999999984 468899999997544333344568899999999999999999999954
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 357999999999 6999999998899999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ...+.+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|.+..
T Consensus 178 ~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------- 242 (304)
T 3ubd_A 178 DHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK---------- 242 (304)
T ss_dssp ---C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred CCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC----------
Confidence 3221 2356799999999999987 689999999999999999999999999988777666554310
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. .....+|+++.+||++
T Consensus 243 ------------------------------------------------------------~---~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 243 ------------------------------------------------------------L---GMPQFLSPEAQSLLRM 259 (304)
T ss_dssp ------------------------------------------------------------C---CCCTTSCHHHHHHHHH
T ss_pred ------------------------------------------------------------C---CCCCcCCHHHHHHHHH
Confidence 0 0113478999999999
Q ss_pred hcccCCCCCCC-----HHHHhcCccccCC
Q 007542 338 MLAFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
||+.||++||| ++|+|+||||+++
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999999998 5899999999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=474.38 Aligned_cols=297 Identities=27% Similarity=0.439 Sum_probs=225.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~ 96 (599)
..++|++++.||+|+||+||+|+++ .+++.||||++... ....++.+|+.+|+.+ +||||++++++|..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--- 91 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--- 91 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE---
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE---
Confidence 4578999999999999999999875 46889999998642 3456788999999998 59999999999943
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-Cceeeecccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFGla~ 174 (599)
..++|||||||+ ++|.+++. .+++..++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 92 --~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 --NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp --TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 457999999998 69999983 59999999999999999999999999999999999999887 899999999998
Q ss_pred cccCCCCC-------------------------cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCC
Q 007542 175 VAFNDTPT-------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKP 229 (599)
Q Consensus 175 ~~~~~~~~-------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~ 229 (599)
........ ....++.+||++|+|||++.+. ..|+.++||||+|||+|||++|++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCC
Confidence 65322110 1123457899999999998763 468999999999999999999997
Q ss_pred CC-CCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHH
Q 007542 230 LF-PGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRY 308 (599)
Q Consensus 230 pF-~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~ 308 (599)
|| .+.+..+++..|.+++|++.......... ........ ......+..
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~--~~~~~~~~-----------------------------~p~~~~~~~ 294 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFG--KSILCSKE-----------------------------VPAQDLRKL 294 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT--EEEEESSC-----------------------------CCCCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhcc--cccccccc-----------------------------CcchhhhHH
Confidence 66 67788999999999999765544333110 00000000 000000111
Q ss_pred HHhcc---c---------CCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 309 LSSMR---K---------KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 309 i~~~~---~---------~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
...+. . .........++.+|++++|||++||++||++|+||+|||+||||+++
T Consensus 295 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 295 CERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 11000 0 00111224467789999999999999999999999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-56 Score=486.44 Aligned_cols=332 Identities=37% Similarity=0.699 Sum_probs=265.8
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-CC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-RE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~~ 98 (599)
...++|++++.||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++..... .+
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 44689999999999999999999999999999999998776677778889999999999999999999999975532 45
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+||||||++++|.+.+.. .+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 568999999999999998854 499999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
. ...+..+||++|+|||++.+ ..|+.++||||||||+|+|++|++||.|.+..+++..|.+.+|.|.++.+..+
T Consensus 217 ~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 S----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C----CCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred C----cccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 2 22456799999999999987 68999999999999999999999999999999999999999999999876541
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC-----------
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA----------- 327 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~----------- 327 (599)
....+.++...+......+...++..
T Consensus 291 -------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (464)
T 3ttj_A 291 -------------------------------------------QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327 (464)
T ss_dssp -------------------------------------------CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHH
T ss_pred -------------------------------------------chhhhhHhhcccccCCCChHHhCcccccccccccccc
Confidence 22344555555444444444444432
Q ss_pred -CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 328 -NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 328 -s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
++.+++||++||++||.+|||++|+|+||||+.+.++..+... +....++.++....+.+++++++++|+..++.
T Consensus 328 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 403 (464)
T 3ttj_A 328 KASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAP-PPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403 (464)
T ss_dssp HHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCC-C-----------CCCHHHHHHHHHHHHHC---
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCC-CCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence 6789999999999999999999999999999987665433221 12234556677788999999999999986554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=468.53 Aligned_cols=258 Identities=26% Similarity=0.358 Sum_probs=216.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.++|||||++++++.+ ...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~-----~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVRE-----GPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEE-----TTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 4679999999999999999999999999999999974321 2479999999999999999999943 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-ceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-~lKL~DFGla~~~~~~ 179 (599)
+|||||||+ |+|.++|+..+.+++..++.|+.||+.||.|||++|||||||||+|||++.+| .+||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999 69999999988999999999999999999999999999999999999999997 6999999999876433
Q ss_pred CCCc--ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 180 TPTA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 180 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......+||+.|||||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 2211 11234589999999999987 6899999999999999999999999998776554444432
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.+.++.+..+.+++.+.+||.+
T Consensus 271 ----------------------------------------------------------~~~~~~~~~~~~s~~~~~li~~ 292 (336)
T 4g3f_A 271 ----------------------------------------------------------EPPPIREIPPSCAPLTAQAIQE 292 (336)
T ss_dssp ----------------------------------------------------------SCCGGGGSCTTSCHHHHHHHHH
T ss_pred ----------------------------------------------------------CCCCchhcCccCCHHHHHHHHH
Confidence 1112234456789999999999
Q ss_pred hcccCCCCCCCHHHH-------------hcCccccCCcc
Q 007542 338 MLAFEPKDRPTAEEA-------------LADPYFKGLAK 363 (599)
Q Consensus 338 mL~~DP~~RpTa~e~-------------L~HP~f~~~~~ 363 (599)
||+.||.+|||+.|+ |+|||+....+
T Consensus 293 ~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 293 GLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 999999999999997 67999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=457.00 Aligned_cols=342 Identities=48% Similarity=0.858 Sum_probs=291.0
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..+..+++|++++.||+|+||.||+|++..++..||||++.. .........+.+|+.+|+.++||||+++++++.....
T Consensus 21 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred EeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc-ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 456778999999999999999999999999999999999974 2344456788999999999999999999999976655
Q ss_pred CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
.....+|+||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~~~~~iv~e~~~~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 100 EQMKDVYIVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEcccCcCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 556789999999999999999764 6999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.............+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|...+|.|+.+.+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 4433333334567899999999987542 568999999999999999999999999999999999999999999998776
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
. ..+.....+...++.....++...++..++.+.+||.
T Consensus 258 ~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 295 (364)
T 3qyz_A 258 C------------------------------------------IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD 295 (364)
T ss_dssp T------------------------------------------CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHH
T ss_pred H------------------------------------------hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHH
Confidence 5 4455566777777777778888888999999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhh
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQM 405 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~~~ 405 (599)
+||++||.+|||++|+|+||||+.......++.... .+.++.+...+.++++++++++|+..|+|..
T Consensus 296 ~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 362 (364)
T 3qyz_A 296 KMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 362 (364)
T ss_dssp HHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC-----CCHHHHHHHHHHHTGGGCC--
T ss_pred HHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCcccccccCCHHHHHHHHHHHHHHhhhhc
Confidence 999999999999999999999999876655554432 2344556678889999999999999988764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=447.44 Aligned_cols=263 Identities=26% Similarity=0.443 Sum_probs=200.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc------
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR------ 96 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~------ 96 (599)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ......+++.+|+.+|+.++|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3699999999999999999999999999999999643 233445788999999999999999999999864332
Q ss_pred -CCCccEEEEEecCC-ccHHHHHHhCCCC---CHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 97 -REFKDIYVVFELME-SDLHQVIKANDDL---TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 97 -~~~~~lylV~E~~~-g~L~~~i~~~~~l---se~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
....++|||||||. |+|.+++...+.+ .+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 12346899999998 6999999877544 456788999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCc---------ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 007542 172 LARVAFNDTPTA---------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (599)
Q Consensus 172 la~~~~~~~~~~---------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~ 242 (599)
+|+......... ...+..+||+.|||||++.+ ..|+.++||||||||+|||++ ||.+. .+....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~ 236 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT 236 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence 998764332211 12345789999999999987 689999999999999999996 56542 222222
Q ss_pred HHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcC
Q 007542 243 MTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322 (599)
Q Consensus 243 I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 322 (599)
+........+.
T Consensus 237 ~~~~~~~~~p~--------------------------------------------------------------------- 247 (299)
T 4g31_A 237 LTDVRNLKFPP--------------------------------------------------------------------- 247 (299)
T ss_dssp HHHHHTTCCCH---------------------------------------------------------------------
T ss_pred HHHHhcCCCCC---------------------------------------------------------------------
Confidence 22221111111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 323 ~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.++..++.+.+||++||+.||.+|||+.|+|+||||+++.
T Consensus 248 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 248 LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 1122356688999999999999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=444.30 Aligned_cols=332 Identities=42% Similarity=0.766 Sum_probs=279.6
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~ 97 (599)
+...++|.+.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 556789999999999999999999999999999999998766666667889999999999999999999999965432 2
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
....+|+||||+.++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 233569999999999998874 359999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ....++|++|+|||++.+. ..++.++|||||||++++|++|+.||.+.+..+++..|.+..|.+..+.+..
T Consensus 196 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 196 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence 22 2456889999999998652 5789999999999999999999999999999999999999999998876544
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
........++..+.......+...++..++.+.+||.+
T Consensus 269 ------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 306 (371)
T 4exu_A 269 ------------------------------------------LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 306 (371)
T ss_dssp ------------------------------------------CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred ------------------------------------------hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHH
Confidence 33444566677777766677777788899999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
||++||.+|||++|+|+||||+.+..+..+..... .+....+...++.+++++.+++|+.+|+|
T Consensus 307 ~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 307 MLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp HSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred HCCCChhhcCCHHHHhcCcccccCCCccccccccc--CcCcchhhcccchHHHHHHHHHHHHhccc
Confidence 99999999999999999999999876655443321 22333455678899999999999999876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=474.27 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=226.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++++.||+|+||+||+|+++.+|+.||||++... .......+.+|+.+|+.|+|||||+++++|.+ ...+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~ 229 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEM 229 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEE
Confidence 6899999999999999999999999999999999653 34456788999999999999999999999954 4579
Q ss_pred EEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC--CceeeecccccccccC
Q 007542 103 YVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFN 178 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~--~~lKL~DFGla~~~~~ 178 (599)
|||||||+ |+|+++|.. .+.+++..++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999 599999964 4679999999999999999999999999999999999999864 8999999999987643
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. .....+||++|+|||++.+ ..|+.++||||||||+|+||+|++||.+.+..+++..|......++
T Consensus 310 ~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 376 (573)
T 3uto_A 310 KQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------- 376 (573)
T ss_dssp TS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------
T ss_pred CC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC-------
Confidence 22 2356789999999999987 6899999999999999999999999999988877776654322211
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
...++.+|+.++|||++|
T Consensus 377 --------------------------------------------------------------~~~~~~~s~~~~dli~~~ 394 (573)
T 3uto_A 377 --------------------------------------------------------------DSAFSGISEDGKDFIRKL 394 (573)
T ss_dssp --------------------------------------------------------------SGGGTTSCHHHHHHHHTT
T ss_pred --------------------------------------------------------------cccccCCCHHHHHHHHHH
Confidence 123456889999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCccC
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
|++||.+|||++|+|+||||+....+
T Consensus 395 L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 395 LLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp SCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred ccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 99999999999999999999976543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=436.27 Aligned_cols=332 Identities=42% Similarity=0.766 Sum_probs=280.1
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~ 97 (599)
+...++|.+.+.||+|+||.||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 445689999999999999999999999999999999998765555667788999999999999999999999965432 2
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
....+|+||||+.++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEeccccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 2345799999999999888743 59999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ....++|++|+|||++.+. ..++.++|||||||++++|++|+.||.+.+..+++..|.+..|.++.+.+..
T Consensus 178 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 22 2456889999999998652 5689999999999999999999999999999999999999999998876543
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
+.......++..++......+...++..++.+.+||.+
T Consensus 251 ------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (353)
T 3coi_A 251 ------------------------------------------LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288 (353)
T ss_dssp ------------------------------------------CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH
T ss_pred ------------------------------------------HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH
Confidence 33444566777777777777788888999999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
||+.||.+|||++|+|+||||+.+..++.++.... .+....+...++.+++++.|++|+.+++|
T Consensus 289 ~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 289 MLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp HSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred HcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccchhhccCCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999998876655444332 23445566789999999999999998765
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=431.20 Aligned_cols=338 Identities=43% Similarity=0.803 Sum_probs=278.1
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.+...++|++.+.||+|+||.||+|.+..+|+.||||++.. .........+.+|+.+|+.++||||+++++++......
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc-cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 35678999999999999999999999999999999999964 23344566788999999999999999999998766555
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
....+|+||||+.++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 5678999999999999999987 469999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCc-------ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 178 NDTPTA-------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 178 ~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
...... ......+||+.|+|||++.+. ..++.++|||||||++++|++|++||.+.+..+++..+....|.|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 322111 112346889999999987542 568999999999999999999999999999999999999998887
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
....... .........++..+.......+...++.+++.
T Consensus 243 ~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
T 2b9h_A 243 HSDNDLR-----------------------------------------CIESPRAREYIKSLPMYPAAPLEKMFPRVNPK 281 (353)
T ss_dssp CSTTTTT-----------------------------------------TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred chhcccc-----------------------------------------ccccchhhHHhhcccCCCCcchhhhcccCCHH
Confidence 6431100 02334455666666665666666777889999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCc--chhhHhhhcCCHHHHHHHHHHHHH
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK--MEFEFERRRITKEDVRELIYREIL 399 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~--~~~~~e~~~~~~e~~~~~~~~e~~ 399 (599)
+.+||.+||+.||.+|||++|+|+||||+.......++...++.. +++......++.+++++++++|+.
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 282 GIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred HHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 999999999999999999999999999999877666665555443 344445677899999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=438.76 Aligned_cols=331 Identities=37% Similarity=0.687 Sum_probs=255.1
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-cCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s-~~~ 98 (599)
...++|++++.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ..+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3468999999999999999999999999999999999866556666778899999999999999999999996543 234
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+|+||||++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ccceEEEEEcCCCCHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 458999999999999999863 599999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. .....+||+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|.++.+..+
T Consensus 180 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 180 SF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cc----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 21 2345689999999999987 67999999999999999999999999999999999999999999998766431
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC------------
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN------------ 326 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~------------ 326 (599)
. .....++...+......+...++.
T Consensus 254 ~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (371)
T 2xrw_A 254 Q-------------------------------------------PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290 (371)
T ss_dssp C-------------------------------------------HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHH
T ss_pred h-------------------------------------------hHHHHHHhhCccccccchhhhcccccCccccccccc
Confidence 1 111222222222111111111111
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 402 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~ 402 (599)
.++.+++||++||++||.+|||++|+|+||||+.+..+...... +........+.+..+.++++++++.++..+.
T Consensus 291 ~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 291 KASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCC-CCCCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred ccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCC-CCCCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence 25678999999999999999999999999999987553221111 1111233445567788999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=468.48 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=212.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHH---HHHHHHhcCCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILR---EIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~r---Ei~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
-++|+++++||+|+||+||+|+++.+|+.||||+|++... .......+.+ ++.+++.++|||||+++++|.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~---- 263 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT---- 263 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----
Confidence 3689999999999999999999999999999999964211 1112223333 4566677789999999999954
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...+|||||||. |+|.++|...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 357999999999 699999999899999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... ..+.+||+.|+|||++... ..|+.++||||||||+|||++|++||.+.+..+....+...+.
T Consensus 343 ~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-------- 408 (689)
T 3v5w_A 343 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-------- 408 (689)
T ss_dssp SSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--------
T ss_pred CCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--------
Confidence 4332 2456999999999998531 5799999999999999999999999987544332221111000
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
... .....+|+++++||.
T Consensus 409 -----------------------------------------------------------~~~---~~p~~~S~~a~dLI~ 426 (689)
T 3v5w_A 409 -----------------------------------------------------------MAV---ELPDSFSPELRSLLE 426 (689)
T ss_dssp -----------------------------------------------------------CCC---CCCTTSCHHHHHHHH
T ss_pred -----------------------------------------------------------CCC---CCCccCCHHHHHHHH
Confidence 000 122458999999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCccccCC
Q 007542 337 RMLAFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
+||+.||.+|++ ++|+++||||+++
T Consensus 427 ~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 999999999998 8999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=422.66 Aligned_cols=296 Identities=40% Similarity=0.664 Sum_probs=238.5
Q ss_pred cccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
.+-.+.-+..++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++.
T Consensus 11 ~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 11 RENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp ----CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 333455578899999999999999999999985 5999999999765444445677889999999999999999999994
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 93 PPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
. ...+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 90 ~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 90 S-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp C-----SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred c-----CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCc
Confidence 3 35799999999999999988754 59999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
+++....... ..+..++|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|...+|.+.
T Consensus 165 ~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 240 (311)
T 3niz_A 165 LARAFGIPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240 (311)
T ss_dssp TCEETTSCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred CceecCCCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence 9987543221 23456889999999998652 5689999999999999999999999999999999999999999988
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHH-HhcccCCCCCCcCCCCCCCHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYL-SSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~s~~ 330 (599)
+..+...... ..+. .........++....+..+++
T Consensus 241 ~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (311)
T 3niz_A 241 PREWPQVQEL--------------------------------------------PLWKQRTFQVFEKKPWSSIIPGFCQE 276 (311)
T ss_dssp TTTSGGGTTS--------------------------------------------HHHHSCCCCCCCCCCHHHHSTTCCHH
T ss_pred hHHhhhhhcc--------------------------------------------chhhhcccccccCCcHHHhCcccCHH
Confidence 7644321000 0000 001111223344456778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+++||.+||++||.+|||++|+|+||||+++.
T Consensus 277 ~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 277 GIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 99999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=424.56 Aligned_cols=265 Identities=24% Similarity=0.351 Sum_probs=215.2
Q ss_pred ccccccCCCCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccc
Q 007542 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIK 88 (599)
Q Consensus 14 ~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~ 88 (599)
|-+...-..++|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.+.+|+.+|+.++|||||+++
T Consensus 4 d~~~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 4 DTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp GGSCCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhhhcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 33333344578999999999999999999875 46889999999753 344567899999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCC-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCC
Q 007542 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKAN-------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKP 154 (599)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~-------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (599)
+++... ..+|||||||+ |+|.++|... ..+++..+..|+.||+.||.|||+++|+||||||
T Consensus 82 g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp 156 (299)
T 4asz_A 82 GVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 156 (299)
T ss_dssp EEECSS-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCH
Confidence 999543 46999999999 6999999764 3699999999999999999999999999999999
Q ss_pred CceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 007542 155 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPG 233 (599)
Q Consensus 155 ~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g 233 (599)
+|||++.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++||||+||++|||+| |++||.+
T Consensus 157 ~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 157 RNCLVGENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred hhEEECCCCcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999875432211 11234578999999999987 689999999999999999998 8999998
Q ss_pred CChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcc
Q 007542 234 KNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMR 313 (599)
Q Consensus 234 ~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~ 313 (599)
.+..+.+..|.+..
T Consensus 234 ~~~~~~~~~i~~~~------------------------------------------------------------------ 247 (299)
T 4asz_A 234 LSNNEVIECITQGR------------------------------------------------------------------ 247 (299)
T ss_dssp SCHHHHHHHHHHTC------------------------------------------------------------------
T ss_pred CCHHHHHHHHHcCC------------------------------------------------------------------
Confidence 87665554443210
Q ss_pred cCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 314 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 314 ~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.. .....+++.+.+||.+||+.||++|||++|+ |+|++.+.
T Consensus 248 ---~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 248 ---VL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp ---CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred ---CC---CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 00 1123578899999999999999999999999 56777654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=423.80 Aligned_cols=257 Identities=23% Similarity=0.296 Sum_probs=206.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.+++++.+.||+|+||+||+|++. ..||||+++.........+.+.+|+.+|+.++|||||++++++.. ..
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence 478999999999999999999753 369999998655556667889999999999999999999998742 25
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|||||||+ |+|.+++... +.+++..+..|+.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 799999999 6999999765 57999999999999999999999999999999999999999999999999999875332
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ....+..+||+.|+|||++.+. ...|+.++|||||||+||||+||+.||.+.+...++..+....
T Consensus 186 ~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~----------- 253 (307)
T 3omv_A 186 SG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG----------- 253 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT-----------
T ss_pred Cc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC-----------
Confidence 21 1123456899999999998542 2458999999999999999999999999876555443332110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.....+....+++++.+.+||.+|
T Consensus 254 --------------------------------------------------------~~~p~~~~~~~~~~~~l~~li~~c 277 (307)
T 3omv_A 254 --------------------------------------------------------YASPDLSKLYKNCPKAMKRLVADC 277 (307)
T ss_dssp --------------------------------------------------------CCCCCSTTSCTTSCHHHHHHHHHH
T ss_pred --------------------------------------------------------CCCCCcccccccchHHHHHHHHHH
Confidence 011122344567889999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|+.||++|||+.|++++
T Consensus 278 l~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 278 VKKVKEERPLFPQILSS 294 (307)
T ss_dssp TCSSSTTSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=423.85 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=203.3
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|.+.++||+|+||+||+|+++ .++..||||+++.. .....+.+.+|+.+|+.++|||||++++++..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence 467999999999999999999865 46889999999742 34456789999999999999999999999954
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN---------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
...+|||||||+ |+|.+++... +.+++..+..|+.||+.||.|||+.+||||||||+|||++
T Consensus 115 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 347999999999 6999999754 3589999999999999999999999999999999999999
Q ss_pred CCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhH
Q 007542 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~ 239 (599)
.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999875432211 12245689999999999987 689999999999999999998 8999998876665
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
+..|.+.. ..
T Consensus 270 ~~~i~~g~---------------------------------------------------------------------~~- 279 (329)
T 4aoj_A 270 IDCITQGR---------------------------------------------------------------------EL- 279 (329)
T ss_dssp HHHHHHTC---------------------------------------------------------------------CC-
T ss_pred HHHHHcCC---------------------------------------------------------------------CC-
Confidence 54443210 00
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.....+++.+.+||.+||+.||++|||++|++++
T Consensus 280 --~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 280 --ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp --CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred --CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1113578899999999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=413.18 Aligned_cols=287 Identities=39% Similarity=0.635 Sum_probs=236.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++++.||+|+||+||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 58999999999999999999999999999999997655555566788999999999999999999999843 3579
Q ss_pred EEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+||||++++|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887766 56899999999999999999999999999999999999999999999999999987532221
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~-~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
.....++|++|+|||++.+. ..++.++|||||||++|+|++|. ++|.+.+..+++..+.+.+|.+..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 23456889999999998662 44899999999999999999765 56888999999999999999988764332110
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
... +.. .........+....+..++.+.+||++||+
T Consensus 233 ~~~-----~~~---------------------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 268 (292)
T 3o0g_A 233 LPD-----YKP---------------------------------------YPMYPATTSLVNVVPKLNATGRDLLQNLLK 268 (292)
T ss_dssp STT-----CCC---------------------------------------CCCCCTTCCCTTTSTTCCHHHHHHHHHHSC
T ss_pred ccc-----ccc---------------------------------------cccccCCcchhhcccccChHHHHHHHHHhc
Confidence 000 000 000011122334556789999999999999
Q ss_pred cCCCCCCCHHHHhcCccccCCc
Q 007542 341 FEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+||.+|||++|+|+||||+++.
T Consensus 269 ~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 269 CNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp SSGGGSCCHHHHHTSGGGTTC-
T ss_pred cChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=421.56 Aligned_cols=332 Identities=36% Similarity=0.668 Sum_probs=261.4
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---------ChhhHHHHHHHHHHHHhcCCCCcccccee
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---------HVSDATRILREIKLLRLLRHPDIVEIKHI 90 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~---------~~~~~~~i~rEi~iL~~l~HpnIv~l~~v 90 (599)
...++|++++.||+|+||.||+|.+.. |..||||++..... .......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 457899999999999999999999855 99999999964322 22234788999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeec
Q 007542 91 LLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (599)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~D 169 (599)
+..........+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 8665444556899999999999999998654 799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
||+++...... ......+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.
T Consensus 178 fg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 178 FNLAREDTADA----NKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp TTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cCccccccccc----ccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99997543222 22456899999999988653 56899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhc-ccCCCCCCcCCCCCCC
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM-RKKKPIPFSQKFPNAN 328 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~s 328 (599)
|..+.+.. .......+++... .......+....+..+
T Consensus 253 ~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (362)
T 3pg1_A 253 PKIEDVVM------------------------------------------FSSPSARDYLRNSLSNVPARAWTAVVPTAD 290 (362)
T ss_dssp CCHHHHHH------------------------------------------TSCHHHHHHTTTCCCCCCCCCHHHHSTTSC
T ss_pred CChHHhhh------------------------------------------ccchhhhHHHHhhcccCChhhHHhhCCCCC
Confidence 98876544 2222223333222 2222333445567789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYH 402 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~ 402 (599)
+.+.+||.+||++||.+|||++|+|+||||+++..+.+...... ..+.++....+.+++++.++.|+.+|+
T Consensus 291 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 291 PVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLS---ERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTCC---CCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccccccc---cccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999865443322211 233455567788999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=417.13 Aligned_cols=261 Identities=26% Similarity=0.455 Sum_probs=225.6
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.. .
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-----E 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----C
Confidence 44578999999999999999999999999999999998766666677889999999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 57999999997 69999999888999999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. .....+||++|+|||++.+ ..+ +.++||||||||+|+|++|++||.+.+.......+....
T Consensus 167 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------- 230 (328)
T 3fe3_A 167 GG----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---------- 230 (328)
T ss_dssp SC----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred CC----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 22 2356789999999999976 344 579999999999999999999999987665554443210
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. ......++.+.+||++
T Consensus 231 ----------------------------------------------------------~-----~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 231 ----------------------------------------------------------Y-----RIPFYMSTDCENLLKR 247 (328)
T ss_dssp ----------------------------------------------------------C-----CCCTTSCHHHHHHHHH
T ss_pred ----------------------------------------------------------C-----CCCCCCCHHHHHHHHH
Confidence 0 0112468899999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
||++||.+|||++|+|+||||+.....
T Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~~~~ 274 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRWINAGHEE 274 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred HCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence 999999999999999999999976543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=418.99 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=208.9
Q ss_pred CCceEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
-+++++++.||+|+||+||+|.. ..+++.||||+++... .....+.+.+|+.+|+.++|||||++++++...
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-- 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-- 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--
Confidence 35789999999999999999985 3467899999997533 233457799999999999999999999999543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv 159 (599)
..+|||||||+ |+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+||||
T Consensus 102 ---~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 ---QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp ---SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ---CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 46899999999 7999999653 358999999999999999999999999999999999999
Q ss_pred cCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhh
Q 007542 160 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVH 238 (599)
Q Consensus 160 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~ 238 (599)
+.++.+||+|||+|+........ ...+..+||+.|+|||++.+ ..|+.++||||+||++|||+| |.+||.+.+..+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred CCCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999875432211 12345689999999999977 689999999999999999998 899999987766
Q ss_pred HHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCC
Q 007542 239 QLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI 318 (599)
Q Consensus 239 ~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~ 318 (599)
.+..|.+.. ..
T Consensus 256 ~~~~i~~~~---------------------------------------------------------------------~~ 266 (308)
T 4gt4_A 256 VVEMIRNRQ---------------------------------------------------------------------VL 266 (308)
T ss_dssp HHHHHHTTC---------------------------------------------------------------------CC
T ss_pred HHHHHHcCC---------------------------------------------------------------------CC
Confidence 555443210 00
Q ss_pred CCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 319 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 319 ~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.....+++.+.+||.+||+.||.+|||+.|++++
T Consensus 267 ---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 267 ---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1123577889999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=411.28 Aligned_cols=285 Identities=38% Similarity=0.655 Sum_probs=232.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++++.||+|+||+||+|.+ .+|+.||||++............+.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence 5899999999999999999998 7899999999975443333446788999999999999999999999543 479
Q ss_pred EEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999865 6799999999999999999999999999999999999999999999999999987532211
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......+|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+.+.+|.+....+...
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 228 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV--- 228 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG---
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh---
Confidence 12455789999999998652 46899999999999999999999999999999999999998888765432210
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
... ..+-..+....+.++.......++.+.+||.+||+.
T Consensus 229 --------~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 267 (288)
T 1ob3_A 229 --------TEL---------------------------------PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL 267 (288)
T ss_dssp --------GGS---------------------------------TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred --------hcc---------------------------------cccccccccccCccHHHHhhhcCHHHHHHHHHHcCC
Confidence 000 000001122234445556677899999999999999
Q ss_pred CCCCCCCHHHHhcCccccCC
Q 007542 342 EPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~ 361 (599)
||.+|||++|+|+||||++.
T Consensus 268 dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 268 DPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp STTTSCCHHHHHTSGGGGC-
T ss_pred CcccCCCHHHHhcCcchhhc
Confidence 99999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=413.67 Aligned_cols=288 Identities=34% Similarity=0.570 Sum_probs=234.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC---ChhhHHHHHHHHHHHHhcC---CCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE---HVSDATRILREIKLLRLLR---HPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~---~~~~~~~i~rEi~iL~~l~---HpnIv~l~~v~~~~s 95 (599)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 5799999999999999999999999999999999864321 1112345667887777664 999999999997654
Q ss_pred cCCCccEEEEEecCCccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 96 RREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
......+++||||++++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 344446899999999999999987654 999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
+...... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.++..
T Consensus 168 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQM----ALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCC----CSGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCc----ccCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 8653322 2345689999999999976 678999999999999999999999999999999999999999988765
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.+.. ..... . ..+....+.++....+.+++.+.+
T Consensus 242 ~~~~-----------~~~~~----------------------------~-------~~~~~~~~~~~~~~~~~~~~~~~~ 275 (308)
T 3g33_A 242 DWPR-----------DVSLP----------------------------R-------GAFPPRGPRPVQSVVPEMEESGAQ 275 (308)
T ss_dssp TSCS-----------SCSSC----------------------------G-------GGSCCCCCCCHHHHSCSCCHHHHH
T ss_pred hccc-----------hhhcc----------------------------c-------cccCCCCCCcHHHhCccccHHHHH
Confidence 3221 11000 0 012223344455566788999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||.+||++||.+|||+.|+|+||||+..
T Consensus 276 li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 276 LLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=424.67 Aligned_cols=289 Identities=36% Similarity=0.639 Sum_probs=235.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~~~~ 100 (599)
..+|+++++||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 3479999999999999999999999999999999864211 23379999999999999999999864321 2334
Q ss_pred cEEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-Cceeeeccccccc
Q 007542 101 DIYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFGla~~ 175 (599)
++++||||++++|.+++.. ...+++..++.+++||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6789999999988777653 5679999999999999999999999999999999999999965 6689999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ...+++|++|+|||++.+. ..|+.++||||||||+|||++|++||.+.+..+++..|.+.+|.|..+.+
T Consensus 207 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 207 LVRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp CCTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 543322 2457899999999998652 47899999999999999999999999999999999999999999999887
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC-CCCCHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF-PNANPLALRL 334 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~s~~a~dL 334 (599)
..+.. .+... .++.....++...+ +..++.+++|
T Consensus 282 ~~~~~-------~~~~~--------------------------------------~~p~~~~~~~~~~~~~~~~~~~~~L 316 (420)
T 1j1b_A 282 REMNP-------NYTEF--------------------------------------KFPQIKAHPWTKVFRPRTPPEAIAL 316 (420)
T ss_dssp HHHCS-------CCCCC--------------------------------------CCCCCCCCCHHHHSCTTSCHHHHHH
T ss_pred HhhCh-------hhhhh--------------------------------------ccCccCCCCHHHhcCCCCCHHHHHH
Confidence 65210 00000 01111112222222 4578999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCccCCC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAKVER 366 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~ 366 (599)
|++||++||.+|||+.|+|+||||+++.....
T Consensus 317 i~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 317 CSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred HHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 99999999999999999999999998865543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=421.83 Aligned_cols=288 Identities=36% Similarity=0.640 Sum_probs=235.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-CCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-REFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~~~~ 100 (599)
..+|+++++||+|+||+||+|.+..+++ ||+|++..... ...+|+.+|+.++||||+++++++..... .+..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4679999999999999999999987776 88888753221 12379999999999999999999865432 3345
Q ss_pred cEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec-CCCceeeeccccccc
Q 007542 101 DIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~----~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~-~~~~lKL~DFGla~~ 175 (599)
.+|+||||+.++|.+.+. ....+++..++.+++||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 688999999988776654 356899999999999999999999999999999999999999 799999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ...+++|++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|+|+.+.+
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCCC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 643322 2456899999999998652 56899999999999999999999999999999999999999999999887
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC-CCCHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP-NANPLALRL 334 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~s~~a~dL 334 (599)
..... .+... .++...+.++...++ ..++.+.+|
T Consensus 267 ~~~~~----~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~l 301 (394)
T 4e7w_A 267 KTMNP----NYMEH-----------------------------------------KFPQIRPHPFSKVFRPRTPPDAIDL 301 (394)
T ss_dssp HHHCG----GGSSS-----------------------------------------CCCCCCCCCHHHHSCTTCCHHHHHH
T ss_pred HhhCh----hhhhh-----------------------------------------ccccccCCcHHHhccccCCHHHHHH
Confidence 66321 00000 011222333333333 488999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCccCCC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAKVER 366 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~ 366 (599)
|.+||++||.+|||+.|+|+||||+++.....
T Consensus 302 i~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 302 ISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333 (394)
T ss_dssp HHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCC
T ss_pred HHHHhCCChhhCCCHHHHhcChhhhhhccccc
Confidence 99999999999999999999999999876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=416.39 Aligned_cols=267 Identities=28% Similarity=0.448 Sum_probs=228.1
Q ss_pred cccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcCCCCcccccee
Q 007542 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLRHPDIVEIKHI 90 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~~i~rEi~iL~~l~HpnIv~l~~v 90 (599)
.+..-...++|++++.||+|+||+||+|+++.+|+.||||+++...... .....+.+|+.+|+.++||||++++++
T Consensus 4 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 83 (361)
T 2yab_A 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV 83 (361)
T ss_dssp CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence 3444566789999999999999999999999999999999997543221 235678899999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC----ce
Q 007542 91 LLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KL 165 (599)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~----~l 165 (599)
+.. ...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 84 ~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 84 YEN-----RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp EEC-----SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred EEe-----CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCE
Confidence 943 357999999997 69999998888999999999999999999999999999999999999998877 79
Q ss_pred eeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHH
Q 007542 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTD 245 (599)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~ 245 (599)
||+|||++....... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..|..
T Consensus 159 kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~ 232 (361)
T 2yab_A 159 KLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232 (361)
T ss_dssp EECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred EEEecCCceEcCCCC----ccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999999998764322 2345689999999999977 6799999999999999999999999999887777666654
Q ss_pred hcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCC
Q 007542 246 LLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFP 325 (599)
Q Consensus 246 ~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 325 (599)
.....+.+ .++
T Consensus 233 ~~~~~~~~---------------------------------------------------------------------~~~ 243 (361)
T 2yab_A 233 VSYDFDEE---------------------------------------------------------------------FFS 243 (361)
T ss_dssp TCCCCCHH---------------------------------------------------------------------HHT
T ss_pred cCCCCCch---------------------------------------------------------------------hcc
Confidence 33222221 124
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 326 NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 326 ~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+++.+++||.+||..||.+|||++|+|+||||++.
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 578889999999999999999999999999999865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=415.02 Aligned_cols=295 Identities=33% Similarity=0.580 Sum_probs=220.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.++.+|+.||||+++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 76 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHT-----EN 76 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CC
Confidence 3578999999999999999999999999999999996432 22334677899999999999999999999953 35
Q ss_pred cEEEEEecCCccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 101 DIYVVFELMESDLHQVIKAN------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 77 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 77 KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred eEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 79999999999999998753 358999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... .....++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.++...
T Consensus 157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 157 AFGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp ETTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred ecCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 7543221 22456889999999998652 4689999999999999999999999999999999999999999887654
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+....... .+...+.... .......+. .......++.+.+|
T Consensus 233 ~~~~~~~~-----~~~~~~~~~~------------------------~~~~~~~~~----------~~~~~~~~~~l~~l 273 (317)
T 2pmi_A 233 WPSVTKLP-----KYNPNIQQRP------------------------PRDLRQVLQ----------PHTKEPLDGNLMDF 273 (317)
T ss_dssp CGGGGGCT-----TCCTTCCCCC------------------------CCCSHHHHG----------GGCSSCCCHHHHHH
T ss_pred hhhhhhhh-----hccccccccc------------------------chhHHHhhc----------ccccccCCHHHHHH
Confidence 32211000 0000000000 000000000 01123578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
|.+||+.||.+|||++|+|+||||++....
T Consensus 274 i~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 274 LHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred HHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 999999999999999999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=414.63 Aligned_cols=297 Identities=35% Similarity=0.561 Sum_probs=225.1
Q ss_pred cccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
......-...++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp --------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred eccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 33334445568999999999999999999999999999999999765444444567789999999999999999999985
Q ss_pred CCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec-----CCCceee
Q 007542 93 PPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-----ADCKLKI 167 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~-----~~~~lKL 167 (599)
. ...+|+||||++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 104 ~-----~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 104 H-----NHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp E-----TTEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred c-----CCEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEE
Confidence 3 35799999999999999999998999999999999999999999999999999999999994 4556999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
+|||+++....... .....++|+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+.+.+
T Consensus 179 ~Dfg~a~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 254 (329)
T 3gbz_A 179 GDFGLARAFGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254 (329)
T ss_dssp CCTTHHHHHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CcCCCccccCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh
Confidence 99999987643221 23456789999999998662 458999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
|.|....+...... ..+...+.. .........+ ....
T Consensus 255 ~~~~~~~~~~~~~~-----~~~~~~~~~------------------------~~~~~~~~~~--------------~~~~ 291 (329)
T 3gbz_A 255 GLPDDTTWPGVTAL-----PDWKQSFPK------------------------FRGKTLKRVL--------------GALL 291 (329)
T ss_dssp CCCCTTTSTTGGGS-----TTCCTTCCC------------------------CCCCCHHHHH--------------GGGS
T ss_pred CCCchhhhhhhhhh-----hhhhhhhhh------------------------hccccHhhhc--------------cccc
Confidence 98876543221000 000000000 0000000000 0126
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
++.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 292 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 292 DDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 7889999999999999999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=405.10 Aligned_cols=293 Identities=35% Similarity=0.620 Sum_probs=231.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
-++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.. ...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCe
Confidence 368999999999999999999999999999999997655555556778899999999999999999999843 357
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 8999999995 677787777889999999999999999999999999999999999999999999999999998754222
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. .....++|++|+|||++.+. ..++.++|||||||++++|++|++||.+.+..+.+..+.+.++...+........
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 23456899999999998652 5689999999999999999999999999999999999999999887765433110
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
..|...... .......++...++..++.+.+||.+||+
T Consensus 233 ---~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 270 (311)
T 4agu_A 233 ---NQYFSGVKI---------------------------------------PDPEDMEPLELKFPNISYPALGLLKGCLH 270 (311)
T ss_dssp ---CGGGTTCCC---------------------------------------CCCSSCCCHHHHCTTCCHHHHHHHHHHCC
T ss_pred ---ccccccCcC---------------------------------------CCccccchhhhhcccccHHHHHHHHHHcc
Confidence 000000000 00000111223346789999999999999
Q ss_pred cCCCCCCCHHHHhcCccccCCccCC
Q 007542 341 FEPKDRPTAEEALADPYFKGLAKVE 365 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~~~~~ 365 (599)
+||.+|||++|+|+||||+++...+
T Consensus 271 ~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 271 MDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp SSTTTSCCHHHHHTSGGGTTCC---
T ss_pred CChhhcCCHHHHhcChHHHhccCHH
Confidence 9999999999999999999886543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=414.19 Aligned_cols=289 Identities=35% Similarity=0.626 Sum_probs=229.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++++.||+|+||+||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEE
Confidence 5899999999999999999999999999999999643211 112244579999999999999999999853 3579
Q ss_pred EEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+||||++++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 9999999999999998754 59999999999999999999999999999999999999999999999999997643222
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
......++|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.|..+.+....
T Consensus 155 --~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 229 (324)
T 3mtl_A 155 --KTYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL-- 229 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG--
T ss_pred --cccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh--
Confidence 123456789999999998652 568999999999999999999999999999999999999999998876443210
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
....... ..........+....+.+++.+.+||.+||++
T Consensus 230 ---------------------------------------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 268 (324)
T 3mtl_A 230 ---------------------------------------SNEEFKT--YNYPKYRAEALLSHAPRLDSDGADLLTKLLQF 268 (324)
T ss_dssp ---------------------------------------GCHHHHH--TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred ---------------------------------------cchhhcc--cccccccchhhhhhcCCCCHHHHHHHHHHcCc
Confidence 0000000 01112222233344567899999999999999
Q ss_pred CCCCCCCHHHHhcCccccCCccC
Q 007542 342 EPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
||.+|||++|+|+||||.++...
T Consensus 269 dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 269 EGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp SGGGSCCHHHHTTSGGGGGGCST
T ss_pred CcccCCCHHHHhcChhhhhcccc
Confidence 99999999999999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=419.02 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=208.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC-CCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~v~~~~s 95 (599)
.++|++++.||+|+||+||+|.+..+ ++.||||+++.. ......+.+.+|+.+|+.++| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 46899999999999999999987654 468999999743 233456778999999999975 8999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceE
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNIL 158 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (599)
...+|||||||+ |+|.++|+.. ..+++..+..|+.||+.||.|||+++||||||||+|||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 236899999999 6999999753 34899999999999999999999999999999999999
Q ss_pred ecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChh
Q 007542 159 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVV 237 (599)
Q Consensus 159 v~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~ 237 (599)
++.++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++||||+||++|||+| |++||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999987643322 222345689999999999987 689999999999999999998 99999986644
Q ss_pred hHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCC
Q 007542 238 HQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317 (599)
Q Consensus 238 ~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~ 317 (599)
..+..+... ...
T Consensus 295 ~~~~~~i~~--------------------------------------------------------------------g~~ 306 (353)
T 4ase_A 295 EEFCRRLKE--------------------------------------------------------------------GTR 306 (353)
T ss_dssp HHHHHHHHH--------------------------------------------------------------------TCC
T ss_pred HHHHHHHHc--------------------------------------------------------------------CCC
Confidence 333222110 000
Q ss_pred CCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 318 ~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
. ......++++.+||.+||+.||.+|||+.|+++|
T Consensus 307 ~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 307 M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 0 1113468899999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=417.91 Aligned_cols=287 Identities=34% Similarity=0.694 Sum_probs=232.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc----
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR---- 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~---- 96 (599)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45799999999999999999999999999999999864322 12379999999999999999999864322
Q ss_pred -----------------------------CCCccEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhh
Q 007542 97 -----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH 143 (599)
Q Consensus 97 -----------------------------~~~~~lylV~E~~~g~L~~~i~----~~~~lse~~i~~i~~QIl~aL~yLH 143 (599)
.+..++++||||++++|.+.+. ....+++..++.++.||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 2345689999999998877765 3568999999999999999999999
Q ss_pred hCceEeccCCCCceEec-CCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHH
Q 007542 144 TANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA 222 (599)
Q Consensus 144 s~gIvHrDLKP~NILv~-~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~ 222 (599)
++||+||||||+|||++ .++.+||+|||+++....... ...+++|+.|+|||++.+. ..++.++||||+||++|
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHH
Confidence 99999999999999998 689999999999986543322 2456889999999998662 46899999999999999
Q ss_pred HHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhccc
Q 007542 223 ELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRN 302 (599)
Q Consensus 223 eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~ 302 (599)
+|++|++||.+.+..+++..|.+.+|.|+.+.+...... +...
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~-------~~~~------------------------------ 276 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH-------YTEV------------------------------ 276 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT-------C--C------------------------------
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc-------cccc------------------------------
Confidence 999999999999999999999999999999887652210 0000
Q ss_pred HHHHHHHHhcccCCCCCCcCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 303 EKARRYLSSMRKKKPIPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 303 ~~~~~~i~~~~~~~~~~~~~~~-~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
.++......+...+ ...++.+.+||.+||++||.+|||+.|+|+||||+.+..
T Consensus 277 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 277 --------RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp --------CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred --------cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 00111111222222 347889999999999999999999999999999987643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=405.91 Aligned_cols=303 Identities=34% Similarity=0.540 Sum_probs=236.9
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc--
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-- 96 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-- 96 (599)
.+..++|++++.||+|+||.||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 356789999999999999999999999999999999997554444445677899999999999999999999865321
Q ss_pred -CCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 -REFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 -~~~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.....+|+||||++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ----CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 124578999999999999888765 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC-CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
....... ........+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..|....|.++++
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7542221 12233567889999999988652 468999999999999999999999999999999999999999988775
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.+........ +.... ..... .......+... ..++.+.+
T Consensus 252 ~~~~~~~~~~--~~~~~----~~~~~----------------------~~~~~~~~~~~-------------~~~~~~~~ 290 (351)
T 3mi9_A 252 VWPNVDNYEL--YEKLE----LVKGQ----------------------KRKVKDRLKAY-------------VRDPYALD 290 (351)
T ss_dssp TSTTGGGCGG--GTSSC----CCSSC----------------------CCCHHHHHHHH-------------HCCHHHHH
T ss_pred hccccccchh--hcccc----ccccc----------------------ccCHHHHhhhc-------------cCChHHHH
Confidence 4332100000 00000 00000 00000000000 13678999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
||.+||++||.+|||++|+|+||||.....
T Consensus 291 li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 291 LIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred HHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 999999999999999999999999987543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=416.12 Aligned_cols=309 Identities=30% Similarity=0.515 Sum_probs=231.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc------CCCCccccceeecCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL------RHPDIVEIKHILLPP 94 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l------~HpnIv~l~~v~~~~ 94 (599)
...+|+++++||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+ .|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~- 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF- 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence 46789999999999999999999999999999999974 233446677899888887 56799999999843
Q ss_pred CcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc--eeeecc
Q 007542 95 SRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDF 170 (599)
Q Consensus 95 s~~~~~~lylV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~--lKL~DF 170 (599)
...+|+||||+.++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+||
T Consensus 171 ----~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 171 ----RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp ----TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred ----CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 35799999999999999998764 5999999999999999999999999999999999999999987 999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
|+++..... ....++|+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|
T Consensus 247 G~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 247 GSSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp TTCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999764322 235689999999999977 579999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcc-cCCCCCCcCCC-CCCC
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMR-KKKPIPFSQKF-PNAN 328 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~-~~~s 328 (599)
+.+.+......... ....++............. .. ......+ ...+. ......+...+ ...+
T Consensus 319 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~----------~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~ 382 (429)
T 3kvw_A 319 SQKLLDASKRAKNF--VSSKGYPRYCTVTTLSDGS--VV----------LNGGRSR--RGKLRGPPESREWGNALKGCDD 382 (429)
T ss_dssp CHHHHHTBTTHHHH--BCTTSCBTTSCEECCCC----CE----------ECCEECT--TCCEECSTTCSCHHHHTTTCCC
T ss_pred CHHHHHhhhhhhhc--cCCCCCccccccccccccc--cc----------ccccccc--hhhccCCccchhhHhhccccch
Confidence 99877542111110 0000000000000000000 00 0000000 00000 00000111111 2357
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+.+++||++||++||.+|||++|+|+||||+..
T Consensus 383 ~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 383 PLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred HHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 889999999999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=408.27 Aligned_cols=290 Identities=37% Similarity=0.608 Sum_probs=231.1
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh---hhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV---SDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~---~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
...++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence 34689999999999999999999999999999999996432211 112467899999999999999999999943
Q ss_pred CCCccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 84 --~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 84 --KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp --TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred --CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 34689999999999999987654 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ..+..++|++|+|||++.+. ..++.++|||||||++|+|++|.++|.+.+..+++..|.+..|.+..+.+
T Consensus 162 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccCCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 533221 23456899999999998652 45899999999999999999999999999999999999999998876543
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
...| ...+.+ .+......++...+...++.+.+||
T Consensus 238 ~~~~-----------~~~~~~----------------------------------~~~~~~~~~~~~~~~~~~~~~~~li 272 (346)
T 1ua2_A 238 PDMC-----------SLPDYV----------------------------------TFKSFPGIPLHHIFSAAGDDLLDLI 272 (346)
T ss_dssp SSTT-----------SSTTCC----------------------------------CCCCCCCCCHHHHCTTCCHHHHHHH
T ss_pred hhhc-----------cCcccc----------------------------------cccccCCCChHHhhccCCHHHHHHH
Confidence 3211 100000 0111122334445577889999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
++||+.||.+|||++|+|+||||++...
T Consensus 273 ~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 273 QGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp HHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred HHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 9999999999999999999999987644
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=411.12 Aligned_cols=257 Identities=24% Similarity=0.416 Sum_probs=216.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
.++|+++++||+|+||.||+|+++.+|+.||||+++... ........+.+|+.+|+.+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~----- 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP----- 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-----
Confidence 478999999999999999999999999999999997432 1223456788999999988 699999999999543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 47999999999 59999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|....-
T Consensus 177 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------- 241 (353)
T 3txo_A 177 NG---VTTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------- 241 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred CC---ccccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 21 12345689999999999977 5789999999999999999999999999887776665543110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.....+++.+.+||++|
T Consensus 242 ---------------------------------------------------------------~~p~~~~~~~~~li~~l 258 (353)
T 3txo_A 242 ---------------------------------------------------------------VYPTWLHEDATGILKSF 258 (353)
T ss_dssp ---------------------------------------------------------------CCCTTSCHHHHHHHHHH
T ss_pred ---------------------------------------------------------------CCCCCCCHHHHHHHHHH
Confidence 01123688899999999
Q ss_pred cccCCCCCCCH------HHHhcCccccCC
Q 007542 339 LAFEPKDRPTA------EEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpTa------~e~L~HP~f~~~ 361 (599)
|+.||.+||++ +|+|+||||+++
T Consensus 259 L~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 259 MTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp TCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred hhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999999999 999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=403.80 Aligned_cols=257 Identities=24% Similarity=0.432 Sum_probs=219.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|+++++||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|+.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence 3689999999999999999999999999999999964321 223456788999999999999999999999543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 7999999998 599999998888999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......|...
T Consensus 159 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------- 220 (337)
T 1o6l_A 159 GA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------- 220 (337)
T ss_dssp TC---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred CC---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence 21 2346789999999999977 67999999999999999999999999887765544443210
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.. .....+++.+.+||.+||
T Consensus 221 ---------------------------------------------------------~~---~~p~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 221 ---------------------------------------------------------EI---RFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp ---------------------------------------------------------CC---CCCTTSCHHHHHHHHHHT
T ss_pred ---------------------------------------------------------CC---CCCCCCCHHHHHHHHHHh
Confidence 00 011357889999999999
Q ss_pred ccCCCCCC-----CHHHHhcCccccCC
Q 007542 340 AFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
+.||.+|| +++|+++||||+++
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 99999999 99999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=418.62 Aligned_cols=262 Identities=28% Similarity=0.452 Sum_probs=223.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||+||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++. +..
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECC
Confidence 357899999999999999999999999999999999765444456678899999999999999999999994 345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec---CCCceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~---~~~~lKL~DFGla~~~ 176 (599)
.+|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 7999999998 59999999988999999999999999999999999999999999999998 4588999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+....+..|......
T Consensus 164 ~~~~---~~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------- 231 (444)
T 3soa_A 164 EGEQ---QAWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD------- 231 (444)
T ss_dssp CTTC---CBCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-------
T ss_pred cCCC---ceeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC-------
Confidence 4322 22356789999999999977 67999999999999999999999999988776665555432111
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.....++.+++.+.+||.
T Consensus 232 --------------------------------------------------------------~~~~~~~~~s~~~~~li~ 249 (444)
T 3soa_A 232 --------------------------------------------------------------FPSPEWDTVTPEAKDLIN 249 (444)
T ss_dssp --------------------------------------------------------------CCTTTTTTSCHHHHHHHH
T ss_pred --------------------------------------------------------------CCccccccCCHHHHHHHH
Confidence 112234568899999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||+.||.+|||+.|+|+||||++.
T Consensus 250 ~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 250 KMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHcCCChhHCCCHHHHhcCccccCC
Confidence 9999999999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=398.08 Aligned_cols=301 Identities=41% Similarity=0.646 Sum_probs=235.1
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC---
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS--- 95 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s--- 95 (599)
+...++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 4567999999999999999999999999999999999864 23455678899999999999999999999985432
Q ss_pred ------cCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec-CCCceeee
Q 007542 96 ------RREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKIC 168 (599)
Q Consensus 96 ------~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~-~~~~lKL~ 168 (599)
..+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 133467999999999999999865 5799999999999999999999999999999999999997 56799999
Q ss_pred cccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 007542 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (599)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg 248 (599)
|||+++................+|.+|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998754322222223455789999999987542 5689999999999999999999999999999999999988888
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
.+..+........ ...++.........++....+.++
T Consensus 243 ~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~ 279 (320)
T 2i6l_A 243 VVHEEDRQELLSV-------------------------------------------IPVYIRNDMTEPHKPLTQLLPGIS 279 (320)
T ss_dssp CCCHHHHHHHHTT-------------------------------------------SCHHHHHHTTSCCCCHHHHSTTCC
T ss_pred CCchhhhhhhhhc-------------------------------------------CcccccccccCCCCChhHhcchhh
Confidence 7776655441100 001111111222334445567789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 366 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~ 366 (599)
+.+.+||.+||+.||.+|||++|+|+||||+....+..
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 280 REAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred HHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence 99999999999999999999999999999997654433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=400.33 Aligned_cols=304 Identities=21% Similarity=0.348 Sum_probs=236.5
Q ss_pred cccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-----CCCcccc
Q 007542 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----HPDIVEI 87 (599)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-----HpnIv~l 87 (599)
..+-...-..++|+++++||+|+||+||+|++..+++.||||++.. .......+.+|+.+|+.+. ||||+++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 3344444557899999999999999999999999999999999963 2344566778999999997 9999999
Q ss_pred ceeecCCCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC----
Q 007542 88 KHILLPPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---- 161 (599)
Q Consensus 88 ~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---- 161 (599)
++++... ..+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYY-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred cceeeEC-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 9998543 4799999999889999998764 5999999999999999999999999999999999999975
Q ss_pred ---------------------CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHH
Q 007542 162 ---------------------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (599)
Q Consensus 162 ---------------------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~I 220 (599)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++||||||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~i 248 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCV 248 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcC--CCCCCccchHHHHHH
Confidence 788999999999864322 235689999999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhc
Q 007542 221 FAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQV 300 (599)
Q Consensus 221 l~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 300 (599)
+|+|++|++||.+.+..+.+..+....+.++...+..........+............. .
T Consensus 249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~--------------------~ 308 (360)
T 3llt_A 249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPEN--------------------A 308 (360)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTT--------------------C
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCccc--------------------c
Confidence 99999999999999999999999999999988876653322211111111100000000 0
Q ss_pred ccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 007542 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 301 ~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
........+. ... .......++.+.+||.+||++||.+|||++|+|+||||+
T Consensus 309 ~~~~~~~~~~---~~~----~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 309 SSINSIKHVK---KCL----PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SCHHHHHHHH---TCC----CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cchhhhhhhh---hcc----cccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0000000000 000 000112457889999999999999999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=408.61 Aligned_cols=311 Identities=23% Similarity=0.297 Sum_probs=223.1
Q ss_pred cCCCCceEEEEEeeec--CceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 19 YGEGSRYKIEEVIGKG--SYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G--~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.+..++|+++++||+| +||.||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--- 97 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--- 97 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE---
Confidence 4678999999999999 99999999999999999999998665555667788899999999999999999999954
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 98 --DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred --CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 347999999999 6999999876 67999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCC----CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 174 RVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 174 ~~~~~~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
........ ........+||+.|+|||++.+....|+.++||||||||+|+|++|++||.+.+....+..+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~--- 252 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG--- 252 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC---
Confidence 65422111 11112335889999999998763346899999999999999999999999988766655443321
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHH---hcccCCCCCCcCCCCC
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS---SMRKKKPIPFSQKFPN 326 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~ 326 (599)
..+..+..........+..... . .........+. ........+.......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~---~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSR---S------------------------VANSGLSDSLTTSTPRPSNGDSPSHPYHRT 305 (389)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCccccccccccccccccccc---c------------------------ccccccccccccCccccccCCCCCCccccc
Confidence 1111000000000000000000 0 00000000000 0000011112223456
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
+++.+.+||.+||++||.+|||++|+|+||||+++...
T Consensus 306 ~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 306 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred cCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence 88999999999999999999999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=398.57 Aligned_cols=262 Identities=28% Similarity=0.453 Sum_probs=223.1
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
...++|++.+.||+|+||.||+|.++.+|+.||||++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 85 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 85 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence 45678999999999999999999999999999999997533221 245778899999999999999999999954
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC----ceeeecc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDF 170 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~----~lKL~DF 170 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 86 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 86 ---KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 357999999997 69999998888899999999999999999999999999999999999999887 7999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
|+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.......
T Consensus 163 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 163 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp TTCEECCTTS----CCCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred CCCeECCCCC----ccccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 9998764322 1245689999999999976 678999999999999999999999999887766665554322221
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
+. ..++..++.
T Consensus 237 ~~---------------------------------------------------------------------~~~~~~~~~ 247 (326)
T 2y0a_A 237 ED---------------------------------------------------------------------EYFSNTSAL 247 (326)
T ss_dssp CH---------------------------------------------------------------------HHHTTSCHH
T ss_pred Cc---------------------------------------------------------------------cccccCCHH
Confidence 11 112456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 248 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 9999999999999999999999999999854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=406.87 Aligned_cols=260 Identities=29% Similarity=0.479 Sum_probs=222.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|.++.+|+.||||++............+.+|+.+|+.++||||+++++++.. ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 468999999999999999999999999999999997655555566789999999999999999999999943 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC---ceeeeccccccccc
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLARVAF 177 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~---~lKL~DFGla~~~~ 177 (599)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 899999998 59999998888899999999999999999999999999999999999998654 59999999998654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+....+..|.......
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------- 249 (362)
T 2bdw_A 183 DSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY------- 249 (362)
T ss_dssp TCC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred CCc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 322 2345689999999999977 679999999999999999999999999887665555443211110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
....+..+++.+.+||.+
T Consensus 250 --------------------------------------------------------------~~~~~~~~~~~~~~li~~ 267 (362)
T 2bdw_A 250 --------------------------------------------------------------PSPEWDTVTPEAKSLIDS 267 (362)
T ss_dssp --------------------------------------------------------------CTTGGGGSCHHHHHHHHH
T ss_pred --------------------------------------------------------------CcccccCCCHHHHHHHHH
Confidence 111234578899999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||+.||.+|||+.|+|+||||...
T Consensus 268 ~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 268 MLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HcCCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=399.30 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=222.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||+||+|.+..+++.||+|++.. .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 74 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFES-----ME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TT
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CC
Confidence 46899999999999999999999999999999999864 23455678899999999999999999999943 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC--CCceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~--~~~lKL~DFGla~~~ 176 (599)
.+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 7999999998 59999997654 7999999999999999999999999999999999999997 789999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+.+....++.+
T Consensus 155 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 225 (321)
T 1tki_A 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE--- 225 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH---
T ss_pred CCCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh---
Confidence 4322 2345689999999999977 568999999999999999999999999988777666665433222221
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.++.+++.+.+||.
T Consensus 226 ------------------------------------------------------------------~~~~~s~~~~~li~ 239 (321)
T 1tki_A 226 ------------------------------------------------------------------AFKEISIEAMDFVD 239 (321)
T ss_dssp ------------------------------------------------------------------HHTTSCHHHHHHHH
T ss_pred ------------------------------------------------------------------hhccCCHHHHHHHH
Confidence 12457889999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCc
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+||..||.+|||+.|+|+||||+...
T Consensus 240 ~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 240 RLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHcCCChhHCcCHHHHhcChhhccCc
Confidence 99999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=402.48 Aligned_cols=256 Identities=30% Similarity=0.503 Sum_probs=214.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-++|++++.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.++||||+++++++... .
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----T 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----C
Confidence 46899999999999999999999999999999999643211 12235788999999999999999999999543 4
Q ss_pred cEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 101 DIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
.+|+||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 79999999999999999888899999999999999999999999999999999999999999999999999998653322
Q ss_pred CCcccccccccCccccCccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.........
T Consensus 163 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------- 219 (336)
T 3h4j_B 163 ----FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------- 219 (336)
T ss_dssp ----TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------------
T ss_pred ----ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------
Confidence 2345689999999999976 344 7899999999999999999999987543221000
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
............++.+.+||++||
T Consensus 220 --------------------------------------------------------i~~~~~~~p~~~s~~~~~li~~~L 243 (336)
T 3h4j_B 220 --------------------------------------------------------VNSCVYVMPDFLSPGAQSLIRRMI 243 (336)
T ss_dssp --------------------------------------------------------CCSSCCCCCTTSCHHHHHHHHTTS
T ss_pred --------------------------------------------------------HHcCCCCCcccCCHHHHHHHHHHc
Confidence 000011122347899999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+.||.+|||++|+|+||||+..
T Consensus 244 ~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 244 VADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CSSGGGSCCHHHHTTCHHHHTT
T ss_pred CCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=397.19 Aligned_cols=254 Identities=24% Similarity=0.430 Sum_probs=219.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.+ ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 3689999999999999999999999999999999964321 12345677899999999999999999999954 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 7999999998 599999999889999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|.+..
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------ 219 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------ 219 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 134689999999999977 679999999999999999999999999887666555443210
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
. ...+.+++.+.+||++||
T Consensus 220 ----------------------------------------------------------~---~~p~~~~~~~~~li~~lL 238 (318)
T 1fot_A 220 ----------------------------------------------------------L---RFPPFFNEDVKDLLSRLI 238 (318)
T ss_dssp ----------------------------------------------------------C---CCCTTSCHHHHHHHHHHT
T ss_pred ----------------------------------------------------------C---CCCCCCCHHHHHHHHHHh
Confidence 0 011346889999999999
Q ss_pred ccCCCCCC-----CHHHHhcCccccCC
Q 007542 340 AFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
..||.+|+ +++|+++||||+++
T Consensus 239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 239 TRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999 99999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=393.02 Aligned_cols=259 Identities=27% Similarity=0.451 Sum_probs=218.7
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 89 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG----- 89 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----
Confidence 45679999999999999999999999999999999986432 23356788999999999999999999998543
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 46899999997 6999999775 699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 169 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------- 234 (297)
T 3fxz_A 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------- 234 (297)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---------
T ss_pred ccc---ccCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 322 2345689999999999977 67999999999999999999999999887766554443221100
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.......+++.+.+||.+|
T Consensus 235 -------------------------------------------------------------~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 235 -------------------------------------------------------------ELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp -------------------------------------------------------------CCSCGGGSCHHHHHHHHHH
T ss_pred -------------------------------------------------------------CCCCccccCHHHHHHHHHH
Confidence 0011134678899999999
Q ss_pred cccCCCCCCCHHHHhcCccccCC
Q 007542 339 LAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|+.||.+|||++|+|+||||+..
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=402.25 Aligned_cols=292 Identities=33% Similarity=0.582 Sum_probs=233.9
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
|..-++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 95 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK----- 95 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----
Confidence 456789999999999999999999999999999999997655555556778899999999999999999999843
Q ss_pred CccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 3578999999996 566666667789999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......+|++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....|...+.....
T Consensus 176 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 176 APGE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 3221 22456799999999998662 4689999999999999999999999999999999999999999887765433
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.... ..+.+... + ......+....++.+++.+.+||.+
T Consensus 252 ~~~~--~~~~~~~~--~--------------------------------------~~~~~~~~~~~~~~~~~~l~~li~~ 289 (331)
T 4aaa_A 252 FNKN--PVFAGVRL--P--------------------------------------EIKEREPLERRYPKLSEVVIDLAKK 289 (331)
T ss_dssp HHHC--GGGTTCCC--C--------------------------------------CCSSCCCHHHHSTTSCHHHHHHHHH
T ss_pred hhhc--cccccccC--c--------------------------------------cccccchhhhcccchhHHHHHHHHH
Confidence 1110 00000000 0 0011122233456789999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||++||.+|||++|+|+||||+..
T Consensus 290 ~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 290 CLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HhccCcccCCCHHHHhcCchhccC
Confidence 999999999999999999999853
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=402.67 Aligned_cols=259 Identities=24% Similarity=0.388 Sum_probs=219.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~ 98 (599)
..++|+++++||+|+||.||+|+++.+|+.||||+++.... .......+.+|..+|+.+ +||||+++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----- 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----- 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-----
Confidence 45799999999999999999999999999999999974321 123456678899999877 89999999999954
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 347999999998 5999999988889999999999999999999999999999999999999999999999999997543
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|....
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 234 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------- 234 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 2221 2346789999999999987 679999999999999999999999999887666554443200
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. .....+++.+.+||.+
T Consensus 235 ------------------------------------------------------------~---~~p~~~s~~~~~li~~ 251 (345)
T 1xjd_A 235 ------------------------------------------------------------P---FYPRWLEKEAKDLLVK 251 (345)
T ss_dssp ------------------------------------------------------------C---CCCTTSCHHHHHHHHH
T ss_pred ------------------------------------------------------------C---CCCcccCHHHHHHHHH
Confidence 0 0112478899999999
Q ss_pred hcccCCCCCCCHH-HHhcCccccCCc
Q 007542 338 MLAFEPKDRPTAE-EALADPYFKGLA 362 (599)
Q Consensus 338 mL~~DP~~RpTa~-e~L~HP~f~~~~ 362 (599)
||+.||.+|||+. |+++||||+++.
T Consensus 252 lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 252 LFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HhcCCHhHcCCChHHHHcCccccCCC
Confidence 9999999999998 999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=396.76 Aligned_cols=267 Identities=22% Similarity=0.386 Sum_probs=215.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
.++|++++.||+|+||.||+|+++.+++.||||+++.... .......+.+|+.+|+.+ +||||+++++++.+ .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 4689999999999999999999999999999999975433 344567788999999988 89999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 57999999998 59999999888899999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+........ ....+
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------~~~~~----- 225 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTED----- 225 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHH-----
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-------cccHH-----
Confidence 211 2346789999999999987 678999999999999999999999997532111000 00000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.....+. . .... ....+++.+.+||++|
T Consensus 226 ---------------------------------------------~~~~~i~---~-~~~~---~p~~~s~~~~~li~~l 253 (345)
T 3a8x_A 226 ---------------------------------------------YLFQVIL---E-KQIR---IPRSLSVKAASVLKSF 253 (345)
T ss_dssp ---------------------------------------------HHHHHHH---H-CCCC---CCTTSCHHHHHHHHHH
T ss_pred ---------------------------------------------HHHHHHH---c-CCCC---CCCCCCHHHHHHHHHH
Confidence 0000000 0 0111 1235789999999999
Q ss_pred cccCCCCCCCH------HHHhcCccccCCc
Q 007542 339 LAFEPKDRPTA------EEALADPYFKGLA 362 (599)
Q Consensus 339 L~~DP~~RpTa------~e~L~HP~f~~~~ 362 (599)
|+.||.+|||+ +|+++||||+++.
T Consensus 254 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 254 LNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp TCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred hcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 99999999995 8999999999763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=380.05 Aligned_cols=265 Identities=29% Similarity=0.477 Sum_probs=225.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ES 78 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CC
Confidence 4689999999999999999999999999999999997655556667788999999999999999999999843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc---eeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~---lKL~DFGla~~~ 176 (599)
..|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 6899999998 599999988888999999999999999999999999999999999999987665 999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... ......+|+.|+|||++.+ ..++.++|||||||++++|++|+.||.+.+.......+......
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 225 (284)
T 3kk8_A 159 NDSE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------- 225 (284)
T ss_dssp CSSC----BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------
T ss_pred ccCc----cccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc-------
Confidence 4322 2245689999999999977 67899999999999999999999999887766555444321111
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.....+...++.+.+||.
T Consensus 226 --------------------------------------------------------------~~~~~~~~~~~~~~~li~ 243 (284)
T 3kk8_A 226 --------------------------------------------------------------YPSPEWDTVTPEAKSLID 243 (284)
T ss_dssp --------------------------------------------------------------CCTTTTTTSCHHHHHHHH
T ss_pred --------------------------------------------------------------CCchhhcccCHHHHHHHH
Confidence 111223467889999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCccCC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLAKVE 365 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~~~~ 365 (599)
+||+.||.+|||++|+|+||||++.....
T Consensus 244 ~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 244 SMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp HHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred HHcccChhhCCCHHHHhcCccccCChhHH
Confidence 99999999999999999999998765543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=397.95 Aligned_cols=207 Identities=26% Similarity=0.294 Sum_probs=165.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+.+|.+.++||+|+||+||+|++ +|+.||||+++.. ........+|+..+..++|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 56899999999999999999976 6899999999642 112223345666677889999999999986432 12246
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC--------ceEeccCCCCceEecCCCceeeecccc
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
+|||||||+ |+|.++++.. .++++.+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999999 6999999865 699999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCc-ccccccccCccccCcccccccc----CCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 173 ARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 173 a~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~----~~~s~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
|+......... ......+||++|+|||++.+.. ..|+.++||||||||||||+||.++|....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~ 222 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc
Confidence 98765433221 1223568999999999986521 136789999999999999999998886543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=399.16 Aligned_cols=292 Identities=35% Similarity=0.602 Sum_probs=225.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc--CCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--REF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~--~~~ 99 (599)
-++|++.+.||+|+||.||+|.++.+|+.||||++.... ....+..+|+..++.++||||+++++++..... ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 468999999999999999999999999999999985422 223355678888899999999999999865322 223
Q ss_pred ccEEEEEecCCccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHhh--hCceEeccCCCCceEecC-CCceeeecccc
Q 007542 100 KDIYVVFELMESDLHQVIK----ANDDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILANA-DCKLKICDFGL 172 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~----~~~~lse~~i~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILv~~-~~~lKL~DFGl 172 (599)
..+|+||||++++|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 4588999999998876665 4567899999999999999999999 999999999999999997 89999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
++....... .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+.+.+|.++.
T Consensus 179 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 179 AKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 987543322 2456789999999998652 45899999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcC----CCCCCC
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ----KFPNAN 328 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~----~~~~~s 328 (599)
+.+..+....... ........++.. .....+
T Consensus 254 ~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~~~~~~~~ 288 (360)
T 3e3p_A 254 EVLRKLNPSHTDV---------------------------------------------DLYNSKGIPWSNVFSDHSLKDA 288 (360)
T ss_dssp HHHHHHCTTCCCG---------------------------------------------GGGCCCCCCHHHHTTTCCCTTH
T ss_pred HHHHhcccchhhc---------------------------------------------cccccccCCcccccchhhcccc
Confidence 8776632110000 000011111111 223367
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVER 366 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~ 366 (599)
+.+.+||.+||++||.+|||+.|+|+||||+++.....
T Consensus 289 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 289 KEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 88999999999999999999999999999999876544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=393.17 Aligned_cols=292 Identities=34% Similarity=0.601 Sum_probs=237.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEEC-CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDT-RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~-~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~v~~~~s~ 96 (599)
..++|++++.||+|+||.||+|.+. .+|+.||||++............+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4589999999999999999999995 6789999999975433333333556788777766 89999999999864332
Q ss_pred CCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.....+|+||||++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 3456799999999999999998754 49999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
..... .......+|..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+++..|.+.+|.+..+.
T Consensus 169 ~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCC----CCccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 64321 12345688999999999977 5789999999999999999999999999999999999999888887653
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+.. ..... . ..+......++....+.+++.+.+|
T Consensus 243 ~~~-----------~~~~~----------------------------~-------~~~~~~~~~~~~~~~~~~~~~~~~l 276 (326)
T 1blx_A 243 WPR-----------DVALP----------------------------R-------QAFHSKSAQPIEKFVTDIDELGKDL 276 (326)
T ss_dssp SCT-----------TCSSC----------------------------G-------GGSCCCCCCCGGGTCCSCCHHHHHH
T ss_pred Ccc-----------ccccc----------------------------h-------hhhcccCcchhhhccccCCHHHHHH
Confidence 321 00000 0 0011122334455667889999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
|.+||..||.+|||+.|+|+||||+++...
T Consensus 277 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 277 LLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred HHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 999999999999999999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=390.87 Aligned_cols=263 Identities=27% Similarity=0.447 Sum_probs=223.8
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
...++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-- 86 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence 45678999999999999999999999999999999997533221 235678899999999999999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC----ceeeecc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDF 170 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~----~lKL~DF 170 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 87 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 87 ---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp ---SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred ---CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 357999999997 69999999888899999999999999999999999999999999999999888 7999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
|++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 164 g~~~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 164 GLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp TTCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred ccceecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 99987543221 245679999999999976 678999999999999999999999999888776665554432222
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
+++ .++..++.
T Consensus 238 ~~~---------------------------------------------------------------------~~~~~~~~ 248 (321)
T 2a2a_A 238 DEE---------------------------------------------------------------------FFSHTSEL 248 (321)
T ss_dssp CHH---------------------------------------------------------------------HHTTCCHH
T ss_pred Chh---------------------------------------------------------------------hhcccCHH
Confidence 111 12356788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+.+||.+||..||.+|||++|+|+||||++..
T Consensus 249 ~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp HHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 99999999999999999999999999998653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=410.03 Aligned_cols=300 Identities=32% Similarity=0.542 Sum_probs=214.6
Q ss_pred CCCceEE-EEEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKI-EEVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i-~~~IG~G~~g~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..+.|++ .++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.++||||+++++++...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 90 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH--- 90 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEET---
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecC---
Confidence 3466877 458999999999999976 578999999996432 234677999999999999999999999542
Q ss_pred CCccEEEEEecCCccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe----cCCCc
Q 007542 98 EFKDIYVVFELMESDLHQVIKAN---------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCK 164 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~---------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv----~~~~~ 164 (599)
....+||||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 91 ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 23579999999999999988632 249999999999999999999999999999999999999 67799
Q ss_pred eeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh--------
Q 007542 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-------- 236 (599)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~-------- 236 (599)
+||+|||+++...............+||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+.
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999998764332222234567899999999998762 4589999999999999999999999987764
Q ss_pred -hhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 237 -VHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 237 -~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
.+++..|.+.+|.|....|..+...... ..+...+.. .........+++.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~-----------------------~~~~~~~~~-~~~~~~~~~~~~~----- 300 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEH-----------------------STLMKDFRR-NTYTNCSLIKYME----- 300 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTH-----------------------HHHHHHCCG-GGGTTCCHHHHHH-----
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcch-----------------------hhhhhhccc-cCCCcchhhhhHh-----
Confidence 4889999999999987654331100000 000000000 0000000111111
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
......++.+.+||.+||++||.+|||++|+|+||||.+...
T Consensus 301 ------~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 301 ------KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp ------TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred ------hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 112234678999999999999999999999999999987644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=404.67 Aligned_cols=266 Identities=21% Similarity=0.386 Sum_probs=213.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
.++|+++++||+|+||.||+|+++.+++.||||++++.... ......+.+|..+|+.+ +||||+++++++.. .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 47899999999999999999999999999999999754322 23345678999999877 89999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 47999999998 59999999888999999999999999999999999999999999999999999999999999975322
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+... ....+
T Consensus 206 ~~---~~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-------~~~~~----- 268 (396)
T 4dc2_A 206 PG---DTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTED----- 268 (396)
T ss_dssp TT---CCBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------CCHH-----
T ss_pred CC---CccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-------hhhHH-----
Confidence 22 12356789999999999987 689999999999999999999999997543211000 00000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.....+.. ... .....+++.+.+||++|
T Consensus 269 ---------------------------------------------~~~~~i~~----~~~---~~p~~~s~~~~~li~~l 296 (396)
T 4dc2_A 269 ---------------------------------------------YLFQVILE----KQI---RIPRSLSVKAASVLKSF 296 (396)
T ss_dssp ---------------------------------------------HHHHHHHH----CCC---CCCTTSCHHHHHHHHHH
T ss_pred ---------------------------------------------HHHHHHhc----ccc---CCCCcCCHHHHHHHHHH
Confidence 00000000 011 11235789999999999
Q ss_pred cccCCCCCCCH------HHHhcCccccCC
Q 007542 339 LAFEPKDRPTA------EEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpTa------~e~L~HP~f~~~ 361 (599)
|+.||.+|+++ +|+++||||+++
T Consensus 297 L~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 297 LNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp TCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred hcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 99999999995 899999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=398.88 Aligned_cols=255 Identities=20% Similarity=0.367 Sum_probs=220.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++++.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++.+ .
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----N 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----C
Confidence 3579999999999999999999999999999999996422 122345678899999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 47999999997 69999999888899999999999999999999999999999999999999999999999999987533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..|....
T Consensus 194 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------- 254 (350)
T 1rdq_E 194 R------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----------- 254 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred C------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 2 134689999999999987 679999999999999999999999999887665554443210
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
. .....+++.+.+||.+|
T Consensus 255 -----------------------------------------------------------~---~~p~~~~~~~~~li~~l 272 (350)
T 1rdq_E 255 -----------------------------------------------------------V---RFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp -----------------------------------------------------------C---CCCTTCCHHHHHHHHHH
T ss_pred -----------------------------------------------------------C---CCCCCCCHHHHHHHHHH
Confidence 0 01135788999999999
Q ss_pred cccCCCCCCC-----HHHHhcCccccCC
Q 007542 339 LAFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
|+.||.+||+ ++|+++||||+++
T Consensus 273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 273 LQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 9999999998 9999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=417.33 Aligned_cols=260 Identities=32% Similarity=0.501 Sum_probs=217.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|+++.++..||||++............+.+|+.+|+.++||||+++++++.. ...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 358999999999999999999999999999999997654444456778899999999999999999999953 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC---Cceeeeccccccccc
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAF 177 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~---~~lKL~DFGla~~~~ 177 (599)
+|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999998 5999999888889999999999999999999999999999999999999764 559999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... .....+||++|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..+.......
T Consensus 191 ~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------- 256 (494)
T 3lij_A 191 NQK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF------- 256 (494)
T ss_dssp TTB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------
T ss_pred CCc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-------
Confidence 322 2345689999999999864 68999999999999999999999999988776665554322111
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
....+..+++.+.+||++
T Consensus 257 --------------------------------------------------------------~~~~~~~~s~~~~~li~~ 274 (494)
T 3lij_A 257 --------------------------------------------------------------DSPEWKNVSEGAKDLIKQ 274 (494)
T ss_dssp --------------------------------------------------------------CSGGGTTSCHHHHHHHHH
T ss_pred --------------------------------------------------------------CchhcccCCHHHHHHHHH
Confidence 112245678999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCc
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
||++||.+|||++|+|+||||+...
T Consensus 275 ~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 275 MLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HCCCChhhCccHHHHhcCcccccCc
Confidence 9999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=391.89 Aligned_cols=258 Identities=27% Similarity=0.453 Sum_probs=209.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFE--HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~~--~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
..++|++++.||+|+||.||+|++. .+|+.||||+++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 4579999999999999999999985 6899999999975422 22345567899999999999999999999954
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 93 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 ---GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp ---SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 357999999998 6999999988889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|.+...
T Consensus 170 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------ 238 (327)
T 3a62_A 170 ESIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------ 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------
T ss_pred ccccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------
Confidence 5432211 2245689999999999977 6789999999999999999999999998876655544432100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
...+.+++.+.+|
T Consensus 239 -------------------------------------------------------------------~~p~~~~~~~~~l 251 (327)
T 3a62_A 239 -------------------------------------------------------------------NLPPYLTQEARDL 251 (327)
T ss_dssp -------------------------------------------------------------------CCCTTSCHHHHHH
T ss_pred -------------------------------------------------------------------CCCCCCCHHHHHH
Confidence 1113568899999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCccccCC
Q 007542 335 LERMLAFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 335 L~~mL~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
|.+||..||.+|| +++|+|+||||+++
T Consensus 252 i~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999 89999999999976
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=398.98 Aligned_cols=257 Identities=21% Similarity=0.383 Sum_probs=218.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
.++|+++++||+|+||.||+|+++.+|+.||||+++.... .......+.+|..+|..+ +||||+++++++.. .
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----M 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----S
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----C
Confidence 4789999999999999999999999999999999974321 123456778999999887 79999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 57999999998 59999999888899999999999999999999999999999999999999999999999999976422
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|....
T Consensus 174 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~----------- 237 (353)
T 2i0e_A 174 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 237 (353)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred CCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 221 2345689999999999977 679999999999999999999999999887666555543210
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
. .....+++.+.+||.+|
T Consensus 238 -----------------------------------------------------------~---~~p~~~s~~~~~li~~l 255 (353)
T 2i0e_A 238 -----------------------------------------------------------V---AYPKSMSKEAVAICKGL 255 (353)
T ss_dssp -----------------------------------------------------------C---CCCTTSCHHHHHHHHHH
T ss_pred -----------------------------------------------------------C---CCCCCCCHHHHHHHHHH
Confidence 0 01135788999999999
Q ss_pred cccCCCCCC-----CHHHHhcCccccCC
Q 007542 339 LAFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
|..||.+|| +++|+++||||+++
T Consensus 256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 256 MTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp TCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred hhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 999999999 47999999999976
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=399.08 Aligned_cols=261 Identities=28% Similarity=0.434 Sum_probs=213.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~---~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|++.+.||+|+||+||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 97 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS---- 97 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 3578999999999999999999999999999999986321 111235678899999999999999999999843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc---eeeec
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICD 169 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~---lKL~D 169 (599)
...+|+||||++ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 98 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 98 -DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp -TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred -CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 357999999999 6998877543 35899999999999999999999999999999999999987655 99999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
||+++...... ......+||++|+|||++.+ ..|+.++||||||||+|+|++|++||.+.. ...+..+......
T Consensus 177 fg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 177 FGVAIQLGESG---LVAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYK 250 (351)
T ss_dssp CTTCEECCTTS---CBCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCC
T ss_pred CcceeEecCCC---eeecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCC
Confidence 99998764322 12345689999999999977 678999999999999999999999998753 2222222211111
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
.. ...++.+++
T Consensus 251 ~~---------------------------------------------------------------------~~~~~~~s~ 261 (351)
T 3c0i_A 251 MN---------------------------------------------------------------------PRQWSHISE 261 (351)
T ss_dssp CC---------------------------------------------------------------------HHHHTTSCH
T ss_pred CC---------------------------------------------------------------------ccccccCCH
Confidence 11 111245788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+.+||.+||..||.+|||+.|+|+||||++.
T Consensus 262 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 262 SAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 99999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=412.89 Aligned_cols=267 Identities=22% Similarity=0.387 Sum_probs=221.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|+++++||+|+||+||+|+++.+++.||||+++.... .......+.+|+.+|..++||||+++++++.+ .
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-----D 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----C
Confidence 35789999999999999999999999999999999964211 11122347789999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+|||||||. |+|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 57999999997 699999987 4689999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
.... ...+..+||++|+|||++... ...|+.++|||||||++|||++|++||.+.+..+.+..|.+..+
T Consensus 227 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------ 298 (437)
T 4aw2_A 227 EDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 298 (437)
T ss_dssp TTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH------
T ss_pred cCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc------
Confidence 3221 123456899999999998621 15689999999999999999999999999887777666642100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
...+......+++.+++|
T Consensus 299 --------------------------------------------------------------~~~~p~~~~~~s~~~~dL 316 (437)
T 4aw2_A 299 --------------------------------------------------------------RFQFPTQVTDVSENAKDL 316 (437)
T ss_dssp --------------------------------------------------------------HCCCCSSCCCSCHHHHHH
T ss_pred --------------------------------------------------------------cccCCcccccCCHHHHHH
Confidence 011223345689999999
Q ss_pred HHHhcccCCCC--CCCHHHHhcCccccCCc
Q 007542 335 LERMLAFEPKD--RPTAEEALADPYFKGLA 362 (599)
Q Consensus 335 L~~mL~~DP~~--RpTa~e~L~HP~f~~~~ 362 (599)
|++||..+|++ |++++|+++||||+++.
T Consensus 317 i~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 317 IRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp HHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred HHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 99999999988 99999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=417.56 Aligned_cols=271 Identities=33% Similarity=0.516 Sum_probs=224.2
Q ss_pred CCcccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcccccee
Q 007542 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90 (599)
Q Consensus 11 ~~~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v 90 (599)
+.-.....-...++|+++++||+|+||+||+|.++.+++.||||++............+.+|+.+|+.++||||++++++
T Consensus 10 ~~~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 89 (486)
T 3mwu_A 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89 (486)
T ss_dssp ----CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 33333344445789999999999999999999999999999999996543333456788999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec---CCCcee
Q 007542 91 LLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLK 166 (599)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~---~~~~lK 166 (599)
+.. ...+|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 90 ~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 164 (486)
T 3mwu_A 90 LED-----SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIK 164 (486)
T ss_dssp EEC-----SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEE
T ss_pred EEc-----CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEE
Confidence 954 357999999998 59999998888999999999999999999999999999999999999995 456799
Q ss_pred eecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 007542 167 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (599)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~ 246 (599)
|+|||+++...... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..+...
T Consensus 165 l~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 165 IIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (486)
T ss_dssp ECSCSCTTTBCCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EEECCcCeECCCCC----ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 99999998654322 2345689999999999875 5899999999999999999999999998877666555432
Q ss_pred cCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC
Q 007542 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN 326 (599)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 326 (599)
.... ....+..
T Consensus 238 ~~~~---------------------------------------------------------------------~~~~~~~ 248 (486)
T 3mwu_A 238 KYAF---------------------------------------------------------------------DLPQWRT 248 (486)
T ss_dssp CCCS---------------------------------------------------------------------CSGGGGG
T ss_pred CCCC---------------------------------------------------------------------CCcccCC
Confidence 1111 0112345
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+++.+.+||.+||++||.+|||+.|+|+||||+...
T Consensus 249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 788999999999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=394.98 Aligned_cols=262 Identities=29% Similarity=0.440 Sum_probs=203.4
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
....++|++++.||+|+||+||+|+++.+++.||||++..... ....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---- 88 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTP---- 88 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC----
Confidence 3457899999999999999999999999999999999975322 235677999999999999999999999543
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc--eeeeccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARV 175 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~--lKL~DFGla~~ 175 (599)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 89 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 89 -THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred -CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 47999999997 699999988888999999999999999999999999999999999999987765 99999999975
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCc-chhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~-~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
..... .....+||++|+|||++.+ ..++. ++|||||||++|+|++|++||.+.+....+..+....
T Consensus 168 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~------- 234 (361)
T 3uc3_A 168 SVLHS----QPKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI------- 234 (361)
T ss_dssp -----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH-------
T ss_pred ccccC----CCCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-------
Confidence 32221 1245689999999999876 45544 4899999999999999999998765432222211100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+ .... . ......+++.+.+|
T Consensus 235 ------------------------------------------------------~-~~~~--~---~~~~~~~s~~~~~l 254 (361)
T 3uc3_A 235 ------------------------------------------------------L-SVKY--S---IPDDIRISPECCHL 254 (361)
T ss_dssp ------------------------------------------------------H-TTCC--C---CCTTSCCCHHHHHH
T ss_pred ------------------------------------------------------h-cCCC--C---CCCcCCCCHHHHHH
Confidence 0 0000 0 01112478899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|.+||+.||.+|||++|+|+||||...
T Consensus 255 i~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 255 ISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999999999999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=401.22 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=217.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|+++++||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++.+. .
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----E 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence 478999999999999999999999999999999996422 1223456788999999999999999999999543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 7999999998 599999999889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
. .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------ 232 (384)
T 4fr4_A 169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------ 232 (384)
T ss_dssp C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH------------
T ss_pred C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH------------
Confidence 2 23567899999999998642 145899999999999999999999999865433221111100
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
... . ......+++.+.+||.+|
T Consensus 233 ---------------------------------------------------~~~----~---~~~p~~~s~~~~~li~~l 254 (384)
T 4fr4_A 233 ---------------------------------------------------ETT----V---VTYPSAWSQEMVSLLKKL 254 (384)
T ss_dssp ---------------------------------------------------HHC----C---CCCCTTSCHHHHHHHHHH
T ss_pred ---------------------------------------------------hhc----c---cCCCCcCCHHHHHHHHHH
Confidence 000 0 011235788999999999
Q ss_pred cccCCCCCCC-HHHHhcCccccCC
Q 007542 339 LAFEPKDRPT-AEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpT-a~e~L~HP~f~~~ 361 (599)
|+.||.+||+ ++++++||||+++
T Consensus 255 L~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 255 LEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp SCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred hcCCHhHhcccHHHHHcChhhhcC
Confidence 9999999998 9999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=388.21 Aligned_cols=290 Identities=29% Similarity=0.562 Sum_probs=226.9
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCC
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS 95 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s 95 (599)
..++..++|++++.||+|+||.||+|++..+++.||||+++. .....+.+|+.+|+.++ ||||+++++++....
T Consensus 30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 104 (330)
T 3nsz_A 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPV 104 (330)
T ss_dssp CCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred hcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC
Confidence 446778999999999999999999999999999999999863 23467889999999997 999999999996432
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-ceeeeccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-~lKL~DFGla 173 (599)
...+++||||+. ++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 105 ---~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 105 ---SRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp ---TCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ---CCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 357899999999 58888874 489999999999999999999999999999999999999777 8999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCC-CCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF-PGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF-~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+....... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+++..+...+|.+..
T Consensus 179 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 179 EFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp EECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred eEcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 86543322 2456899999999998652 56899999999999999999999777 566778888888887775433
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC-----CCCC
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK-----FPNA 327 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~~ 327 (599)
..+.... .. ......... +.......+... ...+
T Consensus 254 ~~~~~~~--------~~------------------------------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 292 (330)
T 3nsz_A 254 YDYIDKY--------NI------------------------------ELDPRFNDI---LGRHSRKRWERFVHSENQHLV 292 (330)
T ss_dssp HHHHHHT--------TC------------------------------CCCTHHHHH---HCCCCCCCGGGGCCTTTGGGC
T ss_pred hhHHHHh--------cc------------------------------ccccchhhh---hhhccccchhhhccccccccC
Confidence 2211100 00 000000111 111111111111 1237
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
++.+.+||.+||++||.+|||++|+|+||||+++.+
T Consensus 293 ~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 293 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 899999999999999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=391.63 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=214.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++++.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~ 77 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE-----G 77 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----C
Confidence 346799999999999999999999999999999999864221 2234567899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 57899999998 59999998888899999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+...........
T Consensus 158 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~------------ 223 (323)
T 3tki_A 158 NNR-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223 (323)
T ss_dssp TTE-ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHT------------
T ss_pred CCc-ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc------------
Confidence 221 1223456899999999998762 23477899999999999999999999876543221111000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.......+..+++.+.+||.+|
T Consensus 224 ----------------------------------------------------------~~~~~~~~~~~~~~~~~li~~~ 245 (323)
T 3tki_A 224 ----------------------------------------------------------KKTYLNPWKKIDSAPLALLHKI 245 (323)
T ss_dssp ----------------------------------------------------------TCTTSTTGGGSCHHHHHHHHHH
T ss_pred ----------------------------------------------------------ccccCCccccCCHHHHHHHHHH
Confidence 0001111245788899999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|+.||.+|||++|+|+||||+...
T Consensus 246 L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 246 LVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp SCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=410.71 Aligned_cols=257 Identities=25% Similarity=0.440 Sum_probs=210.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|+++++||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----TT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----CC
Confidence 478999999999999999999999999999999997432 223345677899999999999999999999943 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 7999999998 5999999888899999999999999999999998 9999999999999999999999999999975432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ......+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+....+..|....
T Consensus 302 ~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------- 365 (446)
T 4ejn_A 302 DG---ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------- 365 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------
T ss_pred CC---cccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 22 12356789999999999977 679999999999999999999999999887665554443210
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
. .....+++.+.+||.+|
T Consensus 366 -----------------------------------------------------------~---~~p~~~~~~~~~li~~~ 383 (446)
T 4ejn_A 366 -----------------------------------------------------------I---RFPRTLGPEAKSLLSGL 383 (446)
T ss_dssp -----------------------------------------------------------C---CCCTTSCHHHHHHHHHH
T ss_pred -----------------------------------------------------------C---CCCccCCHHHHHHHHHH
Confidence 0 01134688999999999
Q ss_pred cccCCCCCC-----CHHHHhcCccccCC
Q 007542 339 LAFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
|+.||.+|| |++|+|+||||+++
T Consensus 384 L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 384 LKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 999999999 99999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=385.66 Aligned_cols=260 Identities=27% Similarity=0.480 Sum_probs=207.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC------------------------hhhHHHHHHHHHHHH
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH------------------------VSDATRILREIKLLR 77 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~------------------------~~~~~~i~rEi~iL~ 77 (599)
.++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999999999999999999643211 112356889999999
Q ss_pred hcCCCCccccceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCc
Q 007542 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (599)
Q Consensus 78 ~l~HpnIv~l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (599)
.++||||+++++++... ....+|+||||++ ++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999998643 2357899999998 5777654 34579999999999999999999999999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~s~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
||++.++.+||+|||+++....... ......||+.|+|||++.+... .++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999987543221 2345689999999999876211 14788999999999999999999998766
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 236 ~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
.......+....
T Consensus 245 ~~~~~~~~~~~~-------------------------------------------------------------------- 256 (298)
T 2zv2_A 245 IMCLHSKIKSQA-------------------------------------------------------------------- 256 (298)
T ss_dssp HHHHHHHHHHCC--------------------------------------------------------------------
T ss_pred HHHHHHHHhccc--------------------------------------------------------------------
Confidence 543332221100
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
..+ ...+.+++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 257 --~~~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 257 --LEF-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp --CCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred --CCC-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 000 11246788999999999999999999999999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=397.09 Aligned_cols=296 Identities=27% Similarity=0.383 Sum_probs=228.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC--------CCCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--------HPDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~--------HpnIv~l~~v~~~ 93 (599)
.++|+++++||+|+||+||+|++..+++.||||++.. .......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 5899999999999999999999999999999999964 2345577889999999986 7889999999853
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCC-------
Q 007542 94 PSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADC------- 163 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~------- 163 (599)
.. .....+|+||||++++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 133579999999999988888765 4699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------ceeeecccccccccCCCCCcccccccccCccccCcccc
Q 007542 164 ------------------------------------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201 (599)
Q Consensus 164 ------------------------------------------~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l 201 (599)
.+||+|||+++..... .+..+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999875432 2455899999999999
Q ss_pred ccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC------hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCccc
Q 007542 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN------VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCS 275 (599)
Q Consensus 202 ~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~------~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~ 275 (599)
.+ ..++.++||||||||+|+|++|++||.+.+ ..+++..+.+.+|.++...+...... ..+....+....
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCcccccc
Confidence 77 579999999999999999999999998765 56788999999999988776541110 001111111000
Q ss_pred CCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 276 VAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 276 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+... ........+. .. .......++.+.+||.+||++||.+|||++|+|+|
T Consensus 342 ~~~~---------------------~~~~~~~~~~---~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 342 ITKL---------------------KPWGLFEVLV---EK-----YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCC---------------------CCCCHHHHHH---HT-----SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccc---------------------CCcchhHhhh---hh-----cccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 0000000000 00 00112245678999999999999999999999999
Q ss_pred ccccC
Q 007542 356 PYFKG 360 (599)
Q Consensus 356 P~f~~ 360 (599)
|||++
T Consensus 393 p~~~~ 397 (397)
T 1wak_A 393 PWLNS 397 (397)
T ss_dssp GGGGC
T ss_pred ccccC
Confidence 99974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=407.57 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=218.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|+++++||+|+||.||+|+++.+++.||||+++... ........+.+|+.+|+.++||||+++++++.+ .
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-----D 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----C
Confidence 4579999999999999999999999999999999996421 111123347799999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+||||||+. |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 57999999997 6999998764 699999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCccccCcccccccc--CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~--~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.. .......+||+.|+|||++.+.. ..|+.++|||||||++|+|++|++||.+.+....+..|.+....
T Consensus 221 ~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------- 291 (410)
T 3v8s_A 221 EG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS------- 291 (410)
T ss_dssp TS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-------
T ss_pred CC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc-------
Confidence 22 11234678999999999986521 12789999999999999999999999998877776666431000
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
+ . ....+.+++.+++||+
T Consensus 292 -------------------------------------------------------~------~-~p~~~~~s~~~~~li~ 309 (410)
T 3v8s_A 292 -------------------------------------------------------L------T-FPDDNDISKEAKNLIC 309 (410)
T ss_dssp -------------------------------------------------------C------C-CCTTCCCCHHHHHHHH
T ss_pred -------------------------------------------------------c------c-CCCcccccHHHHHHHH
Confidence 0 0 0112457899999999
Q ss_pred HhcccCCCC--CCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKD--RPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~--RpTa~e~L~HP~f~~~ 361 (599)
+||+.+|.+ |++++|+++||||+++
T Consensus 310 ~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 310 AFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999998 9999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=390.81 Aligned_cols=264 Identities=24% Similarity=0.449 Sum_probs=193.7
Q ss_pred CceEEE---EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCC
Q 007542 23 SRYKIE---EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 23 ~rY~i~---~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~ 98 (599)
++|++. +.||+|+||+||+|.++.+|+.||||++.. .....+.+|+.+|+.+. ||||+++++++.+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----- 77 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHD----- 77 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----
Confidence 467775 789999999999999999999999999964 23456779999999997 9999999999943
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC---ceeeecccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFGLAR 174 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~---~lKL~DFGla~ 174 (599)
...+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 357899999998 59999999988999999999999999999999999999999999999998765 89999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..... ..
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------~~---- 220 (325)
T 3kn6_A 158 LKPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC--------TS---- 220 (325)
T ss_dssp ECCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C--------CC----
T ss_pred ecCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc--------cc----
Confidence 6533221 2345678999999999977 67999999999999999999999999875431100 00
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
....+..+...........+..+++.+.+|
T Consensus 221 --------------------------------------------------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (325)
T 3kn6_A 221 --------------------------------------------------AVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250 (325)
T ss_dssp --------------------------------------------------HHHHHHHHTTTCCCCCSHHHHTSCHHHHHH
T ss_pred --------------------------------------------------HHHHHHHHHcCCCCCCcccccCCCHHHHHH
Confidence 000011111111111112224578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
|.+||+.||.+|||++|+|+||||++...
T Consensus 251 i~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp HHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred HHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 99999999999999999999999997643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=395.18 Aligned_cols=219 Identities=34% Similarity=0.606 Sum_probs=191.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCC-----ccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPD-----IVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-Hpn-----Iv~l~~v~~~~s 95 (599)
.++|++++.||+|+||+||+|++..+++.||||+++. .......+.+|+.+++.++ |++ |+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 5899999999999999999999999999999999974 2334566778999998885 554 8888888843
Q ss_pred cCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhh--hCceEeccCCCCceEec--CCCceeeec
Q 007542 96 RREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIH--TANVFHRDLKPKNILAN--ADCKLKICD 169 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILv~--~~~~lKL~D 169 (599)
...+|+||||++++|.+++... ..+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|
T Consensus 128 ---~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 ---RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ---TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ---CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 3579999999999999999876 46999999999999999999999 47999999999999995 478899999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
||+++..... ....++|+.|+|||++.+ ..++.++||||||||+|+|++|++||.+.+..+++..|...+|.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999875322 245689999999999987 57999999999999999999999999999999999999999999
Q ss_pred CCHHHHH
Q 007542 250 PSPEAIA 256 (599)
Q Consensus 250 p~~e~i~ 256 (599)
|+...+.
T Consensus 277 ~~~~~~~ 283 (382)
T 2vx3_A 277 PPAHILD 283 (382)
T ss_dssp CCHHHHT
T ss_pred CCHHHHH
Confidence 9887654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=385.03 Aligned_cols=297 Identities=29% Similarity=0.466 Sum_probs=231.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEE-CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC------ccccceeecC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYD-TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD------IVEIKHILLP 93 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~-~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn------Iv~l~~v~~~ 93 (599)
..++|++++.||+|+||.||+|.+ ..+++.||||+++. .......+.+|+.+++.++|++ ++++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 467999999999999999999998 56899999999964 2344567889999999987654 8999998843
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC----------
Q 007542 94 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---------- 161 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---------- 161 (599)
...+|+||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 -----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 -----HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp -----TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred -----CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 34799999999999999998775 6899999999999999999999999999999999999987
Q ss_pred ---------CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 007542 162 ---------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 162 ---------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 678999999999864322 234589999999999977 679999999999999999999999999
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhc
Q 007542 233 GKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312 (599)
Q Consensus 233 g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~ 312 (599)
+.+..+.+..+.+.++.++...+....... +... ...++. .......++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~~-~~~~~~------------------------~~~~~~~~~~~~ 287 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRK---YFHH-DRLDWD------------------------EHSSAGRYVSRA 287 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGG---GEET-TEECCC------------------------TTSHHHHHHHHH
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchh---HHhh-cccccc------------------------ccccccchhhhc
Confidence 999999999999999988887665511000 0000 000000 000111122111
Q ss_pred ccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 313 ~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.... ..+.......++.+.+||.+||++||.+|||++|+|+||||+.+.
T Consensus 288 ~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 288 CKPL-KEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp CCCG-GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred Ccch-hhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 1100 011111223457789999999999999999999999999999764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=392.68 Aligned_cols=258 Identities=29% Similarity=0.427 Sum_probs=211.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++++.||+|+||+||+|.++.+|+.||||++..... ...+|+.+|..+ +||||+++++++.+ .
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~ 88 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDD-----G 88 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEEC-----S
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEc-----C
Confidence 35789999999999999999999999999999999975322 234788888887 79999999999943 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC----Cceeeecccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLAR 174 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~----~~lKL~DFGla~ 174 (599)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 57999999998 5999999988899999999999999999999999999999999999998543 359999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh---hhHHHHHHHhcCCCC
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV---VHQLDIMTDLLGTPS 251 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~---~~~l~~I~~~lg~p~ 251 (599)
....... .....++|+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+... ...+..|.
T Consensus 169 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~------- 236 (342)
T 2qr7_A 169 QLRAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG------- 236 (342)
T ss_dssp ECBCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH-------
T ss_pred cCcCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc-------
Confidence 7543322 2245689999999999976 5688999999999999999999999986432 11111111
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
..........++.+++.+
T Consensus 237 --------------------------------------------------------------~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 237 --------------------------------------------------------------SGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp --------------------------------------------------------------HCCCCCCSTTTTTSCHHH
T ss_pred --------------------------------------------------------------cCCcccCccccccCCHHH
Confidence 111111123346789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
.+||++||..||.+|||+.|+|+||||.++..
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 99999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=397.98 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=219.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.++.+|+.||+|++... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~ 121 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KY 121 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SS
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CC
Confidence 347899999999999999999999999999999999643 23345678899999999999999999999943 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC--CCceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~--~~~lKL~DFGla~~~ 176 (599)
.+|+||||+. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 7999999998 59999997654 7999999999999999999999999999999999999974 477999999999876
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... .....+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+.+....+..+....-
T Consensus 202 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~-------- 267 (387)
T 1kob_A 202 NPDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW-------- 267 (387)
T ss_dssp CTTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--------
T ss_pred CCCc----ceeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 4322 1234579999999999977 6789999999999999999999999998877665554432110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
......+..+++.+.+||.
T Consensus 268 -------------------------------------------------------------~~~~~~~~~~s~~~~~li~ 286 (387)
T 1kob_A 268 -------------------------------------------------------------EFDEDAFSSVSPEAKDFIK 286 (387)
T ss_dssp -------------------------------------------------------------CCCSSTTTTSCHHHHHHHH
T ss_pred -------------------------------------------------------------CCCccccccCCHHHHHHHH
Confidence 0111234567899999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCc
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+||+.||.+|||++|+|+||||++..
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 287 NLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp TTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=410.64 Aligned_cols=262 Identities=31% Similarity=0.441 Sum_probs=220.4
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-----------hhHHHHHHHHHHHHhcCCCCccccc
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-----------SDATRILREIKLLRLLRHPDIVEIK 88 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~-----------~~~~~i~rEi~iL~~l~HpnIv~l~ 88 (599)
...++|+++++||+|+||+||+|.++.+++.||||++....... .....+.+|+.+|+.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35689999999999999999999999999999999997533211 2356788999999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC---c
Q 007542 89 HILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---K 164 (599)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~---~ 164 (599)
+++.. ...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 113 ~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 113 DVFED-----KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEEEC-----SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred EEEEc-----CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99943 357999999998 59999998888999999999999999999999999999999999999999876 6
Q ss_pred eeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 007542 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~ 244 (599)
+||+|||+++...... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..|.
T Consensus 188 ~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999998764322 2345689999999999864 58999999999999999999999999988877766665
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
........ ..+
T Consensus 261 ~~~~~~~~---------------------------------------------------------------------~~~ 271 (504)
T 3q5i_A 261 KGKYYFDF---------------------------------------------------------------------NDW 271 (504)
T ss_dssp HCCCCCCH---------------------------------------------------------------------HHH
T ss_pred cCCCCCCc---------------------------------------------------------------------ccc
Confidence 42221111 112
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
..+++.+++||++||++||.+|||++|+|+||||+...
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 45788999999999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=384.09 Aligned_cols=252 Identities=27% Similarity=0.312 Sum_probs=207.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|+++++||+|+||+||+|+++.+|+.||||++..............+|+..+..+ +||||+++++++. +...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence 689999999999999999999999999999999876655556666677777766555 8999999999984 3357
Q ss_pred EEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988765 469999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. .....||+.|+|||++.+ .++.++|||||||++++|++|..+|.+.+... .+.. +..++
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~~-------- 271 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLPP-------- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCCH--------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCCc--------
Confidence 1 234579999999999865 58999999999999999999987775532211 1110 00000
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
......++.+.+||.+||+
T Consensus 272 -------------------------------------------------------------~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 272 -------------------------------------------------------------EFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp -------------------------------------------------------------HHHTTSCHHHHHHHHHHSC
T ss_pred -------------------------------------------------------------ccccCCCHHHHHHHHHHcC
Confidence 1113567889999999999
Q ss_pred cCCCCCCCHHHHhcCccccC
Q 007542 341 FEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~ 360 (599)
.||.+|||++|+|+||||++
T Consensus 291 ~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 291 PDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp SSTTTSCCHHHHHTSGGGSC
T ss_pred CChhhCcCHHHHHhCccccC
Confidence 99999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=373.58 Aligned_cols=258 Identities=31% Similarity=0.469 Sum_probs=221.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NT 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC
Confidence 46789999999999999999999999999999999975332 345678899999999999999999999943 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe---cCCCceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv---~~~~~lKL~DFGla~~~ 176 (599)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 7899999998 5999999888889999999999999999999999999999999999999 78899999999999765
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... ......+|+.|+|||++.+ .++.++|||||||++++|++|+.||.+.+....+..+.......+..
T Consensus 160 ~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 229 (277)
T 3f3z_A 160 KPGK----MMRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEK--- 229 (277)
T ss_dssp CTTS----CBCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---
T ss_pred cCcc----chhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCch---
Confidence 4322 2245679999999999865 48999999999999999999999999888776666555433222221
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.+...++.+.+||.
T Consensus 230 ------------------------------------------------------------------~~~~~~~~~~~li~ 243 (277)
T 3f3z_A 230 ------------------------------------------------------------------DWLNVSPQAESLIR 243 (277)
T ss_dssp ------------------------------------------------------------------HHTTSCHHHHHHHH
T ss_pred ------------------------------------------------------------------hhhcCCHHHHHHHH
Confidence 11356788999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||+.||.+|||+.|+|+||||+..
T Consensus 244 ~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 244 RLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=397.55 Aligned_cols=258 Identities=26% Similarity=0.443 Sum_probs=211.4
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHH-HHhcCCCCccccceeecCCCcCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKL-LRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~i-L~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
..++|+++++||+|+||.||+|+++.+++.||||+++.... .......+.+|..+ ++.++||||+++++++..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----- 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----- 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----
Confidence 45789999999999999999999999999999999975432 23344567778876 577899999999999954
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 357999999998 5999999988889999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+....+..|...
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----------- 254 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----------- 254 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-----------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----------
Confidence 2221 2345789999999999987 67999999999999999999999999988766655544321
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. ...+.+++.+.+||++
T Consensus 255 -----------------------------------------------------------~~---~~~~~~~~~~~~li~~ 272 (373)
T 2r5t_A 255 -----------------------------------------------------------PL---QLKPNITNSARHLLEG 272 (373)
T ss_dssp -----------------------------------------------------------CC---CCCSSSCHHHHHHHHH
T ss_pred -----------------------------------------------------------cc---CCCCCCCHHHHHHHHH
Confidence 00 1124578899999999
Q ss_pred hcccCCCCCCCH----HHHhcCccccCC
Q 007542 338 MLAFEPKDRPTA----EEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa----~e~L~HP~f~~~ 361 (599)
||+.||.+|+++ +|+++||||+++
T Consensus 273 lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 273 LLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 999999999996 799999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=403.90 Aligned_cols=266 Identities=22% Similarity=0.345 Sum_probs=218.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|+++++||+|+||.||+|+++.+|+.||||++++.. ........+.+|+.+|..++||||+++++++.+ .
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-----~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-----E 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-----S
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence 4589999999999999999999999999999999996421 111223457789999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+||||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 57999999997 6999999875 479999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCccccCccccccc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
.... ......+||+.|+|||++... ...|+.++||||||||+|||++|++||.+.+..+.+..|...-.
T Consensus 214 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 287 (412)
T 2vd5_A 214 ADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE---- 287 (412)
T ss_dssp TTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred CCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----
Confidence 3221 112346899999999998621 14689999999999999999999999999887776665542100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
...+......+++.++
T Consensus 288 ----------------------------------------------------------------~~~~p~~~~~~s~~~~ 303 (412)
T 2vd5_A 288 ----------------------------------------------------------------HLSLPLVDEGVPEEAR 303 (412)
T ss_dssp ----------------------------------------------------------------HCCCC----CCCHHHH
T ss_pred ----------------------------------------------------------------CcCCCccccCCCHHHH
Confidence 0001111245789999
Q ss_pred HHHHHhcccCCCCC---CCHHHHhcCccccCCc
Q 007542 333 RLLERMLAFEPKDR---PTAEEALADPYFKGLA 362 (599)
Q Consensus 333 dLL~~mL~~DP~~R---pTa~e~L~HP~f~~~~ 362 (599)
+||++||. ||.+| ++++|+++||||+++.
T Consensus 304 dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 304 DFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp HHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 99999999 99998 5999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=407.45 Aligned_cols=257 Identities=32% Similarity=0.505 Sum_probs=218.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|.+++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++... .
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----S 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 4789999999999999999999999999999999964221 122356788999999999999999999999543 4
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 7999999997 699999998889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. .....+||+.|+|||++.+. ..++.++||||||||+|+|++|+.||.+.+....+..|.+...
T Consensus 170 ~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------- 233 (476)
T 2y94_A 170 E----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF----------- 233 (476)
T ss_dssp C----CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-----------
T ss_pred c----cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 2 23456899999999999762 2347899999999999999999999998776555444432110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.....+++.+.+||++||
T Consensus 234 --------------------------------------------------------------~~p~~~s~~~~~Li~~~L 251 (476)
T 2y94_A 234 --------------------------------------------------------------YTPQYLNPSVISLLKHML 251 (476)
T ss_dssp --------------------------------------------------------------CCCTTCCHHHHHHHHHHT
T ss_pred --------------------------------------------------------------CCCccCCHHHHHHHHHHc
Confidence 011246788999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+.||.+|||++|+|+||||+..
T Consensus 252 ~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 252 QVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=374.87 Aligned_cols=262 Identities=25% Similarity=0.336 Sum_probs=218.2
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..+..|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... .+.
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~ 101 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK 101 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCC
Confidence 4567799999999999999999999999999999999866556667788999999999999999999999985432 234
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEec-CCCceeeeccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~-~~~~lKL~DFGla~~ 175 (599)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 57999999998 599999998888999999999999999999999999 99999999999998 789999999999975
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..... .....+|+.|+|||++.+ .++.++|||||||++++|++|+.||.+......+........
T Consensus 182 ~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 246 (290)
T 1t4h_A 182 KRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------- 246 (290)
T ss_dssp CCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-------
T ss_pred ccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-------
Confidence 43221 234579999999998864 589999999999999999999999987554433222111000
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.........++.+.+||
T Consensus 247 ---------------------------------------------------------------~~~~~~~~~~~~l~~li 263 (290)
T 1t4h_A 247 ---------------------------------------------------------------KPASFDKVAIPEVKEII 263 (290)
T ss_dssp ---------------------------------------------------------------CCGGGGGCCCHHHHHHH
T ss_pred ---------------------------------------------------------------CccccCCCCCHHHHHHH
Confidence 00011124567899999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccC
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
.+||+.||.+|||++|+|+||||++
T Consensus 264 ~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 264 EGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHccCChhhCCCHHHHhhCccccc
Confidence 9999999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=375.11 Aligned_cols=258 Identities=30% Similarity=0.471 Sum_probs=210.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++.+.||+|+||.||+|.++.++..||+|++.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 92 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----Y 92 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheec-----C
Confidence 55689999999999999999999999999999999997543 23346778899999999999999999999943 3
Q ss_pred ccEEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe---cCCCceeeeccc
Q 007542 100 KDIYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFG 171 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv---~~~~~lKL~DFG 171 (599)
..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg 172 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFG 172 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence 57999999998 599988854 3679999999999999999999999999999999999999 456889999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
++....... ......+|+.|+|||++.+ .++.++|||||||++++|++|+.||.+.+.......+...
T Consensus 173 ~a~~~~~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~----- 240 (285)
T 3is5_A 173 LAELFKSDE----HSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK----- 240 (285)
T ss_dssp CCCC--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----
T ss_pred cceecCCcc----cCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-----
Confidence 997653322 1245679999999999864 6889999999999999999999999987654433222110
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
...+.......++.+
T Consensus 241 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 241 -----------------------------------------------------------------EPNYAVECRPLTPQA 255 (285)
T ss_dssp -----------------------------------------------------------------CCCCCC--CCCCHHH
T ss_pred -----------------------------------------------------------------CcccccccCcCCHHH
Confidence 001111223468899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
.+||.+||+.||.+|||+.|+|+||||++
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 99999999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=410.42 Aligned_cols=262 Identities=31% Similarity=0.492 Sum_probs=223.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|+++++||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----K 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----C
Confidence 35789999999999999999999999999999999964332 23456788999999999999999999999943 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe---cCCCceeeeccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv---~~~~~lKL~DFGla~~ 175 (599)
..+|+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 57999999998 6999999998899999999999999999999999999999999999999 5678999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..... .....+||++|+|||++.+ .|+.++||||||||+|+|++|++||.+.+..+.+..|........
T Consensus 179 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 247 (484)
T 3nyv_A 179 FEASK----KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE---- 247 (484)
T ss_dssp BCCCC----SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----
T ss_pred ccccc----ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 64322 2345689999999999865 589999999999999999999999999887776665543211110
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
...+..+++.+.+||
T Consensus 248 -----------------------------------------------------------------~~~~~~~s~~~~~li 262 (484)
T 3nyv_A 248 -----------------------------------------------------------------LPQWKKVSESAKDLI 262 (484)
T ss_dssp -----------------------------------------------------------------SGGGGGSCHHHHHHH
T ss_pred -----------------------------------------------------------------CcccccCCHHHHHHH
Confidence 112345788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
++||++||.+|||++|+|+||||+....
T Consensus 263 ~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 263 RKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHCCCChhHCcCHHHHhhChhhccccc
Confidence 9999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=386.68 Aligned_cols=271 Identities=25% Similarity=0.407 Sum_probs=224.5
Q ss_pred CcccccccCCCCceEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccce
Q 007542 12 DVDFFTEYGEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKH 89 (599)
Q Consensus 12 ~~~~~~~~~~~~rY~i~-~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~ 89 (599)
.+-|...-...++|.+. +.||+|+||+||+|++..+|+.||||++............+.+|+.+|+.+. ||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34444444567899998 8999999999999999999999999999865555556778899999999995 699999999
Q ss_pred eecCCCcCCCccEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---CC
Q 007542 90 ILLPPSRREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DC 163 (599)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~~ 163 (599)
++.. ...+|+||||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 97 ~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 97 VYEN-----TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEC-----SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC
T ss_pred EEEe-----CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC
Confidence 9943 3579999999985 999988653 57999999999999999999999999999999999999998 78
Q ss_pred ceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHH
Q 007542 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243 (599)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I 243 (599)
.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+
T Consensus 172 ~~kL~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 245 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245 (327)
T ss_dssp CEEECCGGGCEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cEEEeeCccccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 999999999987543221 244689999999999976 67899999999999999999999999988776665554
Q ss_pred HHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC
Q 007542 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323 (599)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 323 (599)
....... ....
T Consensus 246 ~~~~~~~---------------------------------------------------------------------~~~~ 256 (327)
T 3lm5_A 246 SQVNVDY---------------------------------------------------------------------SEET 256 (327)
T ss_dssp HHTCCCC---------------------------------------------------------------------CTTT
T ss_pred Hhccccc---------------------------------------------------------------------Cchh
Confidence 4322211 1123
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 324 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 324 ~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+...++.+.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 356788999999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=375.72 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=215.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
-++|++++.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----AT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-----CC
Confidence 478999999999999999999999999999999986422 112234568899999999999999999999843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 7999999999 599999988888999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. .....+|+.|+|||++.+ ..++.++|||||||++++|++|+.||.+.+.......+.....
T Consensus 163 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 224 (279)
T 3fdn_A 163 R-----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----------- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------
T ss_pred c-----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----------
Confidence 1 244678999999999977 6788999999999999999999999998776555444332110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
......++.+.+||.+||
T Consensus 225 --------------------------------------------------------------~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 225 --------------------------------------------------------------TFPDFVTEGARDLISRLL 242 (279)
T ss_dssp --------------------------------------------------------------CCCTTSCHHHHHHHHHHC
T ss_pred --------------------------------------------------------------CCCCcCCHHHHHHHHHHh
Confidence 011246788999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCcc
Q 007542 340 AFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
+.||.+|||++|+|+||||+....
T Consensus 243 ~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 243 KHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp CSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred ccChhhCCCHHHHhhCccccCCcc
Confidence 999999999999999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=381.74 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=205.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc------
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR------ 96 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~------ 96 (599)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 57999999999999999999999999999999997432 33456788999999999999999999999854321
Q ss_pred ----------------------------------------------CCCccEEEEEecCC-ccHHHHHHhCCC---CCHH
Q 007542 97 ----------------------------------------------REFKDIYVVFELME-SDLHQVIKANDD---LTPE 126 (599)
Q Consensus 97 ----------------------------------------------~~~~~lylV~E~~~-g~L~~~i~~~~~---lse~ 126 (599)
.....+|+||||++ ++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 11234899999999 599999987653 4566
Q ss_pred HHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC---------cccccccccCccccC
Q 007542 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---------AIFWTDYVATRWYRA 197 (599)
Q Consensus 127 ~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~---------~~~~~~~~gt~~Y~A 197 (599)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 78999999999999999999999999999999999999999999999876443211 112345689999999
Q ss_pred ccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCC
Q 007542 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVA 277 (599)
Q Consensus 198 PE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~ 277 (599)
||++.+ ..++.++|||||||++|+|++|..++. +....+........+
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~------------------------- 292 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFP------------------------- 292 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCC-------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCC-------------------------
Confidence 999977 678999999999999999999865542 111111111110000
Q ss_pred CccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 007542 278 PSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 357 (599)
Q Consensus 278 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~ 357 (599)
..+...++.+.+||.+||+.||.+|||++|+|+|||
T Consensus 293 --------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 293 --------------------------------------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp --------------------------------------------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred --------------------------------------------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 011223567899999999999999999999999999
Q ss_pred ccCC
Q 007542 358 FKGL 361 (599)
Q Consensus 358 f~~~ 361 (599)
|+++
T Consensus 329 f~~~ 332 (332)
T 3qd2_B 329 FENL 332 (332)
T ss_dssp CCCC
T ss_pred hhcC
Confidence 9864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=389.47 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=202.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~ 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFET-----PT 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEec-----CC
Confidence 357799999999999999999999999999999999743 234567799999999999999999999954 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---CCceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~~~lKL~DFGla~~~ 176 (599)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 7999999998 699999988888999999999999999999999999999999999999976 899999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhh-HHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH-QLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~-~l~~I~~~lg~p~~e~i 255 (599)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... .+..+.+
T Consensus 202 ~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~---------- 265 (349)
T 2w4o_A 202 EHQV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN---------- 265 (349)
T ss_dssp ---------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT----------
T ss_pred Cccc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh----------
Confidence 3321 2245679999999999977 578999999999999999999999997655432 2222211
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.........++..++.+.+||
T Consensus 266 -----------------------------------------------------------~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 266 -----------------------------------------------------------CEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp -----------------------------------------------------------TCCCCCTTTTTTSCHHHHHHH
T ss_pred -----------------------------------------------------------CCCccCCchhhhCCHHHHHHH
Confidence 011112233456889999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
++||+.||.+|||+.|+|+||||.+..
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=383.09 Aligned_cols=298 Identities=29% Similarity=0.473 Sum_probs=230.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCC-cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC------ccccceeecC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG-EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD------IVEIKHILLP 93 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg-~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn------Iv~l~~v~~~ 93 (599)
..++|++++.||+|+||.||+|.+..++ ..||||+++. .......+.+|+.+|+.++|++ ++.+.+++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~- 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN- 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-
Confidence 3689999999999999999999998887 6899999964 2344567889999999998766 788888773
Q ss_pred CCcCCCccEEEEEecCCccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe------------
Q 007542 94 PSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA------------ 159 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv------------ 159 (599)
....+|+||||++++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 93 ----FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ----ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred ----eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 334799999999999999887664 69999999999999999999999999999999999999
Q ss_pred -------cCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 007542 160 -------NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 160 -------~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
+.++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56789999999999864322 234589999999999977 679999999999999999999999999
Q ss_pred CCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhc
Q 007542 233 GKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSM 312 (599)
Q Consensus 233 g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~ 312 (599)
+.+..+++..+.+.+|.++...+........ +. .+...+ .......+++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~--~~--~~~~~~------------------------~~~~~~~~~~~~~ 292 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKY--FY--KGGLVW------------------------DENSSDGRYVKEN 292 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGG--EE--TTEECC------------------------CTTSHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhh--hc--cccccc------------------------ccccchhcccccc
Confidence 9999999999999999988877655211000 00 000000 0000011111111
Q ss_pred ccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 313 RKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 313 ~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
..... .........++.+.+||.+||+.||.+|||++|+|+||||+++..
T Consensus 293 ~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 293 CKPLK-SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp CCCGG-GGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred CCccc-ccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 11000 000111223567899999999999999999999999999998743
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=393.38 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=212.9
Q ss_pred CCceEE--EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 22 GSRYKI--EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i--~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.+.|.+ .++||+|+||.||+|.+..+|+.||||+++.. .......+.+|+.+|+.++||||+++++++.. .
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~ 158 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFES-----K 158 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----C
Confidence 345555 67899999999999999999999999999742 23456788999999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe--cCCCceeeeccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA--NADCKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv--~~~~~lKL~DFGla~~ 175 (599)
..+||||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 159 ~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 159 NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 47999999998 5999988765 469999999999999999999999999999999999999 5678899999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..... .....+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..|......+
T Consensus 239 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~----- 307 (373)
T 2x4f_A 239 YKPRE----KLKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL----- 307 (373)
T ss_dssp CCTTC----BCCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS-----
T ss_pred cCCcc----ccccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----
Confidence 64322 1234579999999999976 678999999999999999999999999988777666654322111
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
....++.+++.+.+||
T Consensus 308 ----------------------------------------------------------------~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 308 ----------------------------------------------------------------EDEEFQDISEEAKEFI 323 (373)
T ss_dssp ----------------------------------------------------------------CSGGGTTSCHHHHHHH
T ss_pred ----------------------------------------------------------------ChhhhccCCHHHHHHH
Confidence 1122356789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCC
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+||+.||.+|||++|+|+||||++.
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999999999865
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=380.76 Aligned_cols=281 Identities=25% Similarity=0.385 Sum_probs=208.7
Q ss_pred CCCceEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 007542 21 EGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~-~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~ 98 (599)
..++|++. ++||+|+||.||+|.+..+++.||||++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----- 82 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----- 82 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----
Confidence 45789996 7899999999999999999999999999653 223456788999999885 79999999999853
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc---eeeecccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLAR 174 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~---lKL~DFGla~ 174 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 347999999998 699999998888999999999999999999999999999999999999998776 9999999987
Q ss_pred cccCCCC----CcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 175 VAFNDTP----TAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 175 ~~~~~~~----~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
....... ........+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+..+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---- 238 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR---- 238 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----
Confidence 6532111 11112345799999999998531 134788999999999999999999999876532200000
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
+...+ .........+...........+..+
T Consensus 239 ~~~~~--------------------------------------------------~~~~~~~~~i~~~~~~~~~~~~~~~ 268 (316)
T 2ac3_A 239 GEACP--------------------------------------------------ACQNMLFESIQEGKYEFPDKDWAHI 268 (316)
T ss_dssp --CCH--------------------------------------------------HHHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred cccch--------------------------------------------------hHHHHHHHHHhccCcccCchhcccC
Confidence 00000 0000011111111111111123457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus 269 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 269 SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred CHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 88999999999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=375.45 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=217.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++.+.||+|+||.||+|.+..+|+.||||+++... ......+.+|+.+|+.++||||+++++++.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYES-----T 78 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhccc-----C
Confidence 34578999999999999999999999999999999997432 2234568899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe---cCCCceeeeccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv---~~~~~lKL~DFGla~~ 175 (599)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 57899999998 5999999888889999999999999999999999999999999999999 7789999999999875
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.+....
T Consensus 159 ~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~------ 225 (304)
T 2jam_A 159 EQNG-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE------ 225 (304)
T ss_dssp CCCB-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC------
T ss_pred cCCC-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 4321 1234578999999999977 67899999999999999999999999887765554444321100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.....++..++.+.+||
T Consensus 226 ---------------------------------------------------------------~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 226 ---------------------------------------------------------------FESPFWDDISESAKDFI 242 (304)
T ss_dssp ---------------------------------------------------------------CCTTTTTTSCHHHHHHH
T ss_pred ---------------------------------------------------------------CCccccccCCHHHHHHH
Confidence 01122356788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+||..||.+|||++|+|+||||++..
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=387.88 Aligned_cols=269 Identities=28% Similarity=0.428 Sum_probs=215.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~---~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 99 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED---- 99 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc----
Confidence 3688999999999999999999999999999999986421 133456788999999999999999999999943
Q ss_pred CCccEEEEEecCC-ccHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHH
Q 007542 98 EFKDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTPEHYQFFLYQLL 136 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~----------------------------------------~~~lse~~i~~i~~QIl 136 (599)
...+|+||||++ ++|.+++.. ...+++..++.++.||+
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 357999999998 699998842 11236788999999999
Q ss_pred HHHHHhhhCceEeccCCCCceEecCCC--ceeeecccccccccCCCC-CcccccccccCccccCccccccccCCCCcchh
Q 007542 137 RGLKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAID 213 (599)
Q Consensus 137 ~aL~yLHs~gIvHrDLKP~NILv~~~~--~lKL~DFGla~~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~D 213 (599)
.||.|||+.||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++|
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999999998776 899999999986533221 11123456899999999998653357899999
Q ss_pred hHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHH
Q 007542 214 IWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEV 293 (599)
Q Consensus 214 IWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 293 (599)
||||||++|+|++|+.||.+.+..+.+..+.+.....
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------------------------------- 295 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF------------------------------------------- 295 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT-------------------------------------------
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc-------------------------------------------
Confidence 9999999999999999999888766655544311110
Q ss_pred HHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 294 LILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 294 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
....+..+++.+.+||.+||+.||.+|||+.|+|+||||+++.+
T Consensus 296 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 296 --------------------------ENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp --------------------------TSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred --------------------------CCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 01122346888999999999999999999999999999998753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=371.16 Aligned_cols=262 Identities=28% Similarity=0.476 Sum_probs=218.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~----~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.++|++++.||+|+||.||+|.+..+|+.||||+++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN---- 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence 35799999999999999999999999999999998753222 1236778899999999999999999999854
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC----ceeeecccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDFGL 172 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~----~lKL~DFGl 172 (599)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 80 -KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred -CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 347899999997 69999998888899999999999999999999999999999999999999877 799999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+....... ......+|+.|+|||++.+ ..++.++|||||||++++|++|+.||.+.+..+.+..+.........
T Consensus 159 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T 3bhy_A 159 AHKIEAGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232 (283)
T ss_dssp CEECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred ceeccCCC----cccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence 98653322 1244578999999999976 67899999999999999999999999988766655554432221111
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
..++..++.+.
T Consensus 233 ---------------------------------------------------------------------~~~~~~~~~~~ 243 (283)
T 3bhy_A 233 ---------------------------------------------------------------------EYFSNTSELAK 243 (283)
T ss_dssp ---------------------------------------------------------------------HHHTTCCHHHH
T ss_pred ---------------------------------------------------------------------hhcccCCHHHH
Confidence 11245678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
+||.+||..||.+|||+.|+|+||||+.+..
T Consensus 244 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 9999999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=383.93 Aligned_cols=262 Identities=27% Similarity=0.362 Sum_probs=208.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC--CCccccceeecCCCcCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH--PDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H--pnIv~l~~v~~~~s~~~ 98 (599)
.+++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| +||+++++++..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----- 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----- 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-----
Confidence 467899999999999999999987 568999999997655555666788999999999986 999999999854
Q ss_pred CccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
...+|+|||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 34799999988899999999998999999999999999999999999999999999999997 68899999999986543
Q ss_pred CCCCcccccccccCccccCccccccc---------cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhcC
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLG 248 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~-~~l~~I~~~lg 248 (599)
... .......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ..+..+..
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--- 235 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--- 235 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC---
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc---
Confidence 221 1123456899999999998531 146888999999999999999999999764321 11111110
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
.... .......+
T Consensus 236 -----------------------------------------------------------------~~~~---~~~~~~~~ 247 (343)
T 3dbq_A 236 -----------------------------------------------------------------PNHE---IEFPDIPE 247 (343)
T ss_dssp -----------------------------------------------------------------TTSC---CCCCCCSC
T ss_pred -----------------------------------------------------------------CCcc---cCCcccCC
Confidence 0000 01112346
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 248 ~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 248 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 789999999999999999999999999999854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=384.93 Aligned_cols=273 Identities=24% Similarity=0.338 Sum_probs=217.7
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.-...++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 85 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET- 85 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-
Confidence 33457899999999999999999999999999999999975433 3344567889999999999999999999985432
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.....+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 12235699999998 69999999888899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----- 238 (311)
T ss_dssp ----------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----
T ss_pred ccccccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-----
Confidence 6443322222345679999999999977 678999999999999999999999999887665544433221111
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.......+++.+.+||
T Consensus 239 ----------------------------------------------------------------~~~~~~~~~~~l~~li 254 (311)
T 3ork_A 239 ----------------------------------------------------------------PSARHEGLSADLDAVV 254 (311)
T ss_dssp ----------------------------------------------------------------HHHHSTTCCHHHHHHH
T ss_pred ----------------------------------------------------------------cccccCCCCHHHHHHH
Confidence 1112345788899999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+||+.||.+||++.++|.|+|++...
T Consensus 255 ~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 255 LKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 999999999999999999999998543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=371.74 Aligned_cols=266 Identities=29% Similarity=0.419 Sum_probs=224.0
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
..-...++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 86 (294)
T 2rku_A 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-- 86 (294)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--
Confidence 344678899999999999999999999999999999999865432 33456778899999999999999999999843
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 87 ---NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp ---SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ---CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 357999999999 6999999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... ......+|+.|+|||++.+ ..++.++|||||||++++|++|+.||.+.+..+....+...
T Consensus 164 ~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------- 230 (294)
T 2rku_A 164 KVEYDGE---RKKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------- 230 (294)
T ss_dssp ECCSTTC---CBCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------
T ss_pred ecccCcc---ccccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--------
Confidence 7543222 1244678999999999977 67899999999999999999999999887654433322110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
. .......++.+.+|
T Consensus 231 --------------------------------------------------------------~---~~~~~~~~~~~~~l 245 (294)
T 2rku_A 231 --------------------------------------------------------------E---YSIPKHINPVAASL 245 (294)
T ss_dssp --------------------------------------------------------------C---CCCCTTSCHHHHHH
T ss_pred --------------------------------------------------------------c---CCCccccCHHHHHH
Confidence 0 01113467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCccCC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAKVE 365 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~ 365 (599)
|.+||+.||.+|||++|+|+||||.....+.
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 9999999999999999999999998765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=377.50 Aligned_cols=255 Identities=28% Similarity=0.513 Sum_probs=214.2
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.|...+.||+|+||.||+|+++.+|+.||||++.... ......+.+|+.+|+.++||||+++++++... ..+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEE
Confidence 4889999999999999999999999999999996432 33456788999999999999999999998543 4689
Q ss_pred EEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 104 VVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 589888764 47999999999999999999999999999999999999999999999999999875433221
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-------------- 258 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-------------- 258 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC--------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 245689999999999976 6789999999999999999999999988776554443322100
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
+........++.+.+||.+||+.|
T Consensus 259 --------------------------------------------------------~~~~~~~~~~~~l~~li~~~l~~d 282 (321)
T 2c30_A 259 --------------------------------------------------------PKLKNSHKVSPVLRDFLERMLVRD 282 (321)
T ss_dssp --------------------------------------------------------CCCTTGGGSCHHHHHHHHHHSCSS
T ss_pred --------------------------------------------------------CCcCccccCCHHHHHHHHHHccCC
Confidence 000111246788999999999999
Q ss_pred CCCCCCHHHHhcCccccCC
Q 007542 343 PKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f~~~ 361 (599)
|.+|||++|+|+||||...
T Consensus 283 p~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 283 PQERATAQELLDHPFLLQT 301 (321)
T ss_dssp TTTSCCHHHHHTSGGGGGC
T ss_pred hhhCcCHHHHhcChhhccC
Confidence 9999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=385.22 Aligned_cols=301 Identities=24% Similarity=0.345 Sum_probs=226.9
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-----------CCCccccce
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----------HPDIVEIKH 89 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-----------HpnIv~l~~ 89 (599)
..++|++++.||+|+||+||+|.+..+++.||||++.. .......+.+|+.+|+.++ |+||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35799999999999999999999999999999999963 2344567789999999886 899999999
Q ss_pred eecCCCcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecC-----
Q 007542 90 ILLPPSRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANA----- 161 (599)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~----- 161 (599)
++.... .....+++||||++++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.
T Consensus 94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred HhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence 986432 223478999999988999999874 4699999999999999999999998 9999999999999953
Q ss_pred -CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC-----
Q 007542 162 -DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN----- 235 (599)
Q Consensus 162 -~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~----- 235 (599)
++.+||+|||+++..... .+..++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CcceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 457999999999865432 234589999999999977 578999999999999999999999998765
Q ss_pred -hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc
Q 007542 236 -VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK 314 (599)
Q Consensus 236 -~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~ 314 (599)
..+++..+.+.+|.++...+....... .+....+....+... ........+...
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~-- 299 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTR--TFFNSRGLLRNISKL---------------------KFWPLEDVLTEK-- 299 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHH--HHBCC--CBSSCCCC---------------------CBCCHHHHHHHT--
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhh--hhcCCcchhcccccc---------------------cccchhhhhhhc--
Confidence 567888899999999887665411000 000000000000000 000000000000
Q ss_pred CCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 315 ~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
.......++.+.+||.+||++||.+|||++|+|+||||++....
T Consensus 300 ------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 300 ------YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp ------TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred ------ccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCc
Confidence 00112345678999999999999999999999999999986543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=392.59 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=205.0
Q ss_pred CCCCceEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHH-HhcCCCCccccceeecCCCcC
Q 007542 20 GEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 20 ~~~~rY~i~-~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL-~~l~HpnIv~l~~v~~~~s~~ 97 (599)
...++|.+. ++||+|+||+||+|+++.+|+.||||++.. ...+.+|+.++ +..+||||+++++++.... .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-A 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecc-c
Confidence 345678887 799999999999999999999999999863 23566899887 5558999999999985321 2
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---CCceeeeccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFG 171 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~~~lKL~DFG 171 (599)
+...+||||||+. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 2457999999998 59999998754 5999999999999999999999999999999999999998 7899999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhh----HHHHHHHhc
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH----QLDIMTDLL 247 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~----~l~~I~~~l 247 (599)
+++...... ..+..+||++|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+... ....|..
T Consensus 210 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-- 281 (400)
T 1nxk_A 210 FAKETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-- 281 (400)
T ss_dssp TCEECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--
T ss_pred cccccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--
Confidence 998653221 2345689999999999977 689999999999999999999999998765322 1111100
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
.........+..+
T Consensus 282 -------------------------------------------------------------------~~~~~~~~~~~~~ 294 (400)
T 1nxk_A 282 -------------------------------------------------------------------GQYEFPNPEWSEV 294 (400)
T ss_dssp -------------------------------------------------------------------TCCCCCTTTTTTS
T ss_pred -------------------------------------------------------------------CcccCCCcccccC
Confidence 0000111234568
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
++.+.+||++||+.||.+|||++|+|+||||.+..
T Consensus 295 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 89999999999999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=379.80 Aligned_cols=266 Identities=29% Similarity=0.416 Sum_probs=224.2
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
......++|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 112 (335)
T 2owb_A 35 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-- 112 (335)
T ss_dssp EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred cCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 34456789999999999999999999999999999999987543 233456778899999999999999999999853
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 113 ---~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 113 ---NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ---CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 357999999999 5999999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 190 ~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------- 257 (335)
T 2owb_A 190 KVEYDGE---RKKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------- 257 (335)
T ss_dssp ECCSTTC---CBCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------
T ss_pred ecccCcc---cccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC-------
Confidence 7543222 1245679999999999976 678999999999999999999999998876554433322100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
......+++.+.+|
T Consensus 258 ------------------------------------------------------------------~~~~~~~~~~~~~l 271 (335)
T 2owb_A 258 ------------------------------------------------------------------YSIPKHINPVAASL 271 (335)
T ss_dssp ------------------------------------------------------------------CCCCTTSCHHHHHH
T ss_pred ------------------------------------------------------------------CCCCccCCHHHHHH
Confidence 01113467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCccCC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAKVE 365 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~ 365 (599)
|++||+.||.+|||++|+|+||||.....+.
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999998765443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=372.83 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=197.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.++...++.++||||+++++++.. ...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cCC
Confidence 578999999999999999999999999999999997543333333444455556888899999999999954 346
Q ss_pred EEEEEecCCccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccc
Q 007542 102 IYVVFELMESDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 102 lylV~E~~~g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 899999999998777653 56899999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCcccccccccCccccCcccccc--ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhcCCCCHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~-~~~l~~I~~~lg~p~~e 253 (599)
..... .....+|+.|+|||++.. ....++.++|||||||++++|++|+.||.+... ...+..+..
T Consensus 161 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------- 228 (290)
T 3fme_A 161 VDDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH--------
T ss_pred ccccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc--------
Confidence 43221 233478999999999631 115688999999999999999999999976332 222211111
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
. ..+ .......++.+.+
T Consensus 229 ---------------------------------------------------------~---~~~---~~~~~~~~~~~~~ 245 (290)
T 3fme_A 229 ---------------------------------------------------------E---PSP---QLPADKFSAEFVD 245 (290)
T ss_dssp ---------------------------------------------------------S---CCC---CCCTTTSCHHHHH
T ss_pred ---------------------------------------------------------c---CCC---CcccccCCHHHHH
Confidence 0 000 0112357889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 334 LLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||.+||+.||.+|||++|+|+||||+..
T Consensus 246 li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 246 FTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 9999999999999999999999999854
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=418.91 Aligned_cols=258 Identities=21% Similarity=0.373 Sum_probs=221.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
.++|+++++||+|+||.||+|+++.+++.||||+++... ........+.+|..+|..+ +||+|+.+++++.+ .
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-----~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-----M 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----S
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----C
Confidence 478999999999999999999999999999999997431 1223456678899999887 69999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+||||||+. |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 57999999998 59999999888999999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .....+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+.+..|.....
T Consensus 495 ~~~---~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------- 559 (674)
T 3pfq_A 495 DGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------- 559 (674)
T ss_dssp TTC---CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC----------
T ss_pred CCc---ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 221 2356789999999999977 6899999999999999999999999999887776665542110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.....+++++.+||++|
T Consensus 560 ---------------------------------------------------------------~~p~~~s~~~~~li~~l 576 (674)
T 3pfq_A 560 ---------------------------------------------------------------AYPKSMSKEAVAICKGL 576 (674)
T ss_dssp ---------------------------------------------------------------CCCTTSCHHHHHHHHHH
T ss_pred ---------------------------------------------------------------CCCccCCHHHHHHHHHH
Confidence 01135789999999999
Q ss_pred cccCCCCCCCH-----HHHhcCccccCCc
Q 007542 339 LAFEPKDRPTA-----EEALADPYFKGLA 362 (599)
Q Consensus 339 L~~DP~~RpTa-----~e~L~HP~f~~~~ 362 (599)
|+.||.+|+++ +|+++||||+++.
T Consensus 577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 577 MTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp SCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred ccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999997 9999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=371.15 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=217.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 86 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----R 86 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----C
Confidence 34789999999999999999999999999999999864221 12234678899999999999999999999853 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 57899999998 59999999888899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. .....+++.|+|||++.+ ..++.++|||||||++++|++|+.||.+.+.......+....
T Consensus 167 ~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----------- 228 (284)
T 2vgo_A 167 LR-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD----------- 228 (284)
T ss_dssp SC-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred cc-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc-----------
Confidence 21 234578999999999977 678999999999999999999999998876554433332100
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
. ...+..++.+.+||.+|
T Consensus 229 -----------------------------------------------------------~---~~~~~~~~~~~~li~~~ 246 (284)
T 2vgo_A 229 -----------------------------------------------------------L---KFPPFLSDGSKDLISKL 246 (284)
T ss_dssp -----------------------------------------------------------C---CCCTTSCHHHHHHHHHH
T ss_pred -----------------------------------------------------------c---CCCCcCCHHHHHHHHHH
Confidence 0 11135678899999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCcc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
|..||.+|||++|+|+||||+....
T Consensus 247 l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 247 LRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp SCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred hhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 9999999999999999999986543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=401.36 Aligned_cols=256 Identities=17% Similarity=0.200 Sum_probs=203.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHH---HHHhcCCCCccccc-------e
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIK---LLRLLRHPDIVEIK-------H 89 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~---iL~~l~HpnIv~l~-------~ 89 (599)
..++|++.+.||+|+||.||+|+++.+|+.||||++.... ......+.+.+|+. +|+.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3588999999999999999999999999999999997432 23345678889995 45555799999998 5
Q ss_pred eecCCCc-------CCC-----ccEEEEEecCCccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHhhhCceEec
Q 007542 90 ILLPPSR-------REF-----KDIYVVFELMESDLHQVIKANDDLTP-------EHYQFFLYQLLRGLKYIHTANVFHR 150 (599)
Q Consensus 90 v~~~~s~-------~~~-----~~lylV~E~~~g~L~~~i~~~~~lse-------~~i~~i~~QIl~aL~yLHs~gIvHr 150 (599)
++..... .+. ...||||||++|+|.+++...+.+++ ..+..++.||+.||.|||++||+||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 5433211 011 13899999999999999987655555 7888899999999999999999999
Q ss_pred cCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccC-----------CCCcchhhHhHHH
Q 007542 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGC 219 (599)
Q Consensus 151 DLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-----------~~s~~~DIWSlG~ 219 (599)
||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+ . .|+.++|||||||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999985322 2245577 99999999876 4 6899999999999
Q ss_pred HHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhh
Q 007542 220 IFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQ 299 (599)
Q Consensus 220 Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 299 (599)
++|+|++|+.||.+.+....+..
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~--------------------------------------------------------- 324 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW--------------------------------------------------------- 324 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG---------------------------------------------------------
T ss_pred HHHHHHHCCCCCcccccccchhh---------------------------------------------------------
Confidence 99999999999976543221100
Q ss_pred cccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 300 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 300 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+....+.+++.+.+||.+||+.||.+|||+.|+|+||||+++.
T Consensus 325 --------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 325 --------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp --------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred --------------------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 0112246788999999999999999999999999999998653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=383.31 Aligned_cols=259 Identities=27% Similarity=0.479 Sum_probs=216.5
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------hhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV------SDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~------~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
++|++.+.||+|+||.||+|.++.+|+.||||++....... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 68999999999999999999999999999999986433211 1245678999999999 79999999999843
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...+|+||||+++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 172 ---~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 ---SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp ---SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ---CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 3579999999995 999999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccc----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
...... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 249 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCc----ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 754322 12456899999999998531 1358889999999999999999999998877665555444322111
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
.. ..+...++.
T Consensus 325 ~~---------------------------------------------------------------------~~~~~~~~~ 335 (365)
T 2y7j_A 325 SS---------------------------------------------------------------------PEWDDRSST 335 (365)
T ss_dssp CH---------------------------------------------------------------------HHHSSSCHH
T ss_pred CC---------------------------------------------------------------------cccccCCHH
Confidence 11 112356788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
+.+||.+||+.||.+|||++|+|+||||+
T Consensus 336 ~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 336 VKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 99999999999999999999999999997
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=383.83 Aligned_cols=258 Identities=27% Similarity=0.398 Sum_probs=215.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++++.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----- 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----- 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----
Confidence 346799999999999999999999999999999999754322 23446788999999999999999999998543
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+.|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 47899999999999998864 56799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
. ...+||+.|+|||++.+ ....++.++||||||||+++|++|++||.+.+....+..+....
T Consensus 207 ~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~---------- 269 (348)
T 1u5q_A 207 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE---------- 269 (348)
T ss_dssp B-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------
T ss_pred C-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------
Confidence 1 34589999999999842 12568999999999999999999999998877655443332110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.+. ......++.+.+||.+
T Consensus 270 ----------------------------------------------------------~~~---~~~~~~~~~l~~li~~ 288 (348)
T 1u5q_A 270 ----------------------------------------------------------SPA---LQSGHWSEYFRNFVDS 288 (348)
T ss_dssp ----------------------------------------------------------CCC---CCCTTSCHHHHHHHHH
T ss_pred ----------------------------------------------------------CCC---CCCCCCCHHHHHHHHH
Confidence 000 0123567889999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
||+.||.+|||++++|+||||...
T Consensus 289 ~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 289 CLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HcccChhhCcCHHHHhhChhhhcc
Confidence 999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=394.76 Aligned_cols=278 Identities=17% Similarity=0.145 Sum_probs=199.7
Q ss_pred cccccCCC-CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhc--CCCCccccc--
Q 007542 15 FFTEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLL--RHPDIVEIK-- 88 (599)
Q Consensus 15 ~~~~~~~~-~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l--~HpnIv~l~-- 88 (599)
+...++.. .+|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+++.+ +||||++++
T Consensus 53 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~ 132 (371)
T 3q60_A 53 VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132 (371)
T ss_dssp EEETTTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------C
T ss_pred EEecCCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhcee
Confidence 33444443 449999999999999999999999999999999986443 233456677886555544 699988755
Q ss_pred -----eeecCCCcC------------CCccEEEEEecCCccHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHhhh
Q 007542 89 -----HILLPPSRR------------EFKDIYVVFELMESDLHQVIKAND-DLTPEHY------QFFLYQLLRGLKYIHT 144 (599)
Q Consensus 89 -----~v~~~~s~~------------~~~~lylV~E~~~g~L~~~i~~~~-~lse~~i------~~i~~QIl~aL~yLHs 144 (599)
+++...... ....+||||||++++|.+++...+ .+++... ..++.||+.||.|||+
T Consensus 133 ~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~ 212 (371)
T 3q60_A 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS 212 (371)
T ss_dssp BCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 444322110 114589999999999999998643 3444455 5777999999999999
Q ss_pred CceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHH
Q 007542 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEL 224 (599)
Q Consensus 145 ~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eL 224 (599)
+||+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+....|+.++|||||||++|+|
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 99999999999999999999999999999865321 114567799999999865224689999999999999999
Q ss_pred HhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHH
Q 007542 225 LTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEK 304 (599)
Q Consensus 225 ltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~ 304 (599)
++|+.||.+......- .|....
T Consensus 287 ltg~~Pf~~~~~~~~~------------------------~~~~~~---------------------------------- 308 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKG------------------------SWKRPS---------------------------------- 308 (371)
T ss_dssp HHSSCSTTBCCTTCTT------------------------CCCBCC----------------------------------
T ss_pred HhCCCCCCCcCccccc------------------------chhhhh----------------------------------
Confidence 9999999876422100 000000
Q ss_pred HHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 305 ARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 305 ~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.............++.+++.+.+||.+||++||.+|||+.|+|+||||+++.
T Consensus 309 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 309 ------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp ------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred ------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 0000001111122357899999999999999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=394.88 Aligned_cols=261 Identities=32% Similarity=0.523 Sum_probs=204.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~------~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
.++|.+.+.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4789999999999999999999999999999999964321 11122357899999999999999999999832
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC---ceeeeccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KLKICDFG 171 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~---~lKL~DFG 171 (599)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 212 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 ----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 25799999998 59999998888999999999999999999999999999999999999997644 59999999
Q ss_pred ccccccCCCCCcccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHH-HHHHHhcCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGT 249 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l-~~I~~~lg~ 249 (599)
+++...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|++||.+......+ ..+.....
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~- 362 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY- 362 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC-
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC-
Confidence 998754321 2345689999999999853 1256888999999999999999999999875433222 22211110
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
......++.+++
T Consensus 363 --------------------------------------------------------------------~~~~~~~~~~~~ 374 (419)
T 3i6u_A 363 --------------------------------------------------------------------NFIPEVWAEVSE 374 (419)
T ss_dssp --------------------------------------------------------------------CCCHHHHTTSCH
T ss_pred --------------------------------------------------------------------CCCchhhcccCH
Confidence 111122346788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+.+||.+||++||.+|||++|+|+||||++.
T Consensus 375 ~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 375 KALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 99999999999999999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=387.72 Aligned_cols=262 Identities=27% Similarity=0.375 Sum_probs=208.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC--CCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--HPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~--HpnIv~l~~v~~~~s~~~~ 99 (599)
+.+|++++.||+|+||+||+|.+.. ++.||||++............+.+|+.+|+.++ ||||+++++++...
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~----- 128 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 128 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----
Confidence 4679999999999999999999865 999999999765555566788999999999997 59999999998543
Q ss_pred ccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 100 KDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
..+|||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.....
T Consensus 129 ~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 4699999987789999999988999999999999999999999999999999999999995 689999999999875432
Q ss_pred CCCcccccccccCccccCccccccc---------cCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh-hhHHHHHHHhcCC
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGT 249 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~-~~~l~~I~~~lg~ 249 (599)
.. .......+||+.|+|||++.+. ...|+.++||||||||+|+|++|++||.+... ...+..+.+
T Consensus 208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---- 282 (390)
T 2zmd_A 208 TT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---- 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC----
T ss_pred Cc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC----
Confidence 21 1123456899999999998541 13588999999999999999999999976432 121111110
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
...... .....++
T Consensus 283 ----------------------------------------------------------------~~~~~~---~~~~~~~ 295 (390)
T 2zmd_A 283 ----------------------------------------------------------------PNHEIE---FPDIPEK 295 (390)
T ss_dssp ----------------------------------------------------------------TTSCCC---CCCCSCH
T ss_pred ----------------------------------------------------------------ccccCC---CCccchH
Confidence 000001 1123467
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 296 ~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 296 DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 899999999999999999999999999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.94 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=207.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+..+..+ +||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DD 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TT
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CC
Confidence 4789999999999999999999999999999999986655566677889999999999 89999999999843 34
Q ss_pred cEEEEEecCCc-cHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-------------
Q 007542 101 DIYVVFELMES-DLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD------------- 162 (599)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~------------- 162 (599)
.+|+||||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 78999999984 999999764 679999999999999999999999999999999999999854
Q ss_pred ------CceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh
Q 007542 163 ------CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236 (599)
Q Consensus 163 ------~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~ 236 (599)
..+||+|||++...... ....+|+.|+|||++.+. ..++.++|||||||++++|++|.+++...+.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 47999999999875432 234689999999998762 3677899999999999999999988754321
Q ss_pred hhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCC
Q 007542 237 VHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316 (599)
Q Consensus 237 ~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~ 316 (599)
. ..+.. .
T Consensus 237 ~---~~~~~---------------------------------------------------------------------~- 243 (289)
T 1x8b_A 237 W---HEIRQ---------------------------------------------------------------------G- 243 (289)
T ss_dssp H---HHHHT---------------------------------------------------------------------T-
T ss_pred H---HHHHc---------------------------------------------------------------------C-
Confidence 1 11100 0
Q ss_pred CCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 317 ~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+......+++.+.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus 244 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 244 --RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp --CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred --CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 0111224578899999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=372.50 Aligned_cols=267 Identities=23% Similarity=0.402 Sum_probs=217.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+|+.++||||+++++++... +.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 478999999999999999999999999999999997432 1123456789999999999999999999998532 23
Q ss_pred ccEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 100 KDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 47899999999889888876 3579999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ........+|+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+....+..+.+.
T Consensus 161 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----------- 228 (305)
T 2wtk_C 161 PFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----------- 228 (305)
T ss_dssp TTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------
T ss_pred cccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-----------
Confidence 3221 1223456799999999998763233578999999999999999999999887655443333210
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. .......++.+.+||.+
T Consensus 229 -----------------------------------------------------------~---~~~~~~~~~~l~~li~~ 246 (305)
T 2wtk_C 229 -----------------------------------------------------------S---YAIPGDCGPPLSDLLKG 246 (305)
T ss_dssp -----------------------------------------------------------C---CCCCSSSCHHHHHHHHH
T ss_pred -----------------------------------------------------------C---CCCCCccCHHHHHHHHH
Confidence 0 01123567889999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccCC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKVE 365 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~~ 365 (599)
||..||.+|||++|+|+||||+......
T Consensus 247 ~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 247 MLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp HTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred HccCChhhCCCHHHHhcCcccccCCCCc
Confidence 9999999999999999999998865543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=409.80 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=216.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|+++++||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++.+ .
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----K 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----C
Confidence 3578999999999999999999999999999999996421 122334567899999999999999999999854 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
..+|+||||+. |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 57999999997 69999998754 4999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+.......+.
T Consensus 337 ~~~~----~~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~------------ 398 (576)
T 2acx_A 337 PEGQ----TIKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------ 398 (576)
T ss_dssp CTTC----CEECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH------------
T ss_pred ccCc----cccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH------------
Confidence 4322 1245689999999999977 679999999999999999999999998764321111111
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
+.+... +.. ....+++.+.+||+
T Consensus 399 --------------------------------------------------~~i~~~----~~~---~p~~~s~~~~dLI~ 421 (576)
T 2acx_A 399 --------------------------------------------------RLVKEV----PEE---YSERFSPQARSLCS 421 (576)
T ss_dssp --------------------------------------------------HHHHHC----CCC---CCTTSCHHHHHHHH
T ss_pred --------------------------------------------------HHhhcc----ccc---CCccCCHHHHHHHH
Confidence 011111 111 12457899999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
+||+.||.+|| |++|+++||||+++
T Consensus 422 ~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 422 QLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 99999999999 89999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=369.15 Aligned_cols=265 Identities=28% Similarity=0.431 Sum_probs=219.2
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-------hhhHHHHHHHHHHHHhcC-CCCccccceee
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-------VSDATRILREIKLLRLLR-HPDIVEIKHIL 91 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-------~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~ 91 (599)
+..++|++.+.||+|+||.||+|.++.+|+.||||++...... ......+.+|+.+|+.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4568999999999999999999999999999999999643211 123456789999999996 99999999998
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 92 LPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
.. ...+|+||||++ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 94 ET-----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp EC-----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cc-----CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 43 357999999998 699999998888999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccc----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~ 246 (599)
|++....... ......+|+.|+|||++.+. ...++.++|||||||++++|++|+.||.+.+.......+...
T Consensus 169 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 169 GFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp TTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cchhhcCCCc----ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 9998754322 12456789999999987521 146889999999999999999999999887765544443321
Q ss_pred cCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC
Q 007542 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN 326 (599)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 326 (599)
... .....++.
T Consensus 245 ~~~---------------------------------------------------------------------~~~~~~~~ 255 (298)
T 1phk_A 245 NYQ---------------------------------------------------------------------FGSPEWDD 255 (298)
T ss_dssp CCC---------------------------------------------------------------------CCTTTGGG
T ss_pred Ccc---------------------------------------------------------------------cCcccccc
Confidence 110 00112235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 678899999999999999999999999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.09 Aligned_cols=262 Identities=25% Similarity=0.372 Sum_probs=214.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 79 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCE
Confidence 368999999999999999999999999999999986432 22345778899999999999999999999843 357
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 8999999984 999999877789999999999999999999999999999999999999999999999999997653222
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHH-HHHHHhcCCCCHHHHHHHh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL-DIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l-~~I~~~lg~p~~e~i~~~~ 259 (599)
. ........+|+.|+|||++.+. ..++.++|||||||++++|++|+.||.+.+..... ..+..
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 223 (276)
T 2yex_A 160 R-ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-------------- 223 (276)
T ss_dssp E-ECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT--------------
T ss_pred c-hhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh--------------
Confidence 1 1123456789999999998762 23477899999999999999999999876543211 11100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.......+...++.+.+||.+||
T Consensus 224 ---------------------------------------------------------~~~~~~~~~~~~~~~~~li~~~l 246 (276)
T 2yex_A 224 ---------------------------------------------------------KKTYLNPWKKIDSAPLALLHKIL 246 (276)
T ss_dssp ---------------------------------------------------------TCTTSTTGGGSCHHHHHHHHHHS
T ss_pred ---------------------------------------------------------cccccCchhhcCHHHHHHHHHHC
Confidence 00001112357888999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCc
Q 007542 340 AFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+.||.+|||++|+|+||||++..
T Consensus 247 ~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 247 VENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp CSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCchhCCCHHHHhcCccccChh
Confidence 99999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=383.70 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=210.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh------hhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV------SDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~------~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
.++|++++.||+|+||.||+|+++.+++.||||+++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 579999999999999999999999999999999997533211 133456789999999999999999999943
Q ss_pred cCCCccEEEEEecCC-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 96 RREFKDIYVVFELME-S-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...+|+||||+. | +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 357999999987 5 99999999889999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.....
T Consensus 178 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------- 237 (335)
T 3dls_A 178 AYLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------- 237 (335)
T ss_dssp EECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred eECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence 87643321 245679999999999876 444 889999999999999999999996521100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
.. ........++.+.
T Consensus 238 ------------------------------------------------------------~~-----~~~~~~~~~~~l~ 252 (335)
T 3dls_A 238 ------------------------------------------------------------EA-----AIHPPYLVSKELM 252 (335)
T ss_dssp ------------------------------------------------------------TT-----CCCCSSCCCHHHH
T ss_pred ------------------------------------------------------------hh-----ccCCCcccCHHHH
Confidence 00 0001123688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||.+||+.||.+|||++|+|+||||++.
T Consensus 253 ~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 253 SLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 99999999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=368.85 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=192.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.-++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----S 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----S
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----C
Confidence 34689999999999999999999999999999999964211 11234678899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 57999999998 5999999875 579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
..... .....+|+.|+|||++.+ ..++.++|||||||++++|++|++||.+.+....+..+.
T Consensus 164 ~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 225 (278)
T 3cok_A 164 MPHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------- 225 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------------
T ss_pred CCCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------------
Confidence 22211 234578999999999876 578899999999999999999999998765332211110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. .. .......++.+.+||.+
T Consensus 226 --------------------------------------------------------~-~~---~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 226 --------------------------------------------------------L-AD---YEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp --------------------------------------------------------S-SC---CCCCTTSCHHHHHHHHH
T ss_pred --------------------------------------------------------h-cc---cCCccccCHHHHHHHHH
Confidence 0 00 01123467889999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCc
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
||+.||.+|||++++|+||||....
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=382.97 Aligned_cols=300 Identities=21% Similarity=0.321 Sum_probs=220.4
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~ 104 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG 104 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TT
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CC
Confidence 3679999999999999999999999999999999997532 34456778999999999999999999999854 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 105 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 7999999998 49999999888899999999999999999999996 999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...............
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 234589999999999977 67999999999999999999999999987765543332211111111000000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.. ... .+.... ... .........+..+.......+ .....++.+.+||.+|
T Consensus 258 ~~-~~~-------~~~~~~------------------~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~ 308 (360)
T 3eqc_A 258 RT-PGR-------PLNKFG------------------MDS-RPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKC 308 (360)
T ss_dssp -------------------------------------------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHH
T ss_pred cc-CCC-------cccccc------------------cCC-CCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHH
Confidence 00 000 000000 000 000001111222222222111 1234788999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|++||.+|||++|+|+||||++..
T Consensus 309 L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 309 LIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp HCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred hhcChhhCCCHHHHhhChHhhcch
Confidence 999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=372.75 Aligned_cols=276 Identities=22% Similarity=0.399 Sum_probs=213.8
Q ss_pred CCCCcccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCcccc
Q 007542 9 SSADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEI 87 (599)
Q Consensus 9 ~~~~~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l 87 (599)
+..++++...-...++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+|+.+ +||||+++
T Consensus 10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~ 86 (326)
T 2x7f_A 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATY 86 (326)
T ss_dssp ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeee
Confidence 3445555555677899999999999999999999999999999999986432 2346788999999999 79999999
Q ss_pred ceeecCCCc-CCCccEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC
Q 007542 88 KHILLPPSR-REFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC 163 (599)
Q Consensus 88 ~~v~~~~s~-~~~~~lylV~E~~~g-~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~ 163 (599)
++++..... .....+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC
T ss_pred eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC
Confidence 999865321 113579999999985 999999865 4799999999999999999999999999999999999999999
Q ss_pred ceeeecccccccccCCCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHH
Q 007542 164 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240 (599)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l 240 (599)
.+||+|||++........ ......+|+.|+|||++... ...++.++|||||||++|+|++|+.||.+.+....+
T Consensus 167 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp CEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CEEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 999999999976532211 12345789999999998621 146889999999999999999999999877654443
Q ss_pred HHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCC
Q 007542 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320 (599)
Q Consensus 241 ~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 320 (599)
..+.... .+
T Consensus 244 ~~~~~~~--------------------------------------------------------------------~~--- 252 (326)
T 2x7f_A 244 FLIPRNP--------------------------------------------------------------------AP--- 252 (326)
T ss_dssp HHHHHSC--------------------------------------------------------------------CC---
T ss_pred HHhhcCc--------------------------------------------------------------------cc---
Confidence 3221100 00
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 321 ~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
......+++.+.+||.+||..||.+|||++|+|+||||++.
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 01123568899999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=401.01 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=214.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|+++++||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----KT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----CC
Confidence 4789999999999999999999999999999999964321 12334678899999999999999999999854 35
Q ss_pred cEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 7999999999 6999999764 3699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
....... ....+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+.......+..
T Consensus 339 ~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---------- 403 (543)
T 3c4z_A 339 LKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---------- 403 (543)
T ss_dssp CCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH----------
T ss_pred ccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH----------
Confidence 5433221 245689999999999987 6899999999999999999999999987642111111100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
..+. ... .....+++.+.+||
T Consensus 404 ---------------------------------------------------~i~~-----~~~---~~p~~~s~~~~~li 424 (543)
T 3c4z_A 404 ---------------------------------------------------RVLE-----QAV---TYPDKFSPASKDFC 424 (543)
T ss_dssp ---------------------------------------------------HHHH-----CCC---CCCTTSCHHHHHHH
T ss_pred ---------------------------------------------------HHhh-----ccc---CCCcccCHHHHHHH
Confidence 0000 000 11245789999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCccccCC
Q 007542 336 ERMLAFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 336 ~~mL~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
++||+.||.+||+ ++++++||||+++
T Consensus 425 ~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 425 EALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 9999999999995 5999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=368.71 Aligned_cols=261 Identities=34% Similarity=0.533 Sum_probs=219.4
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. ..
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 94 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SS 94 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CC
Confidence 3579999999999999999999999999999999997655445567789999999999999999999999854 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC---Cceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~---~~lKL~DFGla~~~ 176 (599)
.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 7899999998 5999999887889999999999999999999999999999999999999764 46999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
..... .....+|+.|+|||++.+ .++.++|||||||++++|++|+.||.+.+..+.+..+......
T Consensus 175 ~~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 240 (287)
T 2wei_A 175 QQNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA------- 240 (287)
T ss_dssp CCCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------
T ss_pred cCCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 43221 234568999999999875 4889999999999999999999999987765554443321100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.....+..+++.+.+||.
T Consensus 241 --------------------------------------------------------------~~~~~~~~~~~~~~~li~ 258 (287)
T 2wei_A 241 --------------------------------------------------------------FDLPQWRTISDDAKDLIR 258 (287)
T ss_dssp --------------------------------------------------------------CCSGGGTTSCHHHHHHHH
T ss_pred --------------------------------------------------------------CCchhhhhcCHHHHHHHH
Confidence 001123457889999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCCc
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+||..||.+|||++|+|+||||++..
T Consensus 259 ~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 259 KMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999999998653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=364.90 Aligned_cols=257 Identities=29% Similarity=0.440 Sum_probs=206.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----PT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----CC
Confidence 4789999999999999999999999999999999864221 12235678899999999999999999999854 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ......+|+.|+|||++.+. ...+.++|||||||++++|++|+.||.+.+....+..+....
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 227 (276)
T 2h6d_A 165 E----FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV------------ 227 (276)
T ss_dssp ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred c----ceecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------
Confidence 2 12345789999999998762 233689999999999999999999998766544333332100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.......++.+.+||.+||
T Consensus 228 -------------------------------------------------------------~~~~~~~~~~l~~li~~~l 246 (276)
T 2h6d_A 228 -------------------------------------------------------------FYIPEYLNRSVATLLMHML 246 (276)
T ss_dssp -------------------------------------------------------------CCCCTTSCHHHHHHHHHHT
T ss_pred -------------------------------------------------------------ccCchhcCHHHHHHHHHHc
Confidence 0011246788999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCC
Q 007542 340 AFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+.||.+|||++|+|+||||+..
T Consensus 247 ~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 247 QVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=367.61 Aligned_cols=266 Identities=22% Similarity=0.373 Sum_probs=213.1
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
......++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 88 (302)
T 2j7t_A 13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-- 88 (302)
T ss_dssp SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--
T ss_pred cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC--
Confidence 3456789999999999999999999999999999999998643 234467788999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 89 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 ---GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred ---CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 47899999998 589888875 4679999999999999999999999999999999999999999999999999976
Q ss_pred cccCCCCCcccccccccCccccCcccccc---ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
...... .......+|..|+|||++.. ....++.++|||||||++++|++|..||.+.+....+..+.....
T Consensus 166 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 239 (302)
T 2j7t_A 166 KNLKTL---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP--- 239 (302)
T ss_dssp HHHHHH---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---
T ss_pred cccccc---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC---
Confidence 432111 01134578999999999731 115688999999999999999999999988765544333321100
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
+.......++..+
T Consensus 240 -------------------------------------------------------------------~~~~~~~~~~~~l 252 (302)
T 2j7t_A 240 -------------------------------------------------------------------PTLLTPSKWSVEF 252 (302)
T ss_dssp -------------------------------------------------------------------CCCSSGGGSCHHH
T ss_pred -------------------------------------------------------------------cccCCccccCHHH
Confidence 0001113467889
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+||.+||..||.+|||++|+|+||||+++.
T Consensus 253 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 253 RDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9999999999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=372.92 Aligned_cols=260 Identities=32% Similarity=0.519 Sum_probs=208.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~------~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 4689999999999999999999999999999999964321 112234578999999999999999999998432
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc---eeeeccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFG 171 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~---lKL~DFG 171 (599)
.+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -----ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 3899999998 599999988889999999999999999999999999999999999999987664 9999999
Q ss_pred ccccccCCCCCcccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhH-HHHHHHhcCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ-LDIMTDLLGT 249 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~-l~~I~~~lg~ 249 (599)
+++..... .......||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.+...... ...+.....
T Consensus 163 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 237 (322)
T 2ycf_A 163 HSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY- 237 (322)
T ss_dssp TCEECCCC----HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC-
T ss_pred cceecccc----cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc-
Confidence 99865321 12234578999999999732 125688999999999999999999999987543221 111111100
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
......+...++
T Consensus 238 --------------------------------------------------------------------~~~~~~~~~~~~ 249 (322)
T 2ycf_A 238 --------------------------------------------------------------------NFIPEVWAEVSE 249 (322)
T ss_dssp --------------------------------------------------------------------CCCHHHHTTSCH
T ss_pred --------------------------------------------------------------------ccCchhhhhcCH
Confidence 011112245788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
.+.+||.+||..||.+|||++|+|+||||++
T Consensus 250 ~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 8999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=368.35 Aligned_cols=266 Identities=28% Similarity=0.344 Sum_probs=213.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++++.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++. +.
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----ED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eC
Confidence 4689999999999999999999999999999999986433 23445678899999999999999999999984 33
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 57999999998 49999999888999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 164 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~--------- 228 (294)
T 4eqm_A 164 TSLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--S--------- 228 (294)
T ss_dssp -------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--C---------
T ss_pred cccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--c---------
Confidence 2211 1234679999999999977 67899999999999999999999999987765443222110 0
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.+.......+.+++.+.+||.+|
T Consensus 229 ---------------------------------------------------------~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
T 4eqm_A 229 ---------------------------------------------------------VPNVTTDVRKDIPQSLSNVILRA 251 (294)
T ss_dssp ---------------------------------------------------------CCCHHHHSCTTSCHHHHHHHHHH
T ss_pred ---------------------------------------------------------CCCcchhcccCCCHHHHHHHHHH
Confidence 00001122346788999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCcc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
|..||.+||+..+.|.+.|..-+..
T Consensus 252 l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 252 TEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred hcCCHhHccccHHHHHHHHHHHHhh
Confidence 9999999997667777777665443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=371.48 Aligned_cols=209 Identities=24% Similarity=0.428 Sum_probs=178.3
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
....++|++.++||+|+||+||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 80 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--- 80 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---
Confidence 3567899999999999999999999999999999999974322 233567789999999999999999999985432
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe----cCCCceeeecc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDF 170 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv----~~~~~lKL~DF 170 (599)
...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 247899999998 69999998654 39999999999999999999999999999999999999 77888999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccc------cCCCCcchhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~------~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
|+++....... .....||+.|+|||++... ...++.++|||||||++|+|++|+.||.+..
T Consensus 161 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 161 GAARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp TTCEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CCceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99987643322 2456799999999987521 1578999999999999999999999997544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=384.28 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=210.9
Q ss_pred CceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccC--ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFE--HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~~--~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~ 96 (599)
++|++++.||+|+||.||+|++. .+|+.||||+++.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 130 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 130 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee---
Confidence 79999999999999999999984 5899999999874321 122334567899999999 69999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 347899999998 59999999888899999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..... .......+||+.|+|||++.+....++.++||||||||+|+|++|+.||...........+..
T Consensus 209 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------- 276 (355)
T 1vzo_A 209 FVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276 (355)
T ss_dssp CCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----------
T ss_pred cccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH----------
Confidence 53221 112345689999999999875334578999999999999999999999976543221111110
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
..+. .. ......+++.+.+||
T Consensus 277 ---------------------------------------------------~~~~----~~----~~~~~~~~~~~~~li 297 (355)
T 1vzo_A 277 ---------------------------------------------------RILK----SE----PPYPQEMSALAKDLI 297 (355)
T ss_dssp ---------------------------------------------------HHHH----CC----CCCCTTSCHHHHHHH
T ss_pred ---------------------------------------------------HHhc----cC----CCCCcccCHHHHHHH
Confidence 0000 00 012245788999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCccccCC
Q 007542 336 ERMLAFEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 336 ~~mL~~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
.+||..||.+|| |++|+|+||||+.+
T Consensus 298 ~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 999999999999 99999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=363.77 Aligned_cols=262 Identities=29% Similarity=0.450 Sum_probs=216.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+|+.++||||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence 35799999999999999999999999999999999976555555677899999999999999999999987532 234
Q ss_pred cEEEEEecCC-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHhhhCc-----eEeccCCCCceEecCCCceeeecc
Q 007542 101 DIYVVFELME-SDLHQVIKAN----DDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~----~~lse~~i~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILv~~~~~lKL~DF 170 (599)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 7899999998 4999999753 34999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
|+++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 161 g~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--- 232 (279)
T 2w5a_A 161 GLARILNHDT---SFAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--- 232 (279)
T ss_dssp CHHHHC---C---HHHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---
T ss_pred chheeecccc---ccccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc---
Confidence 9998753321 11234578999999999976 578999999999999999999999998876544333332100
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
+.......++.
T Consensus 233 ---------------------------------------------------------------------~~~~~~~~~~~ 243 (279)
T 2w5a_A 233 ---------------------------------------------------------------------FRRIPYRYSDE 243 (279)
T ss_dssp ---------------------------------------------------------------------CCCCCTTSCHH
T ss_pred ---------------------------------------------------------------------cccCCcccCHH
Confidence 00112356788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+.+||.+||+.||.+|||++|+|+|+|+.+-.
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 99999999999999999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=366.01 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=209.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CC
Confidence 468899999999999999999999999999999998642 234568899999999999999999999853 34
Q ss_pred cEEEEEecCCc-cHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELMES-DLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+|+||||+++ +|.+++. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 78999999985 9999997 456899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 241 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP----------- 241 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-----------
Confidence 221 1245678999999999977 578999999999999999999999998766544332221100
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
. +.......+++.+.+||.+|
T Consensus 242 ----------------------------------------------------------~-~~~~~~~~~~~~l~~li~~~ 262 (314)
T 3com_A 242 ----------------------------------------------------------P-PTFRKPELWSDNFTDFVKQC 262 (314)
T ss_dssp ----------------------------------------------------------C-CCCSSGGGSCHHHHHHHHHH
T ss_pred ----------------------------------------------------------C-cccCCcccCCHHHHHHHHHH
Confidence 0 00011123578899999999
Q ss_pred cccCCCCCCCHHHHhcCccccCCc
Q 007542 339 LAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|..||.+|||+.++|+||||++..
T Consensus 263 l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 263 LVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp TCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ccCChhhCcCHHHHHhCHHHhcCC
Confidence 999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=369.83 Aligned_cols=272 Identities=27% Similarity=0.408 Sum_probs=194.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----D 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----S
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----C
Confidence 46899999999999999999999999999999998864321 23456788999999999999999999998543 4
Q ss_pred cEEEEEecCC-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 101 DIYVVFELME-SDLHQVIKA--------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~--------~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
.+|+||||+. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 6899999997 599999874 4569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 172 LARVAFNDTP--TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 172 la~~~~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
++........ .........+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+.........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9976543211 11112346799999999998642 35889999999999999999999999887655443322210000
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
... ............++
T Consensus 246 ~~~---------------------------------------------------------------~~~~~~~~~~~~~~ 262 (303)
T 2vwi_A 246 SLE---------------------------------------------------------------TGVQDKEMLKKYGK 262 (303)
T ss_dssp CTT---------------------------------------------------------------C-----CCCCCCCH
T ss_pred ccc---------------------------------------------------------------cccccchhhhhhhH
Confidence 000 00011123456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 263 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 263 SFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=365.25 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=204.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||+||+|.+ +|..||||++............+.+|+.+|+.++||||+++++++... ..
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----PN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----TC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Cc
Confidence 57899999999999999999976 688999999976555556667899999999999999999999999543 46
Q ss_pred EEEEEecCC-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCCCceeeeccccccc
Q 007542 102 IYVVFELME-SDLHQVIKANDD---LTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~---lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
+|+||||+. ++|.+++...+. +++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 599999987653 999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------- 256 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------- 256 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC-------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------
Confidence 432211 1245689999999999987 6789999999999999999999999988765544333211000
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.......+++.+.+||
T Consensus 257 ----------------------------------------------------------------~~~~~~~~~~~l~~li 272 (309)
T 3p86_A 257 ----------------------------------------------------------------RLEIPRNLNPQVAAII 272 (309)
T ss_dssp ----------------------------------------------------------------CCCCCTTSCHHHHHHH
T ss_pred ----------------------------------------------------------------CCCCCccCCHHHHHHH
Confidence 0112245788999999
Q ss_pred HHhcccCCCCCCCHHHHhc--CccccC
Q 007542 336 ERMLAFEPKDRPTAEEALA--DPYFKG 360 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~--HP~f~~ 360 (599)
.+||+.||.+|||++|+++ +++++.
T Consensus 273 ~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 273 EGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999998 455543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=361.46 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=216.6
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 92 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----D 92 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----C
Confidence 55678999999999999999999999999999999996432 23446788999999999999999999999854 3
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+++ +|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 478999999985 89998865 5799999999999999999999999999999999999999999999999999977543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... ......+|+.|+|||++.+ ..++.++|||||||++++|++|++||.+.+....+..+..
T Consensus 172 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 233 (303)
T 3a7i_A 172 TQI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK------------- 233 (303)
T ss_dssp TBC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred ccc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-------------
Confidence 221 2245679999999999977 6789999999999999999999999987654433322211
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
..+ .......++.+.+||.+|
T Consensus 234 --------------------------------------------------------~~~---~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 234 --------------------------------------------------------NNP---PTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp --------------------------------------------------------SCC---CCCCSSCCHHHHHHHHHH
T ss_pred --------------------------------------------------------CCC---CCCccccCHHHHHHHHHH
Confidence 000 112245788899999999
Q ss_pred cccCCCCCCCHHHHhcCccccCC
Q 007542 339 LAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|..||.+|||++|+|+||||...
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHH
T ss_pred cCCChhhCcCHHHHhhChhhhcC
Confidence 99999999999999999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=367.97 Aligned_cols=267 Identities=22% Similarity=0.352 Sum_probs=196.2
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
-..++|++++.||+|+||.||+|.+..++. .||||+++...........+.+|+.+|+.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 456799999999999999999999887775 89999997655555667889999999999999999999999865432
Q ss_pred C-CCccEEEEEecCC-ccHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeee
Q 007542 97 R-EFKDIYVVFELME-SDLHQVIKAND------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 97 ~-~~~~lylV~E~~~-g~L~~~i~~~~------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
. .....|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 1234599999999 59999996532 59999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhc
Q 007542 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~l 247 (599)
|||+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 180 Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 180 DFGLSRKIYSGDYY-RQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp CCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred eccccccccccccc-cccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 99999865432211 11233456788999999977 678999999999999999999 999999877665544432210
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
.....+..
T Consensus 257 ------------------------------------------------------------------------~~~~~~~~ 264 (323)
T 3qup_A 257 ------------------------------------------------------------------------RLKQPPEC 264 (323)
T ss_dssp ------------------------------------------------------------------------CCCCCTTC
T ss_pred ------------------------------------------------------------------------CCCCCCcc
Confidence 01112457
Q ss_pred CHHHHHHHHHhcccCCCCCCC-------HHHHhcCccccCC
Q 007542 328 NPLALRLLERMLAFEPKDRPT-------AEEALADPYFKGL 361 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpT-------a~e~L~HP~f~~~ 361 (599)
++.+.+||.+||+.||.+||| ++++|+|||+...
T Consensus 265 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 788999999999999999999 8888999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=367.23 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=208.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcE---EEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~---VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|++.+.||+|+||.||+|.+..+++. ||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 121 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR---- 121 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 468999999999999999999999876654 9999997532 34456778999999999999999999999843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 122 -GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp -GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred -CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 346899999998 5999999765 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...............+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~----- 273 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL----- 273 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----
T ss_pred cccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-----
Confidence 6543332222334456788999999976 578999999999999999999 99999887765554443321110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
.....+++.+.+|
T Consensus 274 -------------------------------------------------------------------~~~~~~~~~l~~l 286 (325)
T 3kul_A 274 -------------------------------------------------------------------PAPMGCPHALHQL 286 (325)
T ss_dssp -------------------------------------------------------------------CCCTTCCHHHHHH
T ss_pred -------------------------------------------------------------------CCCCCcCHHHHHH
Confidence 1123577889999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 007542 335 LERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~ 354 (599)
|.+||..||.+|||+.|+++
T Consensus 287 i~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 287 MLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=357.11 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=202.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC------
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS------ 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s------ 95 (599)
.++|++++.||+|+||.||+|++..+|+.||||++.. .......+.+|+.+|+.++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4689999999999999999999999999999999863 2345577889999999999999999999885421
Q ss_pred --cCCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 96 --RREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 96 --~~~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
......+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 123467899999998 59999998654 68899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-----------CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC-CCChhhH
Q 007542 172 LARVAFNDTP-----------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP-GKNVVHQ 239 (599)
Q Consensus 172 la~~~~~~~~-----------~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~-g~~~~~~ 239 (599)
++........ .........+|+.|+|||++.+. ..++.++|||||||++|+|++ +|. +.+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9976532210 01123456789999999998752 468999999999999999998 343 2111111
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
+..+.. .....
T Consensus 238 ~~~~~~---------------------------------------------------------------------~~~~~ 248 (303)
T 1zy4_A 238 LKKLRS---------------------------------------------------------------------VSIEF 248 (303)
T ss_dssp HHHHHS---------------------------------------------------------------------TTCCC
T ss_pred HHhccc---------------------------------------------------------------------ccccc
Confidence 111110 00000
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
........++.+.+||++||+.||.+|||++|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 111224567789999999999999999999999999999753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.41 Aligned_cols=273 Identities=19% Similarity=0.300 Sum_probs=213.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChh---------------hHHHHHHHHHHHHhcCCCCccc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS---------------DATRILREIKLLRLLRHPDIVE 86 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~---------------~~~~i~rEi~iL~~l~HpnIv~ 86 (599)
.++|++++.||+|+||.||+|.+ +|+.||||++........ ....+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 47999999999999999999998 999999999864321111 1277889999999999999999
Q ss_pred cceeecCCCcCCCccEEEEEecCCc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCc
Q 007542 87 IKHILLPPSRREFKDIYVVFELMES-DLHQV------IKA--NDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKN 156 (599)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~------i~~--~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~N 156 (599)
+++++... ..+|+||||+++ +|.++ +.. ...+++..++.++.||+.||.|||+ .||+||||||+|
T Consensus 108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99999543 479999999995 99988 665 5679999999999999999999999 999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCc-chhhHhHHHHHHHHHhCCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAELLTGKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~-~~DIWSlG~Il~eLltG~~pF~g~~ 235 (599)
||++.++.+||+|||++...... ......+|..|+|||++.+. ..++. ++|||||||++++|++|+.||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999875332 23456899999999998762 25666 9999999999999999999999876
Q ss_pred h-hhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhccc
Q 007542 236 V-VHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRK 314 (599)
Q Consensus 236 ~-~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~ 314 (599)
. .+.+..+.......+.. ...+ ...
T Consensus 257 ~~~~~~~~i~~~~~~~~~~---------------~~~~---------------------------------------~~~ 282 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLD---------------RNHF---------------------------------------LYP 282 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCS---------------SSSS---------------------------------------TTT
T ss_pred cHHHHHHHHhccCcCCccc---------------hhhh---------------------------------------hcc
Confidence 6 44444332211100000 0000 000
Q ss_pred CCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 315 ~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
..........+.+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 283 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 283 LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp TCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 00001112235678999999999999999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=367.86 Aligned_cols=263 Identities=25% Similarity=0.419 Sum_probs=192.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHH-HHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~-iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++... .
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----G 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----S
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----C
Confidence 589999999999999999999999999999999997543 2334455666776 67778999999999999543 4
Q ss_pred cEEEEEecCCccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccc
Q 007542 101 DIYVVFELMESDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-----~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.+|+||||+.++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 7899999999999888864 56799999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCCCcccccccccCccccCcccccc--ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
....... .....||+.|+|||++.. ....++.++|||||||++++|++|+.||.+.+... +.+..
T Consensus 175 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~------- 241 (327)
T 3aln_A 175 QLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQ------- 241 (327)
T ss_dssp C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CC-------
T ss_pred ecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHH-------
Confidence 6533221 234479999999999832 11568899999999999999999999998643211 00000
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC-CcCCCCCCCHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP-FSQKFPNANPLA 331 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~s~~a 331 (599)
+....... ........++.+
T Consensus 242 -----------------------------------------------------------~~~~~~~~~~~~~~~~~~~~l 262 (327)
T 3aln_A 242 -----------------------------------------------------------VVKGDPPQLSNSEEREFSPSF 262 (327)
T ss_dssp -----------------------------------------------------------CCCSCCCCCCCCSSCCCCHHH
T ss_pred -----------------------------------------------------------HhcCCCCCCCCcccccCCHHH
Confidence 00001111 112234678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+||.+||..||.+|||+.|+|+||||....
T Consensus 263 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 263 INFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 9999999999999999999999999998653
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=360.66 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=194.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.-++|++++.||+|+||.||+|.++.+|+.||||++............+.++..+++.++||||+++++++... .
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----T 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----S
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----C
Confidence 35789999999999999999999999999999999975433323333344455578888999999999999543 4
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhC-ceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+|+||||+++.+..+... .+.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 7999999997666666654 56799999999999999999999995 999999999999999999999999999976533
Q ss_pred CCCCcccccccccCccccCcccccc---ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~---~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~-~~~~l~~I~~~lg~p~~e~ 254 (599)
... .....+|+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.. ....+..+...
T Consensus 178 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------- 245 (318)
T 2dyl_A 178 DKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-------- 245 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS--------
T ss_pred Ccc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc--------
Confidence 221 234578999999999842 11468899999999999999999999997643 22222222110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
. .+.......+++.+.+|
T Consensus 246 -------------------------------------------------------------~-~~~~~~~~~~~~~l~~l 263 (318)
T 2dyl_A 246 -------------------------------------------------------------E-PPLLPGHMGFSGDFQSF 263 (318)
T ss_dssp -------------------------------------------------------------C-CCCCCSSSCCCHHHHHH
T ss_pred -------------------------------------------------------------C-CCCCCccCCCCHHHHHH
Confidence 0 01111223578899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
|.+||..||.+|||++|+|+||||++..
T Consensus 264 i~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 264 VKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 9999999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.98 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=208.0
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-------~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~ 93 (599)
.++|++.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 478999999999999999999875 35568999999753 2334567889999999999 89999999999854
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (599)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 346899999998 59999998753 47899999999999999999999999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |+.||.+.+
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999865432211 11234567889999999976 679999999999999999999 999998876
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 236 ~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
..+.+..+....
T Consensus 311 ~~~~~~~~~~~~-------------------------------------------------------------------- 322 (370)
T 2psq_A 311 VEELFKLLKEGH-------------------------------------------------------------------- 322 (370)
T ss_dssp GGGHHHHHHTTC--------------------------------------------------------------------
T ss_pred HHHHHHHHhcCC--------------------------------------------------------------------
Confidence 555443332100
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
. .......++.+.+||.+||+.||.+|||+.|++++
T Consensus 323 -~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 323 -R---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp -C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01123567889999999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.35 Aligned_cols=271 Identities=27% Similarity=0.358 Sum_probs=209.4
Q ss_pred cccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC--CCCcccccee
Q 007542 13 VDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR--HPDIVEIKHI 90 (599)
Q Consensus 13 ~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~--HpnIv~l~~v 90 (599)
+.+-..--.+++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++ |+||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 333333455788999999999999999999885 5899999999765555566788899999999997 5999999999
Q ss_pred ecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 91 LLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
+... ..+|+|||+..++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+||
T Consensus 97 ~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Df 170 (313)
T 3cek_A 97 EITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDF 170 (313)
T ss_dssp EECS-----SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred eecC-----CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeec
Confidence 8543 4699999988889999999988999999999999999999999999999999999999996 589999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccc---------cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh-hHH
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQL 240 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---------~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~-~~l 240 (599)
|+++....... ........||+.|+|||++.+. ...++.++|||||||++++|++|+.||.+.... ..+
T Consensus 171 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 171 GIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp SSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred cccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 99986543221 1122345789999999998641 135788999999999999999999999764321 111
Q ss_pred HHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCC
Q 007542 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320 (599)
Q Consensus 241 ~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 320 (599)
..+.. .....
T Consensus 250 ~~~~~--------------------------------------------------------------------~~~~~-- 259 (313)
T 3cek_A 250 HAIID--------------------------------------------------------------------PNHEI-- 259 (313)
T ss_dssp HHHHC--------------------------------------------------------------------TTSCC--
T ss_pred HHHHh--------------------------------------------------------------------ccccc--
Confidence 11100 00000
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 321 ~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
......++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 260 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 260 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp -CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred -CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 11123467899999999999999999999999999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.46 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=203.4
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEEE
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~lyl 104 (599)
|....+||+|+||.||+|.+..++..||||++... .......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 96 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKI 96 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEE
Confidence 34445899999999999999999999999998643 23445678899999999999999999999843 347899
Q ss_pred EEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-CCceeeecccccccccCC
Q 007542 105 VFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFND 179 (599)
Q Consensus 105 V~E~~~-g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-~~~lKL~DFGla~~~~~~ 179 (599)
||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999997 69999998652 4679999999999999999999999999999999999988 899999999999865432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
.. ......+|+.|+|||++.+....++.++|||||||++|+|++|+.||.+...........
T Consensus 177 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--------------- 238 (295)
T 2clq_A 177 NP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--------------- 238 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH---------------
T ss_pred CC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh---------------
Confidence 21 124567899999999986532348899999999999999999999996543221100000
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
. ... . ........++.+.+||.+||
T Consensus 239 ------------------------------------------------~---~~~-~---~~~~~~~~~~~~~~li~~~l 263 (295)
T 2clq_A 239 ------------------------------------------------G---MFK-V---HPEIPESMSAEAKAFILKCF 263 (295)
T ss_dssp ------------------------------------------------H---HHC-C---CCCCCTTSCHHHHHHHHHTT
T ss_pred ------------------------------------------------c---ccc-c---cccccccCCHHHHHHHHHHc
Confidence 0 000 0 01122457889999999999
Q ss_pred ccCCCCCCCHHHHhcCccccCCc
Q 007542 340 AFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+.||.+|||++|+|+||||+...
T Consensus 264 ~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 264 EPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CSSTTTSCCHHHHHTSGGGCC--
T ss_pred cCChhhCCCHHHHhcChhhhhcc
Confidence 99999999999999999998653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=367.92 Aligned_cols=255 Identities=26% Similarity=0.432 Sum_probs=208.3
Q ss_pred CCceEEEEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~-----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++++.||+|+||+||+|. +..+++.||||+++.. ........+.+|+.+|+.+ +||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 5899999999999999999998 5667899999999743 2334556789999999999 7999999999985432
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCC----------------------------------------------------
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDD---------------------------------------------------- 122 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~---------------------------------------------------- 122 (599)
..+|+||||+. ++|.+++.....
T Consensus 100 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 100 ----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp ----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 35899999999 599999986543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccc
Q 007542 123 --------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 188 (599)
Q Consensus 123 --------------lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~ 188 (599)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~ 254 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGD 254 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT-CEEC--
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc-chhccc
Confidence 89999999999999999999999999999999999999999999999999986533222 122345
Q ss_pred cccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhc
Q 007542 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWC 267 (599)
Q Consensus 189 ~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~ 267 (599)
..+|..|+|||++.+ ..++.++||||||||+|+|++ |+.||.+.+....+.......
T Consensus 255 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------------- 312 (359)
T 3vhe_A 255 ARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------------------- 312 (359)
T ss_dssp CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--------------------
T ss_pred cCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--------------------
Confidence 678899999999876 679999999999999999998 999998866443322221100
Q ss_pred CCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCC
Q 007542 268 GYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP 347 (599)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~Rp 347 (599)
.. .......++.+.+||.+||+.||.+||
T Consensus 313 ------------------------------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp 341 (359)
T 3vhe_A 313 ------------------------------------------------TR---MRAPDYTTPEMYQTMLDCWHGEPSQRP 341 (359)
T ss_dssp ------------------------------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ------------------------------------------------CC---CCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 00 011234678999999999999999999
Q ss_pred CHHHHhcC
Q 007542 348 TAEEALAD 355 (599)
Q Consensus 348 Ta~e~L~H 355 (599)
|+.|+++|
T Consensus 342 s~~ell~~ 349 (359)
T 3vhe_A 342 TFSELVEH 349 (359)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=367.16 Aligned_cols=269 Identities=25% Similarity=0.401 Sum_probs=189.6
Q ss_pred cccccCCCCceEEEE-EeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHH-HHHHhcCCCCccccceeec
Q 007542 15 FFTEYGEGSRYKIEE-VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREI-KLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~-~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi-~iL~~l~HpnIv~l~~v~~ 92 (599)
....+...++|++++ +||+|+||.||+|+++.+|+.||||++... ....+|+ ..++.+.||||+++++++.
T Consensus 20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-------HHHHHHHHHHHHhcCCCChHHHHHHHh
Confidence 345567789999965 699999999999999999999999998641 1222333 3467779999999999985
Q ss_pred CCCcCCCccEEEEEecCCc-cHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---CCcee
Q 007542 93 PPSRREFKDIYVVFELMES-DLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLK 166 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~g-~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~~~lK 166 (599)
... .....+|+||||+.+ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 93 ~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 93 NMH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred hcc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 422 223568999999985 9999998764 6999999999999999999999999999999999999986 45599
Q ss_pred eecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHh
Q 007542 167 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDL 246 (599)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~ 246 (599)
|+|||+++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 172 l~Dfg~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (336)
T 3fhr_A 172 LTDFGFAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244 (336)
T ss_dssp ECCCTTCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred Eeccccceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh
Confidence 99999997653221 234578999999999876 67889999999999999999999999765432211110000
Q ss_pred cCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCC
Q 007542 247 LGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPN 326 (599)
Q Consensus 247 lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 326 (599)
+...........+..
T Consensus 245 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 259 (336)
T 3fhr_A 245 -----------------------------------------------------------------IRLGQYGFPNPEWSE 259 (336)
T ss_dssp -----------------------------------------------------------------------CCCTTTSTT
T ss_pred -----------------------------------------------------------------hhccccccCchhhcc
Confidence 000000011123356
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
+++.+.+||.+||+.||.+|||++|+|+||||++...
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 7899999999999999999999999999999987543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=372.98 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=209.0
Q ss_pred CCceEEEEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~-----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|++++.||+|+||+||+|. +..++..||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 4789999999999999999999 5567889999999642 2344556788999999999999999999998543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC---ce
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC---KL 165 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~---~l 165 (599)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 147 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 ---LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ---CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 45799999997 59999998643 589999999999999999999999999999999999999655 49
Q ss_pred eeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 007542 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~ 244 (599)
||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+....+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSC-TTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCcccccccccccc-ccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999754322111 11234578999999999876 679999999999999999998 999999887665544443
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
.... ....
T Consensus 301 ~~~~------------------------------------------------------------------------~~~~ 308 (367)
T 3l9p_A 301 SGGR------------------------------------------------------------------------MDPP 308 (367)
T ss_dssp TTCC------------------------------------------------------------------------CCCC
T ss_pred cCCC------------------------------------------------------------------------CCCC
Confidence 2110 0112
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
...++.+.+||.+||+.||.+|||+.|+|+|.++-
T Consensus 309 ~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 35678899999999999999999999999997764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.99 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=207.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QA 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC
Confidence 3478999999999999999999986 57789999997532 234568899999999999999999999853 34
Q ss_pred cEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 6899999998 5999999764 4689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ........+|..|+|||++.+ ..++.++|||||||++++|++ |+.||.+.+.......+......
T Consensus 159 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~-------- 226 (269)
T 4hcu_A 159 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------- 226 (269)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred cc--cccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC--------
Confidence 21 111234466788999999976 679999999999999999999 99999887765554443321100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
......++.+.+||.+
T Consensus 227 ----------------------------------------------------------------~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 227 ----------------------------------------------------------------YKPRLASTHVYQIMNH 242 (269)
T ss_dssp ----------------------------------------------------------------CCCTTSCHHHHHHHHH
T ss_pred ----------------------------------------------------------------CCCCcCCHHHHHHHHH
Confidence 0112357889999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 007542 338 MLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~H 355 (599)
||+.||.+|||+.|+|+|
T Consensus 243 ~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 243 CWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCcccCcCHHHHHHH
Confidence 999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=356.87 Aligned_cols=260 Identities=23% Similarity=0.409 Sum_probs=209.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.++||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++.. ..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 80 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DK 80 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CC
Confidence 35799999999999999999999999999999999854 344566788999999999999999999999853 34
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 7999999998 599999987 46799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCc-----------ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 179 DTPTA-----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 179 ~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..+|.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------- 231 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------- 231 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-------
Confidence 22211 01125689999999999987 67899999999999999999999998764321100
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
........+... ..+..
T Consensus 232 -----------------------------------------------------~~~~~~~~~~~~----------~~~~~ 248 (310)
T 3s95_A 232 -----------------------------------------------------FGLNVRGFLDRY----------CPPNC 248 (310)
T ss_dssp -----------------------------------------------------SSBCHHHHHHHT----------CCTTC
T ss_pred -----------------------------------------------------Hhhhhhcccccc----------CCCCC
Confidence 000000111100 12356
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
++.+.+||.+||+.||.+|||+.|+++ |+..+
T Consensus 249 ~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 249 PPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp CTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 778999999999999999999999987 56554
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=365.12 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=210.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcC--CCCccccceeecC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLR--HPDIVEIKHILLP 93 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~~i~rEi~iL~~l~--HpnIv~l~~v~~~ 93 (599)
...++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 45789999999999999999999999999999999996432221 12245668999999996 5999999999954
Q ss_pred CCcCCCccEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec-CCCceeeecc
Q 007542 94 PSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICDF 170 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~--g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~-~~~~lKL~DF 170 (599)
...+++|||++. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+||
T Consensus 120 -----~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 -----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp -----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred -----CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 347899999997 69999999888999999999999999999999999999999999999999 7899999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
|+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. +..
T Consensus 195 g~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~----- 257 (320)
T 3a99_A 195 GSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR----- 257 (320)
T ss_dssp TTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-----
T ss_pred cccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc-----
Confidence 9998764322 2456799999999998652 3347889999999999999999999965321 000
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
... .....+++.
T Consensus 258 -----------------------------------------------------------------~~~---~~~~~~~~~ 269 (320)
T 3a99_A 258 -----------------------------------------------------------------GQV---FFRQRVSSE 269 (320)
T ss_dssp -----------------------------------------------------------------CCC---CCSSCCCHH
T ss_pred -----------------------------------------------------------------ccc---cccccCCHH
Confidence 000 011357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=352.19 Aligned_cols=259 Identities=18% Similarity=0.234 Sum_probs=208.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
.+++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.+ +|+|++++++++. ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EG 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ET
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CC
Confidence 4689999999999999999999999999999999986432 233567899999999 7999999999884 33
Q ss_pred ccEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc-----eeeeccccc
Q 007542 100 KDIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGLA 173 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~-----lKL~DFGla 173 (599)
..+|+||||++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 5789999999889999998754 6999999999999999999999999999999999999988776 999999999
Q ss_pred ccccCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 174 RVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 174 ~~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 8765432211 11345689999999999977 67899999999999999999999999885433222211110000
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
....+.....+.+++
T Consensus 237 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 251 (298)
T 1csn_A 237 -----------------------------------------------------------------KQSTPLRELCAGFPE 251 (298)
T ss_dssp -----------------------------------------------------------------HHHSCHHHHTTTSCH
T ss_pred -----------------------------------------------------------------ccCccHHHHHhhCcH
Confidence 000011122346788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.+.+||.+||+.||.+|||++++++.
T Consensus 252 ~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 252 EFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 99999999999999999999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=348.01 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=206.4
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.+. ++..||||++.... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 76 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EY 76 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CC
Confidence 4579999999999999999999775 67789999997532 234568899999999999999999999843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 77 PIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp SEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 6899999998 68999998754 599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... .......+|..|+|||++.+ ..++.++|||||||++++|++ |+.||.+.+.......+.....
T Consensus 157 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 223 (268)
T 3sxs_A 157 DQY--VSSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR--------- 223 (268)
T ss_dssp TCE--EECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred hhh--hcccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC---------
Confidence 321 11234456778999999876 578999999999999999999 9999988766554433321100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. ......++.+.+||.+
T Consensus 224 ------------------------------------------------------------~---~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 224 ------------------------------------------------------------L---YRPHLASDTIYQIMYS 240 (268)
T ss_dssp ------------------------------------------------------------C---CCCTTSCHHHHHHHHH
T ss_pred ------------------------------------------------------------C---CCCCcChHHHHHHHHH
Confidence 0 0112357889999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 007542 338 MLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~H 355 (599)
||+.||.+|||+.|+|+|
T Consensus 241 ~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=360.99 Aligned_cols=207 Identities=21% Similarity=0.269 Sum_probs=177.9
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~ 98 (599)
-.+++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----- 76 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC----- 76 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEec-----
Confidence 34689999999999999999999999999999999986432 123577999999999 89999999999843
Q ss_pred CccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc-----eeeecccc
Q 007542 99 FKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK-----LKICDFGL 172 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~-----lKL~DFGl 172 (599)
...+|+||||++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 77 GKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred CCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 3478999999988999999874 68999999999999999999999999999999999999999887 99999999
Q ss_pred cccccCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh
Q 007542 173 ARVAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237 (599)
Q Consensus 173 a~~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~ 237 (599)
++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 98754332211 01245789999999999987 67899999999999999999999999986543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=355.97 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=209.4
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 589999999999999999999983 45689999999743 234556788999999999999999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHhhhCceEecc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDD------------------------LTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~------------------------lse~~i~~i~~QIl~aL~yLHs~gIvHrD 151 (599)
...+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+|||
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 346899999998 699999987543 89999999999999999999999999999
Q ss_pred CCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCC
Q 007542 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230 (599)
Q Consensus 152 LKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~p 230 (599)
|||+|||++.++.+||+|||+++....... ........+|..|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cchheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999986543221 111234567888999999876 578999999999999999999 9999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHH
Q 007542 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS 310 (599)
Q Consensus 231 F~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~ 310 (599)
|.+.+.......+....
T Consensus 253 ~~~~~~~~~~~~~~~~~--------------------------------------------------------------- 269 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGH--------------------------------------------------------------- 269 (314)
T ss_dssp STTCCGGGHHHHHHTTC---------------------------------------------------------------
T ss_pred CCCCCHHHHHHHhhcCC---------------------------------------------------------------
Confidence 98876554433322100
Q ss_pred hcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 311 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 311 ~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
........++.+.+||.+||+.||.+|||+.|++++
T Consensus 270 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 270 ---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011224578899999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=353.10 Aligned_cols=271 Identities=23% Similarity=0.372 Sum_probs=205.9
Q ss_pred CCCceEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..++|++++.||+|+||+||+|+ +..+++.||||++.. ........+.+|+.+|+.++||||+++++++....
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 84 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 84 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH-
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 46899999999999999999998 677899999999974 23445678899999999999999999999985422
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 85 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp --HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred --CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 245899999997 59999998764 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
................++..|+|||++.+ ..++.++|||||||++++|++|..+|..... ...+..+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccc
Confidence 76443322222334567888999999977 6789999999999999999999998864321 1111112111100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
. .....+..+......+ .....++.+.+|
T Consensus 236 ~------------------------------------------------~~~~~~~~~~~~~~~~---~~~~~~~~l~~l 264 (295)
T 3ugc_A 236 M------------------------------------------------IVFHLIELLKNNGRLP---RPDGCPDEIYMI 264 (295)
T ss_dssp H------------------------------------------------HHHHHHHHHHTTCCCC---CCTTCCHHHHHH
T ss_pred h------------------------------------------------hHHHHHHHHhccCcCC---CCcCcCHHHHHH
Confidence 0 0011111111111111 234578999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 007542 335 LERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~ 354 (599)
|.+||+.||.+|||+.|+++
T Consensus 265 i~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 265 MTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.38 Aligned_cols=276 Identities=23% Similarity=0.250 Sum_probs=210.4
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
+-..++|+++++||+|+||+||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CC
Confidence 456789999999999999999999865 899999999642 233445667999999999999999999986533 12
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC----------ceEeccCCCCceEecCCCceee
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------NVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~----------gIvHrDLKP~NILv~~~~~lKL 167 (599)
...+|+||||+. ++|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 346899999998 5999999775 599999999999999999999999 9999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccCcccccccc---CCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHH
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~ 244 (599)
+|||+++........ ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+......+....
T Consensus 173 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 173 ADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp CCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred ccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999876433221 1234468999999999986521 245668899999999999999999998876543333333
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
...+.+..+.+... + ........+...+
T Consensus 252 ~~~~~~~~~~~~~~--------------------------------------------------~--~~~~~~~~~~~~~ 279 (322)
T 3soc_A 252 EIGQHPSLEDMQEV--------------------------------------------------V--VHKKKRPVLRDYW 279 (322)
T ss_dssp HHCSSCCHHHHHHH--------------------------------------------------H--TTSCCCCCCCGGG
T ss_pred hhccCCchhhhhhh--------------------------------------------------h--hcccCCCCccccc
Confidence 33344443333220 0 0011111111111
Q ss_pred CC--CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 325 PN--ANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 325 ~~--~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.. .++.+.+||.+||+.||.+|||+.|+++
T Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 2356899999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=351.14 Aligned_cols=251 Identities=20% Similarity=0.301 Sum_probs=205.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
-..++|++++.||+|+||+||+|.+. ++..||||++.... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----Q 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-----C
Confidence 34689999999999999999999875 67889999997532 234568899999999999999999999843 3
Q ss_pred ccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 56999999997 699999987 4579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+......
T Consensus 172 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------- 240 (283)
T 3gen_A 172 DDEY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------- 240 (283)
T ss_dssp CHHH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------
T ss_pred cccc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-------
Confidence 2211 11233456788999999976 578999999999999999998 99999887765554444321110
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
......++.+.+||.
T Consensus 241 -----------------------------------------------------------------~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 241 -----------------------------------------------------------------YRPHLASEKVYTIMY 255 (283)
T ss_dssp -----------------------------------------------------------------CCCTTCCHHHHHHHH
T ss_pred -----------------------------------------------------------------CCCCcCCHHHHHHHH
Confidence 011235788999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q 007542 337 RMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~H 355 (599)
+||+.||.+|||+.|+|+|
T Consensus 256 ~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 256 SCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhHCcCHHHHHHH
Confidence 9999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=351.06 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=198.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|++.+.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----
Confidence 357999999999999999999998764 457999998643 234456778999999999999999999999832
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..+|+||||+. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 88 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 88 --NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred --CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 35799999999 59999998764 699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+....
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~------- 234 (281)
T 1mp8_A 166 MEDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------- 234 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred cCccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-------
Confidence 5432211 1233456788999999976 678999999999999999996 999998877655444332110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
. ....+..++.+.+|
T Consensus 235 --------------------------------------------------------------~---~~~~~~~~~~l~~l 249 (281)
T 1mp8_A 235 --------------------------------------------------------------R---LPMPPNCPPTLYSL 249 (281)
T ss_dssp --------------------------------------------------------------C---CCCCTTCCHHHHHH
T ss_pred --------------------------------------------------------------C---CCCCCCCCHHHHHH
Confidence 0 01224678899999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 007542 335 LERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~H 355 (599)
|.+||+.||.+|||+.|++++
T Consensus 250 i~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 250 MTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=354.99 Aligned_cols=260 Identities=20% Similarity=0.308 Sum_probs=201.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|++.+.||+|+||.||+|.+.. ++..||||+++...........+.+|+.+|+.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 46899999999999999999998765 566899999976555556667899999999999999999999999765444
Q ss_pred CCccEEEEEecCC-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKA------NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~------~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
.....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 4456799999999 599999853 346999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
|+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+....
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 266 (313)
T 3brb_A 192 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-- 266 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--
T ss_pred Ccceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC--
Confidence 999765332211 11233467889999999976 678999999999999999999 999998876655443332110
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
. .......++
T Consensus 267 -------------------------------------------------------------------~---~~~~~~~~~ 276 (313)
T 3brb_A 267 -------------------------------------------------------------------R---LKQPEDCLD 276 (313)
T ss_dssp -------------------------------------------------------------------C---CCCBTTCCH
T ss_pred -------------------------------------------------------------------C---CCCCccccH
Confidence 0 011235778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.+.+||.+||..||.+|||+.+++++
T Consensus 277 ~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=350.40 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=207.4
Q ss_pred CCCCceEEEE-EeeecCceEEEEEE--ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 20 GEGSRYKIEE-VIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 20 ~~~~rY~i~~-~IG~G~~g~Vy~a~--~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
-..++|++.+ .||+|+||.||+|. +..+++.||||+++...........+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 89 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--- 89 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---
Confidence 3468999998 99999999999995 46678999999997654444556789999999999999999999999832
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 90 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred ---CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 35899999998 69999999988899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...............++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------- 236 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------- 236 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--------
T ss_pred eccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------
Confidence 6443322222233456788999999876 578899999999999999999 99999887654433322210
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
.. .......++.+.+|
T Consensus 237 -------------------------------------------------------------~~---~~~~~~~~~~l~~l 252 (291)
T 1xbb_A 237 -------------------------------------------------------------ER---MGCPAGCPREMYDL 252 (291)
T ss_dssp -------------------------------------------------------------CC---CCCCTTCCHHHHHH
T ss_pred -------------------------------------------------------------CC---CCCCCCCCHHHHHH
Confidence 00 01124578899999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 007542 335 LERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~ 354 (599)
|.+||+.||.+|||+.++++
T Consensus 253 i~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 253 MNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=358.46 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=201.4
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhc----CCCCccccceeec
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLL----RHPDIVEIKHILL 92 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~~i~rEi~iL~~l----~HpnIv~l~~v~~ 92 (599)
..++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4678999999999999999999999999999999996432211 1233456899999999 8999999999984
Q ss_pred CCCcCCCccEEEEEec-CC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec-CCCceeeec
Q 007542 93 PPSRREFKDIYVVFEL-ME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN-ADCKLKICD 169 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~-~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~-~~~~lKL~D 169 (599)
. ...+++|+|+ +. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 109 ~-----~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 109 T-----QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ---------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred c-----CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 3 3468999998 55 69999999888899999999999999999999999999999999999999 789999999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
||+++...... .....+|..|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +..
T Consensus 184 fg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~---- 247 (312)
T 2iwi_A 184 FGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILE---- 247 (312)
T ss_dssp CSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH----
T ss_pred cchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhh----
Confidence 99998764322 2456799999999998652 2335589999999999999999999965211 000
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
. . ......+++
T Consensus 248 -------------------------------------------------------------~-----~---~~~~~~~~~ 258 (312)
T 2iwi_A 248 -------------------------------------------------------------A-----E---LHFPAHVSP 258 (312)
T ss_dssp -------------------------------------------------------------T-----C---CCCCTTSCH
T ss_pred -------------------------------------------------------------h-----c---cCCcccCCH
Confidence 0 0 011235788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 899999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=363.48 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=209.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC-------CcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-------GEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t-------g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~ 93 (599)
.++|++.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.+|+.+ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47999999999999999999997543 357999999753 3344567889999999999 89999999999954
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (599)
...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|
T Consensus 147 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 147 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 346899999998 59999998753 48999999999999999999999999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
||++.++.+||+|||+++........ .......+|..|+|||++.+ ..++.++|||||||++++|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865432211 12234567889999999977 679999999999999999999 999998877
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 236 ~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
..+....+....
T Consensus 299 ~~~~~~~~~~~~-------------------------------------------------------------------- 310 (382)
T 3tt0_A 299 VEELFKLLKEGH-------------------------------------------------------------------- 310 (382)
T ss_dssp HHHHHHHHHTTC--------------------------------------------------------------------
T ss_pred HHHHHHHHHcCC--------------------------------------------------------------------
Confidence 555443332110
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
. .......++.+.+||.+||+.||.+|||+.|++++
T Consensus 311 -~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 311 -R---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp -C---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -C---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01123578889999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=349.46 Aligned_cols=250 Identities=21% Similarity=0.423 Sum_probs=211.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.+.||+|+||+||+|.+..++..||||++.. .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CC
Confidence 56899999999999999999999999999999999964 33456778899999999999999999999843 34
Q ss_pred cEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
.+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 6899999999 69999998743 58999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... .......+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------- 230 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------- 230 (288)
T ss_dssp SSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------
T ss_pred CCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--------
Confidence 3322 22334567889999999976 578999999999999999999 9999988765544333321100
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.......++.+.+||.
T Consensus 231 ----------------------------------------------------------------~~~~~~~~~~l~~li~ 246 (288)
T 3kfa_A 231 ----------------------------------------------------------------MERPEGCPEKVYELMR 246 (288)
T ss_dssp ----------------------------------------------------------------CCCCTTCCHHHHHHHH
T ss_pred ----------------------------------------------------------------CCCCCCCCHHHHHHHH
Confidence 0112356788999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 007542 337 RMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~ 354 (599)
+||..||.+|||++|+++
T Consensus 247 ~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 247 ACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHhCCChhhCcCHHHHHH
Confidence 999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=345.98 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=204.2
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhH-----HHHHHHHHHHHhcCCCCccccceeecCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-----TRILREIKLLRLLRHPDIVEIKHILLPP 94 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~-----~~i~rEi~iL~~l~HpnIv~l~~v~~~~ 94 (599)
-..++|++.+.||+|+||.||+|.+..+++.||||++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34689999999999999999999999999999999986433222211 6788999999999999999999998433
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCCCc-----e
Q 007542 95 SRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCK-----L 165 (599)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~~~-----l 165 (599)
. ++||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++. +
T Consensus 96 ~-------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 96 P-------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp T-------EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred C-------eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 2 69999999 6998888765 47999999999999999999999999 999999999999988776 9
Q ss_pred eeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhH--HHHH
Q 007542 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ--LDIM 243 (599)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~--l~~I 243 (599)
||+|||+++.... ......+|+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 169 kl~Dfg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 9999999975432 1245689999999999854335688999999999999999999999987553221 1111
Q ss_pred HHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC
Q 007542 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323 (599)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 323 (599)
.. . .. ....
T Consensus 243 ~~------------------------------------------------------------------~--~~---~~~~ 251 (287)
T 4f0f_A 243 RE------------------------------------------------------------------E--GL---RPTI 251 (287)
T ss_dssp HH------------------------------------------------------------------S--CC---CCCC
T ss_pred hc------------------------------------------------------------------c--CC---CCCC
Confidence 00 0 00 0112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 324 FPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 324 ~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
....++.+.+||.+||+.||.+|||++|+++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 252 PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2457889999999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=358.10 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=210.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
..++|++++.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--
Confidence 3589999999999999999999987 456899999997432 33445778999999999999999999999844
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHhhhCceEec
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN------------------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHR 150 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHr 150 (599)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 122 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 122 ---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 346899999998 5999999864 568999999999999999999999999999
Q ss_pred cCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCC
Q 007542 151 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKP 229 (599)
Q Consensus 151 DLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~ 229 (599)
||||+|||++.++.+||+|||+++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999865322111 11234567899999999876 579999999999999999999 999
Q ss_pred CCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHH
Q 007542 230 LFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYL 309 (599)
Q Consensus 230 pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i 309 (599)
||.+.+..+....+.+.
T Consensus 276 p~~~~~~~~~~~~~~~~--------------------------------------------------------------- 292 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRDG--------------------------------------------------------------- 292 (343)
T ss_dssp TTTTSCHHHHHHHHHTT---------------------------------------------------------------
T ss_pred cCCCCChHHHHHHHhCC---------------------------------------------------------------
Confidence 99887655443333210
Q ss_pred HhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 310 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
. ........++.+.+||.+||+.||.+|||+.+++++ |..+
T Consensus 293 ------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~--L~~~ 333 (343)
T 1luf_A 293 ------N---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI--LQRM 333 (343)
T ss_dssp ------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHT
T ss_pred ------C---cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH--HHHH
Confidence 0 001123567889999999999999999999999874 4443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.88 Aligned_cols=272 Identities=24% Similarity=0.383 Sum_probs=210.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
-...+|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++....
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 345779999999999999999998 67789999999997533 2334577889999999999999999999986532
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 ---GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp ----CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred ---CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 246899999998 599999954 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
.................+|..|+|||++.+ ..++.++|||||||++|+|++|..||... ...+....+.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~ 246 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQ 246 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCcccc
Confidence 876544332233345678889999999876 57889999999999999999999876431 12222222221111
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.........+...... ...+.+++.+.+
T Consensus 247 -------------------------------------------------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 274 (302)
T 4e5w_A 247 -------------------------------------------------MTVTRLVNTLKEGKRL---PCPPNCPDEVYQ 274 (302)
T ss_dssp -------------------------------------------------GHHHHHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred -------------------------------------------------cCHHHHHHHHhccCCC---CCCCCCCHHHHH
Confidence 0111122222222221 123467899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 007542 334 LLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~ 354 (599)
||.+||+.||.+|||+.|+|+
T Consensus 275 li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 275 LMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCCCCCHHHHHH
Confidence 999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=376.39 Aligned_cols=259 Identities=27% Similarity=0.394 Sum_probs=194.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..+|.+.++||+|+||+|+. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++. +..
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~ 91 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEK-----DRQ 91 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETT
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCC
Confidence 45799999999999998763 4467899999999964221 2345899999999 7999999999884 335
Q ss_pred cEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---C--Cceeeecccccc
Q 007542 101 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---D--CKLKICDFGLAR 174 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~--~~lKL~DFGla~ 174 (599)
.+||||||++++|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+++
T Consensus 92 ~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 92 FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 789999999999999998764 4666677899999999999999999999999999999953 2 357899999998
Q ss_pred cccCCCCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
...............+||++|+|||++.+. ...++.++||||||||+|+|++ |.+||.+... .+...+. +...
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~~~~~~---~~~~- 246 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQANILL---GACS- 246 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HHHHHHT---TCCC-
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HHHHHHh---ccCC-
Confidence 764333222233557899999999998631 2467889999999999999999 8999965432 2221111 1000
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
..........+..+.
T Consensus 247 -----------------------------------------------------------------~~~~~~~~~~~~~~~ 261 (432)
T 3p23_A 247 -----------------------------------------------------------------LDCLHPEKHEDVIAR 261 (432)
T ss_dssp -----------------------------------------------------------------CTTSCTTCHHHHHHH
T ss_pred -----------------------------------------------------------------ccccCccccccHHHH
Confidence 000000112345689
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||.+||+.||.+|||++|+|+||||.++
T Consensus 262 ~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 262 ELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 99999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=357.65 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=200.8
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEE----EEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~V----AIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
-..++|+++++||+|+||.||+|++..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 45688999999999999999999998888765 77776532 2233456788999999999999999999999542
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
..++|+||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 -----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred -----CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 4788999998 6999999874 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+.....
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---- 237 (327)
T 3poz_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---- 237 (327)
T ss_dssp HHHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred eEccCCccc-ccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC----
Confidence 876433221 12234466889999999977 679999999999999999999 9999988765544333221110
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
....+..+..+.
T Consensus 238 --------------------------------------------------------------------~~~~~~~~~~~~ 249 (327)
T 3poz_A 238 --------------------------------------------------------------------LPQPPICTIDVY 249 (327)
T ss_dssp --------------------------------------------------------------------CCCCTTBCHHHH
T ss_pred --------------------------------------------------------------------CCCCccCCHHHH
Confidence 011234678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 007542 333 RLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+||.+||+.||.+|||+.|+|++
T Consensus 250 ~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 250 MIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.15 Aligned_cols=257 Identities=20% Similarity=0.245 Sum_probs=206.8
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..+++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.++|++++..+..+.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~ 77 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 77 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEE----ET
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccC----CC
Confidence 457899999999999999999999999999999999864322 2357799999999999988877776632 23
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe---cCCCceeeeccccccc
Q 007542 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv---~~~~~lKL~DFGla~~ 175 (599)
..+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 47899999998899999984 4579999999999999999999999999999999999999 4789999999999987
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh---hHHHHHHHhcC
Q 007542 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV---HQLDIMTDLLG 248 (599)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~---~~l~~I~~~lg 248 (599)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 64432211 11245689999999999987 57899999999999999999999999874422 22222211000
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
. .+.....+.++
T Consensus 236 ~--------------------------------------------------------------------~~~~~~~~~~~ 247 (296)
T 3uzp_A 236 S--------------------------------------------------------------------TPIEVLCKGYP 247 (296)
T ss_dssp H--------------------------------------------------------------------SCHHHHTTTSC
T ss_pred C--------------------------------------------------------------------CchHHHHhhCC
Confidence 0 00111224578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
+.+.+||.+||+.||.+|||++++++
T Consensus 248 ~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 248 SEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 88999999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.30 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=211.7
Q ss_pred ccccccCC-CCceEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccc
Q 007542 14 DFFTEYGE-GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVE 86 (599)
Q Consensus 14 ~~~~~~~~-~~rY~i~~~IG~G~~g~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~ 86 (599)
.+...+.. .++|++.+.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeee
Confidence 34444443 47999999999999999999985 467889999999743 2334567889999999999 8999999
Q ss_pred cceeecCCCcCCCccEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHhhhCce
Q 007542 87 IKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANV 147 (599)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~lse~~i~~i~~QIl~aL~yLHs~gI 147 (599)
+++++... ..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||
T Consensus 92 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 166 (313)
T 1t46_A 92 LLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (313)
T ss_dssp EEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 99999543 46899999998 59999998754 38999999999999999999999999
Q ss_pred EeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-
Q 007542 148 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT- 226 (599)
Q Consensus 148 vHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt- 226 (599)
+||||||+|||++.++.+||+|||+++........ .......+|..|+|||++.+ ..++.++|||||||++++|++
T Consensus 167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~ 243 (313)
T 1t46_A 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSL 243 (313)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCCCccceEEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876443221 12334567889999999876 678999999999999999998
Q ss_pred CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHH
Q 007542 227 GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKAR 306 (599)
Q Consensus 227 G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~ 306 (599)
|+.||.+......+..+....
T Consensus 244 g~~p~~~~~~~~~~~~~~~~~----------------------------------------------------------- 264 (313)
T 1t46_A 244 GSSPYPGMPVDSKFYKMIKEG----------------------------------------------------------- 264 (313)
T ss_dssp TCCSSTTCCSSHHHHHHHHHT-----------------------------------------------------------
T ss_pred CCCCCCcccchhHHHHHhccC-----------------------------------------------------------
Confidence 999998765443322221100
Q ss_pred HHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 307 RYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 307 ~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.. .......++.+.+||.+||+.||.+|||+.|++++
T Consensus 265 -----~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 265 -----FR-------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp -----CC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CC-------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 00 01123567889999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.40 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=200.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.-++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 35789999999999999999999999999999999975433 23335778899999999999999999999843 3
Q ss_pred ccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+|+||||+++ +|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 478999999995 9999999888899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 187 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------------- 249 (309)
T 2h34_A 187 EKL--TQLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ------------- 249 (309)
T ss_dssp ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS-------------
T ss_pred ccc--ccccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc-------------
Confidence 221 12245679999999999976 6789999999999999999999999987654321111110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.........+.+++.+.+||.+|
T Consensus 250 ---------------------------------------------------------~~~~~~~~~~~~~~~l~~li~~~ 272 (309)
T 2h34_A 250 ---------------------------------------------------------AIPRPSTVRPGIPVAFDAVIARG 272 (309)
T ss_dssp ---------------------------------------------------------CCCCGGGTSTTCCTHHHHHHHHH
T ss_pred ---------------------------------------------------------CCCCccccCCCCCHHHHHHHHHh
Confidence 01111223456788999999999
Q ss_pred cccCCCCCC-CHHHHhc
Q 007542 339 LAFEPKDRP-TAEEALA 354 (599)
Q Consensus 339 L~~DP~~Rp-Ta~e~L~ 354 (599)
|+.||.+|| |++++++
T Consensus 273 l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 273 MAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp TCSSGGGSCSSHHHHHH
T ss_pred ccCCHHHHHHhHHHHHH
Confidence 999999999 7888875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=358.30 Aligned_cols=257 Identities=20% Similarity=0.315 Sum_probs=205.1
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcE----EEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~----VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
...-..++|++++.||+|+||.||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3444578999999999999999999999988876 7777764322 1223345678999999999999999999883
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 93 PPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
. ..+++||||+. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df 159 (325)
T 3kex_A 86 G------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADF 159 (325)
T ss_dssp B------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSC
T ss_pred C------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCC
Confidence 2 35899999999 6999999875 57999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
|+++....... ........+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+.......+.....
T Consensus 160 g~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~- 235 (325)
T 3kex_A 160 GVADLLPPDDK-QLLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER- 235 (325)
T ss_dssp SGGGGSCCCTT-CCC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-
T ss_pred CcccccCcccc-cccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-
Confidence 99987643322 122345678889999999976 579999999999999999999 9999988765444333321100
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
. ......++
T Consensus 236 --------------------------------------------------------------------~---~~~~~~~~ 244 (325)
T 3kex_A 236 --------------------------------------------------------------------L---AQPQICTI 244 (325)
T ss_dssp --------------------------------------------------------------------C---CCCTTBCT
T ss_pred --------------------------------------------------------------------C---CCCCcCcH
Confidence 0 01122455
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.+.+||.+||..||.+|||+.|+++|
T Consensus 245 ~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 245 DVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 68899999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=350.80 Aligned_cols=205 Identities=27% Similarity=0.395 Sum_probs=168.6
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh--cCCCCccccceeecCCCcC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL--LRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~--l~HpnIv~l~~v~~~~s~~ 97 (599)
-..++|++++.||+|+||.||+|.+ +|+.||||++.. .....+.+|.+++.. ++||||+++++++.... .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-H 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-T
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-C
Confidence 3568999999999999999999976 689999999863 234556677777777 78999999999875432 2
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh--------hCceEeccCCCCceEecCCCceeee
Q 007542 98 EFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
....+|+||||++ ++|.++++. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3457899999999 599999954 47999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCCCCCc-ccccccccCccccCccccccccC----CCCcchhhHhHHHHHHHHHhC----------CCCCCC
Q 007542 169 DFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG----------KPLFPG 233 (599)
Q Consensus 169 DFGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~----~~s~~~DIWSlG~Il~eLltG----------~~pF~g 233 (599)
|||+++......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| ..||.+
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997654332221 11234589999999999876211 355799999999999999999 777754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=345.58 Aligned_cols=258 Identities=20% Similarity=0.240 Sum_probs=202.7
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
...+++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+.. .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~ 76 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----E 76 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEE----E
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecC----C
Confidence 3567899999999999999999999999999999998754322 2347789999999999988888777643 3
Q ss_pred CccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe---cCCCceeeecccccc
Q 007542 99 FKDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLAR 174 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv---~~~~~lKL~DFGla~ 174 (599)
....|+||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 77 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 77 GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 357899999998899999985 4579999999999999999999999999999999999999 788999999999998
Q ss_pred cccCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhh---HHHHHHHhc
Q 007542 175 VAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVH---QLDIMTDLL 247 (599)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~---~l~~I~~~l 247 (599)
......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 764432211 12235689999999999987 578999999999999999999999998754322 111111000
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
. ..+.......+
T Consensus 235 ~--------------------------------------------------------------------~~~~~~~~~~~ 246 (296)
T 4hgt_A 235 M--------------------------------------------------------------------STPIEVLCKGY 246 (296)
T ss_dssp H--------------------------------------------------------------------HSCHHHHTTTS
T ss_pred c--------------------------------------------------------------------cchhhhhhccC
Confidence 0 00111122456
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
++.+.+||.+||+.||.+|||++++++
T Consensus 247 ~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 247 PSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 788999999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.97 Aligned_cols=267 Identities=24% Similarity=0.278 Sum_probs=200.6
Q ss_pred CCcccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcccccee
Q 007542 11 ADVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90 (599)
Q Consensus 11 ~~~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v 90 (599)
+..++-..--..++|++.+.||+|+||.||+|.+. ..||||+++...........+.+|+.+|+.++||||++++++
T Consensus 12 ~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 12 SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp ------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 33444444445789999999999999999999753 359999998666666677889999999999999999999996
Q ss_pred ecCCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeee
Q 007542 91 LLPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
... ..+++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 89 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~ 162 (289)
T 3og7_A 89 STA------PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIG 162 (289)
T ss_dssp ECS------SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred ccC------CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEc
Confidence 532 35799999999 6999998644 479999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
|||+++....... ........||+.|+|||++... ...++.++|||||||++++|++|+.||.+.+..+.+..+....
T Consensus 163 Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 241 (289)
T 3og7_A 163 DFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG 241 (289)
T ss_dssp CCC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT
T ss_pred cceeccccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc
Confidence 9999976432111 1123456799999999998521 1568889999999999999999999998866544433322110
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
.....+.......
T Consensus 242 -------------------------------------------------------------------~~~~~~~~~~~~~ 254 (289)
T 3og7_A 242 -------------------------------------------------------------------SLSPDLSKVRSNC 254 (289)
T ss_dssp -------------------------------------------------------------------SCCCCTTSSCTTS
T ss_pred -------------------------------------------------------------------ccCcchhhccccC
Confidence 1111223344567
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
++.+.+||.+||+.||.+|||+.|+|+
T Consensus 255 ~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 255 PKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 889999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.69 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=204.9
Q ss_pred CCceEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++.+.||+|+||.||+|.+ ..++..||||++.... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-
Confidence 57999999999999999999997 3467789999997432 223456788999999999 899999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHhhhCceEecc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrD 151 (599)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.||+|||
T Consensus 122 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 122 ----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 46899999998 59999998653 278999999999999999999999999999
Q ss_pred CCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCC
Q 007542 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230 (599)
Q Consensus 152 LKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~p 230 (599)
|||+|||++.++.+||+|||++......... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999866433221 22344567889999999876 578999999999999999998 9999
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHH
Q 007542 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS 310 (599)
Q Consensus 231 F~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~ 310 (599)
|.+......+..+...
T Consensus 275 ~~~~~~~~~~~~~~~~---------------------------------------------------------------- 290 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQN---------------------------------------------------------------- 290 (344)
T ss_dssp STTCCCSHHHHHHHHT----------------------------------------------------------------
T ss_pred cccCCcHHHHHHHHhc----------------------------------------------------------------
Confidence 9886543332222110
Q ss_pred hcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 311 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 311 ~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
... .......++.+.+||.+||+.||.+|||+.|+++|
T Consensus 291 ----~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 291 ----GFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp ----TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 000 01123467899999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=365.25 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=205.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.++.+++.||||+++.. ........+.+|+.+|+.++||||+++++++... ..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QP 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CC
Confidence 57899999999999999999999999999999998743 2233445788999999999999999999999433 46
Q ss_pred EEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 899999998 69999998654 6999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+...
T Consensus 267 ~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~------------ 331 (377)
T 3cbl_A 267 VYA-ASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG------------ 331 (377)
T ss_dssp EEE-CCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT------------
T ss_pred cee-ecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------------
Confidence 110 00112235678999999876 578999999999999999998 99999887654433322110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
...+ .....++.+.+||.+|
T Consensus 332 ---------------------------------------------------------~~~~---~~~~~~~~l~~li~~c 351 (377)
T 3cbl_A 332 ---------------------------------------------------------GRLP---CPELCPDAVFRLMEQC 351 (377)
T ss_dssp ---------------------------------------------------------CCCC---CCTTCCHHHHHHHHHH
T ss_pred ---------------------------------------------------------CCCC---CCCCCCHHHHHHHHHH
Confidence 0001 1124678899999999
Q ss_pred cccCCCCCCCHHHHhc
Q 007542 339 LAFEPKDRPTAEEALA 354 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~ 354 (599)
|+.||.+|||++++++
T Consensus 352 l~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 352 WAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCCchhCcCHHHHHH
Confidence 9999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=355.61 Aligned_cols=274 Identities=23% Similarity=0.349 Sum_probs=214.2
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecC
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~ 93 (599)
++-..++|++++.||+|+||.||+|+ +..+++.||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 34556899999999999999999998 5778999999999742 34456778999999999999999999999864
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
. +...+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 96 ~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 172 (327)
T 3lxl_A 96 P---GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172 (327)
T ss_dssp S---SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred C---CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccc
Confidence 3 3357899999997 699999986 3569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
+++................+|..|+|||++.+ ..++.++|||||||++++|++|..||.+...... ...+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~- 244 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-----RMMGCE- 244 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHCC---
T ss_pred cceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-----hhcccc-
Confidence 99876444332233345678899999999876 5789999999999999999999999875432110 000000
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
............+...... ...+..++.+
T Consensus 245 ------------------------------------------------~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 273 (327)
T 3lxl_A 245 ------------------------------------------------RDVPALSRLLELLEEGQRL---PAPPACPAEV 273 (327)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTTCCC---CCCTTCCHHH
T ss_pred ------------------------------------------------cccccHHHHHHHhhcccCC---CCCCcccHHH
Confidence 0000011111112121111 1235678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.+||.+||+.||.+|||+.|++++
T Consensus 274 ~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 274 HELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.78 Aligned_cols=257 Identities=22% Similarity=0.353 Sum_probs=189.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCC---cC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPS---RR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s---~~ 97 (599)
..+|++.++||+|+||.||+|.+..+++.||||++.. ........+.+|+.+|+.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 5699999999999999999999999999999999853 23455677889999999996 999999999985321 13
Q ss_pred CCccEEEEEecCCccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCCCceeeecccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~---~~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
....+|+||||++|+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 4457899999999999998865 457999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccCccccCcccccc-ccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 007542 173 ARVAFNDTPTA---------IFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (599)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gt~~Y~APE~l~~-~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~ 242 (599)
++......... .......+|+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 98754322110 01124568999999999831 115688999999999999999999999976432211100
Q ss_pred HHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcC
Q 007542 243 MTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322 (599)
Q Consensus 243 I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 322 (599)
. .. ..
T Consensus 265 ~------------------------------------------------------------------------~~---~~ 269 (337)
T 3ll6_A 265 K------------------------------------------------------------------------YS---IP 269 (337)
T ss_dssp -------------------------------------------------------------------------CC---CC
T ss_pred c------------------------------------------------------------------------cc---CC
Confidence 0 00 00
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 323 ~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.....++.+.+||.+||+.||.+|||+.|+|+|
T Consensus 270 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112345668999999999999999999999997
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.87 Aligned_cols=249 Identities=14% Similarity=0.187 Sum_probs=206.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.+. ++.||||++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 478999999999999999999874 889999999866555666778999999999999999999999986532 247
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEecCCCceeeecccccccc
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999998 59999998765 4899999999999999999999999 999999999999999999999999887542
Q ss_pred cCCCCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.. ....+|+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 164 ~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------- 228 (271)
T 3kmu_A 164 QS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL------- 228 (271)
T ss_dssp SC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC-------
T ss_pred cc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC-------
Confidence 21 234789999999998652 12334489999999999999999999988765554333221100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
. .......++.+.+||
T Consensus 229 -------------------------------------------------------------~---~~~~~~~~~~~~~li 244 (271)
T 3kmu_A 229 -------------------------------------------------------------R---PTIPPGISPHVSKLM 244 (271)
T ss_dssp -------------------------------------------------------------C---CCCCTTCCHHHHHHH
T ss_pred -------------------------------------------------------------C---CCCCCCCCHHHHHHH
Confidence 0 012245788999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 007542 336 ERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~ 354 (599)
.+||+.||.+|||++|+++
T Consensus 245 ~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 245 KICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=352.30 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=201.5
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
-..++|++.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-- 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--
Confidence 45789999999999999999999987654 459999997432 33455678899999999999999999999843
Q ss_pred cCCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 96 RREFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g-~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...+|+||||+++ +|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 118 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 118 ---YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ---CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 3579999999985 999999865 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+................+|..|+|||++.+ ..++.++|||||||++++|++ |+.||.+.+..+.+..+.+..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~----- 267 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----- 267 (333)
T ss_dssp ----------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----
T ss_pred hhhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC-----
Confidence 876433222211223456788999999876 678999999999999999998 999998776554433332110
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
.. ......++.+.
T Consensus 268 ----------------------------------------------------------------~~---~~~~~~~~~l~ 280 (333)
T 1mqb_A 268 ----------------------------------------------------------------RL---PTPMDCPSAIY 280 (333)
T ss_dssp ----------------------------------------------------------------CC---CCCTTCBHHHH
T ss_pred ----------------------------------------------------------------cC---CCcccCCHHHH
Confidence 00 11235678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 007542 333 RLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+||.+||+.||.+|||+.+++++
T Consensus 281 ~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 281 QLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=353.25 Aligned_cols=253 Identities=21% Similarity=0.361 Sum_probs=207.8
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|++.+.||+|+||.||+|.++ .++..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 99 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--- 99 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS---
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc---
Confidence 578999999999999999999877 46789999999743 233455678899999999999999999999843
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCce
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKL 165 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~l 165 (599)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 100 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 100 --GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred --CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 346899999998 5999998752 357899999999999999999999999999999999999999999
Q ss_pred eeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHH
Q 007542 166 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMT 244 (599)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~ 244 (599)
||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 178 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCccccccccccc-cccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999976533221 111234467889999999876 578999999999999999999 899998876544433322
Q ss_pred HhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC
Q 007542 245 DLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324 (599)
Q Consensus 245 ~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 324 (599)
.. ......
T Consensus 255 ~~------------------------------------------------------------------------~~~~~~ 262 (322)
T 1p4o_A 255 EG------------------------------------------------------------------------GLLDKP 262 (322)
T ss_dssp TT------------------------------------------------------------------------CCCCCC
T ss_pred cC------------------------------------------------------------------------CcCCCC
Confidence 10 001122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 325 PNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 325 ~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
...++.+.+||.+||+.||.+|||+.|+++|
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 263 DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4578889999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.71 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=206.5
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-------CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-------RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-------~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~ 93 (599)
.++|++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 589999999999999999999986 467889999997432 344567789999999999 89999999999843
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (599)
...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 113 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 187 (334)
T 2pvf_A 113 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187 (334)
T ss_dssp -----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccce
Confidence 346899999998 59999998654 38999999999999999999999999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
||++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999986543221 111233467888999999876 578999999999999999999 999998876
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 236 ~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
..+....+....
T Consensus 265 ~~~~~~~~~~~~-------------------------------------------------------------------- 276 (334)
T 2pvf_A 265 VEELFKLLKEGH-------------------------------------------------------------------- 276 (334)
T ss_dssp HHHHHHHHHHTC--------------------------------------------------------------------
T ss_pred HHHHHHHHhcCC--------------------------------------------------------------------
Confidence 544333322100
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
. .......++.+.+||.+||..||.+|||+.|++++
T Consensus 277 -~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 277 -R---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp -C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -C---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 01123577889999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=340.30 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=206.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 77 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 77 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SS
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CC
Confidence 578999999999999999999986 678999999975332 345788999999999999999999998543 46
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 899999998 5999999875 46899999999999999999999999999999999999999999999999999865321
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
. ........++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+.......+....
T Consensus 158 ~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~----------- 222 (267)
T 3t9t_A 158 Q--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 222 (267)
T ss_dssp H--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred c--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 1 111234467788999999976 578999999999999999999 899998876555443332110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.. ......++.+.+||.+|
T Consensus 223 ----------------------------------------------------------~~---~~~~~~~~~l~~li~~~ 241 (267)
T 3t9t_A 223 ----------------------------------------------------------RL---YKPRLASTHVYQIMNHC 241 (267)
T ss_dssp ----------------------------------------------------------CC---CCCTTSCHHHHHHHHHH
T ss_pred ----------------------------------------------------------cC---CCCccCcHHHHHHHHHH
Confidence 00 01124678899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|+.||.+|||+.|++++
T Consensus 242 l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 242 WRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=344.41 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=208.5
Q ss_pred CCCCceEEEE-EeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 20 GEGSRYKIEE-VIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 20 ~~~~rY~i~~-~IG~G~~g~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
-..++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 81 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--- 81 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---
Confidence 3457788877 9999999999999864 46888999999753 234556788999999999999999999999832
Q ss_pred CCCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~g-~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 82 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 82 ---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp ---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 358999999995 999999654 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
................+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~------- 229 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------- 229 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-------
T ss_pred eeccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-------
Confidence 76433222222233456889999999976 578999999999999999998 99999876654433322210
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
.. ....+..++.+.+
T Consensus 230 --------------------------------------------------------------~~---~~~~~~~~~~l~~ 244 (287)
T 1u59_A 230 --------------------------------------------------------------KR---MECPPECPPELYA 244 (287)
T ss_dssp --------------------------------------------------------------CC---CCCCTTCCHHHHH
T ss_pred --------------------------------------------------------------Cc---CCCCCCcCHHHHH
Confidence 00 1122467889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCc
Q 007542 334 LLERMLAFEPKDRPTAEEALADP 356 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~HP 356 (599)
||.+||+.||.+|||+.|+++|.
T Consensus 245 li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 245 LMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=350.55 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=208.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEE-----CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPP 94 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~-----~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~ 94 (599)
..++|++.+.||+|+||.||+|.+ ..+++.||||++.... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 358999999999999999999985 4577999999997532 334556788999999999 699999999998543
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCce
Q 007542 95 SRREFKDIYVVFELME-SDLHQVIKANDD----------------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNI 157 (599)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~----------------lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (599)
...+|+||||+. ++|.+++..... +++..++.++.||+.||.|||+.||+||||||+||
T Consensus 104 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 104 ----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 235899999999 599999987654 89999999999999999999999999999999999
Q ss_pred EecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCCh
Q 007542 158 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236 (599)
Q Consensus 158 Lv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~ 236 (599)
|++.++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999986543222 122345678899999999876 678999999999999999998 9999987653
Q ss_pred hhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCC
Q 007542 237 VHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKK 316 (599)
Q Consensus 237 ~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~ 316 (599)
...+..... . ..
T Consensus 257 ~~~~~~~~~----------------------------------------------------------------~----~~ 268 (316)
T 2xir_A 257 DEEFCRRLK----------------------------------------------------------------E----GT 268 (316)
T ss_dssp SHHHHHHHH----------------------------------------------------------------H----TC
T ss_pred hHHHHHHhc----------------------------------------------------------------c----Cc
Confidence 332211110 0 00
Q ss_pred CCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 317 PIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 317 ~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
. .......++.+.+||.+||+.||.+|||+.|+++|
T Consensus 269 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 269 R---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01123467889999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.41 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=205.5
Q ss_pred CCCceEEEEEeeecCceEEEEEE-----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAY-----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~-----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
..++|++++.||+|+||.||+|. +..++..||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS- 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-
Confidence 46899999999999999999998 6678899999999643 2344566788999999999999999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---CCc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAND-------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCK 164 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~-------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~~~ 164 (599)
..+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.
T Consensus 106 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 106 ----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred ----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 45799999997 69999998753 4899999999999999999999999999999999999994 446
Q ss_pred eeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHH
Q 007542 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIM 243 (599)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I 243 (599)
+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY-RKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECcccccccccccccc-ccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 999999999765332211 11234567899999999876 578999999999999999998 99999887655444333
Q ss_pred HHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCC
Q 007542 244 TDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQK 323 (599)
Q Consensus 244 ~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 323 (599)
.... ....
T Consensus 259 ~~~~------------------------------------------------------------------------~~~~ 266 (327)
T 2yfx_A 259 TSGG------------------------------------------------------------------------RMDP 266 (327)
T ss_dssp HTTC------------------------------------------------------------------------CCCC
T ss_pred hcCC------------------------------------------------------------------------CCCC
Confidence 2110 0011
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 007542 324 FPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 324 ~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
....++.+.+||.+||+.||.+|||+.|+|+|.|+-
T Consensus 267 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 267 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 235678899999999999999999999999998864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=363.42 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=196.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|++.+.||+|+||.||+|+++ .++..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK---- 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----
Confidence 3578999999999999999999877 467789999997532 34456778999999999999999999999843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 118 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 118 -SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred -CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 346899999997 69999998764 699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...............++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+......
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~----- 269 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL----- 269 (373)
T ss_dssp -----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-----
T ss_pred cccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 6433222111122345778999999976 679999999999999999998 99999877655443333211100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
......+..+.+|
T Consensus 270 -------------------------------------------------------------------~~~~~~~~~l~~l 282 (373)
T 2qol_A 270 -------------------------------------------------------------------PPPMDCPAALYQL 282 (373)
T ss_dssp -------------------------------------------------------------------CCCTTCBHHHHHH
T ss_pred -------------------------------------------------------------------CCCccccHHHHHH
Confidence 0112467889999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 007542 335 LERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~ 354 (599)
|.+||+.||.+|||+.|+++
T Consensus 283 i~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 283 MLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=362.24 Aligned_cols=269 Identities=16% Similarity=0.140 Sum_probs=201.8
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCC-----CcEEEEEEecCccCChhh---------HHHHHHHHHHHHhcCCCCccc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT-----GEKVAIKKINDIFEHVSD---------ATRILREIKLLRLLRHPDIVE 86 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~t-----g~~VAIK~i~~~~~~~~~---------~~~i~rEi~iL~~l~HpnIv~ 86 (599)
..++|++++.||+|+||+||+|.+..+ ++.||||++......... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 356999999999999999999998775 588999998642210000 112334556677778999999
Q ss_pred cceeecCCCcCCCccEEEEEecCCccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec--CCC
Q 007542 87 IKHILLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADC 163 (599)
Q Consensus 87 l~~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~--~~~ 163 (599)
+++++.... .+...+||||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999986532 223568999999988999999876 5799999999999999999999999999999999999999 889
Q ss_pred ceeeecccccccccCCCCC----cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhH
Q 007542 164 KLKICDFGLARVAFNDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQ 239 (599)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~ 239 (599)
.+||+|||+++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 9999999999875432211 111234569999999999987 5799999999999999999999999986433222
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
..........+ .....+....
T Consensus 270 ~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~------ 290 (364)
T 3op5_A 270 YVRDSKIRYRE-----------------------------------------------------NIASLMDKCF------ 290 (364)
T ss_dssp HHHHHHHHHHH-----------------------------------------------------CHHHHHHHHS------
T ss_pred HHHHHHHHhhh-----------------------------------------------------hHHHHHHHhc------
Confidence 21111100000 0011111100
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.....++.+.+||.+||..||.+|||+.++++
T Consensus 291 ---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 291 ---PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp ---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 01356788999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.03 Aligned_cols=210 Identities=17% Similarity=0.202 Sum_probs=170.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChh---------hHHHHHHHHHHHHhcCCCCccccc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVS---------DATRILREIKLLRLLRHPDIVEIK 88 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~---tg~~VAIK~i~~~~~~~~---------~~~~i~rEi~iL~~l~HpnIv~l~ 88 (599)
..++|++++.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 46899999999999999999999987 889999999864321110 112356788999999999999999
Q ss_pred eeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC--cee
Q 007542 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC--KLK 166 (599)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~--~lK 166 (599)
+++.... .+...+|+||||++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9986532 2345799999999779999998877899999999999999999999999999999999999999887 999
Q ss_pred eecccccccccCCCC----CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 007542 167 ICDFGLARVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (599)
Q Consensus 167 L~DFGla~~~~~~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g 233 (599)
|+|||+++....... .........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999987532211 1111245689999999999977 5789999999999999999999999965
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.92 Aligned_cols=251 Identities=22% Similarity=0.370 Sum_probs=203.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECC---CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~---tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 5789999999999999999998654 34569999987532 33456788999999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 24589999999 6999999765 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ......+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~------- 232 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR------- 232 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-------
Confidence 432211 1233467889999999976 678999999999999999998 9999987665544333321100
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
. ......++.+.+||
T Consensus 233 --------------------------------------------------------------~---~~~~~~~~~l~~li 247 (281)
T 3cc6_A 233 --------------------------------------------------------------L---PKPDLCPPVLYTLM 247 (281)
T ss_dssp --------------------------------------------------------------C---CCCTTCCHHHHHHH
T ss_pred --------------------------------------------------------------C---CCCCCCCHHHHHHH
Confidence 0 11134678899999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 007542 336 ERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~H 355 (599)
.+||..||.+|||+.|++++
T Consensus 248 ~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 248 TRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCchhCcCHHHHHHH
Confidence 99999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=340.63 Aligned_cols=248 Identities=28% Similarity=0.447 Sum_probs=193.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC--hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH--VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~--~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.++|++.+.||+|+||.||+|.+. |+.||||++...... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-----E 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-----C
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-----C
Confidence 578999999999999999999874 889999998643222 2335678899999999999999999999854 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCc---eEeccCCCCceEecC--------CCceee
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN---VFHRDLKPKNILANA--------DCKLKI 167 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILv~~--------~~~lKL 167 (599)
..+|+||||++ ++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 46899999998 58888875 457999999999999999999999999 999999999999986 778999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
+|||+++....... ....+|+.|+|||++.+ ..++.++|||||||++++|++|+.||.+.+.......+...
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 229 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN- 229 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-
Confidence 99999976533221 24578999999999876 67899999999999999999999999887654433222110
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
... .......
T Consensus 230 -------------------------------------------------------------------~~~---~~~~~~~ 239 (271)
T 3dtc_A 230 -------------------------------------------------------------------KLA---LPIPSTC 239 (271)
T ss_dssp -------------------------------------------------------------------CCC---CCCCTTC
T ss_pred -------------------------------------------------------------------CCC---CCCCccc
Confidence 000 0112356
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
++.+.+||.+||+.||.+|||+.|+|+|
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 7889999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.38 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=201.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEE----EEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKV----AIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~V----AIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
-..++|+++++||+|+||.||+|.+..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence 45689999999999999999999999888765 66666432 2334567888999999999999999999998543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
..++|++++. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 -----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 90 -----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp -----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred -----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 3788999998 6999999874 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+........ .......+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 165 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---- 237 (327)
T 3lzb_A 165 KLLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---- 237 (327)
T ss_dssp ----------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred eEccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 875432221 12234457889999999977 679999999999999999999 9999988766554333321110
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
....+..++.+.
T Consensus 238 --------------------------------------------------------------------~~~~~~~~~~l~ 249 (327)
T 3lzb_A 238 --------------------------------------------------------------------LPQPPICTIDVY 249 (327)
T ss_dssp --------------------------------------------------------------------CCCCTTBCHHHH
T ss_pred --------------------------------------------------------------------CCCCccCCHHHH
Confidence 011234678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 007542 333 RLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+||.+||..||.+|||+.|+|+.
T Consensus 250 ~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 250 MIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999973
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=372.24 Aligned_cols=262 Identities=27% Similarity=0.389 Sum_probs=193.8
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~ 98 (599)
...+.|.+.++||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++..
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----- 80 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT----- 80 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----
Confidence 45678888999999999999875 4578999999998642 245677999999876 89999999998843
Q ss_pred CccEEEEEecCCccHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC---------
Q 007542 99 FKDIYVVFELMESDLHQVIKANDDL-------TPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--------- 162 (599)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l-------se~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~--------- 162 (599)
...+||||||++++|.+++...... ++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp SSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred CCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence 3579999999999999999876433 233457899999999999999999999999999999754
Q ss_pred ----CceeeecccccccccCCCCC-cccccccccCccccCccccccc-----cCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 007542 163 ----CKLKICDFGLARVAFNDTPT-AIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAELLT-GKPLF 231 (599)
Q Consensus 163 ----~~lKL~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~-----~~~~s~~~DIWSlG~Il~eLlt-G~~pF 231 (599)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++|||||||++|+|++ |+.||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999876433221 1112456899999999998641 1468899999999999999999 99999
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHh
Q 007542 232 PGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS 311 (599)
Q Consensus 232 ~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~ 311 (599)
.+..... ...+......+
T Consensus 241 ~~~~~~~-~~i~~~~~~~~------------------------------------------------------------- 258 (434)
T 2rio_A 241 GDKYSRE-SNIIRGIFSLD------------------------------------------------------------- 258 (434)
T ss_dssp CSTTTHH-HHHHHTCCCCC-------------------------------------------------------------
T ss_pred CCchhhH-HHHhcCCCCcc-------------------------------------------------------------
Confidence 7654322 11111000000
Q ss_pred cccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccC
Q 007542 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 312 ~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
... ......+++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 259 -----~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 259 -----EMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp -----CCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred -----ccc-ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 000 0000123567899999999999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.70 Aligned_cols=252 Identities=18% Similarity=0.289 Sum_probs=203.2
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCC-------cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG-------EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg-------~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~ 93 (599)
..++|++.+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3579999999999999999999998887 47999998643 23456778999999999999999999999954
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc-------
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK------- 164 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~~-lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~------- 164 (599)
. ...|+||||+. ++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 84 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 G-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp T-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred C-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 3 45799999998 699999987754 999999999999999999999999999999999999999887
Q ss_pred -eeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCCChhhHHHH
Q 007542 165 -LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDI 242 (599)
Q Consensus 165 -lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG-~~pF~g~~~~~~l~~ 242 (599)
+||+|||++...... ....+|..|+|||++.+. ..++.++|||||||++|+|++| .++|.+.+.......
T Consensus 159 ~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 999999998654211 234678899999998652 4689999999999999999995 566655443322211
Q ss_pred HHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcC
Q 007542 243 MTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322 (599)
Q Consensus 243 I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 322 (599)
+.. . ..
T Consensus 231 ~~~-------------------------------------------------------------------~-------~~ 236 (289)
T 4fvq_A 231 YED-------------------------------------------------------------------R-------HQ 236 (289)
T ss_dssp HHT-------------------------------------------------------------------T-------CC
T ss_pred hhc-------------------------------------------------------------------c-------CC
Confidence 110 0 00
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 323 ~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
.....++.+.+||.+||+.||.+|||+.|+|+| |..+..
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~l~~ 275 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD--LNSLFT 275 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH--HHTCC-
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH--HHHhcC
Confidence 112345668999999999999999999999996 555543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=350.32 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=206.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPS 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~-----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s 95 (599)
.++|++.+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 5789999999999999999999987765 79999997432 334567789999999999 89999999999854
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN--------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~--------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++
T Consensus 122 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 ---GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 346899999998 5999999752 3589999999999999999999999999999999999999
Q ss_pred CCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhH
Q 007542 161 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQ 239 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~ 239 (599)
.++.+||+|||+++....... ........+|..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999986543322 112234567889999999876 578999999999999999998 9999987654433
Q ss_pred HHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC
Q 007542 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP 319 (599)
Q Consensus 240 l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~ 319 (599)
+..+.... . ..
T Consensus 276 ~~~~~~~~----------------------------------------------------------------~----~~- 286 (333)
T 2i1m_A 276 FYKLVKDG----------------------------------------------------------------Y----QM- 286 (333)
T ss_dssp HHHHHHHT----------------------------------------------------------------C----CC-
T ss_pred HHHHHhcC----------------------------------------------------------------C----CC-
Confidence 22221100 0 00
Q ss_pred CcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 320 FSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 320 ~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
......++.+.+||.+||+.||.+|||+.|++++
T Consensus 287 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 287 --AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 0113457889999999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.90 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=202.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEE--EEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKV--AIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~V--AIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~ 98 (599)
.++|++.+.||+|+||.||+|++..++..+ |||.+... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----- 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----- 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----
Confidence 378999999999999999999999999866 99988642 2233456788999999999 89999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND----------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA 161 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~----------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~ 161 (599)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 357999999998 59999998654 6999999999999999999999999999999999999999
Q ss_pred CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHH
Q 007542 162 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQL 240 (599)
Q Consensus 162 ~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l 240 (599)
++.+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+..
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCccccccc----cccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9999999999997432111 1133456888999999876 578999999999999999998 99999887654433
Q ss_pred HHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCC
Q 007542 241 DIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320 (599)
Q Consensus 241 ~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 320 (599)
..+.. ...
T Consensus 252 ~~~~~---------------------------------------------------------------------~~~--- 259 (327)
T 1fvr_A 252 EKLPQ---------------------------------------------------------------------GYR--- 259 (327)
T ss_dssp HHGGG---------------------------------------------------------------------TCC---
T ss_pred HHhhc---------------------------------------------------------------------CCC---
Confidence 22211 000
Q ss_pred cCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 321 ~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
.......++.+.+||.+||..||.+|||++|+|+|
T Consensus 260 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123567889999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=342.27 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=203.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
...+|++.++||+|+||.||+|.+..++ ..||+|++.. .........+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 98 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS--- 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---
Confidence 4578999999999999999999976543 4689999874 23445567889999999999999999999997533
Q ss_pred CCccEEEEEecCCc-cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELMES-DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~g-~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
....|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 -EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred -CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 2467999999995 999999864 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC-CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 176 AFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 176 ~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
...... .........+|+.|+|||++.+ ..++.++|||||||++++|++ |.++|.+.+..+....+......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---- 251 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---- 251 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC----
T ss_pred ccccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC----
Confidence 533221 1112244577889999999976 678999999999999999999 77888876655543333211100
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
......++.+.+
T Consensus 252 --------------------------------------------------------------------~~~~~~~~~l~~ 263 (298)
T 3f66_A 252 --------------------------------------------------------------------LQPEYCPDPLYE 263 (298)
T ss_dssp --------------------------------------------------------------------CCCTTCCHHHHH
T ss_pred --------------------------------------------------------------------CCCccCCHHHHH
Confidence 011246788999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 007542 334 LLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~ 354 (599)
||.+||+.||.+|||+.|+++
T Consensus 264 li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 264 VMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.06 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=204.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.-+|.+.++||+|+||+||+|.+..++. .||+|++.. .......+.+.+|+.+|+.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 95 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--- 95 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS---
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC---
Confidence 4467888999999999999999766555 799999874 234455678899999999999999999999995432
Q ss_pred CccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
...|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 96 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 96 -GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp -SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred -CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 24589999997 6999999874 57899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCC-CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 177 FNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 177 ~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
..... .........+|..|+|||.+.+ ..++.++|||||||++|+|++ |.++|.+.+..+....+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~------ 246 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR------ 246 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC------
T ss_pred cCCcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC------
Confidence 32211 1112234577899999999977 678999999999999999999 5666766655444333321110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
. ......++.+.+|
T Consensus 247 ---------------------------------------------------------------~---~~~~~~~~~l~~l 260 (298)
T 3pls_A 247 ---------------------------------------------------------------L---PQPEYCPDSLYQV 260 (298)
T ss_dssp ---------------------------------------------------------------C---CCCTTCCHHHHHH
T ss_pred ---------------------------------------------------------------C---CCCccchHHHHHH
Confidence 0 1123467889999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 007542 335 LERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~ 354 (599)
|.+||+.||.+|||+.++|+
T Consensus 261 i~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 261 MQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHH
Confidence 99999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.58 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=197.4
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCc-cCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDI-FEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~-~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++||||+++++++..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----- 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence 4567899999999999999999999999999999999743 2334456778899999999999999999999854
Q ss_pred CccEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 99 FKDIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 99 ~~~lylV~E~~~g-~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 3478999999995 99998864 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh--hHHHHHHHhcCCCC
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV--HQLDIMTDLLGTPS 251 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~--~~l~~I~~~lg~p~ 251 (599)
+....... ......+++.|+|||++.+ ..++.++|||||||++++|++|+.||.+.... .....+.
T Consensus 184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 251 (310)
T 2wqm_A 184 RFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------- 251 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH-------
T ss_pred eeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh-------
Confidence 76533221 1234578999999999876 67899999999999999999999999764321 1111000
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
. ....+ ......++.+
T Consensus 252 -----------------------------------------------------------~---~~~~~--~~~~~~~~~l 267 (310)
T 2wqm_A 252 -----------------------------------------------------------Q---CDYPP--LPSDHYSEEL 267 (310)
T ss_dssp -----------------------------------------------------------T---TCSCC--CCTTTSCHHH
T ss_pred -----------------------------------------------------------c---ccCCC--CcccccCHHH
Confidence 0 00000 0123578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+||.+||..||.+|||+.+++++ ++.+
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~--l~~l 295 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDV--AKRM 295 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH--HHHH
Confidence 999999999999999999999973 4443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=349.68 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=204.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 36899999999999999999999999999999999854 34456678889999999999999999999986321 2335
Q ss_pred cEEEEEecCCc-cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 101 DIYVVFELMES-DLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 78999999995 99999875 46799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCc------ccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 007542 176 AFNDTPTA------IFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (599)
Q Consensus 176 ~~~~~~~~------~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg 248 (599)
........ .......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---------- 253 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---------- 253 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT----------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc----------
Confidence 42111100 011234679999999998652 1237889999999999999999999995311000
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
. .....+.. .... ...+..+
T Consensus 254 ~------------------------------------------------------~~~~~~~~---~~~~---~~~~~~~ 273 (317)
T 2buj_A 254 D------------------------------------------------------SVALAVQN---QLSI---PQSPRHS 273 (317)
T ss_dssp S------------------------------------------------------CHHHHHHC---C--C---CCCTTSC
T ss_pred c------------------------------------------------------hhhHHhhc---cCCC---CccccCC
Confidence 0 00000000 0000 1124578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+.+.+||.+||+.||.+|||++|+|+|
T Consensus 274 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 274 SALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 899999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=369.91 Aligned_cols=262 Identities=18% Similarity=0.189 Sum_probs=199.0
Q ss_pred ccccCCC-CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCC-CCcccc-----
Q 007542 16 FTEYGEG-SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRH-PDIVEI----- 87 (599)
Q Consensus 16 ~~~~~~~-~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~H-pnIv~l----- 87 (599)
..+.+.. ..|.+.++||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.++| .|+..+
T Consensus 70 ~s~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 70 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp EESSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred eccCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 3344443 34899999999999999999999999999999987322 222335678899999999987 332211
Q ss_pred ----ceeec------------CCCcCCCccEEEEEecCCccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHhhh
Q 007542 88 ----KHILL------------PPSRREFKDIYVVFELMESDLHQVIKA-------NDDLTPEHYQFFLYQLLRGLKYIHT 144 (599)
Q Consensus 88 ----~~v~~------------~~s~~~~~~lylV~E~~~g~L~~~i~~-------~~~lse~~i~~i~~QIl~aL~yLHs 144 (599)
.++.. .........++++|+++.++|.+++.. ...+++..+..++.||+.||.|||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 11111 111111345799999999999998852 2357788999999999999999999
Q ss_pred CceEeccCCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCcccccc--------ccCCCCcchhhHh
Q 007542 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWS 216 (599)
Q Consensus 145 ~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~s~~~DIWS 216 (599)
+||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 99999999999999999999999999998764322 244577 99999999831 1145888999999
Q ss_pred HHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHH
Q 007542 217 IGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLIL 296 (599)
Q Consensus 217 lG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 296 (599)
|||++|+|++|+.||.+.+.......
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~~~------------------------------------------------------ 328 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGSEW------------------------------------------------------ 328 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCSGG------------------------------------------------------
T ss_pred HHHHHHHHHHCCCCCCCcchhhhHHH------------------------------------------------------
Confidence 99999999999999987543221100
Q ss_pred hhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 297 HCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 297 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.......+++.+.+||.+||+.||.+|||+.|+|+||||+.+
T Consensus 329 -----------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 329 -----------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp -----------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -----------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 011123567899999999999999999999999999999754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=371.67 Aligned_cols=249 Identities=20% Similarity=0.411 Sum_probs=208.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
..+|++.+.||+|+||.||+|.++.++..||||+++... .....+.+|+.+|+.++||||+++++++... ..
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----Cc
Confidence 468999999999999999999999999999999997532 3467789999999999999999999999543 46
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+||||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999999 6999999864 3589999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... .......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+.......+....
T Consensus 371 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 436 (495)
T 1opk_A 371 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 436 (495)
T ss_dssp CCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred Cce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 221 11233456788999999976 678999999999999999999 999999877554433332100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. .......++.+.+||.+
T Consensus 437 -----------------------------------------------------------~---~~~~~~~~~~l~~li~~ 454 (495)
T 1opk_A 437 -----------------------------------------------------------R---MERPEGCPEKVYELMRA 454 (495)
T ss_dssp -----------------------------------------------------------C---CCCCTTCCHHHHHHHHH
T ss_pred -----------------------------------------------------------C---CCCCCCCCHHHHHHHHH
Confidence 0 01123567889999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||.+|||+.++++
T Consensus 455 cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 455 CWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCcChhHCcCHHHHHH
Confidence 99999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=338.94 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=204.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|.+. ++..||||++.... .....+.+|+.+|+.++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 479999999999999999999875 67789999997432 235678899999999999999999999842 24
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 799999997 69999997543 699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... .......++..|+|||++.+ ..++.++|||||||++++|++ |+.||.+.+..+.+..+....
T Consensus 162 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 227 (279)
T 1qpc_A 162 NEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------- 227 (279)
T ss_dssp SCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred ccc--ccccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc----------
Confidence 221 11234467788999999876 578899999999999999999 999998876554433332110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. .......++.+.+||.+
T Consensus 228 -----------------------------------------------------------~---~~~~~~~~~~l~~li~~ 245 (279)
T 1qpc_A 228 -----------------------------------------------------------R---MVRPDNCPEELYQLMRL 245 (279)
T ss_dssp -----------------------------------------------------------C---CCCCTTCCHHHHHHHHH
T ss_pred -----------------------------------------------------------C---CCCcccccHHHHHHHHH
Confidence 0 01113567889999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||.+|||++++++
T Consensus 246 ~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 246 CWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HhccChhhCCCHHHHHH
Confidence 99999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=343.91 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=192.7
Q ss_pred cCCCCceEEE-EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHH-HhcCCCCccccceeecCCCc
Q 007542 19 YGEGSRYKIE-EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL-RLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 19 ~~~~~rY~i~-~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL-~~l~HpnIv~l~~v~~~~s~ 96 (599)
....++|.++ ++||+|+||.||+|.++.+++.||||++.. ...+.+|+.++ +.++||||+++++++....
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~- 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY- 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-
Confidence 3456778887 789999999999999999999999999853 23566899887 6668999999999985421
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---CCceeeecc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDF 170 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~~~lKL~DF 170 (599)
.+...+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 22457899999998 59999998764 6999999999999999999999999999999999999998 788999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
|++.... + ..++.++|||||||++|+|++|++||.+.+.......+...
T Consensus 165 g~a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~---- 213 (299)
T 3m2w_A 165 GFAKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---- 213 (299)
T ss_dssp TTCEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS----
T ss_pred ccccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH----
Confidence 9886431 1 35778999999999999999999999775432211000000
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
+...........+..+++.
T Consensus 214 -------------------------------------------------------------~~~~~~~~~~~~~~~~~~~ 232 (299)
T 3m2w_A 214 -------------------------------------------------------------IRMGQYEFPNPEWSEVSEE 232 (299)
T ss_dssp -------------------------------------------------------------SCTTCCSSCHHHHTTSCHH
T ss_pred -------------------------------------------------------------HhhccccCCchhcccCCHH
Confidence 0000000000112457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
+.+||.+||+.||.+|||++|+|+||||++....
T Consensus 233 ~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~ 266 (299)
T 3m2w_A 233 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence 9999999999999999999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=355.65 Aligned_cols=206 Identities=16% Similarity=0.203 Sum_probs=170.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCC--------CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRT--------GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~t--------g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
.+++|++.+.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+|+.++||||+++++.+.
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 368999999999999999999999884 889999998642 35779999999999999998543321
Q ss_pred CC-----------CcCCCccEEEEEecCCccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe
Q 007542 93 PP-----------SRREFKDIYVVFELMESDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (599)
Q Consensus 93 ~~-----------s~~~~~~lylV~E~~~g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv 159 (599)
.. ...+...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 10 00123578999999988999999986 689999999999999999999999999999999999999
Q ss_pred cCCC--ceeeecccccccccCCCCC----cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 007542 160 NADC--KLKICDFGLARVAFNDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG 233 (599)
Q Consensus 160 ~~~~--~lKL~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g 233 (599)
+.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9998 8999999999765432211 112244589999999999987 5789999999999999999999999987
Q ss_pred CC
Q 007542 234 KN 235 (599)
Q Consensus 234 ~~ 235 (599)
..
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 54
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=356.18 Aligned_cols=207 Identities=26% Similarity=0.373 Sum_probs=176.6
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
-...++|++.+.||+|+||.||+|.+ .+|+.||||++... .......+.+|+.+|+.++||||+++++++..
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 106 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE----- 106 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----
Confidence 34568999999999999999999986 47899999998643 33456778999999999999999999999843
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 173 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla 173 (599)
...+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 346899999998 59999886543 5899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCCh
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV 236 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~ 236 (599)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 187 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 187 KKGTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp EECSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 864322211 12244568999999999876 5789999999999999999999999987543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=342.90 Aligned_cols=261 Identities=22% Similarity=0.316 Sum_probs=201.5
Q ss_pred ccccCCCCceEEEEEeeecCceEEEEEEECC-CCc--EEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceee
Q 007542 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTR-TGE--KVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHIL 91 (599)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~-tg~--~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~ 91 (599)
.+..-..++|++++.||+|+||+||+|.+.. ++. .||||+++.... .......+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 11 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3444567899999999999999999998643 333 689998864322 334567889999999999999999999998
Q ss_pred cCCCcCCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeec
Q 007542 92 LPPSRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICD 169 (599)
Q Consensus 92 ~~~s~~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~D 169 (599)
... .+++||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 91 ~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 91 LTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp CSS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred ccC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcc
Confidence 543 3789999998 6999999764 5799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcC
Q 007542 170 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLG 248 (599)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg 248 (599)
||+++................+|..|+|||++.+ ..++.++|||||||++++|++ |+.||.+.+....+..+.....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC
Confidence 9999876443332222334567889999999876 578899999999999999999 9999988776554433321100
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
........+
T Consensus 243 -----------------------------------------------------------------------~~~~~~~~~ 251 (291)
T 1u46_A 243 -----------------------------------------------------------------------RLPRPEDCP 251 (291)
T ss_dssp -----------------------------------------------------------------------CCCCCTTCC
T ss_pred -----------------------------------------------------------------------CCCCCcCcC
Confidence 001123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+.+.+||.+||..||.+|||+.+++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 899999999999999999999999973
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=338.72 Aligned_cols=249 Identities=29% Similarity=0.388 Sum_probs=204.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC------
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS------ 95 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s------ 95 (599)
..+|++++.||+|+||.||+|.+..+|+.||||++.... ..+.+|+.+|+.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 468999999999999999999999999999999996421 24668999999999999999999874311
Q ss_pred -----cCCCccEEEEEecCCc-cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceee
Q 007542 96 -----RREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKI 167 (599)
Q Consensus 96 -----~~~~~~lylV~E~~~g-~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL 167 (599)
......+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 1123568999999995 999999754 57999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhc
Q 007542 168 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLL 247 (599)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~l 247 (599)
+|||++........ .....+|+.|+|||++.+ ..++.++|||||||++++|++|..+|.... ..
T Consensus 164 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~-------- 227 (284)
T 2a19_B 164 GDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS--KF-------- 227 (284)
T ss_dssp CCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HH--------
T ss_pred Ccchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HH--------
Confidence 99999987643321 234579999999999976 678999999999999999999987763210 00
Q ss_pred CCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCC
Q 007542 248 GTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNA 327 (599)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 327 (599)
...+... .....+
T Consensus 228 -------------------------------------------------------------~~~~~~~------~~~~~~ 240 (284)
T 2a19_B 228 -------------------------------------------------------------FTDLRDG------IISDIF 240 (284)
T ss_dssp -------------------------------------------------------------HHHHHTT------CCCTTS
T ss_pred -------------------------------------------------------------HHHhhcc------cccccC
Confidence 0000000 011346
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 007542 328 NPLALRLLERMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 328 s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
++.+.+||.+||..||.+|||+.|+++|.|.-
T Consensus 241 ~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 241 DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 78899999999999999999999999997754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=348.56 Aligned_cols=270 Identities=24% Similarity=0.344 Sum_probs=206.3
Q ss_pred CCCce-EEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 21 EGSRY-KIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 21 ~~~rY-~i~~~IG~G~~g~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
..++| ++++.||+|+||.||++. +..+++.||||+++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA- 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC-
Confidence 45566 999999999999997774 4558899999999753 2344567789999999999999999999998643
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
+...+|+||||++ ++|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 106 --~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 106 --GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp --TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred --CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 2357899999998 5999999765 49999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
................+|..|+|||++.+ ..++.++|||||||++++|++|..||...... .....+.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~- 254 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQ- 254 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHH-
T ss_pred cccccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccc-
Confidence 76543322222345678889999999976 57889999999999999999999998653211 11111111110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
.........+...... ......++.+.+|
T Consensus 255 ------------------------------------------------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 283 (318)
T 3lxp_A 255 ------------------------------------------------MTVLRLTELLERGERL---PRPDKCPAEVYHL 283 (318)
T ss_dssp ------------------------------------------------HHHHHHHHHHHTTCCC---CCCTTCCHHHHHH
T ss_pred ------------------------------------------------hhHHHHHHHHhcccCC---CCCccccHHHHHH
Confidence 0001111111111111 1234578999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 007542 335 LERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~ 354 (599)
|.+||+.||.+|||++|+++
T Consensus 284 i~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 284 MKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=361.82 Aligned_cols=243 Identities=23% Similarity=0.390 Sum_probs=202.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|.+. |+.||||+++.. ...+.+.+|+.+|+.++||||+++++++... ...
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~ 261 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 261 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCc
Confidence 578999999999999999999764 789999999753 2456788999999999999999999998543 236
Q ss_pred EEEEEecCC-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 899999998 599999987653 79999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..+.+..
T Consensus 342 ~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 403 (450)
T 1k9a_A 342 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------- 403 (450)
T ss_dssp -----------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC----------
T ss_pred cc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 11 22356889999999976 679999999999999999998 999998876554433332100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. .......++.+.+||.+
T Consensus 404 -----------------------------------------------------------~---~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 404 -----------------------------------------------------------K---MDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp -----------------------------------------------------------C---CCCCTTCCHHHHHHHHH
T ss_pred -----------------------------------------------------------C---CCCCCcCCHHHHHHHHH
Confidence 0 01123578899999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||.+|||+.++++
T Consensus 422 cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 422 CWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcCCChhHCcCHHHHHH
Confidence 99999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=361.95 Aligned_cols=207 Identities=25% Similarity=0.430 Sum_probs=175.9
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..+++|++.++||+|+||.||+|++..+|+.||||++..... ......+.+|+.+|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---T 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---T
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---C
Confidence 457899999999999999999999999999999999974322 233567789999999999999999999985432 2
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe----cCCCceeeeccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA----NADCKLKICDFG 171 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv----~~~~~lKL~DFG 171 (599)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 46899999998 59999997643 39999999999999999999999999999999999999 778889999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccc------cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~------~~~~s~~~DIWSlG~Il~eLltG~~pF~g~ 234 (599)
+++...... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.
T Consensus 162 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 162 AARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp GCEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 998753322 23456799999999987531 035778999999999999999999999754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=376.34 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=204.0
Q ss_pred ceEEE-EEeeecCceEEEEEEE--CCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 24 RYKIE-EVIGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 24 rY~i~-~~IG~G~~g~Vy~a~~--~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.+.+. +.||+|+||.||+|.+ +.+++.||||+++...........+.+|+.+|+.++||||+++++++.. .
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~ 442 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------E 442 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence 34443 4899999999999954 5677899999998665555567889999999999999999999999842 2
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 4799999999 699999998889999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.......+...+|..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+.......+.....
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---------- 590 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------- 590 (635)
T ss_dssp ------------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred ccccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 322222334457788999999976 679999999999999999998 9999998876655444432110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.......++.+.+||.+|
T Consensus 591 --------------------------------------------------------------~~~p~~~~~~l~~li~~c 608 (635)
T 4fl3_A 591 --------------------------------------------------------------MGCPAGCPREMYDLMNLC 608 (635)
T ss_dssp --------------------------------------------------------------CCCCTTCCHHHHHHHHHH
T ss_pred --------------------------------------------------------------CCCCCCCCHHHHHHHHHH
Confidence 011235778999999999
Q ss_pred cccCCCCCCCHHHHhc
Q 007542 339 LAFEPKDRPTAEEALA 354 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~ 354 (599)
|+.||.+|||++++++
T Consensus 609 l~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 609 WTYDVENRPGFAAVEL 624 (635)
T ss_dssp TCSSTTTSCCHHHHHH
T ss_pred cCCCHhHCcCHHHHHH
Confidence 9999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.42 Aligned_cols=243 Identities=23% Similarity=0.382 Sum_probs=195.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|.+ +|+.||||+++.. ...+.+.+|+.+++.++||||+++++++... ...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 89 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 89 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCc
Confidence 58999999999999999999976 4889999998642 3456788999999999999999999997533 236
Q ss_pred EEEEEecCCc-cHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~--lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+++ +|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999985 99999986543 89999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ....++..|+|||++.+ ..++.++|||||||++++|++ |++||.+.+..+....+...
T Consensus 170 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~----------- 230 (278)
T 1byg_A 170 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------- 230 (278)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------
T ss_pred cc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------
Confidence 21 23367889999999976 678999999999999999998 99999876654433222110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. .......++.+.+||++
T Consensus 231 ----------------------------------------------------------~~---~~~~~~~~~~l~~li~~ 249 (278)
T 1byg_A 231 ----------------------------------------------------------YK---MDAPDGCPPAVYEVMKN 249 (278)
T ss_dssp ----------------------------------------------------------CC---CCCCTTCCHHHHHHHHH
T ss_pred ----------------------------------------------------------CC---CCCcccCCHHHHHHHHH
Confidence 00 11224578899999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||.+|||+.|+++
T Consensus 250 ~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HhcCChhhCCCHHHHHH
Confidence 99999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=348.92 Aligned_cols=207 Identities=24% Similarity=0.338 Sum_probs=163.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHH--HHhcCCCCccccceeecCCCcCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKL--LRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~i--L~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
..++|++++.||+|+||.||+|.+ +++.||||++... ....+..|..+ +..++||||+++++.+......+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 357999999999999999999965 7899999998632 23334444444 55689999999998665433344
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC---------ceEeccCCCCceEecCCCceeee
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA---------NVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
...+|+||||++ ++|.+++.... .++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 557899999997 69999997654 58999999999999999999999 99999999999999999999999
Q ss_pred cccccccccCCCC-----CcccccccccCccccCcccccccc-----CCCCcchhhHhHHHHHHHHHhCC-CCCCCCC
Q 007542 169 DFGLARVAFNDTP-----TAIFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAELLTGK-PLFPGKN 235 (599)
Q Consensus 169 DFGla~~~~~~~~-----~~~~~~~~~gt~~Y~APE~l~~~~-----~~~s~~~DIWSlG~Il~eLltG~-~pF~g~~ 235 (599)
|||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|+|++|. ++|++.+
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 9999987543211 111223567999999999986521 24567899999999999999995 5555544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.34 Aligned_cols=209 Identities=26% Similarity=0.392 Sum_probs=175.5
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~--~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
.|.....|...+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 26 ~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 101 (307)
T 2nru_A 26 NFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-- 101 (307)
T ss_dssp TTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--
Confidence 355566677779999999999999975 68899999997532 233446788999999999999999999999854
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKA---NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~---~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 102 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg 178 (307)
T 2nru_A 102 ---GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFG 178 (307)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecc
Confidence 346899999997 699999974 3469999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV 237 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~ 237 (599)
+++....... ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+....
T Consensus 179 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 179 LARASEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp TCEECCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cccccccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9986543221 112234679999999999865 4789999999999999999999999876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.74 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=204.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------Cc
Confidence 578999999999999999999875 57789999997532 346788999999999999999999999842 35
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 799999998 69999997542 689999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... .......++..|+|||++.. ..++.++|||||||+++||++ |+.||.+.+..+.+..+......
T Consensus 337 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------- 404 (454)
T 1qcf_A 337 NEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------- 404 (454)
T ss_dssp HHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC--------
T ss_pred Cce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 111 11123456788999999976 579999999999999999999 99999987765554443321100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
......++.+.+||.+
T Consensus 405 ----------------------------------------------------------------~~~~~~~~~l~~li~~ 420 (454)
T 1qcf_A 405 ----------------------------------------------------------------PRPENCPEELYNIMMR 420 (454)
T ss_dssp ----------------------------------------------------------------CCCTTSCHHHHHHHHH
T ss_pred ----------------------------------------------------------------CCCCCCCHHHHHHHHH
Confidence 0113567889999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||..||.+|||++++++
T Consensus 421 cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 421 CWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhHCcCHHHHHH
Confidence 99999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.86 Aligned_cols=203 Identities=22% Similarity=0.401 Sum_probs=172.3
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
....++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+|+.++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 99 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTP---- 99 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS----
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecC----
Confidence 34578999999999999999999974 47899999999753221 1223678999999999999999999999543
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHhhhC---ceEeccCCCCceEecCCCceeeecc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND----DLTPEHYQFFLYQLLRGLKYIHTA---NVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~----~lse~~i~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
...++||||+. ++|.+++.... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 100 -TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp -SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred -CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 46799999998 59999998653 499999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFP 232 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~ 232 (599)
|+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 179 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 179 GLAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp SSCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCccc
Confidence 99987543222 22345679999999999876 578999999999999999999999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.57 Aligned_cols=271 Identities=22% Similarity=0.364 Sum_probs=208.3
Q ss_pred CCCceEEEEEeeecCceEEEEEE----ECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAY----DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~----~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..++|++++.||+|+||.||+|. +..+|+.||||++... .......+.+|+.+|+.++||||+++++++....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG- 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC-
Confidence 45789999999999999999998 4678999999999752 3445678899999999999999999999985432
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
...+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 116 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 --RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred --CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 246899999998 5999999876 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
................++..|+|||++.+ ..++.++|||||||++++|++|..+|.... ..+.+..+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchh
Confidence 76443322122234567788999999876 578899999999999999999998875421 11112222211100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
+. .......+...... ......++.+.+|
T Consensus 267 ~~------------------------------------------------~~~~~~~~~~~~~~---~~~~~~~~~l~~l 295 (326)
T 2w1i_A 267 MI------------------------------------------------VFHLIELLKNNGRL---PRPDGCPDEIYMI 295 (326)
T ss_dssp HH------------------------------------------------HHHHHHHHHTTCCC---CCCTTCCHHHHHH
T ss_pred hh------------------------------------------------HHHHHHHhhcCCCC---CCCCcccHHHHHH
Confidence 00 00111111111111 1234578999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 007542 335 LERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~ 354 (599)
|.+||+.||.+|||+.|+++
T Consensus 296 i~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 296 MTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=344.11 Aligned_cols=209 Identities=27% Similarity=0.371 Sum_probs=164.8
Q ss_pred CcccccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc--CCCCccccce
Q 007542 12 DVDFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLL--RHPDIVEIKH 89 (599)
Q Consensus 12 ~~~~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l--~HpnIv~l~~ 89 (599)
.......-...++|++++.||+|+||.||+|.+. ++.||||++.. .......+|..++..+ +||||+++++
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 3444444455689999999999999999999874 89999999853 2234445666665554 8999999999
Q ss_pred eecCCCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC--------ceEeccCCCCceEec
Q 007542 90 ILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA--------NVFHRDLKPKNILAN 160 (599)
Q Consensus 90 v~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILv~ 160 (599)
++.... .....+|+||||+. ++|.++++.. .+++..++.++.||+.||.|||+. ||+||||||+|||++
T Consensus 99 ~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 99 ADIKGT-GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEEESC-GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred EEccCC-CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 986542 22357999999998 5999999765 699999999999999999999999 999999999999999
Q ss_pred CCCceeeecccccccccCCCCC-cccccccccCccccCccccccccCCCCc------chhhHhHHHHHHHHHhCCCCC
Q 007542 161 ADCKLKICDFGLARVAFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTP------AIDIWSIGCIFAELLTGKPLF 231 (599)
Q Consensus 161 ~~~~lKL~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~s~------~~DIWSlG~Il~eLltG~~pF 231 (599)
.++.+||+|||+++........ .......+||+.|+|||++.+ ..+.. ++|||||||++|+|++|..+|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 9999999999999765432221 111235689999999999876 33444 399999999999999994433
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=337.76 Aligned_cols=244 Identities=30% Similarity=0.458 Sum_probs=193.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|++.+.||+|+||.||+|.+ +++.||||++.. ......+.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------- 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN------- 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------
Confidence 357899999999999999999976 478999999863 2456778899999999999999999998742
Q ss_pred cEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhh---CceEeccCCCCceEecCCCc-eeeecccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHT---ANVFHRDLKPKNILANADCK-LKICDFGL 172 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs---~gIvHrDLKP~NILv~~~~~-lKL~DFGl 172 (599)
.+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 3689999998 59999998765 47899999999999999999999 89999999999999998887 79999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
+...... .....||+.|+|||++.+ ..++.++|||||||++++|++|+.||.+...... ..+.
T Consensus 153 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-------- 215 (307)
T 2eva_A 153 ACDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMW-------- 215 (307)
T ss_dssp ------------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHH--------
T ss_pred ccccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHH--------
Confidence 9754322 134478999999999977 6789999999999999999999999975432110 0000
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
...... ........++.+.
T Consensus 216 ----------------------------------------------------------~~~~~~---~~~~~~~~~~~l~ 234 (307)
T 2eva_A 216 ----------------------------------------------------------AVHNGT---RPPLIKNLPKPIE 234 (307)
T ss_dssp ----------------------------------------------------------HHHTTC---CCCCBTTCCHHHH
T ss_pred ----------------------------------------------------------HHhcCC---CCCcccccCHHHH
Confidence 000000 0112345788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 007542 333 RLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+||.+||+.||.+|||++|++++
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999983
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.70 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=196.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
..+|++.++||+|+||.||+|.+..++ ..||||.++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---- 162 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---- 162 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----
Confidence 356899999999999999999876443 46899988642 3445667899999999999999999999987432
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
....|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 246799999999 59999998654 6899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCC-cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 177 FNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 177 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...... ........+|..|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-------- 312 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-------- 312 (373)
T ss_dssp ---------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--------
T ss_pred cccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--------
Confidence 332211 111234567889999999976 678999999999999999999 78899876654433322210
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
... ......++.+.+|
T Consensus 313 -------------------------------------------------------------~~~---~~p~~~~~~l~~l 328 (373)
T 3c1x_A 313 -------------------------------------------------------------RRL---LQPEYCPDPLYEV 328 (373)
T ss_dssp -------------------------------------------------------------CCC---CCCTTCCHHHHHH
T ss_pred -------------------------------------------------------------CCC---CCCCCCCHHHHHH
Confidence 000 0113467889999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 007542 335 LERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~H 355 (599)
|.+||..||.+|||+.|++++
T Consensus 329 i~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 329 MLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=359.36 Aligned_cols=247 Identities=27% Similarity=0.391 Sum_probs=199.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 4789999999999999999999864 4679999997532 235678899999999999999999999843 35
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 799999998 5999999643 4699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+.....
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~--------- 399 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 399 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 2211 1223456788999999876 679999999999999999999 9999998776554443321100
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. ...+..++.+.+||.+
T Consensus 400 ------------------------------------------------------------~---~~~~~~~~~l~~li~~ 416 (452)
T 1fmk_A 400 ------------------------------------------------------------M---PCPPECPESLHDLMCQ 416 (452)
T ss_dssp ------------------------------------------------------------C---CCCTTSCHHHHHHHHH
T ss_pred ------------------------------------------------------------C---CCCCCCCHHHHHHHHH
Confidence 0 1113567889999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 007542 338 MLAFEPKDRPTAEEALA 354 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~ 354 (599)
||+.||.+|||++++++
T Consensus 417 cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 417 CWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=361.07 Aligned_cols=259 Identities=19% Similarity=0.260 Sum_probs=204.6
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.+++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+. ....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~ 76 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGD 76 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETT
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCC
Confidence 468999999999999999999999999999999988643222 24678999999999866555555543 2335
Q ss_pred cEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe---cCCCceeeecccccccc
Q 007542 101 DIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv---~~~~~lKL~DFGla~~~ 176 (599)
..||||||+.++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 77 ~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 7899999998899999985 4579999999999999999999999999999999999999 68899999999999876
Q ss_pred cCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 177 FNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
....... ......+||..|+|||++.+ ..++.++||||||||||+|++|+.||.+.........+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---- 230 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---- 230 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----
T ss_pred cCCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----
Confidence 5432211 11235689999999999987 6799999999999999999999999988654333222221100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
..... .+......+++.+.
T Consensus 231 --------------------------------------------------~~~~~-----------~~~~l~~~~p~~l~ 249 (483)
T 3sv0_A 231 --------------------------------------------------KKVAT-----------SIEALCRGYPTEFA 249 (483)
T ss_dssp --------------------------------------------------HHHHS-----------CHHHHHTTSCHHHH
T ss_pred --------------------------------------------------ccccc-----------cHHHHhcCCcHHHH
Confidence 00000 00011135678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 007542 333 RLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
+||.+||..||.+||+++++++
T Consensus 250 ~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 250 SYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=347.86 Aligned_cols=201 Identities=16% Similarity=0.234 Sum_probs=170.6
Q ss_pred CCCceEEEEEeeecCceEEEEE-----EECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC---CCCccccceeec
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSA-----YDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR---HPDIVEIKHILL 92 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a-----~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~---HpnIv~l~~v~~ 92 (599)
..++|.+.++||+|+||+||+| .+..+++.||||+++.. ....+.+|+.+++.++ |+||+.+++++.
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3578999999999999999999 47788999999999642 3456778888888887 899999999985
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-----
Q 007542 93 PPSRREFKDIYVVFELME-SDLHQVIKA-----NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA----- 161 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~-----~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~----- 161 (599)
.. ...||||||++ |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 138 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 138 FQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp CS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred cC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 43 46899999998 699999974 457999999999999999999999999999999999999998
Q ss_pred ------CCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 007542 162 ------DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (599)
Q Consensus 162 ------~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~ 234 (599)
++.+||+|||+++....... ....+..+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||...
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred cccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 89999999999976432221 223456789999999999987 57999999999999999999999998643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=367.68 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=200.8
Q ss_pred CCCceEEEE-EeeecCceEEEEEEECC--CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEE-VIGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~-~IG~G~~g~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|.+.+ .||+|+||.||+|.++. ++..||||+++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---- 407 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 407 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----
Confidence 345666666 89999999999998763 56679999997542 33456789999999999999999999999843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 408 --~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp --SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred --CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 25899999999 5999999754 4699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...............++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+.+..|....
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------- 556 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------- 556 (613)
T ss_dssp CC--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC-------
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 5432221111122345688999999976 679999999999999999998 999999877655444332100
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
. ....+.+++.+.+|
T Consensus 557 --------------------------------------------------------------~---~~~p~~~~~~l~~l 571 (613)
T 2ozo_A 557 --------------------------------------------------------------R---MECPPECPPELYAL 571 (613)
T ss_dssp --------------------------------------------------------------C---CCCCTTCCHHHHHH
T ss_pred --------------------------------------------------------------C---CCCCCcCCHHHHHH
Confidence 0 01123578899999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 007542 335 LERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~ 354 (599)
|.+||..||.+|||+.++++
T Consensus 572 i~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 572 MSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999854
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=381.38 Aligned_cols=285 Identities=26% Similarity=0.343 Sum_probs=211.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s-~~~~~ 100 (599)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47899999999999999999999999999999998753 23455677899999999999999999999975422 12346
Q ss_pred cEEEEEecCC-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc---eeeeccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND---DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK---LKICDFGLA 173 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~---~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~---lKL~DFGla 173 (599)
..|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999997 69999998754 6999999999999999999999999999999999999997765 999999999
Q ss_pred ccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 174 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......+... .......
T Consensus 172 ~~~~~~~----~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~ 242 (676)
T 3qa8_A 172 KELDQGE----LCTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNE 242 (676)
T ss_dssp CBTTSCC----CCCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC-----
T ss_pred ccccccc----ccccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccch
Confidence 8754332 2245689999999999976 68999999999999999999999999875433211000 0000000
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCC-CCCcCCCCCCCHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP-IPFSQKFPNANPLAL 332 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~s~~a~ 332 (599)
. +.-..... ........ .......+.+++.+.
T Consensus 243 ---~--------~~~~~~l~------------------------------------g~~~~~~~lp~p~~l~~~ls~~L~ 275 (676)
T 3qa8_A 243 ---H--------IVVYDDLT------------------------------------GAVKFSSVLPTPNHLSGILAGKLE 275 (676)
T ss_dssp ------------CCSCCCCS------------------------------------SSCCCCSSSCCSCCCCGGGHHHHH
T ss_pred ---h--------hhhhhhhc------------------------------------cccccccccCCchhhchhhhHHHH
Confidence 0 00000000 00000000 011122334678899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
+||.+||.+||.+|||++|+|+||||+.+..
T Consensus 276 dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 276 RWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp HHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred HHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 9999999999999999999999999987644
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=341.14 Aligned_cols=204 Identities=26% Similarity=0.363 Sum_probs=168.0
Q ss_pred cccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHh--cCCCCccccceeec
Q 007542 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRL--LRHPDIVEIKHILL 92 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~--l~HpnIv~l~~v~~ 92 (599)
+.......++|++.+.||+|+||.||+|.+ +|+.||||++.. .....+.+|+.+++. ++||||+++++++.
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 333334468999999999999999999987 589999999863 234567789999888 78999999999986
Q ss_pred CCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh--------hCceEeccCCCCceEecCCC
Q 007542 93 PPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH--------TANVFHRDLKPKNILANADC 163 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILv~~~~ 163 (599)
... .....+|+||||+.+ +|.+++... .+++..++.++.||+.||.||| +.||+||||||+|||++.++
T Consensus 107 ~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 107 KDN-GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCC-SSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred ccC-CccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 543 223479999999995 999999764 6999999999999999999999 89999999999999999999
Q ss_pred ceeeecccccccccCCCCCc-ccccccccCccccCccccccccC----CCCcchhhHhHHHHHHHHHhC
Q 007542 164 KLKICDFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTG 227 (599)
Q Consensus 164 ~lKL~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~----~~s~~~DIWSlG~Il~eLltG 227 (599)
.+||+|||++.......... .......+|+.|+|||++.+... .++.++|||||||++|+|++|
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 99999999998764432211 12245689999999999865211 234689999999999999999
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=364.35 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=204.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++||||+++++++.. ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------cc
Confidence 5789999999999999999999865 4679999997532 235678999999999999999999999843 35
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+||||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 799999998 5999999643 4699999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ........++..|+|||++.. ..++.++|||||||+||||++ |+.||.+.+..+.+..+....
T Consensus 416 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 481 (535)
T 2h8h_A 416 NE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---------- 481 (535)
T ss_dssp HH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Cc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 11 011123456788999999876 679999999999999999999 999999877655444332110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. .....+++.+.+||.+
T Consensus 482 -----------------------------------------------------------~~---~~~~~~~~~l~~li~~ 499 (535)
T 2h8h_A 482 -----------------------------------------------------------RM---PCPPECPESLHDLMCQ 499 (535)
T ss_dssp -----------------------------------------------------------CC---CCCTTCCHHHHHHHHH
T ss_pred -----------------------------------------------------------CC---CCCCCCCHHHHHHHHH
Confidence 00 1123567889999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 007542 338 MLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~H 355 (599)
||+.||.+|||++++++.
T Consensus 500 cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 500 CWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHH
Confidence 999999999999999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.49 Aligned_cols=199 Identities=19% Similarity=0.162 Sum_probs=160.3
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC------ChhhHHHHHHHHHHHHhcC---------CCCcc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE------HVSDATRILREIKLLRLLR---------HPDIV 85 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~------~~~~~~~i~rEi~iL~~l~---------HpnIv 85 (599)
..++|++++.||+|+||+||+|++ +|+.||||++..... .......+.+|+.+|+.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999987 789999999975422 2233477889999999886 66666
Q ss_pred ccceeec-----------------CCC--------cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHH
Q 007542 86 EIKHILL-----------------PPS--------RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139 (599)
Q Consensus 86 ~l~~v~~-----------------~~s--------~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL 139 (599)
++.+++. ... ..+...+||||||+. |+|.+.+.. +.+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 6665542 100 012468999999997 555555543 5689999999999999999
Q ss_pred HHhh-hCceEeccCCCCceEecCCC--------------------ceeeecccccccccCCCCCcccccccccCccccCc
Q 007542 140 KYIH-TANVFHRDLKPKNILANADC--------------------KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198 (599)
Q Consensus 140 ~yLH-s~gIvHrDLKP~NILv~~~~--------------------~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~AP 198 (599)
.||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~aP 246 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTCS
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccCh
Confidence 9999 99999999999999999987 899999999987642 234899999999
Q ss_pred cccccccCCCCcchhhHhHHHH-HHHHHhCCCCCCC
Q 007542 199 ELCGSFFSKYTPAIDIWSIGCI-FAELLTGKPLFPG 233 (599)
Q Consensus 199 E~l~~~~~~~s~~~DIWSlG~I-l~eLltG~~pF~g 233 (599)
|++.+ .. +.++||||+|++ .++++.|..||.+
T Consensus 247 E~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 247 DLFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp GGGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhhcC--CC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99987 23 889999998777 7778889988853
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=338.23 Aligned_cols=266 Identities=22% Similarity=0.287 Sum_probs=204.5
Q ss_pred cccccCC-CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecC
Q 007542 15 FFTEYGE-GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLP 93 (599)
Q Consensus 15 ~~~~~~~-~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~ 93 (599)
+...+.. .++|++.+.||+|+||.||+|.+.. .||+|+++...........+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 3344433 5899999999999999999998753 49999997544444444567789999999999999999999954
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
. ..+|+||||+. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 101 ~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 101 P-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp S-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred C-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecC
Confidence 3 46999999998 69999998755 699999999999999999999999999999999999998 7899999999
Q ss_pred ccccccCCCC--CcccccccccCccccCccccccc-------cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHH
Q 007542 172 LARVAFNDTP--TAIFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242 (599)
Q Consensus 172 la~~~~~~~~--~~~~~~~~~gt~~Y~APE~l~~~-------~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~ 242 (599)
+++....... .........||..|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+.......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9875432111 11122345689999999998641 13578899999999999999999999988765544333
Q ss_pred HHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcC
Q 007542 243 MTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322 (599)
Q Consensus 243 I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 322 (599)
+.... ... .
T Consensus 255 ~~~~~---------------------------------------------------------------------~~~--~ 263 (319)
T 2y4i_B 255 MGTGM---------------------------------------------------------------------KPN--L 263 (319)
T ss_dssp HHTTC---------------------------------------------------------------------CCC--C
T ss_pred hccCC---------------------------------------------------------------------CCC--C
Confidence 22110 000 0
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 323 ~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.....++.+.+||.+||..||.+|||+.++++ .|..+.
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~ 301 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP 301 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence 11246677999999999999999999999998 355543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.42 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=204.0
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC---CcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t---g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.++|++.+.||+|+||.||+|.+..+ +..||||++... ......+.+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 47899999999999999999998654 467999988642 233455788999999999999999999999832
Q ss_pred CccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
+.+|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 35799999999 69999998654 6999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+.+..+....
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-------- 609 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 609 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC--------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 432211 1233456789999999976 679999999999999999997 999999877655544432210
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. ...+..++.+.+||
T Consensus 610 -------------------------------------------------------------~~---~~~~~~~~~l~~li 625 (656)
T 2j0j_A 610 -------------------------------------------------------------RL---PMPPNCPPTLYSLM 625 (656)
T ss_dssp -------------------------------------------------------------CC---CCCTTCCHHHHHHH
T ss_pred -------------------------------------------------------------CC---CCCccccHHHHHHH
Confidence 00 11245788999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 007542 336 ERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~ 354 (599)
.+||..||.+|||+.|+++
T Consensus 626 ~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 626 TKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHH
Confidence 9999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.14 Aligned_cols=229 Identities=17% Similarity=0.100 Sum_probs=185.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
.+++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++.. .
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----R 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----C
Confidence 457999999999999999999999999999999999754433 3445788999999999999999999999853 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+.+|+||||++ ++|.++++.. .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------ 175 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------ 175 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC------
T ss_pred CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc------
Confidence 47999999998 5999998543 46667889999999999999999999999999999999999999985542
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
++ .++.++|||||||++|+|++|+.||.+.+..+.+......
T Consensus 176 -----------------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~------------ 217 (286)
T 3uqc_A 176 -----------------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD------------ 217 (286)
T ss_dssp -----------------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC------------
T ss_pred -----------------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH------------
Confidence 22 3678999999999999999999999886543211000000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
............+.+++.+.+||.+|
T Consensus 218 ------------------------------------------------------~~~~~~~~~~~~~~~~~~l~~li~~~ 243 (286)
T 3uqc_A 218 ------------------------------------------------------TAGQPIEPADIDRDIPFQISAVAARS 243 (286)
T ss_dssp ------------------------------------------------------TTSCBCCHHHHCTTSCHHHHHHHHHH
T ss_pred ------------------------------------------------------hccCCCChhhcccCCCHHHHHHHHHH
Confidence 00011111223456889999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|+.||.+| |+.|+++.
T Consensus 244 l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 244 VQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HCTTSSCC-CHHHHHHH
T ss_pred cccCCccC-CHHHHHHH
Confidence 99999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=362.83 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=198.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECC-CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTR-TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~-tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++|++++.||+|+||+||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4899999999999999999999986 7999999998642 2334456788999999999999999999999654432233
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+||||||++ ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 4799999999 588887755 69999999999999999999999999999999999999975 8999999999865322
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
...+||+.|+|||++.+ .++.++||||||||+++|++|.++|.+..... .+...
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~~------ 288 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPEDD------ 288 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTTC------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCccccccc----------ccccc------
Confidence 34579999999999865 35889999999999999999999887532100 00000
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.....++.+.+||.+||
T Consensus 289 ---------------------------------------------------------------~~~~~~~~l~~li~~~l 305 (681)
T 2pzi_A 289 ---------------------------------------------------------------PVLKTYDSYGRLLRRAI 305 (681)
T ss_dssp ---------------------------------------------------------------HHHHHCHHHHHHHHHHT
T ss_pred ---------------------------------------------------------------cccccCHHHHHHHhhhc
Confidence 00012456889999999
Q ss_pred ccCCCCCCCHHHHhcCccccC
Q 007542 340 AFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+.||.+||+..++|.|+|+.-
T Consensus 306 ~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 306 DPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CSSGGGSCSSHHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=292.87 Aligned_cols=185 Identities=18% Similarity=0.118 Sum_probs=133.2
Q ss_pred EeeecCceEEEEEEECCCCcEEEEEEecCccC--------ChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCCc
Q 007542 30 VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--------HVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 30 ~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~--------~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.++.|+.|.+..++...+|+.||+|++..... .....+.+.+|+.+|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 45678888888888888999999999964321 123345689999999999 699999999999 4446
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+||||||++| +|.++|...+.+++. .|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 89999999995 999999999888875 47899999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK 228 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~ 228 (599)
.. ..++.+||+.|+|||++.+ .+..++|+||+|+++++|++|.
T Consensus 393 ~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 393 CS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -C---CSHHHHHHHHHHHHHHC--------------------CCCCTTH
T ss_pred Cc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhcccc
Confidence 22 2356789999999999976 4677899999999999887664
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=256.86 Aligned_cols=192 Identities=21% Similarity=0.259 Sum_probs=141.5
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-h-----hhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-V-----SDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~-----~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..+...++||+|+||.||+| ...+..+++|++...... . ...+++.+|+.+|+.++||||+++..+....
T Consensus 336 ~~~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-- 411 (540)
T 3en9_A 336 KRKIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-- 411 (540)
T ss_dssp ------------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET--
T ss_pred ccCCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC--
Confidence 33455679999999999999 567889999987532211 1 1235588999999999999999554444322
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...||||||++ ++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.
T Consensus 412 ---~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 412 ---DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp ---TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred ---CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence 24599999998 699999875 5689999999999999999999999999999998 999999999987
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 007542 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLF 231 (599)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF 231 (599)
........ ......+||++|+|||++......|+..+|+||..+-..+...++..|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 63321110 012356899999999998764456888899999998888877766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=215.33 Aligned_cols=147 Identities=18% Similarity=0.203 Sum_probs=117.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----------------hhHHHHHHHHHHHHhcCCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----------------SDATRILREIKLLRLLRHPDIV 85 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~----------------~~~~~i~rEi~iL~~l~HpnIv 85 (599)
+..|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 45667779999999999999999 889999999996321110 13456889999999999 5 6
Q ss_pred ccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCc
Q 007542 86 EIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCK 164 (599)
Q Consensus 86 ~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~ 164 (599)
++.+++.. +..|+||||++| +|.+ +. ......++.||+.||.|||+.||+||||||+|||++ ++.
T Consensus 165 ~v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 165 AVPKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp SSCCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred CcCeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 77776522 346999999985 8887 42 134557999999999999999999999999999999 999
Q ss_pred eeeecccccccccCCCCCcccccccccCccccCccccc
Q 007542 165 LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202 (599)
Q Consensus 165 lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 202 (599)
+||+|||+|+. +..+.|||++.
T Consensus 231 vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 231 IWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp EEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred EEEEECCCCeE----------------CCCCCHHHHHH
Confidence 99999999863 33468888864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.9e-20 Score=187.58 Aligned_cols=141 Identities=18% Similarity=0.164 Sum_probs=110.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcE--EEEEEecCccCCh----------------------hhHHHHHHHHHHHH
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHV----------------------SDATRILREIKLLR 77 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~--VAIK~i~~~~~~~----------------------~~~~~i~rEi~iL~ 77 (599)
+.-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|+
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 125 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE 125 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence 45689999999999999999998788999 9999875321110 11236789999999
Q ss_pred hcCCCCcc--ccceeecCCCcCCCccEEEEEecCCc------cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhh-hCceE
Q 007542 78 LLRHPDIV--EIKHILLPPSRREFKDIYVVFELMES------DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH-TANVF 148 (599)
Q Consensus 78 ~l~HpnIv--~l~~v~~~~s~~~~~~lylV~E~~~g------~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLH-s~gIv 148 (599)
.+.|+++. .++.. ...+|||||+++ .|.++... .++..+..++.||+.+|.||| +.||+
T Consensus 126 ~l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~giv 193 (258)
T 1zth_A 126 RAKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELV 193 (258)
T ss_dssp HHHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEE
T ss_pred HHHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 99888652 22221 245899999953 67776432 335678899999999999999 99999
Q ss_pred eccCCCCceEecCCCceeeecccccccc
Q 007542 149 HRDLKPKNILANADCKLKICDFGLARVA 176 (599)
Q Consensus 149 HrDLKP~NILv~~~~~lKL~DFGla~~~ 176 (599)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.5e-16 Score=168.96 Aligned_cols=139 Identities=15% Similarity=0.158 Sum_probs=97.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc---C---------ChhhHHH--------HHHHHHHHHhcCC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF---E---------HVSDATR--------ILREIKLLRLLRH 81 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~---~---------~~~~~~~--------i~rEi~iL~~l~H 81 (599)
+.-|.+.+.||+|++|.||+|.+ .+|+.||||+++... . ....... ..+|...|.++.+
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 44599999999999999999987 479999999875311 0 0000111 1345566666644
Q ss_pred CCccccceeecCCCcCCCccEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec
Q 007542 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN 160 (599)
Q Consensus 82 pnIv~l~~v~~~~s~~~~~~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~ 160 (599)
.++... ..+. ....+|||||++| .|.++. .......++.||+.+|.+||++|||||||||.|||++
T Consensus 173 ~gv~vp-~p~~------~~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 173 EGFPVP-EPIA------QSRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp TTCSCC-CEEE------EETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred cCCCCC-eeee------ccCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 333211 1110 0123799999996 665432 2234567889999999999999999999999999999
Q ss_pred CCC----------ceeeecccccc
Q 007542 161 ADC----------KLKICDFGLAR 174 (599)
Q Consensus 161 ~~~----------~lKL~DFGla~ 174 (599)
.++ .+.|+||+-+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 887 38899999664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=4.2e-11 Score=119.77 Aligned_cols=137 Identities=12% Similarity=0.108 Sum_probs=105.2
Q ss_pred ceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccE
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.|++...++.|+.+.||++.. .+..+++|+...... .....+.+|+.+|+.+. +..+.+++++... .+..
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~ 85 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWS 85 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCce
Confidence 588999999999999999963 478999999864221 12235789999999995 6667788877632 2468
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-------------------------------------
Q 007542 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT------------------------------------- 144 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs------------------------------------- 144 (599)
|+|||+++| +|.+.+. +......++.++.++|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999997 6766521 223345788899999999998
Q ss_pred ----------------------CceEeccCCCCceEecCCCceeeecccccc
Q 007542 145 ----------------------ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 145 ----------------------~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=2.4e-10 Score=113.13 Aligned_cols=133 Identities=14% Similarity=0.068 Sum_probs=94.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFK 100 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~~s~~~~~ 100 (599)
..|.+..+.+.|..+.||++. ..+|..+++|+.... ....+.+|+.+|+.+.+.+ +.+++.+... .+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SS
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CC
Confidence 456665555567779999985 456788999987542 2235678999999986544 4456666532 24
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCc---------------------------------
Q 007542 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--------------------------------- 146 (599)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g--------------------------------- 146 (599)
..|+|||+++| +| . . .... ...++.++.+.|..||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 58999999997 55 3 1 1122 2356677777777777643
Q ss_pred -------------------------eEeccCCCCceEecCCCceeeecccccc
Q 007542 147 -------------------------VFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 147 -------------------------IvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=4.6e-10 Score=115.08 Aligned_cols=184 Identities=17% Similarity=0.250 Sum_probs=118.0
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCc--cccceeecCCCcCCCccEEE
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDI--VEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnI--v~l~~v~~~~s~~~~~~lyl 104 (599)
++.++.|....||++. ..+++|+... ......+.+|..+|+.+. +..+ .+++... ........-|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 4568999999999872 5688998643 234567889999999884 3332 2332222 11122234589
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------
Q 007542 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------------------------------------- 144 (599)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs--------------------------------------- 144 (599)
||++++| .|..... ..++.+....++.|+...|..||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 5544332 246777777888888888888885
Q ss_pred -------------------CceEeccCCCCceEecC--CCceeeecccccccccCCCCCcccccccccCccc---cCccc
Q 007542 145 -------------------ANVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY---RAPEL 200 (599)
Q Consensus 145 -------------------~gIvHrDLKP~NILv~~--~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y---~APE~ 200 (599)
..++|+|++|.|||++. ++.+.|+||+.+....... +......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-------Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-------DFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-------HHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-------HHHHHHhhccccCHHH
Confidence 24799999999999998 4567899999986532110 00001111 22322
Q ss_pred cccccCCC------------CcchhhHhHHHHHHHHHhCCCCC
Q 007542 201 CGSFFSKY------------TPAIDIWSIGCIFAELLTGKPLF 231 (599)
Q Consensus 201 l~~~~~~~------------s~~~DIWSlG~Il~eLltG~~pF 231 (599)
.......| ..-.+.|++|.+++.+.+|.+.|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11100011 12258999999999999998665
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=2.1e-09 Score=112.78 Aligned_cols=144 Identities=14% Similarity=0.204 Sum_probs=103.7
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEec--CccCChhhHHHHHHHHHHHHhcC--CCCccccceeecCCCcCCCc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN--DIFEHVSDATRILREIKLLRLLR--HPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~--~~~~~~~~~~~i~rEi~iL~~l~--HpnIv~l~~v~~~~s~~~~~ 100 (599)
..-++.|+.|.++.||++.. .+..+++|+.. ... .......+.+|+.+|+.+. +..+.+++.++.+. ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g 114 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIG 114 (359)
T ss_dssp CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTS
T ss_pred CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccC
Confidence 44567899999999999864 35688898765 211 1122456789999999997 44577777776433 1224
Q ss_pred cEEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-----------------------------------
Q 007542 101 DIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT----------------------------------- 144 (599)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs----------------------------------- 144 (599)
..|+|||+++| .+.+. ....++......++.++++.|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 57899999997 44321 12347788888999999999999997
Q ss_pred -----------------------CceEeccCCCCceEecCCCc--eeeeccccccc
Q 007542 145 -----------------------ANVFHRDLKPKNILANADCK--LKICDFGLARV 175 (599)
Q Consensus 145 -----------------------~gIvHrDLKP~NILv~~~~~--lKL~DFGla~~ 175 (599)
.+++|+|+++.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 46999999999999998753 68999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=3e-06 Score=86.94 Aligned_cols=133 Identities=22% Similarity=0.206 Sum_probs=87.9
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC---ccccceeecCCCcCCCccEEE
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD---IVEIKHILLPPSRREFKDIYV 104 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn---Iv~l~~v~~~~s~~~~~~lyl 104 (599)
++.++.|....||+. |..+++|+.. .......+.+|..+|+.+.+.. +.+++.+... ..+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEE
Confidence 456888999999988 6778898753 2234567889999999997532 3344444321 2245689
Q ss_pred EEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh---------------------------------------
Q 007542 105 VFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------------------------------------- 144 (599)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs--------------------------------------- 144 (599)
|||+++| .|....- ..++......+..|+.+.|..||+
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 4544221 123444444444444444444443
Q ss_pred ---------------------CceEeccCCCCceEecC---CCce-eeeccccccc
Q 007542 145 ---------------------ANVFHRDLKPKNILANA---DCKL-KICDFGLARV 175 (599)
Q Consensus 145 ---------------------~gIvHrDLKP~NILv~~---~~~l-KL~DFGla~~ 175 (599)
..++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 24699999999999997 4554 8999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=8.9e-06 Score=81.03 Aligned_cols=131 Identities=19% Similarity=0.238 Sum_probs=87.3
Q ss_pred EeeecCce-EEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCccEEEEEe
Q 007542 30 VIGKGSYG-VVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFE 107 (599)
Q Consensus 30 ~IG~G~~g-~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~lylV~E 107 (599)
.+..|..+ .||+......+..+++|+-.. .....+.+|..+|+.+. +--+-+++.++.+ .+.-|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEE
Confidence 34556555 689887777788899997642 34567889999999885 3234556665532 246799999
Q ss_pred cCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhC-----------------------------------------
Q 007542 108 LMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTA----------------------------------------- 145 (599)
Q Consensus 108 ~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~----------------------------------------- 145 (599)
+++| ++.+..... ......+..++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9997 555544321 112223444444444444421
Q ss_pred -----------------ceEeccCCCCceEecCCCceeeecccccc
Q 007542 146 -----------------NVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 146 -----------------gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 27999999999999987777899999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=1.7e-05 Score=83.94 Aligned_cols=78 Identities=19% Similarity=0.147 Sum_probs=48.5
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccC--C---hhhHHHHHHHHHHHHhcCC--CCcc-ccceeecCCCcCC
Q 007542 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE--H---VSDATRILREIKLLRLLRH--PDIV-EIKHILLPPSRRE 98 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~--~---~~~~~~i~rEi~iL~~l~H--pnIv-~l~~v~~~~s~~~ 98 (599)
-.+.||.|..+.||++.+..++..|+||....... . .....++.+|..+|+.+.. +..+ +++.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~---- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T---- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence 35689999999999997666778999998653211 0 1123466789999988742 3333 444322 1
Q ss_pred CccEEEEEecCCc
Q 007542 99 FKDIYVVFELMES 111 (599)
Q Consensus 99 ~~~lylV~E~~~g 111 (599)
...++|||++++
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 124799999985
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.00 E-value=2.3e-05 Score=80.48 Aligned_cols=30 Identities=20% Similarity=0.324 Sum_probs=27.1
Q ss_pred CceEeccCCCCceEecCCCceeeecccccc
Q 007542 145 ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 145 ~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=3.1e-05 Score=80.52 Aligned_cols=85 Identities=11% Similarity=0.141 Sum_probs=52.4
Q ss_pred eEEEEEe-eecCceEEEEEEECC------CCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcC-C--CCccccceeecC
Q 007542 25 YKIEEVI-GKGSYGVVCSAYDTR------TGEKVAIKKINDIFE-HVSDATRILREIKLLRLLR-H--PDIVEIKHILLP 93 (599)
Q Consensus 25 Y~i~~~I-G~G~~g~Vy~a~~~~------tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~-H--pnIv~l~~v~~~ 93 (599)
...++.| +.|....+|+..... ++..+++|+...... .......+.+|+.+|+.+. + -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 889999999875431 267889987643210 0001235678999988885 3 245566666533
Q ss_pred CCcCCCccEEEEEecCCc
Q 007542 94 PSRREFKDIYVVFELMES 111 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~g 111 (599)
.. ..+..|+|||+++|
T Consensus 102 ~~--~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GD--VLGTPFFLMDYVEG 117 (357)
T ss_dssp ST--TTSSCEEEEECCCC
T ss_pred CC--ccCCceEEEEecCC
Confidence 21 12345899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0014 Score=69.80 Aligned_cols=32 Identities=16% Similarity=0.313 Sum_probs=28.1
Q ss_pred hhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 143 HTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 143 Hs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 466899999999999999876 99999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00078 Score=68.29 Aligned_cols=68 Identities=15% Similarity=0.063 Sum_probs=42.0
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc-ccceeecCCCcCCCccEEEEE
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~v~~~~s~~~~~~lylV~ 106 (599)
++.|+.|....+|++ ..+++|+....... .....+|+.+++.+...++. +++... .. .-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~-----~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PA-----TGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT-----TCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CC-----CCEEEE
Confidence 678999999999998 56888877532111 11124688888877533333 444332 11 126899
Q ss_pred ecC-Cc
Q 007542 107 ELM-ES 111 (599)
Q Consensus 107 E~~-~g 111 (599)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0024 Score=65.02 Aligned_cols=153 Identities=15% Similarity=0.146 Sum_probs=80.3
Q ss_pred cccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCc--cccceeec
Q 007542 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILL 92 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI--v~l~~v~~ 92 (599)
++..|+. ....-++.|+.|....+|+.... +..+++|+.... .....+..|+.+++.+...++ .+++....
T Consensus 15 ~l~~~~~-~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~ 87 (322)
T 2ppq_A 15 FLTQYDV-GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 87 (322)
T ss_dssp HHTTBCC-CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHhCCC-CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence 3344555 34445677888988999998643 336889987642 122345678888887753232 22222110
Q ss_pred CCC-cCCCccEEEEEecCCcc-H--------H---HH---HH-hCCC--------CCHHHHHHHH---------------
Q 007542 93 PPS-RREFKDIYVVFELMESD-L--------H---QV---IK-ANDD--------LTPEHYQFFL--------------- 132 (599)
Q Consensus 93 ~~s-~~~~~~lylV~E~~~g~-L--------~---~~---i~-~~~~--------lse~~i~~i~--------------- 132 (599)
... ....+..++|+++++|. + . +. ++ .... .........+
T Consensus 88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~ 167 (322)
T 2ppq_A 88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 167 (322)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence 000 00113568999999862 1 0 01 11 1101 1111111100
Q ss_pred HHHHHHHHHhh-------hCceEeccCCCCceEecCCCceeeecccccc
Q 007542 133 YQLLRGLKYIH-------TANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 133 ~QIl~aL~yLH-------s~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+...+..++ ..+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01233444444 2369999999999999877666899998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0098 Score=59.63 Aligned_cols=77 Identities=12% Similarity=-0.017 Sum_probs=52.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC---ccccceeecCCCcCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD---IVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn---Iv~l~~v~~~~s~~~~ 99 (599)
.+..-++.+|.|..+.||+... .+|+.|++|+-.... ......+.+|...|+.|.--. +.+++.+.
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 4566788999999999999964 678999999764321 122234678999999885322 33333321
Q ss_pred ccEEEEEecCCc
Q 007542 100 KDIYVVFELMES 111 (599)
Q Consensus 100 ~~lylV~E~~~g 111 (599)
.-++|||++.+
T Consensus 84 -~~~lv~e~l~~ 94 (288)
T 3f7w_A 84 -DRTLAMEWVDE 94 (288)
T ss_dssp -TTEEEEECCCC
T ss_pred -CceEEEEeecc
Confidence 12789999873
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0098 Score=57.61 Aligned_cols=96 Identities=18% Similarity=0.105 Sum_probs=64.9
Q ss_pred cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhh-hCceEeccCCCCceEecCCCceeeecccccccccCCCCCccccccc
Q 007542 112 DLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 189 (599)
Q Consensus 112 ~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~ 189 (599)
+|.++++.. .+++|+++|.+++|.+.+|.-+- .+.-..+=+.|..|++..+|.|-+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 799999864 58999999999999999988872 12212334557889999999988774 2111
Q ss_pred ccCccccCccccccccCCCCcchhhHhHHHHHHHHHh
Q 007542 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT 226 (599)
Q Consensus 190 ~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt 226 (599)
.....+.+||... ...+.+.=|||||+++|.-|-
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence 1122456888753 245678899999999999884
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0076 Score=61.39 Aligned_cols=137 Identities=18% Similarity=0.118 Sum_probs=77.0
Q ss_pred EEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC--ccccceeecCCC--cCCCccEEE
Q 007542 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPS--RREFKDIYV 104 (599)
Q Consensus 29 ~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~~s--~~~~~~lyl 104 (599)
..|+ |....||++.. .+|+.+++|+..... .....+.+|+.+++.+.... +.+++.. +.. ....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4466 77889998742 356689999885321 13456778999888885322 3334332 110 011235688
Q ss_pred EEecCCcc-H------------------HHHHHhCC-----CCCHHHH----------------------HHHHHHHHHH
Q 007542 105 VFELMESD-L------------------HQVIKAND-----DLTPEHY----------------------QFFLYQLLRG 138 (599)
Q Consensus 105 V~E~~~g~-L------------------~~~i~~~~-----~lse~~i----------------------~~i~~QIl~a 138 (599)
||++++|. + +....... .++.... ...+.+++..
T Consensus 105 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (328)
T 1zyl_A 105 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA 184 (328)
T ss_dssp EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHH
Confidence 99999861 1 11111010 1111110 1112222222
Q ss_pred HHHh----hhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 139 LKYI----HTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 139 L~yL----Hs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
+.-+ ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 185 l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 185 VTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 2222 234689999999999998 4 89999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0078 Score=64.47 Aligned_cols=72 Identities=14% Similarity=0.109 Sum_probs=47.9
Q ss_pred EEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCC
Q 007542 27 IEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRRE 98 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~v~~~~s~~~ 98 (599)
-++.|+.|-...||++.... .+..|++|+.... . ....+.+|..+++.+...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~-----~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E--TESHLVAESVIFTLLSERHLGPKLYGIFS-----G 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C--CHHHHHHHHHHHHHHHHTTSSSCEEEEET-----T
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC-----C
Confidence 35678889999999997542 3578999987421 1 12345589999988864444 45555441 1
Q ss_pred CccEEEEEecCCc
Q 007542 99 FKDIYVVFELMES 111 (599)
Q Consensus 99 ~~~lylV~E~~~g 111 (599)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 288999985
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0063 Score=62.34 Aligned_cols=32 Identities=25% Similarity=0.455 Sum_probs=27.3
Q ss_pred hCceEeccCCCCceEecCC----Cceeeeccccccc
Q 007542 144 TANVFHRDLKPKNILANAD----CKLKICDFGLARV 175 (599)
Q Consensus 144 s~gIvHrDLKP~NILv~~~----~~lKL~DFGla~~ 175 (599)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3579999999999999875 6799999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.015 Score=59.62 Aligned_cols=75 Identities=17% Similarity=0.126 Sum_probs=54.3
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC---CCccccceeecCCCcCCCcc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH---PDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H---pnIv~l~~v~~~~s~~~~~~ 101 (599)
-.-.+.|+.|....+|+... ++..+++|+... .....+.+|...|+.|.. ..+.+++.+... ...
T Consensus 38 i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~ 105 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGH 105 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSE
T ss_pred eeeeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCc
Confidence 34467899999999999863 577888997643 235667899999988852 446666665532 246
Q ss_pred EEEEEecCCc
Q 007542 102 IYVVFELMES 111 (599)
Q Consensus 102 lylV~E~~~g 111 (599)
.|+|||+++|
T Consensus 106 ~~lvme~l~G 115 (312)
T 3jr1_A 106 SFLLLEALNK 115 (312)
T ss_dssp EEEEEECCCC
T ss_pred eEEEEEeccC
Confidence 8999999985
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0061 Score=63.53 Aligned_cols=73 Identities=8% Similarity=0.019 Sum_probs=42.1
Q ss_pred EEEEeeecCceEEEEEEECC--------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCc-cccceeecCCCcC
Q 007542 27 IEEVIGKGSYGVVCSAYDTR--------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRR 97 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~--------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~v~~~~s~~ 97 (599)
-++.|+.|....+|++.... .+..+++|+..... .......+|..+|+.+...++ .+++... .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C---
Confidence 35678888889999987543 13688888764311 111123578888888863343 3555443 1
Q ss_pred CCccEEEEEecCCc
Q 007542 98 EFKDIYVVFELMES 111 (599)
Q Consensus 98 ~~~~lylV~E~~~g 111 (599)
-++|+|+++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 1689999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.011 Score=62.29 Aligned_cols=139 Identities=13% Similarity=0.192 Sum_probs=79.8
Q ss_pred CceEEEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCc-cccceeecCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPP 94 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~v~~~~ 94 (599)
+..+ ++.|..|-...+|++.... ++..|++|+.... ......+.+|..+++.|.--++ .+++..+.
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-- 124 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFP-- 124 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--
Confidence 3344 3567678888899987532 3578999975321 1234455689999988863333 45555441
Q ss_pred CcCCCccEEEEEecCCc-cH-----------HHHH------HhCC-----CC--CHHHHHHHHHHHHH------------
Q 007542 95 SRREFKDIYVVFELMES-DL-----------HQVI------KAND-----DL--TPEHYQFFLYQLLR------------ 137 (599)
Q Consensus 95 s~~~~~~lylV~E~~~g-~L-----------~~~i------~~~~-----~l--se~~i~~i~~QIl~------------ 137 (599)
+ .+|+||++| .| ..+. +... .. -...+..++.++-.
T Consensus 125 ---~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~ 197 (379)
T 3feg_A 125 ---E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL 197 (379)
T ss_dssp ---T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred ---C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence 1 289999986 21 1111 1111 11 13455666554422
Q ss_pred -------HHHHh----hh----CceEeccCCCCceEecCC----Cceeeecccccc
Q 007542 138 -------GLKYI----HT----ANVFHRDLKPKNILANAD----CKLKICDFGLAR 174 (599)
Q Consensus 138 -------aL~yL----Hs----~gIvHrDLKP~NILv~~~----~~lKL~DFGla~ 174 (599)
.+..| .. ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12222 22 258999999999999876 789999998774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.015 Score=60.02 Aligned_cols=31 Identities=19% Similarity=0.326 Sum_probs=27.5
Q ss_pred CceEeccCCCCceEecCCCceeeeccccccc
Q 007542 145 ANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 145 ~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.19 Score=54.13 Aligned_cols=72 Identities=18% Similarity=0.196 Sum_probs=45.7
Q ss_pred EEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCCCccEEEEE
Q 007542 28 EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~v~~~~s~~~~~~lylV~ 106 (599)
++.|+.|-...+|++.....+..|++|+.........+ -.+|..+|+.|...++ .+++.++. + .+|+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~-----~----G~v~ 180 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFT-----N----GRIE 180 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET-----T----EEEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC-----C----eEEE
Confidence 56788899999999976544578999987432111111 1489999999975555 35555541 1 2599
Q ss_pred ecCCc
Q 007542 107 ELMES 111 (599)
Q Consensus 107 E~~~g 111 (599)
||++|
T Consensus 181 e~I~G 185 (458)
T 2qg7_A 181 EFMDG 185 (458)
T ss_dssp ECCCS
T ss_pred EeeCC
Confidence 99985
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.38 E-value=0.62 Score=49.58 Aligned_cols=72 Identities=11% Similarity=0.033 Sum_probs=44.6
Q ss_pred EEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCc-cccceeecCCCcCCC
Q 007542 28 EEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI-VEIKHILLPPSRREF 99 (599)
Q Consensus 28 ~~~IG~G~~g~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI-v~l~~v~~~~s~~~~ 99 (599)
++.|..|-...+|++.... .+..|++++....... .....+|..+++.+..-++ .++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~------- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP------- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET-------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC-------
Confidence 4567778888999987642 1578999886432111 1123478888888853333 34444331
Q ss_pred ccEEEEEecCCc
Q 007542 100 KDIYVVFELMES 111 (599)
Q Consensus 100 ~~lylV~E~~~g 111 (599)
-++|+||++|
T Consensus 145 --~~~I~efI~G 154 (424)
T 3mes_A 145 --EGRIEEFIDG 154 (424)
T ss_dssp --TEEEEECCCS
T ss_pred --CCEEEEEeCC
Confidence 1689999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.06 E-value=1.1 Score=47.07 Aligned_cols=30 Identities=30% Similarity=0.382 Sum_probs=24.9
Q ss_pred ceEeccCCCCceEe------cCCCceeeeccccccc
Q 007542 146 NVFHRDLKPKNILA------NADCKLKICDFGLARV 175 (599)
Q Consensus 146 gIvHrDLKP~NILv------~~~~~lKL~DFGla~~ 175 (599)
.++|+|+.+.|||+ +.+..+.|+||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4467799999998743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 599 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-93 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-84 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-83 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-75 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-72 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-70 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-69 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-68 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-67 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-66 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-65 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-64 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-06 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-05 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-07 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-07 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-05 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-08 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-06 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-55 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-08 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-05 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-08 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-05 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-11 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-10 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-05 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-12 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-06 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-09 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-04 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-04 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 0.001 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-04 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 0.003 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-42 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-05 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 0.004 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-25 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 287 bits (734), Expect = 8e-93
Identities = 163/383 (42%), Positives = 223/383 (58%), Gaps = 47/383 (12%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G RY IG+G+YG+VCSAYD +VAIKKI+ FEH + R LREIK+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LRGLKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
IH+ANV HRDLKP N+L N C LKICDFGLARVA D F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK+ + QL+ + +LG+PS E +
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC---- 239
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
+ N KAR YL S+ K +P++
Sbjct: 240 --------------------------------------IINLKARNYLLSLPHKNKVPWN 261
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFE 381
+ FPNA+ AL LL++ML F P R E+ALA PY + EP A+ +F+ E
Sbjct: 262 RLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDME 319
Query: 382 RRRITKEDVRELIYREILEYHPQ 404
+ KE ++ELI+ E + P
Sbjct: 320 LDDLPKEKLKELIFEETARFQPG 342
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (677), Expect = 3e-84
Identities = 148/388 (38%), Positives = 217/388 (55%), Gaps = 54/388 (13%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + RY+ +G G+YG VC+A+DT+TG +VA+KK++ F+ + A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKHILLPP-SRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
LRGLKYIH+A++ HRDLKP N+ N DC+LKI DFGLAR T T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ + + Y +DIWS+GCI AELLTG+ LFPG + + QL ++ L+GTP E
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE-- 241
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
L ++ +E AR Y+ S+ +
Sbjct: 242 ----------------------------------------LLKKISSESARNYIQSLTQM 261
Query: 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 375
+ F+ F ANPLA+ LLE+ML + R TA +ALA YF + EP A P
Sbjct: 262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP--- 318
Query: 376 MEFEFERRRITKEDVRELIYREILEYHP 403
+ FE R + ++ + L Y E++ + P
Sbjct: 319 YDQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 262 bits (669), Expect = 4e-83
Identities = 140/388 (36%), Positives = 214/388 (55%), Gaps = 54/388 (13%)
Query: 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLL 76
T + + Y+ + +G G+YG VCSA D RTG KVAIKK+ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 77 RLLRHPDIVEIKHILLPPSRRE-FKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQL 135
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQ+
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 136 LRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
L+GL+YIH A + HRDLKP N+ N DC+LKI DFGLAR A ++ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
RAPE+ + + +YT +DIWS+GCI AE++TGK LF G + + QL + + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315
R +++++A+ Y+ + +
Sbjct: 244 QR------------------------------------------LQSDEAKNYMKGLPEL 261
Query: 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTK 375
+ F+ NA+PLA+ LLE+ML + + R TA EALA PYF+ L E EP Q K
Sbjct: 262 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---K 318
Query: 376 MEFEFERRRITKEDVRELIYREILEYHP 403
+ F+ T ++ + + Y+E+L + P
Sbjct: 319 YDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (617), Expect = 2e-75
Identities = 123/377 (32%), Positives = 189/377 (50%), Gaps = 41/377 (10%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
RY+ + IG G+ G+VC+AYD VAIKK++ F++ + A R RE+ L++ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 84 IVEIKHILLPPSR-REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + ++ P EF+D+Y+V ELM+++L QVI+ D E + LYQ+L G+K++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKHL 135
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ +DC LKI DFGLAR A T YV TR+YRAPE+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPEVIL 191
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
Y +DIWS+GCI E++ K LFPG++ + Q + + + LGTP PE + ++ +
Sbjct: 192 GM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
+ P F S+
Sbjct: 250 RNYVENRPKYAGLTFPKLF-------------------------------PDSLFPADSE 278
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFER 382
A LL +ML +P R + ++AL PY E A P + + +
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD-PAEVEAPPPQIYDKQLDE 337
Query: 383 RRITKEDVRELIYREIL 399
R T E+ +ELIY+E++
Sbjct: 338 REHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (591), Expect = 6e-72
Identities = 102/342 (29%), Positives = 151/342 (44%), Gaps = 47/342 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S+Y+ IG+G++G V A +TG+KVA+KK+ E LREIK+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKHILL---PPSRREFKDIYVVFELMESDLHQV-IKANDDLTPEHYQFFLYQLLRG 138
++V + I P R IY+VF+ E DL + T + + LL G
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRA 197
L YIH + HRD+K N+L D LK+ DFGLAR + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PEL Y P ID+W GCI AE+ T P+ G HQL +++ L G+ +PE
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
V E + +K+
Sbjct: 249 VD-----------------------------------------NYELYEKLELVKGQKRK 267
Query: 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ K +P AL L++++L +P R +++AL +F
Sbjct: 268 VKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 3e-70
Identities = 107/373 (28%), Positives = 167/373 (44%), Gaps = 63/373 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKHILLPPSRREFKD-IYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRG 138
IV +++ ++ + + +V + + +++V +A L + + ++YQL R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYIHTANVFHRDLKPKNILANADCKL-KICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L YIH+ + HRD+KP+N+L + D + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PEL YT +ID+WS GC+ AELL G+P+FPG + V QL + +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI-- 247
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
R + K
Sbjct: 248 -------------------------------------------REMNPNYTEFKFPQIKA 264
Query: 318 IPFSQKF-PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKM 376
P+++ F P P A+ L R+L + P R T EA A +F L + T
Sbjct: 265 HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPA 324
Query: 377 EFEFERRRITKED 389
F F + ++
Sbjct: 325 LFNFTTQELSSNP 337
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-69
Identities = 65/340 (19%), Positives = 121/340 (35%), Gaps = 46/340 (13%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++ +G G+ GVV +G +A K I+ + + +I+RE+++L P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPY 65
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV +I + E M+ L QV+K + + +++GL Y+
Sbjct: 66 IVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 143 HTAN-VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+ + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERL 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV-VHQLDIMTDLLGTPSPEAIARVCL 260
+ Y+ DIWS+G E+ G+ P + +L + G +
Sbjct: 176 --QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPF 320
+ G D L + + P
Sbjct: 234 GRPLSSYGMDSR----------------------------PPMAIFELLDYIVNEPPPKL 265
Query: 321 SQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
+ + + L P +R ++ + + K
Sbjct: 266 PSG--VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 7e-68
Identities = 101/348 (29%), Positives = 154/348 (44%), Gaps = 58/348 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLL--- 79
+Y+ IG+G+YG V A D + G VA+K++ +RE+ +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQFFLYQLLR 137
HP++V + + + +VFE ++ DL + + + E + ++QLLR
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
GL ++H+ V HRDLKP+NIL + ++K+ DFGLAR+ T V T WYRA
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYRA 183
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257
PE+ S Y +D+WS+GCIFAE+ KPLF G + V QL + D++G P E R
Sbjct: 184 PEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKP 317
L + K
Sbjct: 242 DVALPRQAF----------------------------------------------HSKSA 255
Query: 318 IPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVE 365
P + + + L LL + L F P R +A AL+ PYF+ L + +
Sbjct: 256 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 1e-67
Identities = 103/352 (29%), Positives = 153/352 (43%), Gaps = 64/352 (18%)
Query: 29 EVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDAT---RILREIKLLRLLRHPDIV 85
+ +G+G + V A D T + VAIKKI + LREIKLL+ L HP+I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 86 EIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ +I +VF+ ME+D + + LTP H + ++ L+GL+Y+H
Sbjct: 64 GLLDA-----FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+ HRDLKP N+L + + LK+ DFGLA+ + +T V TRWYRAPEL
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL-FG 174
Query: 205 FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNI 264
Y +D+W++GCI AELL P PG + + QL + + LGTP+ E +C L +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 265 IWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF 324
+ + + IP F
Sbjct: 235 V---------------------------------------------TFKSFPGIPLHHIF 249
Query: 325 PNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKM 376
A L L++ + F P R TA +AL YF P P ++
Sbjct: 250 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN------RPGPTPGCQL 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (552), Expect = 1e-66
Identities = 111/342 (32%), Positives = 163/342 (47%), Gaps = 55/342 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++ E IG+G+YGVV A + TGE VA+KKI E + +REI LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKAND--DLTPEHYQFFLYQLLRGLKY 141
IV++ + +Y+VFE + DL + + A+ + + +L+QLL+GL +
Sbjct: 63 IVKLLDV-----IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N + +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
Y+ A+DIWS+GCIFAE++T + LFPG + + QL + LGTP V
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT-- 231
Query: 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321
Y S K FS
Sbjct: 232 ------------------------------------------SMPDYKPSFPKWARQDFS 249
Query: 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAK 363
+ P + LL +ML ++P R +A+ ALA P+F+ + K
Sbjct: 250 KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 212 bits (540), Expect = 6e-65
Identities = 106/337 (31%), Positives = 157/337 (46%), Gaps = 55/337 (16%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+YGVV A + GE A+KKI E + +REI +L+ L+H +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 84 IVEIKHILLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV++ ++ K + +VFE + + + L + FL QLL G+ Y
Sbjct: 62 IVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H V HRDLKP+N+L N + +LKI DFGLAR +T + T WYRAP++
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVLM 173
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
KY+ IDIWS+GCIFAE++ G PLFPG + QL + +LGTP+ + V
Sbjct: 174 G-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--- 229
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
+ +Y + +P+P+
Sbjct: 230 -----------------------------------------ELPKYDPNFTVYEPLPWES 248
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ + LL +ML +P R TA++AL YFK
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-64
Identities = 107/339 (31%), Positives = 149/339 (43%), Gaps = 53/339 (15%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y+ E IG+G+YG V A + T E VA+K++ + + LREI LL+ L+H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV + +L + K V + N DL PE + FL+QLL+GL + H
Sbjct: 63 IVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ NV HRDLKP+N+L N + +LK+ +FGLAR ++ V T WYR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAEVVTLWYRPPDVLFG 175
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262
Y+ +ID+WS GCIFAEL PLFPG +V QL + LLGTP+ E +
Sbjct: 176 -AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT--- 231
Query: 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQ 322
K Y
Sbjct: 232 -----------------------------------------KLPDYKPYPMYPATTSLVN 250
Query: 323 KFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
P N LL+ +L P R +AEEAL PYF
Sbjct: 251 VVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 210 bits (534), Expect = 2e-63
Identities = 94/364 (25%), Positives = 165/364 (45%), Gaps = 57/364 (15%)
Query: 5 QRKKSSADVDFFT-EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV 63
R + D + E+G Y++ +G+G Y V A + EKV +K + + +
Sbjct: 16 HRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK- 74
Query: 64 SDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAND 121
+I REIK+L LR P+I+ + I+ P R +VFE + +D Q+ +
Sbjct: 75 ----KIKREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT-- 125
Query: 122 DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT 180
LT +F++Y++L+ L Y H+ + HRD+KP N++ + + KL++ D+GLA
Sbjct: 126 -LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQ 239
+ VA+R+++ PEL + Y ++D+WS+GC+ A ++ K P F G + Q
Sbjct: 185 E----YNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
Query: 240 LDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQ 299
L + +LGT + + F ++L H +
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNI-----------------------ELDPRFNDILGRHSR 276
Query: 300 VRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
R E+ S+ +P AL L+++L ++ + R TA EA+ PYF
Sbjct: 277 KRWER-------------FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 360 GLAK 363
+ K
Sbjct: 324 TVVK 327
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-58
Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 12/217 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y E IG+G+ G V +A D TG++VAI+++N + I+ EI ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIH 143
IV L +++VV E + + + + L+ L+++H
Sbjct: 79 IVNYLDSYL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 203
+ V HRD+K NIL D +K+ DFG + + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTR 190
Query: 204 FFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Y P +DIWS+G + E++ G+P + +N + L
Sbjct: 191 --KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.1 bits (114), Expect = 1e-06
Identities = 10/48 (20%), Positives = 18/48 (37%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ P Q + + L R L + + R +A+E L + K
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-57
Identities = 58/247 (23%), Positives = 108/247 (43%), Gaps = 18/247 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRH 81
++I +GKG +G V A + ++ +A+K + E ++ RE+++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P+I+ + +R +Y++ E +++ ++ + ++ +L L
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LKI DFG + A + T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-----TTLCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP----SPEAIA 256
+ +D+WS+G + E L GKP F ++ + T + A
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 233
Query: 257 RVCLLLN 263
+ LL
Sbjct: 234 LISRLLK 240
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (106), Expect = 1e-05
Identities = 11/47 (23%), Positives = 15/47 (31%), Gaps = 3/47 (6%)
Query: 314 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
+ F A L+ R+L P RP E L P+
Sbjct: 217 SRVEFTFPDFVT---EGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 6e-57
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 9/218 (4%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+ + + +G+G+YG V A + T E VA+K + D+ V I +EI + ++L H +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHEN 64
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLH-QVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ + Y+ E I+ + + Q F +QL+ G+ Y+
Sbjct: 65 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LKI DFGLA V F T Y APEL
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
+ +D+WS G + +L G+ + + Q
Sbjct: 179 R-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.2 bits (122), Expect = 1e-07
Identities = 9/48 (18%), Positives = 18/48 (37%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
K+ + + + L LL ++L P R T + D ++
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 3e-56
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 15/230 (6%)
Query: 14 DFFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILRE 72
+ F + + IG GS+G V A D R E VAIKK++ + I++E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFF 131
++ L+ LRHP+ ++ + L ++V E S + L
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 132 LYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 191
+ L+GL Y+H+ N+ HRD+K NIL + +K+ DFG A + +V
Sbjct: 121 THGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVG 173
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
T ++ APE + +Y +D+WS+G EL KP N + L
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.2 bits (122), Expect = 1e-07
Identities = 14/86 (16%), Positives = 30/86 (34%), Gaps = 4/86 (4%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 371
+ + P S + ++ L P+DRPT+E L +
Sbjct: 227 AQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
Query: 372 PVTKMEFEFERRRITKEDVRELIYRE 397
TK E + +++++++E
Sbjct: 284 QRTKDAVR-ELDNLQYRKMKKILFQE 308
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-56
Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 18/227 (7%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
Y++ IG GSYG G+ + K+++ ++ ++ E+ LLR L+HP+I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 85 VEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD----LTPEHYQFFLYQLLRGL 139
V ++ + +Y+V E E DL VI L E + QL L
Sbjct: 66 VRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 140 KYIH-----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
K H V HRDLKP N+ + +K+ DFGLAR+ +DT A +V T +
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVGTPY 179
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD 241
Y +PE Y DIWS+GC+ EL P F +
Sbjct: 180 YMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 224
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (99), Expect = 8e-05
Identities = 11/49 (22%), Positives = 20/49 (40%), Gaps = 3/49 (6%)
Query: 309 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 357
+R+ K ++ ++ RML + RP+ EE L +P
Sbjct: 223 AGKIREGKFRRIPYRYS---DELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 190 bits (483), Expect = 8e-56
Identities = 59/239 (24%), Positives = 105/239 (43%), Gaps = 17/239 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y I E +G G++GVV + TG A K + H SD + +EI+ + +LRHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPT 84
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVI-KANDDLTPEHYQFFLYQLLRGLKY 141
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ +GL +
Sbjct: 85 LVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H N H DLKP+NI+ +LK+ DFGL T + APE
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV----KVTTGTAEFAAPE 195
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ D+WS+G + LL+G F G+N L + A + +
Sbjct: 196 VA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 53.5 bits (128), Expect = 3e-08
Identities = 12/90 (13%), Positives = 28/90 (31%)
Query: 283 VFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342
++++ +L E L +++ F + + ++L +
Sbjct: 208 MWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD 267
Query: 343 PKDRPTAEEALADPYFKGLAKVEREPSAQP 372
P R T +AL P+ R+
Sbjct: 268 PNTRMTIHQALEHPWLTPGNAPGRDSQIPS 297
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 1e-55
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 15/222 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++I +G G++G V A + T A K I+ + + + EI +L HP+
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPN 70
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVI--KANDDLTPEHYQFFLYQLLRGLKY 141
IV++ +++++ E + + LT Q Q L L Y
Sbjct: 71 IVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H + HRDLK NIL D +K+ DFG++ ++ T ++ APE+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVV 182
Query: 202 GSFFSK---YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
SK Y D+WS+G E+ +P N + L
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (113), Expect = 2e-06
Identities = 8/46 (17%), Positives = 14/46 (30%)
Query: 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
K P + + L++ L R T + L P+
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 187 bits (476), Expect = 1e-55
Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 23/244 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDA-------TRILREIKLL 76
Y+ +E++G+G VV T ++ A+K I+ A L+E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
LL + +H N+ HRDLKP+NIL + D +K+ DFG + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGT 249
Y APE+ Y +D+WS G I LL G P F + + L IM+
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 250 PSPE 253
SPE
Sbjct: 235 GSPE 238
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 52.4 bits (125), Expect = 5e-08
Identities = 18/77 (23%), Positives = 33/77 (42%)
Query: 283 VFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342
+++ +L + K L + S ++ + + L+ R L +
Sbjct: 198 MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 257
Query: 343 PKDRPTAEEALADPYFK 359
P+ R TAEEALA P+F+
Sbjct: 258 PQKRYTAEEALAHPFFQ 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-55
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 13/224 (5%)
Query: 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+G K + IG+GS+ V DT T +VA ++ D S+ R E ++L+ L+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGL 139
HP+IV + + K I +V ELM S L +K + + + + Q+L+GL
Sbjct: 67 HPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 125
Query: 140 KYIHTAN--VFHRDLKPKNIL-ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
+++HT + HRDLK NI +KI D GLA + A+ + T +
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFM 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
APE+ + KY ++D+++ G E+ T + + Q+
Sbjct: 181 APEM---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 221
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (106), Expect = 1e-05
Identities = 6/45 (13%), Positives = 17/45 (37%)
Query: 315 KKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFK 359
+ + A P ++E + +R + ++ L +F+
Sbjct: 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 188 bits (479), Expect = 3e-55
Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 17/239 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y I E +G G++GVV + TG K IN + D + EI ++ L HP
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPK 87
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLKY 141
++ + + ++ ++ E + +L I A D ++ ++ Q GLK+
Sbjct: 88 LINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H ++ H D+KP+NI+ +KI DFGLA D AT + APE
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAPE 198
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ D+W+IG + LL+G F G++ + L + +A + V
Sbjct: 199 IVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 53.9 bits (129), Expect = 2e-08
Identities = 14/52 (26%), Positives = 26/52 (50%)
Query: 309 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKG 360
L ++++ F + +P A ++ +L EP+ R T +AL P+ KG
Sbjct: 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 7e-55
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 14/247 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
V++ + +Y + +L + I+ +F+ +++ L+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N D ++I DFG A+V ++ A +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIAR 257
+ D+W++GCI +L+ G P F N I+ P P+A
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240
Query: 258 VCLLLNI 264
V LL +
Sbjct: 241 VEKLLVL 247
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (99), Expect = 8e-05
Identities = 15/54 (27%), Positives = 23/54 (42%), Gaps = 9/54 (16%)
Query: 314 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEA------LADPYFKGL 361
K F +KF P A L+E++L + R EE A P+F+ +
Sbjct: 223 IKLEYDFPEKFF---PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 3e-54
Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 17/234 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
Y +V+G G++ V A D RT + VAIK I + EI +L ++HP+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPN 68
Query: 84 IVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
IV + I +Y++ +L+ +L I T ++Q+L +KY+
Sbjct: 69 IVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 143 HTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + D K+ I DFGL+++ + + T Y APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL----STACGTPGYVAPE 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTPSP 252
+ Y+ A+D WSIG I LL G P F +N + I+ SP
Sbjct: 180 VLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 62.7 bits (152), Expect = 3e-11
Identities = 15/106 (14%), Positives = 42/106 (39%)
Query: 283 VFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342
++I +L + +E + + K + S + + + A + ++ +
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKD 251
Query: 343 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 388
P+ R T E+AL P+ G +++ +++ F + + +
Sbjct: 252 PEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-54
Identities = 53/239 (22%), Positives = 109/239 (45%), Gaps = 18/239 (7%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
+Y I E +G+G +G+V +T + + K + +D + +EI +L + RH +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRN 62
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHYQFFLYQLLRGLKY 141
I+ + +++ ++FE + D+ + I + +L +++Q+ L++
Sbjct: 63 ILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 142 IHTANVFHRDLKPKNIL--ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+H+ N+ H D++P+NI+ +KI +FG AR + +T Y APE
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT----APEYYAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ + A D+WS+G + LL+G F + ++ + + T EA +
Sbjct: 174 VHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.5 bits (141), Expect = 7e-10
Identities = 22/106 (20%), Positives = 44/106 (41%), Gaps = 2/106 (1%)
Query: 283 VFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342
++++ +L E ++ + ++ + + F + A+ ++R+L E
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245
Query: 343 PKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKE 388
K R TA EAL P+ K K+ER + T + I K+
Sbjct: 246 RKSRMTASEALQHPWLKQ--KIERVSTKVIRTLKHRRYYHTLIKKD 289
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 13/221 (5%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ + + IG GS+G V Y + VA+K +N E+ +LR RH
Sbjct: 8 GQITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 140
+I+ + +V + E S L+ + + Q +G+
Sbjct: 65 NILLFMGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 199
Y+H ++ HRDLK NI + D +KI DFGLA V + + F + + APE
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAPEV 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
+ + Y+ D+++ G + EL+TG+ + N Q+
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 178 bits (452), Expect = 3e-52
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 5/219 (2%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
RY++ E++G G V A D R VA+K + D+ S R RE + L HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKY 141
IV + + Y+V E ++ L ++ +TP+ + + L +
Sbjct: 68 AIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 142 IHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 201
H + HRD+KP NI+ +A +K+ DFG+AR + + + T Y +PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 202 GSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
D++S+GC+ E+LTG+P F G + V
Sbjct: 187 RG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-50
Identities = 61/247 (24%), Positives = 105/247 (42%), Gaps = 17/247 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLL-RLLRH 81
+ + +++GKGS+G V A +T + AIK + D+ D + E ++L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
P + + ++ V E + DL I++ F+ +++ GL+
Sbjct: 63 PFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
++H+ + +RDLK NIL + D +KI DFG+ + + T Y APE+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIA 256
KY ++D WS G + E+L G+ F G++ I D P EA
Sbjct: 175 LLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
Query: 257 RVCLLLN 263
+ L
Sbjct: 233 LLVKLFV 239
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (104), Expect = 3e-05
Identities = 28/189 (14%), Positives = 58/189 (30%), Gaps = 24/189 (12%)
Query: 193 RWYRAPELC--GSFFS--KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248
+ E G + D+ AE++ G K +V++ + ++L
Sbjct: 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136
Query: 249 TPSPEA------IARVCLLLNIIWCGYDGFMCSVAPSCFL---------VFAIFFFFTEV 293
+ + +L + + G +AP L ++ E+
Sbjct: 137 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 196
Query: 294 LILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAE-EA 352
LI + S+R P + + A LL ++ EP+ R +
Sbjct: 197 LIGQSPFHGQDEEELFHSIRMDNP-FYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDI 252
Query: 353 LADPYFKGL 361
P F+ +
Sbjct: 253 RQHPLFREI 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-50
Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 22/238 (9%)
Query: 24 RYKI-EEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIK-LLRLLRH 81
YK+ +V+G G G V ++ RT EK A+K + D + RE++ R +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQC 64
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDD--LTPEHYQFFLYQLLRG 138
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 65 PHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 139 LKYIHTANVFHRDLKPKNIL---ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 195
++Y+H+ N+ HRD+KP+N+L + LK+ DFG A+ + T T +Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----LTTPCYTPYY 179
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
APE+ G KY + D+WS+G I LL G P F + + M + E
Sbjct: 180 VAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (163), Expect = 1e-12
Identities = 20/105 (19%), Positives = 42/105 (40%), Gaps = 1/105 (0%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQ 371
+R + + ++ + L+ +L EP R T E + P+ KV + P
Sbjct: 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-H 287
Query: 372 PVTKMEFEFERRRITKEDVRELIYREILEYHPQMLKEFLEGSEPT 416
++ + ER KE++ + ++Y +K+ + S P
Sbjct: 288 TSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPL 332
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-49
Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 20/229 (8%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRL 78
S+Y++ ++G G +G V S VAIK + + + + TR+ E+ LL+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 79 LR--HPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQ 134
+ ++ + P ++ E E DL I L E + F +Q
Sbjct: 64 VSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 135 LLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATR 193
+L +++ H V HRD+K +NIL + + +LK+ DFG + + +TD+ TR
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTR 173
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDI 242
Y PE + + + +WS+G + +++ G F + + +
Sbjct: 174 VYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV 221
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (112), Expect = 2e-06
Identities = 13/48 (27%), Positives = 20/48 (41%), Gaps = 3/48 (6%)
Query: 314 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361
+ + F Q+ L+ LA P DRPT EE P+ + +
Sbjct: 217 IRGQVFFRQRVS---SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 62/244 (25%), Positives = 100/244 (40%), Gaps = 20/244 (8%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
Y E +G G + VV + TG + A K I I RE+ +L+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRG 138
+HP+++ + + D+ ++ EL+ L + + LT E FL Q+L G
Sbjct: 71 QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 139 LKYIHTANVFHRDLKPKNILANAD----CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 194
+ Y+H+ + H DLKP+NI+ ++KI DFGLA + T
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTPE 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254
+ APE+ D+WSIG I LL+G F G L ++ + E
Sbjct: 182 FVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
Query: 255 IARV 258
+
Sbjct: 240 FSNT 243
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (132), Expect = 8e-09
Identities = 16/78 (20%), Positives = 34/78 (43%)
Query: 283 VFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342
+++I +L + + L+++ + F N + LA + R+L +
Sbjct: 199 MWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD 258
Query: 343 PKDRPTAEEALADPYFKG 360
PK R T +++L P+ K
Sbjct: 259 PKKRMTIQDSLQHPWIKP 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-48
Identities = 60/245 (24%), Positives = 116/245 (47%), Gaps = 16/245 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPD 83
+ +++GKG++G V + TG A+K + ++ + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESD-LHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+ +K+ R + V E L + T E +F+ +++ L+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ +V +RD+K +N++ + D +KI DFGL + +D T + T Y APE+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLE 178
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIARV 258
+ Y A+D W +G + E++ G+ F ++ + I+ + + P SPEA + +
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236
Query: 259 CLLLN 263
LL
Sbjct: 237 AGLLK 241
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 1e-04
Identities = 13/53 (24%), Positives = 21/53 (39%), Gaps = 8/53 (15%)
Query: 314 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 361
+ I F + P A LL +L +PK R A+E + +F +
Sbjct: 218 LMEEIRFPRTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (429), Expect = 6e-48
Identities = 61/252 (24%), Positives = 106/252 (42%), Gaps = 23/252 (9%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN----DIFEHVSDATRILREIKLLRLL 79
+ + +IG+G +G V TG+ A+K ++ + + + A + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRG 138
P IV + + P + + + +LM DLH + + + +F+ +++ G
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
L+++H V +RDLKP NIL + ++I D GLA P A T Y AP
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMAP 174
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP-------S 251
E+ Y + D +S+GC+ +LL G F + +I L S
Sbjct: 175 EVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 252 PEAIARVCLLLN 263
PE + + LL
Sbjct: 234 PELRSLLEGLLQ 245
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.5 bits (94), Expect = 4e-04
Identities = 14/66 (21%), Positives = 22/66 (33%), Gaps = 8/66 (12%)
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPT-----AEEALAD 355
K + + M + F P LLE +L + R A+E
Sbjct: 209 HKTKDKHEIDRMTLTMAVELPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265
Query: 356 PYFKGL 361
P+F+ L
Sbjct: 266 PFFRSL 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 164 bits (417), Expect = 4e-47
Identities = 45/248 (18%), Positives = 90/248 (36%), Gaps = 20/248 (8%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD-LTPEHYQFFLYQLLRGLK 140
+ + +E +V +L+ L ++ + + Q+L ++
Sbjct: 60 CTGIPNVYYFG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YIHTANVFHRDLKPKNILANADC-----KLKICDFGLARVAFNDTPTAIFW----TDYVA 191
IH ++ +RD+KP N L + + DFG+ + + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251
T Y + + + D+ ++G +F L G + G +
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
Query: 252 PEAIARVC 259
+ +C
Sbjct: 234 STPLRELC 241
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-47
Identities = 57/249 (22%), Positives = 104/249 (41%), Gaps = 23/249 (9%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ + IGKG +G V G KVA+K I + + A L E ++ LRH
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHS 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD--LTPEHYQFFLYQLLRGL 139
++V++ +++ E +Y+V E M L +++ L + F + +
Sbjct: 61 NLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+Y+ N HRDL +N+L + D K+ DFGL + A + T + APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPE 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
K++ D+WS G + E+ + G+ +P + + + +P+
Sbjct: 171 AL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 259 CLLLNIIWC 267
+ + C
Sbjct: 229 VYEV-MKNC 236
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (412), Expect = 3e-46
Identities = 65/260 (25%), Positives = 113/260 (43%), Gaps = 17/260 (6%)
Query: 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEK---VAIKKINDIFEHVSDATRILRE 72
F + + S KIE+VIG G +G VCS + G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 IKLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHYQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT--PTAIFWTD 188
L + G+KY+ N HRDL +NIL N++ K+ DFGL+R +DT PT
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLL 247
+ AP + K+T A D+WS G + E+++ G+ + ++ +
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250
Query: 248 GTPSPEAIARVCLLLNIIWC 267
P P L ++ C
Sbjct: 251 RLPPPMDCPSALHQL-MLDC 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (413), Expect = 3e-46
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 19/245 (7%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHPD 83
++I +G GS+G V G A+K + +I + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHY-QFFLYQLLRGLKYI 142
I+ + ++ + I+++ + +E + P +F+ ++ L+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + + +KI DFG A+ + T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLD-IMTDLLGTP---SPEAIARV 258
+ Y +ID WS G + E+L G F N + + I+ L P + + +
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232
Query: 259 CLLLN 263
L+
Sbjct: 233 SRLIT 237
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 38.9 bits (90), Expect = 0.001
Identities = 11/55 (20%), Positives = 19/55 (34%), Gaps = 10/55 (18%)
Query: 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDR-----PTAEEALADPYFKGL 361
+ + P P N LL R++ + R E+ P+FK +
Sbjct: 214 LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-46
Identities = 55/244 (22%), Positives = 103/244 (42%), Gaps = 13/244 (5%)
Query: 28 EEVIGKGSYGVVCSAY--DTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV 85
++ +G G++G V Y + + VA+K + + + +L E +++ L +P IV
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 86 EIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT 144
+ I E + +V E+ E L++ ++ N + ++ ++Q+ G+KY+
Sbjct: 72 RMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 145 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSF 204
+N HRDL +N+L KI DFGL++ D T + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY- 184
Query: 205 FSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLN 263
K++ D+WS G + E + G+ + G ++ P R L
Sbjct: 185 -YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL- 242
Query: 264 IIWC 267
+ C
Sbjct: 243 MNLC 246
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (412), Expect = 1e-45
Identities = 69/371 (18%), Positives = 117/371 (31%), Gaps = 67/371 (18%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+RY + +G G + V A D VA+K + EIKLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR---GDKVYTEAAEDEIKLLQRVNDA 69
Query: 83 DIVE------------IKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQF 130
D + + H + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQLLRGLKYIHTA-NVFHRDLKPKNILANAD------CKLKICDFGLARVAFNDTPTA 183
QLL GL Y+H + H D+KP+N+L ++KI D G A
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 185
Query: 184 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNV------V 237
+T+ + TR YR+PE+ + + DIWS C+ EL+TG LF
Sbjct: 186 --YTNSIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
Query: 238 HQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILH 297
+ + +LLG + + FF + L+ +
Sbjct: 242 DHIAQIIELLGELPSYLLRNG------------------------KYTRTFFNSRGLLRN 277
Query: 298 CQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPY 357
+ + + K + L ML +P+ R A + P+
Sbjct: 278 ISKLKFWPLEDVLTEKYKFS-------KDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 330
Query: 358 FKGLAKVEREP 368
K +E
Sbjct: 331 LKDTLGMEEIR 341
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (411), Expect = 1e-45
Identities = 49/246 (19%), Positives = 102/246 (41%), Gaps = 17/246 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLLRHP 82
++ + +G GS+G V +G A+K ++ + L E ++L+ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
+V+ L + V+ + ++ ++ + H +F+ Q++ +Y+
Sbjct: 102 FLVK----LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+N+L + +++ DFG A+ T T APE+
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP------EALAPEIIL 211
Query: 203 SFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP----SPEAIARV 258
S Y A+D W++G + E+ G P F + + + S + +
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 259 CLLLNI 264
LL +
Sbjct: 270 RNLLQV 275
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 6e-45
Identities = 48/230 (20%), Positives = 86/230 (37%), Gaps = 18/230 (7%)
Query: 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH 81
G+RY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQG 61
Query: 82 PDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+ E +V EL+ S + + + Q++ ++
Sbjct: 62 GVGIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 141 YIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVAFNDTPTAIFW----TDYVATR 193
YIH+ N HRD+KP N L + I DFGLA+ + + T
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIM 243
Y + + + D+ S+G + G + G +
Sbjct: 178 RYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 19/249 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
++E +G+G +G V +VAIK + L+E ++++ LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHE 72
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME---SDLHQVIKANDDLTPEHYQFFLYQLLRGL 139
+V++ ++ + IY+V E M + L Q+ G+
Sbjct: 73 KLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
Y+ N HRDL+ NIL + K+ DFGLAR+ ++ TA + APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTAPE 184
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
++T D+WS G + EL T G+ +PG LD + P P
Sbjct: 185 AALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242
Query: 259 CLLLNIIWC 267
L + C
Sbjct: 243 LHDL-MCQC 250
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (92), Expect = 7e-04
Identities = 17/66 (25%), Positives = 26/66 (39%), Gaps = 10/66 (15%)
Query: 309 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA--DPYFKGLAKVER 366
L + + +P + P L+ + EP++RPT E A + YF
Sbjct: 224 LDQVERGYRMPCPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST----- 275
Query: 367 EPSAQP 372
EP QP
Sbjct: 276 EPQYQP 281
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 1e-44
Identities = 50/246 (20%), Positives = 103/246 (41%), Gaps = 11/246 (4%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
+ ++ +G G YG V + VA+K + E + L+E +++ ++HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 73
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
++V++ + ++ + + L + +++ + Q+ ++Y+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL 131
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
N HRDL +N L + +K+ DFGL+R+ DT TA + APE
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPESLA 189
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
+K++ D+W+ G + E+ T G +PG ++ +++ PE
Sbjct: 190 Y--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 262 LNIIWC 267
L + C
Sbjct: 248 L-MRAC 252
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-44
Identities = 61/249 (24%), Positives = 100/249 (40%), Gaps = 19/249 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
K+ E +G G +G V Y KVA+K + + L E L++ L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQ 68
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELMESDL---HQVIKANDDLTPEHYQFFLYQLLRGL 139
+V + ++ + IY++ E ME+ + LT Q+ G+
Sbjct: 69 RLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 140 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 199
+I N HRDL+ NIL + KI DFGLAR+ ++ TA + APE
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTAPE 180
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258
+ +T D+WS G + E++T G+ +PG + + P+
Sbjct: 181 AI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 259 CLLLNIIWC 267
L + C
Sbjct: 239 LYQL-MRLC 246
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-44
Identities = 55/252 (21%), Positives = 98/252 (38%), Gaps = 17/252 (6%)
Query: 24 RYKIEEVIGKGSYGVVCSAY---DTRTGEKVAIKKIN-DIFEHVSDATRILREIKLLRLL 79
++ E +G GS+GVV + VA+K + D+ +RE+ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
H +++ + ++ + +V EL S L ++ K + Q+
Sbjct: 69 DHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
G+ Y+ + HRDL +N+L +KI DFGL R + + + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD-IMTDLLGTPSPEAI 255
PE + ++ A D W G E+ T G+ + G N L I + P PE
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 256 ARVCLLLNIIWC 267
+ + ++ C
Sbjct: 241 PQDIYNV-MVQC 251
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-44
Identities = 51/246 (20%), Positives = 95/246 (38%), Gaps = 17/246 (6%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI 84
+ +G G +GVV R VAIK I E + E K++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 85 VEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
V++ + + + I+++ E M L+ + + + + ++Y+
Sbjct: 62 VQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 143 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 202
+ HRDL +N L N +K+ DFGL+R +D T+ + PE+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEVLM 174
Query: 203 SFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261
SK++ DIW+ G + E+ + GK + + + L P +
Sbjct: 175 Y--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232
Query: 262 LNIIWC 267
+ + C
Sbjct: 233 I-MYSC 237
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 67/344 (19%), Positives = 113/344 (32%), Gaps = 72/344 (20%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD 83
++E IGKG +G V GE+VA+K + + EI +LRH +
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 58
Query: 84 IVEIKHILLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYI 142
I+ + + +++V + E L + +T E GL ++
Sbjct: 59 ILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHL 116
Query: 143 HTA--------NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA-IFWTDYVATR 193
H + HRDLK KNIL + I D GLA + T T I V T+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 194 WYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGT 249
Y APE+ + + DI+++G +F E+ + G + +QL +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVPSD 235
Query: 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYL 309
PS E + R+ +
Sbjct: 236 PSVEEM--------------------------------------------------RKVV 245
Query: 310 SSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEAL 353
+ + IP + A + +++ R TA
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-44
Identities = 62/277 (22%), Positives = 115/277 (41%), Gaps = 42/277 (15%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLL- 76
+ +V+G G++G V +A + +VA+K + + + S+ ++ E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMT 95
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 122
+L H +IV + IY++FE DL +++ +
Sbjct: 96 QLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 123 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
LT E F YQ+ +G++++ + HRDL +N+L +KICDFGL
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231
AR +D+ + + + APE F YT D+WS G + E+ + G +
Sbjct: 211 ARDIMSDS-NYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 232 PGKNVVHQL-DIMTDLLGTPSPEAIARVCLLLNIIWC 267
PG V ++ + P ++ + C
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYII-MQSC 303
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-43
Identities = 60/248 (24%), Positives = 104/248 (41%), Gaps = 17/248 (6%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHP 82
S + IG G +G+V Y +KVAIK I E + E +++ L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHP 60
Query: 83 DIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHY-QFFLYQLLRGLK 140
+V++ + L + I +VFE ME L ++ L + G+
Sbjct: 61 KLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ A V HRDL +N L + +K+ DFG+ R +D T T + +PE+
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTKFPVKWASPEV 173
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
FS+Y+ D+WS G + E+ + GK + ++ ++ ++ P +
Sbjct: 174 F--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231
Query: 260 LLLNIIWC 267
+ + C
Sbjct: 232 YQI-MNHC 238
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-43
Identities = 52/238 (21%), Positives = 97/238 (40%), Gaps = 15/238 (6%)
Query: 24 RYKIEEV-IGKGSYGVVCSAYD--TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
I ++ +G G++G V + VAIK + E +D ++RE +++ L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLD 67
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRG 138
+P IV + + + + + +V E+ LH+ + +++ + L+Q+ G
Sbjct: 68 NPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 198
+KY+ N HRDL +N+L KI DFGL++ D + + AP
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
E K++ D+WS G E L+ G+ + + + P
Sbjct: 182 ECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (86), Expect = 0.003
Identities = 12/68 (17%), Positives = 26/68 (38%), Gaps = 6/68 (8%)
Query: 301 RNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEE---ALADPY 357
+ K ++ + + K + + P P L+ ++ +DRP + Y
Sbjct: 214 KKMKGPEVMAFIEQGKRMECPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
Query: 358 FKGLAKVE 365
+ +KVE
Sbjct: 271 YSLASKVE 278
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-42
Identities = 46/236 (19%), Positives = 102/236 (43%), Gaps = 12/236 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYDTR---TGEKVAIKKIN--DIFEHVSDATRILREIKLLRL 78
+++ +V+G G+YG V TG+ A+K + I + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLR 137
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 85 IRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L+++H + +RD+K +NIL +++ + + DFGL++ F T + +
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMAP 199
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPE 253
+ G S + A+D WS+G + ELLTG F + ++ + P
Sbjct: 200 DIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 6e-05
Identities = 12/54 (22%), Positives = 25/54 (46%), Gaps = 6/54 (11%)
Query: 314 KKKPIPFSQKFP-NANPLALRLLERMLAFEPKDRP-----TAEEALADPYFKGL 361
++ + +P + LA L++R+L +PK R A+E +F+ +
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-42
Identities = 59/252 (23%), Positives = 107/252 (42%), Gaps = 16/252 (6%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK----VAIKKINDIFEHVSDATRILREIKLLRL 78
S ++VIG G +G V + K VAIK + + L E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQ 65
Query: 79 LRHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLL 136
H +I+ ++ + ++K + ++ E ME + + + + + + L +
Sbjct: 66 FSHHNIIRLEGV-----ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 196
G+KY+ N HRDL +NIL N++ K+ DFGL+RV +D + +
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255
APE K+T A D+WS G + E++T G+ + + + + D P+P
Sbjct: 181 APEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC 238
Query: 256 ARVCLLLNIIWC 267
L ++ C
Sbjct: 239 PSAIYQL-MMQC 249
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 54/248 (21%), Positives = 98/248 (39%), Gaps = 14/248 (5%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLR 80
+K +V+G G++G V GE VAIK++ + ++ IL E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVD 69
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLK 140
+P + + I L + + + L V + D++ ++ + Q+ +G+
Sbjct: 70 NPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 141 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L +KI DFGLA++ + A E
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-LGAEEKEYHAEGGKVPIKWMALES 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259
YT D+WS G EL+T G + G I+ P P
Sbjct: 185 ILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 260 LLLNIIWC 267
++ ++ C
Sbjct: 243 YMI-MVKC 249
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-41
Identities = 57/251 (22%), Positives = 100/251 (39%), Gaps = 15/251 (5%)
Query: 24 RYKIEEVIGKGSYGVVCSAYD---TRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR 80
EVIG+G +G V A+K +N I + + ++ L E +++
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-GEVSQFLTEGIIMKDFS 86
Query: 81 HPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQ--FFLYQLLRG 138
HP+++ + I L VV M+ + N+ P F Q+ +G
Sbjct: 87 HPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 139 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATRWYRA 197
+K++ + HRDL +N + + +K+ DFGLAR + + + T + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
E + K+T D+WS G + EL+T G P +P N + PE
Sbjct: 203 LESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 260
Query: 257 RVCLLLNIIWC 267
+ ++ C
Sbjct: 261 DPLYEV-MLKC 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 3e-40
Identities = 54/276 (19%), Positives = 99/276 (35%), Gaps = 41/276 (14%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
+ + IG+G++G V A VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + K + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGV-----CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172
L+ Q+ G+ Y+ HRDL +N L + +KI DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231
+R ++ D + RW + ++YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFY---NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWC 267
G + + D PE L + C
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYNL-MRLC 278
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 64/272 (23%), Positives = 104/272 (38%), Gaps = 37/272 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLL- 76
+R + +G G++G V A VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD------------- 122
L H +IV + V+ E DL ++ D
Sbjct: 82 YLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 123 -----LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
L E F YQ+ +G+ ++ + N HRDL +NIL KICDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236
ND+ + + +W + YT D+WS G EL + G +PG V
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFN---CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 237 VHQL-DIMTDLLGTPSPEAIARVCLLLNIIWC 267
+ ++ + SPE + + C
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDI-MKTC 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-39
Identities = 57/266 (21%), Positives = 99/266 (37%), Gaps = 34/266 (12%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLL-RLL 79
+ K ++VIG+G++G V A + G + AIK++ + D E+++L +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLG 68
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD---------------- 122
HP+I+ + +Y+ E +L ++ +
Sbjct: 69 HHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 123 LTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182
L+ + F + RG+ Y+ HRDL +NIL + KI DFGL+R
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLD 241
T + A E S YT D+WS G + E+++ G + G +
Sbjct: 184 ----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 242 IMTDLLGTPSPEAIARVCLLLNIIWC 267
+ P L + C
Sbjct: 238 KLPQGYRLEKPLNCDDEVYDL-MRQC 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-39
Identities = 55/251 (21%), Positives = 95/251 (37%), Gaps = 18/251 (7%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRT---GEKVAIKKINDIFEHVSDATRILREIKLLRLL 79
R ++ IG+G +G V VAIK + S + L+E +R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMRQF 65
Query: 80 RHPDIVEIKHILLPPSRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLR 137
HP IV++ ++ ++++ EL + L + YQL
Sbjct: 66 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 138 GLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 197
L Y+ + HRD+ +N+L +++ +K+ DFGL+R + T + + A
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKWMA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256
PE ++T A D+W G E+L G F G + + + P P
Sbjct: 178 PESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 257 RVCLLLNIIWC 267
L + C
Sbjct: 236 PTLYSL-MTKC 245
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.004
Identities = 15/63 (23%), Positives = 25/63 (39%), Gaps = 8/63 (12%)
Query: 309 LSSMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREP 368
+ + + +P PN P L+ + A++P RP E A L+ + E
Sbjct: 219 IGRIENGERLPMP---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ-----LSTILEEE 270
Query: 369 SAQ 371
AQ
Sbjct: 271 KAQ 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 55/271 (20%), Positives = 107/271 (39%), Gaps = 36/271 (13%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-------KVAIKKINDIFEHVSDATRILREIKL 75
R + + +G+G++G V A + KVA+K + D + ++ E+++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEM 71
Query: 76 L-RLLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIK--------------- 118
+ + +H +I+ + + +YV+ E +L + ++
Sbjct: 72 MKMIGKHKNIINLLGA-----CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 119 -ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177
+ L+ + YQ+ RG++Y+ + HRDL +N+L D +KI DFGLAR
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNV 236
+ + +W L YT D+WS G + E+ T G +PG V
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 237 VHQLDIMTDLLGTPSPEAIARVCLLLNIIWC 267
++ + P ++ + C
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMM-MRDC 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-37
Identities = 60/269 (22%), Positives = 110/269 (40%), Gaps = 32/269 (11%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYD-----TRTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
R K+ + +G+G++G V A T T VA+K + + H + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKAN---------------- 120
+ H ++V + P + V+ E + +L +++
Sbjct: 73 IGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
D LT EH + +Q+ +G++++ + HRDL +NIL + +KICDFGLAR + D
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 187
Query: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQ 239
P + D + APE YT D+WS G + E+ + +PG + +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 240 L-DIMTDLLGTPSPEAIARVCLLLNIIWC 267
+ + +P+ ++ C
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQT-MLDC 273
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-37
Identities = 48/262 (18%), Positives = 95/262 (36%), Gaps = 27/262 (10%)
Query: 23 SRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLR 77
+ + +G+GS+G+V +VAIK +N+ + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMK 78
Query: 78 LLRHPDIVEIKHILLPPSRREFKDIYVVFELME-SDLHQVIKANDD----------LTPE 126
+V + ++ V+ ELM DL +++ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 127 HYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 186
++ G+ Y++ HRDL +N + D +KI DFG+ R +T
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYRKG 192
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTD 245
+ + +PE +T D+WS G + E+ T + + G + L + +
Sbjct: 193 GKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 246 LLGTPSPEAIARVCLLLNIIWC 267
P+ + L + C
Sbjct: 251 GGLLDKPDNCPDMLFEL-MRMC 271
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 100 bits (250), Expect = 5e-25
Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 27/203 (13%)
Query: 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKI--------NDIFEHVSDATRILREIKLL 76
I +++G+G V + Y + +K +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLL 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD-YVATRWY 195
+ + + H DL N+L ++ + I DF + + I D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIG 218
Y DI S
Sbjct: 173 S---------RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 599 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.71 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.27 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.24 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.83 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-60 Score=497.83 Aligned_cols=334 Identities=42% Similarity=0.782 Sum_probs=277.7
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
+.|...++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.++|||||+++++|.....
T Consensus 12 ~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 34667899999999999999999999999999999999998766666677889999999999999999999999976532
Q ss_pred -CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 -REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 -~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
....++||||||++.+|..+++. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 92 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 33457899999998888888765 4799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.... .+..++|++|+|||++.+. ..++.++||||+||++|+|++|++||.+.+..+++..+....|.++.+.+
T Consensus 171 ~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 5432 2567899999999998652 46789999999999999999999999999999999999999999998876
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. ........+...+.......+...+++++++++|||
T Consensus 244 ~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 281 (346)
T d1cm8a_ 244 QR------------------------------------------LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281 (346)
T ss_dssp HT------------------------------------------CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHH
T ss_pred hh------------------------------------------hcchhhhhhhccCCcccccchHHhccCCCHHHHHHH
Confidence 54 334445566677777777888888899999999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
.+||.+||.+|||++|+|+||||+++...+.+|..+ +++..++....+.+++++++++|+++|+|
T Consensus 282 ~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 282 EKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred HHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence 999999999999999999999999998777776554 34455666677899999999999999886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-58 Score=484.34 Aligned_cols=340 Identities=48% Similarity=0.849 Sum_probs=283.9
Q ss_pred ccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 18 EYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 18 ~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
.|..++||++++.||+|+||+||+|+++.+|+.||||+++.. ......+++.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 467889999999999999999999999999999999999743 3445567889999999999999999999999776655
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
....+|||+++++++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55678899888889999999765 69999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
............+||+.|+|||++... ..|+.++||||+||++|+|++|++||.+.+..++...+...++.+..+....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 443333344667899999999998553 5789999999999999999999999999999999999999999988775433
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
........+...+......++...++.+++.+++||.+
T Consensus 240 ------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 277 (345)
T d1pmea_ 240 ------------------------------------------IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277 (345)
T ss_dssp ------------------------------------------CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH
T ss_pred ------------------------------------------hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHH
Confidence 33334456666677777778888899999999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChh
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHPQ 404 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~~ 404 (599)
||++||.+||||+|+|+||||+....+.+++..... +.++.+.+..+++++++++++|...++|+
T Consensus 278 ~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~e~~~~~~~ 342 (345)
T d1pmea_ 278 MLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFDMELDDLPKEKLKELIFEETARFQPG 342 (345)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--C--------CCHHHHHHHHHHHSGGGSTT
T ss_pred HccCChhHCcCHHHHhcCHhhccCCCCccCccccCc--cCCChhhhhCCHHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999988776665544332 34455667889999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-58 Score=483.90 Aligned_cols=334 Identities=43% Similarity=0.827 Sum_probs=284.0
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
+.|.+.+||++++.||+|+||+||+|+++.+|+.||||+++.........+++.+|+.+|+.++|||||++++++.....
T Consensus 12 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp SEEEEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 34667899999999999999999999999999999999998776666777889999999999999999999999965433
Q ss_pred -CCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 -REFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 -~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
++...+|+++++.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|++|||++..
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred cccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcc
Confidence 33445677777666899998854 5799999999999999999999999999999999999999999999999999965
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
... ......||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|.+..+.+..+..
T Consensus 171 ~~~------~~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTG------GGSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cCc------ccccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 432 23456899999999987652 45789999999999999999999999999999999999999999888755
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. ........+...+.......+...+...+++++|||
T Consensus 244 ~~------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 281 (348)
T d2gfsa1 244 KK------------------------------------------ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281 (348)
T ss_dssp TT------------------------------------------CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHH
T ss_pred hh------------------------------------------ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHH
Confidence 43 334445566666666666777777889999999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREILEYHP 403 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~~~~~ 403 (599)
++||++||.+||||+|+|+||||+++..+..++...+. +.+++....+.+++++++++|+.+|.|
T Consensus 282 ~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~k~~~~~e~~~~~p 346 (348)
T d2gfsa1 282 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346 (348)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---CCGGGGCCCCHHHHHHHHHHHHHTCCC
T ss_pred HHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---CCcccchhcCHHHHHHHHHHHhhccCC
Confidence 99999999999999999999999999888777766543 567788899999999999999998876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=472.61 Aligned_cols=329 Identities=37% Similarity=0.690 Sum_probs=254.9
Q ss_pred cCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc-C
Q 007542 19 YGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR-R 97 (599)
Q Consensus 19 ~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~-~ 97 (599)
|..-++|+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||++++++|..... +
T Consensus 13 f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 13 FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccc
Confidence 444589999999999999999999999999999999998766666777889999999999999999999999965432 3
Q ss_pred CCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...++|+||||+.++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 93 ~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp TCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred cCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence 557899999999998888774 469999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ..+..++|+.|+|||++.+ ..++.++||||+||++++|++|++||.+.+...++.+|...++.+.++.+..
T Consensus 171 ~~~----~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 171 TSF----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp --------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccc----ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 322 2356789999999999987 6899999999999999999999999999999999999999999999887654
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC------------C
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF------------P 325 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~------------~ 325 (599)
.. .....+...............+ .
T Consensus 245 ~~-------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (355)
T d2b1pa1 245 LQ-------------------------------------------PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281 (355)
T ss_dssp SC-------------------------------------------HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHH
T ss_pred hh-------------------------------------------hhHHHHhhcCccccccccccccccccccccccccc
Confidence 11 1112222222211111111111 1
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCccCCCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHH
Q 007542 326 NANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLAKVEREPSAQPVTKMEFEFERRRITKEDVRELIYREIL 399 (599)
Q Consensus 326 ~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~~~~~e~~~~~~~~~~~~~e~~~~~~e~~~~~~~~e~~ 399 (599)
..+++++|||++||.+||++||||+|+|+||||+...+++.+....+ ...+.+++.+..+.++++++|++|++
T Consensus 282 ~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 282 LKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp HHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC--------CCCCCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCC-CCCCcchhhhhcCHHHHHHHHHHHhc
Confidence 24678999999999999999999999999999998765433332222 33455677788999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=465.81 Aligned_cols=284 Identities=36% Similarity=0.571 Sum_probs=229.8
Q ss_pred EEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChh---hHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccEE
Q 007542 27 IEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVS---DATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDIY 103 (599)
Q Consensus 27 i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~---~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ly 103 (599)
.+++||+|+||+||+|+++.+|+.||||+++....... ....+.+|+.+|+.++|||||++++++... ..+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence 57899999999999999999999999999975332221 134688999999999999999999999543 4689
Q ss_pred EEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCCC
Q 007542 104 VVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 182 (599)
Q Consensus 104 lV~E~~~g~L~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~~ 182 (599)
|||||+.+++...+. ....+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 999999975555444 456799999999999999999999999999999999999999999999999999976543322
Q ss_pred cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhhh
Q 007542 183 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLLL 262 (599)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~ 262 (599)
.....+||++|+|||++... ..|+.++||||+|||+|||++|++||.+.+..+++..|.+.+|+|..+.+..
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~----- 227 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD----- 227 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS-----
T ss_pred --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc-----
Confidence 23456899999999998652 5689999999999999999999999999999999999999999998764322
Q ss_pred hhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcccC
Q 007542 263 NIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAFE 342 (599)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~D 342 (599)
....... ..+......++...++..++.++|||.+||++|
T Consensus 228 ------~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~d 267 (299)
T d1ua2a_ 228 ------MCSLPDY----------------------------------VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267 (299)
T ss_dssp ------TTSSTTC----------------------------------CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSS
T ss_pred ------hhccchh----------------------------------hhhccCCCCChHHhcccCCHHHHHHHHHHccCC
Confidence 1100000 001122334455566788999999999999999
Q ss_pred CCCCCCHHHHhcCccccCCccC
Q 007542 343 PKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 343 P~~RpTa~e~L~HP~f~~~~~~ 364 (599)
|++||||+|+|+||||++...+
T Consensus 268 P~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 268 PCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp TTTSCCHHHHHTSGGGTSSSCC
T ss_pred hhhCcCHHHHhCCHhhCCCCCC
Confidence 9999999999999999976543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=458.54 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=214.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
-++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|+.++|||||++++++.+ .+.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~ 77 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI 77 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Cce
Confidence 467999999999999999999999999999999996432 22234578899999999999999999999954 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999 5999999888899999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCccccCccccccccCC-CCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~-~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ....+..+||+.|+|||++.+ .. ++.++||||||||+|+|++|++||.+.+...+...+...
T Consensus 158 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~------------- 221 (271)
T d1nvra_ 158 R-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------- 221 (271)
T ss_dssp E-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-------------
T ss_pred c-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Confidence 1 222456789999999999876 44 467899999999999999999999876544332221110
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.......++.+++.+.+||.+||
T Consensus 222 ---------------------------------------------------------~~~~~~~~~~~s~~~~~li~~~L 244 (271)
T d1nvra_ 222 ---------------------------------------------------------KKTYLNPWKKIDSAPLALLHKIL 244 (271)
T ss_dssp ---------------------------------------------------------TCTTSTTGGGSCHHHHHHHHHHS
T ss_pred ---------------------------------------------------------CCCCCCccccCCHHHHHHHHHHc
Confidence 00111223457899999999999
Q ss_pred ccCCCCCCCHHHHhcCccccC
Q 007542 340 AFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+.||++|||++|+|+||||+.
T Consensus 245 ~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 245 VENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp CSSTTTSCCHHHHTTCTTTTC
T ss_pred CCChhHCcCHHHHhcCHhhCc
Confidence 999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=453.42 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=219.1
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||+||+|+++.+|+.||||++.... ........+.+|+.+|+.++|||||++++++.+ ...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-----ATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-----CCE
Confidence 57999999999999999999999999999999986432 122345678899999999999999999999954 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999999 6999999988899999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+.-
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------------- 220 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------- 220 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 245689999999999987 679999999999999999999999999887766555443210
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
. .....+++.+.+||.+||+
T Consensus 221 ---------------------------------------------------------~---~~p~~~s~~~~~li~~~L~ 240 (263)
T d2j4za1 221 ---------------------------------------------------------F---TFPDFVTEGARDLISRLLK 240 (263)
T ss_dssp ---------------------------------------------------------C---CCCTTSCHHHHHHHHHHTC
T ss_pred ---------------------------------------------------------C---CCCccCCHHHHHHHHHHcc
Confidence 0 0113478899999999999
Q ss_pred cCCCCCCCHHHHhcCccccC
Q 007542 341 FEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~ 360 (599)
.||.+|||++|+|+||||++
T Consensus 241 ~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 241 HNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp SSGGGSCCHHHHHTCHHHHH
T ss_pred CCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-56 Score=455.99 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=219.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|+.++|||||++++++.. ...
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCE
Confidence 568999999999999999999999999999999997432 2345678999999999999999999999954 347
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|||||||+ |+|.+++..+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999 5999887764 69999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+.... .+
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~---------- 234 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TP---------- 234 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SC----------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CC----------
Confidence 2 2356689999999999987 679999999999999999999999999888766655443211 00
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
.....+.+++.+++||.+||+
T Consensus 235 -----------------------------------------------------------~~~~~~~~s~~~~~li~~~L~ 255 (293)
T d1yhwa1 235 -----------------------------------------------------------ELQNPEKLSAIFRDFLNRCLD 255 (293)
T ss_dssp -----------------------------------------------------------CCSSGGGSCHHHHHHHHHHTC
T ss_pred -----------------------------------------------------------CCCCcccCCHHHHHHHHHHcc
Confidence 001123578899999999999
Q ss_pred cCCCCCCCHHHHhcCccccC
Q 007542 341 FEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~ 360 (599)
.||.+|||++|+|+||||+.
T Consensus 256 ~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 256 MDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp SSTTTSCCHHHHTTCGGGGG
T ss_pred CChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=464.76 Aligned_cols=297 Identities=22% Similarity=0.332 Sum_probs=219.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+. ..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 78 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 78 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 578999999999999999999999999999999997543 334457889999999999999999999999543 47
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|||||||. |+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999 5999999988899999999999999999999997 48999999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChh-hHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVV-HQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~-~~l~~I~~~lg~p~~e~i~~~ 258 (599)
. .++.+||++|+|||++.+ ..|+.++||||+|||+|||++|+.||.+.+.. .++..+....|.+........
T Consensus 159 ~-----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 159 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp T-----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred c-----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 2 245799999999999987 68999999999999999999999999887643 333333333443322111000
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
+.+.. .... .... .......+.+..+....+..+. ....|++++|||++|
T Consensus 232 -------~~~~~-----~~~~-------------~~~~---~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~ 281 (322)
T d1s9ja_ 232 -------TPGRP-----LSSY-------------GMDS---RPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKC 281 (322)
T ss_dssp ------------------------------------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHH
T ss_pred -------ccccc-----cccc-------------cccc---ccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHH
Confidence 00000 0000 0000 0000011112222222221111 123688999999999
Q ss_pred cccCCCCCCCHHHHhcCccccCC
Q 007542 339 LAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|++||.+||||+|+|+||||+..
T Consensus 282 L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 282 LIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp TCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cCCChhHCcCHHHHhhCHhhCcC
Confidence 99999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=456.40 Aligned_cols=289 Identities=38% Similarity=0.633 Sum_probs=236.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence 58999999999999999999999999999999997544444445788999999999999999999999954 3579
Q ss_pred EEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 103 YVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 103 ylV~E~~~g~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
|+||||+.+++.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887777754 3479999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
......+||+.|+|||++... ..++.++||||+||++|+|++|+.||.+.+..+++..+.+..|.+....+.....
T Consensus 157 ---~~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 ---RTYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp ---BCTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ---ccceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 223566899999999987652 4568899999999999999999999999999999999999999887653322100
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
. ..+...........+...++.++++++|||++||+
T Consensus 233 --------~------------------------------------~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~ 268 (298)
T d1gz8a_ 233 --------M------------------------------------PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLH 268 (298)
T ss_dssp --------S------------------------------------TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTC
T ss_pred --------c------------------------------------cccccccccccccchhhhccCCCHHHHHHHHHHcc
Confidence 0 00001111222233344567889999999999999
Q ss_pred cCCCCCCCHHHHhcCccccCCccC
Q 007542 341 FEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
+||++|||++|+|+||||+++.++
T Consensus 269 ~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 269 YDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp SSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred CChhHCcCHHHHhCCHhhccCCCC
Confidence 999999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=450.04 Aligned_cols=263 Identities=28% Similarity=0.448 Sum_probs=224.9
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC----ChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE----HVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~----~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
...++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 84 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-- 84 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 456899999999999999999999999999999999964322 12246788999999999999999999999954
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC----ceeeecc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC----KLKICDF 170 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~----~lKL~DF 170 (599)
...+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+||
T Consensus 85 ---~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 85 ---KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp ---SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred ---CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 357999999999 69999999888999999999999999999999999999999999999998876 4999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
|+|+...... ......+|+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+..+.+..|...-...
T Consensus 162 G~a~~~~~~~----~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 162 GLAHKIDFGN----EFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp TTCEECTTSC----BCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred hhhhhcCCCc----cccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9998764322 2345689999999999987 679999999999999999999999999988877776665432222
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
+. ..+++.|+.
T Consensus 236 ~~---------------------------------------------------------------------~~~~~~s~~ 246 (293)
T d1jksa_ 236 ED---------------------------------------------------------------------EYFSNTSAL 246 (293)
T ss_dssp CH---------------------------------------------------------------------HHHTTSCHH
T ss_pred Cc---------------------------------------------------------------------hhcCCCCHH
Confidence 11 112457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+++||++||+.||.+|||++|+|+||||++..
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999998653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=444.95 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=216.6
Q ss_pred CCce-EEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 22 GSRY-KIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY-~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.+|| ++.++||+|+||+||+|+++.++..||+|++..........+.+.+|+.+|+.++|||||++++++.... ....
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCC
Confidence 4456 7788999999999999999999999999999866556666778999999999999999999999986432 2345
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCc--eEeccCCCCceEec-CCCceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILv~-~~~~lKL~DFGla~~~ 176 (599)
.+||||||++ |+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 7999999999 599999998889999999999999999999999999 99999999999997 4789999999999864
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|+.||.+......+...... |.++
T Consensus 166 ~~~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~----- 231 (270)
T d1t4ha_ 166 RAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP----- 231 (270)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC-----
T ss_pred cCC-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC-----
Confidence 322 1245689999999999865 5999999999999999999999999876544433221110 0000
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
.......++++.+||.
T Consensus 232 ----------------------------------------------------------------~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 232 ----------------------------------------------------------------ASFDKVAIPEVKEIIE 247 (270)
T ss_dssp ----------------------------------------------------------------GGGGGCCCHHHHHHHH
T ss_pred ----------------------------------------------------------------cccCccCCHHHHHHHH
Confidence 0111346788999999
Q ss_pred HhcccCCCCCCCHHHHhcCcccc
Q 007542 337 RMLAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~ 359 (599)
+||+.||++|||++|+|+||||+
T Consensus 248 ~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=453.91 Aligned_cols=290 Identities=34% Similarity=0.611 Sum_probs=237.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCC-CcEEEEEEecCccCChhhHHHHHHHHHHHHhc---CCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRT-GEKVAIKKINDIFEHVSDATRILREIKLLRLL---RHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~t-g~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l---~HpnIv~l~~v~~~~s~~ 97 (599)
.++|++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57999999999999999999999766 66799999975444433344566888887766 799999999999755444
Q ss_pred CCccEEEEEecCCccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELMESDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
....+|+||||+++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 5568999999999866655543 35799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.... ......+||+.|+|||++.+ ..|+.++||||+||++|||++|++||.+.+..+++..|...+|.|..+.+
T Consensus 166 ~~~~----~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQ----MALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGG----GGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hccc----ccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 4322 23456789999999999977 68999999999999999999999999999999999999999999877543
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. ..... -..+......+.......+++.++|||
T Consensus 240 ~~-----------~~~~~-----------------------------------~~~~~~~~~~~~~~~~~~~s~~~~dli 273 (305)
T d1blxa_ 240 PR-----------DVALP-----------------------------------RQAFHSKSAQPIEKFVTDIDELGKDLL 273 (305)
T ss_dssp CT-----------TCSSC-----------------------------------GGGSCCCCCCCGGGTCCSCCHHHHHHH
T ss_pred cc-----------cccch-----------------------------------hhhhccccccchhhccccCCHHHHHHH
Confidence 22 00000 001122233445556678899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCcc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLAK 363 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~~ 363 (599)
.+||++||++||||+|+|+||||+++..
T Consensus 274 ~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 274 LKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 9999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-56 Score=454.09 Aligned_cols=259 Identities=26% Similarity=0.456 Sum_probs=218.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|+++++||+|+||+||+|+++.+|+.||||+++... ........+.+|+.+|+.++||||+++++++.+ .+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-----SSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-----CCE
Confidence 67999999999999999999999999999999996432 122345678999999999999999999999954 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999 5999999998999999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+....+..|.+.-
T Consensus 163 ~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~------------- 226 (288)
T d1uu3a_ 163 K-QARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE------------- 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-------------
T ss_pred c-ccccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 2 122355789999999999987 679999999999999999999999999987766655543210
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
.. ....+++.+++||++||+
T Consensus 227 ---------------------------------------------------------~~---~p~~~s~~~~~li~~~L~ 246 (288)
T d1uu3a_ 227 ---------------------------------------------------------YD---FPEKFFPKARDLVEKLLV 246 (288)
T ss_dssp ---------------------------------------------------------CC---CCTTCCHHHHHHHHTTSC
T ss_pred ---------------------------------------------------------CC---CCccCCHHHHHHHHHHcc
Confidence 00 113578899999999999
Q ss_pred cCCCCCCCHHH------HhcCccccCCc
Q 007542 341 FEPKDRPTAEE------ALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~RpTa~e------~L~HP~f~~~~ 362 (599)
.||.+|||++| +++||||+++.
T Consensus 247 ~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 247 LDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp SSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred CCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 99999999987 58899999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=446.26 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=209.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.++|||||++++++.+. ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 5689999999999999999999999999999999987655666677899999999999999999999998643 2346
Q ss_pred EEEEEecCC-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHhhhCc-----eEeccCCCCceEecCCCceeeeccc
Q 007542 102 IYVVFELME-SDLHQVIKA----NDDLTPEHYQFFLYQLLRGLKYIHTAN-----VFHRDLKPKNILANADCKLKICDFG 171 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~lse~~i~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILv~~~~~lKL~DFG 171 (599)
+|||||||+ |+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence 899999999 699998864 457999999999999999999999876 9999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
+|+....... ..+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..|.+.
T Consensus 160 ~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~----- 229 (269)
T d2java1 160 LARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----- 229 (269)
T ss_dssp HHHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----
T ss_pred ceeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----
Confidence 9987643322 2346789999999999977 67999999999999999999999999988766554444320
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
.+......+++++
T Consensus 230 -------------------------------------------------------------------~~~~~~~~~s~~l 242 (269)
T d2java1 230 -------------------------------------------------------------------KFRRIPYRYSDEL 242 (269)
T ss_dssp -------------------------------------------------------------------CCCCCCTTSCHHH
T ss_pred -------------------------------------------------------------------CCCCCCcccCHHH
Confidence 0111223578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYF 358 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f 358 (599)
.+||.+||+.||.+|||++|+|+|||+
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-55 Score=454.44 Aligned_cols=260 Identities=29% Similarity=0.453 Sum_probs=207.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..++|+++++||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||++++++.+ ..
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~ 80 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYES-----GG 80 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CC
Confidence 457799999999999999999999999999999999754322 234567899999999999999999999954 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec---CCCceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN---ADCKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~---~~~~lKL~DFGla~~~ 176 (599)
.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 7999999999 69999999988999999999999999999999999999999999999995 4789999999999865
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......|.+.-.
T Consensus 161 ~~~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-------- 226 (307)
T d1a06a_ 161 DPGS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-------- 226 (307)
T ss_dssp ----------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC--------
T ss_pred cCCC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--------
Confidence 3322 2345789999999999987 6799999999999999999999999998877665555442111
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
......++.+|+.+.+||.
T Consensus 227 -------------------------------------------------------------~~~~~~~~~~s~~~~~li~ 245 (307)
T d1a06a_ 227 -------------------------------------------------------------EFDSPYWDDISDSAKDFIR 245 (307)
T ss_dssp -------------------------------------------------------------CCCTTTTTTSCHHHHHHHH
T ss_pred -------------------------------------------------------------CCCCccccCCCHHHHHHHH
Confidence 1111234578999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||+.||.+|||++|+|+||||++.
T Consensus 246 ~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 246 HLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-55 Score=456.86 Aligned_cols=256 Identities=24% Similarity=0.440 Sum_probs=222.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|+++++||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++||||+++++++.+ ...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-----HDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-----SSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-----ccc
Confidence 57999999999999999999999999999999997532 123346778899999999999999999999954 457
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999 6999999999999999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
. .....+||++|+|||++.+ ..|+.++||||||||+|||++|++||.+.+....+..|...
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~-------------- 220 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------------- 220 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--------------
Confidence 2 2356799999999999987 68999999999999999999999999998876655444320
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
.. .....+|+++++||++||+
T Consensus 221 --------------------------------------------------------~~---~~p~~~s~~~~dli~~~L~ 241 (337)
T d1o6la_ 221 --------------------------------------------------------EI---RFPRTLSPEAKSLLAGLLK 241 (337)
T ss_dssp --------------------------------------------------------CC---CCCTTSCHHHHHHHHHHTC
T ss_pred --------------------------------------------------------CC---CCCccCCHHHHHHHHhhcc
Confidence 00 1123578999999999999
Q ss_pred cCCCCCC-----CHHHHhcCccccCC
Q 007542 341 FEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
+||.+|+ +++|+|+||||+++
T Consensus 242 ~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 242 KDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCchhhcccccccHHHHHcCcccccC
Confidence 9999999 49999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.8e-55 Score=460.09 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=224.2
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
-++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+ .+.
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 97 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNE 97 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCE
Confidence 46899999999999999999999999999999999753 34456788999999999999999999999943 357
Q ss_pred EEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC--CCceeeeccccccccc
Q 007542 102 IYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA--DCKLKICDFGLARVAF 177 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~--~~~lKL~DFGla~~~~ 177 (599)
+|||||||+ |+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999 699999854 467999999999999999999999999999999999999964 6889999999998764
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... .....+||++|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+.+..|......++
T Consensus 178 ~~~----~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 245 (350)
T d1koaa2 178 PKQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD------ 245 (350)
T ss_dssp TTS----CEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC------
T ss_pred ccc----ccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 322 2345789999999999987 6799999999999999999999999999888777766654322211
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
...++.+++.+++||.+
T Consensus 246 ---------------------------------------------------------------~~~~~~~s~~~~~li~~ 262 (350)
T d1koaa2 246 ---------------------------------------------------------------DSAFSGISEDGKDFIRK 262 (350)
T ss_dssp ---------------------------------------------------------------CGGGGGCCHHHHHHHHH
T ss_pred ---------------------------------------------------------------cccccCCCHHHHHHHHH
Confidence 12234578899999999
Q ss_pred hcccCCCCCCCHHHHhcCccccCCccC
Q 007542 338 MLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
||++||++|||++|+|+||||+....+
T Consensus 263 ~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 263 LLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HccCChhHCcCHHHHhcCcccCCCCCC
Confidence 999999999999999999999976543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=449.09 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=218.1
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
..+.|++++.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.+ .+
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~ 82 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----EN 82 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CC
Confidence 346799999999999999999999999999999999653 33455678899999999999999999999954 35
Q ss_pred cEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 101 DIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
.+|||||||. |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 7999999999 599998765 45799999999999999999999999999999999999999999999999999975422
Q ss_pred CCCCcccccccccCccccCccccccc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~---~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
.. ......+||+.|+|||++... ...|+.++|||||||++|+|++|++||.+.+..+.+..|....
T Consensus 163 ~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~-------- 231 (288)
T d2jfla1 163 TI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE-------- 231 (288)
T ss_dssp HH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--------
T ss_pred Cc---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--------
Confidence 11 122456899999999998431 2458999999999999999999999999888776655543210
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.+.....+.+++++.+||
T Consensus 232 --------------------------------------------------------------~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 232 --------------------------------------------------------------PPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp --------------------------------------------------------------CCCCSSGGGSCHHHHHHH
T ss_pred --------------------------------------------------------------CCCCCccccCCHHHHHHH
Confidence 001111235788999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccC
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~ 360 (599)
++||+.||.+|||++|+|+||||+.
T Consensus 250 ~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-54 Score=457.78 Aligned_cols=261 Identities=27% Similarity=0.426 Sum_probs=225.0
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
...++|++++.||+|+||+||+|+++.+|+.||||+++.. .......+.+|+.+|+.++|||||++++++.+ .
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~ 98 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----K 98 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----S
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence 3456899999999999999999999999999999999753 23445678899999999999999999999954 3
Q ss_pred ccEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEec--CCCceeeeccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILAN--ADCKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~--~~~~lKL~DFGla~~ 175 (599)
..+|||||||+ |+|.+.+...+ .+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeeccccee
Confidence 57999999999 69999887654 699999999999999999999999999999999999998 578999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..... ......||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|......+
T Consensus 179 ~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----- 247 (352)
T d1koba_ 179 LNPDE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF----- 247 (352)
T ss_dssp CCTTS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC-----
T ss_pred cCCCC----ceeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----
Confidence 64332 2345689999999999987 679999999999999999999999999988877776665422211
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
....++.+++++.+||
T Consensus 248 ----------------------------------------------------------------~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 248 ----------------------------------------------------------------DEDAFSSVSPEAKDFI 263 (352)
T ss_dssp ----------------------------------------------------------------CSSTTTTSCHHHHHHH
T ss_pred ----------------------------------------------------------------CcccccCCCHHHHHHH
Confidence 1233467899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 336 ERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 336 ~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
++||++||.+|||++|+|+||||++..
T Consensus 264 ~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999999999999999999998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.6e-55 Score=445.24 Aligned_cols=284 Identities=38% Similarity=0.655 Sum_probs=233.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
+||+++++||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++++... +.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Cce
Confidence 69999999999999999999985 889999999976544444467899999999999999999999999543 479
Q ss_pred EEEEecCCccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMESDLHQVI-KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g~L~~~i-~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
|+|||++.+.+...+ ...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 999999997655555 4467899999999999999999999999999999999999999999999999999987643322
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCLL 261 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~ 261 (599)
.....++++.|+|||++.+. ..++.++||||+||++|||++|++||.+.+..+++..|...+|.+....+.....
T Consensus 156 ---~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 230 (286)
T d1ob3a_ 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE- 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred ---ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh-
Confidence 22455789999999998653 5679999999999999999999999999999999999999999987654322100
Q ss_pred hhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhccc
Q 007542 262 LNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLAF 341 (599)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~ 341 (599)
..++........+.+.....+.+++.+.|||++||++
T Consensus 231 -------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 267 (286)
T d1ob3a_ 231 -------------------------------------------LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKL 267 (286)
T ss_dssp -------------------------------------------STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCS
T ss_pred -------------------------------------------hhhcccccccccCcchhhhcccCCHHHHHHHHHHccC
Confidence 0001111223344555666778999999999999999
Q ss_pred CCCCCCCHHHHhcCccccC
Q 007542 342 EPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 342 DP~~RpTa~e~L~HP~f~~ 360 (599)
||++|||++|+|+||||++
T Consensus 268 dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 268 DPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTTSCCHHHHHTSGGGGC
T ss_pred ChhHCcCHHHHhcCcccCc
Confidence 9999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-54 Score=445.95 Aligned_cols=253 Identities=24% Similarity=0.437 Sum_probs=220.7
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+.+|+.++|||||++++++.+ ...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-----CCe
Confidence 57999999999999999999999999999999996432 222346778999999999999999999999954 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+|||||. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999 589999999999999999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|...-
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------- 217 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------- 217 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-------------
Confidence 245689999999999987 679999999999999999999999999988766555543210
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
. ...+.+++.+.+||.+||.
T Consensus 218 ---------------------------------------------------------~---~~p~~~s~~~~~li~~~L~ 237 (316)
T d1fota_ 218 ---------------------------------------------------------L---RFPPFFNEDVKDLLSRLIT 237 (316)
T ss_dssp ---------------------------------------------------------C---CCCTTSCHHHHHHHHHHTC
T ss_pred ---------------------------------------------------------C---CCCCCCCHHHHHHHHHHhh
Confidence 0 1124578899999999999
Q ss_pred cCCCCCC-----CHHHHhcCccccCC
Q 007542 341 FEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
.||.+|+ |++|+|+||||+++
T Consensus 238 ~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 238 RDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hCHHhccccchhhHHHHHcCcccccC
Confidence 9999996 99999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-54 Score=446.14 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=216.2
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC-hhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH-VSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~-~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.+|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+.+|+.+|+.++|||||++++++.+. ..
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CE
Confidence 5799999999999999999999999999999999754333 33456789999999999999999999999543 47
Q ss_pred EEEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|||||||.+ +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999995 6666677778899999999999999999999999999999999999999999999999999976432
Q ss_pred CCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
....+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~------------ 230 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------ 230 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------------
Confidence 1346899999999998642 2458999999999999999999999999877666554443210
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.+. .....+++.+.+||.+||
T Consensus 231 --------------------------------------------------------~~~---~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 231 --------------------------------------------------------SPA---LQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp --------------------------------------------------------CCC---CSCTTSCHHHHHHHHHHT
T ss_pred --------------------------------------------------------CCC---CCCCCCCHHHHHHHHHHC
Confidence 000 011357889999999999
Q ss_pred ccCCCCCCCHHHHhcCccccC
Q 007542 340 AFEPKDRPTAEEALADPYFKG 360 (599)
Q Consensus 340 ~~DP~~RpTa~e~L~HP~f~~ 360 (599)
+.||.+|||++|+|+||||..
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHHS
T ss_pred cCChhHCcCHHHHHhCHHhcC
Confidence 999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-54 Score=452.93 Aligned_cols=253 Identities=20% Similarity=0.365 Sum_probs=220.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+++|+.+|+.++|||||++++++.. ...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-----ccc
Confidence 68999999999999999999999999999999996422 223345678999999999999999999999944 357
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999 599999998889999999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+....+..|.....
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------ 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------ 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred -----cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC------------
Confidence 235689999999999987 6799999999999999999999999999887666555532110
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
.....+++.+.+||++||+
T Consensus 256 -------------------------------------------------------------~~p~~~s~~~~~li~~~L~ 274 (350)
T d1rdqe_ 256 -------------------------------------------------------------RFPSHFSSDLKDLLRNLLQ 274 (350)
T ss_dssp -------------------------------------------------------------CCCTTCCHHHHHHHHHHSC
T ss_pred -------------------------------------------------------------CCCccCCHHHHHHHHHHhh
Confidence 1123578999999999999
Q ss_pred cCCCCCC-----CHHHHhcCccccCC
Q 007542 341 FEPKDRP-----TAEEALADPYFKGL 361 (599)
Q Consensus 341 ~DP~~Rp-----Ta~e~L~HP~f~~~ 361 (599)
.||.+|+ |++|+|+||||+++
T Consensus 275 ~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 275 VDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp SCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hCHHhccccccccHHHHHcCccccCC
Confidence 9999995 99999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=447.81 Aligned_cols=287 Identities=36% Similarity=0.606 Sum_probs=234.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC-cCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS-RREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s-~~~~~ 100 (599)
.-+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.++||||++++++|.... ..+..
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 3479999999999999999999999999999999965322 1237999999999999999999986543 23456
Q ss_pred cEEEEEecCCccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-ceeeeccccccc
Q 007542 101 DIYVVFELMESDLHQVI----KANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARV 175 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i----~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-~lKL~DFGla~~ 175 (599)
++|||||||++++.+.+ .....+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 78999999998765554 3456799999999999999999999999999999999999999875 899999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
..... .....+||+.|+|||++.+. ..|+.++||||+||++|||++|++||.+.+..+++..|.+.+|.+..+.+
T Consensus 173 ~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGE----PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTS----CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccCCc----ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 64332 23457899999999987652 57899999999999999999999999999999999999999999999877
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCc-CCCCCCCHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS-QKFPNANPLALRL 334 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~s~~a~dL 334 (599)
....... ... .+......++. ...+..+++++||
T Consensus 248 ~~~~~~~-------~~~--------------------------------------~~~~~~~~~~~~~~~~~~s~~~~dL 282 (350)
T d1q5ka_ 248 REMNPNY-------TEF--------------------------------------KFPQIKAHPWTKVFRPRTPPEAIAL 282 (350)
T ss_dssp HHHCC----------CC--------------------------------------CCCCCCCCCGGGTSCTTSCHHHHHH
T ss_pred hhhccch-------hhc--------------------------------------cccccccCchhhhcccCCCHHHHHH
Confidence 6521100 000 01111112222 2235689999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccCCccC
Q 007542 335 LERMLAFEPKDRPTAEEALADPYFKGLAKV 364 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~HP~f~~~~~~ 364 (599)
|.+||++||.+||||.|+|+||||+++..+
T Consensus 283 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 283 CSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred HHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 999999999999999999999999988654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-53 Score=433.54 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=222.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh-------hhHHHHHHHHHHHHhcC-CCCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV-------SDATRILREIKLLRLLR-HPDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~-------~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~ 93 (599)
.++|++++.||+|+||+||+|+++.+|+.||||+++...... ...+.+.+|+.+|+.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 479999999999999999999999999999999997533221 12346889999999997 9999999999953
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
...+|||||||+ |+|.++|+..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 -----~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 82 -----NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred -----CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 457999999998 59999999988999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccc----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcC
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLG 248 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg 248 (599)
++...... ..+..+||..|+|||++.+. ...++.++||||+|||+|+|++|+.||.+.+..+.+..|.+.--
T Consensus 157 a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 157 SCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp CEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred eeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 98764322 23567899999999998531 23578899999999999999999999999887766655543110
Q ss_pred CCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCC
Q 007542 249 TPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNAN 328 (599)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s 328 (599)
.......+++|
T Consensus 233 ---------------------------------------------------------------------~~~~~~~~~~s 243 (277)
T d1phka_ 233 ---------------------------------------------------------------------QFGSPEWDDYS 243 (277)
T ss_dssp ---------------------------------------------------------------------CCCTTTGGGSC
T ss_pred ---------------------------------------------------------------------CCCCcccccCC
Confidence 01112234688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 329 PLALRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 329 ~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 244 ~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 999999999999999999999999999999853
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=443.13 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=222.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
.-+||++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+.+|+.++|||||++++++.+ ..
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~ 74 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES-----ME 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TT
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CC
Confidence 347899999999999999999999999999999999753 2344568899999999999999999999943 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC--Cceeeecccccccc
Q 007542 101 DIYVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVA 176 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~--~~lKL~DFGla~~~ 176 (599)
.+|||||||+ ++|.++|...+ .+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 7999999999 59999998765 79999999999999999999999999999999999999854 57999999999875
Q ss_pred cCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 177 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
.... .....++|+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+.+..|.+....++.
T Consensus 155 ~~~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~---- 224 (321)
T d1tkia_ 155 KPGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE---- 224 (321)
T ss_dssp CTTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH----
T ss_pred ccCC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh----
Confidence 3322 2245688999999999977 67999999999999999999999999999888777776653332222
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
..++.+|+++++||.
T Consensus 225 -----------------------------------------------------------------~~~~~~s~~~~~li~ 239 (321)
T d1tkia_ 225 -----------------------------------------------------------------EAFKEISIEAMDFVD 239 (321)
T ss_dssp -----------------------------------------------------------------HHHTTSCHHHHHHHH
T ss_pred -----------------------------------------------------------------hhccCCCHHHHHHHH
Confidence 122457889999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccCC
Q 007542 337 RMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||+.||.+|||++|+|+||||++-
T Consensus 240 ~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 240 RLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-54 Score=443.62 Aligned_cols=298 Identities=34% Similarity=0.561 Sum_probs=229.4
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc---
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR--- 96 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~--- 96 (599)
..-+||++++.||+|+||+||+|+++.+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 44689999999999999999999999999999999997654555556778899999999999999999999865321
Q ss_pred CCCccEEEEEecCCccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELMESDLHQVIK-ANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~-~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
.....+|+||||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 2235799999999976666554 445899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCC-cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... .......+||++|+|||++.+. ..|+.++||||+||++|||++|++||.+.+....+..|.+.+|.++++.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 5432211 1223456899999999998652 5789999999999999999999999999999999999999999888753
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCC--CCCCHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKF--PNANPLAL 332 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~--~~~s~~a~ 332 (599)
+.. .... .....+... ......+...+ ...++.++
T Consensus 246 ~~~-----------~~~~-------------------------------~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 282 (318)
T d3blha1 246 WPN-----------VDNY-------------------------------ELYEKLELV-KGQKRKVKDRLKAYVRDPYAL 282 (318)
T ss_dssp STT-----------CCCC--------------------------------------CC-SSCCBCHHHHHHHHHCCHHHH
T ss_pred ccc-----------cchh-------------------------------hhhhhhccc-ccccccchhhhccccCCHHHH
Confidence 322 0000 000000000 00000000000 02467899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
|||.+||++||++||||+|+|+||||+..
T Consensus 283 dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 283 DLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred HHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 99999999999999999999999999854
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-53 Score=446.56 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=212.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHH---HHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRIL---REIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~---rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
++|+++++||+|+||.||+|+++.+|+.||||++..... .......+. +|+.+++.++|||||++++++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----- 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----- 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-----
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-----
Confidence 579999999999999999999999999999999863221 111122333 44667777789999999999954
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
...+|||||||. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 357999999999 6999999998899999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ....+||+.|+|||++... ..|+.++||||||||+|+|++|+.||.+.+..+....+......
T Consensus 159 ~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-------- 224 (364)
T d1omwa3 159 KKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-------- 224 (364)
T ss_dssp SSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC--------
T ss_pred CCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------
Confidence 332 2456899999999998642 56899999999999999999999999886644433222111110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
+ ......+++.+.+||.+
T Consensus 225 -----------------------------------------------------------~---~~~~~~~s~~~~~li~~ 242 (364)
T d1omwa3 225 -----------------------------------------------------------A---VELPDSFSPELRSLLEG 242 (364)
T ss_dssp -----------------------------------------------------------C---CCCCSSSCHHHHHHHHH
T ss_pred -----------------------------------------------------------C---CCCCCCCCHHHHHHHHH
Confidence 0 11224588999999999
Q ss_pred hcccCCCCCCC-----HHHHhcCccccCC
Q 007542 338 MLAFEPKDRPT-----AEEALADPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpT-----a~e~L~HP~f~~~ 361 (599)
||+.||.+||| |+|+|+||||+++
T Consensus 243 ~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 99999999999 8999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-53 Score=430.05 Aligned_cols=287 Identities=37% Similarity=0.596 Sum_probs=237.0
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
+||+++++||+|+||+||+|+++.+|+.||||+++..........++.+|+.+|+.++||||+++++++... ..+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cce
Confidence 689999999999999999999999999999999976555556778899999999999999999999999543 478
Q ss_pred EEEEecCCc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCCC
Q 007542 103 YVVFELMES-DLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 181 (599)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~~ 181 (599)
++|++++.+ +|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999995 7777778888999999999999999999999999999999999999999999999999999987643322
Q ss_pred CcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCC-CCCCChhhHHHHHHHhcCCCCHHHHHHHhh
Q 007542 182 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPL-FPGKNVVHQLDIMTDLLGTPSPEAIARVCL 260 (599)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~p-F~g~~~~~~l~~I~~~lg~p~~e~i~~~~~ 260 (599)
......++.+|+|||++... ..++.++||||+||++|+|++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ---~~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22455788999999998762 4578999999999999999998755 788888899999999888887653322100
Q ss_pred hhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhcc
Q 007542 261 LLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERMLA 340 (599)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~ 340 (599)
.. .+. ..-............+..++.+.|||++||+
T Consensus 233 ~~-----~~~---------------------------------------~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~ 268 (292)
T d1unla_ 233 LP-----DYK---------------------------------------PYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268 (292)
T ss_dssp ST-----TCC---------------------------------------CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSC
T ss_pred cc-----ccc---------------------------------------ccccccccchhhhccccCCHHHHHHHHHHcc
Confidence 00 000 0000011223445567789999999999999
Q ss_pred cCCCCCCCHHHHhcCccccCCc
Q 007542 341 FEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 341 ~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
+||++||||+|+|+||||+++.
T Consensus 269 ~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 269 CNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp SSGGGSCCHHHHTTSGGGSSCS
T ss_pred CChhHCcCHHHHhcChhhcCCC
Confidence 9999999999999999999865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=438.47 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=218.6
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc-CChhhHHHHHHHHHHHH-hcCCCCccccceeecCCCcCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF-EHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~-~~~~~~~~i~rEi~iL~-~l~HpnIv~l~~v~~~~s~~~~~ 100 (599)
++|+++++||+|+||+||+|.++.+|+.||||++++.. ........+.+|+.++. .++|||||++++++.+ ..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-----~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-----KE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-----SS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-----CC
Confidence 57999999999999999999999999999999996422 12234556677877764 6899999999999954 35
Q ss_pred cEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 101 DIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 7999999999 599999999889999999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
. ...+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|.. +.+
T Consensus 157 ~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~--------- 220 (320)
T d1xjda_ 157 D---AKTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNP--------- 220 (320)
T ss_dssp T---CCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCC---------
T ss_pred c---ccccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCC---------
Confidence 2 22356789999999999987 6899999999999999999999999999887666555432 100
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
.....+++.+.+||++||
T Consensus 221 --------------------------------------------------------------~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 221 --------------------------------------------------------------FYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp --------------------------------------------------------------CCCTTSCHHHHHHHHHHS
T ss_pred --------------------------------------------------------------CCCccCCHHHHHHHHHhc
Confidence 011357899999999999
Q ss_pred ccCCCCCCCHH-HHhcCccccCC
Q 007542 340 AFEPKDRPTAE-EALADPYFKGL 361 (599)
Q Consensus 340 ~~DP~~RpTa~-e~L~HP~f~~~ 361 (599)
+.||.+|||++ |+++||||+++
T Consensus 239 ~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ccCCCCCcCHHHHHHhCchhccC
Confidence 99999999995 89999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-52 Score=433.18 Aligned_cols=290 Identities=29% Similarity=0.541 Sum_probs=228.2
Q ss_pred ccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCC
Q 007542 16 FTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPP 94 (599)
Q Consensus 16 ~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~ 94 (599)
..+++..++|+++++||+|+||+||+|+++.+|+.||||+++. ...+++.+|+.+|+.++ ||||+++++++...
T Consensus 28 ~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 28 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp CCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred ccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 3457788999999999999999999999999999999999964 23567889999999996 99999999998543
Q ss_pred CcCCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCC-ceeeecccc
Q 007542 95 SRREFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADC-KLKICDFGL 172 (599)
Q Consensus 95 s~~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~-~lKL~DFGl 172 (599)
....+|+||||+. ++|.++. +.+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 103 ---~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 103 ---VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp ---TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred ---CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccc
Confidence 2357999999999 4776653 4699999999999999999999999999999999999998755 699999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCC-CChhhHHHHHHHhcCCCC
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPG-KNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g-~~~~~~l~~I~~~lg~p~ 251 (599)
|+....... ....++|+.|+|||++.+. ..|+.++||||+||++++|++|+.||.. .+..++...|...+|.+.
T Consensus 177 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~ 251 (328)
T d3bqca1 177 AEFYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251 (328)
T ss_dssp CEECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred ceeccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence 987643322 3566899999999998663 5689999999999999999999988864 456778888888888765
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCC-----CcCCCCC
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIP-----FSQKFPN 326 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~ 326 (599)
...+....... .+.. +........... .......
T Consensus 252 ~~~~~~~~~~~--~~~~---------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~ 290 (328)
T d3bqca1 252 LYDYIDKYNIE--LDPR---------------------------------------FNDILGRHSRKRWERFVHSENQHL 290 (328)
T ss_dssp HHHHHHHTTCC--CCGG---------------------------------------GGGTCCCCCCCCGGGGCCTTTGGG
T ss_pred hhhhhhhcccc--cCcc---------------------------------------cchhcccccccchhhccccccccc
Confidence 54443211000 0000 000000000111 1112234
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 327 ANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 327 ~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
++++++|||++||++||++||||+|||+||||+++.
T Consensus 291 ~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 291 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 789999999999999999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=425.99 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=209.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCCh----hhHHHHHHHHHHHHhcC--CCCccccceeecCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHV----SDATRILREIKLLRLLR--HPDIVEIKHILLPP 94 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~----~~~~~i~rEi~iL~~l~--HpnIv~l~~v~~~~ 94 (599)
..++|++.++||+|+||+||+|+++.+|+.||||+++...... ....++.+|+.+|+.++ |||||++++++.+
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~- 80 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 80 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-
Confidence 3679999999999999999999999999999999996432211 12344678999999997 8999999999954
Q ss_pred CcCCCccEEEEEecCC--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC-Cceeeeccc
Q 007542 95 SRREFKDIYVVFELME--SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD-CKLKICDFG 171 (599)
Q Consensus 95 s~~~~~~lylV~E~~~--g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~-~~lKL~DFG 171 (599)
.+.+|+||||+. +++.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 81 ----~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 81 ----PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp ----SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ----CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 357999999997 3888999888899999999999999999999999999999999999999855 799999999
Q ss_pred ccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 172 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
+|+..... ..+..+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+. |.+ +
T Consensus 157 ~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~--~--- 219 (273)
T d1xwsa_ 157 SGALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--G--- 219 (273)
T ss_dssp TCEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--C---
T ss_pred cceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--c---
Confidence 99865332 23567899999999998762 3456789999999999999999999976321 100 0
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
.. ...+.+|+++
T Consensus 220 -----------------------------------------------------------------~~---~~~~~~s~~~ 231 (273)
T d1xwsa_ 220 -----------------------------------------------------------------QV---FFRQRVSSEC 231 (273)
T ss_dssp -----------------------------------------------------------------CC---CCSSCCCHHH
T ss_pred -----------------------------------------------------------------cc---CCCCCCCHHH
Confidence 00 0113578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+||++||++||++|||++|+|+||||+++
T Consensus 232 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=437.88 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=209.6
Q ss_pred CCCceEEEE-EeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHH-hcCCCCccccceeecCCCcCC
Q 007542 21 EGSRYKIEE-VIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLR-LLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~~-~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~-~l~HpnIv~l~~v~~~~s~~~ 98 (599)
.-++|++++ +||+|+||+||+|+++.+|+.||||+++. ...+.+|+.++. .++|||||+++++|.+.. ..
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cC
Confidence 346899875 69999999999999999999999999863 245678999865 458999999999985421 23
Q ss_pred CccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---CCceeeecccc
Q 007542 99 FKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGL 172 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~~~lKL~DFGl 172 (599)
...+|||||||+ |+|.++|... ..+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 357999999998 5999999875 36999999999999999999999999999999999999986 46799999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
|+....... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+.......+......
T Consensus 161 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~--- 231 (335)
T d2ozaa1 161 AKETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--- 231 (335)
T ss_dssp CEECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS---
T ss_pred eeeccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc---
Confidence 987643322 245689999999999987 67999999999999999999999999887655443333211100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
.........++.+|+++.
T Consensus 232 --------------------------------------------------------------~~~~~~~~~~~~~s~~~~ 249 (335)
T d2ozaa1 232 --------------------------------------------------------------GQYEFPNPEWSEVSEEVK 249 (335)
T ss_dssp --------------------------------------------------------------CSSSCCTTHHHHSCHHHH
T ss_pred --------------------------------------------------------------CCCCCCCcccccCCHHHH
Confidence 000000011234788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 333 RLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
+||++||+.||.+|||++|+|+||||...
T Consensus 250 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 250 MLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 99999999999999999999999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-51 Score=418.66 Aligned_cols=267 Identities=25% Similarity=0.379 Sum_probs=213.7
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++|++++.||+|+||+||+|+++.+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.... ...
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence 46899999999999999999999999999999999976443 3344568999999999999999999999986543 223
Q ss_pred ccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 100 KDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
..+||||||++ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+.....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 46899999999 59999999888999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
...........+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+.+..+...
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~------------ 229 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE------------ 229 (277)
T ss_dssp ---------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------------
T ss_pred ccccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc------------
Confidence 4333334466789999999999977 67999999999999999999999999988776655444321
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.+.+.....+++|+.+.+||.+|
T Consensus 230 ---------------------------------------------------------~~~~~~~~~~~~s~~l~~li~~~ 252 (277)
T d1o6ya_ 230 ---------------------------------------------------------DPIPPSARHEGLSADLDAVVLKA 252 (277)
T ss_dssp ---------------------------------------------------------CCCCGGGTSSSCCHHHHHHHHHH
T ss_pred ---------------------------------------------------------CCCCCchhccCCCHHHHHHHHHH
Confidence 12222334467899999999999
Q ss_pred cccCCCCCCCHHHHhcCcccc
Q 007542 339 LAFEPKDRPTAEEALADPYFK 359 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~HP~f~ 359 (599)
|+.||.+||+..+.|.|+|++
T Consensus 253 L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 253 LAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp TCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCCHhHCHhHHHHHHHHHHH
Confidence 999999999444444466653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-50 Score=408.08 Aligned_cols=255 Identities=22% Similarity=0.366 Sum_probs=205.7
Q ss_pred eEEE-EEeeecCceEEEEEEEC--CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 25 YKIE-EVIGKGSYGVVCSAYDT--RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 25 Y~i~-~~IG~G~~g~Vy~a~~~--~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
+.+. ++||+|+||+||+|.++ .+++.||||+++.........+.+.+|+.+|++++|||||++++++.. ..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SS
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CC
Confidence 3443 47999999999999864 456789999997655555556789999999999999999999999843 24
Q ss_pred EEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 102 IYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
+||||||++ |+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 789999999 6999999998899999999999999999999999999999999999999999999999999998765443
Q ss_pred CCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHHh
Q 007542 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARVC 259 (599)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~~ 259 (599)
..........||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....|.+ |
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~--~----------- 226 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--G----------- 226 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--T-----------
T ss_pred cccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--C-----------
Confidence 33323345678999999999976 679999999999999999998 8999998776554433321 0
Q ss_pred hhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHhc
Q 007542 260 LLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERML 339 (599)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~mL 339 (599)
... .....+++.+.+||.+||
T Consensus 227 --------------------------------------------------------~~~---~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 227 --------------------------------------------------------ERM---GCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --------------------------------------------------------CCC---CCCTTCCHHHHHHHHHHT
T ss_pred --------------------------------------------------------CCC---CCCcccCHHHHHHHHHHc
Confidence 001 112357889999999999
Q ss_pred ccCCCCCCCHHHH---hcCcccc
Q 007542 340 AFEPKDRPTAEEA---LADPYFK 359 (599)
Q Consensus 340 ~~DP~~RpTa~e~---L~HP~f~ 359 (599)
+.||.+|||++++ |+|+|+.
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999998 5666654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=407.67 Aligned_cols=257 Identities=24% Similarity=0.305 Sum_probs=207.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||+||+|+. +..||||+++.........+.+.+|+.+|++++|||||++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 57899999999999999999964 3469999997655556677889999999999999999999998732 35
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999999 6999999765 56999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccCccccCccccccc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ....+...||+.|+|||++.+. ...|+.++||||+||++|||++|+.||.+.+...++..+....
T Consensus 158 ~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~----------- 225 (276)
T d1uwha_ 158 SG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG----------- 225 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHT-----------
T ss_pred CC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcC-----------
Confidence 22 1223556899999999998542 1358999999999999999999999999876555443332110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.....+.....+.++.+.+||.+|
T Consensus 226 --------------------------------------------------------~~~p~~~~~~~~~~~~l~~li~~c 249 (276)
T d1uwha_ 226 --------------------------------------------------------YLSPDLSKVRSNCPKAMKRLMAEC 249 (276)
T ss_dssp --------------------------------------------------------SCCCCGGGSCTTCCHHHHHHHHHH
T ss_pred --------------------------------------------------------CCCCcchhccccchHHHHHHHHHH
Confidence 011122334456788999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|+.||.+|||++|+++|
T Consensus 250 l~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 250 LKKKRDERPLFPQILAS 266 (276)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.7e-50 Score=408.30 Aligned_cols=259 Identities=20% Similarity=0.398 Sum_probs=210.9
Q ss_pred cccCC-CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCC
Q 007542 17 TEYGE-GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPS 95 (599)
Q Consensus 17 ~~~~~-~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s 95 (599)
.+|.+ .++|++.+.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++...
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~- 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE- 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeC-
Confidence 34433 47899999999999999999999999999999999753 23456789999999999999999999999543
Q ss_pred cCCCccEEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccc
Q 007542 96 RREFKDIYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGL 172 (599)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGl 172 (599)
..+|||||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 86 ----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 86 ----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred ----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccc
Confidence 46899999999 6999999764 4789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC-CCCCCCChhhHHHHHHHhcCCCC
Q 007542 173 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~-~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
|+....... ...+...||..|+|||++.+ ..|+.++||||+||++|||++|. ++|.+.+.....+.+...
T Consensus 162 a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~----- 232 (287)
T d1opja_ 162 SRLMTGDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD----- 232 (287)
T ss_dssp TTTCCSSSS--EEETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-----
T ss_pred eeecCCCCc--eeeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-----
Confidence 987643322 22344568899999999877 68999999999999999999965 555555443322222110
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
.. .......++.+
T Consensus 233 ----------------------------------------------------------------~~---~~~~~~~~~~l 245 (287)
T d1opja_ 233 ----------------------------------------------------------------YR---MERPEGCPEKV 245 (287)
T ss_dssp ----------------------------------------------------------------CC---CCCCTTCCHHH
T ss_pred ----------------------------------------------------------------CC---CCCCccchHHH
Confidence 00 01223578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccccCC
Q 007542 332 LRLLERMLAFEPKDRPTAEEALADPYFKGL 361 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~ 361 (599)
.+||.+||+.||++|||++|+++ +|..+
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred HHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 99999999999999999999976 45543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=400.12 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=198.1
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|+++ +++.||||+++... ...+.+.+|+.+|+.++|||||++++++... ..
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~ 74 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----AP 74 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccC-----Cc
Confidence 478999999999999999999975 57789999997532 3346789999999999999999999999543 46
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred eEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCC
Confidence 899999999 6999998765 46899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... ......||..|+|||++.+ ..|+.++||||+||++|||++ |.++|.+.+....+..|.....
T Consensus 155 ~~~--~~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---------- 220 (263)
T d1sm2a_ 155 QYT--SSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 220 (263)
T ss_dssp ------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC----------
T ss_pred Cce--eecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC----------
Confidence 222 1234678999999999987 679999999999999999999 6788877766555444432110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
.. .....++.+.+||.+|
T Consensus 221 -----------------------------------------------------------~~---~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 221 -----------------------------------------------------------LY---KPRLASTHVYQIMNHC 238 (263)
T ss_dssp -----------------------------------------------------------CC---CCTTSCHHHHHHHHHH
T ss_pred -----------------------------------------------------------CC---CccccCHHHHHHHHHH
Confidence 00 0124578899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|+.||++|||++|+|+|
T Consensus 239 l~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=405.45 Aligned_cols=259 Identities=22% Similarity=0.351 Sum_probs=213.2
Q ss_pred CCCceEEEEE-eeecCceEEEEEEECC--CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEV-IGKGSYGVVCSAYDTR--TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~-IG~G~~g~Vy~a~~~~--tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.+.+|+.+|+.++|||||++++++..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----
Confidence 4467889885 9999999999998764 4557999999753 344556789999999999999999999999843
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..+|||||||+ |+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 --EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp --SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 24899999999 5999988654 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
...............||+.|+|||++.. ..++.++||||+||++|||+| |++||.+.+..+.+..|.+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-------- 228 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------- 228 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--------
T ss_pred ccccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--------
Confidence 6544333333345678999999999976 679999999999999999998 99999987765544443210
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
... ...+.+++.+.+|
T Consensus 229 -------------------------------------------------------------~~~---~~p~~~~~~l~~l 244 (285)
T d1u59a_ 229 -------------------------------------------------------------KRM---ECPPECPPELYAL 244 (285)
T ss_dssp -------------------------------------------------------------CCC---CCCTTCCHHHHHH
T ss_pred -------------------------------------------------------------CCC---CCCCcCCHHHHHH
Confidence 000 1124578899999
Q ss_pred HHHhcccCCCCCCCHHHH---hcCccccC
Q 007542 335 LERMLAFEPKDRPTAEEA---LADPYFKG 360 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~---L~HP~f~~ 360 (599)
|.+||+.||++|||+.++ |+|+|+.-
T Consensus 245 i~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999887 67888753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-49 Score=406.16 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=198.5
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCc---EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGE---KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~---~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..++|++.++||+|+||+||+|+++.+++ .||||++.... .....+.+.+|+.+|+.++|||||++++++...
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 99 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--- 99 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC---
Confidence 35789999999999999999999987765 58899886432 334557799999999999999999999999543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..+|+|||||+ |+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 100 --~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 100 --TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp --SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred --CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 46899999999 5899988874 4799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCc--ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCH
Q 007542 176 AFNDTPTA--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSP 252 (599)
Q Consensus 176 ~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~ 252 (599)
........ .......+|+.|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..|......
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--- 252 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL--- 252 (299)
T ss_dssp ------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 64332211 11223567899999999876 689999999999999999998 89999988766555444321100
Q ss_pred HHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHH
Q 007542 253 EAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLAL 332 (599)
Q Consensus 253 e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~ 332 (599)
......++.+.
T Consensus 253 ---------------------------------------------------------------------~~~~~~~~~l~ 263 (299)
T d1jpaa_ 253 ---------------------------------------------------------------------PPPMDCPSALH 263 (299)
T ss_dssp ---------------------------------------------------------------------CCCTTCCHHHH
T ss_pred ---------------------------------------------------------------------CCCccchHHHH
Confidence 01235778899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 007542 333 RLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 333 dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
+||.+||+.||.+|||+.|++++
T Consensus 264 ~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 264 QLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=403.43 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=207.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||.||+|+++ ++..||||+++... ...+.+.+|+.+|++++|||||++++++.. ..
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~ 81 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence 369999999999999999999975 67889999997532 334678999999999999999999998743 24
Q ss_pred EEEEEecCC-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAN--DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 799999999 6998877543 3699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
... ...+...||+.|+|||++.. ..|+.++||||+||++|||+| |+++|.+.+..+.+..+.+..
T Consensus 162 ~~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~---------- 227 (272)
T d1qpca_ 162 NEY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------- 227 (272)
T ss_dssp SCE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------
T ss_pred Ccc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------
Confidence 221 22345678999999999876 579999999999999999999 567777666554443332110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.. ......++.+.+||.+
T Consensus 228 -----------------------------------------------------------~~---~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 228 -----------------------------------------------------------RM---VRPDNCPEELYQLMRL 245 (272)
T ss_dssp -----------------------------------------------------------CC---CCCTTCCHHHHHHHHH
T ss_pred -----------------------------------------------------------CC---CCcccChHHHHHHHHH
Confidence 00 0113577889999999
Q ss_pred hcccCCCCCCCHHHHhc--Ccccc
Q 007542 338 MLAFEPKDRPTAEEALA--DPYFK 359 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~--HP~f~ 359 (599)
||+.||++|||++|+++ |+||.
T Consensus 246 cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 246 CWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999998 88886
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=411.76 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=206.4
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCc-----EEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGE-----KVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~-----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~ 96 (599)
++|+++++||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+.+ +|||||++++++...
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 689999999999999999999876654 69999986432 223446788999999988 899999999999543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHhhhCceEeccC
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND-----------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRDL 152 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrDL 152 (599)
..+|||||||+ |+|.++|.... .+++..++.|+.||+.||+|||++||+||||
T Consensus 114 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 114 ---GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ---CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 46899999999 69999997642 4889999999999999999999999999999
Q ss_pred CCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 007542 153 KPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLF 231 (599)
Q Consensus 153 KP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF 231 (599)
||+|||++.++.+||+|||+|+....... ........||+.|+|||++.+ ..|+.++||||+||++|||++ |++||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999987544322 222345678999999999876 689999999999999999997 89999
Q ss_pred CCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHh
Q 007542 232 PGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSS 311 (599)
Q Consensus 232 ~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~ 311 (599)
.+.+....+..+...-
T Consensus 268 ~~~~~~~~~~~~~~~~---------------------------------------------------------------- 283 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNG---------------------------------------------------------------- 283 (325)
T ss_dssp TTCCCSHHHHHHHHTT----------------------------------------------------------------
T ss_pred CCCCHHHHHHHHHhcC----------------------------------------------------------------
Confidence 9876555444332110
Q ss_pred cccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 312 MRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 312 ~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
... ......++.+.+||.+||+.||++|||++|+++|
T Consensus 284 ----~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 284 ----FKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ----CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 000 1123578899999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=416.36 Aligned_cols=264 Identities=23% Similarity=0.384 Sum_probs=215.5
Q ss_pred CceEEEEEeeecCceEEEEEEEC---CCCcEEEEEEecCcc--CChhhHHHHHHHHHHHHhcCC-CCccccceeecCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDT---RTGEKVAIKKINDIF--EHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSR 96 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~---~tg~~VAIK~i~~~~--~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~v~~~~s~ 96 (599)
++|++++.||+|+||+||+|++. .+|+.||||+++... ......+.+.+|+.+|++++| |||+++++++.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 77999999999999999999974 478999999997432 122335667899999999976 899999999844
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 101 --~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 --ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred --CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 347999999999 69999999998999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCCHHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPSPEAI 255 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~~e~i 255 (599)
...... .......|++.|+|||.+.+....++.++|||||||+||+|++|+.||.+.+..+....+....
T Consensus 179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-------- 248 (322)
T d1vzoa_ 179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------- 248 (322)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence 533221 2234568999999999986643467889999999999999999999998876554443332110
Q ss_pred HHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHH
Q 007542 256 ARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLL 335 (599)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL 335 (599)
.. . . .......++++++||
T Consensus 249 -----------------------------------------------------~~---~--~---~~~~~~~s~~~~~li 267 (322)
T d1vzoa_ 249 -----------------------------------------------------LK---S--E---PPYPQEMSALAKDLI 267 (322)
T ss_dssp -----------------------------------------------------HH---C--C---CCCCTTSCHHHHHHH
T ss_pred -----------------------------------------------------cc---C--C---CCCcccCCHHHHHHH
Confidence 00 0 0 012245789999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCccccCCc
Q 007542 336 ERMLAFEPKDRP-----TAEEALADPYFKGLA 362 (599)
Q Consensus 336 ~~mL~~DP~~Rp-----Ta~e~L~HP~f~~~~ 362 (599)
++||++||.+|| |++|+|+||||+++.
T Consensus 268 ~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 268 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 999999999999 599999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-49 Score=395.14 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=209.5
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|+++++||+|+||+||+|++ .++..||||+++... ...+.+++|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~ 73 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRP 73 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCc
Confidence 46889999999999999999998 478899999997532 234678899999999999999999999953 346
Q ss_pred EEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCC
Q 007542 102 IYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 179 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~ 179 (599)
+|+||||++ |+|.+++... ..+++..+..++.||++||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 74 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred eEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 999999998 6899887654 57999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHHH
Q 007542 180 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
... ......+|..|+|||++.+ ..|+.++||||+||++|||+| |+.||.+.+..+....|.+....
T Consensus 154 ~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~--------- 220 (258)
T d1k2pa_ 154 EYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL--------- 220 (258)
T ss_dssp SCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred Cce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 221 2244678999999999987 679999999999999999998 89999988776655544321110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
+ .....++.+.+||++|
T Consensus 221 ------------------------------------------------------------~---~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 221 ------------------------------------------------------------Y---RPHLASEKVYTIMYSC 237 (258)
T ss_dssp ------------------------------------------------------------C---CCTTCCHHHHHHHHHT
T ss_pred ------------------------------------------------------------C---CcccccHHHHHHHHHH
Confidence 0 1124678899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|+.||++|||++|+|+|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCCHhHCcCHHHHHHH
Confidence 99999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=394.63 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=198.3
Q ss_pred CceEEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
++|++++.||+|+||+||+|++..++ ..||||+++.. ........+.+|+.+|+.++|||||++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 68999999999999999999987654 56899988643 234445778999999999999999999999842
Q ss_pred ccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccccc
Q 007542 100 KDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF 177 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~ 177 (599)
..+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 35899999999 6898887654 579999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHH
Q 007542 178 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIA 256 (599)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~ 256 (599)
..... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..|.+..
T Consensus 160 ~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~--------- 226 (273)
T d1mp8a_ 160 DSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---------
T ss_pred CCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence 32221 2244578999999999976 689999999999999999998 899999887766554443210
Q ss_pred HHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHH
Q 007542 257 RVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLE 336 (599)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~ 336 (599)
. ....+++++.+.+||.
T Consensus 227 ------------------------------------------------------------~---~~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 227 ------------------------------------------------------------R---LPMPPNCPPTLYSLMT 243 (273)
T ss_dssp ------------------------------------------------------------C---CCCCTTCCHHHHHHHH
T ss_pred ------------------------------------------------------------C---CCCCCCCCHHHHHHHH
Confidence 0 0123567899999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q 007542 337 RMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 337 ~mL~~DP~~RpTa~e~L~H 355 (599)
+||+.||.+|||++|+++|
T Consensus 244 ~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 244 KCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=389.67 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=196.0
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCC----cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTG----EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg----~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
..++|++.++||+|+||.||+|.++.++ ..||||+++... .......+++|+.+|+.++|||||++++++...
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-- 81 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-- 81 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--
Confidence 3468999999999999999999987665 479999996432 334456789999999999999999999999543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+++|||||. ++|.+++... +.+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 82 ---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 ---KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp ---SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ---CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhh
Confidence 46899999999 4788877654 579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhcCCCCHH
Q 007542 175 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPE 253 (599)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG-~~pF~g~~~~~~l~~I~~~lg~p~~e 253 (599)
................||..|+|||++.+ ..|+.++||||+||++|||++| .++|.+.+....+..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------- 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG------- 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------
T ss_pred cccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-------
Confidence 76443322222334578999999999977 6899999999999999999995 5556555444333322210
Q ss_pred HHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHH
Q 007542 254 AIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALR 333 (599)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~d 333 (599)
... ....+.++.+.+
T Consensus 230 --------------------------------------------------------------~~~---~~~~~~~~~l~~ 244 (283)
T d1mqba_ 230 --------------------------------------------------------------FRL---PTPMDCPSAIYQ 244 (283)
T ss_dssp --------------------------------------------------------------CCC---CCCTTCBHHHHH
T ss_pred --------------------------------------------------------------CCC---CCchhhHHHHHH
Confidence 001 111346788999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 007542 334 LLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 334 LL~~mL~~DP~~RpTa~e~L~ 354 (599)
||.+||+.||++|||+.|+++
T Consensus 245 li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 245 LMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHCcCCHhHCcCHHHHHH
Confidence 999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=396.52 Aligned_cols=252 Identities=22% Similarity=0.355 Sum_probs=201.4
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCc----EEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGE----KVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRR 97 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~----~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~ 97 (599)
..+|+++++||+|+||+||+|.+..+|+ +||+|+++... .....+.+.+|+.+|+.++|||||++++++...
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---
Confidence 4679999999999999999999988876 58888886432 233467789999999999999999999999543
Q ss_pred CCccEEEEEecCC-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeeccccccc
Q 007542 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV 175 (599)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~ 175 (599)
..++|+|++. ++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ---~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 84 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp ---SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred ---CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 4677888877 6898887764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHH
Q 007542 176 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEA 254 (599)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~ 254 (599)
....... .......||+.|+|||++.+ ..|+.++||||+||++|||+| |.+||.+.+.......+.+..
T Consensus 161 ~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~------- 230 (317)
T d1xkka_ 161 LGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------- 230 (317)
T ss_dssp TTTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-------
T ss_pred ccccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 6433222 22234578999999999877 679999999999999999998 899998876555443332110
Q ss_pred HHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHH
Q 007542 255 IARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRL 334 (599)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dL 334 (599)
.. ...+..++.+.+|
T Consensus 231 --------------------------------------------------------------~~---~~p~~~~~~~~~l 245 (317)
T d1xkka_ 231 --------------------------------------------------------------RL---PQPPICTIDVYMI 245 (317)
T ss_dssp --------------------------------------------------------------CC---CCCTTBCHHHHHH
T ss_pred --------------------------------------------------------------CC---CCCcccCHHHHHH
Confidence 00 1123577889999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 007542 335 LERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 335 L~~mL~~DP~~RpTa~e~L~H 355 (599)
|.+||..||.+|||+.|+|+|
T Consensus 246 i~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 246 MVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCChhhCcCHHHHHHH
Confidence 999999999999999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=391.65 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=204.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++.+.||+|+||.||+|+++.+ ..||||+++... ...+.+.+|+.+|+.++|||||++++++.. ..
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~ 85 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 85 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CC
Confidence 36899999999999999999998655 579999997533 234678999999999999999999999842 24
Q ss_pred EEEEEecCC-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKA--NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+|+||||+. |+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 799999999 688887754 35799999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG-~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.... ..+...+|+.|+|||++.. ..++.++||||+|||+|||++| +++|.+.+..+.+..|.....
T Consensus 166 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------- 232 (285)
T d1fmka3 166 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 232 (285)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred CCce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 2221 2244678999999999976 6899999999999999999995 666777666555544432110
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
. ...+.+++.+.+||.+
T Consensus 233 ------------------------------------------------------------~---~~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 233 ------------------------------------------------------------M---PCPPECPESLHDLMCQ 249 (285)
T ss_dssp ------------------------------------------------------------C---CCCTTSCHHHHHHHHH
T ss_pred ------------------------------------------------------------C---CCCcccCHHHHHHHHH
Confidence 0 1224578899999999
Q ss_pred hcccCCCCCCCHHHHhc--CccccCC
Q 007542 338 MLAFEPKDRPTAEEALA--DPYFKGL 361 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~--HP~f~~~ 361 (599)
||+.||++|||++++++ |+||+..
T Consensus 250 cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 250 CWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 99999999999999988 8899765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=390.21 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=197.3
Q ss_pred CceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSR 96 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~ 96 (599)
++|+++++||+|+||.||+|.+.. +++.||||+++... .......+.+|+.++.++ +|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 689999999999999999999754 45789999987432 334456777888887776 689999999988543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv 159 (599)
...+|+|||||+ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 90 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp --TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 246899999999 6999999753 248899999999999999999999999999999999999
Q ss_pred cCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCCChhh
Q 007542 160 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVH 238 (599)
Q Consensus 160 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG-~~pF~g~~~~~ 238 (599)
+.++.+||+|||+|+....... ....+..+||+.|+|||++.+ ..|+.++||||+||++|||++| .+||.+.+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp CGGGCEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCcEEEccCcchhhcccccc-ccccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999987543322 222345689999999999977 6899999999999999999986 57888765444
Q ss_pred HHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCC
Q 007542 239 QLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI 318 (599)
Q Consensus 239 ~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~ 318 (599)
.+..+... ....
T Consensus 245 ~~~~~~~~--------------------------------------------------------------------~~~~ 256 (299)
T d1ywna1 245 EFCRRLKE--------------------------------------------------------------------GTRM 256 (299)
T ss_dssp HHHHHHHH--------------------------------------------------------------------TCCC
T ss_pred HHHHHHhc--------------------------------------------------------------------CCCC
Confidence 33222110 0000
Q ss_pred CCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 319 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 319 ~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
......++.+.+||.+||+.||.+|||++|+|+|
T Consensus 257 ---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 257 ---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1123578899999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=388.26 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=202.3
Q ss_pred cccCCCCceEEEEEeeecCceEEEEEEECC-CC--cEEEEEEecCccC-ChhhHHHHHHHHHHHHhcCCCCccccceeec
Q 007542 17 TEYGEGSRYKIEEVIGKGSYGVVCSAYDTR-TG--EKVAIKKINDIFE-HVSDATRILREIKLLRLLRHPDIVEIKHILL 92 (599)
Q Consensus 17 ~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~-tg--~~VAIK~i~~~~~-~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~ 92 (599)
|.+-..++|++++.||+|+||.||+|+... ++ ..||||+++.... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445556789999999999999999998643 33 3689999875433 3344578999999999999999999999995
Q ss_pred CCCcCCCccEEEEEecCC-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecc
Q 007542 93 PPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDF 170 (599)
Q Consensus 93 ~~s~~~~~~lylV~E~~~-g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DF 170 (599)
++ .+++||||++ ++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~------~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 82 TP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp SS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred ec------chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 32 4689999999 688887765 457999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCC
Q 007542 171 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGT 249 (599)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~ 249 (599)
|+++................++.+|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+.+..|.+.--.
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence 999987554443333455678889999999987 679999999999999999998 89999998877665554321100
Q ss_pred CCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCH
Q 007542 250 PSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANP 329 (599)
Q Consensus 250 p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~ 329 (599)
....+.+++
T Consensus 234 -----------------------------------------------------------------------~~~~~~~~~ 242 (273)
T d1u46a_ 234 -----------------------------------------------------------------------LPRPEDCPQ 242 (273)
T ss_dssp -----------------------------------------------------------------------CCCCTTCCH
T ss_pred -----------------------------------------------------------------------CCCcccccH
Confidence 012245788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 330 LALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 330 ~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.+.+||.+||+.||++|||++|+++
T Consensus 243 ~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 243 DIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-46 Score=385.08 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=206.7
Q ss_pred CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSR 96 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~ 96 (599)
.++|++++.||+|+||+||+|+++ .+++.||||+++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC--
Confidence 467999999999999999999875 356899999997432 334456799999999999999999999999543
Q ss_pred CCCccEEEEEecCC-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHhhhCceEecc
Q 007542 97 REFKDIYVVFELME-SDLHQVIKAND------------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (599)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrD 151 (599)
..+++||||+. |+|.+++.... .+++..+..|+.||+.||+|||+.||||||
T Consensus 89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 89 ---KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ---CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 46899999999 69999996532 378999999999999999999999999999
Q ss_pred CCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC-CC
Q 007542 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PL 230 (599)
Q Consensus 152 LKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~-~p 230 (599)
|||+|||++.++.+||+|||+|+....... ....+...+|+.|+|||++.+ ..|+.++||||||||+|||++|. +|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999986533221 122345678899999999987 68999999999999999999985 78
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHH
Q 007542 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS 310 (599)
Q Consensus 231 F~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~ 310 (599)
|.+.+..+.+..+.+..
T Consensus 243 ~~~~~~~e~~~~v~~~~--------------------------------------------------------------- 259 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGN--------------------------------------------------------------- 259 (301)
T ss_dssp TTTSCHHHHHHHHHTTC---------------------------------------------------------------
T ss_pred CCCCCHHHHHHHHHcCC---------------------------------------------------------------
Confidence 98877666554443210
Q ss_pred hcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 311 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 311 ~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.......+++++.+||.+||+.||++|||+.|+++
T Consensus 260 ---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 260 ---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01112357889999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=379.47 Aligned_cols=244 Identities=23% Similarity=0.389 Sum_probs=196.9
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCcc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~ 101 (599)
.++|++++.||+|+||+||+|++ +|..||||+++.. ...+.+.+|+.+|++++||||+++++++... ...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCc
Confidence 35799999999999999999987 4789999999642 3456788999999999999999999998543 235
Q ss_pred EEEEEecCC-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccC
Q 007542 102 IYVVFELME-SDLHQVIKAND--DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 178 (599)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~ 178 (599)
+||||||++ |+|.+++...+ .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 799999998 69999996543 589999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCChhhHHHHHHHhcCCCCHHHHHH
Q 007542 179 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKNVVHQLDIMTDLLGTPSPEAIAR 257 (599)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~~~~~l~~I~~~lg~p~~e~i~~ 257 (599)
.. ....+|..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+.+..|.+
T Consensus 156 ~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------ 215 (262)
T d1byga_ 156 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 215 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred CC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------
Confidence 22 33467889999999976 679999999999999999998 7999987765554433321
Q ss_pred HhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHH
Q 007542 258 VCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLER 337 (599)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~ 337 (599)
.... ...+..++.+.+||++
T Consensus 216 ---------------------------------------------------------~~~~---~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 216 ---------------------------------------------------------GYKM---DAPDGCPPAVYEVMKN 235 (262)
T ss_dssp ---------------------------------------------------------TCCC---CCCTTCCHHHHHHHHH
T ss_pred ---------------------------------------------------------CCCC---CCCccCCHHHHHHHHH
Confidence 0001 1224577899999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 007542 338 MLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 338 mL~~DP~~RpTa~e~L~H 355 (599)
||+.||.+|||+.|++++
T Consensus 236 cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcccCHhHCcCHHHHHHH
Confidence 999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=380.21 Aligned_cols=252 Identities=25% Similarity=0.416 Sum_probs=202.8
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCC-------cEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTG-------EKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg-------~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~ 93 (599)
.++|++++.||+|+||.||+|++..++ ..||||+++... .......+.+|+..+.++ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 579999999999999999999976654 479999997533 334456788999998888 79999999999954
Q ss_pred CCcCCCccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCc
Q 007542 94 PSRREFKDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKN 156 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (599)
...+|+||||++ |+|.++|... ..+++..+..++.||+.||+|||+.|||||||||+|
T Consensus 91 -----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 -----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp -----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 346899999999 6999999754 258999999999999999999999999999999999
Q ss_pred eEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCC
Q 007542 157 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPLFPGKN 235 (599)
Q Consensus 157 ILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~pF~g~~ 235 (599)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 99999999999999999876543322 22345678999999999976 689999999999999999998 799998876
Q ss_pred hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccC
Q 007542 236 VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKK 315 (599)
Q Consensus 236 ~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~ 315 (599)
....+..+.+.
T Consensus 243 ~~~~~~~i~~~--------------------------------------------------------------------- 253 (299)
T d1fgka_ 243 VEELFKLLKEG--------------------------------------------------------------------- 253 (299)
T ss_dssp HHHHHHHHHTT---------------------------------------------------------------------
T ss_pred HHHHHHHHHcC---------------------------------------------------------------------
Confidence 55433332210
Q ss_pred CCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 316 KPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 316 ~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
... .....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 254 ~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 254 HRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 000 112357889999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-45 Score=386.81 Aligned_cols=296 Identities=24% Similarity=0.332 Sum_probs=213.7
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-----------CCCcccccee
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-----------HPDIVEIKHI 90 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-----------HpnIv~l~~v 90 (599)
++||+++++||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+|+.++ |+||++++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 36799999999999999999999999999999999742 233466788999988875 4778889988
Q ss_pred ecCCCcCCCccEEEEEecCC--ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHhhh-CceEeccCCCCceEecCCCc-
Q 007542 91 LLPPSRREFKDIYVVFELME--SDLHQVIK--ANDDLTPEHYQFFLYQLLRGLKYIHT-ANVFHRDLKPKNILANADCK- 164 (599)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~--g~L~~~i~--~~~~lse~~i~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILv~~~~~- 164 (599)
+... .....++|++++. ++...... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 89 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred eeec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 7432 2234556665554 34433333 34578999999999999999999998 89999999999999987653
Q ss_pred -----eeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC----
Q 007542 165 -----LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN---- 235 (599)
Q Consensus 165 -----lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~---- 235 (599)
+||+|||.+...... ....+||+.|+|||++.. ..|+.++||||+||++++|++|+.||.+.+
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cccceeeEeecccccccccc------cccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 999999999764322 234689999999999876 679999999999999999999999997654
Q ss_pred --hhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcc
Q 007542 236 --VVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMR 313 (599)
Q Consensus 236 --~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~ 313 (599)
..+.+..+...+|.++.+.+........ +.........+... ............
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~- 293 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRT--FFNSRGLLRNISKL---------------------KFWPLEDVLTEK- 293 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHH--HBCC--CBSSCCCC---------------------CBCCHHHHHHHT-
T ss_pred cchhHHHHHHHHHhCCCCHHHhhccccccc--ccccchhhhccccc---------------------cCCchhhhcccc-
Confidence 3567788889999988876644111000 00000000000000 000000000000
Q ss_pred cCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccCCc
Q 007542 314 KKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALADPYFKGLA 362 (599)
Q Consensus 314 ~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~HP~f~~~~ 362 (599)
.......++.++|||.+||.+||.+||||+|||+||||++..
T Consensus 294 -------~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 294 -------YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp -------TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred -------cccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 011233567899999999999999999999999999999654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=381.16 Aligned_cols=257 Identities=21% Similarity=0.354 Sum_probs=210.7
Q ss_pred cccCC-CCceEEEEEeeecCceEEEEEEECC-----CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcccccee
Q 007542 17 TEYGE-GSRYKIEEVIGKGSYGVVCSAYDTR-----TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHI 90 (599)
Q Consensus 17 ~~~~~-~~rY~i~~~IG~G~~g~Vy~a~~~~-----tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v 90 (599)
.+|.+ .++|++++.||+|+||+||+|.++. ++..||||+++.. ........+.+|+.+|++++||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 44534 3899999999999999999998753 4678999999753 344455678999999999999999999999
Q ss_pred ecCCCcCCCccEEEEEecCC-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEe
Q 007542 91 LLPPSRREFKDIYVVFELME-SDLHQVIKAN----------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILA 159 (599)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~----------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv 159 (599)
+... ..+++||||+. |+|.+++... ..+++..+..++.||++||.|||+++|+||||||+|||+
T Consensus 92 ~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 92 VSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 166 (308)
T ss_dssp ECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred EecC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence 9433 46899999999 7999988642 246889999999999999999999999999999999999
Q ss_pred cCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhC-CCCCCCCChhh
Q 007542 160 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTG-KPLFPGKNVVH 238 (599)
Q Consensus 160 ~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG-~~pF~g~~~~~ 238 (599)
+.++.+||+|||+++....... ........+|+.|+|||.+.+ ..++.++||||+||++|||++| .+||.+.+...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~ 243 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred cCCceEEEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999987643322 222344578999999999977 6789999999999999999998 58898877666
Q ss_pred HHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCC
Q 007542 239 QLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPI 318 (599)
Q Consensus 239 ~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~ 318 (599)
.+..|.+..
T Consensus 244 ~~~~i~~~~----------------------------------------------------------------------- 252 (308)
T d1p4oa_ 244 VLRFVMEGG----------------------------------------------------------------------- 252 (308)
T ss_dssp HHHHHHTTC-----------------------------------------------------------------------
T ss_pred HHHHHHhCC-----------------------------------------------------------------------
Confidence 554443210
Q ss_pred CCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 319 PFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 319 ~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
.....+.+++.+.+||.+||+.||.+|||++|+|+
T Consensus 253 -~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01112356789999999999999999999999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=385.31 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=201.9
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcE--EEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCccccceeecCCCcCCC
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEK--VAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~--VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v~~~~s~~~~ 99 (599)
++|++.++||+|+||+||+|+++.+|.. ||||+++... .....+.+.+|+.+|+.+ +|||||++++++...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----- 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----
Confidence 7899999999999999999999988875 6778775322 223456789999999998 699999999999543
Q ss_pred ccEEEEEecCC-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCC
Q 007542 100 KDIYVVFELME-SDLHQVIKAN----------------DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANAD 162 (599)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~----------------~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~ 162 (599)
..+|+||||++ |+|.++|... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 47999999999 6999999754 578999999999999999999999999999999999999999
Q ss_pred CceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCC-CCCCCCChhhHHH
Q 007542 163 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGK-PLFPGKNVVHQLD 241 (599)
Q Consensus 163 ~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~-~pF~g~~~~~~l~ 241 (599)
+.+||+|||+++....... .....||..|+|||.+.+ ..|+.++||||||||+|||++|. +||.+.+..+.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEcccccccccccccc----ccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999976532221 124468999999999976 68999999999999999999964 6788776555433
Q ss_pred HHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCc
Q 007542 242 IMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFS 321 (599)
Q Consensus 242 ~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 321 (599)
.|.+ ... .
T Consensus 238 ~i~~---------------------------------------------------------------------~~~---~ 245 (309)
T d1fvra_ 238 KLPQ---------------------------------------------------------------------GYR---L 245 (309)
T ss_dssp HGGG---------------------------------------------------------------------TCC---C
T ss_pred HHHh---------------------------------------------------------------------cCC---C
Confidence 3321 000 0
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 007542 322 QKFPNANPLALRLLERMLAFEPKDRPTAEEALAD 355 (599)
Q Consensus 322 ~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~H 355 (599)
......++.+.+||.+||+.||++|||++|+|+|
T Consensus 246 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1123578899999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=379.24 Aligned_cols=266 Identities=20% Similarity=0.252 Sum_probs=206.3
Q ss_pred CCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCC
Q 007542 20 GEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREF 99 (599)
Q Consensus 20 ~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~ 99 (599)
..++||++++.||+|+||+||+|+++.+|+.||||++..... ...+.+|+.+++.++|+|++..+..+.. +.
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~ 75 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGA----EG 75 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEE----ET
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEe----cC
Confidence 457899999999999999999999999999999998865322 2346789999999998877766655532 33
Q ss_pred ccEEEEEecCCccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC---CCceeeeccccccc
Q 007542 100 KDIYVVFELMESDLHQVIKA-NDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARV 175 (599)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~---~~~lKL~DFGla~~ 175 (599)
...++||||++++|.+.+.. .+.+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.
T Consensus 76 ~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 76 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 57899999999988887765 457999999999999999999999999999999999999764 45799999999987
Q ss_pred ccCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCCC
Q 007542 176 AFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTPS 251 (599)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p~ 251 (599)
........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~--- 230 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 230 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---
Confidence 65432211 12345689999999999987 6799999999999999999999999988665443322211000
Q ss_pred HHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHH
Q 007542 252 PEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLA 331 (599)
Q Consensus 252 ~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a 331 (599)
.....+.....+++++++
T Consensus 231 --------------------------------------------------------------~~~~~~~~~~~~~~p~~~ 248 (299)
T d1ckia_ 231 --------------------------------------------------------------KKMSTPIEVLCKGYPSEF 248 (299)
T ss_dssp --------------------------------------------------------------HHHHSCHHHHTTTSCHHH
T ss_pred --------------------------------------------------------------ccCCCChhHhccCCCHHH
Confidence 000011122335678899
Q ss_pred HHHHHHhcccCCCCCCCHH---HHhcCccccC
Q 007542 332 LRLLERMLAFEPKDRPTAE---EALADPYFKG 360 (599)
Q Consensus 332 ~dLL~~mL~~DP~~RpTa~---e~L~HP~f~~ 360 (599)
.+||.+||+.||.+||+++ ++|+|+|.+.
T Consensus 249 ~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 249 ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 9999999999999999987 4577877654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=378.43 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=210.9
Q ss_pred ccCC-CCceEEEEEeeecCceEEEEEEEC-----CCCcEEEEEEecCccCChhhHHHHHHHHHHHHhc-CCCCcccccee
Q 007542 18 EYGE-GSRYKIEEVIGKGSYGVVCSAYDT-----RTGEKVAIKKINDIFEHVSDATRILREIKLLRLL-RHPDIVEIKHI 90 (599)
Q Consensus 18 ~~~~-~~rY~i~~~IG~G~~g~Vy~a~~~-----~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l-~HpnIv~l~~v 90 (599)
.|.. .++|++.++||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+++.+ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4433 489999999999999999999863 567899999997533 345566789999999999 69999999999
Q ss_pred ecCCCcCCCccEEEEEecCC-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHhhhCceEecc
Q 007542 91 LLPPSRREFKDIYVVFELME-SDLHQVIKAND------------------DLTPEHYQFFLYQLLRGLKYIHTANVFHRD 151 (599)
Q Consensus 91 ~~~~s~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~lse~~i~~i~~QIl~aL~yLHs~gIvHrD 151 (599)
+... ..+|||||||+ |+|.+++.... .+++..+..++.||+.||+|||++||+|||
T Consensus 96 ~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD 170 (311)
T d1t46a_ 96 CTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (311)
T ss_dssp ECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9543 46899999999 69999987543 589999999999999999999999999999
Q ss_pred CCCCceEecCCCceeeecccccccccCCCCCcccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHh-CCCC
Q 007542 152 LKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLT-GKPL 230 (599)
Q Consensus 152 LKP~NILv~~~~~lKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLlt-G~~p 230 (599)
|||+|||++.++.+||+|||+++....... ....+..+||+.|+|||++.. ..++.++|||||||++|||++ |.++
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~ 247 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSP 247 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccccccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCC
Confidence 999999999999999999999987644332 233456789999999999976 679999999999999999998 7888
Q ss_pred CCCCChhhHHHHHHHhcCCCCHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHH
Q 007542 231 FPGKNVVHQLDIMTDLLGTPSPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLS 310 (599)
Q Consensus 231 F~g~~~~~~l~~I~~~lg~p~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~ 310 (599)
|.+.+....+..+.+.-
T Consensus 248 ~~~~~~~~~~~~~i~~~--------------------------------------------------------------- 264 (311)
T d1t46a_ 248 YPGMPVDSKFYKMIKEG--------------------------------------------------------------- 264 (311)
T ss_dssp STTCCSSHHHHHHHHHT---------------------------------------------------------------
T ss_pred CCCCCHHHHHHHHHhcC---------------------------------------------------------------
Confidence 88776655444333210
Q ss_pred hcccCCCCCCcCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 007542 311 SMRKKKPIPFSQKFPNANPLALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 311 ~~~~~~~~~~~~~~~~~s~~a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
++. ......++.+.+||.+||+.||++|||++|+|+
T Consensus 265 -~~~-------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 265 -FRM-------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp -CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCC-------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000 011346788999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=371.03 Aligned_cols=251 Identities=22% Similarity=0.323 Sum_probs=198.2
Q ss_pred EEEEEeeecCceEEEEEEECCCC---cEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCccccceeecCCCcCCCccE
Q 007542 26 KIEEVIGKGSYGVVCSAYDTRTG---EKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFKDI 102 (599)
Q Consensus 26 ~i~~~IG~G~~g~Vy~a~~~~tg---~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv~l~~v~~~~s~~~~~~l 102 (599)
.+.++||+|+||+||+|++..++ ..||||+++. .......+++.+|+.+|++++||||+++++++... ...+
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence 44689999999999999987654 3699999974 23455678899999999999999999999997532 2468
Q ss_pred EEEEecCC-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeeecccccccccCCC
Q 007542 103 YVVFELME-SDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180 (599)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~DFGla~~~~~~~ 180 (599)
++|||||+ ++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999 68999887543 67788899999999999999999999999999999999999999999999998764432
Q ss_pred CC-cccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCC-hhhHHHHHHHhcCCCCHHHHHHH
Q 007542 181 PT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKN-VVHQLDIMTDLLGTPSPEAIARV 258 (599)
Q Consensus 181 ~~-~~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~-~~~~l~~I~~~lg~p~~e~i~~~ 258 (599)
.. ........||..|+|||++.. ..++.++|||||||++|||++|..||.... ..+....+..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~------------- 249 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-------------
T ss_pred cccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence 22 122345678999999999876 679999999999999999999766665432 2111111110
Q ss_pred hhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHHHHHHHHHh
Q 007542 259 CLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPLALRLLERM 338 (599)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~a~dLL~~m 338 (599)
..... ..+..++.+.+||.+|
T Consensus 250 --------------------------------------------------------g~~~~---~p~~~~~~l~~li~~c 270 (311)
T d1r0pa_ 250 --------------------------------------------------------GRRLL---QPEYCPDPLYEVMLKC 270 (311)
T ss_dssp --------------------------------------------------------TCCCC---CCTTCCHHHHHHHHHH
T ss_pred --------------------------------------------------------CCCCC---CcccCcHHHHHHHHHH
Confidence 00000 1134678899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 007542 339 LAFEPKDRPTAEEALAD 355 (599)
Q Consensus 339 L~~DP~~RpTa~e~L~H 355 (599)
|+.||++|||+.|+++|
T Consensus 271 l~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 271 WHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-43 Score=363.46 Aligned_cols=257 Identities=18% Similarity=0.244 Sum_probs=205.6
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCC-CCccccceeecCCCcCCCc
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRH-PDIVEIKHILLPPSRREFK 100 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~H-pnIv~l~~v~~~~s~~~~~ 100 (599)
+++|+++++||+|+||+||+|+++.+|+.||||+++... ....+.+|+++++.++| +|++.+++++. ...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCC
Confidence 579999999999999999999999999999999886432 22346689999999975 89999998874 335
Q ss_pred cEEEEEecCCccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecC-----CCceeeecccccc
Q 007542 101 DIYVVFELMESDLHQVIKAND-DLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANA-----DCKLKICDFGLAR 174 (599)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~-----~~~lKL~DFGla~ 174 (599)
..|+||||++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 789999999999999997754 7999999999999999999999999999999999999974 5789999999998
Q ss_pred cccCCCCCc----ccccccccCccccCccccccccCCCCcchhhHhHHHHHHHHHhCCCCCCCCChhhHHHHHHHhcCCC
Q 007542 175 VAFNDTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIMTDLLGTP 250 (599)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~s~~~DIWSlG~Il~eLltG~~pF~g~~~~~~l~~I~~~lg~p 250 (599)
......... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~-- 230 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-- 230 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH--
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh--
Confidence 764332211 12345689999999999987 6799999999999999999999999987654433222211000
Q ss_pred CHHHHHHHhhhhhhhhcCCCCCcccCCCccchhhhhhhhhHHHHHHhhhcccHHHHHHHHhcccCCCCCCcCCCCCCCHH
Q 007542 251 SPEAIARVCLLLNIIWCGYDGFMCSVAPSCFLVFAIFFFFTEVLILHCQVRNEKARRYLSSMRKKKPIPFSQKFPNANPL 330 (599)
Q Consensus 251 ~~e~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~s~~ 330 (599)
. ....+..+..++++++
T Consensus 231 ----------------------------------------------------~-----------~~~~~~~~l~~~~p~~ 247 (293)
T d1csna_ 231 ----------------------------------------------------K-----------KQSTPLRELCAGFPEE 247 (293)
T ss_dssp ----------------------------------------------------H-----------HHHSCHHHHTTTSCHH
T ss_pred ----------------------------------------------------c-----------cCCCChHHhcCCCCHH
Confidence 0 0001112233567888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 007542 331 ALRLLERMLAFEPKDRPTAEEALA 354 (599)
Q Consensus 331 a~dLL~~mL~~DP~~RpTa~e~L~ 354 (599)
+.+||..|+..+|.+||+.+.+.+
T Consensus 248 l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 248 FYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCcccCcCHHHHHH
Confidence 999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=374.27 Aligned_cols=205 Identities=26% Similarity=0.322 Sum_probs=165.9
Q ss_pred CCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHH--HHHHHHHhcCCCCccccceeecCCCcCC
Q 007542 21 EGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRIL--REIKLLRLLRHPDIVEIKHILLPPSRRE 98 (599)
Q Consensus 21 ~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~--rEi~iL~~l~HpnIv~l~~v~~~~s~~~ 98 (599)
++.+|.+.+.||+|+||.||+|++ +|+.||||+++.. ...... +|+..+..++||||+++++++.... ..
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~ 72 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT 72 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Cc
Confidence 357899999999999999999975 6899999998642 223333 4555556789999999999996543 23
Q ss_pred CccEEEEEecCC-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhh--------CceEeccCCCCceEecCCCceeeec
Q 007542 99 FKDIYVVFELME-SDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHT--------ANVFHRDLKPKNILANADCKLKICD 169 (599)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs--------~gIvHrDLKP~NILv~~~~~lKL~D 169 (599)
...+|+|||||. |+|.+++++. .+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 346899999998 6999999875 69999999999999999999996 5999999999999999999999999
Q ss_pred ccccccccCCCCCc-ccccccccCccccCccccccccC----CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 007542 170 FGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAELLTGKPLFPGK 234 (599)
Q Consensus 170 FGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~----~~s~~~DIWSlG~Il~eLltG~~pF~g~ 234 (599)
||+++......... ......+||+.|+|||++.+... .++.++|||||||+||||++|.++|...
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 99998765433221 22345789999999999865211 2677899999999999999999887543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=2.5e-24 Score=205.23 Aligned_cols=168 Identities=18% Similarity=0.124 Sum_probs=121.0
Q ss_pred eEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCC----------------hhhHHHHHHHHHHHHhcCCCCccccc
Q 007542 25 YKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEH----------------VSDATRILREIKLLRLLRHPDIVEIK 88 (599)
Q Consensus 25 Y~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~----------------~~~~~~i~rEi~iL~~l~HpnIv~l~ 88 (599)
|.+.++||+|+||+||+|++. +|+.||||+++..... ......+.+|+..|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999984 7899999987531110 01123455788999999999999887
Q ss_pred eeecCCCcCCCccEEEEEecCCccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHhhhCceEeccCCCCceEecCCCceeee
Q 007542 89 HILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKIC 168 (599)
Q Consensus 89 ~v~~~~s~~~~~~lylV~E~~~g~L~~~i~~~~~lse~~i~~i~~QIl~aL~yLHs~gIvHrDLKP~NILv~~~~~lKL~ 168 (599)
+.. ..++||||+++... ..+++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+
T Consensus 81 ~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred Eec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 654 12799999997322 125566778899999999999999999999999999999865 58999
Q ss_pred cccccccccCCCCCcccccccccCccccCc--ccccc-ccCCCCcchhhHhHHHH
Q 007542 169 DFGLARVAFNDTPTAIFWTDYVATRWYRAP--ELCGS-FFSKYTPAIDIWSIGCI 220 (599)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~AP--E~l~~-~~~~~s~~~DIWSlG~I 220 (599)
|||+|........ ..|... +.+.. +...|+..+|+||+.--
T Consensus 145 DFG~a~~~~~~~~-----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGW-----------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTH-----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCc-----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 9999976432211 011111 00000 11468889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.15 E-value=3.9e-06 Score=80.85 Aligned_cols=83 Identities=11% Similarity=0.070 Sum_probs=53.8
Q ss_pred CceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcC-CCCccccceeecCCCcCCCcc
Q 007542 23 SRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLR-HPDIVEIKHILLPPSRREFKD 101 (599)
Q Consensus 23 ~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~-HpnIv~l~~v~~~~s~~~~~~ 101 (599)
..|++.+..+-++.+.||+.. .++..++||+...... .....+.+|...|+.+. +--+.+++.+.. ..+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEe-----cCCc
Confidence 467777766555667899874 5677788998754322 12335678999988875 323455555542 2246
Q ss_pred EEEEEecCCc-cHH
Q 007542 102 IYVVFELMES-DLH 114 (599)
Q Consensus 102 lylV~E~~~g-~L~ 114 (599)
.|+||++++| .+.
T Consensus 85 ~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 85 SNLLMSEADGVLCS 98 (263)
T ss_dssp EEEEEECCSSEEHH
T ss_pred eEEEEEeccccccc
Confidence 7999999997 443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.71 E-value=6.4e-05 Score=77.29 Aligned_cols=82 Identities=21% Similarity=0.143 Sum_probs=48.3
Q ss_pred CCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCcc----C-ChhhHHHHHHHHHHHHhcC-C-C-CccccceeecC
Q 007542 22 GSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIF----E-HVSDATRILREIKLLRLLR-H-P-DIVEIKHILLP 93 (599)
Q Consensus 22 ~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~----~-~~~~~~~i~rEi~iL~~l~-H-p-nIv~l~~v~~~ 93 (599)
....+ .+.||.|....||++.+..+++.|+||.-.... . ......+..+|...|+.+. + | .+.+++.+.
T Consensus 26 ~~~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-- 102 (392)
T d2pula1 26 KSTLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-- 102 (392)
T ss_dssp --CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--
T ss_pred CCCee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--
Confidence 33444 456899999999999887788899999643211 1 1123456678998888773 2 2 233444332
Q ss_pred CCcCCCccEEEEEecCCc
Q 007542 94 PSRREFKDIYVVFELMES 111 (599)
Q Consensus 94 ~s~~~~~~lylV~E~~~g 111 (599)
. ..-++|||++++
T Consensus 103 ~-----~~~~lvmE~L~~ 115 (392)
T d2pula1 103 T-----EMAVTVMEDLSH 115 (392)
T ss_dssp T-----TTTEEEECCCTT
T ss_pred C-----CCCEEEEeccCC
Confidence 1 123789999985
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.27 E-value=0.00032 Score=66.48 Aligned_cols=71 Identities=8% Similarity=0.010 Sum_probs=45.2
Q ss_pred EeeecCc-eEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCC--ccccceeecCCCcCCCccEEEEE
Q 007542 30 VIGKGSY-GVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPD--IVEIKHILLPPSRREFKDIYVVF 106 (599)
Q Consensus 30 ~IG~G~~-g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~Hpn--Iv~l~~v~~~~s~~~~~~lylV~ 106 (599)
.+..|.. +.||+.. ..++..+++|..... ....+.+|...|+.+.... +.+++.+..+ .+..|+||
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEE
Confidence 4455554 6789886 356777888876432 2234668888888775333 4455555432 24679999
Q ss_pred ecCCc
Q 007542 107 ELMES 111 (599)
Q Consensus 107 E~~~g 111 (599)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.67 E-value=0.0035 Score=61.91 Aligned_cols=72 Identities=14% Similarity=0.034 Sum_probs=43.7
Q ss_pred ceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCc--cccceeecCCCcCCCccEEEEEecCCc
Q 007542 36 YGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDI--VEIKHILLPPSRREFKDIYVVFELMES 111 (599)
Q Consensus 36 ~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnI--v~l~~v~~~~s~~~~~~lylV~E~~~g 111 (599)
--.||++.. .+|..|++|+.... ....+.+..|+..|..|...+| +..+..--..........+.|+++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 457999864 57889999987532 2235667889999988863332 222111101111223467889999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.24 E-value=0.0049 Score=60.21 Aligned_cols=153 Identities=14% Similarity=0.086 Sum_probs=77.4
Q ss_pred cccccCCCCceEEEEEeeecCceEEEEEEECCCCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc--ccceeec
Q 007542 15 FFTEYGEGSRYKIEEVIGKGSYGVVCSAYDTRTGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV--EIKHILL 92 (599)
Q Consensus 15 ~~~~~~~~~rY~i~~~IG~G~~g~Vy~a~~~~tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv--~l~~v~~ 92 (599)
++..|+.+ ...-.+.|..|---+.|+... ++..+++|++... .....+..|+.+|..|...++. ..+....
T Consensus 11 ~l~~Y~lg-~~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~----~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 11 FLTQYDVG-SLTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HHTTBCCC-CEEEEEEECC---EEEEEEEE--SSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHhCCCC-CceEeecCCCCcccCeEEEEE--CCCcEEEEEcCCC----CCHHHHHHHHHHHHhhhhccccccccceecC
Confidence 45566664 455566777888788898854 3345899987532 2234556788888887533322 1111000
Q ss_pred CCC-cCCCccEEEEEecCCc------cH------HHHH---Hh-CC--------CCC------------------HHHHH
Q 007542 93 PPS-RREFKDIYVVFELMES------DL------HQVI---KA-ND--------DLT------------------PEHYQ 129 (599)
Q Consensus 93 ~~s-~~~~~~lylV~E~~~g------~L------~~~i---~~-~~--------~ls------------------e~~i~ 129 (599)
... ..-....+.++.++.+ +. ...+ .. .. ... .....
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 000 0001234455555543 10 0000 00 00 000 01112
Q ss_pred HHHHHHHHHHHHhhh----CceEeccCCCCceEecCCCceeeecccccc
Q 007542 130 FFLYQLLRGLKYIHT----ANVFHRDLKPKNILANADCKLKICDFGLAR 174 (599)
Q Consensus 130 ~i~~QIl~aL~yLHs----~gIvHrDLKP~NILv~~~~~lKL~DFGla~ 174 (599)
..+..+...+...+. .||||+|+.++||+++.+...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 223333333333332 479999999999999988777899999773
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.83 E-value=0.021 Score=57.66 Aligned_cols=74 Identities=14% Similarity=0.128 Sum_probs=48.5
Q ss_pred ceEEEEEeeecCceEEEEEEECC-------CCcEEEEEEecCccCChhhHHHHHHHHHHHHhcCCCCcc-ccceeecCCC
Q 007542 24 RYKIEEVIGKGSYGVVCSAYDTR-------TGEKVAIKKINDIFEHVSDATRILREIKLLRLLRHPDIV-EIKHILLPPS 95 (599)
Q Consensus 24 rY~i~~~IG~G~~g~Vy~a~~~~-------tg~~VAIK~i~~~~~~~~~~~~i~rEi~iL~~l~HpnIv-~l~~v~~~~s 95 (599)
..+ ++.|+.|-.-.+|++.... ..+.|.+++... ........+|..+++.+.-.+++ +++.++.
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--- 115 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----PETESHLVAESVIFTLLSERHLGPKLYGIFS--- 115 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET---
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC----cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC---
Confidence 344 4678888889999987643 345677776542 12233456899999988633444 6666652
Q ss_pred cCCCccEEEEEecCCc
Q 007542 96 RREFKDIYVVFELMES 111 (599)
Q Consensus 96 ~~~~~~lylV~E~~~g 111 (599)
+ .+|+||++|
T Consensus 116 --~----g~I~efi~g 125 (395)
T d1nw1a_ 116 --G----GRLEEYIPS 125 (395)
T ss_dssp --T----EEEECCCCE
T ss_pred --C----ceEEEEecc
Confidence 1 578999985
|